
<html lang="en"     class="pb-page"  data-request-id="388b05b2-5f39-4a54-8e62-c60d865ebfda"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.0c00352;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-19;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges" /></meta><meta name="dc.Creator" content="Pauline  Zipfel" /></meta><meta name="dc.Creator" content="Christophe  Rochais" /></meta><meta name="dc.Creator" content="Kévin  Baranger" /></meta><meta name="dc.Creator" content="Santiago  Rivera" /></meta><meta name="dc.Creator" content="Patrick  Dallemagne" /></meta><meta name="dc.Description" content="Although matrix metalloproteinases (MMPs) are implicated in the regulation of numerous physiological processes, evidence of their pathological roles have also been obtained in the last decades, mak..." /></meta><meta name="Description" content="Although matrix metalloproteinases (MMPs) are implicated in the regulation of numerous physiological processes, evidence of their pathological roles have also been obtained in the last decades, mak..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 27, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00352" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00352" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00352" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00352" /></link>
        
    
    

<title>Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00352" /></meta><meta property="og:title" content="Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0012.jpeg" /></meta><meta property="og:description" content="Although matrix metalloproteinases (MMPs) are implicated in the regulation of numerous physiological processes, evidence of their pathological roles have also been obtained in the last decades, making MMPs attractive therapeutic targets for several diseases. Recent discoveries of their involvement in central nervous system (CNS) disorders, and in particular in Alzheimer’s disease (AD), have paved the way to consider MMP modulators as promising therapeutic strategies. Over the past few decades, diverse approaches have been undertaken in the design of therapeutic agents targeting MMPs for various purposes, leading, more recently, to encouraging developments. In this article, we will present recent examples of inhibitors ranging from small molecules and peptidomimetics to biologics. We will also discuss the scientific knowledge that has led to the development of emerging tools and techniques to overcome the challenges of selective MMP inhibition." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00352"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00352">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00352&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00352&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00352&amp;href=/doi/10.1021/acs.jmedchem.0c00352" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 10705-10725</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00345" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00507" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Pauline Zipfel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pauline Zipfel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Normandie Univ, UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie), F-14032 Caen, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pauline++Zipfel">Pauline Zipfel</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christophe Rochais</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christophe Rochais</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Normandie Univ, UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie), F-14032 Caen, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christophe++Rochais">Christophe Rochais</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7996-2082" title="Orcid link">http://orcid.org/0000-0001-7996-2082</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kévin Baranger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kévin Baranger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=K%C3%A9vin++Baranger">Kévin Baranger</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Santiago Rivera</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Santiago Rivera</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Santiago++Rivera">Santiago Rivera</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Patrick Dallemagne</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick Dallemagne</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Normandie Univ, UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le Médicament de Normandie), F-14032 Caen, France</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +33-231566813. Email: <a href="/cdn-cgi/l/email-protection#a5d5c4d1d7ccc6ce8bc1c4c9c9c0c8c4c2cbc0e5d0cbccc6c4c0cb8bc3d7"><span class="__cf_email__" data-cfemail="d2a2b3a6a0bbb1b9fcb6b3bebeb7bfb3b5bcb792a7bcbbb1b3b7bcfcb4a0">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Dallemagne">Patrick Dallemagne</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4845-615X" title="Orcid link">http://orcid.org/0000-0002-4845-615X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00352&amp;href=/doi/10.1021%2Facs.jmedchem.0c00352" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 10705–10725</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 27, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 February 2020</li><li><span class="item_label"><b>Published</b> online</span>27 May 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 October 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00352" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00352</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10705%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPauline%2BZipfel%252C%2BChristophe%2BRochais%252C%2BK%25C3%25A9vin%2BBaranger%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D19%26contentID%3Dacs.jmedchem.0c00352%26title%3DMatrix%2BMetalloproteinases%2Bas%2BNew%2BTargets%2Bin%2BAlzheimer%25E2%2580%2599s%2BDisease%253A%2BOpportunities%2Band%2BChallenges%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10725%26publicationDate%3DOctober%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00352"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2063</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">9</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00352" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Pauline&quot;,&quot;last_name&quot;:&quot;Zipfel&quot;},{&quot;first_name&quot;:&quot;Christophe&quot;,&quot;last_name&quot;:&quot;Rochais&quot;},{&quot;first_name&quot;:&quot;Kévin&quot;,&quot;last_name&quot;:&quot;Baranger&quot;},{&quot;first_name&quot;:&quot;Santiago&quot;,&quot;last_name&quot;:&quot;Rivera&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Dallemagne&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;10705-10725&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00352&quot;},&quot;abstract&quot;:&quot;Although matrix metalloproteinases (MMPs) are implicated in the regulation of numerous physiological processes, evidence of their pathological roles have also been obtained in the last decades, making MMPs attractive therapeutic targets for several diseases. Recent discoveries of their involvement in central nervous system (CNS) disorders, and in particular in Alzheimer’s disease (AD), have paved the way to consider MMP modulators as promising therapeutic strategies. Over the past few decades, diverse approaches have been undertaken in the design of therapeutic agents targeting MMPs for various purposes, leading, more recently, to encouraging developments. In this article, we will present recent examples of inhibitors ranging from small molecules and peptidomimetics to biologics. We will also discuss the scientific knowledge that has led to the development of emerging tools and techniques to overcome the challenges of selective MMP inhibition.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00352&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00352" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00352&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00352" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00352&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00352" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00352&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00352&amp;href=/doi/10.1021/acs.jmedchem.0c00352" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00352" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00352" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00352%26sid%3Dliteratum%253Aachs%26pmid%3D32459966%26genre%3Darticle%26aulast%3DZipfel%26date%3D2020%26atitle%3DMatrix%2BMetalloproteinases%2Bas%2BNew%2BTargets%2Bin%2BAlzheimer%25E2%2580%2599s%2BDisease%253A%2BOpportunities%2Band%2BChallenges%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D19%26spage%3D10705%26epage%3D10725%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=290729" title="Nervous system diseases">Nervous system diseases</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/jmcmar.2020.63.issue-19/20201008/jmcmar.2020.63.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Although matrix metalloproteinases (MMPs) are implicated in the regulation of numerous physiological processes, evidence of their pathological roles have also been obtained in the last decades, making MMPs attractive therapeutic targets for several diseases. Recent discoveries of their involvement in central nervous system (CNS) disorders, and in particular in Alzheimer’s disease (AD), have paved the way to consider MMP modulators as promising therapeutic strategies. Over the past few decades, diverse approaches have been undertaken in the design of therapeutic agents targeting MMPs for various purposes, leading, more recently, to encouraging developments. In this article, we will present recent examples of inhibitors ranging from small molecules and peptidomimetics to biologics. We will also discuss the scientific knowledge that has led to the development of emerging tools and techniques to overcome the challenges of selective MMP inhibition.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction: General Remarks about Alzheimer’s Disease Nowadays</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD), the most common form of dementia (∼70%) in the elderly, is a chronic and neurodegenerative brain disorder characterized by memory loss and other cognitive impairments. In 2018, the number of people living with dementia in the world was estimated at 50 million and this number will likely more than triple to 152 million by 2050.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> With only four drugs approved (Donepezil, Galantamine, Rivastigmine, and Memantine) to barely relieve the symptoms of AD, finding a cure, or at least a treatment that delays the progression of the disease, remains a real challenge for the community. Because of the heavy economic and societal impacts, there is an urgent need to find new treatments that target the molecular causes of the neurodegenerative process. During the past three decades, scientists have debated about the true molecular causes of the disease, but these remain elusive to this day. Two abnormal aggregates of β-amyloid peptide (Aβ) and hyperphosphorylated Tau protein, respectively, constitute what has been considered for many years the main pathological features of AD: extracellular amyloid plaques (also known as senile plaques) and intracellular neurofibrillary tangles. Other pathophysiological disturbances in AD have also been pointed out, such as alterations in cholinergic and glutamatergic neurotransmission, neuroinflammation, oxidative stress, and mitochondrial dysfunctions. In 2020, it is still unclear how these interconnected events influence each other, why they become damaging over time, or what is their exact chronology. Thus, ongoing experimental and clinical research continues to expand knowledge of potential new biological targets involved in the pathogenesis of AD.</div><div class="NLM_p last">In this context, matrix metalloproteinases (MMPs) have been recently highlighted in the literature as potential new relevant biological targets in AD. In this paper, we will review the pathophysiological activities of MMPs in the central nervous system (CNS) in general and more specifically in AD. We will then focus our attention on the challenges to be addressed when targeting MMPs and discuss the different strategies and their evolution for the design of therapeutic agents that modulate their activities.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Description of the Matrix Metalloproteinase Family</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60861" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60861" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">MMPs, also known as matrixins, form a family of endopeptidases characterized by the presence of a zinc cation stabilized by interactions with three histidine residues in their catalytic site. They belong to the larger metzincin superfamily of metalloproteinases and are present in most tissues of the body. To date, there are more than 20 MMPs described in humans (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). They are classified according to their abilities to cleave substrates (initially discovered) in collagenases, gelatinases, and matrilysins, and according to the localization (stroma) where they were first identified for stromelysins. Most MMPs are secreted, but a group of six proteinases bound to the membrane are referred to as membrane-type MMPs (MT-MMPs). Finally, a more heterogeneous group is often classified as “others”.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. MMPs Classification in Humans, Adapted from ref <a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and in Accordance with UniProt Database (www.uniprot.org)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">class</th><th class="colsep0 rowsep0" align="center">numbering</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">collagenases</td><td class="colsep0 rowsep0">MMP-1, MMP-8, MMP-13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">gelatinases</td><td class="colsep0 rowsep0">MMP-2, MMP-9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stromelysins</td><td class="colsep0 rowsep0">MMP-3, MMP-10, MMP-11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">matrilysins</td><td class="colsep0 rowsep0">MMP-7, MMP-26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MT-MMP (membrane type)</td><td class="colsep0 rowsep0">MMP-14 (MT1-MMP), MMP-15 (MT2-MMP), MMP-16 (MT3-MMP), MMP-17 (MT4-MMP), MMP-24 (MT5-MMP), MMP-25 (MT6-MMP)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">others</td><td class="colsep0 rowsep0">MMP-12, MMP-19, MMP-20, MMP-21, MMP-23, MMP-27, MMP-28</td></tr></tbody></table></div></div><div class="NLM_p">All of these MMPs are synthesized with a common N-terminal signal sequence, which is then cleaved in the endoplasmic reticulum to form the latent proenzymes. MMPs are made up of at least two domains, which are the pro-domain (containing the so-called “cysteine-switch” sequence motif, Pro-Arg-Cys-Gly-Xxx-Pro-Asp, except for MMP-23) and the zinc-containing catalytic domain. The cysteine residue of the pro-domain binds to the catalytic zinc as the fourth ligand in tetrahedral coordination sphere and thus keeps MMPs in their inactive form. Class-specific domains complete their structure (hemopexin-like domain, hinge region, collagen-binding domain, membrane anchored domain,...).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> These proMMPs, also called zymogens, are activated by different mechanisms and subsequently either secreted in the extracellular space or attached to the cell membrane, although new intracellular MMP activities have also been reported.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The activation step includes most of the time the “cysteine switch” event, consisting in successive cleavages inside the pro-domain by trypsin, plasmin, or other MMPs, which results in the release of the pro-domain and the disruption of the Cys–Zinc interaction. Other activation mechanisms have been reported, including the formation of complexes between proMMPs and endogenous tissue inhibitors of MMPs (TIMPs), as well as furin cleavage in the trans-Golgi network.<a onclick="showRef(event, 'ref3 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref6">(3,6)</a></div><div class="NLM_p">MMPs are involved in the proteolysis of extracellular matrix components, in addition to a large number of nonmatrix substrates such as growth factors, cytokines, chemokines, and cell surface proteins receptors, to name just a few, which may become activated or inactivated. Thus, depending on their localization and their substrate specificity, MMPs have physiological functions involved in homeostatic processes such as development, morphogenesis, and tissue reorganization.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Like all proteinases, their activities must be tightly regulated because of their biological importance and potency. The activation/inhibition balance is maintained at several levels in vivo, including gene expression, proMMPs activation, and endogenous inhibition in the extracellular medium by the family of TIMPs (TIMP-1 to TIMP-4), as well as by other inhibitors such as α2-macroglobulin, a plasma inhibitor.<a onclick="showRef(event, 'ref7 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref7 ref9 ref10">(7,9,10)</a> The four TIMPs are macromolecules containing about 190 amino acids, which form equimolecular complexes with individual MMPs in their active form depending on their specificity and thereby block the active site of MMPs.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">In some situations, the disruption of the MMP/TIMP balance is observed, as upregulation of MMP activity has been associated with many disorders such as cancer, arthritis, scarring processes, atherosclerosis, infections, and inflammatory and immune diseases,<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a> for which the development of specific MMP inhibitors has been validated as a genuine therapeutic strategy (e.g., MMP-1, -2, and -7 in cancer).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> More recently, MMP involvement has also been confirmed in neurodegenerative diseases.<a onclick="showRef(event, 'ref10 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref10 ref17 ref18">(10,17,18)</a></div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.1.  Involvement of MMPs in the Central Nervous System Physiology</h3><div class="NLM_p">In the CNS, MMPs are expressed at a modest level in physiological conditions and their regional distribution varies depending on the MMP. They are produced by all brain cells, e.g., endothelial cells, oligodendrocytes, astrocytes, microglia, and neurons<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and contribute together with TIMPs to nervous system physiology during ontogenesis, neurogenesis, angiogenesis, and neuronal plasticity.<a onclick="showRef(event, 'ref5 ref20'); return false;" href="javascript:void(0);" class="ref ref5 ref20">(5,20)</a> MMPs implication in neuronal plasticity has been mainly linked to their ability to influence learning and memory and what is believed to be the underlying cellular substrate, long-term potentiation (LTP).<a onclick="showRef(event, 'ref5 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref5 ref21 ref22">(5,21,22)</a> MMP-9, MMP-3, and MT5-MMP have been mainly studied in this context. Moreover, MMPs (e.g., MMP-2, MMP-9, MT3-MMP, MT5-MMP) have also been involved in synaptogenesis,<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22−24)</a> migration of neural cells and their precursors,<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25−27)</a> and nervous tissue regeneration.<a onclick="showRef(event, 'ref26 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref26 ref28 ref29 ref30 ref31 ref32">(26,28−32)</a></div><div class="NLM_p">However, MMPs are ambivalent enzymes that can also exert negative effects depending on the biological context.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Along this line, upregulation of MMP expression has been extensively documented in a myriad of pathological processes including excitotoxic epileptic seizures,<a onclick="showRef(event, 'ref22 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref22 ref33 ref34">(22,33,34)</a> hypoxia/ischemia,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> neuronal death,<a onclick="showRef(event, 'ref35 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref37">(35,37)</a> microbial infections,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> blood–brain barrier (BBB) disruption,<a onclick="showRef(event, 'ref35 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref35 ref38 ref39">(35,38,39)</a> neuroinflammation,<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> demyelination,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> as well as glioma progression.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> MT1-MMP also seems to influence familial amyloidotic polyneuropathy, a rare, systemic disease with autosomal dominant transmission due to a mutation in the transthyretin gene.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Various MMPs are also involved in several chronic neurodegenerative diseases, such as Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s disease, multiple sclerosis, and AD.<a onclick="showRef(event, 'ref17 ref18 ref44'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref44">(17,18,44)</a> Neuroinflammation is systematically a common feature of these various brain pathologies, during which the production and activation of specific MMPs are initiated or amplified by neural (astrocytes, microglia, endothelial cells,...) or immune cells (macrophages, lymphocytes, neutrophils,...).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p last">Because MMPs are multifaceted enzymes that mediate a myriad of physiological and pathological pathways, the risk/benefit outcome must be carefully estimated when considering their inhibition in order to prevent/anticipate unwanted side effects. Better understanding of the molecular interactions of MMPs in a given spatiotemporal setting is therefore a prerequisite to implement innovative drug discovery strategies that interfere with their harmful effects while sparing their physiological actions. These topics have been discussed in detail for a number of CNS disorders and physiological conditions in a series of recent reviews.<a onclick="showRef(event, 'ref18 ref38 ref39 ref41 ref45'); return false;" href="javascript:void(0);" class="ref ref18 ref38 ref39 ref41 ref45">(18,38,39,41,45)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">3.  MMPs in Alzheimer’s Disease</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There is growing evidence that several MMPs may contribute to or interfere with the pathophysiological mechanisms of AD. The following paragraphs will provide an update on the latest developments in this area based on knowledge gained directly from AD patients or in vitro/in vivo models of AD.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.1.  General Implication of MMPs in AD</h3><div class="NLM_p">Elevated expression of different MMPs has been reported in AD brains, including MMP-1, MMP-2, MMP-3, MMP-9, MMP-13, and MT1-MMP (and also MT5-MMP that we will address separately).<a onclick="showRef(event, 'ref46 ref47 ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49 ref50">(46−50)</a> The effects of these MMPs have been mostly related to their functional interactions with Aβ or Tau. Aβ results from the proteolytic processing of amyloid precursor protein (APP), a type I transmembrane protein of 695–770 amino acids, whose physiological functions are not yet fully elucidated.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51,52)</a> There are two main physiological proteolytic pathways for APP that are mediated by proteinases called secretases: the nonamyloidogenic pathway, which is neuroprotective, precludes Aβ production and is predominant under physiological conditions, and the amyloidogenic pathway, which leads to the production and eventually neurotoxic accumulation of the Aβ peptide under pathological conditions (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of the two classical APP processing pathways. In blue, the nonamyloidogenic pathway, which mainly occurs at the plasma membrane level, and in red, the amyloidogenic pathway, which mainly occurs in the endosomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the nonamyloidogenic pathway, APP is first cleaved at the α-site by an α-secretase (mainly ADAM-10 and -17, for a disintegrin and metalloproteinase domain), leading to the extracellular release of a soluble N-terminal fragment sAPPα with neurotrophic properties, and a residual membrane-associated C-terminal fragment α (CTFα, also called C83). Cleavage of C83 within the transmembrane domain by the γ-secretase complex (consisting of presenilin 1 or 2, nicastrin, anterior pharynx-defective-1, and presenilin enhancer-2) generates an extracellular nontoxic p3 fragment and an APP intracellular domain (AICD) fragment that is unstable and rapidly degraded in this processing pathway.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p">APP can also undergo amyloidogenic processing when cleaved at its β site by a β-secretase (mainly BACE-1 for beta-site APP cleaving enzyme 1), thus generating the secreted ectodomain sAPPβ and the neurotoxic membrane-associated CTFβ fragment (also called C99).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Subsequent cleavage of CTFβ by the γ-secretase results in the formation of Aβ and the AICD fragment. The latter can be translocated to the nucleus, where it could be involved in the regulation of gene expression and other processes, e.g., apoptosis.<a onclick="showRef(event, 'ref54 ref56'); return false;" href="javascript:void(0);" class="ref ref54 ref56">(54,56)</a> The levels of Aβ are tightly regulated by two main degradation proteolytic pathways that take place extracellularly or intracellularly after receptor-mediated endocytosis. MMPs are among the Aβ-degrading enzymes, along with neprilysin, insulin-degrading enzyme, angiotensin-converting enzyme, and endothelin-converting enzyme.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> In pathological conditions such as AD, different pathogenic events result in an imbalance between Aβ production and clearance. Thus, abnormal accumulation of Aβ in the form of oligomers or amyloid plaques is believed to play a central role in the pathogenesis of AD and to be responsible for synaptic and cognitive deficits as well as neuroinflammation.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p">Among the Aβ-degrading enzymes, MMP-2 and MMP-9, expressed in reactive astrocytes surrounding amyloid plaques, have demonstrated their in vitro and in vivo ability to degrade soluble Aβ and amyloid plaques into nontoxic fragments (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), possibly illustrating a mode of action by which these MMPs could help preserve neurons from amyloid toxicity under AD conditions.<a onclick="showRef(event, 'ref47 ref59 ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref47 ref59 ref60 ref61 ref62">(47,59−62)</a> This is also partly inferred from in vivo studies where genetic deletion (knockout mice) or pharmacological inactivation of MMP-2 and MMP-9 in non-AD mice caused increased levels of Aβ.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Clearly, analogous MMP-2/MMP-9 knockout or knockdown experiments are still lacking in transgenic AD mouse models. Meanwhile, reduced amyloid pathology following immune-based therapy in an AD mouse model has been associated with an intriguing increase of MMP-9 levels in the brain.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> In pace with a potential beneficial effect of MMP-9 in AD, it has been shown that its overexpression in a mouse model of AD promotes the increase in the levels of neuroprotective sAPPα, along with a decrease in Aβ oligomers and the improvement of cognitive abilities.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> This study is interesting from a biochemical standpoint because it reflects the possibility that APP is a physiological substrate of MMP-9, which could occasionally behave as a α-secretase-like enzyme. However, chronic overexpression of MMP-9 as a valuable therapeutic approach is arguable, because MMP-9, unlike MMP-2, has been found to be neurotoxic for hippocampal neurons.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Moreover, an increase in cortical MMP-9 activity during early AD has been shown to correlate with cognitive deficits, possibly related to proteolytic degradation of nerve growth factor.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Further caution is advised by data indicating that detrimental brain hemorrhages following anti-Aβ immunotherapy trials are associated with the upregulation of MMP-9 levels and activities,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> which is consistent with the pro-inflammatory role of MMP-9 and its contribution to BBB breakdown.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Overview of the Main Pathophysiological Functions of MMPs in AD and in Other Pathological and Physiological Settings</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">MMP</th><th class="colsep0 rowsep0" align="center">producing cells implicated in AD</th><th class="colsep0 rowsep0" align="center">pathophysiological roles in AD</th><th class="colsep0 rowsep0" align="center">other functions</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-1</td><td class="colsep0 rowsep0">neurons; astrocytes; microglial cells; endothelilal cells; immune cells</td><td class="colsep0 rowsep0">neuroinflammation; neuronal death<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></td><td class="colsep0 rowsep0">cancer;<a onclick="showRef(event, 'ref2 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref2 ref15 ref16">(2,15,16)</a> atherosclerosis;<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> immunity;<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> vascular remodeling<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-2</td><td class="colsep0 rowsep0">astrocytes; neurons; microglial cells; endothelial cells; oligodendrocytes; immune cells</td><td class="colsep0 rowsep0">Aβ degradation;<a onclick="showRef(event, 'ref47 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref47 ref62 ref63">(47,62,63)</a> neuroinflammation;<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> associated with Tau aggregates;<a onclick="showRef(event, 'ref74 ref18'); return false;" href="javascript:void(0);" class="ref ref74 ref18">(74,18)</a> associated with Aβ deposits<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></td><td class="colsep0 rowsep0">cancer;<a onclick="showRef(event, 'ref2 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref2 ref15 ref16">(2,15,16)</a> learning and memory disabilities;<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> neuroinflammation;<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> atherosclerosis;<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> vascular remodeling<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-3</td><td class="colsep0 rowsep0">astrocytes; neurons; microglial cells; endothelial cells; oligodendrocytes; immune cells</td><td class="colsep0 rowsep0">Aβ degradation;<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> blood-cerebrospinal fluid barrier degradation<a onclick="showRef(event, 'ref101 ref18'); return false;" href="javascript:void(0);" class="ref ref101 ref18">(101,18)</a></td><td class="colsep0 rowsep0">cancer;<a onclick="showRef(event, 'ref2 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref2 ref15 ref16">(2,15,16)</a> synaptogenesis;<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> α-synuclein cleavage;<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> neuroinflammation;<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> atherosclerosis;<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> vascular remodeling<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-9</td><td class="colsep0 rowsep0">astrocytes; neurons; microglial cells; endothelial cells; oligodendrocytes; immune cells</td><td class="colsep0 rowsep0">vasculature damages;<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Aβ degradation;<a onclick="showRef(event, 'ref60 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62 ref63">(60−63)</a> sAPPα production;<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> associated with Tau aggregates;<a onclick="showRef(event, 'ref66 ref18'); return false;" href="javascript:void(0);" class="ref ref66 ref18">(66,18)</a> associated with Aβ deposits<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></td><td class="colsep0 rowsep0">cancer;<a onclick="showRef(event, 'ref2 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref2 ref15 ref16">(2,15,16)</a> synaptic plasticity;<a onclick="showRef(event, 'ref105 ref106'); return false;" href="javascript:void(0);" class="ref ref105 ref106">(105,106)</a> learning and memory;<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> neuronal death;<a onclick="showRef(event, 'ref34 ref37'); return false;" href="javascript:void(0);" class="ref ref34 ref37">(34,37)</a> myelinization;<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> neuroinflammation;<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> atherosclerosis;<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> vascular remodeling<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-12</td><td class="colsep0 rowsep0">macrophages; microglial cells; neurons; astrocytes; oligodendrocytes; endothelial cells; immune cells</td><td class="colsep0 rowsep0">neuroinflammation<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a></td><td class="colsep0 rowsep0">neuroinflammation;<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> neurodegeneration;<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> neuroprotection;<a onclick="showRef(event, 'ref110 ref111'); return false;" href="javascript:void(0);" class="ref ref110 ref111">(110,111)</a> myelinization;<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> inflammation;<a onclick="showRef(event, 'ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref112 ref113">(112,113)</a> immunity;<a onclick="showRef(event, 'ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref114 ref115">(114,115)</a> atherosclerosis;<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> vascular remodeling;<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> cancer<a onclick="showRef(event, 'ref116 ref117'); return false;" href="javascript:void(0);" class="ref ref116 ref117">(116,117)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MMP-13</td><td class="colsep0 rowsep0">microglial cells; neurons; astrocytes; endothelial cells; oligodendrocytes; immune cells</td><td class="colsep0 rowsep0">increased BACE1 levels<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></td><td class="colsep0 rowsep0">neuroprotection;<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> cancer;<a onclick="showRef(event, 'ref2 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref2 ref15 ref16">(2,15,16)</a> vascular remodeling;<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> atherosclerosis<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MT1-MMP</td><td class="colsep0 rowsep0">astrocytes; neurons; microglial cells; endothelial cells; immune cells</td><td class="colsep0 rowsep0">APP metabolism;<a onclick="showRef(event, 'ref18 ref47 ref77 ref87 ref119'); return false;" href="javascript:void(0);" class="ref ref18 ref47 ref77 ref87 ref119">(18,47,77,87,119)</a> Aβ degradation;<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Aβ production;<a onclick="showRef(event, 'ref77 ref18'); return false;" href="javascript:void(0);" class="ref ref77 ref18">(77,18)</a> associated with Aβ deposits<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></td><td class="colsep0 rowsep0">neuroinflammation;<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> glioblastoma;<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> cancer;<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> immunity/inflammation;<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122,123)</a> cell migration;<a onclick="showRef(event, 'ref26 ref124'); return false;" href="javascript:void(0);" class="ref ref26 ref124">(26,124)</a> atherosclerosis;<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> vascular remodeling<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MT5-MMP</td><td class="colsep0 rowsep0">neurons; astrocytes; immune cells</td><td class="colsep0 rowsep0">Aβ production; neuroinflammation; synaptic failure; learning and memory disabilities;<a onclick="showRef(event, 'ref125 ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref125 ref126 ref127">(125−127)</a> APP metabolism;<a onclick="showRef(event, 'ref18 ref119 ref125 ref126 ref128'); return false;" href="javascript:void(0);" class="ref ref18 ref119 ref125 ref126 ref128">(18,119,125,126,128)</a> associated with Aβ deposits<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></td><td class="colsep0 rowsep0">synaptogenesis/nervous tissue remodeling and repair;<a onclick="showRef(event, 'ref28 ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref28 ref129 ref130">(28,129,130)</a> inflammation;<a onclick="showRef(event, 'ref28 ref131'); return false;" href="javascript:void(0);" class="ref ref28 ref131">(28,131)</a> cancer;<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> brain tumor;<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> synaptic activity<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a></td></tr></tbody></table></div></div><div class="NLM_p">In line with this idea, the presence of the ε4 allele of apolipoprotein E (ApoE) in the genome (a major genetic risk factor for AD) leads to BBB breakdown through the proinflammatory cyclophilin A pathway that involves the activation of MMP-9.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The upregulation of MMP-2 activity has also been linked with BBB leakage,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and it is known that oligomeric Aβ can stimulate the levels of MMP-2 in astrocytes surrounding amyloid plaques, certainly mediated by the release of proinflammatory cytokines by microglia.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> Altogether, these data highlight the possibility that both MMP-2 and MMP-9 could exert detrimental effects in AD through the induction of BBB leakage, which may in turn support chronic inflammation. BBB breakdown has been controversial for years in the AD field due to the absence of massive leukocyte infiltration as it is observed in other disorders such as multiple sclerosis, stroke, or epilepsy.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71,72)</a> However, recent works reporting BBB dysfunctions in animal models of AD<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> and in humans,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> point out the necessity of considering BBB demising factors as potential therapeutic targets.</div><div class="NLM_p">In the series of other possible adverse effects of MMP-2 and MMP-9 in AD, the upregulation of MMP-2, at early and middle stages of AD in neurons containing neurofibrillary tangles, has raised the suspicion that the proteinase could promote the pathogenic accumulation of Tau aggregates.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Similar hypotheses have been put forward in brains from AD patients, where upregulated MMP-9 expression has been found associated with neurofibrillary tangles.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><div class="NLM_p">It is reasonable to suggest that sustained inhibition of MMP-2, which is constitutively expressed in the brain, may be consistent with the chronic nature of AD progression, whereas transient upregulation of MMP-9 could be better targeted in a narrower time frame, for example, in the context of peripheral infection leading to accelerated cognitive decline in AD patients, which is likely related to the opening of the BBB and concomitant neuroinflammation.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> In any case, the development of specific inhibitors for these MMPs could help clarify their function in AD, taking into account their spatiotemporal pattern of expression/activity, which has yet to be mapped in detail.</div><div class="NLM_p">MT1-MMP expression is strongly upregulated in the brain of AD mice in reactive astrocytes surrounding amyloid deposit,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> as well as in microglia/macrophages<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and neurons.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Like MMP-2 and MMP-9, MT1-MMP seems to display a dual functionality in AD. Thus, exogenously added to cell cultures, MT1-MMP can degrade soluble and aggregated Aβ species in vitro and in situ,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> but if overexpressed in HEK cells carrying the APP Swedish mutation, the enzyme leads to an increase in CTFβ and Aβ levels, thereby highlighting its potential contribution to AD pathogenesis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The pro-amyloidogenic effect of MT1-MMP involves a β-secretase-dependent mechanism and/or the promotion of APP trafficking into endosomes, where Aβ production mainly occurs.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> In vivo confirmation of the functional benefits of MT1-MMP inhibition is necessary and experimentally within reach, for example, through genetic or pharmacological approaches that suppress or inhibit MT1-MMP activity. In the former case, because MT1-MMP deletion causes mice lethality shortly after birth,<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78,79)</a> conditional MT1-MMP deficient mice should therefore be generated in an AD background. In the second case, selective MT1-MMP blocking antibodies<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80,81)</a> could be infused in AD mice at prodromal-like stages of the pathology.</div><div class="NLM_p">A series of studies reported that APP contains a proteinase inhibitor domain for MMP-2 located in the C-terminal glycosylated region of soluble APP forms.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Inside this domain, a decapeptide sequence Ile-Ser-Tyr-Gly-Asn-Asp-Ala-Leu-Met-Pro termed APP-derived peptide inhibitor (APP-IP) specifically inhibits MMP-2.<a onclick="showRef(event, 'ref83 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref83 ref84 ref85">(83−85)</a> Interestingly, the conversion of pro-MMP-2 into the active MMP-2 form was prevented by a fusion protein containing the APP-IP in TIMP-2.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The chimera combined potent APP-IP-mediated inhibition of the MMP-2 catalytic site and selective recognition of the MMP-2 hemopexin domain by TIMP-2. It is noteworthy that not only can MT1-MMP cleave APP upstream of the APP-IP to release soluble APP lacking APP-IP,<a onclick="showRef(event, 'ref77 ref87'); return false;" href="javascript:void(0);" class="ref ref77 ref87">(77,87)</a> but this process can be performed in cooperation with MMP-2.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> This novel functional interaction between both MMPs adds to the well-known ability of MT1-MMP to catalyze the conversion of inactive pro-MMP-2 to its active MMP-2 form.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> In this context, an increase in active levels of MMP-2 mediated by MT1-MMP could promote the formation of sAPP without APP-IP, resulting in a reduced ability of the system to inhibit MMP-2 that could further contribute to the cleavage of APP and so on. Functional links between MT1-MMP and MMP-2 could broaden the spectrum and potency of their pathogenic actions but also expand the possibilities of specifically targeting either proteinase to interfere with the proteolytic cascade.</div><div class="NLM_p">If MMP-2, MMP-9, and MT1-MMP act as Aβ-degrading enzymes as well as pathogenic effectors, is there any justification for activating or inhibiting these proteinases? Promoting MMP activity, especially chronically, may be inherently risky. Indeed, the natural inhibitors, TIMPs, usually exceed MMPs content. In addition, MMPs are mainly present in their inactive forms. All of this together implies that keeping a tight control on MMP activity appears to be essential to preserve tissue homeostasis. A hypothetical degradation strategy of Aβ based on the activation of MMPs could result in the indiscriminate degradation of many physiologically important substrates, in addition to the activation/amplification of difficult to control proteolytic cascades involving MMPs or other proteinases (e.g., serine proteinases), characteristic of many pathogenic processes. Therefore, it is likely that promoting MMP activity may eventually increase the risk/benefit ratio. On the other hand, inhibiting a given MMP could also affect a number of physiologically relevant off-target substrates and have side effects. This is, for instance, one of the main obstacles to AD therapies aiming at inhibiting γ-secretase to block the generation of Aβ (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), because the catalysis of other substrates by this enzyme supports physiological functions.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> In the case of MMPs inhibition, one would expect that the biochemical/biological redundancy of this family of proteinases would limit these drawbacks, as other MMPs could take over the cleavage of a physiological substrate affected by the specific inhibition of a particular MMP. Overall, specific inhibition of MMPs appears to be a more appropriate strategy than their activation or upregulation for the prospects of potential therapeutic interventions.</div><div class="NLM_p">The possible implication of MMP-13 in AD has been recently highlighted,<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> as elevated levels of the enzyme were found in the brain of AD patients and AD mice.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The same work linked the involvement of MMP-13 in amyloid pathology by its ability to regulate BACE-1 expression through the phosphatidylinositol kinase-3 (PI3K) signaling pathway. In addition, downregulating MMP-13 activity through pharmacological inhibition or MMP-13 knockdown in AD mice improved amyloid pathology and cognitive deficits.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Previously, another study showed that Aβ peptide could induce MMP-13 in microglial cells through a PI3K/Akt-dependent mechanism,<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> likely implying a regulatory feedback between MMP-13 and Aβ.</div><div class="NLM_p">Other MMPs have also proven to respond to Aβ. Thus, cultured microglia from post-mortem AD brains exposed to Aβ showed increased levels of MMP-1, MMP-3, MMP-9, MMP-10, and MMP-12, possibly indicating the involvement of these MMPs in AD associated neuroinflammation,<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> but also in neurodegeneration as suggested for MMP-1.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a></div><div class="NLM_p last">Despite a growing number of reports linking elevated levels of MMPs in different CNS areas with the progression of AD,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> there is a clear need for detailed mapping of the regulation of individual MMPs at different stages of disease. Taken together, these data should consolidate expectations about the importance of MMPs in AD and prefigure functional specificities of each proteinase in the disease context.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.2.  MT5-MMP, a New Potential Target in AD</h3><div class="NLM_p">Among MMPs, MT-MMPs are expressed at a higher level in the CNS, and particularly MT1-MMP, MT3-MMP, MT4-MMP, and MT5-MMP.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> MT5-MMP was identified in 1999 as the most abundant subtype of MT-MMPs in the brain,<a onclick="showRef(event, 'ref133 ref135'); return false;" href="javascript:void(0);" class="ref ref133 ref135">(133,135)</a> being the only member of the MMP family predominantly expressed at the cerebral level, in embryos and in postnatal pups, in areas of intense neuronal plasticity, suggesting altogether a key role in brain development.<a onclick="showRef(event, 'ref129 ref136'); return false;" href="javascript:void(0);" class="ref ref129 ref136">(129,136)</a> Its stable postdevelopmental expression suggests also an implication in neuronal remodeling under physiological and regenerative conditions in adulthood.<a onclick="showRef(event, 'ref28 ref45 ref130 ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref28 ref45 ref130 ref137 ref138">(28,45,130,137,138)</a></div><div class="NLM_p">MT5-MMP has been recently identified has a new player in AD. Indeed, MT5-MMP was first found to be colocalized with amyloid plaques in AD brains, which suggested its participation in the remodeling of injured zones.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> The generally accepted vision of APP metabolism (see above amyloidogenic/nonamyloidogenic proteolytic pathways) has been recognized as simplistic in recent years in light of the discovery of new APP proteinases.<a onclick="showRef(event, 'ref138 ref140'); return false;" href="javascript:void(0);" class="ref ref138 ref140">(138,140)</a> As early as 2006, it was demonstrated the capacity of MT1-, MT3-, and MT5-MMP to cleave APP in cellulo, at a new site upstream of the β-secretase cleavage site.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> This work described the formation of APP fragments, different from those classically reported after α- and β-secretase cleavages.</div><div class="NLM_p">Recently, independent works from two teams have shown that processing of APP by MT5-MMP leads to the generation of new fragments through its η-secretase activity, eventually leading to neurotoxic effects in vitro and in vivo.<a onclick="showRef(event, 'ref125 ref128'); return false;" href="javascript:void(0);" class="ref ref125 ref128">(125,128)</a></div><div class="NLM_p">Willem et al. confirmed in 2015<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> a physiological pathway for APP proteolysis mediated by MT5-MMP at the site previously described by Ahmad et al.,<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> that they called η site VLAN<sub>504</sub>-M<sub>505</sub>ISEPR (APP<sub>695</sub> numbering). MT5-MMP was capable of displaying η-secretase activity in vivo, unlike its close homologue MT1-MMP.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> In this new APP proteolytic pathway, MT5-MMP can generate a soluble sAPPη fragment and a residual CTFη fragment anchored to the membrane (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). CTFη can then be consecutively cleaved either by β-secretase (BACE-1) or by α-secretase (ADAM-10) to release two fragments, a short (92 amino acids) and a slightly longer (108 amino acids) called Aη-β and Aη-α, respectively. In the same study, the authors demonstrated the neurotoxic potential of the Aη-α peptide, which inhibited LTP in primary rat neuronal cultures, while Aη-β had no toxic effect. These data questioned the positive and negative roles generally attributed to α- and β-secretases, respectively. In addition, it was shown that genetic and pharmacological inhibition of BACE-1 (β-secretase) in mice promoted the accumulation of CTFη and Aη-α. As these fragments (at least Aη-α) are potentially neurotoxic, ongoing therapeutic strategies on β-secretase inhibitors should take these data into account as a possible cause of side effects. Although the toxicity of CTFη has not yet been established, they noted that CTFη levels, as those of neurotoxic CTFβ, were enriched in dystrophic neurites in an AD mouse model and in human AD brains.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of APP processing by η-secretase. Aη-α is neurotoxic, but Aη-β is not.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At the same time, the contribution of MT5-MMP to AD pathogenesis was first unveiled by Baranger et al.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> They examined the impact of MT5-MMP deficiency in vivo in the 5xFAD mouse model of AD and reported reduced amyloidosis, illustrated by a striking drop in the levels of Aβ (oligomers and amyloid plaques) and CTFβ. Reduced Aβ load was concomitant with durable reduced neuroinflammation and gliosis, as well as the improvement of LTP and learning and memory. Interestingly, these changes occurred without modifications of the activities of α-, β-, and γ- secretases in the cortex and hippocampus. In the same study, they showed in vitro that MT5-MMP can interact and colocalize with APP and also confirmed that MT5-MMP can stimulate Aβ and CTFβ production. Overexpression of MT5-MMP was able to trigger the release of a soluble APP fragment of 95 kDa (sAPP95) in HEK cells, which seems to correspond to the sAPPη fragment described by Willem et al.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> It is noteworthy that sAPP95 levels were significantly reduced in the brain of AD mice deficient for MT5-MMP, therefore further confirming that APP is an in vivo substrate of MT5-MMP.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></div><div class="NLM_p">The pro-amyloidogenic feature of MT5-MMP and its η-secretase activity in the metabolism of APP constitute two pathogenic mechanisms, which may be complementary in AD (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). It has been suggested, and then confirmed by Baranger et al., that the pro-amyloidogenic function of MT5-MMP could go through a modulation of APP trafficking by facilitating APP sorting in the endosomes, which are a main locus of Aβ formation.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> In addition, MT5-MMP could also contribute to AD pathogenesis through the activation of pro-inflammatory pathways.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic representation of the two newly described disease pathways involving MT5-MMP in the pathogenesis of AD. A third synergistic/complementary pathway would be the role of MT5-MMP in the regulation of inflammatory processes in the CNS, but data are still needed to demonstrate this.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It is also significant to note that MT5-MMP deficient mice are viable and show no detectable overt abnormalities.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Keeping in mind that MT5-MMP expression is primarily localized in the nervous system, this information reinforces the idea that MT5-MMP may constitute a relevant therapeutic target in AD, as MT5-MMP inhibitors of therapeutic interest in AD would have limited impact on other organs.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">4.  Major Challenges in the Design of Therapeutic Agents Targeting MMPs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02481" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02481" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Given the broad implications of MMPs that have been identified in various neural diseases, including AD, it seems relevant to consider these enzymes as potential new therapeutic targets. However, to develop agents targeting MMPs, it is essential to consider inherent challenges, mainly linked to their broad substrate specificity and high structural homology. In addition, it is important to consider BBB permeability of these agents as CNS targeting drugs. Indeed, despite the high therapeutic potential of MMP inhibitors, almost all clinical trials have failed in the past mainly due to low selectivity and poor target validation.<a onclick="showRef(event, 'ref2 ref10'); return false;" href="javascript:void(0);" class="ref ref2 ref10">(2,10)</a></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">4.1.  Broad Substrate Specificity</h3><div class="NLM_p last">As mentioned earlier, MMPs are capable of cleaving a substantial number of extracellular matrix components as well as an increasing number of nonmatrix substrates. This confers a wide range of action, and sometimes overlapping substrate specificities to these enzymes, that explain their pleiotropic effects in physiological and pathological conditions.<a onclick="showRef(event, 'ref7 ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref7 ref141 ref142">(7,141,142)</a> The search for new MMP substrates using proteomic approaches is still ongoing, with the idea that a thorough knowledge of the substrate repertoire will limit the undesirable side effects associated with unknown substrates. Combining proteomics approaches with studies aimed at characterizing the spatiotemporal expression of MMPs and their substrates should ultimately serve to better understand their biological functions (beneficial and/or detrimental), which is a major challenge in the development of specific MMP inhibitors.<a onclick="showRef(event, 'ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref142 ref143">(142,143)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">4.2.  Structural Homology</h3><div class="NLM_p">MMPs share a multidomain common structure, with the particularity of catalytic sites that have a high homology in the amino acid sequence.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Another characteristic of this proteinase family is the presence of a zinc cation in the catalytic site that is coordinated to three histidine residues within the conserved His-Glu-Xxx-Xxx-His-Xxx-Xxx-Gly-Xxx-Xxx-His motif, and a conserved methionine residue that forms the “Met-turn” region (1,4-β-turn). This conserved zinc-binding environment is what allows MMPs to be included in the Metzincins superfamily.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> In addition to a zinc atom with catalytic functions, MMPs also share in their active site another zinc atom as well as several calcium ions that act as structural elements in the architecture of the proteinase.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></div><div class="NLM_p">Given the high structural homology between MMPs and the large number of members of this family, a major challenge in the development of therapeutic agents is thus selectivity. To introduce selectivity between MMPs, it is necessary to have detailed structural knowledge for each of them. To this end, tertiary MMP structures are of critical importance to design appropriate and selective therapeutic agents. Most of the structures have been solved by X-ray or nuclear magnetic resonance (NMR) techniques. This mainly concerns catalytic sites, alone or in complex with substrates or various therapeutic agents, although some structures have also been determined for other MMP domains.<a onclick="showRef(event, 'ref3 ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref3 ref146 ref147">(3,146,147)</a></div><div class="NLM_p">The nomenclature of Schechter and Berger is commonly used to describe catalytic sites of endopeptidases and their substrates.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> According to this nomenclature, the MMP catalytic site can be divided in several subsites: S1′, S2′, S3′, ...S<i>n</i>′ on the right side of the catalytic zinc cation, i.e., primed side, and S1, S2, S3, ...S<i>n</i> on the left side of the catalytic Zn ion, i.e., unprimed side (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Schematic representation of substrate binding in a MMP catalytic site, with the implication of different subsites S<i>n</i> of the MMP for the accommodation of various amino acids P<i>n</i> of the substrate. In yellow, the zinc cation (Zn) is essential for the cleavage of the peptide bond (indicated by the arrow between P1–P1′). This cartoon has been generated with PyMOL software from the crystal structure of MT3-MMP available in the PDB Data Bank (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RM8">1RM8</a>).<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By analogy, the corresponding chemical groups on the substrate/analogue that interact with these subsites are named P1, P2, ...P<i>n</i>, and P1′, P2′, ...P<i>n</i>′. In MMPs, the nonprimed side subsites (mainly S1, S2, S3) have a relatively flat surface and are more exposed to the solvent than the primed-side subsites (mainly S1′, S2′, S3′), characterized by deep and shallow pockets forming a cleft. The primed-side sites are thus more prone to interactions with the substrates and/or inhibitors and have therefore received more attention in the design of therapeutic agents. Among the subsites in the cleft of the active site, the most interesting is the S1′ pocket, which is the closest to the catalytic zinc (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). This hydrophobic S1′ pocket is the main determinant of enzymatic specificity, as it is critical for substrate recognition. Therefore, it appears to be the most interesting pocket for the design of therapeutic agents because it is the deepest, most flexible, and most variable pocket in terms of size, amino acid sequence, and shape between MMPs.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Nevertheless, other specificity determinants should be considered to improve selectivity, such as the S2′ pocket.<a onclick="showRef(event, 'ref144 ref147 ref151'); return false;" href="javascript:void(0);" class="ref ref144 ref147 ref151">(144,147,151)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Schematic representation of the general catalytic site of MMPs, illustrated by MT3-MMP crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RM8">1RM8</a>). The S1′ pocket (in red), close to Zn cation (in yellow) is deep, hydrophobic, and variable in size and shape among the MMPs. The S2′ shallow pocket (in green) is very similar among MMPs and is partially exposed to solvent. This image has been generated with PyMOL software.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">A challenge for the coming years will therefore be to characterize the remaining 3D structures of MMPs in order to facilitate structure-based drug design and achieve higher selectivity, either for the catalytic site or for potential exosites.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">4.3.  BBB Permeability</h3><div class="NLM_p">BBB is a protective element of the brain that provides a defense against pathogenic factors present in the systemic circulation and is therefore crucial for proper synaptic and neuronal functioning. BBB breakdown was demonstrated in several neurodegenerative disorders and particularly in AD, for which the role of its disruption in the pathogenesis of AD is becoming increasingly clear.<a onclick="showRef(event, 'ref72 ref73 ref152'); return false;" href="javascript:void(0);" class="ref ref72 ref73 ref152">(72,73,152)</a> In AD, BBB breakdown has been associated with increased BBB permeability, cerebral microbleeds, impaired glucose transport, impaired P-glycoprotein 1 function, CNS leukocyte infiltration, capillary leakages, pericyte and endothelial degeneration, aberrant angiogenesis, as well as molecular changes.<a onclick="showRef(event, 'ref72 ref153'); return false;" href="javascript:void(0);" class="ref ref72 ref153">(72,153)</a> All of these alterations lead to the accumulation of toxic molecules in the brain, including Aβ species, that initiate multiple pathways of neurodegeneration. MMPs are versatile enzymes, as seen above, which can have detrimental effects on BBB in various pathological conditions and thus could constitute potential therapeutic targets to restore BBB integrity, especially in stroke.<a onclick="showRef(event, 'ref154 ref155'); return false;" href="javascript:void(0);" class="ref ref154 ref155">(154,155)</a></div><div class="NLM_p last">The relation between BBB breakdown and brain delivery of neuropharmaceuticals remains a controversial issue. Some say that local BBB disruption could be used by therapeutic agents, and paradoxically by MMP inhibitors themselves, to gain access into CNS, while others postulate that drug delivery requires functionally and structurally healthy BBB.<a onclick="showRef(event, 'ref72 ref156'); return false;" href="javascript:void(0);" class="ref ref72 ref156">(72,156)</a> CNS delivery of therapeutic agents targeting brain MMPs is indeed another major challenge. Various general strategies for CNS drug delivery can be considered: endogenous cellular mechanisms at the BBB (passive diffusion, carrier-mediated transport, receptor-mediated transcytosis, ....), intranasal drug delivery, use of nanomedicine, direct injection into CNS, or transient opening of the BBB (e.g., focused ultrasound).<a onclick="showRef(event, 'ref72 ref157 ref158'); return false;" href="javascript:void(0);" class="ref ref72 ref157 ref158">(72,157,158)</a> More generally, the physicochemical properties of the designed therapeutic agents should be optimized in accordance with the delivery strategy expected in terms of molecular weight, lipophilicity, hydrogen bounding, polar surface area, ionization at physiological pH, etc.<a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159,160)</a> To conclude, various strategies can be explored to increase brain penetration of potential newly designed MMPs therapeutic agents.</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">5.  MMPs Inhibition: Strategies and Evolution</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14826" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14826" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Faced with the increase of functions attributed to MMPs in various pathological conditions, the development of MMP inhibitors has been investigated over time. The general awareness that MMPs assume broader functions than previously thought has led to the search of the most selective agents as a first step in order to better understand the physiological and pathological role of these enzymes. We will describe the various pharmacological strategies that have been pursued to this end (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) from the initial idea to block the activity of MMPs by inhibiting their catalytic site. We will thus present the different types of synthetic inhibitors that have been successively designed, using different strategies and with improved results in terms of selectivity. We will finally discuss more recent developments of therapeutic agents targeting exosites, such as monoclonal antibodies (mAb) and protein-based inhibitors. These are designed to target secondary binding sites and to mimic the endogenous regulatory system of MMPs, mainly the TIMPs and the MMP pro-domains, which keep enzymes inactive. As there are just a few examples of therapeutic agents targeting MMPs for brain disorders at the moment, and none for the recently studied MT5-MMP, we will introduce in this section broader examples to present global advancements in the field. We will also include the very few examples that deal with the BBB challenge.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Schematic representation of physiological and pharmacological regulation of MMP activity. Physiological regulation is represented in the blue box with proMMP-3 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SLM">1SLM</a>), active MMP-3 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CAQ">1CAQ</a>), and the MMP-3/TIMP-1 complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UEA">1UEA</a>). Pharmacological regulation is presented in red by a zinc-chelating inhibitor <b>11</b> complexed with MMP-12 catalytic site (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GQL">4GQL</a>) and by GS-5745 exosite-based mAb of MMP-9 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TH9">5TH9</a>). Surface representation of MMP catalytic site with the secondary structure highlighted in gray, catalytic zinc ion in yellow. The image has been generated with PyMOL software.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">5.1.  Marketed Compounds with Anti-MMPs Properties</h3><div class="NLM_p">There are only a few therapeutic drugs on the market that display broad MMP inhibition, and MMPs are generally not even the primary targets. Apart from their known antimicrobial activity, tetracycline-derived compounds, such as doxycycline <b>1</b> and minocycline, have been shown to inhibit MMPs, particularly collagenases (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A).<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Doxycycline hyclate is the only MMP inhibitor with this mechanism that has been approved in periodontal disease by the Food and Drug Administration. It has to be noted that minocycline is one of the few MMP inhibitors that has been reported to have a good penetration of the BBB.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> In addition to tetracyclines, bisphosphonates like alendronate <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A), which are commonly used for cancer and bone conditions, also appear to inhibit MMPs.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Statins, originally designed as cholesterol-lowering drugs (e.g., simvastatin <b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A), have also more recently shown anti-MMP properties.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> Finally, thalidomide <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A), now available again only through a restricted distribution program, has also shown MMP inhibitory capacity.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Examples of structures of nonselective MMPs inhibitors. (A) Marketed compounds (B) first generation, peptides/peptidomimetics; (C) second generation, nonpeptidomimetics. *Yellow spheres indicate the zinc binding group (ZBG) on designed MMP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">5.2.  First Generation of Broad-Spectrum Peptidic/Peptidomimetic Inhibitors</h3><div class="NLM_p">In the early design of MMP inhibitors in the 1970s, a substrate-based approach was followed based on the knowledge available at the time. A first generation of peptides/peptidomimetics was developed to mimic the structure of their physiological peptide substrates. The requirement for the development of MMP inhibitors was at this time the presence of a zinc binding group (ZBG) on the peptidic scaffold in order to chelate the catalytic zinc atom and block enzyme activity. Hydroxamic acid groups were thus initially chosen for their high potency. Batimastat <b>5</b> (also called BB-94, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B) and many other potent compounds were developed using this approach (for review and complete structure–activity relationships, see Whittaker et al.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a>). As represented by batimastat <b>5</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, these inhibitors were designed to fit the binding cavity of MMPs, both through their capacity to chelate zinc and through their peptidic scaffold that can form hydrogen bonds with the proteinase backbone and distribute its various substituents to the enzyme subsites. However, these peptide-based inhibitors failed in clinical trials for various reasons, including poor oral bioavailability, metabolic instability, lack of MMP selectivity, incomplete knowledge of MMPs biology at the time of the trials, as well as unwanted side effects.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Other more orally bioavailable inhibitors, but equally disappointing in clinical trials, were designed by modification of the peptidomimetic backbone. This is the case of marimastat <b>6</b> (also called BB-2516), which possesses a hydroxyl group α-substituent (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B).<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> However, some of these compounds are still used today as nonselective pharmacological tools in preclinical models.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Crystal structure of the catalytic domain of MT3-MMP complexed with the nonselective inhibitor batimastat <b>5</b> in blue (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RM8">1RM8</a>). Surface representation of the protein with the secondary structure is highlighted in gray, the S1′ pocket in red and the catalytic zinc ion in yellow. The inset shows a zoom of the catalytic site with ligand–protein interactions represented as yellow dashed lines. The image has been generated with PyMOL software.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> (B) Schematic representation of the binding mode of batimastat <b>5</b> in the catalytic site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">5.3.  Second Generation of Broad-Spectrum Nonpeptidomimetic Inhibitors</h3><div class="NLM_p">Nonpeptidyl inhibitors were then explored to target the active site of MMPs and led to a second generation of MMP inhibitors. Different analogues were synthesized, including sulfonamide hydroxamates, like the potent prinomastat <b>7</b> (also called AG3340, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C).<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> The intense utilization of the hydroxamic acid, plus its lack of specificity, as well as the high competition in the design of MMP inhibitors at that time, led to the search for alternative weaker ZBG such as retrohydroxamates, carboxylates, thiols, phosphorus-based, and novel original groups (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref151 ref166 ref168 ref169 ref170'); return false;" href="javascript:void(0);" class="ref ref151 ref166 ref168 ref169 ref170">(151,166,168−170)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Development of various ZBGs over time, represented with their pros and cons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">MMP inhibitors bearing other ZBG were thus developed, like tanomastat <b>8</b> (also called BAY12-9566), possessing a carboxylic acid (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C).<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> These nonpeptidyl inhibitors demonstrated better in vivo pharmacokinetic profiles but again showed only relatively poor selectivity and therefore failed in clinical trials.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">5.4.  Third Generation of Selective Inhibitors</h3><div class="NLM_p">Scientific research over the past two decades has brought new knowledge in the field of MMP inhibitor design and generated technological advances that provide new opportunities, notably in the search of selectivity. The resolution of 3D structures of MMPs is now much more advanced than in the early days of MMPs research, providing key information about MMP structures and MMP–inhibitor interactions that enable the use of structure-based approaches and rational inhibitor design. In addition, this third generation of inhibitors was designed by fully exploiting the presence of various substrate-binding pockets, which surround the catalytically active zinc ion.<a onclick="showRef(event, 'ref151 ref171'); return false;" href="javascript:void(0);" class="ref ref151 ref171">(151,171)</a> Major selectivity differences were obtained by targeting “selectivity” S1′ pockets of MMPs, which have been widely studied and classified as small, medium, and large according to the MMP.<a onclick="showRef(event, 'ref150 ref172'); return false;" href="javascript:void(0);" class="ref ref150 ref172">(150,172)</a> This was achieved in particular through the development of effective technologies and tools based on computer science, high throughput screening (HTS), crystallography, molecular modeling, and fragment approach.<a onclick="showRef(event, 'ref173 ref174'); return false;" href="javascript:void(0);" class="ref ref173 ref174">(173,174)</a> To reach selectivity, scientists are often taking advantage of a combination of these tools. Numerous MMP inhibitors started to emerge with encouraging results in terms of selectivity, in particular for MMP-13 and MMP-12.<a onclick="showRef(event, 'ref168 ref171 ref175 ref176 ref177'); return false;" href="javascript:void(0);" class="ref ref168 ref171 ref175 ref176 ref177">(168,171,175−177)</a></div><div class="NLM_p">The sulfonamide moiety has been well studied in the design of MMP inhibitors as an appropriate linker between a substituent oriented to the zinc (mainly a ZBG) and sulfonyl substituents oriented to the S1′ pocket. In addition, the sulfonamide linker has shown its ability to do crucial hydrogen bonding in the catalytic site.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> Successive modifications of this template led to the discovery of various compounds, including N-substituted arylsulfonamide carboxylates like the sugar-based MMP-12 selective inhibitor <b>9</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A).<a onclick="showRef(event, 'ref179 ref180'); return false;" href="javascript:void(0);" class="ref ref179 ref180">(179,180)</a> Rigidified arylsulfides were also obtained, as illustrated with compound <b>10</b>, a selective MMP-12 inhibitor bearing in addition an original <i>N</i>-1-hydroxypiperidine-2,6-dione ZBG (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A).<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Examples of third generation of selective inhibitors with catalytic site interactions represented (pockets S<i>n</i>). Yellow spheres indicate the ZBG. (A) Nonpeptidomimetic, (B) mechanism-based, and (C) peptidomimetic inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, a novel concept for the selective inhibition of MMPs was introduced with the discovery of compound <b>11</b> (also called SB-3CT, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B), a mechanism-based specific inhibitor of MMP-2 and, to a lesser extent, MMP-9 (i.e., suicide substrate).<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> The inhibitor binds deeply in the S1′ pocket of the catalytic site with the biphenyl ether moiety, while the sulfur atom of the thiirane group coordinates the catalytic zinc. It has been proposed that a nucleophilic attack of a glutamic acid of the active site leads to the opening of the thiirane ring to generate the corresponding thiolate and forms a covalent ester bond that mimics the proMMP state (slow binding inhibition).<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Compound <b>11</b> and its derivatives have been evaluated in different models of brain diseases thanks to their ability to cross the BBB.<a onclick="showRef(event, 'ref184 ref185 ref186 ref187'); return false;" href="javascript:void(0);" class="ref ref184 ref185 ref186 ref187">(184−187)</a></div><div class="NLM_p">Scientists also succeeded more recently to develop selective pseudopeptides, mainly phosphinic pseudopeptides bearing a phosphoryl weak ZBG, which are relatively stable transition-state analogues. Devel et al. designed the highly potent and selective MMP-12 phosphinic inhibitor <b>12</b> (also called RXP470.1) by introducing an isoxazole side chain to fill the S1′ cavity as well as a Glu-Glu motif to occupy S2′ and S3′ subsites (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C).<a onclick="showRef(event, 'ref188 ref189'); return false;" href="javascript:void(0);" class="ref ref188 ref189">(188,189)</a> An interesting study on this compound revealed the crucial and complex role of the ZBG to modulate either the potency, dynamics, or selectivity of the inhibitor.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> The same group then developed a new generation of nonphosphinic pseudopeptides with modified P1′ side chains, like compound <b>13</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C), which were even more selective than <b>12</b>.<a onclick="showRef(event, 'ref191 ref192'); return false;" href="javascript:void(0);" class="ref ref191 ref192">(191,192)</a> In addition to their potential interest as therapeutic agents, some peptidomimetics could be used as probes and pharmacological or diagnostic tools in cellulo or in preclinical models.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a></div><div class="NLM_p">Another example of selective inhibitor is the intriguing synthetic APP-IP decapeptide <b>14</b> that interacts with the catalytic site of MMP-2 (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C). As discussed above, the sequence of APP-IP corresponds to an internal sequence of APP (residues 586–595, APP<sub>770</sub> numbering) that was identified as the minimal region required for MMP-2 inhibition.<a onclick="showRef(event, 'ref83 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref83 ref84 ref85">(83−85)</a> APP-IP <b>14</b> specifically inhibits MMP-2 with an IC<sub>50</sub> value of 30 nM while sparing MMPs like MT1-MMP, MMP-3, -7, and -9, with IC<sub>50</sub> values between 2 μM and >10 μM.<a onclick="showRef(event, 'ref83 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref83 ref84 ref85">(83−85)</a></div><div class="NLM_p last">The hydroxamate-based gelatinases inhibitor BBB-permeable <b>15</b> has come to light in a paper just published by Bertran et al. (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C).<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> They have successfully developed through a multidisciplinary approach a selective potent inhibitor of MMP-2 and MMP-9 with potential for the treatment of CNS, as suggested by its ability to cross in vitro and in vivo the BBB. They have applied a structure-based drug design approach, after an initial in silico screening, to optimize the potency, the selectivity as well as the permeability of the compounds. When considering multiple parameters since the beginning, it is also feasible to overcome several main challenges in the development of MMP inhibitors, namely selectivity and BBB permeability.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">5.5.  Fourth Generation of Exosite-Based Inhibitors</h3><div class="NLM_p">In recent years, inhibitors that target exosites have also been studied to help unravel the complex issue of the selectivity.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> Some of the least conserved regions among MMPs, known as hot spots, have been specifically identified for each MMP, opening up new opportunities to develop an even more selective fourth generation of exosite-based inhibitors.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> Secondary binding sites have been found, notably for MMP-13 in the catalytic domain, for MT1-MMP in the hemopexin-like domain as well as in the catalytic site, and for MMP-2 and MMP-9 in the collagen binding domain.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> Very potent peptides and small molecules have thus been developed, in particular for MMP-13.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a></div><div class="NLM_p">To circumvent broad-spectrum MMP inhibition or the inhibition of other metalloenzymes, the development of compounds that do not interact with the zinc, without any ZBG, was considered in the meantime.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> In this context, an interesting approach allowed the identification of ZBG-free highly selective and potent MMP-13 inhibitors. As a result of initial HTS experiments, a first lead capable of binding the S1′ specificity subsite, also called the S1′′ pocket, has been identified.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> The latter, as mentioned earlier, is a well-known exosite of the MMP-13 catalytic site. Studies based on the relationship between structure and activity, as well as the crystallization of a complex formed by one of the inhibitors and MMP-13, allowed use of comparative structural analyses to design a highly potent zinc-chelating inhibitor, compound <b>16</b>, which was nonselective (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A).<a onclick="showRef(event, 'ref200 ref201 ref202'); return false;" href="javascript:void(0);" class="ref ref200 ref201 ref202">(200−202)</a> Another structure-guided molecular design led in a second phase to the synthesis of inhibitor <b>17</b>, which was in this case selective for MMP-13 through the removal of the ZBG (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A).<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Examples of the fourth-generation exosite-based MMP inhibitors. (A) MMP-13 inhibitors with protein–inhibitor interactions represented (MMP pockets S<i>n</i>′ are visualized and yellow spheres indicate the ZBG). (B) Other exosite-based MMP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In another example, Nara et al. also first identified a hit compound by HTS, which was then cocrystallized with the catalytic site of MMP-13. Next, they applied a structure-based drug design approach to target the deep S1′ pocket and the unique MMP-13 adjacent side pocket S1′′. This led to the identification of the highly potent and selective MMP-13 inhibitor <b>18</b> lacking the ZBG, but which was limited by its pharmacokinetic profile (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A).<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> Nara et al. optimized compound <b>18</b> by introducing a 1,2,4-triazol-3-yl group as ZBG, resulting in MMP-13 inhibitor <b>19</b> with excellent potency and selectivity, as well as improved favorable pharmacokinetic properties (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A).<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> Despite some concerns about off-targets and as depicted with this example, selective MMP inhibitors bearing a ZBG can be successfully developed by carefully examining the inhibitor scaffold to target specific subsites of individual MMPs.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a></div><div class="NLM_p">Inhibitors targeting exosites are beginning to emerge also for other MMPs. The in silico docking approach, followed by an experimental assay, identified a selective inhibitor of the hemopexin-like domain of MMP-9 (exosite), compound <b>20</b>, which reduced cancer cell migration and proliferation without modulating MMP-9 catalytic activity (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B).<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> The hemopexin domain of MT1-MMP was also exploited for exosite-based inhibitor development. In this case, a virtual ligand screening led to the identification of compound NSC405020 <b>21</b>, a small molecule that binds the MT1-MMP hemopexin domain, showed antitumor efficacy in vitro and impaired MT1-MMP homodimerization but not proteolytic activity (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B).<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> An unprecedented pharmacological approach was developed with compound JNJ0966 <b>22</b>, which selectively inhibits the conversion of inactive proMMP-9 into its active form by MMP-3, but neither inhibits active MMP-9 nor MMP-1, MMP-3, and MT1-MMP (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>B). Compound <b>22</b> was shown to interact directly with an exosite located near the proMMP-9 cleavage site inside the prodomain and to reduce experimental autoimmune encephalomyelitis in vivo, thus validating this pharmacological approach.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> Another small molecule inhibitor <b>23</b> that targets specifically the hemopexin domain of proMMP-9 (not proMMP-2, nor proMT1-MMP) has been discovered and shown to block in vivo cancer cell invasion and angiogenesis. This compound was designed by in silico studies, based on compound <b>20</b>, and demonstrated its ability to prevent proMMP-9 homodimerization which is critical for cell migration.<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a></div><div class="NLM_p last">The search for small organic molecules targeting the active site remains the most followed strategy at present. However, other strategies to control MMP activities via alternative exosites offer significant opportunities in MMP drug design.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">5.6.  Development of Macromolecules</h3><div class="NLM_p">Given the challenges of developing selective MMP inhibitors that target the catalytic site, exosites outside the catalytic site are now also being explored, as referred above.<a onclick="showRef(event, 'ref195 ref196 ref197'); return false;" href="javascript:void(0);" class="ref ref195 ref196 ref197">(195−197)</a> However, the relatively small size of peptides and/or small molecules limits the possibilities of targeting more specific interactions in more distant exosites. This goal can be more easily reached with emerging protein-based agents.<a onclick="showRef(event, 'ref209 ref210 ref211'); return false;" href="javascript:void(0);" class="ref ref209 ref210 ref211">(209−211)</a> Indeed, highly selective engineered mAb (or nanobodies) directed against different MMPs, including MMP-2, -8, -9, -13, and MT1-MMP, were developed targeting either exosites or the catalytic site.<a onclick="showRef(event, 'ref14 ref212 ref213 ref214'); return false;" href="javascript:void(0);" class="ref ref14 ref212 ref213 ref214">(14,212−214)</a> Another approach is to try to mimic the endogenous regulatory system of MMPs with endogenous-like inhibitors, i.e., TIMPs or pro-domain analogues, which are nontoxic and well-known.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> In this context, protein engineering tools have been used to design a family of N-terminally modified TIMPs.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> For example, a fusion protein consisting of the synthetic decapeptide APP-IP <b>14</b> and TIMP-2 was designed and demonstrated 10<sup>6</sup> greater inhibitory activity against MMP-2 (IC<sub>50</sub> 0.7 pM), compared to MMP-1, -3, -7, -8, -9, or MT1-MMP (IC<sub>50</sub> > 1 μM).<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> This protein-based inhibitor has shown its ability to interact both with the catalytic site and the hemopexin-like domain of MMP-2.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a></div><div class="NLM_p last">Although outstanding selectivity can be obtained with this type of macromolecules, a number of limitations have to be taken into account with these therapeutic agents, mainly high cost of production, difficulties in distribution/stability/clearance, permeability problems across the biological membranes, as well as immunogenicity.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">6.  Conclusions and Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We have presented in this article the complex roles of MMPs in physiological and pathological processes, as well as their potential therapeutic interest. Various types of therapeutic agents have been developed over time to address the challenge of making increasingly selective MMP modulators in order to decipher MMP specific functions and to limit side effects. Small molecules, peptides, or protein-based inhibitors are part of the repertoire of new molecules, and the discovery of specific exosites broadens the range of possibilities to generate new highly selective compounds. Some of the available agents demonstrate already their efficacy in in vivo models of several diseases such as atherosclerosis with MMP-12,<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> osteoarthritis with MMP-13,<a onclick="showRef(event, 'ref203 ref216 ref217 ref218'); return false;" href="javascript:void(0);" class="ref ref203 ref216 ref217 ref218">(203,216−218)</a> cancer,<a onclick="showRef(event, 'ref80 ref206 ref219 ref220 ref221'); return false;" href="javascript:void(0);" class="ref ref80 ref206 ref219 ref220 ref221">(80,206,219−221)</a> and rheumatoid arthritis<a onclick="showRef(event, 'ref222'); return false;" href="javascript:void(0);" class="ref ref222">(222)</a> with MT1-MMP. Some of them are currently involved in clinical trials, including andecaliximab (GS-5745), a mAb targeting MMP-9 for glioblastoma (NCT03631836) or FP-025 (Foresee Pharmaceutical), a MMP-12 nonhydroxamate inhibitor for allergic asthma (NCT03858686).</div><div class="NLM_p last">However, even if selectivity remains the primary objective at the moment, it is important to note the possible synergy of targeting more than one MMP for better efficacy through a polypharmacological approach. Along this line, we could cite ZHAWOC6941, a nonhydroxamate dual inhibitor of MMP-7 and MMP-13, two validated targets in cancer,<a onclick="showRef(event, 'ref223'); return false;" href="javascript:void(0);" class="ref ref223">(223)</a> or ZHAWOC7726, a TIMP peptidomimetic, with a good selectivity toward the anticancer targets MMP-13, MMP-2, and MMP-9.<a onclick="showRef(event, 'ref224'); return false;" href="javascript:void(0);" class="ref ref224">(224)</a> The use of multitarget agents with pleiotropic actions might highlight future trends in the field of neurodegenerative diseases, and especially AD, a complex multicausal disorder. This would imply targeting more than one MMP (among MMP-1, -2, -3, -9, -12, -13, MT1-MMP, or MT5-MMP) with pan-specific inhibitors,<a onclick="showRef(event, 'ref225'); return false;" href="javascript:void(0);" class="ref ref225">(225)</a> or combining targeting of one MMP with another target of interest in AD, e.g., cholinesterases.<a onclick="showRef(event, 'ref226'); return false;" href="javascript:void(0);" class="ref ref226">(226)</a> Beyond specificity considerations, targeting of MMPs in AD must take into account their generally wide distribution, with the exception of MT5-MMP, that is primarily expressed in the nervous system. Thus, inhibition of MT5-MMP may offer some advantage in terms of brain targeting relative to other MMP homologues. On the basis of progress in structural biology, design of druggable inhibitors toward MT5-MMP appears as a realistic achievement and makes it altogether a peculiarly promising target among MMPs for a positive impact in AD. In any event, therapeutic strategies should ideally consider delivery of active compounds with molecular conjugates that optimize access to the brain via the BBB. The prospects of future anti-MMP therapies in AD should also integrate the possibility that fragments resulting from substrate cleavage may be targets per se and their actions more easily modulated than the proteolytic processes that generate them. Increasing knowledge on the nature of MMP substrates, many of them inflammatory mediators, should open new avenues for therapeutic intervention in this domain as well. Finally, the chronic nature of AD and the fact that the pathological processes precede symptoms by 10–15 years makes it necessary to consider when to target a given MMP based on its pattern of expression over time during disease progression. A better knowledge of the spatiotemporal distribution of MMPs in the brain should therefore increase the chances of accurately defining the time frame of intervention. Overall, a thorough knowledge of the pathophysiological processes underlying AD appears to be an inevitable path to designing more effective therapeutic strategies, including those based on MMP inhibition.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00352" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Dallemagne</span> - <span class="hlFld-Affiliation affiliation">Normandie
Univ, UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le
Médicament de Normandie), F-14032 Caen, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4845-615X" title="Orcid link">http://orcid.org/0000-0002-4845-615X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1f6f7e6b6d767c74317b7e73737a727e78717a5f6a71767c7e7a7131796d"><span class="__cf_email__" data-cfemail="8cfcedf8fee5efe7a2e8ede0e0e9e1edebe2e9ccf9e2e5efede9e2a2eafe">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pauline Zipfel</span> - <span class="hlFld-Affiliation affiliation">Normandie
Univ, UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le
Médicament de Normandie), F-14032 Caen, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christophe Rochais</span> - <span class="hlFld-Affiliation affiliation">Normandie
Univ, UNICAEN, CERMN (Centre d’Etudes et de Recherche sur le
Médicament de Normandie), F-14032 Caen, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7996-2082" title="Orcid link">http://orcid.org/0000-0001-7996-2082</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kévin Baranger</span> - <span class="hlFld-Affiliation affiliation">Aix-Marseille
Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Santiago Rivera</span> - <span class="hlFld-Affiliation affiliation">Aix-Marseille
Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Pauline Zipfel</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=BIO-d7e1847-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Pauline Zipfel</b> obtained her Pharm.D. degree in 2017 from the University of Strasbourg (France). The same year, she joined the group of Prof. P. Dallemagne at the “Centre d’Etudes et de Recherche sur le Médicament de Normandie” (CERMN) laboratory at the University of Caen Normandy (France) for a Medicinal Chemistry Ph.D. position. She is currently working in her final year to complete her Ph.D., and her research is investigating the design, synthesis, and biological evaluation of first-in-class small molecule inhibitors of MT5-MMP, as an innovative strategy for the treatment of Alzheimer’s disease. She also decided to join in 2019 the European Federation for Medicinal Chemistry (EFMC) communication team to promote cooperation between medicinal chemists in Europe and around the World.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Christophe Rochais</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=BIO-d7e1852-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Christophe Rochais</b> received his Engineer Diploma in Chemistry from ENSCMu in 2002 and his Ph.D. in the group or Prof. S. Rault from the University of Caen Basse-Normandie (2002–2005). After a postdoctoral fellowship in the University of Nottingham, he was appointed Lecturer in Organic Chemistry in the School of Pharmacy at the University of Caen Normandie in 2007, and since 2014 he assumed the position of Professor. His research interests include medicinal chemistry program in the field of enzymatic inhibition and GPCR modulation to develop pharmacological tools and bioactive compounds. He is leading a research group dedicated to the development of pleiotropic agents of interest for Alzheimer’s disease and has been recently appointed as a member of the French National Academy of Pharmacy.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Kévin Baranger</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=BIO-d7e1857-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Kévin Baranger</b> received his Ph.D. in protein biochemistry within the group of Professor Thierry Moreau from the University of Tours in 2008. After completing a postdoctoral fellowship at the NICN lab of Aix-Marseille University (2009–2017), under the supervision of Dr. Santiago Rivera, he was appointed CNRS researcher at the Institute of NeuroPathophysiology UMR7051 at Aix-Marseille University. He is a specialist of proteinases/inhibitors in pathophysiologic processes. Since 2009, his work has been dedicated to understanding the role of MT5- and MT1-MMP in Alzheimer’s disease pathogenesis and to the development of new therapeutic strategies.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Santiago Rivera</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=BIO-d7e1862-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Santiago Rivera</b> received his Ph.D. in Neuroscience from the University of Barcelona in 1990. After a postdoctorate at the University of California (Irvine) and Inserm (Paris), he was appointed researcher at the CNRS in 1998 and became head of the Neural Plasticity and Degeneration group in 2002. In 2010, he was appointed Research Director at the CNRS, and since 2018 he is Deputy Director of the Institute of Neuropathophysiology at the University of Aix-Marseille. He is a member of the scientific advisory board of various Alzheimer’s disease foundations. Dr. Rivera’s work has focused primarily on the study of the pathophysiological mechanisms underlying neurodegenerative disorders, in particular the role of MMPs and their natural inhibitors, and on the search for innovative therapeutic approaches in Alzheimer’s disease.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Patrick Dallemagne</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=BIO-d7e1867-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Patrick Dallemagne</b> studied pharmacy at the University of Caen and obtained his Pharm.D. in 1983. He received his Ph.D. in Medicinal Chemistry in 1988 and his Habilitation Diploma in 1990. He became Associate Professor of Medicinal Chemistry at the University of Caen Normandie in 1991 and was received Professor in 1999. He is currently head of the Centre d’Etudes et de Recherche sur le Médicament de Normandie, where he developed a lot of novel compounds with therapeutic interest in oncology and neurosciences areas. Actually, his group works on programs concerning novel Multitarget directed ligands and recently succeeded in the design of donecopride, a first dual 5-HT<sub>4</sub>R agonist/AChEI currently in preclinical trials against Alzheimer’s disease. He is a member of the French National Academy of Pharmacy.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55531" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55531" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Ph.D. project of P.Z. (MT5-MMP “Design, Synthesis and Biological Evaluation of Novel MT5-MMP Inhibitors with Potential Interest for Alzheimer’s Disease”) is cofinanced by the European Union under the “FEDER-FSE 2014-2020” operational program and supported by France Alzheimer. This work is cofunded by Région Normandie. This work was supported by funding from the CNRS and Aix-Marseille Université, by France Alzheimer grants to S.R. and P.D., and by the French National Research Agency (ANR-MAD5) to S.R., as part of the second “Investissements d’Avenir” program. K.B. was granted by the Excellence Initiative of Aix-Marseille Université, A*MIDEX, a French “Investissements d’Avenir” program. Some pictures were created in part from Servier Medical Art (SMART) images, licensed under a Creative Common Attribution 3.0 Generic License. <a href="http://smart.servier.com/" class="extLink">http://smart.servier.com/</a></p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β peptide</p></td></tr><tr><td class="NLM_term">ADAM</td><td class="NLM_def"><p class="first last">a disintegrin and metalloproteinase domain</p></td></tr><tr><td class="NLM_term">AICD</td><td class="NLM_def"><p class="first last">APP intracellular domain</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">CTF</td><td class="NLM_def"><p class="first last">C-terminal fragment</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">mAb</td><td class="NLM_def"><p class="first last">monoclonal antibody</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">matrix metalloproteinase</p></td></tr><tr><td class="NLM_term">MT-MMP</td><td class="NLM_def"><p class="first last">membrane-type MMP</p></td></tr><tr><td class="NLM_term">sAPP</td><td class="NLM_def"><p class="first last">soluble APP</p></td></tr><tr><td class="NLM_term">TIMP</td><td class="NLM_def"><p class="first last">tissue inhibitor of matrix metalloproteinase</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc binding group</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 226 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, C.</span></span> <i>World Alzheimer Report 2018. The State of the Art of Dementia Research: New Frontiers</i>; <span class="NLM_publisher-name">London Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2018</span>; <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf</a> (accessed 2020-02-08).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=C.+Patterson&title=World+Alzheimer+Report+2018.+The+State+of+the+Art+of+Dementia+Research%3A+New+Frontiers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DC.%26jtitle%3DWorld%2520Alzheimer%2520Report%25202018.%2520The%2520State%2520of%2520the%2520Art%2520of%2520Dementia%2520Research%253A%2520New%2520Frontiers%26pub%3DLondon%2520Alzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandenbroucke, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span> <span> </span><span class="NLM_article-title">Is There New Hope for Therapeutic Matrix Metalloproteinase Inhibition?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">904</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1038/nrd4390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrd4390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25376097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2jtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=904-927&issue=12&author=R.+E.+Vandenbrouckeauthor=C.+Libert&title=Is+There+New+Hope+for+Therapeutic+Matrix+Metalloproteinase+Inhibition%3F&doi=10.1038%2Fnrd4390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Is there new hope for therapeutic matrix metalloproteinase inhibition?</span></div><div class="casAuthors">Vandenbroucke, Roosmarijn E.; Libert, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">904-927</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that form a family of 24 members in mammals.  Evidence of the pathol. roles of MMPs in various diseases, combined with their druggability, has made them attractive therapeutic targets.  Initial drug discovery efforts focused on the roles of MMPs in cancer progression, and more than 50 MMP inhibitors have been investigated in clin. trials in various cancers.  However, all of these trials failed.  Reasons for failure include the lack of inhibitor specificity and insufficient knowledge about the complexity of the disease biol.  MMPs are also known to be involved in several inflammatory processes, and there are new therapeutic opportunities for MMP inhibitors to treat such diseases.  In this Review, we discuss the recent advances made in understanding the role of MMPs in inflammatory diseases and the therapeutic potential of MMP inhibition in those conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpua2GBt8P5b7Vg90H21EOLACvtfcHk0lhrzBGx5G41cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2jtb3I&md5=032265fe59e9f7567e4d3c7d072b3cde</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd4390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4390%26sid%3Dliteratum%253Aachs%26aulast%3DVandenbroucke%26aufirst%3DR.%2BE.%26aulast%3DLibert%26aufirst%3DC.%26atitle%3DIs%2520There%2520New%2520Hope%2520for%2520Therapeutic%2520Matrix%2520Metalloproteinase%2520Inhibition%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26issue%3D12%26spage%3D904%26epage%3D927%26doi%3D10.1038%2Fnrd4390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maskos, K.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of MMPs in Complex with Physiological and Pharmacological Inhibitors</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2004.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.biochi.2004.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15781312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2005&pages=249-263&issue=3%E2%80%934&author=K.+Maskos&title=Crystal+Structures+of+MMPs+in+Complex+with+Physiological+and+Pharmacological+Inhibitors&doi=10.1016%2Fj.biochi.2004.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of MMPs in complex with physiological and pharmacological inhibitors</span></div><div class="casAuthors">Maskos, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">249-263</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of multidomain Zn-endopeptidases that function in the extracellular space or attached to the cell membrane.  Their proteolytic activity is controlled by the presence of endogenous inhibitors, including TIMPs, α-macroglobulin, and others.  Disruption of the proteinase-inhibitor balance is obsd. in serious diseases such as arthritis, tumor growth, and metastasis, rendering the MMPs attractive targets for drug intervention by pharmacol. inhibitors.  The detn. of MMP structures is of crit. importance in order to understand their substrate preferences, dimerization events, and their assocn. with matrix components and inhibitors.  Thus, MMP structures may contribute significantly to the development of specific MMP inhibitors, which should allow precise control of individual members of the MMP family without affecting all members or the closely related metalloproteinases such as ADAMs and ADAMTSs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN46VmWEyg47Vg90H21EOLACvtfcHk0lgAumhbGSjnvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVWqt7o%253D&md5=4e8015d72053e021c29d75b817326f67</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2004.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2004.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DMaskos%26aufirst%3DK.%26atitle%3DCrystal%2520Structures%2520of%2520MMPs%2520in%2520Complex%2520with%2520Physiological%2520and%2520Pharmacological%2520Inhibitors%26jtitle%3DBiochimie%26date%3D2005%26volume%3D87%26issue%3D3%25E2%2580%25934%26spage%3D249%26epage%3D263%26doi%3D10.1016%2Fj.biochi.2004.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagase, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, G.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of Matrix Metalloproteinases and TIMPs</span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1016/j.cardiores.2005.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.cardiores.2005.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16405877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=562-573&issue=3&author=H.+Nagaseauthor=R.+Visseauthor=G.+Murphy&title=Structure+and+Function+of+Matrix+Metalloproteinases+and+TIMPs&doi=10.1016%2Fj.cardiores.2005.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of matrix metalloproteinases and TIMPs</span></div><div class="casAuthors">Nagase, Hideaki; Visse, Robert; Murphy, Gillian</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">562-573</span>CODEN:
                <span class="NLM_cas:coden">CVREAU</span>;
        ISSN:<span class="NLM_cas:issn">0008-6363</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs), also called matrixins, function in the extracellular environment of cells and degrade both matrix and non-matrix proteins.  They play central roles in morphogenesis, wound healing, tissue repair and remodelling in response to injury, e.g. after myocardial infarction, and in progression of diseases such as atheroma, arthritis, cancer and chronic tissue ulcers.  They are multi-domain proteins and their activities are regulated by tissue inhibitors of metalloproteinases (TIMPs).  This review introduces the members of the MMP family and discusses their domain structure and function, proenyme activation, the mechanism of inhibition by TIMPs and their significance in physiol. and pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo77sy3-HPv0rVg90H21EOLACvtfcHk0lgAumhbGSjnvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVKitg%253D%253D&md5=2c9b99a424f3a604cc4dc899ddc41cd7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cardiores.2005.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardiores.2005.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DH.%26aulast%3DVisse%26aufirst%3DR.%26aulast%3DMurphy%26aufirst%3DG.%26atitle%3DStructure%2520and%2520Function%2520of%2520Matrix%2520Metalloproteinases%2520and%2520TIMPs%26jtitle%3DCardiovasc.%2520Res.%26date%3D2006%26volume%3D69%26issue%3D3%26spage%3D562%26epage%3D573%26doi%3D10.1016%2Fj.cardiores.2005.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, D. M.</span></span> <span> </span><span class="NLM_article-title">Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">15337</span>– <span class="NLM_lpage">15357</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3467-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.3467-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21084591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWitbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=15337-15357&issue=46&author=S.+Riveraauthor=M.+Khrestchatiskyauthor=L.+Kaczmarekauthor=G.+A.+Rosenbergauthor=D.+M.+Jaworski&title=Metzincin+Proteases+and+Their+Inhibitors%3A+Foes+or+Friends+in+Nervous+System+Physiology%3F&doi=10.1523%2FJNEUROSCI.3467-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?</span></div><div class="casAuthors">Rivera, Santiago; Khrestchatisky, Michel; Kaczmarek, Leszek; Rosenberg, Gary A.; Jaworski, Diane M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">15337-15357</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  Members of the metzincin family of metalloproteinases have long been considered merely degradative enzymes for extracellular matrix mols.  Recently, however, there was growing appreciation for these proteinases and their endogenous inhibitors, tissue inhibitors of metalloproteinases (TIMPs), as fine modulators of nervous system physiol. and pathol.  Present all along the phylogenetic tree, in all neural cell types, from the nucleus to the synapse and in the extracellular space, metalloproteinases exhibit a complex spatiotemporal profile of expression in the nervous parenchyma and at the neurovascular interface.  The irreversibility of their proteolytic activity on numerous biofactors (e.g., growth factors, cytokines, receptors, DNA repair enzymes, matrix proteins) is ideally suited to sustain structural changes that are involved in physiol. or postlesion remodeling of neural networks, learning consolidation or impairment, neurodegenerative and neuroinflammatory processes, or progression of malignant gliomas.  The present review provides a state of the art overview of the involvement of the metzincin/TIMP system in these processes and the prospects of new therapeutic strategies based on the control of metalloproteinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfLsAcOVia_LVg90H21EOLACvtfcHk0lgAumhbGSjnvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWitbzN&md5=4100fcb2749bca6f8e1ebdd5ac0dfc66</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3467-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3467-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DKaczmarek%26aufirst%3DL.%26aulast%3DRosenberg%26aufirst%3DG.%2BA.%26aulast%3DJaworski%26aufirst%3DD.%2BM.%26atitle%3DMetzincin%2520Proteases%2520and%2520Their%2520Inhibitors%253A%2520Foes%2520or%2520Friends%2520in%2520Nervous%2520System%2520Physiology%253F%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26issue%3D46%26spage%3D15337%26epage%3D15357%26doi%3D10.1523%2FJNEUROSCI.3467-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D. B. C.</span></span> <span> </span><span class="NLM_article-title">Recent Insights into Natural Product Inhibitors of Matrix Metalloproteinases</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2024</span>– <span class="NLM_lpage">2037</span>, <span class="refDoi"> DOI: 10.1039/C9MD00165D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1039%2FC9MD00165D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=32904148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFSqu7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2024-2037&issue=12&author=G.+B.+Kumarauthor=B.+G.+Nairauthor=J.+J.+P.+Perryauthor=D.+B.+C.+Martin&title=Recent+Insights+into+Natural+Product+Inhibitors+of+Matrix+Metalloproteinases&doi=10.1039%2FC9MD00165D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent insights into natural product inhibitors of matrix metalloproteinases</span></div><div class="casAuthors">Kumar, Geetha B.; Nair, Bipin G.; Perry, J. Jefferson P.; Martin, David B. C.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2024-2037</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Members of the matrix metalloproteinase (MMP) family have biol. functions that are central to human health and disease, and MMP inhibitors have been investigated for the treatment of cardiovascular disease, cancer and neurodegenerative disorders.  The outcomes of initial clin. trials with the first generation of MMP inhibitors proved disappointing.  However, our growing understanding of the complexities of the MMP function in disease, and an increased understanding of MMP protein architecture and control of activity now provide new opportunities and avenues to develop MMP-focused therapies.  Natural products that affect MMP activities have been of strong interest as templates for drug discovery, and for their use as chem. tools to help delineate the roles of MMPs that still remain to be defined.  Herein, we highlight the most recent discoveries of structurally diverse natural product inhibitors to these proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5GeivYWCCS7Vg90H21EOLACvtfcHk0liJYlWEjg8xKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSqu7%252FF&md5=66bb0d887885b178dc5246e1adeec2dd</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1039%2FC9MD00165D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9MD00165D%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DG.%2BB.%26aulast%3DNair%26aufirst%3DB.%2BG.%26aulast%3DPerry%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3DMartin%26aufirst%3DD.%2BB.%2BC.%26atitle%3DRecent%2520Insights%2520into%2520Natural%2520Product%2520Inhibitors%2520of%2520Matrix%2520Metalloproteinases%26jtitle%3DMedChemComm%26date%3D2019%26volume%3D10%26issue%3D12%26spage%3D2024%26epage%3D2037%26doi%3D10.1039%2FC9MD00165D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sternlicht, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werb, Z.</span></span> <span> </span><span class="NLM_article-title">How Matrix Metalloproteinases Regulate Cell Behavior</span>. <i>Annu. Rev. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1146/annurev.cellbio.17.1.463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1146%2Fannurev.cellbio.17.1.463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11687497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1Omsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2001&pages=463-516&issue=1&author=M.+D.+Sternlichtauthor=Z.+Werb&title=How+Matrix+Metalloproteinases+Regulate+Cell+Behavior&doi=10.1146%2Fannurev.cellbio.17.1.463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">How matrix metalloproteinases regulate cell behavior</span></div><div class="casAuthors">Sternlicht, Mark D.; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">463-516</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) constitute a multigene family of over 25 secreted and cell surface enzymes that process or degrade numerous pericellular substrates.  Their targets include other proteinases, proteinase inhibitors, clotting factors, chemotactic mols., latent growth factors, growth factor-binding proteins, cell surface receptors, cell-cell adhesion mols., and virtually all structural extracellular matrix proteins.  Thus MMPs are able to regulate many biol. processes and are closely regulated themselves.  We review recent advances that help to explain how MMPs work, how they are controlled, and how they influence biol. behavior.  These advances shed light on how the structure and function of the MMPs are related and on how their transcription, secretion, activation, inhibition, localization, and clearance are controlled.  MMPs participate in numerous normal and abnormal processes, and there are new insights into the key substrates and mechanisms responsible for regulating some of these processes in vivo.  Our knowledge in the field of MMP biol. is rapidly expanding, yet we still do not fully understand how these enzymes regulate most processes of development, homeostasis, and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzwWw3I6HsLLVg90H21EOLACvtfcHk0liJYlWEjg8xKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1Omsbs%253D&md5=5af2db8479b20df72e8a9d083c92ae2b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.17.1.463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.17.1.463%26sid%3Dliteratum%253Aachs%26aulast%3DSternlicht%26aufirst%3DM.%2BD.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DHow%2520Matrix%2520Metalloproteinases%2520Regulate%2520Cell%2520Behavior%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2001%26volume%3D17%26issue%3D1%26spage%3D463%26epage%3D516%26doi%3D10.1146%2Fannurev.cellbio.17.1.463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Page-McCaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewald, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werb, Z.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases and the Regulation of Tissue Remodelling</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/nrm2125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrm2125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17318226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVGrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=221-233&issue=3&author=A.+Page-McCawauthor=A.+J.+Ewaldauthor=Z.+Werb&title=Matrix+Metalloproteinases+and+the+Regulation+of+Tissue+Remodelling&doi=10.1038%2Fnrm2125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and the regulation of tissue remodelling</span></div><div class="casAuthors">Page-McCaw, Andrea; Ewald, Andrew J.; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-233</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) were discovered because of their role in amphibian metamorphosis, yet they have attracted more attention because of their roles in disease.  Despite intensive scrutiny in vitro, in cell culture and in animal models, the normal physiol. roles of these extracellular proteases have been elusive.  Recent studies in mice and flies point to essential roles of MMPs as mediators of change and phys. adaptation in tissues, whether developmentally regulated, environmentally induced or disease assocd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruFGsYuEMGL7Vg90H21EOLACvtfcHk0liJYlWEjg8xKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVGrs74%253D&md5=8c3655e653939cd016e2949c6b017e93</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrm2125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2125%26sid%3Dliteratum%253Aachs%26aulast%3DPage-McCaw%26aufirst%3DA.%26aulast%3DEwald%26aufirst%3DA.%2BJ.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DMatrix%2520Metalloproteinases%2520and%2520the%2520Regulation%2520of%2520Tissue%2520Remodelling%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26issue%3D3%26spage%3D221%26epage%3D233%26doi%3D10.1038%2Fnrm2125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaffney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomonov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehorai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Multilevel Regulation of Matrix Metalloproteinases in Tissue Homeostasis Indicates Their Molecular Specificity in Vivo</span>. <i>Matrix Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44–46</i></span> (<span class="NLM_issue">Ldl</span>),  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/j.matbio.2015.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.matbio.2015.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25622911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFChsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44%E2%80%9346&publication_year=2015&pages=191-199&issue=Ldl&author=J.+Gaffneyauthor=I.+Solomonovauthor=E.+Zehoraiauthor=I.+Sagi&title=Multilevel+Regulation+of+Matrix+Metalloproteinases+in+Tissue+Homeostasis+Indicates+Their+Molecular+Specificity+in+Vivo&doi=10.1016%2Fj.matbio.2015.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Multilevel regulation of matrix metalloproteinases in tissue homeostasis indicates their molecular specificity in vivo</span></div><div class="casAuthors">Gaffney, Jean; Solomonov, Inna; Zehorai, Eldar; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Matrix Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44-46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-199</span>CODEN:
                <span class="NLM_cas:coden">MTBOEC</span>;
        ISSN:<span class="NLM_cas:issn">0945-053X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) play a crucial role in irreversible remodeling of the extracellular matrix (ECM) in normal homeostasis and pathol. states.  Accumulating data from various studies strongly suggest that MMPs are tightly regulated, starting from the level of gene expression all the way to zymogen activation and endogenous inhibition, with each level controlled by multiple factors.  Recent in vivo findings indicate that cell-ECM and cell-cell interactions, as well as ECM bio-active products, contribute an addnl. layer of regulation at all levels, indicating that individual MMP expression and activity in vivo are highly coordinated and tissue specific processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczmX5xOgBnbVg90H21EOLACvtfcHk0ljCPFYObPkCYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFChsL0%253D&md5=b2e2f0a1a371681655144defe7d2375b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.matbio.2015.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.matbio.2015.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DGaffney%26aufirst%3DJ.%26aulast%3DSolomonov%26aufirst%3DI.%26aulast%3DZehorai%26aufirst%3DE.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DMultilevel%2520Regulation%2520of%2520Matrix%2520Metalloproteinases%2520in%2520Tissue%2520Homeostasis%2520Indicates%2520Their%2520Molecular%2520Specificity%2520in%2520Vivo%26jtitle%3DMatrix%2520Biol.%26date%3D2015%26volume%3D44%25E2%2580%259346%26issue%3DLdl%26spage%3D191%26epage%3D199%26doi%3D10.1016%2Fj.matbio.2015.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span>; <span class="NLM_string-name">Rivera, S.</span>; <span class="NLM_string-name">Liechti, F. D.</span>; <span class="NLM_string-name">Grandgirard, D.</span>; <span class="NLM_string-name">Bigas, J.</span>; <span class="NLM_string-name">Seco, J.</span>; <span class="NLM_string-name">Tarrago, T.</span>; <span class="NLM_string-name">Leib, S. L.</span>; <span class="NLM_string-name">Khrestchatisky, M.</span></span> <span> </span><span class="NLM_article-title">Endogenous and Synthetic MMP Inhibitors in CNS Physiopathology</span>; In <span class="NLM_publisher-loc">Progress in Brain Research</span>, <span class="NLM_year">2014</span>; Chapter 214, pp  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1016/B978-0-444-63486-3.00014-1</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FB978-0-444-63486-3.00014-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Baranger%2C+K.%3B+Rivera%2C+S.%3B+Liechti%2C+F.+D.%3B+Grandgirard%2C+D.%3B+Bigas%2C+J.%3B+Seco%2C+J.%3B+Tarrago%2C+T.%3B+Leib%2C+S.+L.%3B+Khrestchatisky%2C+M.+Endogenous+and+Synthetic+MMP+Inhibitors+in+CNS+Physiopathology%3B+In+Progress+in+Brain+Research%2C+2014%3B+Chapter+214%2C+pp+313%E2%80%93351+10.1016%2FB978-0-444-63486-3.00014-1."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-63486-3.00014-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-444-63486-3.00014-1%26sid%3Dliteratum%253Aachs%26aulast%3DBaranger%26aufirst%3DK.%26atitle%3DEndogenous%2520and%2520Synthetic%2520MMP%2520Inhibitors%2520in%2520CNS%2520Physiopathology%26date%3D2014%26spage%3D313%26epage%3D351%26doi%3D10.1016%2FB978-0-444-63486-3.00014-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brew, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinakarpandian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagase, H.</span></span> <span> </span><span class="NLM_article-title">Tissue Inhibitors of Metalloproteinases: Evolution, Structure and Function</span>. <i>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1477</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1016/S0167-4838(99)00279-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0167-4838%2899%2900279-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10708863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsFGktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1477&publication_year=2000&pages=267-283&issue=1%E2%80%932&author=K.+Brewauthor=D.+Dinakarpandianauthor=H.+Nagase&title=Tissue+Inhibitors+of+Metalloproteinases%3A+Evolution%2C+Structure+and+Function&doi=10.1016%2FS0167-4838%2899%2900279-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue inhibitors of metalloproteinases: evolution, structure and function</span></div><div class="casAuthors">Brew, K.; Dinakarpandian, D.; Nagase, H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1477</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">267-283</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 74 refs.  Matrix metalloproteinases (MMPs) play a key role in the normal physiol. of connective tissue during development, morphogenesis, and wound healing, but their unregulated activity has been implicated in numerous disease processes including arthritis, tumor cell metastasis, and atherosclerosis.  An important mechanism for the regulation of the activity of MMPs is via binding to a family of homologous proteins referred to as TIMPs (TIMP-1 to TIMP-4).  The 2-domain TIMPs are of relatively small size, yet have been found to exhibit several biochem. and physiol./biol. functions, including inhibition of active MMPs, proMMP activation, cell growth promotion, matrix binding, inhibition of angiogenesis, and the induction of apoptosis.  Mutations in TIMP-3 are the cause of Sorsby's fundus dystrophy in humans, a disease that results in early onset macular degeneration.  This review highlights the evolution of TIMPs, the recently elucidated high-resoln. structures of TIMPs and their complexes with metalloproteinases, and the results of mutational and other studies of structure-function relations that have enhanced the understanding of the mechanism and specificity of the inhibition of MMPs by TIMPs.  Several intriguing questions, such as the basis of the multiple biol. functions of TIMPs, the kinetics of TIMP-MMP interactions, and the differences in binding in some TIMP-metalloproteinase pairs are discussed which, although not fully resolved, serve to illustrate the kind of issues that are important for a full understanding of the interactions between families of mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKocbVzzBH47Vg90H21EOLACvtfcHk0ljCPFYObPkCYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsFGktbs%253D&md5=f797232a6ea04d3d5e5f9e983477da8b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2899%2900279-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252899%252900279-4%26sid%3Dliteratum%253Aachs%26aulast%3DBrew%26aufirst%3DK.%26aulast%3DDinakarpandian%26aufirst%3DD.%26aulast%3DNagase%26aufirst%3DH.%26atitle%3DTissue%2520Inhibitors%2520of%2520Metalloproteinases%253A%2520Evolution%252C%2520Structure%2520and%2520Function%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D2000%26volume%3D1477%26issue%3D1%25E2%2580%25932%26spage%3D267%26epage%3D283%26doi%3D10.1016%2FS0167-4838%2899%2900279-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stamenkovic, I.</span></span> <span> </span><span class="NLM_article-title">Extracellular Matrix Remodelling: The Role of Matrix Metalloproteinases</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>200</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">448</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1002/path.1400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fpath.1400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12845612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvF2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2003&pages=448-464&issue=4&author=I.+Stamenkovic&title=Extracellular+Matrix+Remodelling%3A+The+Role+of+Matrix+Metalloproteinases&doi=10.1002%2Fpath.1400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular matrix remodelling: the role of matrix metalloproteinases</span></div><div class="casAuthors">Stamenkovic, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">448-464</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a growing family of metalloendopeptidases that cleave the protein components of the extracellular matrix and thereby play a central role in tissue remodelling.  For many years following their discovery, MMPs were believed to function primarily as regulators of ECM compn. and to facilitate cell migration simply by removing barriers such as collagen.  It is becoming increasingly clear, however, that MMPs are implicated in the functional regulation of a host of non-ECM mols. that include growth factors and their receptors, cytokines and chemokines, adhesion receptors and cell surface proteoglycans, and a variety of enzymes.  MMPs therefore play an important role in the control of cellular interactions with and response to their environment in conditions that promote tissue turnover, be they physiol., such as normal development, or pathol., such as inflammation and cancer.  This review summarizes some of the recent discoveries that have shed new light on the role of MMPs in physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAyYsJuRleu7Vg90H21EOLACvtfcHk0ljCPFYObPkCYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvF2ns7g%253D&md5=b0c96583501213ed146c9396563361cd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fpath.1400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1400%26sid%3Dliteratum%253Aachs%26aulast%3DStamenkovic%26aufirst%3DI.%26atitle%3DExtracellular%2520Matrix%2520Remodelling%253A%2520The%2520Role%2520of%2520Matrix%2520Metalloproteinases%26jtitle%3DJ.%2520Pathol.%26date%3D2003%26volume%3D200%26issue%3D4%26spage%3D448%26epage%3D464%26doi%3D10.1002%2Fpath.1400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parks, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Boado, Y. S.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases as Modulators of Inflammation and Innate Immunity</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1038/nri1418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnri1418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15286728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=617-629&issue=8&author=W.+C.+Parksauthor=C.+L.+Wilsonauthor=Y.+S.+L%C3%B3pez-Boado&title=Matrix+Metalloproteinases+as+Modulators+of+Inflammation+and+Innate+Immunity&doi=10.1038%2Fnri1418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases as modulators of inflammation and innate immunity</span></div><div class="casAuthors">Parks, William C.; Wilson, Carole L.; Lopez-Boado, Yolanda S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">617-629</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  As their name implies, matrix metalloproteinases are thought to be responsible for the turnover and degrdn. of the extracellular matrix.  However, matrix degrdn. is neither the sole nor the main function of these proteinases.  Indeed, as the authors discuss here, recent findings indicate that matrix metalloproteinases act on pro-inflammatory cytokines, chemokines and other proteins to regulate varied aspects of inflammation and immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBtb_YA4ZbNbVg90H21EOLACvtfcHk0lgWTPzJuF8sVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWktrc%253D&md5=2f0172ac025916666fda425f6869c360</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnri1418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1418%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DW.%2BC.%26aulast%3DWilson%26aufirst%3DC.%2BL.%26aulast%3DL%25C3%25B3pez-Boado%26aufirst%3DY.%2BS.%26atitle%3DMatrix%2520Metalloproteinases%2520as%2520Modulators%2520of%2520Inflammation%2520and%2520Innate%2520Immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2004%26volume%3D4%26issue%3D8%26spage%3D617%26epage%3D629%26doi%3D10.1038%2Fnri1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomonov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Next Generation Matrix Metalloproteinase Inhibitors — Novel Strategies Bring New Prospects</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1864</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1927</span>– <span class="NLM_lpage">1939</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2017.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbamcr.2017.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28636874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCrtbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2017&pages=1927-1939&issue=11&author=M.+Levinauthor=Y.+Udiauthor=I.+Solomonovauthor=I.+Sagi&title=Next+Generation+Matrix+Metalloproteinase+Inhibitors+%E2%80%94+Novel+Strategies+Bring+New+Prospects&doi=10.1016%2Fj.bbamcr.2017.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects</span></div><div class="casAuthors">Levin, Maxim; Udi, Yael; Solomonov, Inna; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">11_Part_A</span>),
    <span class="NLM_cas:pages">1927-1939</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enzymic proteolysis of cell surface proteins and extracellular matrix (ECM) is crit. for tissue homeostasis and cell signaling.  These proteolytic activities are mediated predominantly by a family of proteases termed matrix metalloproteinases (MMPs).  The growing evidence in recent years that ECM and non-ECM bioactive mols. (e.g., growth factors, cytokines, chemokines, on top of matrikines and matricryptins) have versatile functions redefines our view on the roles matrix remodeling enzymes play in many physiol. and pathol. processes, and underscores the notion that ECM proteolytic reaction mechanisms represent master switches in the regulation of crit. biol. processes and govern cell behavior.  Accordingly, MMPs are not only responsible for direct degrdn. of ECM mols. but are also key modulators of cardinal bioactive factors.  Many attempts were made to manipulate ECM degrdn. by targeting MMPs using small peptidic and org. inhibitors.  However, due to the high structural homol. shared by these enzymes, the majority of the developed compds. are broad-spectrum inhibitors affecting the proteolytic activity of various MMPs and other zinc-related proteases.  These inhibitors, in many cases, failed as therapeutic agents, mainly due to the bilateral role of MMPs in pathol. conditions such as cancer, in which MMPs have both pro- and anti-tumorigenic effects.  Despite the important role of MMPs in many human diseases, none of the broad-range synthetic MMP inhibitors that were designed have successfully passed clin. trials.  It appears that, designing highly selective MMP inhibitors that are also effective in vivo, is not trivial.  The challenges related to designing selective and effective metalloprotease inhibitors, are assocd. in part with the aforesaid high structural homol. and the dynamic nature of their protein scaffolds.  Great progress was achieved in the last decade in understanding the biochem. and biol. of MMPs activity.  This knowledge, combined with lessons from the past has drawn new "boundaries" for the development of the next-generation MMP inhibitors.  These novel agents are currently designed to be highly specific, capable to discriminate between the homologous MMPs and ideally administered as a short-term topical treatment.  In this review we discuss the latest progress in the fields of MMP inhibitors in terms of structure, function and their specific activity.  The development of novel highly specific inhibitors targeting MMPs paves the path to study complex biol. processes assocd. with ECM proteolysis in health and disease.  This article is part of a Special Issue entitled: Matrix Metalloproteinases edited by Rafael Fridman.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoxMizX3oHyrVg90H21EOLACvtfcHk0lgWTPzJuF8sVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCrtbjL&md5=245b0e34dd6cedaf2b301400dded146f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2017.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2017.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DM.%26aulast%3DUdi%26aufirst%3DY.%26aulast%3DSolomonov%26aufirst%3DI.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DNext%2520Generation%2520Matrix%2520Metalloproteinase%2520Inhibitors%2520%25E2%2580%2594%2520Novel%2520Strategies%2520Bring%2520New%2520Prospects%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2017%26volume%3D1864%26issue%3D11%26spage%3D1927%26epage%3D1939%26doi%3D10.1016%2Fj.bbamcr.2017.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleifeld, O.</span></span> <span> </span><span class="NLM_article-title">Validating Matrix Metalloproteinases as Drug Targets and Anti-Targets for Cancer Therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1038/nrc1821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrc1821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16498445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=227-239&issue=3&author=C.+M.+Overallauthor=O.+Kleifeld&title=Validating+Matrix+Metalloproteinases+as+Drug+Targets+and+Anti-Targets+for+Cancer+Therapy&doi=10.1038%2Fnrc1821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour microenvironment - Opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span></div><div class="casAuthors">Overall, Christopher M.; Kleifeld, Oded</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-239</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) mediate homeostasis of the extracellular environment.  They have multiple signaling activities that are commonly altered during tumorigenesis and that might serve as intervention points for anticancer drugs.  However, there are many criteria to consider in validating MMPs as drug targets and for the development of MMP inhibitors.  The inhibition of some MMPs could have pro-tumorigenic effects (making them anti-targets), counterbalancing the benefits of target inhibition.  These effects might partially account for the failure of MMP inhibitors in clin. trials.  What are the major challenges in MMP target validation and MMP-inhibitor-drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3iBQEggRc7Vg90H21EOLACvtfcHk0lgWTPzJuF8sVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D&md5=3edfeca153a62c759443d0893a6212e2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc1821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1821%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DValidating%2520Matrix%2520Metalloproteinases%2520as%2520Drug%2520Targets%2520and%2520Anti-Targets%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26issue%3D3%26spage%3D227%26epage%3D239%26doi%3D10.1038%2Fnrc1821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fingleton, B.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases as Valid Clinical Targets</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.2174/138161207779313551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F138161207779313551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17313364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlWhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=333-346&issue=3&author=B.+Fingleton&title=Matrix+Metalloproteinases+as+Valid+Clinical+Targets&doi=10.2174%2F138161207779313551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases as valid clinical targets</span></div><div class="casAuthors">Fingleton, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">333-346</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinase family of enzymes was a pharmaceutical target for over 20 years.  In that time, many drugs were developed but none have successfully passed clin. trials.  A significant problem was development of dose-limiting side-effects that were revealed during long-term clin. trials in diseases such as arthritis and various cancers.  There are, however, other clin. settings where evidence for MMP function contributing to the pathophysiol. of disease is strong.  A no. of these settings will be discussed here together with evidence from animal models that MMP inhibition is a valid strategy to be considered.  A major advantage with many of these settings is that drug exposure may not have to be long-term and/or systemic thus reducing the possibility that side-effects will stymie MMPI-based therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYKVax9TQ4HrVg90H21EOLACvtfcHk0lgwhuEfNIrgBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlWhsLo%253D&md5=0023ab6fa8337c8bbac5e21029ff47e6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F138161207779313551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161207779313551%26sid%3Dliteratum%253Aachs%26aulast%3DFingleton%26aufirst%3DB.%26atitle%3DMatrix%2520Metalloproteinases%2520as%2520Valid%2520Clinical%2520Targets%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2007%26volume%3D13%26issue%3D3%26spage%3D333%26epage%3D346%26doi%3D10.2174%2F138161207779313551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brkic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balusu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenbroucke, R. E.</span></span> <span> </span><span class="NLM_article-title">Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2015</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1155/2015/620581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1155%2F2015%2F620581" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2015&publication_year=2015&pages=1-27&author=M.+Brkicauthor=S.+Balusuauthor=C.+Libertauthor=R.+E.+Vandenbroucke&title=Friends+or+Foes%3A+Matrix+Metalloproteinases+and+Their+Multifaceted+Roles+in+Neurodegenerative+Diseases&doi=10.1155%2F2015%2F620581"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1155%2F2015%2F620581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2015%252F620581%26sid%3Dliteratum%253Aachs%26aulast%3DBrkic%26aufirst%3DM.%26aulast%3DBalusu%26aufirst%3DS.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DVandenbroucke%26aufirst%3DR.%2BE.%26atitle%3DFriends%2520or%2520Foes%253A%2520Matrix%2520Metalloproteinases%2520and%2520Their%2520Multifaceted%2520Roles%2520in%2520Neurodegenerative%2520Diseases%26jtitle%3DMediators%2520Inflammation%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D27%26doi%3D10.1155%2F2015%2F620581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-González, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span> <span> </span><span class="NLM_article-title">Metalloproteinases and Their Tissue Inhibitors in Alzheimer’s Disease and Other Neurodegenerative Disorders</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3167</span>– <span class="NLM_lpage">3191</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03178-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03178-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31197405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFKqtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3167-3191&issue=16&author=S.+Riveraauthor=L.+Garc%C3%ADa-Gonz%C3%A1lezauthor=M.+Khrestchatiskyauthor=K.+Baranger&title=Metalloproteinases+and+Their+Tissue+Inhibitors+in+Alzheimer%E2%80%99s+Disease+and+Other+Neurodegenerative+Disorders&doi=10.1007%2Fs00018-019-03178-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders</span></div><div class="casAuthors">Rivera, Santiago; Garcia-Gonzalez, Laura; Khrestchatisky, Michel; Baranger, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3167-3191</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  As life expectancy increases worldwide, age-related neurodegenerative diseases will increase in parallel.  The lack of effective treatment strategies may soon lead to an unprecedented health, social and economic crisis.  Any attempt to halt the progression of these diseases requires a thorough knowledge of the pathophysiol. mechanisms involved to facilitate the identification of new targets and the application of innovative therapeutic strategies.  The metzincin superfamily of metalloproteinases includes matrix metalloproteinases (MMP), a disintegrin and metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS).  These multigenic and multifunctional proteinase families regulate the functions of an increasing no. of signalling and scaffolding mols. involved in neuroinflammation, blood-brain barrier disruption, protein misfolding, synaptic dysfunction or neuronal death.  Metalloproteinases and their physiol. inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), are therefore, at the crossroads of mol. and cellular mechanisms that support neurodegenerative processes, and emerge as potential new therapeutic targets.  We provide an overview of current knowledge on the role and regulation of metalloproteinases and TIMPs in four major neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkTuzJDrAsULVg90H21EOLACvtfcHk0lgwhuEfNIrgBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFKqtLvF&md5=673f1fa0c8e5a9d7ccf09e36f101d64b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03178-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03178-2%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DGarc%25C3%25ADa-Gonz%25C3%25A1lez%26aufirst%3DL.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DBaranger%26aufirst%3DK.%26atitle%3DMetalloproteinases%2520and%2520Their%2520Tissue%2520Inhibitors%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Other%2520Neurodegenerative%2520Disorders%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3167%26epage%3D3191%26doi%3D10.1007%2Fs00018-019-03178-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dzwonek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rylski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases and Their Endogenous Inhibitors in Neuronal Physiology of the Adult Brain</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>567</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2004.03.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.febslet.2004.03.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15165905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVGhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=567&publication_year=2004&pages=129-135&issue=1&author=J.+Dzwonekauthor=M.+Rylskiauthor=L.+Kaczmarek&title=Matrix+Metalloproteinases+and+Their+Endogenous+Inhibitors+in+Neuronal+Physiology+of+the+Adult+Brain&doi=10.1016%2Fj.febslet.2004.03.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain</span></div><div class="casAuthors">Dzwonek, Joanna; Rylski, Marcin; Kaczmarek, Leszek</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">567</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-135</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  More than 20 matrix metalloproteinases (MMPs) and four of their endogenous tissue inhibitors (TIMPs) act together to control tightly temporally restricted, focal proteolysis of extracellular matrix.  In the neurons of the adult brain several components of the TIMP/MMP system are expressed and are responsive to changes in neuronal activity.  Furthermore, functional studies, esp. involving blocking of MMP activities, along with the identification of MMP substrates in the brain strongly suggest that this enzymic system plays an important physiol. role in adult brain neurons, possibly being pivotal for neuronal plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1-hrHbZhH-LVg90H21EOLACvtfcHk0lgwhuEfNIrgBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVGhtL8%253D&md5=4cad884f15616d01706fb4372c292929</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2004.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2004.03.070%26sid%3Dliteratum%253Aachs%26aulast%3DDzwonek%26aufirst%3DJ.%26aulast%3DRylski%26aufirst%3DM.%26aulast%3DKaczmarek%26aufirst%3DL.%26atitle%3DMatrix%2520Metalloproteinases%2520and%2520Their%2520Endogenous%2520Inhibitors%2520in%2520Neuronal%2520Physiology%2520of%2520the%2520Adult%2520Brain%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D567%26issue%3D1%26spage%3D129%26epage%3D135%26doi%3D10.1016%2Fj.febslet.2004.03.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V.</span></span> <span> </span><span class="NLM_article-title">MMPs in the Central Nervous System: Where the Good Guys Go Bad</span>. <i>Semin. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.semcdb.2007.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.semcdb.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17646116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=42-51&issue=1&author=S.+Agrawalauthor=L.+Lauauthor=V.+Yong&title=MMPs+in+the+Central+Nervous+System%3A+Where+the+Good+Guys+Go+Bad&doi=10.1016%2Fj.semcdb.2007.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">MMPs in the central nervous system: Where the good guys go bad</span></div><div class="casAuthors">Agrawal, Smriti M.; Lau, Lorraine; Yong, V. Wee</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-51</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are expressed in the developing, healthy adult and diseased CNS.  We emphasize the regulation of neurogenesis and oligodendrogenesis by MMPs during CNS development, and highlight physiol. roles of MMPs in the healthy adult CNS, such as in synaptic plasticity, learning and memory.  Nonetheless, MMPs as "the good guys" go bad in neurol. conditions, likely aided by the sudden and massive upregulation of several MMP members.  We stress the necessity of drawing a fine balance in the treatment of neurol. diseases, and we suggest that MMP inhibitors do have therapeutic potential early after CNS injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIq75CDeMzKrVg90H21EOLACvtfcHk0liAowu7MGTKMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtLbM&md5=420efe9ae3a47284b9b6c578f86a9dc8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DLau%26aufirst%3DL.%26aulast%3DYong%26aufirst%3DV.%26atitle%3DMMPs%2520in%2520the%2520Central%2520Nervous%2520System%253A%2520Where%2520the%2520Good%2520Guys%2520Go%2520Bad%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2008%26volume%3D19%26issue%3D1%26spage%3D42%26epage%3D51%26doi%3D10.1016%2Fj.semcdb.2007.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brzdak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiera, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozrzymas, J. W.</span></span> <span> </span><span class="NLM_article-title">Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.3389/fncel.2017.00178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3389%2Ffncel.2017.00178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28154525" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=1-22&author=P.+Brzdakauthor=D.+Nowakauthor=G.+Wieraauthor=J.+W.+Mozrzymas&title=Multifaceted+Roles+of+Metzincins+in+CNS+Physiology+and+Pathology%3A+From+Synaptic+Plasticity+and+Cognition+to+Neurodegenerative+Disorders&doi=10.3389%2Ffncel.2017.00178"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2017.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2017.00178%26sid%3Dliteratum%253Aachs%26aulast%3DBrzdak%26aufirst%3DP.%26aulast%3DNowak%26aufirst%3DD.%26aulast%3DWiera%26aufirst%3DG.%26aulast%3DMozrzymas%26aufirst%3DJ.%2BW.%26atitle%3DMultifaceted%2520Roles%2520of%2520Metzincins%2520in%2520CNS%2520Physiology%2520and%2520Pathology%253A%2520From%2520Synaptic%2520Plasticity%2520and%2520Cognition%2520to%2520Neurodegenerative%2520Disorders%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2017%26volume%3D11%26spage%3D1%26epage%3D22%26doi%3D10.3389%2Ffncel.2017.00178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beroun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaluk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pijet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefaniuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span> <span> </span><span class="NLM_article-title">MMPs in Learning and Memory and Neuropsychiatric Disorders</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3207</span>– <span class="NLM_lpage">3228</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03180-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03180-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31172215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3207-3228&issue=16&author=A.+Berounauthor=S.+Mitraauthor=P.+Michalukauthor=B.+Pijetauthor=M.+Stefaniukauthor=L.+Kaczmarek&title=MMPs+in+Learning+and+Memory+and+Neuropsychiatric+Disorders&doi=10.1007%2Fs00018-019-03180-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">MMPs in learning and memory and neuropsychiatric disorders</span></div><div class="casAuthors">Beroun, Anna; Mitra, Shiladitya; Michaluk, Piotr; Pijet, Barbara; Stefaniuk, Marzena; Kaczmarek, Leszek</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3207-3228</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are a group of over twenty proteases, operating chiefly extracellularly to cleave components of the extracellular matrix, cell adhesion mols. as well as cytokines and growth factors.  By virtue of their expression and activity patterns in animal models and clin. investigations, as well as functional studies with gene knockouts and enzyme inhibitors, MMPs have been demonstrated to play a paramount role in many physiol. and pathol. processes in the brain.  In particular, they have been shown to influence learning and memory processes, as well as major neuropsychiatric disorders such as schizophrenia, various kinds of addiction, epilepsy, fragile X syndrome, and depression.  A possible link connecting all those conditions is either physiol. or aberrant synaptic plasticity where some MMPs, e.g., MMP-9, have been demonstrated to contribute to the structural and functional reorganization of excitatory synapses that are located on dendritic spines.  Another common theme linking the aforementioned pathol. conditions is neuroinflammation and MMPs have also been shown to be important mediators of immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvmSrkxQ1bZbVg90H21EOLACvtfcHk0liAowu7MGTKMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtb3N&md5=b9f915c9a3c7d3455a22107e055e721e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03180-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03180-8%26sid%3Dliteratum%253Aachs%26aulast%3DBeroun%26aufirst%3DA.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DMichaluk%26aufirst%3DP.%26aulast%3DPijet%26aufirst%3DB.%26aulast%3DStefaniuk%26aufirst%3DM.%26aulast%3DKaczmarek%26aufirst%3DL.%26atitle%3DMMPs%2520in%2520Learning%2520and%2520Memory%2520and%2520Neuropsychiatric%2520Disorders%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3207%26epage%3D3228%26doi%3D10.1007%2Fs00018-019-03180-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kacervosky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salesse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowing, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambaldi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaubien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmbeck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloutier, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, A. E.</span></span> <span> </span><span class="NLM_article-title">MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0962-17.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.0962-17.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29196321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsF2rtL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=518-529&issue=3&author=R.+L.+Sanzauthor=G.+B.+Ferraroauthor=J.+Kacervoskyauthor=C.+Salesseauthor=E.+Gowingauthor=L.+Huaauthor=I.+Rambaldiauthor=F.+Beaubienauthor=K.+Holmbeckauthor=J.+F.+Cloutierauthor=M.+Levesqueauthor=K.+Muraiauthor=A.+E.+Fournier&title=MT3-MMP+Promotes+Excitatory+Synapse+Formation+by+Promoting+Nogo-66+Receptor+Ectodomain+Shedding&doi=10.1523%2FJNEUROSCI.0962-17.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">MT3-MMP promotes excitatory synapse formation by promoting Nogo-66 receptor ectodomain shedding</span></div><div class="casAuthors">Sanz, Ricardo L.; Ferraro, Gino B.; Kacervosky, Johannes; Salesse, Charleen; Gowing, Elizabeth; Hua, Luyang; Rambaldi, Isabel; Beaubien, Francois; Holmbeck, Kenn; Cloutier, J. F.; Levesque, Martin; Murai, Keith; Fournier, Alyson E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">518-529</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">1529-2401</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Cell-surface mols. are dynamically regulated at the synapse to assemble and disassemble adhesive contacts that are important for synaptogenesis and for tuning synaptic transmission.  Metalloproteinases dynamically regulate cellular behaviors through the processing of cell surface mols.  In the present study, we evaluated the role of membrane-type metalloproteinases (MT-MMPs) in excitatory synaptogenesis.  We find that MT3-MMP and MT5-MMP are broadly expressed in the mouse cerebral cortex and that MT3-MMP loss-of-function interferes with excitatory synapse development in dissocd. cortical neurons and in vivo.  We identify Nogo-66 receptor (NgR1) as an MT3-MMP substrate that is required for MT3-MMP-dependent synapse formation.  Introduction of the shed ectodomain of NgR1 is sufficient to accelerate excitatory synapse formation in dissocd. cortical neurons and in vivo.  Together, our findings support a role for MT3-MMP-dependent shedding of NgR1 in regulating excitatory synapse development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQE96Le1Qn4rVg90H21EOLACvtfcHk0liAowu7MGTKMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2rtL7L&md5=8a29dd05ed2c3fe61b80e7261da83fad</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0962-17.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0962-17.2017%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DR.%2BL.%26aulast%3DFerraro%26aufirst%3DG.%2BB.%26aulast%3DKacervosky%26aufirst%3DJ.%26aulast%3DSalesse%26aufirst%3DC.%26aulast%3DGowing%26aufirst%3DE.%26aulast%3DHua%26aufirst%3DL.%26aulast%3DRambaldi%26aufirst%3DI.%26aulast%3DBeaubien%26aufirst%3DF.%26aulast%3DHolmbeck%26aufirst%3DK.%26aulast%3DCloutier%26aufirst%3DJ.%2BF.%26aulast%3DLevesque%26aufirst%3DM.%26aulast%3DMurai%26aufirst%3DK.%26aulast%3DFournier%26aufirst%3DA.%2BE.%26atitle%3DMT3-MMP%2520Promotes%2520Excitatory%2520Synapse%2520Formation%2520by%2520Promoting%2520Nogo-66%2520Receptor%2520Ectodomain%2520Shedding%26jtitle%3DJ.%2520Neurosci.%26date%3D2018%26volume%3D38%26issue%3D3%26spage%3D518%26epage%3D529%26doi%3D10.1523%2FJNEUROSCI.0962-17.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Powell, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, L. L.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1615</span>– <span class="NLM_lpage">1631</span>, <span class="refDoi"> DOI: 10.1089/neu.2018.5994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1089%2Fneu.2018.5994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30444175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BB3crhsFyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2019&pages=1615-1631&issue=10&author=M.+A.+Powellauthor=R.+T.+Blackauthor=T.+L.+Smithauthor=T.+M.+Reevesauthor=L.+L.+Phillips&title=Matrix+Metalloproteinase+9+and+Osteopontin+Interact+to+Support+Synaptogenesis+in+the+Olfactory+Bulb+after+Mild+Traumatic+Brain+Injury&doi=10.1089%2Fneu.2018.5994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury</span></div><div class="casAuthors">Powell Melissa A; Black Raiford T; Smith Terry L; Reeves Thomas M; Phillips Linda L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1615-1631</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Olfactory receptor axons reinnervate the olfactory bulb (OB) after chemical or transection lesion.  Diffuse brain injury damages the same axons, but the time course and regulators of OB reinnervation are unknown.  Gelatinases (matrix metalloproteinase [MMP]2, MMP9) and their substrate osteopontin (OPN) are candidate mediators of synaptogenesis after central nervous system (CNS) insult, including olfactory axon damage.  Here, we examined the time course of MMP9, OPN, and OPN receptor CD44 response to diffuse OB injury.  FVBV/NJ mice received mild midline fluid percussion insult (mFPI), after which MMP9 activity and both OPN and CD44 protein expression were measured.  Diffuse mFPI induced time-dependent increase in OB MMP9 activity and elevated the cell signaling 48-kD OPN fragment.  This response was bimodal at 1 and 7 days post-injury.  MMP9 activity was also correlated with 7-day reduction in a second 32-kD OPN peptide.  CD44 increase peaked at 3 days, delayed relative to MMP9/OPN response.  MMP9 and OPN immunohistochemistry suggested that deafferented tufted and mitral neurons were the principal sites for these molecular interactions.  Analysis of injured MMP9 knockout (KO) mice showed that 48-kD OPN production was dependent on OB MMP9 activity, but with no KO effect on CD44 induction.  Olfactory marker protein (OMP), used to identify injured olfactory axons, revealed persistent axon damage in the absence of MMP9.  MMP9 KO ultrastructure at 21 days post-injury indicated that persistent OMP reduction was paired with delayed removal of degenerated axons.  These results provide evidence that diffuse, concussive brain trauma induces a post-injury interaction between MMP9, OPN, and CD44, which mediates synaptic plasticity and reinnervation within the OB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzRtA6ZuEPHcyail4HZd-ifW6udTcc2eYCIqK0Z-gORbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crhsFyhtQ%253D%253D&md5=f8a38773f5f794704c9ef4faad061e00</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1089%2Fneu.2018.5994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2018.5994%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DM.%2BA.%26aulast%3DBlack%26aufirst%3DR.%2BT.%26aulast%3DSmith%26aufirst%3DT.%2BL.%26aulast%3DReeves%26aufirst%3DT.%2BM.%26aulast%3DPhillips%26aufirst%3DL.%2BL.%26atitle%3DMatrix%2520Metalloproteinase%25209%2520and%2520Osteopontin%2520Interact%2520to%2520Support%2520Synaptogenesis%2520in%2520the%2520Olfactory%2520Bulb%2520after%2520Mild%2520Traumatic%2520Brain%2520Injury%26jtitle%3DJ.%2520Neurotrauma%26date%3D2019%26volume%3D36%26issue%3D10%26spage%3D1615%26epage%3D1631%26doi%3D10.1089%2Fneu.2018.5994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollet, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Diguardher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanessian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-2 (MMP-2) Regulates Astrocyte Motility in Connection with the Actin Cytoskeleton and Integrins</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1002/glia.20349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fglia.20349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16845676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD28rhtFSrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=272-284&issue=4&author=C.+Ogierauthor=A.+Bernardauthor=A.-M.+Cholletauthor=T.+Le+Diguardherauthor=S.+Hanessianauthor=G.+Chartonauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=Matrix+Metalloproteinase-2+%28MMP-2%29+Regulates+Astrocyte+Motility+in+Connection+with+the+Actin+Cytoskeleton+and+Integrins&doi=10.1002%2Fglia.20349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins</span></div><div class="casAuthors">Ogier Crystel; Bernard Anne; Chollet Anne-Marie; LE Diguardher Thierry; Hanessian Stephen; Charton Gerard; Khrestchatisky Michel; Rivera Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">272-84</span>
        ISSN:<span class="NLM_cas:issn">0894-1491</span>.
    </div><div class="casAbstract">Matrix Metalloproteinases (MMPs) play a role in migration of many cell types outside the central nervous system (CNS).  Among neural cells, astrocytes are one of the main sources of MMPs in physiological and postlesional conditions.  However, no data are available on the possible role of MMPs in astrocyte motility.  Using an in vitro model of 2D migration and broad spectrum and selective MMP inhibitors, the authors demonstrated that MMP-2, but not MMP-9, is a key enzyme for astrocyte migration.  In support of these data, the authors found constitutive expression of MMP-2 in astrocytes, while MMP-9 was nearly undetectable by gel zymography and immunocytochemical methods.  The inhibition of migration by MMP inhibitors correlated with changes in cell morphology and in the organization of the actin cytoskeleton.  In parallel, the characteristic focalized distribution of MMP-2 at the migration front observed in control cells became more diffuse and internalized by treatments that inhibited migration.  The disruption of actin by cytochalasin D caused the partial recruitment of MMP-2 and gelatinolytic activity into actin aggregates, indicating a connection between the proteinase and the actin cytoskeleton.  Finally, the authors found a co-localization of beta1-integrin with MMP-2 at the leading edge of migrating astrocytes.  Altogether, these data provide the first evidence for the implication of MMP-2 in astrocyte motility, probably through the interaction of the proteinase with beta1-integrin that could act as a linker between pericellular proteolysis and the actin cytoskeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2YOB1XGyB6Rgd2Wuil24tfW6udTcc2eYCIqK0Z-gORbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhtFSrsw%253D%253D&md5=30bdc476c4dd2c4f2998e3abe91a7059</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fglia.20349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20349%26sid%3Dliteratum%253Aachs%26aulast%3DOgier%26aufirst%3DC.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DChollet%26aufirst%3DA.-M.%26aulast%3DLe%2BDiguardher%26aufirst%3DT.%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DCharton%26aufirst%3DG.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DMatrix%2520Metalloproteinase-2%2520%2528MMP-2%2529%2520Regulates%2520Astrocyte%2520Motility%2520in%2520Connection%2520with%2520the%2520Actin%2520Cytoskeleton%2520and%2520Integrins%26jtitle%3DGlia%26date%3D2006%26volume%3D54%26issue%3D4%26spage%3D272%26epage%3D284%26doi%3D10.1002%2Fglia.20349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ould-Yahoui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbai, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clément, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gigmes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Féron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Role of Matrix Metalloproteinases in Migration and Neurotrophic Properties of Nasal Olfactory Stem and Ensheathing Cells</span>. <i>Cell Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.3727/096368912X657468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3727%2F096368912X657468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23043957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252Fjt1Gjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=993-1010&issue=6&author=A.+Ould-Yahouiauthor=O.+Sbaiauthor=K.+Barangerauthor=A.+Bernardauthor=Y.+Gueyeauthor=E.+Charratauthor=B.+Cl%C3%A9mentauthor=D.+Gigmesauthor=V.+Diveauthor=S.+D.+Girardauthor=F.+F%C3%A9ronauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=Role+of+Matrix+Metalloproteinases+in+Migration+and+Neurotrophic+Properties+of+Nasal+Olfactory+Stem+and+Ensheathing+Cells&doi=10.3727%2F096368912X657468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells</span></div><div class="casAuthors">Ould-Yahoui Adlane; Sbai Oualid; Baranger Kevin; Bernard Anne; Gueye Yatma; Charrat Eliane; Clement Benoit; Gigmes Didier; Dive Vincent; Girard Stephane D; Feron Francois; Khrestchatisky Michel; Rivera Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Cell transplantation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-1010</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Adult olfactory ectomesenchymal stem cells (OE-MSCs) and olfactory ensheathing cells (OECs), both from the nasal olfactory lamina propria, display robust regenerative properties when transplanted into the nervous system, but the mechanisms supporting such therapeutic effects remain unknown.  Matrix metalloproteinases (MMPs) are an important family of proteinases contributing to cell motility and axonal outgrowth across the extracellular matrix (ECM) in physiological and pathological conditions.  In this study, we have characterized for the first time in nasal human OE-MSCs the expression profile of some MMPs currently associated with cell migration and invasiveness.  We demonstrate different patterns of expression for MMP-1, MMP-2, MMP-9, and MT1-MMP upon cell migration when compared with nonmigrating cells.  Our results establish a correspondence between the localization of these proteinases in the migration front with the ability of cells to migrate.  Using various modulators of MMP activity, we also show that at least MMP-2, MMP-9, and MT1-MMP contribute to OE-MSC migration in an in vitro 3D test.  Furthermore, we demonstrate under the same conditions of culture used for in vivo transplantation that OE-MSCs and OECs secrete neurotrophic factors that promote neurite outgrowth of cortical and dorsal root ganglia (DRG) neurons, as well as axo-dendritic differentiation of cortical neurons.  These effects were abolished by the depletion of MMP-2 and MMP-9 from the culture conditioned media.  Altogether, our results provide the first evidence that MMPs may contribute to the therapeutic features of OE-MSCs and OECs through the control of their motility and/or their neurotrophic properties.  Our data provide new insight into the mechanisms of neuroregeneration and will contribute to optimization of cell therapy strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXZWHF9AnWD0HdcurJClFcfW6udTcc2ea-Bjw7zOy-yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252Fjt1Gjtg%253D%253D&md5=3a5aee22d272446314649e8d77d82315</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3727%2F096368912X657468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3727%252F096368912X657468%26sid%3Dliteratum%253Aachs%26aulast%3DOuld-Yahoui%26aufirst%3DA.%26aulast%3DSbai%26aufirst%3DO.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DGueye%26aufirst%3DY.%26aulast%3DCharrat%26aufirst%3DE.%26aulast%3DCl%25C3%25A9ment%26aufirst%3DB.%26aulast%3DGigmes%26aufirst%3DD.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DGirard%26aufirst%3DS.%2BD.%26aulast%3DF%25C3%25A9ron%26aufirst%3DF.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DRole%2520of%2520Matrix%2520Metalloproteinases%2520in%2520Migration%2520and%2520Neurotrophic%2520Properties%2520of%2520Nasal%2520Olfactory%2520Stem%2520and%2520Ensheathing%2520Cells%26jtitle%3DCell%2520Transplant.%26date%3D2013%26volume%3D22%26issue%3D6%26spage%3D993%26epage%3D1010%26doi%3D10.3727%2F096368912X657468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gueye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferhat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbai, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ould-Yahoui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauvin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risso, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Féron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span> <span> </span><span class="NLM_article-title">Trafficking and Secretion of Matrix Metalloproteinase-2 in Olfactory Ensheathing Glial Cells: A Role in Cell Migration?</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1002/glia.21146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fglia.21146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21360755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC3M3nsVelsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=750-770&issue=5&author=Y.+Gueyeauthor=L.+Ferhatauthor=O.+Sbaiauthor=J.+Biancoauthor=A.+Ould-Yahouiauthor=A.+Bernardauthor=E.+Charratauthor=J.-P.+Chauvinauthor=J.-J.+Rissoauthor=F.+F%C3%A9ronauthor=S.+Riveraauthor=M.+Khrestchatisky&title=Trafficking+and+Secretion+of+Matrix+Metalloproteinase-2+in+Olfactory+Ensheathing+Glial+Cells%3A+A+Role+in+Cell+Migration%3F&doi=10.1002%2Fglia.21146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Trafficking and secretion of matrix metalloproteinase-2 in olfactory ensheathing glial cells: A role in cell migration?</span></div><div class="casAuthors">Gueye Yatma; Ferhat Lotfi; Sbai Oualid; Bianco John; Ould-Yahoui Adlane; Bernard Anne; Charrat Eliane; Chauvin Jean-Paul; Risso Jean-Jacques; Feron Francois; Rivera Santiago; Khrestchatisky Michel</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">750-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Olfactory ensheathing cells (OECs) are unique glia found only in the olfactory system.  They retain exceptional plasticity and support olfactory neurogenesis and retargeting across the PNS:CNS boundary in the olfactory system.  OECs have been shown to improve functional outcome when transplanted into rodents with spinal cord injury.  The growth-promoting properties of implanted OECs encompass their ability to migrate through the scar tissue and render it more permissive for axonal outgrowth, but the underlying molecular mechanisms remain poorly understood.  OECs appear to regulate molecules of the extracellular matrix (ECM) that inhibit axonal growth.  Among the proteins that have the potential to promote cell migration, axonal regeneration and remodeling of the ECM are matrix metalloproteinases (MMPs), a family of endopeptidases that cleave matrix, soluble, and membrane-bound proteins and that are regulated by their endogenous inhibitors, the tissue inhibitors of MMPs (TIMPs).  Little is known about MMP/TIMP trafficking, secretion, and role in OECs.  Using a combination of cell biology, biochemistry, pharmacology, and imaging techniques, we show that MMP-2 and MMP-9 are expressed and proteolytically active in the olfactory epithelium and in particular in the OECs of the lamina propria.  These proteinases and regulatory proteins such as MT1-MMP and TIMP-2 are expressed in cultured OECs.  MMPs exhibit nuclear localization and vesicular trafficking and secretion, with distribution along microtubules and microfilaments and co-localization with the molecular motor protein kinesin.  Finally, we show that MMPs are involved in migration of OECs in vitro on different ECM substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJoWRA2BTI_7JzI8owOhpDfW6udTcc2ea-Bjw7zOy-yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3nsVelsw%253D%253D&md5=1ed5499efb20313bb8c428bf34b62662</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fglia.21146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.21146%26sid%3Dliteratum%253Aachs%26aulast%3DGueye%26aufirst%3DY.%26aulast%3DFerhat%26aufirst%3DL.%26aulast%3DSbai%26aufirst%3DO.%26aulast%3DBianco%26aufirst%3DJ.%26aulast%3DOuld-Yahoui%26aufirst%3DA.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DCharrat%26aufirst%3DE.%26aulast%3DChauvin%26aufirst%3DJ.-P.%26aulast%3DRisso%26aufirst%3DJ.-J.%26aulast%3DF%25C3%25A9ron%26aufirst%3DF.%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26atitle%3DTrafficking%2520and%2520Secretion%2520of%2520Matrix%2520Metalloproteinase-2%2520in%2520Olfactory%2520Ensheathing%2520Glial%2520Cells%253A%2520A%2520Role%2520in%2520Cell%2520Migration%253F%26jtitle%3DGlia%26date%3D2011%26volume%3D59%26issue%3D5%26spage%3D750%26epage%3D770%26doi%3D10.1002%2Fglia.21146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, L. L.</span></span> <span> </span><span class="NLM_article-title">MT5-MMP, ADAM-10, and N-Cadherin Act in Concert To Facilitate Synapse Reorganization after Traumatic Brain Injury</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1922</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.1089/neu.2012.2383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1089%2Fneu.2012.2383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=22489706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC38rjslWktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=1922-1940&issue=10&author=K.+M.+Warrenauthor=T.+M.+Reevesauthor=L.+L.+Phillips&title=MT5-MMP%2C+ADAM-10%2C+and+N-Cadherin+Act+in+Concert+To+Facilitate+Synapse+Reorganization+after+Traumatic+Brain+Injury&doi=10.1089%2Fneu.2012.2383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury</span></div><div class="casAuthors">Warren Kelly M; Reeves Thomas M; Phillips Linda L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1922-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Matrix metalloproteinases (MMPs) influence synaptic recovery following traumatic brain injury (TBI).  Membrane type 5-matrix metalloproteinase (MT5-MMP) and a distintegrin and metalloproteinase-10 (ADAM-10) are membrane-bound MMPs that cleave N-cadherin, a protein critical to synapse stabilization.  This study examined protein and mRNA expression of MT5-MMP, ADAM-10, and N-cadherin after TBI, contrasting adaptive and maladaptive synaptogenesis.  The effect of MMP inhibition on MT5-MMP, ADAM-10, and N-cadherin was assessed during maladaptive plasticity and correlated with synaptic function.  Rats were subjected to adaptive unilateral entorhinal cortical lesion (UEC) or maladaptive fluid percussion TBI+bilateral entorhinal cortical lesion (TBI+BEC).  Hippocampal MT5-MMP and ADAM-10 protein was significantly elevated 2 and 7 days post-injury.  At 15 days after UEC, each MMP returned to control level, while TBI+BEC ADAM-10 remained elevated.  At 2 and 7 days, N-cadherin protein was below control.  By the 15-day synapse stabilization phase, UEC N-cadherin rose above control, a shift not seen for TBI+BEC.  At 7 days, increased TBI+BEC ADAM-10 transcript correlated with protein elevation.  UEC ADAM-10 mRNA did not change, and no differences in MT5-MMP or N-cadherin mRNA were detected.  Confocal imaging showed MT5-MMP, ADAM-10, and N-cadherin localization within reactive astrocytes.  MMP inhibition attenuated ADAM-10 protein 15 days after TBI+BEC and increased N-cadherin.  This inhibition partially restored long-term potentiation induction, but did not affect paired-pulse facilitation.  Our results confirm time- and injury-dependent expression of MT5-MMP, ADAM-10, and N-cadherin during reactive synaptogenesis.  Persistent ADAM-10 expression was correlated with attenuated N-cadherin level and reduced functional recovery.  MMP inhibition shifted ADAM-10 and N-cadherin toward adaptive expression and improved synaptic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSwaFZpur1YCSm0e6ZOaemfW6udTcc2eaQ63rZh254LLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rjslWktQ%253D%253D&md5=cb8b4e709e1c613b9af8eaecd0ee5995</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1089%2Fneu.2012.2383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2012.2383%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DK.%2BM.%26aulast%3DReeves%26aufirst%3DT.%2BM.%26aulast%3DPhillips%26aufirst%3DL.%2BL.%26atitle%3DMT5-MMP%252C%2520ADAM-10%252C%2520and%2520N-Cadherin%2520Act%2520in%2520Concert%2520To%2520Facilitate%2520Synapse%2520Reorganization%2520after%2520Traumatic%2520Brain%2520Injury%26jtitle%3DJ.%2520Neurotrauma%26date%3D2012%26volume%3D29%26issue%3D10%26spage%3D1922%26epage%3D1940%26doi%3D10.1089%2Fneu.2012.2383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huntley, G. W.</span></span> <span> </span><span class="NLM_article-title">Synaptic Circuit Remodelling by Matrix Metalloproteinases in Health and Disease</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">757</span>, <span class="refDoi"> DOI: 10.1038/nrn3320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrn3320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23047773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOgtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=743-757&issue=11&author=G.+W.+Huntley&title=Synaptic+Circuit+Remodelling+by+Matrix+Metalloproteinases+in+Health+and+Disease&doi=10.1038%2Fnrn3320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic circuit remodelling by matrix metalloproteinases in health and disease</span></div><div class="casAuthors">Huntley, George W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">743-757</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are extracellularly acting enzymes that have long been known to have deleterious roles in brain injury and disease.  In particular, widespread and protracted MMP activity can contribute to neuronal loss and synaptic dysfunction.  However, recent studies show that rapid and focal MMP-mediated proteolysis proactively drives synaptic structural and functional remodelling that is crucial for ongoing cognitive processes.  Deficits in synaptic remodelling are assocd. with psychiatric and neurol. disorders, and aberrant MMP expression or function may contribute to the mol. mechanisms underlying these deficits.  This Review explores the paradigm shift in our understanding of the contribution of MMPs to normal and abnormal synaptic plasticity and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4dGOLqydN2rVg90H21EOLACvtfcHk0ljKHIu90itaOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOgtrjM&md5=a42ae1fe3253ee329628845e623ef13f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnrn3320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3320%26sid%3Dliteratum%253Aachs%26aulast%3DHuntley%26aufirst%3DG.%2BW.%26atitle%3DSynaptic%2520Circuit%2520Remodelling%2520by%2520Matrix%2520Metalloproteinases%2520in%2520Health%2520and%2520Disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26issue%3D11%26spage%3D743%26epage%3D757%26doi%3D10.1038%2Fnrn3320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, P. H.</span></span> <span> </span><span class="NLM_article-title">Myelin Formation during Development of the CNS Is Delayed in Matrix Metalloproteinase-9 and −12 Null Mice</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2207</span>– <span class="NLM_lpage">2214</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1880-05.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.1880-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16495447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFCmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2207-2214&issue=8&author=P.+H.+Larsen&title=Myelin+Formation+during+Development+of+the+CNS+Is+Delayed+in+Matrix+Metalloproteinase-9+and+%E2%88%9212+Null+Mice&doi=10.1523%2FJNEUROSCI.1880-05.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice</span></div><div class="casAuthors">Larsen, Peter H.; DaSilva, Angelika Goncalves; Conant, Katherine; Yong, V. Wee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2207-2214</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We have addressed whether and how matrix metalloproteinases (MMPs) might be required for myelin formation in normal ontogeny.  Using a probe for multiple MMPs and the developing mouse optic nerve, we found 2 members, MMP-9 and -12, to be upregulated during the period of myelin formation.  These MMPs partake in myelinogenesis because myelination in the corpus callosum of MMP-9 and(or) MMP-12 null mice was deficient from postnatal days 7 to 14 compared with that of wild-type mice.  The deficient myelination was correlated with fewer mature oligodendrocytes, but similar precursor cell nos., in MMP null animals compared with wild type.  Because an important growth factor for oligodendrocyte maturation is insulin-like growth factor-1 (IGF-1), we addressed whether this was involved in the deficient myelination in MMP null mice.  Indeed, the addn. of IGF-1 normalized the lack of maturation of oligodendrocytes that occurred in cultures from MMP-12 null mice.  Furthermore, we detd. that IGF binding protein 6 (IGFBP-6), which sequesters IGF-1, was a substrate for MMP processing.  Finally, we found IGFBP-6 levels to remain high in MMP-deficient mice.  These results reveal a novel function for MMP-9 and -12 in developmental myelination likely through regulating IGF-1 bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMnPNy0rTJOrVg90H21EOLACvtfcHk0ljKHIu90itaOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFCmsrY%253D&md5=7cc05c8fa6bf91b6ff7937a9a8ac46a9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1880-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1880-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DP.%2BH.%26atitle%3DMyelin%2520Formation%2520during%2520Development%2520of%2520the%2520CNS%2520Is%2520Delayed%2520in%2520Matrix%2520Metalloproteinase-9%2520and%2520%25E2%2588%259212%2520Null%2520Mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26issue%3D8%26spage%3D2207%26epage%3D2214%26doi%3D10.1523%2FJNEUROSCI.1880-05.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, J.-Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goussev, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werb, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble-Haeusslein, L. J.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-2 Facilitates Wound Healing Events That Promote Functional Recovery after Spinal Cord Injury</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">9841</span>– <span class="NLM_lpage">9850</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1993-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.1993-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17005848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=9841-9850&issue=39&author=J.-Y.+C.+Hsuauthor=R.+McKeonauthor=S.+Goussevauthor=Z.+Werbauthor=J.-U.+Leeauthor=A.+Trivediauthor=L.+J.+Noble-Haeusslein&title=Matrix+Metalloproteinase-2+Facilitates+Wound+Healing+Events+That+Promote+Functional+Recovery+after+Spinal+Cord+Injury&doi=10.1523%2FJNEUROSCI.1993-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury</span></div><div class="casAuthors">Hsu, Jung-Yu C.; McKeon, Robert; Goussev, Staci; Werb, Zena; Lee, Jung-Uek; Trivedi, Alpa; Noble-Haeusslein, Linda J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9841-9850</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are proteolytic enzymes that are involved in both injury and repair mechanisms in the CNS.  Pharmacol. blockade of MMPs, limited to the first several days after spinal cord injury, improves locomotor recovery.  This beneficial response is, however, lost when treatment is extended beyond the acutely injured cord to include wound healing and tissue remodeling.  This suggests that some MMPs play a beneficial role in wound healing.  To test this hypothesis, we investigated the role of MMP-2, which is actively expressed during wound healing, in white matter sparing and axonal plasticity, the formation of a glial scar, and locomotor recovery after spinal cord injury.  MMP-2 increased between 7 and 14 d after injury, where it was immunolocalized in reactive astrocytes bordering the lesion epicenter.  There was reduced white matter sparing and fewer serotonergic fibers, caudal to the lesion in injured MMP-2 null animals.  MMP-2 deficiency also resulted in increased immunoreactivity to chondroitin sulfate proteoglycans and a more extensive astrocytic scar.  Most importantly, locomotion in an open field, performance on a rotarod, and grid walking were significantly impaired in injured MMP-2 null mice.  Our findings suggest that MMP-2 promotes functional recovery after injury by regulating the formation of a glial scar and white matter sparing and/or axonal plasticity.  Thus, strategies exploiting MMPs as therapeutic targets must balance these beneficial effects during wound healing with their adverse interactions in the acutely injured spinal cord.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphjd-RTmz7UrVg90H21EOLACvtfcHk0lh51OQGla0Mlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLjE&md5=771b194d45103ab319d78ba6c397a036</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1993-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1993-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DJ.-Y.%2BC.%26aulast%3DMcKeon%26aufirst%3DR.%26aulast%3DGoussev%26aufirst%3DS.%26aulast%3DWerb%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DJ.-U.%26aulast%3DTrivedi%26aufirst%3DA.%26aulast%3DNoble-Haeusslein%26aufirst%3DL.%2BJ.%26atitle%3DMatrix%2520Metalloproteinase-2%2520Facilitates%2520Wound%2520Healing%2520Events%2520That%2520Promote%2520Functional%2520Recovery%2520after%2520Spinal%2520Cord%2520Injury%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26issue%3D39%26spage%3D9841%26epage%3D9850%26doi%3D10.1523%2FJNEUROSCI.1993-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stallcup, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opdenakker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">35</span>),  <span class="NLM_fpage">11127</span>– <span class="NLM_lpage">11135</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.23-35-11127.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.23-35-11127.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=14657171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=11127-11135&issue=35&author=P.+H.+Larsenauthor=J.+E.+Wellsauthor=W.+B.+Stallcupauthor=G.+Opdenakkerauthor=V.+W.+Yong&title=Matrix+Metalloproteinase-9+Facilitates+Remyelination+in+Part+by+Processing+the+Inhibitory+NG2+Proteoglycan&doi=10.1523%2FJNEUROSCI.23-35-11127.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan</span></div><div class="casAuthors">Larsen, Peter H.; Wells, Jennifer E.; Stallcup, William B.; Opdenakker, Ghislain; Yong, V. Wee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">11127-11135</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Remyelination is a crit. repair process that is initiated after a demyelinating insult.  The failure to remyelinate contributes to neurol. diseases such as multiple sclerosis.  Here, we test the hypothesis that proteinase activity is required for the extensive remodeling of the extracellular matrix that occurs during remyelination.  We show that mice lacking matrix metalloproteinase (MMP)-9 are impaired in myelin reformation after lysolecithin-induced demyelination.  This deficiency may be explained at least in part by the failure to clear the accumulation of NG2, an inhibitory proteoglycan that retards the maturation and differentiation of oligodendrocytes that are needed for remyelination.  These results emphasize for the first time that upregulation of MMP activity can be important for facilitating regeneration from some types of CNS injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtnQwqRVH0_7Vg90H21EOLACvtfcHk0lh51OQGla0Mlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtb8%253D&md5=135805c7644c2e867f01ce2bc4b4841d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.23-35-11127.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.23-35-11127.2003%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DP.%2BH.%26aulast%3DWells%26aufirst%3DJ.%2BE.%26aulast%3DStallcup%26aufirst%3DW.%2BB.%26aulast%3DOpdenakker%26aufirst%3DG.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DMatrix%2520Metalloproteinase-9%2520Facilitates%2520Remyelination%2520in%2520Part%2520by%2520Processing%2520the%2520Inhibitory%2520NG2%2520Proteoglycan%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26issue%3D35%26spage%3D11127%26epage%3D11135%26doi%3D10.1523%2FJNEUROSCI.23-35-11127.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottschall, P. E.</span></span> <span> </span><span class="NLM_article-title">Regional and Age-Related Expression of Gelatinases in the Brains of Young and Old Rats after Treatment with Kainic Acid</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>295</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/S0304-3940(00)01582-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0304-3940%2800%2901582-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11078924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVCkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=9-12&issue=1%E2%80%932&author=J.+W.+Zhangauthor=S.+Debauthor=P.+E.+Gottschall&title=Regional+and+Age-Related+Expression+of+Gelatinases+in+the+Brains+of+Young+and+Old+Rats+after+Treatment+with+Kainic+Acid&doi=10.1016%2FS0304-3940%2800%2901582-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Regional and age-related expression of gelatinases in the brains of young and old rats after treatment with kainic acid</span></div><div class="casAuthors">Zhang, J. W.; Deb, S.; Gottschall, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">9-12</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Due to the possible detrimental impact of local inflammatory responses in neurodegenerative disease, it was of interest to measure the expression of extracellular matrix-degrading enzymes, a group of proteases that are induced during an inflammatory response, in the brains of old and young animals in a model of neuronal death.  Doses of kainic acid were administered that resulted in comparable hippocampal pyramidal neuron loss in young and old F344/BN hybrid rats, even though each age group received widely differing doses.  Two matrix metalloproteinases (MMPs), MMP-2 and MMP-9, were differentially induced with respect to time after kainic acid in sensitive brain regions in both young and old rats.  However, the elevation of MMP-9 in the temporal lobe 12 h after injection in old rats was significantly greater than that obsd. in young animals.  These results suggest that early and late induction of MMPs may play a role in neuronal death and repair mechanisms, resp., and that inflammatory mechanisms in the central nervous system (CNS) of old rats are exaggerated compared to young rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnJzOvs3yq_rVg90H21EOLACvtfcHk0ljuLSZOI-Dbtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVCkt7Y%253D&md5=daf5532e29dd5adcc79adf570592a9a8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2800%2901582-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252800%252901582-2%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BW.%26aulast%3DDeb%26aufirst%3DS.%26aulast%3DGottschall%26aufirst%3DP.%2BE.%26atitle%3DRegional%2520and%2520Age-Related%2520Expression%2520of%2520Gelatinases%2520in%2520the%2520Brains%2520of%2520Young%2520and%2520Old%2520Rats%2520after%2520Treatment%2520with%2520Kainic%2520Acid%26jtitle%3DNeurosci.%2520Lett.%26date%3D2000%26volume%3D295%26issue%3D1%25E2%2580%25932%26spage%3D9%26epage%3D12%26doi%3D10.1016%2FS0304-3940%2800%2901582-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jourquin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decanis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanessian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollet, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Diguardher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Neuronal Activity-Dependent Increase of Net Matrix Metalloproteinase Activity Is Associated with MMP-9 Neurotoxicity after Kainate</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1507</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1046/j.1460-9568.2003.02876.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1046%2Fj.1460-9568.2003.02876.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=14511330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD3svpt1Cjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=1507-1517&issue=6&author=J.+Jourquinauthor=E.+Tremblayauthor=N.+Decanisauthor=G.+Chartonauthor=S.+Hanessianauthor=A.-M.+Cholletauthor=T.+Le+Diguardherauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=Neuronal+Activity-Dependent+Increase+of+Net+Matrix+Metalloproteinase+Activity+Is+Associated+with+MMP-9+Neurotoxicity+after+Kainate&doi=10.1046%2Fj.1460-9568.2003.02876.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate</span></div><div class="casAuthors">Jourquin Jerome; Tremblay Evelyne; Decanis Nadege; Charton Gerard; Hanessian Stephen; Chollet Anne-Marie; Le Diguardher Thierry; Khrestchatisky Michel; Rivera Santiago</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1507-17</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Matrix metalloproteinases (MMPs) and the tissue inhibitors of MMPs (TIMPs) are emerging as important modulators of brain physiopathology.  Dramatic changes in the expression of MMPs and TIMPs occur during excitotoxic/neuroinflammatory processes.  However, only the measurement of net protease activity is relevant physiologically, and the functional consequences of MMP/TIMP ratio modifications in the brain remain elusive.  In order to assess MMP activity and effects in brain tissue, we combined in vivo and organotypic culture models of kainate (KA)-induced excitotoxicity to provoke selective neuronal death and neuroinflammation in the hippocampus.  Using in situ zymography, we show that KA-induced excitotoxic seizures in rats increase net MMP activity in hippocampal neurons 8 h after seizures, before their death, and that this increase is neuronal activity-dependent.  Three days after KA, proteolytic activity increases in blood vessels and reactive glial cells of vulnerable areas, in relation with neuroinflammation.  At 7 and 15 days, proteolysis remains high in blood vessels whereas it is reduced in glia.  In organotypic hippocampal cultures, which lack blood cell-mediated inflammation and extrinsic connections, a broad-spectrum inhibitor of MMPs (MMPI), but also a selective MMP-9 inhibitor, protect hippocampal neurons against KA-induced excitotoxicity.  Moreover, recombinant MMP-9, but not MMP-2, induces selective pyramidal cell death in these cultures and KA-induced neuronal activity exacerbates the neuronal death promoting effects of MMP-9.  These data strongly implicate MMPs, and MMP-9 in particular, in both excitotoxic neuronal damage and subsequent neuroinflammatory processes, and suggest that selective MMPIs could be therapeutically relevant in related neurological disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROkTDnPFyF0RWfpMXQLRstfW6udTcc2eaSvXrzaefhfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svpt1Cjtg%253D%253D&md5=d2f68cccdafec7c518902ca815627c4a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.2003.02876.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.2003.02876.x%26sid%3Dliteratum%253Aachs%26aulast%3DJourquin%26aufirst%3DJ.%26aulast%3DTremblay%26aufirst%3DE.%26aulast%3DDecanis%26aufirst%3DN.%26aulast%3DCharton%26aufirst%3DG.%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DChollet%26aufirst%3DA.-M.%26aulast%3DLe%2BDiguardher%26aufirst%3DT.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DNeuronal%2520Activity-Dependent%2520Increase%2520of%2520Net%2520Matrix%2520Metalloproteinase%2520Activity%2520Is%2520Associated%2520with%2520MMP-9%2520Neurotoxicity%2520after%2520Kainate%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2003%26volume%3D18%26issue%3D6%26spage%3D1507%26epage%3D1517%26doi%3D10.1046%2Fj.1460-9568.2003.02876.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gasche, Y.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases and Diseases of the Central Nervous System with a Special Emphasis on Ischemic Brain</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1289</span>– <span class="NLM_lpage">1301</span>, <span class="refDoi"> DOI: 10.2741/1883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2741%2F1883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16368516" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=1289-1301&issue=1&author=Y.+Gasche&title=Matrix+Metalloproteinases+and+Diseases+of+the+Central+Nervous+System+with+a+Special+Emphasis+on+Ischemic+Brain&doi=10.2741%2F1883"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2741%2F1883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F1883%26sid%3Dliteratum%253Aachs%26aulast%3DGasche%26aufirst%3DY.%26atitle%3DMatrix%2520Metalloproteinases%2520and%2520Diseases%2520of%2520the%2520Central%2520Nervous%2520System%2520with%2520a%2520Special%2520Emphasis%2520on%2520Ischemic%2520Brain%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2006%26volume%3D11%26issue%3D1%26spage%3D1289%26epage%3D1301%26doi%3D10.2741%2F1883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jourquin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timsit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szklarczyk, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gearing, A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span> <span> </span><span class="NLM_article-title">Gelatinase B and TIMP-1 Are Regulated in a Cell- and Time-Dependent Manner in Association with Neuronal Death and Glial Reactivity after Global Forebrain Ischemia</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1046/j.0953-816x.2001.01838.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1046%2Fj.0953-816x.2001.01838.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11860503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD387ktFymtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=19-32&issue=1&author=S.+Riveraauthor=C.+Ogierauthor=J.+Jourquinauthor=S.+Timsitauthor=A.+W.+Szklarczykauthor=K.+Millerauthor=A.+J.+H.+Gearingauthor=L.+Kaczmarekauthor=M.+Khrestchatisky&title=Gelatinase+B+and+TIMP-1+Are+Regulated+in+a+Cell-+and+Time-Dependent+Manner+in+Association+with+Neuronal+Death+and+Glial+Reactivity+after+Global+Forebrain+Ischemia&doi=10.1046%2Fj.0953-816x.2001.01838.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia</span></div><div class="casAuthors">Rivera Santiago; Ogier Crystel; Jourquin Jerome; Timsit Serge; Szklarczyk Arkadius W; Miller Karen; Gearing Andrew J H; Kaczmarek Leszek; Khrestchatisky Michel</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-32</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Matrix metalloproteinases (MMPs) belong to a large family of endopeptidases that regulate the pericellular environment through the cleavage of protein components of the extracellular matrix, membrane receptors and cytokines.  MMP activity is controlled by the multifunctional tissue inhibitors of metalloproteinases (TIMPs).  Proteases and their inhibitors are critically involved in developmental and pathological processes in numerous organs, including the brain.  Global transient cerebral ischemia induces selective delayed neuronal death and neuroinflammation.  We compared, in discrete vulnerable and resistant areas of the ischemic rat hippocampus, the kinetics and cellular distribution of gelatinase B and its principal inhibitor TIMP-1 and we assessed by in situ zymography, the net gelatinolytic activity at the cellular level.  We show that gelatinases are expressed and active in neurons, suggesting that MMPs play a role in maintaining neural homeostasis.  In the ischemic rat brain, expression and activity of gelatinase B, and expression of TIMP-1 are altered in a time-, region- and cell-dependent manner.  Gelatinase B is induced first in reactive microglia and subsequently in reactive astrocytes.  In situ, increases in gelatinase activity accompanied the progression of neuronal death and glial reactivity.  Our results suggest that MMPs and TIMPs are involved in cell viability and tissue remodelling in the ischemic brain, and reinforces the idea that the MMP/TIMP system contributes both to neuronal demise and tissue repair in the context of glial reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR2N4CuMIbAh2K_SFaaT9INfW6udTcc2eZA-ciCbunNQbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ktFymtw%253D%253D&md5=b81eb3cb819d7cdbccf51b6fed3cf026</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1046%2Fj.0953-816x.2001.01838.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0953-816x.2001.01838.x%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DOgier%26aufirst%3DC.%26aulast%3DJourquin%26aufirst%3DJ.%26aulast%3DTimsit%26aufirst%3DS.%26aulast%3DSzklarczyk%26aufirst%3DA.%2BW.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DGearing%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DKaczmarek%26aufirst%3DL.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26atitle%3DGelatinase%2520B%2520and%2520TIMP-1%2520Are%2520Regulated%2520in%2520a%2520Cell-%2520and%2520Time-Dependent%2520Manner%2520in%2520Association%2520with%2520Neuronal%2520Death%2520and%2520Glial%2520Reactivity%2520after%2520Global%2520Forebrain%2520Ischemia%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2002%26volume%3D15%26issue%3D1%26spage%3D19%26epage%3D32%26doi%3D10.1046%2Fj.0953-816x.2001.01838.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Z.</span></span> <span> </span><span class="NLM_article-title">S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death</span>. <i>Science (Washington, DC, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span> (<span class="NLM_issue">5584</span>),  <span class="NLM_fpage">1186</span>– <span class="NLM_lpage">1190</span>, <span class="refDoi"> DOI: 10.1126/science.1073634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1126%2Fscience.1073634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12183632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=1186-1190&issue=5584&author=Z.+Gu&title=S-Nitrosylation+of+Matrix+Metalloproteinases%3A+Signaling+Pathway+to+Neuronal+Cell+Death&doi=10.1126%2Fscience.1073634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">S-Nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death</span></div><div class="casAuthors">Gu, Zezong; Kaul, Marcus; Yan, Boxu; Kridel, Steven J.; Cui, Jiankun; Strongin, Alex; Smith, Jeffrey W.; Liddington, Robert C.; Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5584</span>),
    <span class="NLM_cas:pages">1186-1190</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of neurodegenerative diseases and stroke.  However, the mechanism of MMP activation remains unclear.  We report that MMP activation involves S-nitrosylation.  During cerebral ischemia in vivo, MMP-9 colocalized with neuronal nitric oxide synthase.  S-Nitrosylation activated MMP-9 in vitro and induced neuronal apoptosis.  Mass spectrometry identified the active deriv. of MMP-9, both in vitro and in vivo, as a stable sulfinic or sulfonic acid, whose formation was triggered by S-nitrosylation.  These findings suggest a potential extracellular proteolysis pathway to neuronal cell death in which S-nitrosylation activates MMPs, and further oxidn. results in a stable posttranslational modification with pathol. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrXst1UtWNrVg90H21EOLACvtfcHk0ljPikCueTcMBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVOhtL8%253D&md5=367fff24338ee8628f875afdf45dab24</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscience.1073634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1073634%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DZ.%26atitle%3DS-Nitrosylation%2520of%2520Matrix%2520Metalloproteinases%253A%2520Signaling%2520Pathway%2520to%2520Neuronal%2520Cell%2520Death%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2002%26volume%3D297%26issue%3D5584%26spage%3D1186%26epage%3D1190%26doi%3D10.1126%2Fscience.1073634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leppert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandgirard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leib, S. L.</span></span> <span> </span><span class="NLM_article-title">MMPs and ADAMs in Neurological Infectious Diseases and Multiple Sclerosis</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3097</span>– <span class="NLM_lpage">3116</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03174-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03174-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31172218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3097-3116&issue=16&author=L.+Muriauthor=D.+Leppertauthor=D.+Grandgirardauthor=S.+L.+Leib&title=MMPs+and+ADAMs+in+Neurological+Infectious+Diseases+and+Multiple+Sclerosis&doi=10.1007%2Fs00018-019-03174-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">MMPs and ADAMs in neurological infectious diseases and multiple sclerosis</span></div><div class="casAuthors">Muri, Lukas; Leppert, David; Grandgirard, Denis; Leib, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3097-3116</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Metalloproteinases-such as matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinases (ADAMs)-are involved in various diseases of the nervous system but also contribute to nervous system development, synaptic plasticity and neuroregeneration upon injury.  MMPs and ADAMs proteolytically cleave many substrates including extracellular matrix components but also signaling mols. and receptors.  During neuroinfectious disease with assocd. neuroinflammation, MMPs and ADAMs regulate blood-brain barrier breakdown, bacterial invasion, neutrophil infiltration and cytokine signaling.  Specific and broad-spectrum inhibitors for MMPs and ADAMs have exptl. been shown to decrease neuroinflammation and brain damage in diseases with excessive neuroinflammation as a common denominator, such as pneumococcal meningitis and multiple sclerosis, thereby improving the disease outcome.  Timing of metalloproteinase inhibition appears to be crit. to effectively target the cascade of pathophysiol. processes leading to brain damage without inhibiting the neuroregenerative effects of metalloproteinases.  As the crit. role of metalloproteinases in neuronal repair mechanisms and regeneration was only lately recognized, the original idea of chronic MMP inhibition needs to be conceptually revised.  Recently accumulated research urges for a second chance of metalloproteinase inhibitors, which-when correctly applied and dosed-harbor the potential to improve the outcome of different neuroinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNTkbwv59ML7Vg90H21EOLACvtfcHk0lgiqm1kCiMNcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtb3K&md5=8c5982c714d4efa05479dcc87890d6f9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03174-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03174-6%26sid%3Dliteratum%253Aachs%26aulast%3DMuri%26aufirst%3DL.%26aulast%3DLeppert%26aufirst%3DD.%26aulast%3DGrandgirard%26aufirst%3DD.%26aulast%3DLeib%26aufirst%3DS.%2BL.%26atitle%3DMMPs%2520and%2520ADAMs%2520in%2520Neurological%2520Infectious%2520Diseases%2520and%2520Multiple%2520Sclerosis%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3097%26epage%3D3116%26doi%3D10.1007%2Fs00018-019-03174-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramiro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simats, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Guillamon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bustamante, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosell, A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases and ADAMs in Stroke</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3117</span>– <span class="NLM_lpage">3140</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03175-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03175-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31165904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3117-3140&issue=16&author=J.+Montanerauthor=L.+Ramiroauthor=A.+Simatsauthor=M.+Hern%C3%A1ndez-Guillamonauthor=P.+Delgadoauthor=A.+Bustamanteauthor=A.+Rosell&title=Matrix+Metalloproteinases+and+ADAMs+in+Stroke&doi=10.1007%2Fs00018-019-03175-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and ADAMs in stroke</span></div><div class="casAuthors">Montaner, Joan; Ramiro, Laura; Simats, Alba; Hernandez-Guillamon, Mar; Delgado, Pilar; Bustamante, Alejandro; Rosell, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3117-3140</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Stroke is a leading cause of death and disability worldwide.  However, after years of in-depth research, the pathophysiol. of stroke is still not fully understood.  Increasing evidence shows that matrix metalloproteinases (MMPs) and "a disintegrin and metalloproteinase" (ADAMs) participate in the neuro-inflammatory cascade that is triggered during stroke but also in recovery phases of the disease.  This review covers the involvement of these proteins in brain injury following cerebral ischemia which has been widely studied in recent years, with efforts to modulate this group of proteins in neuroprotective therapies, together with their implication in neurorepair mechanisms.  Moreover, the review also discusses the role of these proteins in specific forms of neurovascular disease, such as small vessel diseases and intracerebral hemorrhage.  Finally, the potential use of MMPs and ADAMs as guiding biomarkers of brain injury and repair for decision-making in cases of stroke is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRW7-MAdUcWrVg90H21EOLACvtfcHk0lgiqm1kCiMNcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtbbP&md5=d5177f9d70e49ef9800be878f1b9070c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03175-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03175-5%26sid%3Dliteratum%253Aachs%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DRamiro%26aufirst%3DL.%26aulast%3DSimats%26aufirst%3DA.%26aulast%3DHern%25C3%25A1ndez-Guillamon%26aufirst%3DM.%26aulast%3DDelgado%26aufirst%3DP.%26aulast%3DBustamante%26aufirst%3DA.%26aulast%3DRosell%26aufirst%3DA.%26atitle%3DMatrix%2520Metalloproteinases%2520and%2520ADAMs%2520in%2520Stroke%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3117%26epage%3D3140%26doi%3D10.1007%2Fs00018-019-03175-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, G. A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases in Neuroinflammation</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1002/glia.10108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fglia.10108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12203394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD38vksVWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=279-291&issue=3&author=G.+A.+Rosenberg&title=Matrix+Metalloproteinases+in+Neuroinflammation&doi=10.1002%2Fglia.10108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases in neuroinflammation</span></div><div class="casAuthors">Rosenberg Gary A</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-91</span>
        ISSN:<span class="NLM_cas:issn">0894-1491</span>.
    </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are a gene family of neutral proteases that are important in normal development, wound healing, and a wide variety of pathological processes, including the spread of metastatic cancer cells, arthritic destruction of joints, atherosclerosis, and neuroinflammation.  In the central nervous system (CNS), MMPs have been shown to degrade components of the basal lamina, leading to disruption of the blood-brain barrier (BBB), and to contribute to the neuroinflammatory response in many neurological diseases.  Brain cells express both constitutive and inducible MMPs in response to cellular stress.  MMPs are tightly regulated to avoid unwanted proteolysis.  Secreted as inactive enzymes, the MMPs require activation by other proteases and free radicals.  The MMPs are part of a larger class of metalloproteinases (MPs), which includes the recently discovered ADAMs (a disintegrin and metalloproteinase domain) and ADAMTS (a disintegrin and metalloproteinase thrombospondin) families.  MPs have complex roles at the cell surface and within the extracellular matrix.  At the cell surface, they act as sheddases, releasing growth factors, death receptors, and death-inducing ligands, making them important in cell survival and death.  Tissue inhibitors of metalloproteinases (TIMPs) are endogenous inhibitors that regulate the activity of the MMPs.  Synthetic inhibitors have been developed for the treatment of arthritis and cancer.  These hydroxymate-based compounds have been shown to reduce injury in experimental allergic encephalomyelitis (EAE), experimental allergic neuritis (EAN), cerebral ischemia, intracerebral hemorrhage, and viral and bacterial infections.  MPs have both beneficial and detrimental roles; understanding their expression in various CNS insults will allow for the use of MMP inhibitors in the treatment of neurological disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqaNxQnG0x0zC850By6mxpfW6udTcc2ebPx0RqU_SQ7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vksVWqtQ%253D%253D&md5=eca79ccb4df70f06593ab5796ec1c17f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fglia.10108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.10108%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DG.%2BA.%26atitle%3DMatrix%2520Metalloproteinases%2520in%2520Neuroinflammation%26jtitle%3DGlia%26date%3D2002%26volume%3D39%26issue%3D3%26spage%3D279%26epage%3D291%26doi%3D10.1002%2Fglia.10108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases in the CNS: Interferons Get Nervous</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3083</span>– <span class="NLM_lpage">3095</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03171-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03171-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31165203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2hs7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3083-3095&issue=16&author=S.+Chopraauthor=C.+M.+Overallauthor=A.+Dufour&title=Matrix+Metalloproteinases+in+the+CNS%3A+Interferons+Get+Nervous&doi=10.1007%2Fs00018-019-03171-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases in the CNS: interferons get nervous</span></div><div class="casAuthors">Chopra, Sameeksha; Overall, Christopher M.; Dufour, Antoine</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3083-3095</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) have been investigated in context of chronic inflammatory diseases and demonstrated to degrade multiple components of the extracellular matrix (ECM).  However, following several disappointing MMP clin. trials, recent studies have demonstrated unexpected novel functions of MMPs in viral infections and autoimmune inflammatory diseases in unanticipated locations.  Thus, MMPs play addnl. functions in inflammation than just ECM degrdn.  They can regulate the activity of chemokines and cytokines of the immune response by precise proteolytic processing resulting in activation or inactivation of signaling pathways.  MMPs have been demonstrated to cleave multiple substrates of the central nervous systems (CNS) and contribute to promoting and dampening diseases of the CNS.  Initially, believed to be solely promoting pathologies, more than 10 MMPs to date have been shown to have protective functions.  Here, we present some of the beneficial and destructive roles of MMPs in CNS pathologies and discuss strategies for the use of MMP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqylHe7Yphs1LVg90H21EOLACvtfcHk0lhsgicG8mfyeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2hs7%252FE&md5=0709b7ad3fb4ad6352085106573587ad</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03171-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03171-9%26sid%3Dliteratum%253Aachs%26aulast%3DChopra%26aufirst%3DS.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DDufour%26aufirst%3DA.%26atitle%3DMatrix%2520Metalloproteinases%2520in%2520the%2520CNS%253A%2520Interferons%2520Get%2520Nervous%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3083%26epage%3D3095%26doi%3D10.1007%2Fs00018-019-03171-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, J.</span></span> <span> </span><span class="NLM_article-title">The Role of Matrix Metalloproteinases in Glioma Invasion</span>. <i>Front. Biosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e261</span>, <span class="refDoi"> DOI: 10.2741/1016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2741%2F1016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12456313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFygtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=e261&author=M.+Nakadaauthor=Y.+Okadaauthor=J.+Yamashita&title=The+Role+of+Matrix+Metalloproteinases+in+Glioma+Invasion&doi=10.2741%2F1016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The role of matrix metalloproteinases in glioma invasion</span></div><div class="casAuthors">Nakada, Mitsutoshi; Okada, Yasunori; Yamashita, Junkoh</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">E261-E269</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinase (MMP) family plays an important role in the degrdn. of extracellular matrix (ECM) in various physiol. and pathol. conditions.  Accumulated evidence has suggested that MMPs contribute to cancer cell invasion of the surrounding normal tissues and metastasis through the cell-surface ECM degrdn.  Strong correlations have been reported between elevated MMP levels and tumor cell invasiveness in human gliomas.  Among them, attention has been focused on gelatinases (MMP-2 and MMP-9) and membrane type MMPs (MT-MMPs).  We discuss here the biol. significance of these MMP's in the glioblastoma invasion processes.  A better understanding of cell-ECM interactions will help in developing therapeutic strategies to decrease the invasion of gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDqAKkp7DVCrVg90H21EOLACvtfcHk0lh5Y6nx4n8iYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFygtbY%253D&md5=f406f06276196ac7e70aa7fa20f841f5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2741%2F1016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F1016%26sid%3Dliteratum%253Aachs%26aulast%3DNakada%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DJ.%26atitle%3DThe%2520Role%2520of%2520Matrix%2520Metalloproteinases%2520in%2520Glioma%2520Invasion%26jtitle%3DFront.%2520Biosci.%26date%3D2003%26volume%3D8%26spage%3De261%26doi%3D10.2741%2F1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span> <span> </span><span class="NLM_article-title">MMP-14 Overexpression Correlates with the Neurodegenerative Process in Familial Amyloidotic Polyneuropathy</span>. <i>Dis. Models &amp; Mech.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1253</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1242/dmm.028571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1242%2Fdmm.028571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28993312" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=1253-1260&issue=10&author=D.+Martinsauthor=J.+Moreiraauthor=N.+P.+Gon%C3%A7alvesauthor=M.+J.+Saraiva&title=MMP-14+Overexpression+Correlates+with+the+Neurodegenerative+Process+in+Familial+Amyloidotic+Polyneuropathy&doi=10.1242%2Fdmm.028571"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1242%2Fdmm.028571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.028571%26sid%3Dliteratum%253Aachs%26aulast%3DMartins%26aufirst%3DD.%26aulast%3DMoreira%26aufirst%3DJ.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DN.%2BP.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26atitle%3DMMP-14%2520Overexpression%2520Correlates%2520with%2520the%2520Neurodegenerative%2520Process%2520in%2520Familial%2520Amyloidotic%2520Polyneuropathy%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2017%26volume%3D10%26issue%3D10%26spage%3D1253%26epage%3D1260%26doi%3D10.1242%2Fdmm.028571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, G. A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases and Their Multiple Roles in Neurodegenerative Diseases</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(09)70016-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS1474-4422%2809%2970016-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19161911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFCgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=205-216&issue=2&author=G.+A.+Rosenberg&title=Matrix+Metalloproteinases+and+Their+Multiple+Roles+in+Neurodegenerative+Diseases&doi=10.1016%2FS1474-4422%2809%2970016-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and their multiple roles in neurodegenerative diseases</span></div><div class="casAuthors">Rosenberg, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-216</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) and proteins contg. a disintegrin and metalloproteinase domain (ADAM) are important in neuroinflammation, and recent studies have linked their actions to neurodegenerative disorders.  MMPs act as cell-surface sheddases and can affect cell signalling initiated by growth factors or death receptors.  Four tissue inhibitors of metalloproteinases (TIMPs) regulate metalloproteinase activity.  These proteases increase the permeability of the blood-brain barrier, which can cause edema, hemorrhage, and cell death.  MMPs also participate in tissue repair by promoting angiogenesis and neurogenesis.  In vascular cognitive impairment, MMPs change permeability of the blood-brain barrier and might contribute to white matter damage.  MMPs and ADAMs might contribute to the formation and degrdn. of amyloid proteins in Alzheimer's disease and cause death of dopaminergic neurons in Parkinson's disease.  In this Review, by examg. the effects of neuroinflammation, we try to understand the role that MMPs might have in neurodegenerative diseases.  Therapeutic strategies that use inhibitors of MMPs could represent potential novel treatments for neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEXuGYramRwrVg90H21EOLACvtfcHk0lh5Y6nx4n8iYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFCgu7k%253D&md5=e84c6afbc8da51b37c834ef478b7c7ec</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970016-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970016-X%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DG.%2BA.%26atitle%3DMatrix%2520Metalloproteinases%2520and%2520Their%2520Multiple%2520Roles%2520in%2520Neurodegenerative%2520Diseases%26jtitle%3DLancet%2520Neurol.%26date%3D2009%26volume%3D8%26issue%3D2%26spage%3D205%26epage%3D216%26doi%3D10.1016%2FS1474-4422%2809%2970016-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble-Haeusslein, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, L. L.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase Signals Following Neurotrauma Are Right on Cue</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3141</span>– <span class="NLM_lpage">3156</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03176-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03176-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31168660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3141-3156&issue=16&author=A.+Trivediauthor=L.+J.+Noble-Haeussleinauthor=J.+M.+Levineauthor=A.+D.+Santucciauthor=T.+M.+Reevesauthor=L.+L.+Phillips&title=Matrix+Metalloproteinase+Signals+Following+Neurotrauma+Are+Right+on+Cue&doi=10.1007%2Fs00018-019-03176-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase signals following neurotrauma are right on cue</span></div><div class="casAuthors">Trivedi, Alpa; Noble-Haeusslein, Linda J.; Levine, Jonathan M.; Santucci, Alison D.; Reeves, Thomas M.; Phillips, Linda L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3141-3156</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Neurotrauma, a term referencing both traumatic brain and spinal cord injuries, is unique to neurodegeneration in that onset is clearly defined.  From the perspective of matrix metalloproteinases (MMPs), there is opportunity to define their temporal participation in injury and recovery beginning at the level of the synapse.  Here we examine the diverse roles of MMPs in the context of targeted insults (optic nerve lesion and hippocampal and olfactory bulb deafferentation), and clin. relevant focal models of traumatic brain and spinal cord injuries.  Time-specific MMP postinjury signaling is crit. to synaptic recovery after focal axonal injuries; members of the MMP family exhibit a signature temporal profile corresponding to axonal degeneration and regrowth, where they direct postinjury reorganization and synaptic stabilization.  In both traumatic brain and spinal cord injuries, MMPs mediate early secondary pathogenesis including disruption of the blood-brain barrier, creating an environment that may be hostile to recovery.  They are also crit. players in wound healing including angiogenesis and the formation of an inhibitory glial scar.  Exptl. strategies to reduce their activity in the acute phase result in long-term neurol. recovery after neurotrauma and have led to the first clin. trial in spinal cord injured pet dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxJl5ChtEOH7Vg90H21EOLACvtfcHk0lgLxFenm4RSXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtbbJ&md5=bd3be350964cc8e703d84dd6bbd1e142</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03176-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03176-4%26sid%3Dliteratum%253Aachs%26aulast%3DTrivedi%26aufirst%3DA.%26aulast%3DNoble-Haeusslein%26aufirst%3DL.%2BJ.%26aulast%3DLevine%26aufirst%3DJ.%2BM.%26aulast%3DSantucci%26aufirst%3DA.%2BD.%26aulast%3DReeves%26aufirst%3DT.%2BM.%26aulast%3DPhillips%26aufirst%3DL.%2BL.%26atitle%3DMatrix%2520Metalloproteinase%2520Signals%2520Following%2520Neurotrauma%2520Are%2520Right%2520on%2520Cue%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3141%26epage%3D3156%26doi%3D10.1007%2Fs00018-019-03176-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leake, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whateley, J.</span></span> <span> </span><span class="NLM_article-title">Brain Matrix Metalloproteinase 1 Levels Are Elevated in Alzheimer’s Disease</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1016/S0304-3940(00)01418-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0304-3940%2800%2901418-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10984641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlGrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2000&pages=201-203&issue=3&author=A.+Leakeauthor=C.+Morrisauthor=J.+Whateley&title=Brain+Matrix+Metalloproteinase+1+Levels+Are+Elevated+in+Alzheimer%E2%80%99s+Disease&doi=10.1016%2FS0304-3940%2800%2901418-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease</span></div><div class="casAuthors">Leake, A.; Morris, C. M.; Whateley, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-203</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Several lines of evidence indicate that there may be an inflammatory component to the pathol. of Alzheimer's disease (AD), the major form of degenerative dementia in the elderly.  Activity of inflammatory cells, and the elaboration of toxic mols. by such cells may be a significant factor in disease progression.  In peripheral inflammatory states, the increased activity of matrix metalloproteinase (MMP) enzymes are a major cause of tissue breakdown and secondary damage in diseases such as rheumatoid arthritis.  The activity of such enzymes in the normal or diseased central nervous system is, however, not well characterized.  We have therefore detd. the levels of MMP 1 (collagenase) in the normal human brain and in AD.  MMP1 levels were relatively low though were significantly elevated by approx. 50% in AD in all cortical areas examd.  Given the activity towards collagen of MMP1, it is possible that enhanced MMP1 activity in AD, may contribute to the blood-brain barrier dysfunction seen in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLLIi5Trl5fbVg90H21EOLACvtfcHk0lgLxFenm4RSXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlGrtLk%253D&md5=a66d1cb72b51558511e4988a59f1679b</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2800%2901418-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252800%252901418-X%26sid%3Dliteratum%253Aachs%26aulast%3DLeake%26aufirst%3DA.%26aulast%3DMorris%26aufirst%3DC.%26aulast%3DWhateley%26aufirst%3DJ.%26atitle%3DBrain%2520Matrix%2520Metalloproteinase%25201%2520Levels%2520Are%2520Elevated%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeurosci.%2520Lett.%26date%3D2000%26volume%3D291%26issue%3D3%26spage%3D201%26epage%3D203%26doi%3D10.1016%2FS0304-3940%2800%2901418-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Py, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchalant, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Differential Spatio-Temporal Regulation of MMPs in the 5xFAD Mouse Model of Alzheimer’s Disease: Evidence for a pro-Amyloidogenic Role of MT1-MMP</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2014.00247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3389%2Ffnagi.2014.00247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24478697" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1-17&author=N.+A.+Pyauthor=A.+E.+Bonnetauthor=A.+Bernardauthor=Y.+Marchalantauthor=E.+Charratauthor=F.+Checlerauthor=M.+Khrestchatiskyauthor=K.+Barangerauthor=S.+Rivera&title=Differential+Spatio-Temporal+Regulation+of+MMPs+in+the+5xFAD+Mouse+Model+of+Alzheimer%E2%80%99s+Disease%3A+Evidence+for+a+pro-Amyloidogenic+Role+of+MT1-MMP&doi=10.3389%2Ffnagi.2014.00247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2014.00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2014.00247%26sid%3Dliteratum%253Aachs%26aulast%3DPy%26aufirst%3DN.%2BA.%26aulast%3DBonnet%26aufirst%3DA.%2BE.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DMarchalant%26aufirst%3DY.%26aulast%3DCharrat%26aufirst%3DE.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DDifferential%2520Spatio-Temporal%2520Regulation%2520of%2520MMPs%2520in%2520the%25205xFAD%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Evidence%2520for%2520a%2520pro-Amyloidogenic%2520Role%2520of%2520MT1-MMP%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2014%26volume%3D6%26spage%3D1%26epage%3D17%26doi%3D10.3389%2Ffnagi.2014.00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asahina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span> <span> </span><span class="NLM_article-title">Selective Distribution of Matrix Metalloproteinase-3 (MMP-3) in Alzheimer’s Disease Brain</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1007/PL00007428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2FPL00007428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10672313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotl2k" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2000&pages=91-95&issue=2&author=Y.+Yoshiyamaauthor=M.+Asahinaauthor=T.+Hattori&title=Selective+Distribution+of+Matrix+Metalloproteinase-3+%28MMP-3%29+in+Alzheimer%E2%80%99s+Disease+Brain&doi=10.1007%2FPL00007428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain</span></div><div class="casAuthors">Yoshiyama, Yasumasa; Asahina, Masato; Hattori, Takamichi</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-95</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A growing amt. of evidence indicates that matrix metalloproteinases (MMPs) may play an important role in the pathogenesis of Alzheimer's disease (AD).  Stromelysin-1 (MMP-3) plays a central role in activating latent-type MMPs, which are originally secreted as proenzymes.  We examd. MMP-3 immunoreactivity in the brains of patients who had suffered from Alzheimer's disease and in those of neurol. normal persons.  The interstitium between myelinated axons and astrocytes in the white matter of all brain tissues, and senile plaques in the gray matter of the patients with AD were stained with a monoclonal antibody to MMP-3.  Comparison of the no. of senile plaques stained with the antibody against MMP-3 in the parietal cortex with that in the hippocampus showed that fewer plaques were stained in the hippocampus.  The selective distribution of MMP-3 in the human brain suggests that MMP-3 might play an important role in the pathogenesis of AD, esp. in the degrdn. of β-amyloid protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzYKovp_zFrVg90H21EOLACvtfcHk0ljfMDMftz7qiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotl2k&md5=147796511ba3dff92d1a81a4400cd8e5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1007%2FPL00007428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00007428%26sid%3Dliteratum%253Aachs%26aulast%3DYoshiyama%26aufirst%3DY.%26aulast%3DAsahina%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DT.%26atitle%3DSelective%2520Distribution%2520of%2520Matrix%2520Metalloproteinase-3%2520%2528MMP-3%2529%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Brain%26jtitle%3DActa%2520Neuropathol.%26date%3D2000%26volume%3D99%26issue%3D2%26spage%3D91%26epage%3D95%26doi%3D10.1007%2FPL00007428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.-J.</span></span> <span> </span><span class="NLM_article-title">MMP13 Inhibition Rescues Cognitive Decline in Alzheimer Transgenic Mice via BACE1 Regulation</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1093/brain/awy305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1093%2Fbrain%2Fawy305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30596903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BB3cnmvVShtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2019&pages=176-192&issue=1&author=B.+L.+Zhuauthor=Y.+Longauthor=W.+Luoauthor=Z.+Yanauthor=Y.+J.+Laiauthor=L.+G.+Zhaoauthor=W.+H.+Zhouauthor=Y.+J.+Wangauthor=L.+L.+Shenauthor=L.+Liuauthor=X.-J.+Dengauthor=X.-F.+Wangauthor=F.+Sunauthor=G.-J.+Chen&title=MMP13+Inhibition+Rescues+Cognitive+Decline+in+Alzheimer+Transgenic+Mice+via+BACE1+Regulation&doi=10.1093%2Fbrain%2Fawy305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation</span></div><div class="casAuthors">Zhu Bing-Lin; Long Yan; Lai Yu-Jie; Zhao Li-Ge; Liu Lu; Deng Xiao-Juan; Wang Xue-Feng; Chen Guo-Jun; Luo Wei; Yan Zhen; Zhou Wei-Hui; Wang Yan-Jiang; Shen Lin-Lin; Sun Fei</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-192</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MMP13 (matrix metallopeptidase 13) plays a key role in bone metabolism and cancer development, but has no known functions in Alzheimer's disease.  In this study, we used high-throughput small molecule screening in SH-SY5Y cells that stably expressed a luciferase reporter gene driven by the BACE1 (β-site amyloid precursor protein cleaving enzyme 1) promoter, which included a portion of the 5' untranslated region (5'UTR).  We identified that CL82198, a selective inhibitor of MMP13, decreased BACE1 protein levels in cultured neuronal cells.  This effect was dependent on PI3K (phosphatidylinositide 3-kinase) signalling, and was unrelated to BACE1 gene transcription and protein degradation.  Further, we found that eukaryotic translation initiation factor 4B (eIF4B) played a key role, as the mutation of eIF4B at serine 422 (S422R) or deletion of the BACE1 5'UTR attenuated MMP13-mediated BACE1 regulation.  In APPswe/PS1E9 mice, an animal model of Alzheimer's disease, hippocampal Mmp13 knockdown or intraperitoneal CL82198 administration reduced BACE1 protein levels and the related amyloid-β precursor protein processing, amyloid-β load and eIF4B phosphorylation, whereas spatial and associative learning and memory performances were improved.  Collectively, MMP13 inhibition/CL82198 treatment exhibited therapeutic potential for Alzheimer's disease, via the translational regulation of BACE1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3joSWYgUFxEcLvDNbOD4DfW6udTcc2eYLWzU-CbjNv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnmvVShtg%253D%253D&md5=06bf76e7aea2af9ad9ede52073fb4035</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawy305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawy305%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DB.%2BL.%26aulast%3DLong%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DLai%26aufirst%3DY.%2BJ.%26aulast%3DZhao%26aufirst%3DL.%2BG.%26aulast%3DZhou%26aufirst%3DW.%2BH.%26aulast%3DWang%26aufirst%3DY.%2BJ.%26aulast%3DShen%26aufirst%3DL.%2BL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DX.-J.%26aulast%3DWang%26aufirst%3DX.-F.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DG.-J.%26atitle%3DMMP13%2520Inhibition%2520Rescues%2520Cognitive%2520Decline%2520in%2520Alzheimer%2520Transgenic%2520Mice%2520via%2520BACE1%2520Regulation%26jtitle%3DBrain%26date%3D2019%26volume%3D142%26issue%3D1%26spage%3D176%26epage%3D192%26doi%3D10.1093%2Fbrain%2Fawy305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langenfurth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinnenthal, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinnakota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlo, A.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadelmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siffrin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peaschke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heppner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettenmann, H.</span></span> <span> </span><span class="NLM_article-title">Membrane-Type 1 Metalloproteinase Is Upregulated in Microglia/brain Macrophages in Neurodegenerative and Neuroinflammatory Diseases</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1002/jnr.23288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fjnr.23288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24323769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2014&pages=275-286&issue=3&author=A.+Langenfurthauthor=J.+L.+Rinnenthalauthor=K.+Vinnakotaauthor=V.+Prinzauthor=A.-S.+Carloauthor=C.+Stadelmannauthor=V.+Siffrinauthor=S.+Peaschkeauthor=M.+Endresauthor=F.+Heppnerauthor=R.+Glassauthor=S.+A.+Wolfauthor=H.+Kettenmann&title=Membrane-Type+1+Metalloproteinase+Is+Upregulated+in+Microglia%2Fbrain+Macrophages+in+Neurodegenerative+and+Neuroinflammatory+Diseases&doi=10.1002%2Fjnr.23288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases</span></div><div class="casAuthors">Langenfurth, Anika; Rinnenthal, Jan Leo; Vinnakota, Katyayni; Prinz, Vincent; Carlo, Anne-Sophie; Stadelmann, Christine; Siffrin, Volker; Peaschke, Susann; Endres, Matthias; Heppner, Frank; Glass, Rainer; Wolf, Susanne A.; Kettenmann, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-286</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">We previously reported that glioma cells induce the expression of membrane-type 1 metalloproteinase (MT1-MMP or MMP-14) in tumor-assocd. microglia/macrophages and promote tumor growth, whereas MMP-14 expression in microglia under physiol. conditions is very low.  Here, we show that the increase in MMP-14 expression is also found in microglia/macrophages assocd. with neurodegenerative and neuroinflammatory pathologies in mouse models as well as in human biopsies or post-mortem tissue.  We found that microglial/macrophage MMP-14 expression was upregulated in Alzheimer's disease tissue, in active lesions of multiple sclerosis, and in tissue from stage II stroke as well as in the corresponding mouse models for the human diseases.  In contrast, we obsd. no upregulation for MMP-14 in microglia/macrophages in the early phase of stroke or in the corresponding mouse model, in human amyotrophic lateral sclerosis (ALS) tissue or in a mouse model of ALS as well as in human cases of acute brain trauma.  These data indicate that MMP-14 expression is not a general marker for activated microglia/macrophages but is upregulated in defined stages of neuroinflammatory and neurodegenerative diseases and that there is generally a good match between mouse models and human brain pathologies.  © 2013 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyk7U-94DwprVg90H21EOLACvtfcHk0liQg_ibR2hBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsbbN&md5=45856ef31c1982645c4bc9c12c7f0e6d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fjnr.23288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.23288%26sid%3Dliteratum%253Aachs%26aulast%3DLangenfurth%26aufirst%3DA.%26aulast%3DRinnenthal%26aufirst%3DJ.%2BL.%26aulast%3DVinnakota%26aufirst%3DK.%26aulast%3DPrinz%26aufirst%3DV.%26aulast%3DCarlo%26aufirst%3DA.-S.%26aulast%3DStadelmann%26aufirst%3DC.%26aulast%3DSiffrin%26aufirst%3DV.%26aulast%3DPeaschke%26aufirst%3DS.%26aulast%3DEndres%26aufirst%3DM.%26aulast%3DHeppner%26aufirst%3DF.%26aulast%3DGlass%26aufirst%3DR.%26aulast%3DWolf%26aufirst%3DS.%2BA.%26aulast%3DKettenmann%26aufirst%3DH.%26atitle%3DMembrane-Type%25201%2520Metalloproteinase%2520Is%2520Upregulated%2520in%2520Microglia%252Fbrain%2520Macrophages%2520in%2520Neurodegenerative%2520and%2520Neuroinflammatory%2520Diseases%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2014%26volume%3D92%26issue%3D3%26spage%3D275%26epage%3D286%26doi%3D10.1002%2Fjnr.23288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawkins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, D. H.</span></span> <span> </span><span class="NLM_article-title">Insights into the Physiological Function of the β-Amyloid Precursor Protein: Beyond Alzheimer’s Disease</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>129</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">756</span>– <span class="NLM_lpage">769</span>, <span class="refDoi"> DOI: 10.1111/jnc.12675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fjnc.12675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24517464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotFentbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2014&pages=756-769&issue=5&author=E.+Dawkinsauthor=D.+H.+Small&title=Insights+into+the+Physiological+Function+of+the+%CE%B2-Amyloid+Precursor+Protein%3A+Beyond+Alzheimer%E2%80%99s+Disease&doi=10.1111%2Fjnc.12675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease</span></div><div class="casAuthors">Dawkins, Edgar; Small, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">756-769</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The β-amyloid precursor protein (APP) has been extensively studied for its role as the precursor of the β-amyloid protein (Aβ) of Alzheimer's disease.  However, the normal function of APP remains largely unknown.  This article reviews studies on the structure, expression and post-translational processing of APP, as well as studies on the effects of APPin vitro and in vivo.  We conclude that the published data provide strong evidence that APP has a trophic function.  APP is likely to be involved in neural stem cell development, neuronal survival, neurite outgrowth and neurorepair.  However, the mechanisms by which APP exerts its actions remain to be elucidated.  The available evidence suggests that APP interacts both intracellularly and extracellularly to regulate various signal transduction mechanisms.  This article reviews studies on the structure, expression and post-translational processing of β-amyloid precursor protein (APP), as well as studies on the effects of APP in vitro and in vivo.  We conclude that the published data provide strong evidence that APP has a trophic function.  APP is likely to be involved in neural stem cell development, neuronal survival, neurite outgrowth and neurorepair.  However, the mechanisms by which APP exerts its actions remain to be elucidated.  The available evidence suggests that APP interacts both intracellularly and extracellularly to regulate various signal transduction mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9em4KObLccLVg90H21EOLACvtfcHk0liQg_ibR2hBiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotFentbY%253D&md5=0e8bf111322cb475ee2e799038e1aeb9</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12675%26sid%3Dliteratum%253Aachs%26aulast%3DDawkins%26aufirst%3DE.%26aulast%3DSmall%26aufirst%3DD.%2BH.%26atitle%3DInsights%2520into%2520the%2520Physiological%2520Function%2520of%2520the%2520%25CE%25B2-Amyloid%2520Precursor%2520Protein%253A%2520Beyond%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D129%26issue%3D5%26spage%3D756%26epage%3D769%26doi%3D10.1111%2Fjnc.12675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korte, M.</span></span> <span> </span><span class="NLM_article-title">Not Just Amyloid: Physiological Functions of the Amyloid Precursor Protein Family</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1038/nrn.2017.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrn.2017.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28360418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltl2itr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=281-298&issue=5&author=U.+C.+M%C3%BCllerauthor=T.+Dellerauthor=M.+Korte&title=Not+Just+Amyloid%3A+Physiological+Functions+of+the+Amyloid+Precursor+Protein+Family&doi=10.1038%2Fnrn.2017.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Not just amyloid: physiological functions of the amyloid precursor protein family</span></div><div class="casAuthors">Mueller, Ulrike C.; Deller, Thomas; Korte, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">281-298</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyloid precursor protein (APP) gives rise to the amyloid-β peptide and thus has a key role in the pathogenesis of Alzheimer disease.  By contrast, the physiol. functions of APP and the closely related APP-like proteins (APLPs) remain less well understood.  Studying these physiol. functions has been challenging and has required a careful long-term strategy, including the anal. of different App-knockout and Aplp-knockout mice.  In this Review, we summarize these findings, focusing on the in vivo roles of APP family members and their processing products for CNS development, synapse formation and function, brain injury and neuroprotection, as well as ageing.  In addn., we discuss the implications of APP physiol. for therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptIVhbzrwCcrVg90H21EOLACvtfcHk0lgfzUDjbr_oYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltl2itr8%253D&md5=9fae9ec257825e9cf70ed14389ccbbb9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnrn.2017.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn.2017.29%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DU.%2BC.%26aulast%3DDeller%26aufirst%3DT.%26aulast%3DKorte%26aufirst%3DM.%26atitle%3DNot%2520Just%2520Amyloid%253A%2520Physiological%2520Functions%2520of%2520the%2520Amyloid%2520Precursor%2520Protein%2520Family%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2017%26volume%3D18%26issue%3D5%26spage%3D281%26epage%3D298%26doi%3D10.1038%2Fnrn.2017.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">APP Processing in Alzheimer’s Disease</span>. <i>Mol. Brain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1186/1756-6606-4-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1186%2F1756-6606-4-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21214928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1ahtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=3&issue=1&author=Y.+Zhangauthor=R.+Thompsonauthor=H.+Zhangauthor=H.+Xu&title=APP+Processing+in+Alzheimer%E2%80%99s+Disease&doi=10.1186%2F1756-6606-4-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">APP processing in Alzheimer's disease</span></div><div class="casAuthors">Zhang, Yun-wu; Thompson, Robert; Zhang, Han; Xu, Huaxi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  An important pathol. feature of Alzheimer's disease (AD) is the presence of extracellular senile plaques in the brain.  Senile plaques are composed of aggregations of small peptides called β-amyloid (Aβ).  Multiple lines of evidence demonstrate that overprodn./aggregation of Aβ in the brain is a primary cause of AD and inhibition of Aβ generation has become a hot topic in AD research.  Aβ is generated from β-amyloid precursor protein (APP) through sequential cleavages first by β-secretase and then by gamma:-secretase complex.  Alternatively, APP can be cleaved by α-secretase within the Aβ domain to release sol. APPα and preclude Aβ generation.  Cleavage of APP by caspases may also contribute to AD pathologies.  Therefore, understanding the metab./processing of APP is crucial for AD therapeutics.  Here we review current knowledge of APP processing regulation as well as the pathophysiol. functions of APP and its metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7EtjtYnHM3rVg90H21EOLACvtfcHk0lgfzUDjbr_oYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1ahtQ%253D%253D&md5=53536166472a4503c3e71dfc2db605f1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1186%2F1756-6606-4-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-6606-4-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DThompson%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DAPP%2520Processing%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DMol.%2520Brain%26date%3D2011%26volume%3D4%26issue%3D1%26spage%3D3%26doi%3D10.1186%2F1756-6606-4-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coronel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernabeu-Zornoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñiz-Moreno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambrano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liste, I.</span></span> <span> </span><span class="NLM_article-title">Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">7107</span>– <span class="NLM_lpage">7117</span>, <span class="refDoi"> DOI: 10.1007/s12035-018-0914-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs12035-018-0914-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29383688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVaisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2018&pages=7107-7117&issue=9&author=R.+Coronelauthor=A.+Bernabeu-Zornozaauthor=C.+Palmerauthor=M.+Mu%C3%B1iz-Morenoauthor=A.+Zambranoauthor=E.+Canoauthor=I.+Liste&title=Role+of+Amyloid+Precursor+Protein+%28APP%29+and+Its+Derivatives+in+the+Biology+and+Cell+Fate+Specification+of+Neural+Stem+Cells&doi=10.1007%2Fs12035-018-0914-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells</span></div><div class="casAuthors">Coronel, Raquel; Bernabeu-Zornoza, Adela; Palmer, Charlotte; Muniz-Moreno, Mar; Zambrano, Alberto; Cano, Eva; Liste, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7107-7117</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Amyloid precursor protein (APP) is a member of the APP family of proteins, and different enzymic processing leads to the prodn. of several derivs. that are shown to have distinct biol. functions.  APP is involved in the pathol. of Alzheimer's disease (AD), the most common neurodegenerative disorder causing dementia.  Furthermore, it is believed that individuals with Down syndrome (DS) have increased APP expression, due to an extra copy of chromosome 21 (Hsa21), that contains the gene for APP.  Nevertheless, the physiol. function of APP remains unclear.  It is known that APP plays an important role in neural growth and maturation during brain development, possibly by influencing proliferation, cell fate specification and neurogenesis of neural stem cells (NSCs).  Proteolytic cleavage of APP occurs mainly via two mutually exclusive pathways, the non-amyloidogenic pathway or the amyloidogenic pathway.  Other alternative pathways (η-secretase, δ-secretase and meprin pathways) have also been described for the physiol. processing of APP.  The different metabolites generated from these pathways, including sol. APPα (sAPPα), sol. APPβ (sAPPβ), β-amyloid (Aβ) peptides and the APP intracellular domain (AICD), have different functions detd. by their structural differences, equil. and concn. with respect to other fragments derived from APP.  This review discusses recent observations regarding possible functions of APP and its proteolytic derivs. in the biol. and phenotypic specification of NSCs.  This can be important for a better understanding of the pathogenesis and the development of future therapeutic applications for AD and/or DS, diseases in which alterations in neurogenesis have been described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE0PhCosTk8bVg90H21EOLACvtfcHk0lii_BepQorxVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVaisL4%253D&md5=8c320dc5edb2db739b0b59cfb4dc94a8</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs12035-018-0914-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-018-0914-2%26sid%3Dliteratum%253Aachs%26aulast%3DCoronel%26aufirst%3DR.%26aulast%3DBernabeu-Zornoza%26aufirst%3DA.%26aulast%3DPalmer%26aufirst%3DC.%26aulast%3DMu%25C3%25B1iz-Moreno%26aufirst%3DM.%26aulast%3DZambrano%26aufirst%3DA.%26aulast%3DCano%26aufirst%3DE.%26aulast%3DListe%26aufirst%3DI.%26atitle%3DRole%2520of%2520Amyloid%2520Precursor%2520Protein%2520%2528APP%2529%2520and%2520Its%2520Derivatives%2520in%2520the%2520Biology%2520and%2520Cell%2520Fate%2520Specification%2520of%2520Neural%2520Stem%2520Cells%26jtitle%3DMol.%2520Neurobiol.%26date%3D2018%26volume%3D55%26issue%3D9%26spage%3D7107%26epage%3D7117%26doi%3D10.1007%2Fs12035-018-0914-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauritzen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardossi-Piquard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranaldi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-George-Hyslop, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Thuc, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chami, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunys, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span> <span> </span><span class="NLM_article-title">The β-Secretase-Derived C-Terminal Fragment of APP, C99, But Not A, Is a Key Contributor to Early Intraneuronal Lesions in Triple-Transgenic Mouse Hippocampus</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">16243</span>– <span class="NLM_lpage">16255</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2775-12.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.2775-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23152608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslagurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=16243-16255&issue=46&author=I.+Lauritzenauthor=R.+Pardossi-Piquardauthor=C.+Bauerauthor=E.+Brighamauthor=J.-D.+Abrahamauthor=S.+Ranaldiauthor=P.+Fraserauthor=P.+St-George-Hyslopauthor=O.+Le+Thucauthor=V.+Espinauthor=L.+Chamiauthor=J.+Dunysauthor=F.+Checler&title=The+%CE%B2-Secretase-Derived+C-Terminal+Fragment+of+APP%2C+C99%2C+But+Not+A%2C+Is+a+Key+Contributor+to+Early+Intraneuronal+Lesions+in+Triple-Transgenic+Mouse+Hippocampus&doi=10.1523%2FJNEUROSCI.2775-12.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus</span></div><div class="casAuthors">Lauritzen, Inger; Pardossi-Piquard, Raphaelle; Bauer, Charlotte; Brigham, Elizabeth; Abraham, Jean-Daniel; Ranaldi, Sebastien; Fraser, Paul; St-George-Hyslop, Peter; Le Thuc, Ophelia; Espin, Vanessa; Chami, Linda; Dunys, Julie; Checler, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16243-16255</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Triple-transgenic mice (3xTgAD) overexpressing Swedish-mutated β-amyloid precursor protein (βAPPswe), P310L-Tau (TauP301L), and physiol. levels of M146V-presenilin-1 (PS1M146V) display extracellular amyloid-β peptides (Aβ) deposits and Tau tangles.  More disputed is the observation that these mice accumulate intraneuronal Aβ that has been linked to synaptic dysfunction and cognitive deficits.  Here, we provide immunohistol., genetic, and pharmacol. evidences for early, age-dependent, and hippocampus-specific accumulation of the β-secretase-derived βAPP fragment C99 that is obsd. from 3 mo of age and enhanced by pharmacol. blockade of γ-secretase.  Notably, intracellular Aβ is only detectable several months later and appears, as is the case of C99, in enlarged cathepsin B-pos. structures, while extracellular Aβ deposits are detected ∼12 mo of age and beyond.  Early C99 prodn. occurs mainly in the CA1/subicular interchange area of the hippocampus corresponding to the first region exhibiting plaques and tangles in old mice.  Furthermore, the comparison of 3xTgAD mice with double-transgenic mice bearing the βAPPswe and TauP301L mutations but expressing endogenous PS1 (2xTgAD) demonstrate that C99 accumulation is not accounted for by a loss of function triggered by PS1 mutation that would have prevented C99 secondary cleavage by γ-secretase.  Together, our work identifies C99 as the earliest βAPP catabolite and main contributor to the intracellular βAPP-related immunoreactivity in 3xTgAD mice, suggesting its implication as an initiator of the neurodegenerative process and cognitive alterations taking place in this mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDXJ9_L4EulrVg90H21EOLACvtfcHk0lii_BepQorxVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslagurzF&md5=891ceec67b06650dc91133376298f38a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2775-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2775-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DLauritzen%26aufirst%3DI.%26aulast%3DPardossi-Piquard%26aufirst%3DR.%26aulast%3DBauer%26aufirst%3DC.%26aulast%3DBrigham%26aufirst%3DE.%26aulast%3DAbraham%26aufirst%3DJ.-D.%26aulast%3DRanaldi%26aufirst%3DS.%26aulast%3DFraser%26aufirst%3DP.%26aulast%3DSt-George-Hyslop%26aufirst%3DP.%26aulast%3DLe%2BThuc%26aufirst%3DO.%26aulast%3DEspin%26aufirst%3DV.%26aulast%3DChami%26aufirst%3DL.%26aulast%3DDunys%26aufirst%3DJ.%26aulast%3DChecler%26aufirst%3DF.%26atitle%3DThe%2520%25CE%25B2-Secretase-Derived%2520C-Terminal%2520Fragment%2520of%2520APP%252C%2520C99%252C%2520But%2520Not%2520A%252C%2520Is%2520a%2520Key%2520Contributor%2520to%2520Early%2520Intraneuronal%2520Lesions%2520in%2520Triple-Transgenic%2520Mouse%2520Hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26issue%3D46%26spage%3D16243%26epage%3D16255%26doi%3D10.1523%2FJNEUROSCI.2775-12.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bukhari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glotzbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolbe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loosse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T.</span></span> <span> </span><span class="NLM_article-title">Small Things Matter: Implications of APP Intracellular Domain AICD Nuclear Signaling in the Progression and Pathogenesis of Alzheimer’s Disease</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2017.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.pneurobio.2017.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28587768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCiu7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2017&pages=189-213&author=H.+Bukhariauthor=A.+Glotzbachauthor=K.+Kolbeauthor=G.+Leonhardtauthor=C.+Loosseauthor=T.+M%C3%BCller&title=Small+Things+Matter%3A+Implications+of+APP+Intracellular+Domain+AICD+Nuclear+Signaling+in+the+Progression+and+Pathogenesis+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.pneurobio.2017.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Small things matter: Implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Bukhari, Hassan; Glotzbach, Annika; Kolbe, Katharina; Leonhardt, Gregor; Loosse, Christina; Mueller, Thorsten</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">189-213</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common neurodegenerative disease with tens of millions of people affected worldwide.  The pathogenesis is still poorly understood and various therapeutical approaches targeting the amyloid β (Aβ) peptide, a product of the amyloidogenic cleavage of the amyloid precursor protein (APP), failed.  Moreover, a couple of studies critically questioned the relevance of Aβ in the pathogenesis of AD.  Thus, new ideas need to be studied and one highly interesting hypothesis is the APP mediated signal transduction to the nucleus.  As a consequence nuclear -potentially toxic- structures emerge, which were recently found to a high extent in human AD tissue and thus, may contribute to neurodegeneration.  Relevant for the signaling machinery are modifications at the very C-terminal end of the precursor protein, the APP intracellular domain (AICD).  In this review we update the knowledge on mechanisms on AICD referring to our 2008 article: The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-Relevance for Alzheimer's disease (T. Muller, et al., 2008).  We summarize how AICD is generated and degraded, we describe its intramol. motifs, translational modifications, and how those as well as APP dimerization influence AICD generation and function.  Moreover, we resume the AICD interactome and elucidate AICDs involvement in nuclear signaling, transcriptional regulation, cell death, DNA repair and cell cycle re-entry and we give insights in its physiol. function.  Results are summarized in the comprehensive poster "The world of AICD".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-9zXleK9M27Vg90H21EOLACvtfcHk0liDUvTK4ilk2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCiu7jP&md5=cb30208ad0c6b447bca1caeeeaf9ec7a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2017.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2017.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DBukhari%26aufirst%3DH.%26aulast%3DGlotzbach%26aufirst%3DA.%26aulast%3DKolbe%26aufirst%3DK.%26aulast%3DLeonhardt%26aufirst%3DG.%26aulast%3DLoosse%26aufirst%3DC.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%26atitle%3DSmall%2520Things%2520Matter%253A%2520Implications%2520of%2520APP%2520Intracellular%2520Domain%2520AICD%2520Nuclear%2520Signaling%2520in%2520the%2520Progression%2520and%2520Pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2017%26volume%3D156%26spage%3D189%26epage%3D213%26doi%3D10.1016%2Fj.pneurobio.2017.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, A. J.</span></span> <span> </span><span class="NLM_article-title">β-Amyloid Catabolism: Roles for Neprilysin (NEP) and Other Metallopeptidases?</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.00855.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1046%2Fj.1471-4159.2002.00855.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12067222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD38XivVensL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2002&pages=1-8&issue=1&author=J.+A.+Carsonauthor=A.+J.+Turner&title=%CE%B2-Amyloid+Catabolism%3A+Roles+for+Neprilysin+%28NEP%29+and+Other+Metallopeptidases%3F&doi=10.1046%2Fj.1471-4159.2002.00855.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid catabolism: Roles for neprilysin (NEP) and other metallopeptidases?</span></div><div class="casAuthors">Carson, Julie A.; Turner, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The steady-state level of amyloid β-peptide (Aβ) represents a balance between its biosynthesis from the amyloid precursor protein (APP) through the action of the β- and γ-secretases and its catabolism by a variety of proteolytic enzymes.  Recent attention has focused on members of the neprilysin (NEP) family of zinc metalloproteinases in amyloid metab.  NEP itself degrades both Aβ1-40 and Aβ1-42 in vitro and in vivo, and this metab. is prevented by NEP inhibitors.  Other NEP family members, for example endothelin-converting enzyme, may contribute to amyloid catabolism and may also play a role in neuroprotection.  Another metalloproteinase, insulysin (insulin-degrading enzyme) has also been advocated as an amyloid-degrading enzyme and may contribute more generally to metab. of amyloid-forming peptides.  Other candidate enzymes proposed include angiotensin-converting enzyme, some matrix metalloproteinases, plasmin and, indirectly, thimet oligopeptidase (endopeptidase-24.15).  This review critically evaluates the evidence relating to proteinases implicated in amyloid catabolism.  Therapeutic strategies aimed at promoting Aβ degrdn. may provide a novel approach to the therapy of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1hGDjPTnKErVg90H21EOLACvtfcHk0liDUvTK4ilk2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivVensL4%253D&md5=b6dd1e3da2676578cd6e7ecbf044e84b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.00855.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.00855.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarson%26aufirst%3DJ.%2BA.%26aulast%3DTurner%26aufirst%3DA.%2BJ.%26atitle%3D%25CE%25B2-Amyloid%2520Catabolism%253A%2520Roles%2520for%2520Neprilysin%2520%2528NEP%2529%2520and%2520Other%2520Metallopeptidases%253F%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D81%26issue%3D1%26spage%3D1%26epage%3D8%26doi%3D10.1046%2Fj.1471-4159.2002.00855.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span> <span> </span><span class="NLM_article-title">Amyloid Precursor Protein Processing and Alzheimer’s Disease</span>. <i>Annu. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1146/annurev-neuro-061010-113613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1146%2Fannurev-neuro-061010-113613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21456963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVyju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=185-204&issue=1&author=R.+J.+O%E2%80%99Brienauthor=P.+C.+Wong&title=Amyloid+Precursor+Protein+Processing+and+Alzheimer%E2%80%99s+Disease&doi=10.1146%2Fannurev-neuro-061010-113613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid precursor protein processing and Alzheimer's disease</span></div><div class="casAuthors">O'Brien, Richard J.; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">185-204</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-assocd. protein tau.  Genetic, biochem., and behavioral research suggest that physiol. generation of the neurotoxic Aβ peptide from sequential amyloid precursor protein (APP) proteolysis is the crucial step in the development of AD.  APP is a single-pass transmembrane protein expressed at high levels in the brain and metabolized in a rapid and highly complex fashion by a series of sequential proteases, including the intramembranous γ-secretase complex, which also process other key regulatory mols.  Why Aβ accumulates in the brains of elderly individuals is unclear but could relate to changes in APP metab. or Aβ elimination.  Lessons learned from biochem. and genetic studies of APP processing will be crucial to the development of therapeutic targets to treat AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVXA7Il6AlxLVg90H21EOLACvtfcHk0ljtNczEzITVhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVyju7k%253D&md5=6d186f110797eb5472fbc30fd9d397a6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1146%2Fannurev-neuro-061010-113613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-neuro-061010-113613%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%2BJ.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DAmyloid%2520Precursor%2520Protein%2520Processing%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2011%26volume%3D34%26issue%3D1%26spage%3D185%26epage%3D204%26doi%3D10.1146%2Fannurev-neuro-061010-113613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasunic, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotter, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, R.</span></span> <span> </span><span class="NLM_article-title">Proteolysis of Aβ Peptide from Alzheimer Disease Brain by Gelatinase A</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>205</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1755</span>– <span class="NLM_lpage">1761</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1994.2872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1006%2Fbbrc.1994.2872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=7811262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK2MXivV2rurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1994&pages=1755-1761&issue=3&author=A.+E.+Roherauthor=T.+C.+Kasunicauthor=A.+S.+Woodsauthor=R.+J.+Cotterauthor=M.+J.+Ballauthor=R.+Fridman&title=Proteolysis+of+A%CE%B2+Peptide+from+Alzheimer+Disease+Brain+by+Gelatinase+A&doi=10.1006%2Fbbrc.1994.2872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolysis of Aβ peptide from Alzheimer disease brain by gelatinase A</span></div><div class="casAuthors">Roher, A. E.; Kasunic, T. C.; Woods, A. S.; Cotter, R. J.; Ball, M. J.; Bridman, R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1755-61</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">It has been recently reported that the 72 kDa proteolytic enzyme gelatinase A/type IV collagenase/matrix metalloproteinase 2 (MMP2) hydrolyzed the Lys 16-Leu 17 peptide bond of a synthetic decapeptide (YEVHHQKLVFF) representing the sol. Aβ sequence of amino acid residues 10-20.  The aim was to test if this enzyme could also degrade the insol. 40-42 residues long Aβ peptides purified from Alzheimer Disease brain.  The results indicate that MMP2 hydrolyzes Aβ1-40 and Aβ1-42 peptides at Lys 16-Leu 17, at Leu 34-Met 35, and Met 35-Val 36 peptide bonds.  These results suggest that MMP2 has the ability of degrading Aβ of AD in vitro.  If this hydrolysis also occurs in the brain's extracellular matrix, the enzymic action of gelatinase A could prevent the generation of amyloidogenic Aβ1-40(42).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY2naFWxJm17Vg90H21EOLACvtfcHk0ljtNczEzITVhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXivV2rurs%253D&md5=4b59b56e98cb4bd7ca28ac3588e03f78</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1994.2872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1994.2872%26sid%3Dliteratum%253Aachs%26aulast%3DRoher%26aufirst%3DA.%2BE.%26aulast%3DKasunic%26aufirst%3DT.%2BC.%26aulast%3DWoods%26aufirst%3DA.%2BS.%26aulast%3DCotter%26aufirst%3DR.%2BJ.%26aulast%3DBall%26aufirst%3DM.%2BJ.%26aulast%3DFridman%26aufirst%3DR.%26atitle%3DProteolysis%2520of%2520A%25CE%25B2%2520Peptide%2520from%2520Alzheimer%2520Disease%2520Brain%2520by%2520Gelatinase%2520A%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1994%26volume%3D205%26issue%3D3%26spage%3D1755%26epage%3D1761%26doi%3D10.1006%2Fbbrc.1994.2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Backstrom, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tökés, Z. A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-β Peptide (1–40)</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7910</span>– <span class="NLM_lpage">7919</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.16-24-07910.1996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.16-24-07910.1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=8987819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK28XnsF2nt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=7910-7919&issue=24&author=J.+R.+Backstromauthor=G.+P.+Limauthor=M.+J.+Cullenauthor=Z.+A.+T%C3%B6k%C3%A9s&title=Matrix+Metalloproteinase-9+%28MMP-9%29+Is+Synthesized+in+Neurons+of+the+Human+Hippocampus+and+Is+Capable+of+Degrading+the+Amyloid-%CE%B2+Peptide+%281%E2%80%9340%29&doi=10.1523%2FJNEUROSCI.16-24-07910.1996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40)</span></div><div class="casAuthors">Backstrom, Jon R.; Lim, Giselle P.; Cullen, Michael J.; Toekes, Zoltan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7910-7919</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We reported earlier that the levels of Ca2+-dependent metalloproteinases are increased in Alzheimer's disease (AD) specimens, relative to control specimens.  Here we show that these enzymes are forms of the matrix metalloproteinase MMP-9 (EC 3.4.24.35) and are expressed in the human hippocampus.  Affinity-purified antibodies to MMP-9 labeled pyramidal neurons, but not granular neurons or glial cells.  MMP-9 mRNA is expressed in pyramidal neurons, as detd. with digoxigenin-labeled MMP-9 riboprobes, and the presence of this mRNA is confirmed with reverse transcriptase PCR.  The cellular distribution of MMP-9 is altered in AD because 76% of the total 100 kDa enzyme activity is found in the sol. fraction of control specimens, whereas only 51% is detectable in the same fraction from AD specimens.  The accumulated 100 kDa enzyme from AD brain is latent and can be converted to an active form with aminophenylmercuric acetate.  MMP-9 also is detected in close proximity to extracellular amyloid plaques.  Because a major constituent of plaques is the 4 kDa β-amyloid peptide, synthetic Aβ1-40 was incubated with activated MMP-9.  The enzyme cleaves the peptide at several sites, predominantly at Leu34-Met35 within the membrane-spanning domain.  These results establish that neurons have the capacity to synthesize MMP-9, which, on activation, may degrade extracellular substrates such as β-amyloid.  Because the latent form of MMP-9 accumulates in AD brain, it is hypothesized that the lack of enzyme activation contributes to the accumulation of insol. β-amyloid peptides in plaques.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpADNH9q_TcxbVg90H21EOLACvtfcHk0ljtNczEzITVhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsF2nt7c%253D&md5=2fd7f6e68d94bc5a5ddcd94f3611e6da</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.16-24-07910.1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.16-24-07910.1996%26sid%3Dliteratum%253Aachs%26aulast%3DBackstrom%26aufirst%3DJ.%2BR.%26aulast%3DLim%26aufirst%3DG.%2BP.%26aulast%3DCullen%26aufirst%3DM.%2BJ.%26aulast%3DT%25C3%25B6k%25C3%25A9s%26aufirst%3DZ.%2BA.%26atitle%3DMatrix%2520Metalloproteinase-9%2520%2528MMP-9%2529%2520Is%2520Synthesized%2520in%2520Neurons%2520of%2520the%2520Human%2520Hippocampus%2520and%2520Is%2520Capable%2520of%2520Degrading%2520the%2520Amyloid-%25CE%25B2%2520Peptide%2520%25281%25E2%2580%259340%2529%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26issue%3D24%26spage%3D7910%26epage%3D7919%26doi%3D10.1523%2FJNEUROSCI.16-24-07910.1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirrito, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">24566</span>– <span class="NLM_lpage">24574</span>, <span class="refDoi"> DOI: 10.1074/jbc.M602440200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M602440200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16787929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1eqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=24566-24574&issue=34&author=P.+Yanauthor=X.+Huauthor=H.+Songauthor=K.+Yinauthor=R.+J.+Batemanauthor=J.+R.+Cirritoauthor=Q.+Xiaoauthor=F.+F.+Hsuauthor=J.+W.+Turkauthor=J.+Xuauthor=C.+Y.+Hsuauthor=D.+M.+Holtzmanauthor=J.-M.+Lee&title=Matrix+Metalloproteinase-9+Degrades+Amyloid-%CE%B2+Fibrils+in+Vitro+and+Compact+Plaques+in+Situ&doi=10.1074%2Fjbc.M602440200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ</span></div><div class="casAuthors">Yan, Ping; Hu, Xiaoyan; Song, Haowei; Yin, Kejie; Bateman, Randall J.; Cirrito, John R.; Xiao, Qingli; Hsu, Fong F.; Turk, John W.; Xu, Jan; Hsu, Chung Y.; Holtzman, David M.; Lee, Jin-Moo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">24566-24574</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The pathol. hallmark of Alzheimer disease is the senile plaque principally composed of tightly aggregated amyloid-β fibrils (fAβ), which are thought to be resistant to degrdn. and clearance.  In this study, we explored whether proteases capable of degrading sol. Aβ (sAβ) could degrade fAβ as well.  We demonstrate that matrix metalloproteinase-9 (MMP-9) can degrade fAβ and that this ability is not shared by other sAβ-degrading enzymes examd., including endothelin-converting enzyme, insulin-degrading enzyme, and neprilysin. fAβ was decreased in samples incubated with MMP-9 compared with other proteases, assessed using thioflavin-T.  Furthermore, fAβ breakdown with MMP-9 but not with other proteases was demonstrated by TEM.  Proteolytic digests of purified fAβ were analyzed with matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify sites of Aβ that are cleaved during its degrdn.  Only MMP-9 digests contained fragments (Aβ1-20 and Aβ1-30) from fAβ1-42 substrate; the corresponding cleavage sites are thought to be important for β-pleated sheet formation.  To det. whether MMP-9 can degrade plaques formed in vivo, fresh brain slices from aged APP/PS1 mice were incubated with proteases.  MMP-9 digestion resulted in a decrease in thioflavin-S (ThS) staining.  Consistent with a role for endogenous MMP-9 in this process in vivo, MMP-9 immunoreactivity was detected in astrocytes surrounding amyloid plaques in the brains of aged APP/PS1 and APPsw mice, and increased MMP activity was selectively obsd. in compact ThS-pos. plaques.  These findings suggest that MMP-9 can degrade fAβ and may contribute to ongoing clearance of plaques from amyloid-laden brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphNEml788nF7Vg90H21EOLACvtfcHk0lgAq2JWYYG5uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1eqtrc%253D&md5=e70cd7fec515ff195e0fff84a25fa1f8</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M602440200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M602440200%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DK.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DCirrito%26aufirst%3DJ.%2BR.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DHsu%26aufirst%3DF.%2BF.%26aulast%3DTurk%26aufirst%3DJ.%2BW.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DHsu%26aufirst%3DC.%2BY.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DJ.-M.%26atitle%3DMatrix%2520Metalloproteinase-9%2520Degrades%2520Amyloid-%25CE%25B2%2520Fibrils%2520in%2520Vitro%2520and%2520Compact%2520Plaques%2520in%2520Situ%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D34%26spage%3D24566%26epage%3D24574%26doi%3D10.1074%2Fjbc.M602440200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Guillamon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawhirt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blais, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostagno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J.</span></span> <span> </span><span class="NLM_article-title">Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">15078</span>– <span class="NLM_lpage">15091</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.610931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M114.610931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25897080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvV2nt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=15078-15091&issue=24&author=M.+Hernandez-Guillamonauthor=S.+Mawhirtauthor=S.+Blaisauthor=J.+Montanerauthor=T.+A.+Neubertauthor=A.+Rostagnoauthor=J.+Ghiso&title=Sequential+Amyloid-%CE%B2+Degradation+by+the+Matrix+Metalloproteases+MMP-2+and+MMP-9&doi=10.1074%2Fjbc.M114.610931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9</span></div><div class="casAuthors">Hernandez-Guillamon, Mar; Mawhirt, Stephanie; Blais, Steven; Montaner, Joan; Neubert, Thomas A.; Rostagno, Agueda; Ghiso, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15078-15091</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Matrix metalloproteases (MMPs) MMP-2 and MMP-9 have been implicated in the physiol. catabolism of Alzheimer's amyloid-β (Aβ).  Conversely, their assocn. with vascular amyloid deposits, blood-brain barrier disruption, and hemorrhagic transformations after ischemic stroke also highlights their involvement in pathol. processes.  To better understand this dichotomy, recombinant human (rh) MMP-2 and MMP-9 were incubated with Aβ40 and Aβ42, and the resulting proteolytic fragments were assessed via immunopptn. and quant. mass spectrometry.  Both MMPs generated Aβ fragments truncated only at the C terminus, ending at positions 34, 30, and 16.  Using deuterated homologues as internal stds., we obsd. limited and relatively slow degrdn. of Aβ42 by rhMMP-2, although the enzyme cleaved >80% of Aβ40 during the 1st h of incubation.  RhMMP-9 was significantly less effective, particularly in degrading Aβ(1-42), although the targeted peptide bonds were identical.  Using Aβ(1-34) and Aβ(1-30), we demonstrated that these peptides are also substrates for both MMPs, cleaving Aβ(1-34) to produce Aβ(1-30) first and Aβ(1-16) subsequently.  Consistent with the kinetics obsd. with full-length Aβ, rhMMP-9 degraded only a minute fraction of Aβ(1-34) and was even less effective in producing Aβ(1-16).  Further degrdn. of Aβ(1-16) by either MMP-2 or MMP-9 was not obsd. even after prolonged incubation times.  Notably, all MMP-generated C-terminally truncated Aβ fragments were highly sol. and did not exhibit fibrillogenic properties or induce cytotoxicity in human cerebral microvascular endothelial or neuronal cells supporting the notion that these truncated Aβ species are assocd. with clearance mechanisms rather than being key elements in the fibrillogenesis process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZOL0ljnEWorVg90H21EOLACvtfcHk0lgAq2JWYYG5uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvV2nt7k%253D&md5=f72014b81c4af7000f34b608d13f12af</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.610931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.610931%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Guillamon%26aufirst%3DM.%26aulast%3DMawhirt%26aufirst%3DS.%26aulast%3DBlais%26aufirst%3DS.%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DNeubert%26aufirst%3DT.%2BA.%26aulast%3DRostagno%26aufirst%3DA.%26aulast%3DGhiso%26aufirst%3DJ.%26atitle%3DSequential%2520Amyloid-%25CE%25B2%2520Degradation%2520by%2520the%2520Matrix%2520Metalloproteases%2520MMP-2%2520and%2520MMP-9%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D24%26spage%3D15078%26epage%3D15091%26doi%3D10.1074%2Fjbc.M114.610931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirrito, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, F.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-Beta Peptide Catabolism</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">10939</span>– <span class="NLM_lpage">10948</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2085-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.2085-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17065436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFymsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=10939-10948&issue=43&author=K.-J.+Yinauthor=J.+R.+Cirritoauthor=P.+Yanauthor=X.+Huauthor=Q.+Xiaoauthor=X.+Panauthor=R.+Batemanauthor=H.+Songauthor=F.-F.+Hsuauthor=J.+Turkauthor=J.+Xuauthor=C.+Y.+Hsuauthor=J.+C.+Millsauthor=D.+M.+Holtzmanauthor=J.-M.+Lee&title=Matrix+Metalloproteinases+Expressed+by+Astrocytes+Mediate+Extracellular+Amyloid-Beta+Peptide+Catabolism&doi=10.1523%2FJNEUROSCI.2085-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism</span></div><div class="casAuthors">Yin, Ke-Jie; Cirrito, John R.; Yan, Ping; Hu, Xiaoyan; Xiao, Qingli; Pan, Xiaoou; Bateman, Randall; Song, Haowei; Hsu, Fong-Fu; Turk, John; Xu, Jan; Hsu, Chung Y.; Mills, Jason C.; Holtzman, David M.; Lee, Jin-Moo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">10939-10948</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">It has been postulated that the development of amyloid plaques in Alzheimer's disease (AD) may result from an imbalance between the generation and clearance of the amyloid-β peptide (Aβ).  Although familial AD appears to be caused by Aβ over-prodn., sporadic AD (the most prevalent form) may result from impairment in clearance.  Recent evidence suggests that several proteases may contribute to the degrdn. of Aβ.  Furthermore, astrocytes have recently been implicated as a potential cellular mediator of Aβ degrdn.  In this study, we examd. the possibility that matrix metalloproteinases (MMPs), proteases known to be expressed and secreted by astrocytes, could play a role in extracellular Aβ degrdn.  We found that astrocytes surrounding amyloid plaques showed enhanced expression of MMP-2 and MMP-9 in aged amyloid precursor protein (APP)/presenilin 1 mice.  Moreover, astrocyte-conditioned medium (ACM) degraded Aβ, lowering levels and producing several fragments after incubation with synthetic human Aβ1-40 and Aβ1-42.  This activity was attenuated with specific inhibitors of MMP-2 and -9, as well as in ACM derived from mmp-2 or -9 knock-out (KO) mice.  In vivo, significant increases in the steady-state levels of Aβ were found in the brains of mmp-2 and -9 KO mice compared with wild-type controls.  Furthermore, pharmacol. inhibition of the MMPs with N-[(2R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L- tryptophan methylamide (GM 6001) increased brain interstitial fluid Aβ levels and elimination of half-life in APPsw mice.  These results suggest that MMP-2 and -9 may contribute to extracellular brain Aβ clearance by promoting Aβ catabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSWJwEblOMLLVg90H21EOLACvtfcHk0lgI_CdGsjkhkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFymsLjM&md5=0e8675a83cfeb4f9344a37ff47d44e20</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2085-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2085-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DK.-J.%26aulast%3DCirrito%26aufirst%3DJ.%2BR.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DBateman%26aufirst%3DR.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DHsu%26aufirst%3DF.-F.%26aulast%3DTurk%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DHsu%26aufirst%3DC.%2BY.%26aulast%3DMills%26aufirst%3DJ.%2BC.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DJ.-M.%26atitle%3DMatrix%2520Metalloproteinases%2520Expressed%2520by%2520Astrocytes%2520Mediate%2520Extracellular%2520Amyloid-Beta%2520Peptide%2520Catabolism%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26issue%3D43%26spage%3D10939%26epage%3D10948%26doi%3D10.1523%2FJNEUROSCI.2085-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koronyo-Hamaoui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koronyo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azoulay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seksenyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakhsheshian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogeri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farkas, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, M.</span></span> <span> </span><span class="NLM_article-title">Attenuation of AD-like Neuropathology by Harnessing Peripheral Immune Cells: Local Elevation of IL-10 and MMP-9</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1424</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2009.06402.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fj.1471-4159.2009.06402.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19780903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGqtrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2009&pages=1409-1424&issue=6&author=M.+Koronyo-Hamaouiauthor=M.+K.+Koauthor=Y.+Koronyoauthor=D.+Azoulayauthor=A.+Seksenyanauthor=G.+Kunisauthor=M.+Phamauthor=J.+Bakhsheshianauthor=P.+Rogeriauthor=K.+L.+Blackauthor=D.+L.+Farkasauthor=M.+Schwartz&title=Attenuation+of+AD-like+Neuropathology+by+Harnessing+Peripheral+Immune+Cells%3A+Local+Elevation+of+IL-10+and+MMP-9&doi=10.1111%2Fj.1471-4159.2009.06402.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9</span></div><div class="casAuthors">Koronyo-Hamaoui, Maya; Ko, MinHee K.; Koronyo, Yosef; Azoulay, David; Seksenyan, Akop; Kunis, Gilad; Pham, Michael; Bakhsheshian, Joshua; Rogeri, Patricia; Black, Keith L.; Farkas, Daniel L.; Schwartz, Michal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1409-1424</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Immunization with an altered myelin-derived peptide (MOG45D) improves recovery from acute CNS insults, partially via recruitment of monocyte-derived macrophages that locally display a regulatory activity.  Here, we investigated the local alterations in the cellular and mol. immunol. milieu assocd. with attenuation of Alzheimer's disease-like pathol. following immunotherapy.  We found that immunization of amyloid precursor protein/presenilin 1 double-transgenic mice with MOG45D peptide, loaded on dendritic cells, led to a substantial redn. of parenchymal and perivascular amyloid beta (Aβ)-plaque burden and sol. Aβ(1-42) peptide levels as well as reduced astrogliosis and levels of a key glial scar protein (chondroitin sulfate proteoglycan).  These changes were assocd. with a shift in the local innate immune response, manifested by increased Iba1+/CD45high macrophages that engulfed Aβ, reduced pro-inflammatory (tumor necrosis factor-α) and increased anti-inflammatory (interleukin-10) cytokines, as well as a significant increase in growth factors (IGF-1 and TGFβ) in the brain.  Furthermore, the levels of matrix metalloproteinase-9, an enzyme shown to degrade Aβ and is assocd. with glial scar formation, were significantly elevated in the brain following immunization.  Altogether, these results indicate that boosting systemic immune cells leads to a local immunomodulation manifested by elevated levels of anti-inflammatory cytokines and metalloproteinases that contribute to ameliorating Alzheimer's disease pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru6rP_iiSL6LVg90H21EOLACvtfcHk0lgI_CdGsjkhkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGqtrjP&md5=cda5be12bdac04ebe4fb719087b8b0ae</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06402.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06402.x%26sid%3Dliteratum%253Aachs%26aulast%3DKoronyo-Hamaoui%26aufirst%3DM.%26aulast%3DKo%26aufirst%3DM.%2BK.%26aulast%3DKoronyo%26aufirst%3DY.%26aulast%3DAzoulay%26aufirst%3DD.%26aulast%3DSeksenyan%26aufirst%3DA.%26aulast%3DKunis%26aufirst%3DG.%26aulast%3DPham%26aufirst%3DM.%26aulast%3DBakhsheshian%26aufirst%3DJ.%26aulast%3DRogeri%26aufirst%3DP.%26aulast%3DBlack%26aufirst%3DK.%2BL.%26aulast%3DFarkas%26aufirst%3DD.%2BL.%26aulast%3DSchwartz%26aufirst%3DM.%26atitle%3DAttenuation%2520of%2520AD-like%2520Neuropathology%2520by%2520Harnessing%2520Peripheral%2520Immune%2520Cells%253A%2520Local%2520Elevation%2520of%2520IL-10%2520and%2520MMP-9%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D111%26issue%3D6%26spage%3D1409%26epage%3D1424%26doi%3D10.1111%2Fj.1471-4159.2009.06402.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fragkouli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsilibary, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzinia, A. K.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective Role of MMP-9 Overexpression in the Brain of Alzheimer’s 5xFAD Mice</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2014.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.nbd.2014.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25008761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCjsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=179-189&author=A.+Fragkouliauthor=E.+C.+Tsilibaryauthor=A.+K.+Tzinia&title=Neuroprotective+Role+of+MMP-9+Overexpression+in+the+Brain+of+Alzheimer%E2%80%99s+5xFAD+Mice&doi=10.1016%2Fj.nbd.2014.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice</span></div><div class="casAuthors">Fragkouli, Apostolia; Tsilibary, Effie C.; Tzinia, Athina K.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-189</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Accumulation of amyloid-β (Αβ) peptide is believed to play a central role in the pathogenesis of Alzheimer's disease (AD).  Lowering Aβ levels in the brain may thus improve synaptic and cognitive deficits obsd. in AD patients.  In the non-amyloidogenic pathway, the amyloid-β precursor protein (APP) is cleaved within the Aβ peptide sequence by α-secretases, giving rise to the potent neurotrophic N-terminal fragment sΑPPα.  We have previously reported that gelatinase B/matrix metalloproteinase 9 (MMP-9), a matrix metalloproteinase critically involved in neuronal plasticity, acts as α-secretase both in vitro and in vivo and reduces Aβ levels in vitro.  In the present study, we demonstrate that neuronal overexpression of MMP-9 in a transgenic AD mouse model harboring five familial AD-related mutations (5xFAD) resulted in increased sAPPα levels and decreased Aβ oligomers without affecting amyloid plaque load in the brain.  Functionally, overexpression of MMP-9 prevented the cognitive deficits displayed by 5xFAD mice, an improvement that was accompanied by increased levels of the pre-synaptic protein synaptophysin and mature brain-derived neurotrophic factor (BDNF) in the brain.  These results suggest that in vivo activation of endogenous MMP-9 could be a promising target for interference with development and/or progression of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBRqVJAyoPBbVg90H21EOLACvtfcHk0lj33qA2PJMEFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCjsbnF&md5=59028958f6f956f9880a2c67b78e5432</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2014.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2014.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DFragkouli%26aufirst%3DA.%26aulast%3DTsilibary%26aufirst%3DE.%2BC.%26aulast%3DTzinia%26aufirst%3DA.%2BK.%26atitle%3DNeuroprotective%2520Role%2520of%2520MMP-9%2520Overexpression%2520in%2520the%2520Brain%2520of%2520Alzheimer%25E2%2580%2599s%25205xFAD%2520Mice%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2014%26volume%3D70%26spage%3D179%26epage%3D189%26doi%3D10.1016%2Fj.nbd.2014.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mufson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuello, A. C.</span></span> <span> </span><span class="NLM_article-title">Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1309</span>– <span class="NLM_lpage">1318</span>, <span class="refDoi"> DOI: 10.1097/NEN.0b013e3181c22569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1097%2FNEN.0b013e3181c22569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19915485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVOhtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2009&pages=1309-1318&issue=12&author=M.+A.+Brunoauthor=E.+J.+Mufsonauthor=J.+Wuuauthor=A.+C.+Cuello&title=Increased+Matrix+Metalloproteinase+9+Activity+in+Mild+Cognitive+Impairment&doi=10.1097%2FNEN.0b013e3181c22569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment</span></div><div class="casAuthors">Bruno, Martin A.; Mufson, Elliott J.; Wuu, Joanne; Cuello, A. Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1309-1318</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Nerve growth factor (NGF)-dependent cholinergic basal forebrain neurons degenerate during the progression of Alzheimer disease (AD).  Elevated proNGF and reduced levels of the TrkA high-affinity NGF receptor occur in prodromal and advanced stages of AD.  We recently described a protease cascade responsible for the conversion of proNGF to mature NGF (mNGF) in which matrix metalloproteinase 9 (MMP-9) degrades mNGF in the extracellular space.  To det. whether this proteolytic cascade is altered during the progression of AD, we examd. human frontal and parietal cortex tissues from aged subjects with a clin. diagnosis of AD, mild cognitive impairment, or no cognitive impairment.  The anal. demonstrated greater MMP-9 activity in both AD and mild cognitive impairment compared with no cognitive impairment brain samples (p < 0.01), which supports the notion that a metabolic failure in the NGF-maturation/degrdn. pathway may be assocd. with an exacerbated degrdn. of mNGF in the cerebral cortex in early AD.  Moreover, there were inverse correlations between Global Cognitive Score and Mini-Mental State Examn. score and MMP-9 activity.  These findings suggest that a redn. in mNGF as a consequence of MMP-9-mediated degrdn. may in part underlie the pathogenesis of cognitive deficits in mild cognitive impairment and AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwo15Y4xpt27Vg90H21EOLACvtfcHk0lj33qA2PJMEFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVOhtLvL&md5=fa3e9f900180eaa2c11397038542f971</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e3181c22569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e3181c22569%26sid%3Dliteratum%253Aachs%26aulast%3DBruno%26aufirst%3DM.%2BA.%26aulast%3DMufson%26aufirst%3DE.%2BJ.%26aulast%3DWuu%26aufirst%3DJ.%26aulast%3DCuello%26aufirst%3DA.%2BC.%26atitle%3DIncreased%2520Matrix%2520Metalloproteinase%25209%2520Activity%2520in%2520Mild%2520Cognitive%2520Impairment%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2009%26volume%3D68%26issue%3D12%26spage%3D1309%26epage%3D1318%26doi%3D10.1097%2FNEN.0b013e3181c22569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilcock, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridnour, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colton, C. A.</span></span> <span> </span><span class="NLM_article-title">Activation of Matrix Metalloproteinases Following Anti-Aβ Immunotherapy; Implications for Microhemorrhage Occurrence</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">115</span>, <span class="refDoi"> DOI: 10.1186/1742-2094-8-115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1186%2F1742-2094-8-115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21906275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlajs77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=115&author=D.+M.+Wilcockauthor=D.+Morganauthor=M.+N.+Gordonauthor=T.+L.+Taylorauthor=L.+A.+Ridnourauthor=D.+A.+Winkauthor=C.+A.+Colton&title=Activation+of+Matrix+Metalloproteinases+Following+Anti-A%CE%B2+Immunotherapy%3B+Implications+for+Microhemorrhage+Occurrence&doi=10.1186%2F1742-2094-8-115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence</span></div><div class="casAuthors">Wilcock, Donna M.; Morgan, Dave; Gordon, Marcia N.; Taylor, Tiffany L.; Ridnour, Lisa A.; Wink, David A.; Colton, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Anti-Aβ immunotherapy is a promising approach to the prevention and treatment of Alzheimer's disease (AD) currently in clin. trials.  There is extensive evidence, both in mice and humans that a significant adverse event is the occurrence of microhemorrhages.  Also, vasogenic edema was reported in phase 2 of a passive immunization clin. trial.  In order to overcome these vascular adverse effects it is crit. that we understand the mechanism(s) by which they occur.  Methods: We have examd. the matrix metalloproteinase (MMP) protein degrdn. system in two previously published anti-Aβ immunotherapy studies.  The first was a passive immunization study in which we examd. 22 mo old APPSw mice that had received anti-Aβ antibodies for 1, 2 or 3 mo.  The second is an active vaccination study in which we examd. 16 mo old APPSw/NOS2-/- mice treated with Aβ vaccination for 4 mo.  Results: There is a significant activation of the MMP2 and MMP9 proteinase degrdn. systems by anti-Aβ immunotherapy, regardless of whether this is delivered through active vaccination or passive immunization.  We have characterized this activation by gene expression, protein expression and zymog. assessment of MMP activity.  Conclusions: Since the MMP2 and MMP9 systems are heavily implicated in the pathophysiol. of intracerbral hemorrhage, these data may provide a potential mechanism of microhemorrhage due to immunotherapy.  Increased activity of the MMP system, therefore, is likely to be a major factor in increased microhemorrhage occurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTafVW7HjmrLVg90H21EOLACvtfcHk0li5IrrYpYgWEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlajs77I&md5=39c3a215f1c8fbac9e68c09415b2c26b</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-8-115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-8-115%26sid%3Dliteratum%253Aachs%26aulast%3DWilcock%26aufirst%3DD.%2BM.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DM.%2BN.%26aulast%3DTaylor%26aufirst%3DT.%2BL.%26aulast%3DRidnour%26aufirst%3DL.%2BA.%26aulast%3DWink%26aufirst%3DD.%2BA.%26aulast%3DColton%26aufirst%3DC.%2BA.%26atitle%3DActivation%2520of%2520Matrix%2520Metalloproteinases%2520Following%2520Anti-A%25CE%25B2%2520Immunotherapy%253B%2520Implications%2520for%2520Microhemorrhage%2520Occurrence%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2011%26volume%3D8%26spage%3D115%26doi%3D10.1186%2F1742-2094-8-115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagare, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deane, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betsholtz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armulik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sallstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berk, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">Apolipoprotein E Controls Cerebrovascular Integrity via Cyclophilin A</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span> (<span class="NLM_issue">7399</span>),  <span class="NLM_fpage">512</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1038/nature11087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnature11087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=22622580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38Xntl2js78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=512-516&issue=7399&author=R.+D.+Bellauthor=E.+A.+Winklerauthor=I.+Singhauthor=A.+P.+Sagareauthor=R.+Deaneauthor=Z.+Wuauthor=D.+M.+Holtzmanauthor=C.+Betsholtzauthor=A.+Armulikauthor=J.+Sallstromauthor=B.+C.+Berkauthor=B.+V.+Zlokovic&title=Apolipoprotein+E+Controls+Cerebrovascular+Integrity+via+Cyclophilin+A&doi=10.1038%2Fnature11087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Apolipoprotein E controls cerebrovascular integrity via cyclophilin A</span></div><div class="casAuthors">Bell, Robert D.; Winkler, Ethan A.; Singh, Itender; Sagare, Abhay P.; Deane, Rashid; Wu, Zhenhua; Holtzman, David M.; Betsholtz, Christer; Armulik, Annika; Sallstrom, Jan; Berk, Bradford C.; Zlokovic, Berislav V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7399</span>),
    <span class="NLM_cas:pages">512-516</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human apolipoprotein E has three isoforms: APOE2, APOE3 and APOE4.  APOE4 is a major genetic risk factor for Alzheimer's disease and is assocd. with Down's syndrome dementia and poor neurol. outcome after traumatic brain injury and hemorrhage.  Neurovascular dysfunction is present in normal APOE4 carriers and individuals with APOE4-assocd. disorders.  In mice, lack of Apoe leads to blood-brain barrier (BBB) breakdown, whereas APOE4 increases BBB susceptibility to injury.  How APOE genotype affects brain microcirculation remains elusive.  Using different APOE transgenic mice, including mice with ablation and/or inhibition of cyclophilin A (CypA), here we show that expression of APOE4 and lack of murine Apoe, but not APOE2 and APOE3, leads to BBB breakdown by activating a proinflammatory CypA-nuclear factor-κB-matrix-metalloproteinase-9 pathway in pericytes.  This, in turn, leads to neuronal uptake of multiple blood-derived neurotoxic proteins, and microvascular and cerebral blood flow redns.  We show that the vascular defects in Apoe-deficient and APOE4-expressing mice precede neuronal dysfunction and can initiate neurodegenerative changes.  Astrocyte-secreted APOE3, but not APOE4, suppressed the CypA-nuclear factor-κB-matrix-metalloproteinase-9 pathway in pericytes through a lipoprotein receptor.  Our data suggest that CypA is a key target for treating APOE4-mediated neurovascular injury and the resulting neuronal dysfunction and degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVs8RaZyMcF7Vg90H21EOLACvtfcHk0li5IrrYpYgWEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xntl2js78%253D&md5=bc9f5173cc57165193023091edb70d89</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnature11087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11087%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DR.%2BD.%26aulast%3DWinkler%26aufirst%3DE.%2BA.%26aulast%3DSingh%26aufirst%3DI.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DDeane%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DBetsholtz%26aufirst%3DC.%26aulast%3DArmulik%26aufirst%3DA.%26aulast%3DSallstrom%26aufirst%3DJ.%26aulast%3DBerk%26aufirst%3DB.%2BC.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DApolipoprotein%2520E%2520Controls%2520Cerebrovascular%2520Integrity%2520via%2520Cyclophilin%2520A%26jtitle%3DNature%26date%3D2012%26volume%3D485%26issue%3D7399%26spage%3D512%26epage%3D516%26doi%3D10.1038%2Fnature11087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nostrand, W. E.</span></span> <span> </span><span class="NLM_article-title">Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1136</span>, <span class="refDoi"> DOI: 10.1021/bi901994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi901994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1127-1136&issue=6&author=M.+C.+Liaoauthor=W.+E.+Van+Nostrand&title=Degradation+of+Soluble+and+Fibrillar+Amyloid+%CE%B2-Protein+by+Matrix+Metalloproteinase+%28MT1-MMP%29+in+Vitro&doi=10.1021%2Fbi901994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Degradation of soluble and fibrillar amyloid β-protein by matrix metalloproteinase (MT1-MMP) in vitro</span></div><div class="casAuthors">Liao, Mei-Chen; Van Nostrand, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1127-1136</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The progressive accumulation of β-amyloid (Aβ) in senile plaques and in the cerebral vasculature is the hallmark of Alzheimer's disease and related disorders.  Degrdn. of Aβ by specific proteolytic enzymes is an important process that regulates its levels in brain.  Matrix metalloproteinase 2 (MMP2) was shown to be expressed in reactive astrocytes surrounding amyloid plaques and may contribute to Aβ degrdn.  Membrane type 1 (MT1) MMP is the physiol. activator for the zymogen pro-MMP2.  Here, we show that, in addn. to MMP2, its activator MT1-MMP is also expressed in reactive astrocytes in regions with amyloid deposits in transgenic mice.  Using a Cos-1 cell expression system, we demonstrated that MT1-MMP can degrade exogenous Aβ40 and Aβ42.  A purified sol. form of MT1-MMP degraded both sol. and fibrillar Aβ peptides in a time-dependent manner, yielding specific degrdn. products.  Mass spectrometry anal. identified multiple MT1-MMP cleavage sites on sol. Aβ40 and Aβ42.  MT1-MMP-mediated Aβ degrdn. was inhibited with the general MMP inhibitor GM6001 or the specific MT1-MMP inhibitor tissue inhibitor of metalloproteinases 2.  Furthermore, in situ expts. showed that purified MT1-MMP degraded parenchymal fibrillar amyloid plaques that form in the brains of Aβ precursor protein transgenic mice.  Together, these findings indicate that MT1-MMP possesses Aβ degrading activity in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9nRa-vya6C7Vg90H21EOLACvtfcHk0ljaqS_hOEof1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFSkug%253D%253D&md5=09b9144ae8f1a1999f397c3cc81e97be</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fbi901994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi901994d%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DM.%2BC.%26aulast%3DVan%2BNostrand%26aufirst%3DW.%2BE.%26atitle%3DDegradation%2520of%2520Soluble%2520and%2520Fibrillar%2520Amyloid%2520%25CE%25B2-Protein%2520by%2520Matrix%2520Metalloproteinase%2520%2528MT1-MMP%2529%2520in%2520Vitro%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26issue%3D6%26spage%3D1127%26epage%3D1136%26doi%3D10.1021%2Fbi901994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poteet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.-H.</span></span> <span> </span><span class="NLM_article-title">Regulation of Matrix Metalloproteinase 2 by Oligomeric Amyloid β Protein</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1387</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2011.02.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.brainres.2011.02.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21376707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFensLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1387&publication_year=2011&pages=141-148&author=W.+Liauthor=E.+Poteetauthor=L.+Xieauthor=R.+Liuauthor=Y.+Wenauthor=S.-H.+Yang&title=Regulation+of+Matrix+Metalloproteinase+2+by+Oligomeric+Amyloid+%CE%B2+Protein&doi=10.1016%2Fj.brainres.2011.02.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein</span></div><div class="casAuthors">Li, Wenjun; Poteet, Ethan; Xie, Luokun; Liu, Ran; Wen, Yi; Yang, Shao-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1387</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-148</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are a group of proteinases that degrade components of the extracellular matrix (ECM).  There is increasing evidence for a link between the activation of MMPs and Alzheimer's disease (AD) pathogenesis, in which both beneficial and detrimental actions of MMPs have been suggested.  It has been demonstrated that MMPs could degrade amyloid β (Aβ) and play important roles in the extracellular Aβ catabolism and clearance.  On the other hand, MMPs could contribute to AD pathogenesis by compromising the blood brain barrier and promoting neurodegeneration.  In the present study, we obsd. that oligomeric Aβ regulates MMP2 expression in a paradoxical manner.  In rat primary astrocyte cultures, oligomeric Aβ down-regulated MMP2 transcription and reduced its extracellular activity.  However, in a widely used mouse model for AD, immunohistochem. demonstrated an increase of MMP2 expression in astrocytes surrounding senile plaques in APP/PS1 transgenic mice brains.  Using real-time PCR, we found that the MMP2 mRNA level was elevated in APP/PS1 transgenic mice brains.  In addn., elevated mRNA levels of MMP stimulating cytokines such as IL-1β and TGFβ were found in the brains of APP/PS1 mice.  Our study suggests a complex regulation of MMP2 expression by oligomeric Aβ in astrocytes.  While oligomeric Aβ directly down-regulates MMP2 expression and activation in astrocytes, it induces prodn. of proinflammatory cytokines which could serve as strong stimulators for MMP2.  Therefore, the ultimate outcome of the oligomeric Aβ on MMP2 activation in astrocytes might be the combination of its direct inhibitory action on astrocyte MMP2 expression and the secondary action of inducing inflammatory cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJsMP3gCEirLVg90H21EOLACvtfcHk0ljaqS_hOEof1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFensLY%253D&md5=4d71423312854581a412f0359a040652</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2011.02.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2011.02.078%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DPoteet%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DWen%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DS.-H.%26atitle%3DRegulation%2520of%2520Matrix%2520Metalloproteinase%25202%2520by%2520Oligomeric%2520Amyloid%2520%25CE%25B2%2520Protein%26jtitle%3DBrain%2520Res.%26date%3D2011%26volume%3D1387%26spage%3D141%26epage%3D148%26doi%3D10.1016%2Fj.brainres.2011.02.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shlosberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benifla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, A.</span></span> <span> </span><span class="NLM_article-title">Blood-brain Barrier Breakdown as a Therapeutic Target in Traumatic Brain Injury</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2010.74</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrneurol.2010.74" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20551947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFKgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=393-403&issue=7&author=D.+Shlosbergauthor=M.+Beniflaauthor=D.+Kauferauthor=A.+Friedman&title=Blood-brain+Barrier+Breakdown+as+a+Therapeutic+Target+in+Traumatic+Brain+Injury&doi=10.1038%2Fnrneurol.2010.74"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury</span></div><div class="casAuthors">Shlosberg, Dan; Benifla, Mony; Kaufer, Daniela; Friedman, Alon</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">393-403</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many individuals who survive traumatic brain injury (TBI) experience long-term complications.  The prevention and management of such complications, however, remain challenging goals for clinicians.  Here, Shlosberg and colleague examine the role of blood-brain barrier (BBB) breakdown in the pathophysiol. of TBI, particularly in the development of delayed TBI-related conditions.  The authors also discuss novel BBB-targeted therapeutic strategies that might be explored to counter or prevent long-term complications in patients.  Traumatic brain injury (TBI) is the leading cause of death in young adults and children.  The treatment of TBI in the acute phase has improved substantially; however, the prevention and management of long-term complications remain a challenge.  Blood-brain barrier (BBB) breakdown has often been documented in patients with TBI, but the role of such vascular pathol. in neurol. dysfunction has only recently been explored.  Animal studies have demonstrated that BBB breakdown is involved in the initiation of transcriptional changes in the neurovascular network that ultimately lead to delayed neuronal dysfunction and degeneration.  Brain imaging data have confirmed the high incidence of BBB breakdown in patients with TBI and suggest that such pathol. could be used as a biomarker in the clinic and in drug trials.  Here, we review the neurol. consequences of TBI, focusing on the long-term complications of such injuries.  We present the clin. evidence for involvement of BBB breakdown in TBI and examine the primary and secondary mechanisms that underlie such pathol.  We go on to consider the consequences of BBB injury, before analyzing potential mechanisms linking vascular pathol. to neuronal dysfunction and degeneration, and exploring possible targets for treatment.  Finally, we highlight areas for future basic research and clin. studies into TBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzyKlkmddfl7Vg90H21EOLACvtfcHk0lgsurhX3jcEbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFKgt7g%253D&md5=dfe95442a1bdf7c56253656e78890b6c</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2010.74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2010.74%26sid%3Dliteratum%253Aachs%26aulast%3DShlosberg%26aufirst%3DD.%26aulast%3DBenifla%26aufirst%3DM.%26aulast%3DKaufer%26aufirst%3DD.%26aulast%3DFriedman%26aufirst%3DA.%26atitle%3DBlood-brain%2520Barrier%2520Breakdown%2520as%2520a%2520Therapeutic%2520Target%2520in%2520Traumatic%2520Brain%2520Injury%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26issue%3D7%26spage%3D393%26epage%3D403%26doi%3D10.1038%2Fnrneurol.2010.74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagare, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">Blood-brain Barrier Breakdown in Alzheimer Disease and Other Neurodegenerative Disorders</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2017.188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrneurol.2017.188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29377008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVeqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=133-150&issue=3&author=M.+D.+Sweeneyauthor=A.+P.+Sagareauthor=B.+V.+Zlokovic&title=Blood-brain+Barrier+Breakdown+in+Alzheimer+Disease+and+Other+Neurodegenerative+Disorders&doi=10.1038%2Fnrneurol.2017.188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders</span></div><div class="casAuthors">Sweeney, Melanie D.; Sagare, Abhay P.; Zlokovic, Berislav V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">133-150</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier (BBB) is a continuous endothelial membrane within brain microvessels that has sealed cell-to-cell contacts and is sheathed by mural vascular cells and perivascular astrocyte end-feet.  The BBB protects neurons from factors present in the systemic circulation and maintains the highly regulated CNS internal milieu, which is required for proper synaptic and neuronal functioning.  BBB disruption allows influx into the brain of neurotoxic blood-derived debris, cells and microbial pathogens and is assocd. with inflammatory and immune responses, which can initiate multiple pathways of neurodegeneration.  This Review discusses neuroimaging studies in the living human brain and post-mortem tissue as well as biomarker studies demonstrating BBB breakdown in Alzheimer disease, Parkinson disease, Huntington disease, amyotrophic lateral sclerosis, multiple sclerosis, HIV-1-assocd. dementia and chronic traumatic encephalopathy.  The pathogenic mechanisms by which BBB breakdown leads to neuronal injury, synaptic dysfunction, loss of neuronal connectivity and neurodegeneration are described.  The importance of a healthy BBB for therapeutic drug delivery and the adverse effects of disease-initiated, pathol. BBB breakdown in relation to brain delivery of neuropharmaceuticals are briefly discussed.  Finally, future directions, gaps in the field and opportunities to control the course of neurol. diseases by targeting the BBB are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpthNnwB5Wnc7Vg90H21EOLACvtfcHk0lgsurhX3jcEbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVeqtbk%253D&md5=2756dc089ed4b6595e4aca5eb6cd9314</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2017.188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2017.188%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DM.%2BD.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DBlood-brain%2520Barrier%2520Breakdown%2520in%2520Alzheimer%2520Disease%2520and%2520Other%2520Neurodegenerative%2520Disorders%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2018%26volume%3D14%26issue%3D3%26spage%3D133%26epage%3D150%26doi%3D10.1038%2Fnrneurol.2017.188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giannoni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango-Lievano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das Neves, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousset, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanneteau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchi, N.</span></span> <span> </span><span class="NLM_article-title">Cerebrovascular Pathology during the Progression of Experimental Alzheimer’s Disease</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2016.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.nbd.2016.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26774030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2016&pages=107-117&author=P.+Giannoniauthor=M.+Arango-Lievanoauthor=I.+Das+Nevesauthor=M.-C.+Roussetauthor=K.+Barangerauthor=S.+Riveraauthor=F.+Jeanneteauauthor=S.+Claeysenauthor=N.+Marchi&title=Cerebrovascular+Pathology+during+the+Progression+of+Experimental+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.nbd.2016.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrovascular pathology during the progression of experimental Alzheimer's disease</span></div><div class="casAuthors">Giannoni, Patrizia; Arango-Lievano, Margarita; Neves, Ines Das; Rousset, Marie-Claude; Baranger, Kevin; Rivera, Santiago; Jeanneteau, Freddy; Claeysen, Sylvie; Marchi, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Clin. and exptl. evidence point to a possible role of cerebrovascular dysfunction in Alzheimer's disease (AD).  The 5xFAD mouse model of AD expresses human amyloid precursor protein and presenilin genes with mutations found in AD patients.  It remains unknown whether amyloid deposition driven by these mutations is assocd. with cerebrovascular changes.  5XFAD and wild type mice (2 to 12 mo old; M2 to M12) were used.  Thinned skull in vivo 2-photon microscopy was used to det. Aβ accumulation on leptomeningeal or superficial cortical vessels over time.  Parenchymal microvascular damage was assessed using FITC-microangiog.  Collagen-IV and CD31 were used to stain basal lamina and endothelial cells.  Methoxy-XO4, Thioflavin-S or 6E10 were used to visualize Aβ accumulation in living mice or in fixed brain tissues.  Positioning of reactive IBA1 microglia and GFAP astrocytes at the vasculature was rendered using confocal microscopy.  Platelet-derived growth factor receptor beta (PDGFRβ) staining was used to visualize perivascular pericytes.  In vivo 2-photon microscopy revealed Methoxy-XO4+ amyloid perivascular deposits on leptomeningeal and penetrating cortical vessels in 5xFAD mice, typical of cerebral amyloid angiopathy (CAA).  Amyloid deposits were visible in vivo at M3 and aggravated over time.  Progressive microvascular damage was concomitant to parenchymal Aβ plaque accumulation in 5xFAD mice.  Microvascular inflammation in 5xFAD mice presented with sporadic FITC-albumin leakages at M4 becoming more prevalent at M9 and M12. 3D colocalization showed inflammatory IBA1+ microglia proximal to microvascular FITC-albumin leaks.  The no. of perivascular PDGFRβ+ pericytes was significantly decreased at M4 in the fronto-parietal cortices, with a trend decrease obsd. in the other structures.  At M9-M12, PDGFRβ+ pericytes displayed hypertrophic perivascular ramifications contiguous to reactive microglia.  Cerebral amyloid angiopathy and microvascular inflammation occur in 5xFAD mice concomitantly to parenchymal plaque deposition.  The prospect of cerebrovascular pharmacol. in AD is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphspRxMza3jrVg90H21EOLACvtfcHk0ljRUhl3P43nDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSntL8%253D&md5=55e32de8e42e02aec08cf6314867ba54</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2016.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2016.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DArango-Lievano%26aufirst%3DM.%26aulast%3DDas%2BNeves%26aufirst%3DI.%26aulast%3DRousset%26aufirst%3DM.-C.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DJeanneteau%26aufirst%3DF.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DMarchi%26aufirst%3DN.%26atitle%3DCerebrovascular%2520Pathology%2520during%2520the%2520Progression%2520of%2520Experimental%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2016%26volume%3D88%26spage%3D107%26epage%3D117%26doi%3D10.1016%2Fj.nbd.2016.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terni, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span> <span> </span><span class="NLM_article-title">Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer’s Disease-Related Pathology</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.3233/JAD-142460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3233%2FJAD-142460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26402409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps12ls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2015&pages=461-469&issue=2&author=B.+Terniauthor=I.+Ferrer&title=Abnormal+Expression+and+Distribution+of+MMP2+at+Initial+Stages+of+Alzheimer%E2%80%99s+Disease-Related+Pathology&doi=10.3233%2FJAD-142460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology</span></div><div class="casAuthors">Terni, Beatrice; Ferrer, Isidro; Alafuzoff, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">461-469</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Previous studies have shown that metalloproteinases (MMPs) participate in the clearance of amyloid-β (Aβ) in Alzheimer's disease (AD); MMP2 and MMP3 cleave sol. Aβ, and both MMP9 and MT1-MMP are able to degrade sol. and fibrillar forms of Aβ.  The present study shows increased expression levels of active MMP2 in the entorhinal cortex at early stages of AD-related pathol. (Braak and Braak stages I/II-0 and III/IV-A) as revealed by western blotting and gelatin zymog.  Confocal microscopy discloses co-localization of MMP2 and phospho-tau in neurofibrillary tangles and dystrophic neurites.  MMP2 has the capacity to cleave recombinant tau in vitro in a dose-dependent manner, consistent with a physiol. function of MMP2 in normal tau proteolysis.  However, MMP2 does not cleave hyperphosphorylated and dephosphorylated tau from enriched paired helical filament fractions.  These observations raise the possibility that accumulation of MMP2 in neurofibrillary tangles and concomitant loss of proteolytic capacity on tau protein is a response geared to eliminating prodn. of toxic truncated tau species in AD brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok7_8G24KdHrVg90H21EOLACvtfcHk0ljRUhl3P43nDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps12ls7c%253D&md5=1dc3e0459a65c3dbaabb80f76a8a5c8d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3233%2FJAD-142460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-142460%26sid%3Dliteratum%253Aachs%26aulast%3DTerni%26aufirst%3DB.%26aulast%3DFerrer%26aufirst%3DI.%26atitle%3DAbnormal%2520Expression%2520and%2520Distribution%2520of%2520MMP2%2520at%2520Initial%2520Stages%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease-Related%2520Pathology%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2015%26volume%3D46%26issue%3D2%26spage%3D461%26epage%3D469%26doi%3D10.3233%2FJAD-142460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asahina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span> <span> </span><span class="NLM_article-title">Expression of Matrix Metalloproteinase-9 and Urinary-Type Plasminogen Activator in Alzheimer’s Disease Brain</span>. <i>Clin. Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11327298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD3MvotlGrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=60-63&author=M.+Asahinaauthor=Y.+Yoshiyamaauthor=T.+Hattori&title=Expression+of+Matrix+Metalloproteinase-9+and+Urinary-Type+Plasminogen+Activator+in+Alzheimer%E2%80%99s+Disease+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain</span></div><div class="casAuthors">Asahina M; Yoshiyama Y; Hattori T</div><div class="citationInfo"><span class="NLM_cas:title">Clinical neuropathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">60-3</span>
        ISSN:<span class="NLM_cas:issn">0722-5091</span>.
    </div><div class="casAbstract">OBJECTIVE:  Urinary-type plasminogen activator (uPA) binding to uPA receptor (uPAR) promotes the activation of matrix metalloproteinase-9 (MMP-9), which degrades amyloid beta protein (Abeta) in vitro.  We investigated the expression of MMP-9, uPA, and uPAR in post-mortem brains from patients with Alzheimer's disease (AD) and those with vascular dementia (VD).  MATERIAL AND METHODS:  We used immunohistochemistry to examine the sections of the parietal lobe and hippocampus from 4 AD and 3 VD patients.  The anti-MMP-9 antibody, anti-uPA antibody, and anti-uPAR antibody were used to perform immunohistological analysis.  RESULTS:  In the brain tissues from the AD patients, we found expression of MMP-9 in the cytoplasm of neurons, neurofibrillary tangles, senile plaques, vascular walls and uPAR expression in the cytoplasm of neurons and vascular walls. uPA was detected only in the vascular walls.  On the other hand, we could not find expression of MMP-9, uPAR and uPA in the brain tissues of the VD patients, except for the vascular walls.  CONCLUSION:  The neurons in the AD brains expressed MMP-9 and uPAR.  MMP-9 may be produced for the degradation of Abeta, but uPA, which activates MMP-9, was not immunolocalized to the neurons in the AD brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkH5aHebIOkkEksK8CslK8fW6udTcc2ebJQ5fKYvI07rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvotlGrtA%253D%253D&md5=3d944cdeb80618d7031ef919cf241e89</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsahina%26aufirst%3DM.%26aulast%3DYoshiyama%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DT.%26atitle%3DExpression%2520of%2520Matrix%2520Metalloproteinase-9%2520and%2520Urinary-Type%2520Plasminogen%2520Activator%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Brain%26jtitle%3DClin.%2520Neuropathol.%26date%3D2001%26volume%3D20%26spage%3D60%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, C.</span></span> <span> </span><span class="NLM_article-title">Systemic Infection, Interleukin 1beta, and Cognitive Decline in Alzheimer’s Disease</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">789</span>, <span class="refDoi"> DOI: 10.1136/jnnp.74.6.788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1136%2Fjnnp.74.6.788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12754353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD3s3jtFGksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2003&pages=788-789&issue=6&author=C.+Holmes&title=Systemic+Infection%2C+Interleukin+1beta%2C+and+Cognitive+Decline+in+Alzheimer%E2%80%99s+Disease&doi=10.1136%2Fjnnp.74.6.788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease</span></div><div class="casAuthors">Holmes C; El-Okl M; Williams A L; Cunningham C; Wilcockson D; Perry V H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">788-9</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">Activated microglia, the resident macrophages of the brain, are a feature of Alzheimer's disease.  Animal models suggest that when activated microglia are further activated by a subsequent systemic infection this results in significantly raised levels of interleukin 1beta within the CNS, which may in turn potentiate neurodegeneration.  This prospective pilot study in Alzheimer's disease subjects showed that cognitive function can be impaired for at least two months after the resolution of a systemic infection and that cognitive impairment is preceded by raised serum levels of interleukin 1beta.  These relations were not confounded by the presence of any subsequent systemic infection or by baseline cognitive scores.  Further research is needed to determine whether recurrent systemic infections drive cognitive decline in Alzheimer's disease subjects through a cytokine mediated pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoMTnUmk96gjQLBVDQn4bCfW6udTcc2ebJQ5fKYvI07rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3jtFGksA%253D%253D&md5=3fd7ba7ccf45e045f370afe15209206b</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.74.6.788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.74.6.788%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DC.%26atitle%3DSystemic%2520Infection%252C%2520Interleukin%25201beta%252C%2520and%2520Cognitive%2520Decline%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2003%26volume%3D74%26issue%3D6%26spage%3D788%26epage%3D789%26doi%3D10.1136%2Fjnnp.74.6.788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paumier, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Py, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-González, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Proamyloidogenic Effects of Membrane Type 1 Matrix Metalloproteinase Involve MMP-2 and BACE-1 Activities, and the Modulation of APP Trafficking</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">2910</span>– <span class="NLM_lpage">2927</span>, <span class="refDoi"> DOI: 10.1096/fj.201801076R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1096%2Ffj.201801076R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30332299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFCls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=2910-2927&issue=2&author=J.-M.+Paumierauthor=N.+A.+Pyauthor=L.+Garc%C3%ADa-Gonz%C3%A1lezauthor=A.+Bernardauthor=D.+Stephanauthor=L.+Louisauthor=F.+Checlerauthor=M.+Khrestchatiskyauthor=K.+Barangerauthor=S.+Rivera&title=Proamyloidogenic+Effects+of+Membrane+Type+1+Matrix+Metalloproteinase+Involve+MMP-2+and+BACE-1+Activities%2C+and+the+Modulation+of+APP+Trafficking&doi=10.1096%2Ffj.201801076R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking</span></div><div class="casAuthors">Paumier, Jean-Michel; Py, Nathalie A.; Garcia-Gonzalez, Laura; Bernard, Anne; Stephan, Delphine; Louis, Laurence; Checler, Frederic; Khrestchatisky, Michel; Baranger, Kevin; Rivera, Santiago</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">2910-2927</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">We previously demonstrated that membrane type 1 (MT1) matrix metalloproteinase (MMP) was up-regulated in the hippocampus of the model of transgenic mice bearing 5 familial mutations on human amyloid precursor protein (APP) and presenilin 1 of Alzheimer disease (AD), and that the proteinase increased the levels of amyloid β peptide (Aβ) and its APP C-terminal fragment of 99 aa in a heterologous cell system.  Here we provide further evidence that MT1-MMP interacts with APP and promotes amyloidogenesis in a proteolytic-dependent manner in Swedish APP-expressing human embryonic kidney 293 (HEKswe) cells.  MT1-MMP-mediated processing of APP releases a sol. APP fragment, sAPP95.  This process partly requires the activation of endogenous MMP-2 but is independent of β-site APP cleaving enzyme 1 (BACE-1) or α-secretase activities.  In contrast, MT1-MMP-mediated increase of Aβ levels involved BACE-1 activity and was inhibited by tissue inhibitor of MMP-2, a natural inhibitor of both MT1-MMP and MMP-2.  Interestingly, near abolishment of basal Aβ prodn. upon BACE-1 inhibition was rescued by MT1-MMP, indicating that the latter could mimic β-secretase-like activity.  Moreover, MT1-MMP promoted APP/Aβ localization in endosomes, where Aβ prodn. mainly occurs.  These data unveil new mechanistic insights to support the proamyloidogenic role of MT1-MMP based on APP processing and trafficking, and reinforce the idea that this proteinase may become a new potential therapeutic target in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbgnsLRQx7n7Vg90H21EOLACvtfcHk0lhr6IbiFUsS4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFCls7o%253D&md5=a15528450b75c49e8fec40cff97030c6</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1096%2Ffj.201801076R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201801076R%26sid%3Dliteratum%253Aachs%26aulast%3DPaumier%26aufirst%3DJ.-M.%26aulast%3DPy%26aufirst%3DN.%2BA.%26aulast%3DGarc%25C3%25ADa-Gonz%25C3%25A1lez%26aufirst%3DL.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DStephan%26aufirst%3DD.%26aulast%3DLouis%26aufirst%3DL.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DProamyloidogenic%2520Effects%2520of%2520Membrane%2520Type%25201%2520Matrix%2520Metalloproteinase%2520Involve%2520MMP-2%2520and%2520BACE-1%2520Activities%252C%2520and%2520the%2520Modulation%2520of%2520APP%2520Trafficking%26jtitle%3DFASEB%2520J.%26date%3D2019%26volume%3D33%26issue%3D2%26spage%3D2910%26epage%3D2927%26doi%3D10.1096%2Ffj.201801076R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmbeck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caterina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kromer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsov, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehron Robey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pidoux, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkedal-Hansen, H.</span></span> <span> </span><span class="NLM_article-title">MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80064-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0092-8674%2800%2980064-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10520996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK1MXmsleqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=81-92&issue=1&author=K.+Holmbeckauthor=P.+Biancoauthor=J.+Caterinaauthor=S.+Yamadaauthor=M.+Kromerauthor=S.+A.+Kuznetsovauthor=M.+Mankaniauthor=P.+Gehron+Robeyauthor=A.+R.+Pooleauthor=I.+Pidouxauthor=J.+M.+Wardauthor=H.+Birkedal-Hansen&title=MT1-MMP-Deficient+Mice+Develop+Dwarfism%2C+Osteopenia%2C+Arthritis%2C+and+Connective+Tissue+Disease+due+to+Inadequate+Collagen+Turnover&doi=10.1016%2FS0092-8674%2800%2980064-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover</span></div><div class="casAuthors">Holmbeck, Kenn; Bianco, Paolo; Caterina, John; Yamada, Susan; Kromer, Mark; Kuznetsov, Sergei A.; Mankani, Mahesh; Robey, Pamela Gehron; Poole, A. Robin; Pidoux, Isabelle; Ward, Jerrold M.; Birkedal-Hansen, Henning</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-92</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">MT1-MMP is a membrane-bound matrix metalloproteinase (MT-MMP) capable of mediating pericellular proteolysis of extracellular matrix components.  MT1-MMP is therefore thought to be an important mol. tool for cellular remodeling of the surrounding matrix.  To establish the biol. role of this membrane proteinase we generated MT1-MMP-deficient mice by gene targeting.  MT1-MMP deficiency causes craniofacial dysmorphism, arthritis, osteopenia, dwarfism, and fibrosis of soft tissues due to ablation of a collagenolytic activity that is essential for modeling of skeletal and extraskeletal connective tissues.  Our findings demonstrate the pivotal function of MT1-MMP in connective tissue metab., and illustrate that modeling of the soft connective tissue matrix by resident cells is essential for the development and maintenance of the hard tissues of the skeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5giSKp25jUbVg90H21EOLACvtfcHk0lhr6IbiFUsS4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsleqs7c%253D&md5=8ecbc7d88158e67867a11ba99edd5679</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980064-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980064-1%26sid%3Dliteratum%253Aachs%26aulast%3DHolmbeck%26aufirst%3DK.%26aulast%3DBianco%26aufirst%3DP.%26aulast%3DCaterina%26aufirst%3DJ.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DKromer%26aufirst%3DM.%26aulast%3DKuznetsov%26aufirst%3DS.%2BA.%26aulast%3DMankani%26aufirst%3DM.%26aulast%3DGehron%2BRobey%26aufirst%3DP.%26aulast%3DPoole%26aufirst%3DA.%2BR.%26aulast%3DPidoux%26aufirst%3DI.%26aulast%3DWard%26aufirst%3DJ.%2BM.%26aulast%3DBirkedal-Hansen%26aufirst%3DH.%26atitle%3DMT1-MMP-Deficient%2520Mice%2520Develop%2520Dwarfism%252C%2520Osteopenia%252C%2520Arthritis%252C%2520and%2520Connective%2520Tissue%2520Disease%2520due%2520to%2520Inadequate%2520Collagen%2520Turnover%26jtitle%3DCell%26date%3D1999%26volume%3D99%26issue%3D1%26spage%3D81%26epage%3D92%26doi%3D10.1016%2FS0092-8674%2800%2980064-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apte, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soininen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baaklini, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauser, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tryggvason, K.</span></span> <span> </span><span class="NLM_article-title">Impaired Endochondral Ossification and Angiogenesis in Mice Deficient in Membrane-Type Matrix Metalloproteinase I</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4052</span>– <span class="NLM_lpage">4057</span>, <span class="refDoi"> DOI: 10.1073/pnas.060037197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1073%2Fpnas.060037197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10737763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=4052-4057&issue=8&author=Z.+Zhouauthor=S.+S.+Apteauthor=R.+Soininenauthor=R.+Caoauthor=G.+Y.+Baakliniauthor=R.+W.+Rauserauthor=J.+Wangauthor=Y.+Caoauthor=K.+Tryggvason&title=Impaired+Endochondral+Ossification+and+Angiogenesis+in+Mice+Deficient+in+Membrane-Type+Matrix+Metalloproteinase+I&doi=10.1073%2Fpnas.060037197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I</span></div><div class="casAuthors">Zhou, Zhongjun; Apte, Suneel S.; Soininen, Raija; Cao, Renhai; Baaklini, George Y.; Rauser, Richard W.; Wang, Jianming; Cao, Yihai; Tryggvason, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4052-4057</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Membrane-type matrix metalloproteinase I (MT1-MMP)-deficient mice were found to have severe defects in skeletal development and angiogenesis.  The craniofacial, axial, and appendicular skeletons were severely affected, leading to a short and domed skull, marked deceleration of postnatal growth, and death by 3 wk of age.  Shortening of bones is a consequence of decreased chondrocyte proliferation in the proliferative zone of the growth plates.  Defective vascular invasion of cartilage leads to enlargement of hypertrophic zones of growth plates and delayed formation of secondary ossification centers in long bones.  In an in vivo corneal angiogenesis assay, null mice did not have angiogenic response to implanted FGF-2, suggesting that the defect in angiogenesis is not restricted to cartilage alone.  In tissues from null mice, activation of latent matrix metalloproteinase 2 was deficient, suggesting that MT1-MMP is essential for its activation in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphY4S7v353E7Vg90H21EOLACvtfcHk0lheVLptwND91g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislSgtLo%253D&md5=3304017873fed4c2541fdba8f3bd4882</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1073%2Fpnas.060037197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.060037197%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DApte%26aufirst%3DS.%2BS.%26aulast%3DSoininen%26aufirst%3DR.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DBaaklini%26aufirst%3DG.%2BY.%26aulast%3DRauser%26aufirst%3DR.%2BW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DTryggvason%26aufirst%3DK.%26atitle%3DImpaired%2520Endochondral%2520Ossification%2520and%2520Angiogenesis%2520in%2520Mice%2520Deficient%2520in%2520Membrane-Type%2520Matrix%2520Metalloproteinase%2520I%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26issue%3D8%26spage%3D4052%26epage%3D4057%26doi%3D10.1073%2Fpnas.060037197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remacle, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieplak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiryaev, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strongin, A. Y.</span></span> <span> </span><span class="NLM_article-title">Selective Function-Blocking Monoclonal Human Antibody Highlights the Important Role of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) in Metastasis</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">2781</span>– <span class="NLM_lpage">2799</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.18632%2Foncotarget.13157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27835863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC2snlt1KktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2781-2799&issue=2&author=A.+G.+Remacleauthor=P.+Cieplakauthor=D.+H.+Namauthor=S.+A.+Shiryaevauthor=X.+Geauthor=A.+Y.+Strongin&title=Selective+Function-Blocking+Monoclonal+Human+Antibody+Highlights+the+Important+Role+of+Membrane+Type-1+Matrix+Metalloproteinase+%28MT1-MMP%29+in+Metastasis&doi=10.18632%2Foncotarget.13157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis</span></div><div class="casAuthors">Remacle Albert G; Cieplak Piotr; Shiryaev Sergey A; Strongin Alex Y; Nam Dong Hyun; Ge Xin</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">2781-2799</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The invasion-promoting MT1-MMP is a cell surface-associated collagenase with a plethora of critical cellular functions.  There is a consensus that MT1-MMP is a key protease in aberrant pericellular proteolysis in migrating cancer cells and, accordingly, a promising drug target.  Because of high homology in the MMP family and a limited success in the design of selective small-molecule inhibitors, it became evident that the inhibitor specificity is required for selective and successful MT1-MMP therapies.  Using the human Fab antibody library (over 1.25×109 individual variants) that exhibited the extended, 23-27 residue long, VH CDR-H3 segments, we isolated a panel of the inhibitory antibody fragments, from which the 3A2 Fab outperformed others as a specific and potent, low nanomolar range, inhibitor of MT1-MMP.  Here, we report the in-depth characterization of the 3A2 antibody.  Our multiple in vitro and cell-based tests and assays, and extensive structural modeling of the antibody/protease interactions suggest that the antibody epitope involves the residues proximal to the protease catalytic site and that, in contrast with tissue inhibitor-2 of MMPs (TIMP-2), the 3A2 Fab inactivates the protease functionality by binding to the catalytic domain outside the active site cavity.  In agreement with the studies in metastasis by others, our animal studies in acute pulmonary melanoma metastasis support a key role of MT1-MMP in metastatic process.  Conversely, the selective anti-MT1-MMP monotherapy significantly alleviated melanoma metastatic burden.  It is likely that further affinity maturation of the 3A2 Fab will result in the lead inhibitor and a proof-of-concept for MT1-MMP targeting in metastatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVH4TOmGh3kny-c-E1v-fmfW6udTcc2eZjyjdzNitiUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snlt1KktA%253D%253D&md5=487e5d594fd55b5981ad0c79e581f3cb</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13157%26sid%3Dliteratum%253Aachs%26aulast%3DRemacle%26aufirst%3DA.%2BG.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DNam%26aufirst%3DD.%2BH.%26aulast%3DShiryaev%26aufirst%3DS.%2BA.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26atitle%3DSelective%2520Function-Blocking%2520Monoclonal%2520Human%2520Antibody%2520Highlights%2520the%2520Important%2520Role%2520of%2520Membrane%2520Type-1%2520Matrix%2520Metalloproteinase%2520%2528MT1-MMP%2529%2520in%2520Metastasis%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D2781%26epage%3D2799%26doi%3D10.18632%2Foncotarget.13157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Udi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomonov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dym, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuniasse, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arroyo, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Inhibition Mechanism of Membrane Metalloprotease by an Exosite-Swiveling Conformational Antibody</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/j.str.2014.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.str.2014.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25482542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=104-115&issue=1&author=Y.+Udiauthor=M.+Grossmanauthor=I.+Solomonovauthor=O.+Dymauthor=H.+Rozenbergauthor=V.+Morenoauthor=P.+Cuniasseauthor=V.+Diveauthor=A.+G.+Arroyoauthor=I.+Sagi&title=Inhibition+Mechanism+of+Membrane+Metalloprotease+by+an+Exosite-Swiveling+Conformational+Antibody&doi=10.1016%2Fj.str.2014.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition mechanism of membrane metalloprotease by an exosite-swiveling conformational antibody</span></div><div class="casAuthors">Udi, Yael; Grossman, Moran; Solomonov, Inna; Dym, Orly; Rozenberg, Haim; Moreno, Vanessa; Cuniasse, Philippe; Dive, Vincent; Arroyo, Alicia Garcia; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-115</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Membrane type 1 metalloprotease (MT1-MMP) is a membrane-anchored, Zn-dependent protease.  MT1-MMP is an important mediator of cell migration and invasion, and overexpression of this enzyme has been correlated with the malignancy of various tumor types.  Therefore, modulators of MT1-MMP activity have been proposed to possess therapeutic potential in numerous invasive diseases.  Here, the authors report the inhibition mode of MT1-MMP by the LEM-2/15 monoclonal antibody fragment, which targets a surface epitope of MT1-MMP.  Specifically, the crystal structures of Fab LEM-2/15 in complex with the MT1-MMP surface antigen suggested that conformational swiveling of the enzyme surface loop was required for effective binding and consequent inhibition of MT1-MMP activity on the cell membrane.  This inhibition mechanism appears to be effective in controlling active MT1-MMP in endothelial cells and at the leading edge of migratory cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ViuLsV_tirVg90H21EOLACvtfcHk0lgF5Ia1lA74yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrtLnN&md5=054384bf26885067fb6eb18540682748</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2014.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2014.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DUdi%26aufirst%3DY.%26aulast%3DGrossman%26aufirst%3DM.%26aulast%3DSolomonov%26aufirst%3DI.%26aulast%3DDym%26aufirst%3DO.%26aulast%3DRozenberg%26aufirst%3DH.%26aulast%3DMoreno%26aufirst%3DV.%26aulast%3DCuniasse%26aufirst%3DP.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DArroyo%26aufirst%3DA.%2BG.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DInhibition%2520Mechanism%2520of%2520Membrane%2520Metalloprotease%2520by%2520an%2520Exosite-Swiveling%2520Conformational%2520Antibody%26jtitle%3DStructure%26date%3D2015%26volume%3D23%26issue%3D1%26spage%3D104%26epage%3D115%26doi%3D10.1016%2Fj.str.2014.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umeda, M.</span></span> <span> </span><span class="NLM_article-title">A Metalloproteinase Inhibitor Domain in Alzheimer Amyloid Protein Precursor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>362</i></span> (<span class="NLM_issue">6423</span>),  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1038/362839a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2F362839a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=8479521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK3sXltFCktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1993&pages=839-841&issue=6423&author=K.+Miyazakiauthor=M.+Hasegawaauthor=K.+Funahashiauthor=M.+Umeda&title=A+Metalloproteinase+Inhibitor+Domain+in+Alzheimer+Amyloid+Protein+Precursor&doi=10.1038%2F362839a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor</span></div><div class="casAuthors">Miyazaki, Kaoru; Hasegawa, Miki; Funahashi, Kayano; Umeda, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">6423</span>),
    <span class="NLM_cas:pages">839-41</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Extracellular deposition of amyloid β-protein (β-AP), or A4 protein (Mr 4,000), is assocd. with Alzheimer's disease and with Down's syndrome (trisomy for chromosome 21).  The large membrane-bound precursor protein (APP) of β-AP is normally cleaved within the β-AP region by a putative proteinase (APP secretase) to release its extracellular portion; β-AP is produced by an alternative proteolytic processing.  Here the authors demonstrate that APP contains a proteinase inhibitor domain for the matrix metalloproteinase gelatinase A, which is located in the C-terminal glycosylated region of the secretory forms of APP.  In addn., the authors show that the gelatinase has an APp secretase-like activity, which hydrolyses the Lys16-Leu17 bond in the β-AP sequence.  These results indicate that the proteinase inhibitor domain of APP and gelatinase A may be involved in the formation of β-AP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLvhVS9kMRfrVg90H21EOLACvtfcHk0lgF5Ia1lA74yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFCktbo%253D&md5=c4c2c24887ae6e7e56a1d7d3213309c8</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2F362839a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F362839a0%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DFunahashi%26aufirst%3DK.%26aulast%3DUmeda%26aufirst%3DM.%26atitle%3DA%2520Metalloproteinase%2520Inhibitor%2520Domain%2520in%2520Alzheimer%2520Amyloid%2520Protein%2520Precursor%26jtitle%3DNature%26date%3D1993%26volume%3D362%26issue%3D6423%26spage%3D839%26epage%3D841%26doi%3D10.1038%2F362839a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span> <span> </span><span class="NLM_article-title">Identification of a Region of β-Amyloid Precursor Protein Essential for Its Gelatinase A Inhibitory Activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">14020</span>– <span class="NLM_lpage">14028</span>, <span class="refDoi"> DOI: 10.1074/jbc.M212264200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M212264200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12586836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVSiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=14020-14028&issue=16&author=S.+Higashiauthor=K.+Miyazaki&title=Identification+of+a+Region+of+%CE%B2-Amyloid+Precursor+Protein+Essential+for+Its+Gelatinase+A+Inhibitory+Activity&doi=10.1074%2Fjbc.M212264200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Region of β-Amyloid Precursor Protein Essential for Its Gelatinase A Inhibitory Activity</span></div><div class="casAuthors">Higashi, Shouichi; Miyazaki, Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">14020-14028</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Because β-amyloid precursor protein (APP) has the abilities both to interact with extracellular matrix and to inhibit gelatinase A activity, this mol. is assumed to play a regulatory role in the gelatinase A-catalyzed degrdn. of extracellular matrix.  To det. a region of APP essential for the inhibitory activity, we prepd. various derivs. of APP.  Functional analyses of proteolytic fragments of sol. APP (sAPP) and glutathione S-transferase fusion proteins, which contain various C-terminal parts of sAPP, showed that a site contg. residues 579-601 of APP770 is essential for the inhibitory activity.  Moreover, a synthetic decapeptide contg. the ISYGNDALMP sequence corresponding to residues 586-595 of APP770 had a gelatinase A inhibitory activity slightly higher than that of sAPP.  Studies of deletion of the NH2- and C-terminal residues and alanine replacement of internal residues of the decapeptide further revealed that Tyr588, Asp591, and Leu593 of APP mainly stabilize the interaction between gelatinase A and the inhibitor.  We also found that the residues of Ile586, Met594, and Pro595 modestly contribute to the inhibitory activity.  The APP-derived decapeptide efficiently inhibited the activity of gelatinase A (IC50 = 30 nM), whereas its inhibitory activity toward membrane type 1 matrix metalloproteinase was much weaker (IC50 = 2 μM).  The decapeptide had poor inhibitory activity toward gelatinase B, matrilysin, and stromelysin (IC50 > 10 μM).  The APP-derived inhibitor formed a complex with active gelatinase A but not with progelatinase A, and the complex formation was prevented completely by a hydroxamate-based synthetic inhibitor.  Therefore, the decapeptide region of APP is likely an active site-directed inhibitor that has high selectivity toward gelatinase A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpErgWhUIbiUbVg90H21EOLACvtfcHk0li4FqD0EnzKpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVSiurs%253D&md5=aca3047fb1e3e6c146e9153e80bffc90</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M212264200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M212264200%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DS.%26aulast%3DMiyazaki%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520a%2520Region%2520of%2520%25CE%25B2-Amyloid%2520Precursor%2520Protein%2520Essential%2520for%2520Its%2520Gelatinase%2520A%2520Inhibitory%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26issue%3D16%26spage%3D14020%26epage%3D14028%26doi%3D10.1074%2Fjbc.M212264200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span> <span> </span><span class="NLM_article-title">Identification of Amino Acid Residues of the Matrix Metalloproteinase-2 Essential for Its Selective Inhibition by β-Amyloid Precursor Protein-Derived Inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">10068</span>– <span class="NLM_lpage">10078</span>, <span class="refDoi"> DOI: 10.1074/jbc.M709509200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M709509200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=18238779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1alu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=10068-10078&issue=15&author=S.+Higashiauthor=K.+Miyazaki&title=Identification+of+Amino+Acid+Residues+of+the+Matrix+Metalloproteinase-2+Essential+for+Its+Selective+Inhibition+by+%CE%B2-Amyloid+Precursor+Protein-Derived+Inhibitor&doi=10.1074%2Fjbc.M709509200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Amino Acid Residues of the Matrix Metalloproteinase-2 Essential for Its Selective Inhibition by β-Amyloid Precursor Protein-derived Inhibitor</span></div><div class="casAuthors">Higashi, Shouichi; Miyazaki, Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">10068-10078</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The extracellular domain of β-amyloid precursor protein (APP) contains an inhibitor against matrix metalloproteinase-2 (MMP-2, gelatinase A).  Our previous study demonstrated that the inhibitor is localized within the ISYGN-DALMP sequence of APP, and a synthetic decapeptide contg. this sequence (named APP-derived inhibitory peptide, APP-IP) selectively inhibits the activity of MMP-2.  To det. the region of interaction that correlates with the selective inhibition, we constructed various MMP-2 mutants.  An MMP-2 mutant, which had the hemopexin-like domain and three fibronectin-like type II domains of MMP-2 deleted, and native MMP-2 showed similar affinities for APP-IP, suggesting that only the catalytic domain of MMP-2 is essential for the interaction.  Studies of chimeric proteases, consisting of various parts of the MMP-2 catalytic domain and those of MMP-7 (matrilysin) or MMP-9 (gelatinase B), further revealed that Ala88 and Gly94 in the non-prime side and Tyr145 and Thr146 in the prime side of the substrate-binding cleft of MMP-2 contribute sep. to the selective inhibition.  Replacement of the amino acid residue at position 94 of a chimeric MMP mutant affected its interaction with the C-terminal Pro10 of APP-IP, whereas that of residues 145-148 affected the interaction with Tyr3 of the inhibitor, suggesting that the N to C direction of APP-IP relative to the substrate-binding cleft of MMP is analogous to that of propeptide in proMMP, and opposite to that of substrate.  When the APP-IP sequence was added to the N terminus of the catalytic domain of MMP-2, the activity of the protease was intramolecularly inhibited.  We speculate that the direction of interaction makes the active site-bound APP-IP resistant to cleavage, thereby supporting the inhibitory action of the peptide inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6URu4T6RQerVg90H21EOLACvtfcHk0li4FqD0EnzKpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1alu74%253D&md5=31f48dd9b93faa418ee728393a40944c</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M709509200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M709509200%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DS.%26aulast%3DMiyazaki%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520Amino%2520Acid%2520Residues%2520of%2520the%2520Matrix%2520Metalloproteinase-2%2520Essential%2520for%2520Its%2520Selective%2520Inhibition%2520by%2520%25CE%25B2-Amyloid%2520Precursor%2520Protein-Derived%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26issue%3D15%26spage%3D10068%26epage%3D10078%26doi%3D10.1074%2Fjbc.M709509200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, S.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Matrix Metalloproteinase-2 (MMP-2)-Selective Inhibitory Action of β-Amyloid Precursor Protein-Derived Inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">33236</span>– <span class="NLM_lpage">33243</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.264176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M111.264176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21813640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOit7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=33236-33243&issue=38&author=H.+Hashimotoauthor=T.+Takeuchiauthor=K.+Komatsuauthor=K.+Miyazakiauthor=M.+Satoauthor=S.+Higashi&title=Structural+Basis+for+Matrix+Metalloproteinase-2+%28MMP-2%29-Selective+Inhibitory+Action+of+%CE%B2-Amyloid+Precursor+Protein-Derived+Inhibitor&doi=10.1074%2Fjbc.M111.264176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Matrix Metalloproteinase-2 (MMP-2)-selective Inhibitory Action of β-Amyloid Precursor Protein-derived Inhibitor</span></div><div class="casAuthors">Hashimoto, Hiroshi; Takeuchi, Tomoka; Komatsu, Kyoko; Miyazaki, Kaoru; Sato, Mamoru; Higashi, Shou-Ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">33236-33243</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Unlike other synthetic or physiol. inhibitors for matrix metalloproteinases (MMPs), the β-amyloid precursor protein-derived inhibitory peptide (APP-IP) having an ISYGNDALMP sequence has a high selectivity toward MMP-2.  Our previous study identified amino acid residues of MMP-2 essential for its selective inhibition by APP-IP and demonstrated that the N to C direction of the decapeptide inhibitor relative to the substrate-binding cleft of MMP-2 is opposite that of substrate.  However, detailed interactions between the two mols. remained to be clarified.  Here, we detd. the crystal structure of the catalytic domain of MMP-2 in complex with APP-IP.  We found that APP-IP in the complex is indeed embedded into the substrate-binding cleft of the catalytic domain in the N to C direction opposite that of substrate.  With the crystal structure, it was first clarified that the arom. side chain of Tyr3 of the inhibitor is accommodated into the S1' pocket of the protease, and the carboxylate group of Asp6 of APP-IP coordinates bidentately to the catalytic zinc of the enzyme.  The Ala7 to Pro10 and Tyr3 to Ile1 strands of the inhibitor extend into the nonprime and the prime sides of the cleft, resp.  Therefore, the decapeptide inhibitor has long range contact with the substrate-binding cleft of the protease.  This mode of interaction is probably essential for the high MMP-2 selectivity of the inhibitor because MMPs share a common architecture in the vicinity of the catalytic center, but whole structures of their substrate-binding clefts have sufficient variety for the inhibitor to distinguish MMP-2 from other MMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp-w8bRwhBtbVg90H21EOLACvtfcHk0lisQvyhsH8N3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOit7zE&md5=c65c71687ad8cf41e092ffb9f1b7853c</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.264176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.264176%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DKomatsu%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DS.%26atitle%3DStructural%2520Basis%2520for%2520Matrix%2520Metalloproteinase-2%2520%2528MMP-2%2529-Selective%2520Inhibitory%2520Action%2520of%2520%25CE%25B2-Amyloid%2520Precursor%2520Protein-Derived%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26issue%3D38%26spage%3D33236%26epage%3D33243%26doi%3D10.1074%2Fjbc.M111.264176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span> <span> </span><span class="NLM_article-title">Molecular Design of a Highly Selective and Strong Protein Inhibitor against Matrix Metalloproteinase-2 (MMP-2)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">9066</span>– <span class="NLM_lpage">9076</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.441758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M112.441758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23395821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvF2ltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=9066-9076&issue=13&author=S.+Higashiauthor=T.+Hiroseauthor=T.+Takeuchiauthor=K.+Miyazaki&title=Molecular+Design+of+a+Highly+Selective+and+Strong+Protein+Inhibitor+against+Matrix+Metalloproteinase-2+%28MMP-2%29&doi=10.1074%2Fjbc.M112.441758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Design of a Highly Selective and Strong Protein Inhibitor against Matrix Metalloproteinase-2 (MMP-2)</span></div><div class="casAuthors">Higashi, Shouichi; Hirose, Tomokazu; Takeuchi, Tomoka; Miyazaki, Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">9066-9076</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Synthetic inhibitors of matrix metalloproteinases (MMPs), designed previously, as well as tissue inhibitors of metalloproteinases (TIMPs) lack enzyme selectivity, which has been a major obstacle for developing inhibitors into safe and effective MMP-targeted drugs.  Here we designed a fusion protein named APP-IP-TIMP-2, in which the ten amino acid residue sequence of APP-derived MMP-2 selective inhibitory peptide (APP-IP) is added to the N terminus of TIMP-2.  The APP-IP and TIMP-2 regions of the fusion protein are designed to interact with the active site and the hemopexin-like domain of MMP-2, resp.  The reactive site of the TIMP-2 region, which has broad specificity against MMPs, is blocked by the APP-IP adduct.  The recombinant APP-IP-TIMP-2 showed strong inhibitory activity toward MMP-2 (Kiapp = 0.68 pm), whereas its inhibitory activity toward MMP-1, MMP-3, MMP-7, MMP-8, MMP-9, or MT1-MMP was six orders of magnitude or more weaker (IC50>1 μm).  The fusion protein inhibited the activation of pro-MMP-2 in the Con A-stimulated HT1080 cells, degrdn. of type IV collagen by the cells, and the migration of stimulated cells.  Compared with the decapeptide APP-IP (t1/2 = 30 min), APP-IP-TIMP-2 (t1/2 » 96h) showed a much longer half-life in cultured tumor cells.  Therefore, the fusion protein may be a useful tool to evaluate contributions of proteolytic activity of MMP-2 in various pathophysiol. processes.  It may also be developed as an effective antitumor drug with restricted side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJmnNeOz2f2rVg90H21EOLACvtfcHk0lisQvyhsH8N3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvF2ltrs%253D&md5=2475403197343ae9f5662727a028fa35</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.441758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.441758%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DS.%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DMiyazaki%26aufirst%3DK.%26atitle%3DMolecular%2520Design%2520of%2520a%2520Highly%2520Selective%2520and%2520Strong%2520Protein%2520Inhibitor%2520against%2520Matrix%2520Metalloproteinase-2%2520%2528MMP-2%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D13%26spage%3D9066%26epage%3D9076%26doi%3D10.1074%2Fjbc.M112.441758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span> <span> </span><span class="NLM_article-title">Novel Processing of β-Amyloid Precursor Protein Catalyzed by Membrane Type 1 Matrix Metalloproteinase Releases a Fragment Lacking the Inhibitor Domain against Gelatinase A †</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6514</span>– <span class="NLM_lpage">6526</span>, <span class="refDoi"> DOI: 10.1021/bi020643m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi020643m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVOjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=6514-6526&issue=21&author=S.+Higashiauthor=K.+Miyazaki&title=Novel+Processing+of+%CE%B2-Amyloid+Precursor+Protein+Catalyzed+by+Membrane+Type+1+Matrix+Metalloproteinase+Releases+a+Fragment+Lacking+the+Inhibitor+Domain+against+Gelatinase+A+%E2%80%A0&doi=10.1021%2Fbi020643m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Processing of β-Amyloid Precursor Protein Catalyzed by Membrane Type 1 Matrix Metalloproteinase Releases a Fragment Lacking the Inhibitor Domain against Gelatinase A</span></div><div class="casAuthors">Higashi, Shouichi; Miyazaki, Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6514-6526</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In various mammalian cell lines, β-amyloid precursor protein (APP) is proteolytically processed to release its NH2-terminal extracellular domain as a sol. APP (sAPP) that contains the inhibitor domain against gelatinase A.  To investigate the roles of sAPP in the regulation of gelatinase A activity, we examd. the correlation between the activation of progelatinase A and processing of APP.  We found that stimulation of HT1080 fibrosarcoma cells with Con A led to an activation of endogenous progelatinase A and to a novel processing of APP, which releases a COOH-terminally truncated form of sAPP (sAPPtrc) into the culture medium.  Reverse zymog. anal. showed that sAPPtrc lacked an inhibitory activity against gelatinase A.  Analyses of prodn. of sAPPtrc in the presence of various metalloproteinase inhibitors showed that membrane type 1 matrix metalloproteinase (MT1-MMP), an activator of progelatinase A, is most likely responsible for the prodn. of sAPPtrc.  When the Con A-stimulated HT1080 cells were cultured in the condition that inhibited MT1-MMP activity, sAPP and APP were assocd. with the extracellular matrix deposited by the cells, whereas these gelatinase A inhibitors in the matrix were displaced by sAPPtrc after exertion of MT1-MMP activity.  Taken together, these data support a model in which MT1-MMP-catalyzed release of sAPPtrc leads to redn. of the extracellular matrix-assocd. gelatinase A inhibitor, sAPP, thus making it feasible for gelatinase A to exert proteolytic activity only near its activator, MT1-MMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYsfjRvMkSgrVg90H21EOLACvtfcHk0lj_0SHJ7H-XnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVOjur0%253D&md5=50e7e5b7929f585d7bfd8c67777d7916</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fbi020643m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi020643m%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DS.%26aulast%3DMiyazaki%26aufirst%3DK.%26atitle%3DNovel%2520Processing%2520of%2520%25CE%25B2-Amyloid%2520Precursor%2520Protein%2520Catalyzed%2520by%2520Membrane%2520Type%25201%2520Matrix%2520Metalloproteinase%2520Releases%2520a%2520Fragment%2520Lacking%2520the%2520Inhibitor%2520Domain%2520against%2520Gelatinase%2520A%2520%25E2%2580%25A0%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26issue%3D21%26spage%3D6514%26epage%3D6526%26doi%3D10.1021%2Fbi020643m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stetler Stevenson, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span> <span> </span><span class="NLM_article-title">Cell Surface Binding and Activation of Gelatinase A Induced by Expression of Membrane-Type-1-Matrix Metalloproteinase (MT1-MMP)</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>385</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(96)00389-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2F0014-5793%2896%2900389-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=8647259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK28XivFOhs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=1996&pages=238-240&issue=3&author=H.+Satoauthor=T.+Takinoauthor=T.+Kinoshitaauthor=K.+Imaiauthor=Y.+Okadaauthor=W.+G.+Stetler+Stevensonauthor=M.+Seiki&title=Cell+Surface+Binding+and+Activation+of+Gelatinase+A+Induced+by+Expression+of+Membrane-Type-1-Matrix+Metalloproteinase+%28MT1-MMP%29&doi=10.1016%2F0014-5793%2896%2900389-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP)</span></div><div class="casAuthors">Sato, Hiroshi; Takino, Takahisa; Kinoshita, Takeshi; Imai, Kazushi; Okada, Yasunori; Stetler Stevenson, William G.; Seiki, Motoharu</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">238-240</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Gelatinase A is secreted as a proenzyme (progelatinase A) which is activated and bound on the surface of tumor and normal cells.  We have reported that the expression of a membrane-type-1-matrix metalloproteinase (MT1-MMP) induces activation of progelatinase A. Here we demonstrate that the expression of MT1-MMP in COS-1 cells induces cell-surface binding of progelatinase A which is consequently processed to an intermediate form.  Processing from the intermediate to the fully active form is dependent on the gelatinase A concn.  These results suggest that the cell-surface binding concs. the gelatinase A intermediate form locally to allow autoproteolytic processing to the fully active form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrluoSxfvDUR7Vg90H21EOLACvtfcHk0lj_0SHJ7H-XnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFOhs7c%253D&md5=e50faabd7aff5b8be0ab6ec62f0e8f7a</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2896%2900389-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252896%252900389-4%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DH.%26aulast%3DTakino%26aufirst%3DT.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DK.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DStetler%2BStevenson%26aufirst%3DW.%2BG.%26aulast%3DSeiki%26aufirst%3DM.%26atitle%3DCell%2520Surface%2520Binding%2520and%2520Activation%2520of%2520Gelatinase%2520A%2520Induced%2520by%2520Expression%2520of%2520Membrane-Type-1-Matrix%2520Metalloproteinase%2520%2528MT1-MMP%2529%26jtitle%3DFEBS%2520Lett.%26date%3D1996%26volume%3D385%26issue%3D3%26spage%3D238%26epage%3D240%26doi%3D10.1016%2F0014-5793%2896%2900389-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haapasalo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, D. M.</span></span> <span> </span><span class="NLM_article-title">The Many Substrates of Presenilin/γ-Secretase</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.3233/JAD-2011-101065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3233%2FJAD-2011-101065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21335653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=3-28&issue=1&author=A.+Haapasaloauthor=D.+M.+Kovacs&title=The+Many+Substrates+of+Presenilin%2F%CE%B3-Secretase&doi=10.3233%2FJAD-2011-101065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Substrates of Presenilin/γ-Secretase</span></div><div class="casAuthors">Haapasalo, Annakaisa; Kovacs, Dora M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-28</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The Alzheimer's disease (AD)-assocd. amyloid-β protein precursor (AβPP) is cleaved by α-, β-, and presenilin (PS)/γ-secretases through sequential regulated proteolysis.  These proteolytic events control the generation of the pathogenic amyloid-β (Aβ) peptide, which excessively accumulates in the brains of individuals afflicted by AD.  A growing no. of addnl. proteins cleaved by PS/γ-secretase continue to be discovered.  Similarly to AβPP, most of these proteins are type-I transmembrane proteins involved in vital signaling functions regulating cell fate, adhesion, migration, neurite outgrowth, or synaptogenesis.  All the identified proteins share common structural features, which are typical for their proteolysis.  The consequences of the PS/γ-secretase-mediated cleavage on the function of many of these proteins are largely unknown.  Here, we review the current literature on the proteolytic processing mediated by the versatile PS/γ-secretase complex.  We begin by discussing the steps of AβPP processing and PS/γ-secretase complex compn. and localization, which give clues to how and where the processing of other PS/γ-secretase substrates may take place.  Then we summarize the typical features of PS/γ-secretase-mediated protein processing.  Finally, we recapitulate the current knowledge on the possible physiol. function of PS/γ-secretase-mediated cleavage of specific substrate proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphYizFVw4_A7Vg90H21EOLACvtfcHk0lhmNX9NmjsKIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSisbY%253D&md5=22ce56939b97019e5c130556f9db7d5f</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-101065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-101065%26sid%3Dliteratum%253Aachs%26aulast%3DHaapasalo%26aufirst%3DA.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26atitle%3DThe%2520Many%2520Substrates%2520of%2520Presenilin%252F%25CE%25B3-Secretase%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2011%26volume%3D25%26issue%3D1%26spage%3D3%26epage%3D28%26doi%3D10.3233%2FJAD-2011-101065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paumier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinakaran, G.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase 13, a New Target for Therapy in Alzheimer’s Disease</span>. <i>Genes Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">2</span>, <span class="refDoi"> DOI: 10.1016/j.gendis.2019.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.gendis.2019.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30906825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1ahu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=1-2&issue=1&author=J.+M.+Paumierauthor=G.+Thinakaran&title=Matrix+Metalloproteinase+13%2C+a+New+Target+for+Therapy+in+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.gendis.2019.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase 13, a new target for therapy in Alzheimer's disease</span></div><div class="casAuthors">Paumier, Jean-Michel; Thinakaran, Gopal</div><div class="citationInfo"><span class="NLM_cas:title">Genes and Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-2</span>CODEN:
                <span class="NLM_cas:coden">GDEIAV</span>;
        ISSN:<span class="NLM_cas:issn">2352-3042</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOyGK4Ipe1UbVg90H21EOLACvtfcHk0lhmNX9NmjsKIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1ahu74%253D&md5=c6c383f8331bd2cc0f84926122156f5c</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.gendis.2019.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gendis.2019.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DPaumier%26aufirst%3DJ.%2BM.%26aulast%3DThinakaran%26aufirst%3DG.%26atitle%3DMatrix%2520Metalloproteinase%252013%252C%2520a%2520New%2520Target%2520for%2520Therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DGenes%2520Dis.%26date%3D2019%26volume%3D6%26issue%3D1%26spage%3D1%26epage%3D2%26doi%3D10.1016%2Fj.gendis.2019.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haneda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, K.</span></span> <span> </span><span class="NLM_article-title">Induction of Matrix Metalloproteinases (MMP3, MMP12 and MMP13) Expression in the Microglia by Amyloid-β Stimulation via the PI3K/Akt Pathway</span>. <i>Exp. Gerontol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1016/j.exger.2006.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.exger.2006.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17198748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsF2htb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=532-537&issue=6&author=S.+Itoauthor=K.+Kimuraauthor=M.+Hanedaauthor=Y.+Ishidaauthor=M.+Sawadaauthor=K.+Isobe&title=Induction+of+Matrix+Metalloproteinases+%28MMP3%2C+MMP12+and+MMP13%29+Expression+in+the+Microglia+by+Amyloid-%CE%B2+Stimulation+via+the+PI3K%2FAkt+Pathway&doi=10.1016%2Fj.exger.2006.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-β stimulation via the PI3K/Akt pathway</span></div><div class="casAuthors">Ito, Sachiko; Kimura, Kenya; Haneda, Masataka; Ishida, Yoshiyuki; Sawada, Makoto; Isobe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">532-537</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease is characterized by the presence of senile plaques in the brain composed primarily of amyloid-β peptide.  Microglia have been reported to surround these Aβ plaques, which have opposite roles, provoking a microglia-mediated inflammatory response that contributes to neuronal cell loss or the removal of Aβ and damaged neurons.  We herein analyzed the process of expression of Matrix metalloproteinases induced by Aβ stimulation.  We found that Aβ1-42 induces a high level of MMP3, MMP12 and MMP13 in the microglia.  The signal transduction pathway for the expression of these MMPs mRNA induced by Aβ1-42 depends on PI3K/Akt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvhGbb9ohGfbVg90H21EOLACvtfcHk0lg9vzboAa3EvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsF2htb0%253D&md5=ec289ea527da6cfee357727db14bc71e</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.exger.2006.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exger.2006.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DHaneda%26aufirst%3DM.%26aulast%3DIshida%26aufirst%3DY.%26aulast%3DSawada%26aufirst%3DM.%26aulast%3DIsobe%26aufirst%3DK.%26atitle%3DInduction%2520of%2520Matrix%2520Metalloproteinases%2520%2528MMP3%252C%2520MMP12%2520and%2520MMP13%2529%2520Expression%2520in%2520the%2520Microglia%2520by%2520Amyloid-%25CE%25B2%2520Stimulation%2520via%2520the%2520PI3K%252FAkt%2520Pathway%26jtitle%3DExp.%2520Gerontol.%26date%3D2007%26volume%3D42%26issue%3D6%26spage%3D532%26epage%3D537%26doi%3D10.1016%2Fj.exger.2006.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalsing-Hernandez, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyes, B. E.</span></span> <span> </span><span class="NLM_article-title">Gene Expression Changes by Amyloid β Peptide-Stimulated Human Postmortem Brain Microglia Identify Activation of Multiple Inflammatory Processes</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1189/jlb.0705377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1189%2Fjlb.0705377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16365156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFKmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2006&pages=596-610&issue=3&author=D.+G.+Walkerauthor=J.+Linkauthor=L.+Lueauthor=J.+E.+Dalsing-Hernandezauthor=B.+E.+Boyes&title=Gene+Expression+Changes+by+Amyloid+%CE%B2+Peptide-Stimulated+Human+Postmortem+Brain+Microglia+Identify+Activation+of+Multiple+Inflammatory+Processes&doi=10.1189%2Fjlb.0705377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression changes by amyloid β peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes</span></div><div class="casAuthors">Walker, Douglas G.; Link, John; Lue, Lih-Fen; Dalsing-Hernandez, Jessica E.; Boyes, Barry E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-610</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A central feature of the inflammatory pathol. in Alzheimer's disease is activated microglia clustered around aggregated amyloid β (Aβ) peptide-contg. plaques.  In vitro-cultured microglia can be activated to an inflammatory state by aggregated Aβ with the induction of a range of different neurotoxic factors and provide a model system for studying microglia Aβ interactions.  Gene expression responses of human postmortem brain-derived microglia to aggregated Aβ were measured using whole genome microarrays to address the hypothesis that Aβ interactions with human microglia primarily induce proinflammatory genes and not activation of genes involved in Aβ phagocytosis and removal.  The results demonstrated that Aβ activation of microglia induced a large alteration in gene transcription including activation of many proinflammatory cytokines and chemokines, most notably, interleukin (IL)-1β, IL-8, and matrix metalloproteinases (MMP), including MMP1, MMP3, MMP9, MMP10, and MMP12.  All of these genes could amplify ongoing inflammation, resulting in further neuronal loss.  Changes in expression of receptors assocd. with Aβ phagocytosis did not match the changes in proinflammatory gene expression.  Time-course gene expression profiling, along with real-time polymerase chain reaction validation of expression changes, demonstrated an acute phase of gene induction for many proinflammatory genes but also chronic activation for many other potentially toxic products.  These chronically activated genes included indoleamine 2,3-dioxygenase and kynureninase, which are involved in formation of the neurotoxin quinolinic acid, and S100A8, a potential proinflammatory chemokine.  These studies show that activation of microglia by Aβ induces multiple genes that could be involved in inflammatory responses contributing to neurodegenerative processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI1Qa73eVxQbVg90H21EOLACvtfcHk0lg9vzboAa3EvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFKmsr4%253D&md5=b56e7e4f40bc1afc185de0b9820b176e</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1189%2Fjlb.0705377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.0705377%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DD.%2BG.%26aulast%3DLink%26aufirst%3DJ.%26aulast%3DLue%26aufirst%3DL.%26aulast%3DDalsing-Hernandez%26aufirst%3DJ.%2BE.%26aulast%3DBoyes%26aufirst%3DB.%2BE.%26atitle%3DGene%2520Expression%2520Changes%2520by%2520Amyloid%2520%25CE%25B2%2520Peptide-Stimulated%2520Human%2520Postmortem%2520Brain%2520Microglia%2520Identify%2520Activation%2520of%2520Multiple%2520Inflammatory%2520Processes%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2006%26volume%3D79%26issue%3D3%26spage%3D596%26epage%3D610%26doi%3D10.1189%2Fjlb.0705377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ierusalimsky, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuleshova, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaban, P. M.</span></span> <span> </span><span class="NLM_article-title">Expression of the Type 1 Metalloproteinase in the Rat Hippocampus after the Intracerebroventricular Injection of β-Amyloid Peptide (25–35)</span>. <i>Acta Neurobiol. Exp. (Wars).</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24457647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC2czovFSnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=571-578&author=V.+N.+Ierusalimskyauthor=E.+P.+Kuleshovaauthor=P.+M.+Balaban&title=Expression+of+the+Type+1+Metalloproteinase+in+the+Rat+Hippocampus+after+the+Intracerebroventricular+Injection+of+%CE%B2-Amyloid+Peptide+%2825%E2%80%9335%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the type 1 metalloproteinase in the rat hippocampus after the intracerebroventricular injection of β-amyloid peptide (25-35)</span></div><div class="casAuthors">Ierusalimsky Victor N; Kuleshova Elena P; Balaban Pavel M</div><div class="citationInfo"><span class="NLM_cas:title">Acta neurobiologiae experimentalis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">571-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The expression of matrix metalloproteinase of the first type was studied in frontal sections of the adult rat brain one month after a single intracerebroventricular injection of beta-amyloid peptide (25-35), which is known to be a well-known model of the development of Alzheimer's disease.  Brain sections were stained immunocytochemically to detect MMP-1 expression, and histologically to reveal the state of hippocampal neurons.  Administration of beta-amyloid peptide induced a significant degeneration of cells in the dorsal hippocampus.  This was demonstrated by a significant decrease in the total number of cells and by the appearance of acidophilic neurons of altered (often triangular) shape.  Altered cells were most often found in the hippocampal field CA3, and in a smaller quantity in the CA1 field.  MMP-1-like immunoreactivity was found in the same hippocampal areas, the staining being restricted to the cells of altered shape (staining of somata and primary neurites).  The data suggest possible involvement of the type 1 metalloproteinase in the development of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqkSBNX-MlXmx8TEN9K18QfW6udTcc2ebGaNPhrFT73rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czovFSnsg%253D%253D&md5=596092e68faf81c906daa72915e25ecd</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIerusalimsky%26aufirst%3DV.%2BN.%26aulast%3DKuleshova%26aufirst%3DE.%2BP.%26aulast%3DBalaban%26aufirst%3DP.%2BM.%26atitle%3DExpression%2520of%2520the%2520Type%25201%2520Metalloproteinase%2520in%2520the%2520Rat%2520Hippocampus%2520after%2520the%2520Intracerebroventricular%2520Injection%2520of%2520%25CE%25B2-Amyloid%2520Peptide%2520%252825%25E2%2580%259335%2529%26jtitle%3DActa%2520Neurobiol.%2520Exp.%2520%2528Wars%2529.%26date%3D2013%26volume%3D73%26spage%3D571%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span> <span> </span><span class="NLM_article-title">Impact of Matrix Metalloproteinases on Atherosclerosis</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">442</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.2174/1389450115666140211115805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F1389450115666140211115805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24517161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksFShu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=442-453&issue=4&author=J.+Linauthor=V.+Kakkarauthor=X.+Lu&title=Impact+of+Matrix+Metalloproteinases+on+Atherosclerosis&doi=10.2174%2F1389450115666140211115805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Matrix Metalloproteinases on Atherosclerosis</span></div><div class="casAuthors">Lin, Juntang; Kakkar, Vijay; Lu, Xinjie</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">442-453</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Atherosclerosis is now widely recognized as a chronic inflammatory disease that involves innate and adaptive immune responses.  Both cellular and humoral components of the immune system have been implicated in atherogenesis.  Growing evidence suggests that immune cells play crucial roles in atherogenic plaque formation.  Vulnerability of the plaque probably plays an important role in rupture.  Most ruptures occur at the periphery of the fibrous cap that covers the lipid-rich core-points where the cap is usually thinnest and most heavily infiltrated by macrophage foam cells.  Sudden rupture of a plaque triggers unstable angina, acute myocardial infarction, and sudden cardiac death.  Initiation of collagen breakdown in plaques requires matrix metalloproteinase (MMP) family members including MMP-1, MMP-8, and MMP- 13.  In addn., other MMPs such as MMP-2, -3, -9, -10 and -12 have also been reported to play roles in atherosclerosis.  This review aims to focus on description of general structural features of MMPs and their roles in atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZlAue_n8tWbVg90H21EOLACvtfcHk0liwMlclu3aHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksFShu74%253D&md5=017aae726ec8344e3f0b5c5541e69ce3</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.2174%2F1389450115666140211115805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450115666140211115805%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DKakkar%26aufirst%3DV.%26aulast%3DLu%26aufirst%3DX.%26atitle%3DImpact%2520of%2520Matrix%2520Metalloproteinases%2520on%2520Atherosclerosis%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2014%26volume%3D15%26issue%3D4%26spage%3D442%26epage%3D453%26doi%3D10.2174%2F1389450115666140211115805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. L.</span></span> <span> </span><span class="NLM_article-title">Metalloproteinases in Atherosclerosis</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>816</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2017.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.ejphar.2017.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28893577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOhur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=816&publication_year=2017&pages=93-106&issue=6&author=J.+L.+Johnson&title=Metalloproteinases+in+Atherosclerosis&doi=10.1016%2Fj.ejphar.2017.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloproteinases in atherosclerosis</span></div><div class="casAuthors">Johnson, Jason L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">816</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-106</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Atherosclerosis underlies most cardiovascular diseases, and is accepted as a primary cause of mortality worldwide.  Proteases have been implicated in the development and progression of atherosclerosis, due to their ability to provoke focal destruction of the vascular extracellular matrix.  Members of the metalloproteinase family, esp. matrix metalloproteinases (MMPs), and their endogenous tissue inhibitors (TIMPs) have been suggested to perform complex dual roles during late-stage progression and rupture of atherosclerotic plaques.  Proposed favorable actions of metalloproteinases include the promotion of vascular smooth muscle growth and survival which stabilizes plaques, while conversely extracellular matrix destruction alongside interminable monocyte/macrophage accumulation can encourage plaque rupture.  This review provides a summary of the cogent evidence connecting the contribution of individual metalloproteinases to atherosclerotic plaque development, progression, and instability.  Topics discussed include structural, functional and cell-specific diversity of MMP members; evidence from animal models of atherosclerosis and comparisons with findings in humans; the dual role of MMPs and the requirement to selectively target individual MMPs; and the need for efficient surrogate markers of MMP inhibition.  Accordingly, as our knowledge of the complex roles individual MMPs play esp. during the progression and rupture of atherosclerotic plaques expands, new impetus is required for clin. trials evaluating the therapeutic potential of selective MMP inhibition, which could limit cardiovascular morbidity and mortality worldwide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpo29nEs4jZ7Vg90H21EOLACvtfcHk0liwMlclu3aHQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOhur3O&md5=2084c3082b303fcd431eba4ebb95812a</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2017.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2017.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BL.%26atitle%3DMetalloproteinases%2520in%2520Atherosclerosis%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D816%26issue%3D6%26spage%3D93%26epage%3D106%26doi%3D10.1016%2Fj.ejphar.2017.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elkington, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuttall, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte-Gil, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Armiento, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, J. S.</span></span> <span> </span><span class="NLM_article-title">MMP-1 Drives Immunopathology in Human Tuberculosis and Transgenic Mice</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1827</span>– <span class="NLM_lpage">1833</span>, <span class="refDoi"> DOI: 10.1172/JCI45666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1172%2FJCI45666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21519144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFKnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=1827-1833&issue=5&author=P.+Elkingtonauthor=T.+Shiomiauthor=R.+Breenauthor=R.+K.+Nuttallauthor=C.+A.+Ugarte-Gilauthor=N.+F.+Walkerauthor=L.+Saraivaauthor=B.+Pedersenauthor=F.+Mauriauthor=M.+Lipmanauthor=D.+R.+Edwardsauthor=B.+D.+Robertsonauthor=J.+D%E2%80%99Armientoauthor=J.+S.+Friedland&title=MMP-1+Drives+Immunopathology+in+Human+Tuberculosis+and+Transgenic+Mice&doi=10.1172%2FJCI45666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-1 drives immunopathology in human tuberculosis and transgenic mice</span></div><div class="casAuthors">Elkington, Paul; Shiomi, Takayuki; Breen, Ronan; Nuttall, Robert K.; Ugarte-Gil, Cesar Augusto; Walker, Naomi F.; Saraiva, Luisa; Pedersen, Bernadette; Mauri, Francesco; Lipman, Marc; Edwards, Dylan R.; Robertson, Brian D.; D'Armiento, Jeanine; Friedland, Jon S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1827-1833</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis can cause lung tissue damage to spread, but the mechanisms driving this immunopathol. are poorly understood.  The breakdown of lung matrix involves MMPs, which have a unique ability to degrade fibrillar collagens at neutral pH.  To det. whether MMPs play a role in the immunopathol. of tuberculosis (TB), we profiled MMPs and their inhibitors, the tissue inhibitor of metalloproteinases (TIMPs), in sputum and bronchoalveolar lavage fluid from patients with TB and symptomatic controls.  MMP-1 concns. were significantly increased in both HIV-neg. and HIV-pos. patients with TB, while TIMP concns. were lower in HIV-neg. TB patients.  In primary human monocytes, M. tuberculosis infection selectively upregulated MMP1 gene expression and secretion, and Ro32-3555, a specific MMP inhibitor, suppressed M. tuberculosis-driven MMP-1 activity.  Since the mouse MMP-1 ortholog is not expressed in the lung and mice infected with M. tuberculosis do not develop tissue destruction equiv. to humans, we infected transgenic mice expressing human MMP-1 with M. tuberculosis to investigate whether MMP-1 caused lung immunopathol.  In the MMP-1 transgenic mice, M. tuberculosis infection increased MMP-1 expression, resulting in alveolar destruction in lung granulomas and significantly greater collagen breakdown.  In summary, MMP-1 may drive tissue destruction in TB and represents a therapeutic target to limit immunopathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoklCcWsJLZhbVg90H21EOLACvtfcHk0lihbPEiBoJjmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFKnt7s%253D&md5=05e4eb412ae0f166c78f3fa8565d73f2</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1172%2FJCI45666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI45666%26sid%3Dliteratum%253Aachs%26aulast%3DElkington%26aufirst%3DP.%26aulast%3DShiomi%26aufirst%3DT.%26aulast%3DBreen%26aufirst%3DR.%26aulast%3DNuttall%26aufirst%3DR.%2BK.%26aulast%3DUgarte-Gil%26aufirst%3DC.%2BA.%26aulast%3DWalker%26aufirst%3DN.%2BF.%26aulast%3DSaraiva%26aufirst%3DL.%26aulast%3DPedersen%26aufirst%3DB.%26aulast%3DMauri%26aufirst%3DF.%26aulast%3DLipman%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DD.%2BR.%26aulast%3DRobertson%26aufirst%3DB.%2BD.%26aulast%3DD%25E2%2580%2599Armiento%26aufirst%3DJ.%26aulast%3DFriedland%26aufirst%3DJ.%2BS.%26atitle%3DMMP-1%2520Drives%2520Immunopathology%2520in%2520Human%2520Tuberculosis%2520and%2520Transgenic%2520Mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26issue%3D5%26spage%3D1827%26epage%3D1833%26doi%3D10.1172%2FJCI45666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1155/2013/928315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1155%2F2013%2F928315" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=1-14&author=Q.+Chenauthor=M.+Jinauthor=F.+Yangauthor=J.+Zhuauthor=Q.+Xiaoauthor=L.+Zhang&title=Matrix+Metalloproteinases%3A+Inflammatory+Regulators+of+Cell+Behaviors+in+Vascular+Formation+and+Remodeling&doi=10.1155%2F2013%2F928315"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1155%2F2013%2F928315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F928315%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DMatrix%2520Metalloproteinases%253A%2520Inflammatory%2520Regulators%2520of%2520Cell%2520Behaviors%2520in%2520Vascular%2520Formation%2520and%2520Remodeling%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D14%26doi%3D10.1155%2F2013%2F928315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barichello, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Generoso, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelon, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simões, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuolo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comim, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal-Pizzol, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quevedo, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Matrix Metalloproteinases-2 and −9 Prevents Cognitive Impairment Induced by Pneumococcal Meningitis in Wistar Rats</span>. <i>Exp. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>239</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1177/1535370213508354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1177%2F1535370213508354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFags7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=239&publication_year=2014&pages=225-231&issue=2&author=T.+Barichelloauthor=J.+S.+Generosoauthor=C.+M.+Michelonauthor=L.+R.+Sim%C3%B5esauthor=S.+G.+Eliasauthor=F.+Vuoloauthor=C.+M.+Comimauthor=F.+Dal-Pizzolauthor=J.+Quevedo&title=Inhibition+of+Matrix+Metalloproteinases-2+and+%E2%88%929+Prevents+Cognitive+Impairment+Induced+by+Pneumococcal+Meningitis+in+Wistar+Rats&doi=10.1177%2F1535370213508354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats</span></div><div class="casAuthors">Barichello, Tatiana; Generoso, Jaqueline S.; Michelon, Cleonice M.; Simoes, Lutiana R.; Elias, Samuel G.; Vuolo, Franciele; Comim, Clarissa M.; Dal-Pizzol, Felipe; Quevedo, Joao</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">239</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-231, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3699</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Pneumococcal meningitis is a relevant clin. disease characterized by an intense inflammatory reaction into the subarachnoid and ventricular spaces, leading to blood-brain barrier breakdown, hearing loss, and cognitive impairment.  Matrix metalloproteinases (MMPs) are capable of degrading components of the basal laminin, thus contributing to BBB damage and neuronal injury.  In the present study, we evaluated the effects of MMP-2, MMP-9, and MMP-2/9 inhibitors on BBB integrity, learning, and memory in Wistar rats subjected to pneumococcal meningitis.  The animals underwent a magna cistern tap and received either 10 μL sterile saline as a placebo or an equiv. vol. of a Streptococcus pneumoniae suspension at a concn. of 5 × 109 cfu/mL.  The rats were randomized into different groups that received adjuvant treatment with MMP-2, MMP-9 or MMP-2/9 inhibitors.  The BBB integrity was evaluated, and the animals were habituated to open-field and object recognition tasks 10 days after meningitis induction.  Adjuvant treatments with inhibitors of MMP-2 or MMP-2/9 prevented BBB breakdown in the hippocampus, and treatments with inhibitors of MMP-2, MMP-9 or MMP-2/9 prevented BBB breakdown in the cortex.  Ten days after meningitis induction, the animals that received adjuvant treatment with the inhibitor of MMP-2/9 demonstrated that animals habituated to the open-field task faster and enhanced memory during short-term and long-term retention test sessions in the object recognition task.  Further investigation is necessary to provide support for MMP inhibitors as an alternative treatment for bacterial meningitis; however, these findings suggest that the meningitis model could be a good research tool for studying the biol. mechanisms involved in the behavioral alterations assocd. with pneumococcal meningitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9hBIe9cGLkLVg90H21EOLACvtfcHk0lihbPEiBoJjmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFags7fE&md5=651ff752d93696620d96b312cbd76fd0</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1177%2F1535370213508354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1535370213508354%26sid%3Dliteratum%253Aachs%26aulast%3DBarichello%26aufirst%3DT.%26aulast%3DGeneroso%26aufirst%3DJ.%2BS.%26aulast%3DMichelon%26aufirst%3DC.%2BM.%26aulast%3DSim%25C3%25B5es%26aufirst%3DL.%2BR.%26aulast%3DElias%26aufirst%3DS.%2BG.%26aulast%3DVuolo%26aufirst%3DF.%26aulast%3DComim%26aufirst%3DC.%2BM.%26aulast%3DDal-Pizzol%26aufirst%3DF.%26aulast%3DQuevedo%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Matrix%2520Metalloproteinases-2%2520and%2520%25E2%2588%25929%2520Prevents%2520Cognitive%2520Impairment%2520Induced%2520by%2520Pneumococcal%2520Meningitis%2520in%2520Wistar%2520Rats%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2014%26volume%3D239%26issue%3D2%26spage%3D225%26epage%3D231%26doi%3D10.1177%2F1535370213508354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hannocks, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwien, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chashchina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burmeister, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korpos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorokin, L.</span></span> <span> </span><span class="NLM_article-title">The Gelatinases, MMP-2 and MMP-9, as Fine Tuners of Neuroinflammatory Processes</span>. <i>Matrix Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>75–76</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/j.matbio.2017.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.matbio.2017.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29158162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOitbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75%E2%80%9376&publication_year=2019&pages=102-113&author=M.-J.+Hannocksauthor=X.+Zhangauthor=H.+Gerwienauthor=A.+Chashchinaauthor=M.+Burmeisterauthor=E.+Korposauthor=J.+Songauthor=L.+Sorokin&title=The+Gelatinases%2C+MMP-2+and+MMP-9%2C+as+Fine+Tuners+of+Neuroinflammatory+Processes&doi=10.1016%2Fj.matbio.2017.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes</span></div><div class="casAuthors">Hannocks, M.-J.; Zhang, X.; Gerwien, H.; Chashchina, A.; Burmeister, M.; Korpos, E.; Song, J.; Sorokin, L.</div><div class="citationInfo"><span class="NLM_cas:title">Matrix Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">75-76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">102-113</span>CODEN:
                <span class="NLM_cas:coden">MTBOEC</span>;
        ISSN:<span class="NLM_cas:issn">0945-053X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review focuses on the complementary roles of MMP-2 and MMP-9 in leukocyte migration into the brain in neuroinflammation, studied mainly in a murine model of exptl. autoimmune encephalomyelitis (EAE) that has similarity to the human disease multiple sclerosis.  We discuss the cellular sources of MMP-2/MMP-9 in EAE, their sites of activity, and how cleavage of the to-date identified MMP-2/MMP-9 substrates at the blood-brain barrier facilitate leukocyte filtration of the central nervous system (CNS).  Where necessary, comparisons are made to inflammatory processes in the periphery and to other MMPs relevant to neuroinflammation.  While the general principles concerning MMP-2 and MMP-9 function discussed here are relevant to all inflammatory situations, the details regarding substrates and mol. mechanisms of action are likely to be specific for neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD6C_B8JJ8ArVg90H21EOLACvtfcHk0lgtfcAwg4TtBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOitbjE&md5=0839dca25d3939f71992607de8ea3af5</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.matbio.2017.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.matbio.2017.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DHannocks%26aufirst%3DM.-J.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGerwien%26aufirst%3DH.%26aulast%3DChashchina%26aufirst%3DA.%26aulast%3DBurmeister%26aufirst%3DM.%26aulast%3DKorpos%26aufirst%3DE.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DSorokin%26aufirst%3DL.%26atitle%3DThe%2520Gelatinases%252C%2520MMP-2%2520and%2520MMP-9%252C%2520as%2520Fine%2520Tuners%2520of%2520Neuroinflammatory%2520Processes%26jtitle%3DMatrix%2520Biol.%26date%3D2019%26volume%3D75%25E2%2580%259376%26spage%3D102%26epage%3D113%26doi%3D10.1016%2Fj.matbio.2017.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volitakis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharples, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xilinas, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoke, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsinger, R. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherny, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnham, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span> <span> </span><span class="NLM_article-title">Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-Dependent Up-Regulation of Metalloprotease Activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">17670</span>– <span class="NLM_lpage">17680</span>, <span class="refDoi"> DOI: 10.1074/jbc.M602487200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M602487200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16648635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFyksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=17670-17680&issue=26&author=A.+R.+Whiteauthor=T.+Duauthor=K.+M.+Laughtonauthor=I.+Volitakisauthor=R.+A.+Sharplesauthor=M.+E.+Xilinasauthor=D.+E.+Hokeauthor=R.+M.+D.+Holsingerauthor=G.+Evinauthor=R.+A.+Chernyauthor=A.+F.+Hillauthor=K.+J.+Barnhamauthor=Q.-X.+Liauthor=A.+I.+Bushauthor=C.+L.+Masters&title=Degradation+of+the+Alzheimer+Disease+Amyloid+%CE%B2-Peptide+by+Metal-Dependent+Up-Regulation+of+Metalloprotease+Activity&doi=10.1074%2Fjbc.M602487200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity</span></div><div class="casAuthors">White, Anthony R.; Du, Tai; Laughton, Katrina M.; Volitakis, Irene; Sharples, Robyn A.; Xilinas, Michel E.; Hoke, David E.; Holsinger, R. M. Damian; Evin, Genevieve; Cherny, Robert A.; Hill, Andrew F.; Barnham, Kevin J.; Li, Qiao-Xin; Bush, Ashley I.; Masters, Colin L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">17670-17680</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Biometals play an important role in Alzheimer disease, and recent reports have described the development of potential therapeutic agents based on modulation of metal bioavailability.  The metal ligand clioquinol (CQ) has shown promising results in animal models and small phase clin. trials; however, the actual mode of action in vivo has not been detd.  We now report a novel effect of CQ on amyloid β-peptide (Aβ) metab. in cell culture.  Treatment of Chinese hamster ovary cells overexpressing amyloid precursor protein with CQ and Cu2+ or Zn2+ resulted in an ∼85 - 90% redn. of secreted Aβ-(1-40) and Aβ-(1-42) compared with untreated controls.  Analogous effects were seen in amyloid precursor protein-overexpressing neuroblastoma cells.  The secreted Aβ was rapidly degraded through up-regulation of matrix metalloprotease (MMP)-2 and MMP-3 after addn. of CQ and Cu2+.  MMP activity was increased through activation of phosphoinositol 3-kinase and JNK.  CQ and Cu2+ also promoted phosphorylation of glycogen synthase kinase-3, and this potentiated activation of JNK and loss of Aβ-(1-40).  Our findings identify an alternative mechanism of action for CQ in the redn. of Aβ deposition in the brains of CQ-treated animals and potentially in Alzheimer disease patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphcWxR7vti2bVg90H21EOLACvtfcHk0lgtfcAwg4TtBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFyksLg%253D&md5=01082a7c6c94dba950d653b992119ded</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M602487200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M602487200%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DA.%2BR.%26aulast%3DDu%26aufirst%3DT.%26aulast%3DLaughton%26aufirst%3DK.%2BM.%26aulast%3DVolitakis%26aufirst%3DI.%26aulast%3DSharples%26aufirst%3DR.%2BA.%26aulast%3DXilinas%26aufirst%3DM.%2BE.%26aulast%3DHoke%26aufirst%3DD.%2BE.%26aulast%3DHolsinger%26aufirst%3DR.%2BM.%2BD.%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26aulast%3DHill%26aufirst%3DA.%2BF.%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DLi%26aufirst%3DQ.-X.%26aulast%3DBush%26aufirst%3DA.%2BI.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26atitle%3DDegradation%2520of%2520the%2520Alzheimer%2520Disease%2520Amyloid%2520%25CE%25B2-Peptide%2520by%2520Metal-Dependent%2520Up-Regulation%2520of%2520Metalloprotease%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D26%26spage%3D17670%26epage%3D17680%26doi%3D10.1074%2Fjbc.M602487200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brkic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balusu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wonterghem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorle, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benilova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hove, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moons, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenbroucke, R. E.</span></span> <span> </span><span class="NLM_article-title">Amyloid Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">12766</span>– <span class="NLM_lpage">12778</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0006-15.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.0006-15.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26377465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVSqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=12766-12778&issue=37&author=M.+Brkicauthor=S.+Balusuauthor=E.+Van+Wonterghemauthor=N.+Gorleauthor=I.+Benilovaauthor=A.+Kremerauthor=I.+Van+Hoveauthor=L.+Moonsauthor=B.+De+Strooperauthor=S.+Kanazirauthor=C.+Libertauthor=R.+E.+Vandenbroucke&title=Amyloid+Oligomers+Disrupt+Blood-CSF+Barrier+Integrity+by+Activating+Matrix+Metalloproteinases&doi=10.1523%2FJNEUROSCI.0006-15.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases</span></div><div class="casAuthors">Brkic, Marjana; Balusu, Sriram; Van Wonterghem, Elien; Gorle, Nina; Benilova, Iryna; Kremer, Anna; Van Hove, Inge; Moons, Lieve; De Strooper, Bart; Kanazir, Selma; Libert, Claude; Vandenbroucke, Roosmarijn E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12766-12778</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The blood-CSF barrier (BCSFB) consists of a monolayer of choroid plexus epithelial (CPE) cells that maintain CNS homeostasis by producing CSF and restricting the passage of undesirable mols. and pathogens into the brain.  Alzheimer's disease is the most common progressive neurodegenerative disorder and is characterized by the presence of amyloid β (Aβ) plaques and neurofibrillary tangles in the brain.  Recent research shows that Alzheimer's disease is assocd. with morphol. changes in CPE cells and compromised prodn. of CSF.  Here, we studied the direct effects of Aβ on the functionality of the BCSFB.  Intracerebroventricular injection of Aβ1-42 oligomers into the cerebral ventricles of mice, a validated Alzheimer's disease model, caused induction of a cascade of detrimental events, including increased inflammatory gene expression in CPE cells and increased levels of proinflammatory cytokines and chemokines in the CSF.  It also rapidly affected CPE cell morphol. and tight junction protein levels.  These changes were assocd. with loss of BCSFB integrity, as shown by an increase in BCSFB leakage.  Aβ1-42 oligomers also increased matrix metalloproteinase (MMP) gene expression in the CPE and its activity in CSF.  Interestingly, BCSFB disruption induced by Aβ1-42 oligomers did not occur in the presence of a broad-spectrum MMP inhibitor or in MMP3-deficient mice.  These data provide evidence that MMPs are essential for the BCSFB leakage induced by Aβ1-42 oligomers.  Our results reveal that Alzheimer's disease-assocd. sol. Aβ1-42 oligomers induce BCSFB dysfunction and suggest MMPs as a possible therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGg-ylkQBzrVg90H21EOLACvtfcHk0lgtfcAwg4TtBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVSqt78%253D&md5=1b7cbd00c8353329f38a81215774253f</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0006-15.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0006-15.2015%26sid%3Dliteratum%253Aachs%26aulast%3DBrkic%26aufirst%3DM.%26aulast%3DBalusu%26aufirst%3DS.%26aulast%3DVan%2BWonterghem%26aufirst%3DE.%26aulast%3DGorle%26aufirst%3DN.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DKremer%26aufirst%3DA.%26aulast%3DVan%2BHove%26aufirst%3DI.%26aulast%3DMoons%26aufirst%3DL.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DKanazir%26aufirst%3DS.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DVandenbroucke%26aufirst%3DR.%2BE.%26atitle%3DAmyloid%2520Oligomers%2520Disrupt%2520Blood-CSF%2520Barrier%2520Integrity%2520by%2520Activating%2520Matrix%2520Metalloproteinases%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26issue%3D37%26spage%3D12766%26epage%3D12778%26doi%3D10.1523%2FJNEUROSCI.0006-15.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillmore, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, L. L.</span></span> <span> </span><span class="NLM_article-title">Elevation of Hippocampal MMP-3 Expression and Activity during Trauma-Induced Synaptogenesis</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>192</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2004.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.expneurol.2004.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15698619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2005&pages=60-72&issue=1&author=H.+J.+Kimauthor=H.+L.+Fillmoreauthor=T.+M.+Reevesauthor=L.+L.+Phillips&title=Elevation+of+Hippocampal+MMP-3+Expression+and+Activity+during+Trauma-Induced+Synaptogenesis&doi=10.1016%2Fj.expneurol.2004.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis</span></div><div class="casAuthors">Kim, H. J.; Fillmore, H. L.; Reeves, T. M.; Phillips, L. L.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-72</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The matrix metalloproteinase (MMP) enzyme family contributes to the regulation of a variety of brain extracellular matrix mols.  In order to assess their role in synaptic plasticity following traumatic brain injury (TBI), we compared expression of stromelysin-1 (MMP-3) protein and mRNA in two rodent models of TBI exhibiting different levels of recovery: adaptive synaptic plasticity following central fluid percussion injury and maladaptive synaptic plasticity generated by combined TBI and bilateral entorhinal cortical lesion (TBI + BEC).  We sampled the hippocampus at 7 days postinjury, targeting a selectively vulnerable brain region and a survival interval exhibiting rapid synaptogenesis.  We report elevated expression of hippocampal MMP-3 mRNA and protein after TBI.  MMP-3 immunohistochem. staining showed increased protein levels relative to sham-injured controls, primarily localized to cell bodies within the deafferented dendritic laminae.  Injury-related differences in MMP-3 protein were also obsd.  TBI alone elevated MMP-3 immunobinding over the stratum lacunosum moleculare (SLM), inner mol. layer and hilus, while TBI + BEC generated more robust increases in MMP-3 reactivity within the deafferented SLM and dentate mol. layer (DML).  Double labeling with GFAP confirmed the presence of MMP-3 within reactive astrocytes induced by each injury model.  Semi-quant. RT-PCR revealed that MMP-3 mRNA also increased after each injury, however, the combined insult induced a much greater elevation than fluid percussion alone: 1.9-fold vs. 79%, resp.  In the TBI + BEC model, MMP-3 up-regulation was spatio-temporally correlated with increased enzyme activity, an effect which was attenuated with the neuroprotective compd. MK-801.  These results show that distinct pathol. conditions elicited by TBI can differentially affect MMP-3 expression during reactive synaptic plasticity.  Notably, these effects are both transcriptional and translational and are correlated with functionally active enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDEiPSZa0oArVg90H21EOLACvtfcHk0lhx1A3pQcuxBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKgsr4%253D&md5=e86e1fc5fbd58d9eea76cacca4a76063</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2004.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2004.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DFillmore%26aufirst%3DH.%2BL.%26aulast%3DReeves%26aufirst%3DT.%2BM.%26aulast%3DPhillips%26aufirst%3DL.%2BL.%26atitle%3DElevation%2520of%2520Hippocampal%2520MMP-3%2520Expression%2520and%2520Activity%2520during%2520Trauma-Induced%2520Synaptogenesis%26jtitle%3DExp.%2520Neurol.%26date%3D2005%26volume%3D192%26issue%3D1%26spage%3D60%26epage%3D72%26doi%3D10.1016%2Fj.expneurol.2004.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joh, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">Role of Matrix Metalloproteinase 3-Mediated α-Synuclein Cleavage in Dopaminergic Cell Death</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">14168</span>– <span class="NLM_lpage">14177</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.222430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M111.222430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21330369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslWju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=14168-14177&issue=16&author=D.+H.+Choiauthor=Y.+J.+Kimauthor=Y.+G.+Kimauthor=T.+H.+Johauthor=M.+F.+Bealauthor=Y.+S.+Kim&title=Role+of+Matrix+Metalloproteinase+3-Mediated+%CE%B1-Synuclein+Cleavage+in+Dopaminergic+Cell+Death&doi=10.1074%2Fjbc.M111.222430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death</span></div><div class="casAuthors">Choi, Dong-Hee; Kim, Youn-Jung; Kim, Young-Gun; Joh, Tong H.; Beal, M. Flint; Kim, Yoon-Seong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">14168-14177</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Evidence suggests that the C-terminal truncation of α-synuclein is equally important as aggregation of α-synuclein in Parkinson disease (PD).  Our previous results showed that an endopeptidase, matrix metalloproteinase-3 (MMP3), was induced and activated in dopaminergic (DA) cells upon stress conditions.  Here, we report that MMP3 cleaved α-synuclein in vitro and in vivo and that α-synuclein and MMP3 were co-localized in Lewy bodies (LB) in the postmortem brains of PD patients.  Incubation of α-synuclein with the catalytic domain of MMP3 (cMMP3) resulted in generation of several peptides, and the peptide profiles of WT α-synuclein (WTsyn) and A53T mutant (A53Tsyn) were different.  Combined anal. using mass spectrometry and N-terminal detn. revealed that MMP3 generated C-terminally truncated peptides of amino acids 1-78, 1-91, and 1-93 and that A53Tsyn produced significantly higher quantities of these peptides.  Similar sizes of peptides were detected in N27 DA cells under oxidative stress and RNA interference to knock down MMP3-attenuated peptide generation.  Co-overexpression of cMMP3 with either WTsyn or A53Tsyn led to a redn. in Triton X-100-insol. aggregates and an increase in protofibril-like small aggregates.  In addn., overexpression of the 1-93-amino acid peptide in the substantia nigra led to DA neuronal loss without LB-like aggregate formation.  The results strongly indicate that MMP3 digestion of α-synuclein in DA neurons plays a pivotal role in the progression of PD through modulation of α-synuclein in aggregation, LB formation, and neurotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7BjPuBR4vibVg90H21EOLACvtfcHk0lhx1A3pQcuxBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslWju70%253D&md5=c67b0e3fed2c0f2feeef2ad09e772ee0</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.222430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.222430%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DD.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DJoh%26aufirst%3DT.%2BH.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DRole%2520of%2520Matrix%2520Metalloproteinase%25203-Mediated%2520%25CE%25B1-Synuclein%2520Cleavage%2520in%2520Dopaminergic%2520Cell%2520Death%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26issue%3D16%26spage%3D14168%26epage%3D14177%26doi%3D10.1074%2Fjbc.M111.222430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bok, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yune, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, B. K.</span></span> <span> </span><span class="NLM_article-title">MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson’s Disease</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1155/2013/370526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1155%2F2013%2F370526" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=1-11&author=Y.+C.+Chungauthor=Y.-S.+Kimauthor=E.+Bokauthor=T.+Y.+Yuneauthor=S.+Maengauthor=B.+K.+Jin&title=MMP-3+Contributes+to+Nigrostriatal+Dopaminergic+Neuronal+Loss%2C+BBB+Damage%2C+and+Neuroinflammation+in+an+MPTP+Mouse+Model+of+Parkinson%E2%80%99s+Disease&doi=10.1155%2F2013%2F370526"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1155%2F2013%2F370526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F370526%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DY.%2BC.%26aulast%3DKim%26aufirst%3DY.-S.%26aulast%3DBok%26aufirst%3DE.%26aulast%3DYune%26aufirst%3DT.%2BY.%26aulast%3DMaeng%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DB.%2BK.%26atitle%3DMMP-3%2520Contributes%2520to%2520Nigrostriatal%2520Dopaminergic%2520Neuronal%2520Loss%252C%2520BBB%2520Damage%252C%2520and%2520Neuroinflammation%2520in%2520an%2520MPTP%2520Mouse%2520Model%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D11%26doi%3D10.1155%2F2013%2F370526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stawarski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefaniuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wlodarczyk, J.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-9 Involvement in the Structural Plasticity of Dendritic Spines</span>. <i>Front. Neuroanat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.3389/fnana.2014.00068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3389%2Ffnana.2014.00068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24523676" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=1-15&issue=7&author=M.+Stawarskiauthor=M.+Stefaniukauthor=J.+Wlodarczyk&title=Matrix+Metalloproteinase-9+Involvement+in+the+Structural+Plasticity+of+Dendritic+Spines&doi=10.3389%2Ffnana.2014.00068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.3389%2Ffnana.2014.00068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnana.2014.00068%26sid%3Dliteratum%253Aachs%26aulast%3DStawarski%26aufirst%3DM.%26aulast%3DStefaniuk%26aufirst%3DM.%26aulast%3DWlodarczyk%26aufirst%3DJ.%26atitle%3DMatrix%2520Metalloproteinase-9%2520Involvement%2520in%2520the%2520Structural%2520Plasticity%2520of%2520Dendritic%2520Spines%26jtitle%3DFront.%2520Neuroanat.%26date%3D2014%26volume%3D8%26issue%3D7%26spage%3D1%26epage%3D15%26doi%3D10.3389%2Ffnana.2014.00068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantz, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stopfer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, E. M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-9 Regulates Neuronal Circuit Development and Excitability</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">3477</span>– <span class="NLM_lpage">3493</span>, <span class="refDoi"> DOI: 10.1007/s12035-015-9295-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs12035-015-9295-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26093382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKhsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2016&pages=3477-3493&issue=5&author=S.+Muraseauthor=C.+L.+Lantzauthor=E.+Kimauthor=N.+Guptaauthor=R.+Higginsauthor=M.+Stopferauthor=D.+A.+Hoffmanauthor=E.+M.+Quinlan&title=Matrix+Metalloproteinase-9+Regulates+Neuronal+Circuit+Development+and+Excitability&doi=10.1007%2Fs12035-015-9295-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix Metalloproteinase-9 Regulates Neuronal Circuit Development and Excitability</span></div><div class="casAuthors">Murase, Sachiko; Lantz, Crystal L.; Kim, Eunyoung; Gupta, Nitin; Higgins, Richard; Stopfer, Mark; Hoffman, Dax A.; Quinlan, Elizabeth M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3477-3493</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">In early postnatal development, naturally occurring cell death, dendritic outgrowth, and synaptogenesis sculpt neuronal ensembles into functional neuronal circuits.  Here, we demonstrate that deletion of the extracellular proteinase matrix metalloproteinase-9 (MMP-9) affects each of these processes, resulting in maladapted neuronal circuitry.  MMP-9 deletion increases the no. of CA1 pyramidal neurons but decreases dendritic length and complexity.  Parallel changes in neuronal morphol. are obsd. in primary visual cortex and persist into adulthood.  Individual CA1 neurons in MMP-9-/- mice have enhanced input resistance and a significant increase in the frequency, but not amplitude, of miniature excitatory postsynaptic currents (mEPSCs).  Addnl., deletion of MMP-9 significantly increases spontaneous neuronal activity in awake MMP-9-/- mice and enhances response to acute challenge by the excitotoxin kainate.  Our data document a novel role for MMP-9-dependent proteolysis: the regulation of several aspects of circuit maturation to constrain excitability throughout life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMOv1yVS2dd7Vg90H21EOLACvtfcHk0li9bw4nmOza4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKhsrfJ&md5=69ad09d0ece8eb0b1ceaa4f9e093f1c6</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1007%2Fs12035-015-9295-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-015-9295-y%26sid%3Dliteratum%253Aachs%26aulast%3DMurase%26aufirst%3DS.%26aulast%3DLantz%26aufirst%3DC.%2BL.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DGupta%26aufirst%3DN.%26aulast%3DHiggins%26aufirst%3DR.%26aulast%3DStopfer%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DD.%2BA.%26aulast%3DQuinlan%26aufirst%3DE.%2BM.%26atitle%3DMatrix%2520Metalloproteinase-9%2520Regulates%2520Neuronal%2520Circuit%2520Development%2520and%2520Excitability%26jtitle%3DMol.%2520Neurobiol.%26date%3D2016%26volume%3D53%26issue%3D5%26spage%3D3477%26epage%3D3493%26doi%3D10.1007%2Fs12035-015-9295-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conant, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">Myelin Formation during Development of the CNS Is Delayed in Matrix Metalloproteinase-9 and −12 Null Mice</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2207</span>– <span class="NLM_lpage">2214</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1880-05.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.1880-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16495447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFCmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2207-2214&issue=8&author=P.+H.+Larsenauthor=A.+G.+DaSilvaauthor=K.+Conantauthor=V.+W.+Yong&title=Myelin+Formation+during+Development+of+the+CNS+Is+Delayed+in+Matrix+Metalloproteinase-9+and+%E2%88%9212+Null+Mice&doi=10.1523%2FJNEUROSCI.1880-05.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice</span></div><div class="casAuthors">Larsen, Peter H.; DaSilva, Angelika Goncalves; Conant, Katherine; Yong, V. Wee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2207-2214</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We have addressed whether and how matrix metalloproteinases (MMPs) might be required for myelin formation in normal ontogeny.  Using a probe for multiple MMPs and the developing mouse optic nerve, we found 2 members, MMP-9 and -12, to be upregulated during the period of myelin formation.  These MMPs partake in myelinogenesis because myelination in the corpus callosum of MMP-9 and(or) MMP-12 null mice was deficient from postnatal days 7 to 14 compared with that of wild-type mice.  The deficient myelination was correlated with fewer mature oligodendrocytes, but similar precursor cell nos., in MMP null animals compared with wild type.  Because an important growth factor for oligodendrocyte maturation is insulin-like growth factor-1 (IGF-1), we addressed whether this was involved in the deficient myelination in MMP null mice.  Indeed, the addn. of IGF-1 normalized the lack of maturation of oligodendrocytes that occurred in cultures from MMP-12 null mice.  Furthermore, we detd. that IGF binding protein 6 (IGFBP-6), which sequesters IGF-1, was a substrate for MMP processing.  Finally, we found IGFBP-6 levels to remain high in MMP-deficient mice.  These results reveal a novel function for MMP-9 and -12 in developmental myelination likely through regulating IGF-1 bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMnPNy0rTJOrVg90H21EOLACvtfcHk0li9bw4nmOza4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFCmsrY%253D&md5=7cc05c8fa6bf91b6ff7937a9a8ac46a9</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1880-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1880-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DP.%2BH.%26aulast%3DDaSilva%26aufirst%3DA.%2BG.%26aulast%3DConant%26aufirst%3DK.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DMyelin%2520Formation%2520during%2520Development%2520of%2520the%2520CNS%2520Is%2520Delayed%2520in%2520Matrix%2520Metalloproteinase-9%2520and%2520%25E2%2588%259212%2520Null%2520Mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26issue%3D8%26spage%3D2207%26epage%3D2214%26doi%3D10.1523%2FJNEUROSCI.1880-05.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihaljevic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassbender, K.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-12 Contributes to Neuroinflammation in the Aged Brain</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1231</span>– <span class="NLM_lpage">1239</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2012.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.neurobiolaging.2012.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23159549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1231-1239&issue=4&author=Y.+Liuauthor=M.+Zhangauthor=W.+Haoauthor=I.+Mihaljevicauthor=X.+Liuauthor=K.+Xieauthor=S.+Walterauthor=K.+Fassbender&title=Matrix+Metalloproteinase-12+Contributes+to+Neuroinflammation+in+the+Aged+Brain&doi=10.1016%2Fj.neurobiolaging.2012.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain</span></div><div class="casAuthors">Liu, Yang; Zhang, Min; Hao, Wenlin; Mihaljevic, Ivan; Liu, Xu; Xie, Kan; Walter, Silke; Fassbender, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1231-1239</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">During aging the brain displays an increased proinflammatory status, which is assocd. with the pathogenesis of aging-related diseases such as Alzheimer's and Parkinson diseases.  Matrix metalloproteinases (MMPs) facilitate the migration of inflammatory cells in tissues and modulate their inflammatory activity.  In this study, we screened expression of MMPs in 3-, 10-, and 18-mo-old mice and obsd. that cerebral MMP-12 expression was strongly upregulated during aging.  We compared the neuroinflammation of 3-, 10-, and 18-mo-old MMP-12-deficient vs. wild type mice by counting microglia and measuring inflammatory gene transcripts in the brain and obsd. that MMP-12 deficiency reduced neuroinflammation during aging.  In order to identify potential mechanisms, we analyzed the inflammatory activity of microglia directly isolated from adult mouse brains or cultured from newborn mice.  We obsd. that MMP-12 deficiency increased the inflammatory activity of adult brain-derived microglia, but did not affect cultured microglia.  We found greater nos. of CD11b/CD45high cells in the parenchyma of MMP-12 wild type than in the parenchyma of MMP-12-deficient mouse brains.  Thus, our study suggested that the upregulated cerebral MMP-12 during aging enhances aging-assocd. neuroinflammation by facilitating recruitment of bone marrow-derived microglia into the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN5JKQoFbEqrVg90H21EOLACvtfcHk0li9bw4nmOza4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmu7vO&md5=0dc055afbeef9c89a4bdf1401551d675</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DMihaljevic%26aufirst%3DI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DFassbender%26aufirst%3DK.%26atitle%3DMatrix%2520Metalloproteinase-12%2520Contributes%2520to%2520Neuroinflammation%2520in%2520the%2520Aged%2520Brain%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26issue%3D4%26spage%3D1231%26epage%3D1239%26doi%3D10.1016%2Fj.neurobiolaging.2012.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abuelnasr, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, X.</span></span> <span> </span><span class="NLM_article-title">Enhanced Expression of Matrix Metalloproteinase-12 Contributes to Npc1 Deficiency-Induced Axonal Degeneration</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2015.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.expneurol.2015.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25864931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVCiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=2015&pages=67-74&author=G.+Liaoauthor=Z.+Wangauthor=E.+Leeauthor=S.+Morenoauthor=O.+Abuelnasrauthor=M.+Baudryauthor=X.+Bi&title=Enhanced+Expression+of+Matrix+Metalloproteinase-12+Contributes+to+Npc1+Deficiency-Induced+Axonal+Degeneration&doi=10.1016%2Fj.expneurol.2015.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration</span></div><div class="casAuthors">Liao, Guanghong; Wang, Zhuangjun; Lee, Erik; Moreno, Stephanie; Abuelnasr, Omar; Baudry, Michel; Bi, Xiaoning</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67-74</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Niemann-Pick type C (NPC) disease is a genetic disorder assocd. with intracellular cholesterol accumulation in the brain and other organs, and neurodegeneration is generally believed to be the fatal cause of the disease.  In view of the emerging role of matrix metalloproteinase-12 (MMP-12) in neuronal injury, we investigated its expression and potential roles in axonal degeneration in Npc1 -/- mouse brain.  Microarray and quant. real-time reversed transcription PCR anal. indicated a marked increase in MMP-12 mRNA levels in cerebellum of 3 wk-old Npc1 -/- mice, as compared to wild-type littermates.  Western blots showed that the ratio of mature MMP-12 over pro-MMP-12 was significantly increased in cerebellum of Npc1 -/-, as compared to wild-type mice.  Immunohistochem. studies confirmed that MMP-12 expression was increased, esp. in the cell bodies of Purkinje neurons in Npc1 -/- mice.  Neuritic growth was significantly reduced by Npc1 siRNA knockdown in nerve growth factor-differentiated PC-12 cells, and this effect was completely reversed by treatment with an MMP-12 specific inhibitor.  Furthermore, in vivo expts. showed that chronic treatment with the MMP-12 inhibitor ameliorated Npc1 deficiency-induced axonal pathol. in the striatum.  Our results indicate that abnormal neuronal expression of MMP-12 may contribute to axonal degeneration in NPC disease, thus providing a potential novel target for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNAgp5KMVr9LVg90H21EOLACvtfcHk0lifaBAVBXlhng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVCiurY%253D&md5=5789a94020fc44c23c7902c87f65e717</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2015.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2015.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DMoreno%26aufirst%3DS.%26aulast%3DAbuelnasr%26aufirst%3DO.%26aulast%3DBaudry%26aufirst%3DM.%26aulast%3DBi%26aufirst%3DX.%26atitle%3DEnhanced%2520Expression%2520of%2520Matrix%2520Metalloproteinase-12%2520Contributes%2520to%2520Npc1%2520Deficiency-Induced%2520Axonal%2520Degeneration%26jtitle%3DExp.%2520Neurol.%26date%3D2015%26volume%3D269%26spage%3D67%26epage%3D74%26doi%3D10.1016%2Fj.expneurol.2015.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves DaSilva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-12 Deficiency Worsens Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in Association with Cytokine and Chemokine Dysregulation</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>174</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">909</span>, <span class="refDoi"> DOI: 10.2353/ajpath.2009.080952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2353%2Fajpath.2009.080952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19218336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ltFCrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2009&pages=898-909&issue=3&author=A.+Goncalves+DaSilvaauthor=V.+W.+Yong&title=Matrix+Metalloproteinase-12+Deficiency+Worsens+Relapsing-Remitting+Experimental+Autoimmune+Encephalomyelitis+in+Association+with+Cytokine+and+Chemokine+Dysregulation&doi=10.2353%2Fajpath.2009.080952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation</span></div><div class="casAuthors">Goncalves DaSilva Angelika; Yong V Wee</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">898-909</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The elevation of several members of the matrix metalloproteinase (MMP) family promotes the pathophysiology of both multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE).  Nonetheless, given the multiple activities of MMPs, it remains possible that increased levels of a particular MMP may have beneficial functions during disease progression.  We reported previously that MMP-12(-/-) mice of the 129/SvEv strain had a poorer EAE outcome than wild-type controls.  However, we did not determine further differences in disease profiles between these groups.  Using the EAE model in 129/SvEv mice, we report that disease in both wild-type and MMP-12(-/-) mice follows a relapsing-remitting course.  Although both mouse groups had similar clinical onsets, subsequent relapses were more severe in MMP-12(-/-) mice; their residual disability at remission was also higher compared with wild-type controls.  The worsened relapses and remissions in MMP-12(-/-) mice occurred despite a deficiency of the antigen recall capacity of lymph node-derived cells as well as a reduction in the proportion of macrophages in the spinal cord during the chronic phase of EAE.  Significantly, large increases of levels of chemokines and cytokines were found in the spinal cords of MMP-12(-/-) mice during chronic EAE.  These results highlight MMP-12 as a beneficial enzyme in EAE and suggest that therapeutic interventions in multiple sclerosis should avoid targeting MMP-12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNjBFWHwNkMT0SWnHPWbmmfW6udTcc2eaJwjCSzH3t7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ltFCrtw%253D%253D&md5=e1f9fdfe133a0b73b208a52f8d47bb41</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2009.080952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2009.080952%26sid%3Dliteratum%253Aachs%26aulast%3DGoncalves%2BDaSilva%26aufirst%3DA.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DMatrix%2520Metalloproteinase-12%2520Deficiency%2520Worsens%2520Relapsing-Remitting%2520Experimental%2520Autoimmune%2520Encephalomyelitis%2520in%2520Association%2520with%2520Cytokine%2520and%2520Chemokine%2520Dysregulation%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2009%26volume%3D174%26issue%3D3%26spage%3D898%26epage%3D909%26doi%3D10.2353%2Fajpath.2009.080952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves DaSilva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liaw, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">Cleavage of Osteopontin by Matrix Metalloproteinase-12 Modulates Experimental Autoimmune Encephalomyelitis Disease in C57BL/6 Mice</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>177</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1458</span>, <span class="refDoi"> DOI: 10.2353/ajpath.2010.091081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2353%2Fajpath.2010.091081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20651245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC3cjosVehsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2010&pages=1448-1458&issue=3&author=A.+Goncalves+DaSilvaauthor=L.+Liawauthor=V.+W.+Yong&title=Cleavage+of+Osteopontin+by+Matrix+Metalloproteinase-12+Modulates+Experimental+Autoimmune+Encephalomyelitis+Disease+in+C57BL%2F6+Mice&doi=10.2353%2Fajpath.2010.091081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL/6 mice</span></div><div class="casAuthors">Goncalves DaSilva Angelika; Liaw Lucy; Yong V Wee</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1448-58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A role for osteopontin (OPN) in promoting disease activity of multiple sclerosis or its animal model experimental autoimmune encephalomyelitis (EAE) has recently been suggested.  As the biological activity of OPN is heavily influenced by posttranslational processing, we investigated the capacity of matrix metalloproteinase (MMP)-12 to cleave OPN and determined whether this influenced disease activity.  We found that OPN mRNA and protein expression in the spinal cord increased with EAE disease in C57BL/6 mice concurrently with MMP-12 expression.  A Western blot of EAE and control spinal cords revealed different OPN-immunoreactive bands, with a pattern that was similar to MMP-12 cleavage of recombinant OPN in vitro.  In addition, OPN fragments in the spinal cord of EAE-afflicted mice were reduced in MMP-12(-/-) mice compared with wild-type controls.  However, examination of OPN(-/-) mice in short- and long-term experiments revealed no difference in EAE outcomes from wild-type animals.  OPN/MMP-12 double null mice were generated, and it was revealed that MMP-12(-/-) mice had a worsening of disease compared with wild-type mice, which returned to wild-type levels in the OPN/MMP-12 double null mice.  These results suggest that EAE disease activity may be modulated by the cleavage of OPN by MMP-12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6YcDfkJ4bbKe0F5ixvZgXfW6udTcc2eaJwjCSzH3t7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjosVehsQ%253D%253D&md5=603ea936e089019b3bf33abf2239f7fb</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.091081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.091081%26sid%3Dliteratum%253Aachs%26aulast%3DGoncalves%2BDaSilva%26aufirst%3DA.%26aulast%3DLiaw%26aufirst%3DL.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DCleavage%2520of%2520Osteopontin%2520by%2520Matrix%2520Metalloproteinase-12%2520Modulates%2520Experimental%2520Autoimmune%2520Encephalomyelitis%2520Disease%2520in%2520C57BL%252F6%2520Mice%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D177%26issue%3D3%26spage%3D1448%26epage%3D1458%26doi%3D10.2353%2Fajpath.2010.091081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellac, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhard, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappelhoff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortelny, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jobin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozmus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlidis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">C-Terminal Truncation of IFN-γ Inhibits Proinflammatory Macrophage Responses and Is Deficient in Autoimmune Disease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-04717-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fs41467-018-04717-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29317637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1yktLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1-18&issue=1&author=A.+Dufourauthor=C.+L.+Bellacauthor=U.+Eckhardauthor=N.+Solisauthor=T.+Kleinauthor=R.+Kappelhoffauthor=N.+Fortelnyauthor=P.+Jobinauthor=J.+Rozmusauthor=J.+Markauthor=P.+Pavlidisauthor=V.+Diveauthor=S.+J.+Barbourauthor=C.+M.+Overall&title=C-Terminal+Truncation+of+IFN-%CE%B3+Inhibits+Proinflammatory+Macrophage+Responses+and+Is+Deficient+in+Autoimmune+Disease&doi=10.1038%2Fs41467-018-04717-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Retraction Note: Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer</span></div><div class="casAuthors">Alioui, Anthony; Dufour, Julie; Leoni, Valerio; Loregger, Anke; Moeton, Martina; Iuliano, Luigi; Zerbinati, Chiara; Septier, Amandine; Val, Pierre; Fouache, Allan; Russo, Vincenzo; Volle, David H.; Lobaccaro, Jean-Marc A.; Zelcer, Noam; Baron, Silvere</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">This paper has been retracted at the request of the authors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru9R05NWL_C7Vg90H21EOLACvtfcHk0lg6IdNSCnIyCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1yktLnP&md5=70f02b3fb4ba2e676f03508740e6bec6</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-04717-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-04717-4%26sid%3Dliteratum%253Aachs%26aulast%3DDufour%26aufirst%3DA.%26aulast%3DBellac%26aufirst%3DC.%2BL.%26aulast%3DEckhard%26aufirst%3DU.%26aulast%3DSolis%26aufirst%3DN.%26aulast%3DKlein%26aufirst%3DT.%26aulast%3DKappelhoff%26aufirst%3DR.%26aulast%3DFortelny%26aufirst%3DN.%26aulast%3DJobin%26aufirst%3DP.%26aulast%3DRozmus%26aufirst%3DJ.%26aulast%3DMark%26aufirst%3DJ.%26aulast%3DPavlidis%26aufirst%3DP.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DBarbour%26aufirst%3DS.%2BJ.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DC-Terminal%2520Truncation%2520of%2520IFN-%25CE%25B3%2520Inhibits%2520Proinflammatory%2520Macrophage%2520Responses%2520and%2520Is%2520Deficient%2520in%2520Autoimmune%2520Disease%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D1%26epage%3D18%26doi%3D10.1038%2Fs41467-018-04717-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bellac, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krisinger, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loonchanta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">auf dem Keller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebeler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappelhoff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burtnick, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">Macrophage Matrix Metalloproteinase-12 Dampens Inflammation and Neutrophil Influx in Arthritis</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.celrep.2014.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25310974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslels7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=618-632&issue=2&author=C.+L.+Bellacauthor=A.+Dufourauthor=M.+J.+Krisingerauthor=A.+Loonchantaauthor=A.+E.+Starrauthor=U.+auf+dem+Kellerauthor=P.+F.+Langeauthor=V.+Goebelerauthor=R.+Kappelhoffauthor=G.+S.+Butlerauthor=L.+D.+Burtnickauthor=E.+M.+Conwayauthor=C.+R.+Robertsauthor=C.+M.+Overall&title=Macrophage+Matrix+Metalloproteinase-12+Dampens+Inflammation+and+Neutrophil+Influx+in+Arthritis&doi=10.1016%2Fj.celrep.2014.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage Matrix Metalloproteinase-12 Dampens Inflammation and Neutrophil Influx in Arthritis</span></div><div class="casAuthors">Bellac, Caroline L.; Dufour, Antoine; Krisinger, Michael J.; Loonchanta, Anantasak; Starr, Amanda E.; auf dem Keller, Ulrich; Lange, Philipp F.; Goebeler, Verena; Kappelhoff, Reinhild; Butler, Georgina S.; Burtnick, Leslie D.; Conway, Edward M.; Roberts, Clive R.; Overall, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">618-632</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Resoln. of inflammation reduces pathol. tissue destruction and restores tissue homeostasis.  Here, we used a proteomic protease substrate discovery approach, terminal amine isotopic labeling of substrates (TAILS), to analyze the role of the macrophage-specific matrix metalloproteinase-12 (MMP12) in inflammation.  In murine peritonitis, MMP12 inactivates antithrombin and activates prothrombin, prolonging the activated partial thromboplastin time.  Furthermore, MMP12 inactivates complement C3 to reduce complement activation and inactivates the chemoattractant anaphylatoxins C3a and C5a, whereas iC3b and C3b opsonin cleavage increases phagocytosis.  Loss of these anti-inflammatory activities in collagen-induced arthritis in Mmp12-/- mice leads to unresolved synovitis and extensive articular inflammation.  Deep articular cartilage loss is assocd. with massive neutrophil infiltration and abnormal DNA neutrophil extracellular traps (NETs).  The NETs are rich in fibrin and extracellular actin, which TAILS identified as MMP12 substrates.  Thus, macrophage MMP12 in arthritis has multiple protective roles in countering neutrophil infiltration, clearing NETs, and dampening inflammatory pathways to prep. for the resoln. of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTQQA25RbqxrVg90H21EOLACvtfcHk0lg6IdNSCnIyCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslels7vO&md5=922ca3be888f3521dbc73c94fe86b333</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DBellac%26aufirst%3DC.%2BL.%26aulast%3DDufour%26aufirst%3DA.%26aulast%3DKrisinger%26aufirst%3DM.%2BJ.%26aulast%3DLoonchanta%26aufirst%3DA.%26aulast%3DStarr%26aufirst%3DA.%2BE.%26aulast%3Dauf%2Bdem%2BKeller%26aufirst%3DU.%26aulast%3DLange%26aufirst%3DP.%2BF.%26aulast%3DGoebeler%26aufirst%3DV.%26aulast%3DKappelhoff%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DG.%2BS.%26aulast%3DBurtnick%26aufirst%3DL.%2BD.%26aulast%3DConway%26aufirst%3DE.%2BM.%26aulast%3DRoberts%26aufirst%3DC.%2BR.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DMacrophage%2520Matrix%2520Metalloproteinase-12%2520Dampens%2520Inflammation%2520and%2520Neutrophil%2520Influx%2520in%2520Arthritis%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3D618%26epage%3D632%26doi%3D10.1016%2Fj.celrep.2014.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartzell, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomis-Rüth, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, S. D.</span></span> <span> </span><span class="NLM_article-title">Macrophage Elastase Kills Bacteria within Murine Macrophages</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>460</i></span> (<span class="NLM_issue">7255</span>),  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1038/nature08181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnature08181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19536155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVagsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2009&pages=637-641&issue=7255&author=A.+M.+Houghtonauthor=W.+O.+Hartzellauthor=C.+S.+Robbinsauthor=F.+X.+Gomis-R%C3%BCthauthor=S.+D.+Shapiro&title=Macrophage+Elastase+Kills+Bacteria+within+Murine+Macrophages&doi=10.1038%2Fnature08181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage elastase kills bacteria within murine macrophages</span></div><div class="casAuthors">Houghton, A. McGarry; Hartzell, William O.; Robbins, Clinton S.; Gomis-Rueth, F. Xavier; Shapiro, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">460</span>
        (<span class="NLM_cas:issue">7255</span>),
    <span class="NLM_cas:pages">637-641</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macrophages are aptly positioned to function as the primary line of defense against invading pathogens in many organs, including the lung and peritoneum.  Their ability to phagocytose and clear microorganisms has been well documented.  Macrophages possess several substances with which they can kill bacteria, including reactive oxygen species, nitric oxide, and antimicrobial proteins.  The authors proposed that macrophage-derived proteinases may contribute to the antimicrobial properties of macrophages.  Macrophage elastase (also known as matrix metalloproteinase 12 or MMP12) is an enzyme predominantly expressed in mature tissue macrophages and is implicated in several disease processes, including emphysema.  Physiol. functions for MMP12 have not been described.  Here the authors show that Mmp12-/- mice exhibit impaired bacterial clearance and increased mortality when challenged with both Gram-neg. and Gram-pos. bacteria at macrophage-rich portals of entry, such as the peritoneum and lung.  Intracellular stores of MMP12 are mobilized to macrophage phagolysosomes after the ingestion of bacterial pathogens.  Once inside phagolysosomes, MMP12 adheres to bacterial cell walls where it disrupts cellular membranes resulting in bacterial death.  The antimicrobial properties of MMP12 do not reside within its catalytic domain, but rather within the C-terminal domain.  This domain contains a unique four amino acid sequence on an exposed β loop of the protein that is required for the obsd. antimicrobial activity.  The present study represents, to the authors' knowledge, the first report of direct antimicrobial activity by a matrix metallopeptidase, and describes a new antimicrobial peptide that is sequentially and structurally unique in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUaQpS82xsLrVg90H21EOLACvtfcHk0lg6IdNSCnIyCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVagsb8%253D&md5=68da572af1af203d98a198a19bf38d47</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnature08181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08181%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DA.%2BM.%26aulast%3DHartzell%26aufirst%3DW.%2BO.%26aulast%3DRobbins%26aufirst%3DC.%2BS.%26aulast%3DGomis-R%25C3%25BCth%26aufirst%3DF.%2BX.%26aulast%3DShapiro%26aufirst%3DS.%2BD.%26atitle%3DMacrophage%2520Elastase%2520Kills%2520Bacteria%2520within%2520Murine%2520Macrophages%26jtitle%3DNature%26date%3D2009%26volume%3D460%26issue%3D7255%26spage%3D637%26epage%3D641%26doi%3D10.1038%2Fnature08181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchant, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellac, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadsworth, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilawchuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendry, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilbron, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucyk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegele, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granville, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManus, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">A New Transcriptional Role for Matrix Metalloproteinase-12 in Antiviral Immunity</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.1038/nm.3508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnm.3508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24784232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlehs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=493-502&issue=5&author=D.+J.+Marchantauthor=C.+L.+Bellacauthor=T.+J.+Moraesauthor=S.+J.+Wadsworthauthor=A.+Dufourauthor=G.+S.+Butlerauthor=L.+M.+Bilawchukauthor=R.+G.+Hendryauthor=A.+G.+Robertsonauthor=C.+T.+Cheungauthor=J.+Ngauthor=L.+Angauthor=Z.+Luoauthor=K.+Heilbronauthor=M.+J.+Norrisauthor=W.+Duanauthor=T.+Bucykauthor=A.+Karpovauthor=L.+Develauthor=D.+Georgiadisauthor=R.+G.+Hegeleauthor=H.+Luoauthor=D.+J.+Granvilleauthor=V.+Diveauthor=B.+M.+McManusauthor=C.+M.+Overall&title=A+New+Transcriptional+Role+for+Matrix+Metalloproteinase-12+in+Antiviral+Immunity&doi=10.1038%2Fnm.3508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity</span></div><div class="casAuthors">Marchant, David J.; Bellac, Caroline L.; Moraes, Theo J.; Wadsworth, Samuel J.; Dufour, Antoine; Butler, Georgina S.; Bilawchuk, Leanne M.; Hendry, Reid G.; Robertson, A. Gordon; Cheung, Caroline T.; Ng, Julie; Ang, Lisa; Luo, Zongshu; Heilbron, Karl; Norris, Michael J.; Duan, Wenming; Bucyk, Taylor; Karpov, Andrei; Devel, Laurent; Georgiadis, Dimitris; Hegele, Richard G.; Luo, Honglin; Granville, David J.; Dive, Vincent; McManus, Bruce M.; Overall, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">493-502</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interferon-α (IFN-α) is essential for antiviral immunity, but in the absence of matrix metalloproteinase-12 (MMP-12) or IκBα (encoded by NFKBIA) we show that IFN-α is retained in the cytosol of virus-infected cells and is not secreted.  Our findings suggest that activated IκBα mediates the export of IFN-α from virus-infected cells and that the inability of cells in Mmp12-/- but not wild-type mice to express IκBα and thus export IFN-α makes coxsackievirus type B3 infection lethal and renders respiratory syncytial virus more pathogenic.  We show here that after macrophage secretion, MMP-12 is transported into virus-infected cells.  In HeLa cells MMP-12 is also translocated to the nucleus, where it binds to the NFKBIA promoter, driving transcription.  We also identified dual-regulated substrates that are repressed both by MMP-12 binding to the substrate's gene exons and by MMP-12-mediated cleavage of the substrate protein itself.  Whereas intracellular MMP-12 mediates NFKBIA transcription, leading to IFN-α secretion and host protection, extracellular MMP-12 cleaves off the IFN-α receptor 2 binding site of systemic IFN-α, preventing an unchecked immune response.  Consistent with an unexpected role for MMP-12 in clearing systemic IFN-α, treatment of coxsackievirus type B3-infected wild-type mice with a membrane-impermeable MMP-12 inhibitor elevates systemic IFN-α levels and reduces viral replication in pancreas while sparing intracellular MMP-12.  These findings suggest that inhibiting extracellular MMP-12 could be a new avenue for the development of antiviral treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOHUFHv6-8LVg90H21EOLACvtfcHk0lhQWPjEfJorRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlehs74%253D&md5=b82d045a6d78984630317c056f831baf</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2Fnm.3508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3508%26sid%3Dliteratum%253Aachs%26aulast%3DMarchant%26aufirst%3DD.%2BJ.%26aulast%3DBellac%26aufirst%3DC.%2BL.%26aulast%3DMoraes%26aufirst%3DT.%2BJ.%26aulast%3DWadsworth%26aufirst%3DS.%2BJ.%26aulast%3DDufour%26aufirst%3DA.%26aulast%3DButler%26aufirst%3DG.%2BS.%26aulast%3DBilawchuk%26aufirst%3DL.%2BM.%26aulast%3DHendry%26aufirst%3DR.%2BG.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DCheung%26aufirst%3DC.%2BT.%26aulast%3DNg%26aufirst%3DJ.%26aulast%3DAng%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DHeilbron%26aufirst%3DK.%26aulast%3DNorris%26aufirst%3DM.%2BJ.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DBucyk%26aufirst%3DT.%26aulast%3DKarpov%26aufirst%3DA.%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DHegele%26aufirst%3DR.%2BG.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DGranville%26aufirst%3DD.%2BJ.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DMcManus%26aufirst%3DB.%2BM.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DA%2520New%2520Transcriptional%2520Role%2520for%2520Matrix%2520Metalloproteinase-12%2520in%2520Antiviral%2520Immunity%26jtitle%3DNat.%2520Med.%26date%3D2014%26volume%3D20%26issue%3D5%26spage%3D493%26epage%3D502%26doi%3D10.1038%2Fnm.3508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisolano, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hautamaki, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehring, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, S. D.</span></span> <span> </span><span class="NLM_article-title">Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung Metastases</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">6149</span>– <span class="NLM_lpage">6155</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-0297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1158%2F0008-5472.CAN-04-0297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16778188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVSksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=6149-6155&issue=12&author=A.+M.+Houghtonauthor=J.+L.+Grisolanoauthor=M.+L.+Baumannauthor=D.+K.+Kobayashiauthor=R.+D.+Hautamakiauthor=L.+C.+Nehringauthor=L.+A.+Corneliusauthor=S.+D.+Shapiro&title=Macrophage+Elastase+%28Matrix+Metalloproteinase-12%29+Suppresses+Growth+of+Lung+Metastases&doi=10.1158%2F0008-5472.CAN-04-0297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung Metastases</span></div><div class="casAuthors">Houghton, A. McGarry; Grisolano, Jay L.; Baumann, Mary L.; Kobayashi, Dale K.; Hautamaki, R. Dean; Nehring, Leslie C.; Cornelius, Lynn A.; Shapiro, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6149-6155</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMP) have been implicated in virtually all aspects of tumor progression.  However, the recent failure of clin. trials employing synthetic MMP inhibitors in cancer chemotherapy has led us to hypothesize that some MMPs may actually serve the host in its defense against tumor progression.  Here we show that mice deficient in macrophage elastase (MMP-12) develop significantly more gross Lewis lung carcinoma pulmonary metastases than their wild-type counterparts both in spontaneous and exptl. metastasis models.  The nos. of micrometastases between the two groups are equiv.; thus, it seems that MMP-12 affects lung tumor growth, and not metastasis formation, per se.  MMP-12 is solely macrophage derived in this model, being expressed by tumor-assocd. macrophages and not by tumor or stromal cells.  The presence of MMP-12 is assocd. with decreased tumor-assocd. microvessel d. in vivo and generates an angiostatic>angiogenic tumor microenvironment that retards lung tumor growth independent of the prodn. of angiostatin.  These data define a role for MMP-12 in suppressing the growth of lung metastases and suggest that inhibitors designed to specifically target tumor-promoting MMPs may yet prove effective as cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCb9UBIxa567Vg90H21EOLACvtfcHk0lhQWPjEfJorRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVSksbw%253D&md5=bbbb7ec77f619e1964406698afdb7972</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-0297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-0297%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DA.%2BM.%26aulast%3DGrisolano%26aufirst%3DJ.%2BL.%26aulast%3DBaumann%26aufirst%3DM.%2BL.%26aulast%3DKobayashi%26aufirst%3DD.%2BK.%26aulast%3DHautamaki%26aufirst%3DR.%2BD.%26aulast%3DNehring%26aufirst%3DL.%2BC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%26aulast%3DShapiro%26aufirst%3DS.%2BD.%26atitle%3DMacrophage%2520Elastase%2520%2528Matrix%2520Metalloproteinase-12%2529%2520Suppresses%2520Growth%2520of%2520Lung%2520Metastases%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D12%26spage%3D6149%26epage%3D6155%26doi%3D10.1158%2F0008-5472.CAN-04-0297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dandachi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radder, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leme, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, S. D.</span></span> <span> </span><span class="NLM_article-title">Macrophage Elastase Induces TRAIL-Mediated Tumor Cell Death through Its Carboxy-Terminal Domain</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>196</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1164/rccm.201606-1150OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1164%2Frccm.201606-1150OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28345958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVShsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2017&pages=353-363&issue=3&author=N.+Dandachiauthor=N.+J.+Kellyauthor=J.+P.+Woodauthor=C.+L.+Burtonauthor=J.+E.+Radderauthor=A.+S.+Lemeauthor=A.+D.+Gregoryauthor=S.+D.+Shapiro&title=Macrophage+Elastase+Induces+TRAIL-Mediated+Tumor+Cell+Death+through+Its+Carboxy-Terminal+Domain&doi=10.1164%2Frccm.201606-1150OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage elastase induces TRAIL-mediated tumor cell death through its carboxy-terminal domain</span></div><div class="casAuthors">Dandachi, Nadine; Kelly, Neil J.; Wood, John P.; Burton, Christine L.; Radder, Josiah E.; Leme, Adriana S.; Gregory, Alyssa D.; Shapiro, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-363</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Macrophage elastase (matrix metalloproteinase [MMP]-12) is a potent protease that contributes to the lung destruction that accompanies cigarette smoking; it simultaneously inhibits lung tumor angiogenesis and metastasis by catalyzing the formation of antiangiogenic peptides.  Recent studies have revealed novel nonproteolytic functions of MMP12, including antimicrobial activity through a peptide within its C-terminal domain (CTD).  Objectives: To det. whether the MMP12 CTD contributes to its antitumor activity in lung cancer.  Methods: We used recombinant MMP12 peptide fragments, including its catalytic domain, CTD, and a 20 amino acid peptide within the CTD (SR20), in an in vitro system to delineate their effects on non-small cell lung cancer cell proliferation and apoptosis.  We translated our findings to two murine models of lung cancer, including orthotopic human xenograft and KrasLSL/G12D mouse models of lung cancer.  Measurements and Main Results: We show that SR20 triggers tumor apoptosis by up-regulation of gene expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptor, death receptor 4, sensitizing cells to an autocrine loop of TRAIL-mediated cell death.  We then demonstrate the therapeutic efficacy of SR20 against two murine models of lung cancer.  Conclusions: The MMP12 CTD initiates TRAIL-mediated tumor cell death through its conserved SR20 peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKg71B_S41HbVg90H21EOLACvtfcHk0lgdlyGcIs8ASQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVShsr3J&md5=aa97658cc776c75bd36cf423dc5fbb02</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1164%2Frccm.201606-1150OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201606-1150OC%26sid%3Dliteratum%253Aachs%26aulast%3DDandachi%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DN.%2BJ.%26aulast%3DWood%26aufirst%3DJ.%2BP.%26aulast%3DBurton%26aufirst%3DC.%2BL.%26aulast%3DRadder%26aufirst%3DJ.%2BE.%26aulast%3DLeme%26aufirst%3DA.%2BS.%26aulast%3DGregory%26aufirst%3DA.%2BD.%26aulast%3DShapiro%26aufirst%3DS.%2BD.%26atitle%3DMacrophage%2520Elastase%2520Induces%2520TRAIL-Mediated%2520Tumor%2520Cell%2520Death%2520through%2520Its%2520Carboxy-Terminal%2520Domain%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2017%26volume%3D196%26issue%3D3%26spage%3D353%26epage%3D363%26doi%3D10.1164%2Frccm.201606-1150OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-San
Segundo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barceló, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morancho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel-Salazar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giralt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosell, A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-13 Participates in Neuroprotection and Neurorepair after Cerebral Ischemia in Mice</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2016.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.nbd.2016.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27001146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2hurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2016&pages=236-246&author=F.+Maauthor=P.+Mart%C3%ADnez-San%0ASegundoauthor=V.+Barcel%C3%B3author=A.+Moranchoauthor=M.+Gabriel-Salazarauthor=D.+Giraltauthor=J.+Montanerauthor=A.+Rosell&title=Matrix+Metalloproteinase-13+Participates+in+Neuroprotection+and+Neurorepair+after+Cerebral+Ischemia+in+Mice&doi=10.1016%2Fj.nbd.2016.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-13 participates in neuroprotection and neurorepair after cerebral ischemia in mice</span></div><div class="casAuthors">Ma, Feifei; Martinez-San Segundo, Pablo; Barcelo, Veronica; Morancho, Anna; Gabriel-Salazar, Marina; Giralt, Dolors; Montaner, Joan; Rosell, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">236-246</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">New neuroreparative and neuroprotective therapies are being sought to treat stroke patients.  One approach is the remodeling of extracellular matrix, which participates in both brain injury and neurovascular repair when matrix metalloproteinases (MMPs) are thought to be key players.  Our aim was to investigate the role of MMP-13 (collagenase-3) in the acute (24 h and 3 days) and delayed (2 wk) phases of stroke.  Permanent and transient cerebral ischemia models involving the cortex were induced in MMP-13 knock-out (KO) and wild-type (WT) mice.  In the transient model, MMP-13 deficiency reduced the amt. of TTC-stained infarct tissue, reduced hemorrhagic events and improved functional outcomes (p < 0.01).  At two weeks, normal neuroblast (DCX +) migration from the subventricular zone toward the peri-infarct area was obsd.  However, MMP-13 deficiency significantly reduced the no. of newborn neuroblasts (DCX +/BrdU +) in the cortical peri-infarct area (p < 0.01).  This result occurred in parallel with aberrant cortical vascular remodeling: post-stroke peri-infarct vessel d. increased in the WT mice (p < 0.01) but this increase was blocked in the MMP-13 KO mice.  Prior to these vascular alterations, the levels of pro-angiogenic factors, including G-CSF, VEGF-A and angiopoietin-2, were lower in the ischemic cortex of MMP-13 KO mice than in WT mice (p < 0.05).  In vitro, gene-silencing of MMP-13 in endothelial progenitor cells (EPCs) confirmed the reduced ability of these cells to build tubulogenic networks in Matrigel substrate.  Together, our results indicate that MMP-13 is a central protease in infarct development and cortical remodeling during post-stroke neurorepair, which is crit. for optimal angiogenic and neurogenic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPU64FYnDIP7Vg90H21EOLACvtfcHk0lgdlyGcIs8ASQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2hurY%253D&md5=1d825d5e2dc04a469e6b7f7c33d9d373</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2016.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2016.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DF.%26aulast%3DMart%25C3%25ADnez-San%2BSegundo%26aufirst%3DP.%26aulast%3DBarcel%25C3%25B3%26aufirst%3DV.%26aulast%3DMorancho%26aufirst%3DA.%26aulast%3DGabriel-Salazar%26aufirst%3DM.%26aulast%3DGiralt%26aufirst%3DD.%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DRosell%26aufirst%3DA.%26atitle%3DMatrix%2520Metalloproteinase-13%2520Participates%2520in%2520Neuroprotection%2520and%2520Neurorepair%2520after%2520Cerebral%2520Ischemia%2520in%2520Mice%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2016%26volume%3D91%26spage%3D236%26epage%3D246%26doi%3D10.1016%2Fj.nbd.2016.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span> <span> </span><span class="NLM_article-title">Cleavage of Amyloid-β Precursor Protein (APP) by Membrane-Type Matrix Metalloproteinases</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>139</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1093/jb/mvj054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1093%2Fjb%2Fmvj054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16567416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslOnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2006&pages=517-526&issue=3&author=M.+Ahmadauthor=T.+Takinoauthor=H.+Miyamoriauthor=T.+Yoshizakiauthor=M.+Furukawaauthor=H.+Sato&title=Cleavage+of+Amyloid-%CE%B2+Precursor+Protein+%28APP%29+by+Membrane-Type+Matrix+Metalloproteinases&doi=10.1093%2Fjb%2Fmvj054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavage of amyloid-β precursor protein (APP) by membrane-type matrix metalloproteinases</span></div><div class="casAuthors">Ahmad, Munirah; Takino, Takahisa; Miyamori, Hisashi; Yoshizaki, Tomokazu; Furukawa, Mitsuru; Sato, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-526</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Amyloid-β precursor protein (APP) was identified on expression cloning from a human placenta cDNA library as a gene product that modulates the activity of membrane-type matrix metalloproteinase-1 (MT1-MMP).  Co-expression of MT1-MMP with APP in HEK293T cells induced cleavage and shedding of the APP ectodomain when co-expressed with APP adaptor protein Fe65.  Among the MT-MMPs tested, MT3-MMP and MT5-MMP also caused efficient APP shedding.  The recombinant APP protein was cleaved by MT3-MMP in vitro at the A463-M464, N579-M580, H622-S623, and H685-Q686 peptide bonds, which included a cleavage site within the amyloid β peptide region known to produce a C-terminal fragment.  The Swedish-type mutant of APP, which produces a high level of amyloid β peptide, was more effectively cleaved by MT3-MMP than wild-type APP in both the presence and absence of Fe65; however, amyloid β peptide prodn. was not affected by MT3-MMP expression.  Expression of MT3-MMP enhanced Fe65-dependent transactivation by APP fused to the Gal4 DNA-binding and transactivation domains.  These results suggest that MT1-MMP, MT3-MMP and MT5-MMP should play an important role in the regulation of APP functions in tissues including the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom9ouPbCR5FbVg90H21EOLACvtfcHk0lgdlyGcIs8ASQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslOnsrw%253D&md5=382d919de1ddb44cdd5b8377af15bffa</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvj054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvj054%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DM.%26aulast%3DTakino%26aufirst%3DT.%26aulast%3DMiyamori%26aufirst%3DH.%26aulast%3DYoshizaki%26aufirst%3DT.%26aulast%3DFurukawa%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DH.%26atitle%3DCleavage%2520of%2520Amyloid-%25CE%25B2%2520Precursor%2520Protein%2520%2528APP%2529%2520by%2520Membrane-Type%2520Matrix%2520Metalloproteinases%26jtitle%3DJ.%2520Biochem.%26date%3D2006%26volume%3D139%26issue%3D3%26spage%3D517%26epage%3D526%26doi%3D10.1093%2Fjb%2Fmvj054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulasov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvaiya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobbs, C.</span></span> <span> </span><span class="NLM_article-title">The Emerging Role of MMP14 in Brain Tumorigenesis and Future Therapeutics</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1846</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2014.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbcan.2014.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OqsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1846&publication_year=2014&pages=113-120&issue=1&author=I.+Ulasovauthor=R.+Yiauthor=D.+Guoauthor=P.+Sarvaiyaauthor=C.+Cobbs&title=The+Emerging+Role+of+MMP14+in+Brain+Tumorigenesis+and+Future+Therapeutics&doi=10.1016%2Fj.bbcan.2014.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of MMP14 in brain tumorigenesis and future therapeutics</span></div><div class="casAuthors">Ulasov, Ilya; Yi, Ruiyang; Guo, Donna; Sarvaiya, Purvaba; Cobbs, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1846</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-120</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glioblastoma is a malignant brain tumor of glial origin.  These tumors are thought to be derived from astrocytic cells that undergo malignant transformation.  A growing body of evidence suggests that upregulation of MMP expression plays a significant role in promoting glioma pathogenesis.  Elevated expression of MMP14 not only promotes glioma invasion and tumor cell proliferation but also plays a role in angiogenesis.  Despite the fact that levels of MMP14 correlate with breast cancer progression, the controversial role of MMP14 in gliomagenesis needs to be elucidated.  In the present review, we discuss the role of MMP14 in glioma progression as well as the mechanisms of MMP14 regulation in the context of future therapeutic manipulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkjVoQGDlhkLVg90H21EOLACvtfcHk0lgdlyGcIs8ASQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OqsrzJ&md5=b6301880ace58fef3c8ff2cdb0eb9b23</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2014.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2014.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DUlasov%26aufirst%3DI.%26aulast%3DYi%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DSarvaiya%26aufirst%3DP.%26aulast%3DCobbs%26aufirst%3DC.%26atitle%3DThe%2520Emerging%2520Role%2520of%2520MMP14%2520in%2520Brain%2520Tumorigenesis%2520and%2520Future%2520Therapeutics%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2014%26volume%3D1846%26issue%3D1%26spage%3D113%26epage%3D120%26doi%3D10.1016%2Fj.bbcan.2014.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span> <span> </span><span class="NLM_article-title">Integrated Functions of Membrane-Type 1 Matrix Metalloproteinase in Regulating Cancer Malignancy: Beyond a Proteinase</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1095</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.1111/cas.13231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fcas.13231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28267240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2017&pages=1095-1100&issue=6&author=T.+Sakamotoauthor=M.+Seiki&title=Integrated+Functions+of+Membrane-Type+1+Matrix+Metalloproteinase+in+Regulating+Cancer+Malignancy%3A+Beyond+a+Proteinase&doi=10.1111%2Fcas.13231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated functions of membrane-type 1 matrix metalloproteinase in regulating cancer malignancy: Beyond a proteinase</span></div><div class="casAuthors">Sakamoto, Takeharu; Seiki, Motoharu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1095-1100</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Membrane-type 1 matrix metalloproteinase (MT1-MMP) is expressed in different types of invasive and proliferative cells, including cancer cells and stromal cells.  MT1-MMP cleaves extracellular matrix proteins, membrane proteins and other pericellular proteins, thereby changing the cellular microenvironment and regulating signal activation.  Crit. roles of protease activity in cancer cell proliferation, invasion and metastasis have been demonstrated by many groups.  MT1-MMP also has a non-protease activity in that it inhibits the oxygen-dependent suppression of hypoxia-inducible factors (HIFs) via Munc18-1-interacting protein 3 (Mint3) and thereby enhances the expression of HIF target genes.  Elevated HIF activity in MT1-MMP-expressing cancer cells is a fundamental mechanism underlying the Warburg effect, a well-known phenomenon where malignant cancer cells exhibit a higher rate of glucose metab.  Because specific intervention of HIF activation by MT1-MMP suppresses tumor formation by cancer cells in mice, both the proteolytic and non-proteolytic activities of MT1-MMP are important for tumor malignancy and function in an integrated manner.  In this review, we summarize recent findings relating to how MT1-MMP activates HIF and its effects on cancer cells and stromal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5zrhUXJIhbVg90H21EOLACvtfcHk0lgs1BIRjhxx8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKnsLw%253D&md5=4efe8f5596e333f13bff1c098cd3dc4e</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1111%2Fcas.13231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13231%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DT.%26aulast%3DSeiki%26aufirst%3DM.%26atitle%3DIntegrated%2520Functions%2520of%2520Membrane-Type%25201%2520Matrix%2520Metalloproteinase%2520in%2520Regulating%2520Cancer%2520Malignancy%253A%2520Beyond%2520a%2520Proteinase%26jtitle%3DCancer%2520Sci.%26date%3D2017%26volume%3D108%26issue%3D6%26spage%3D1095%26epage%3D1100%26doi%3D10.1111%2Fcas.13231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talmi-Frank, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altboum, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomonov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaitin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepfish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuravlev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keren-Shaul, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gat-Viks, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelboim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziv, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amit, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2016.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.chom.2016.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27736644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Wntr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=458-470&issue=4&author=D.+Talmi-Frankauthor=Z.+Altboumauthor=I.+Solomonovauthor=Y.+Udiauthor=D.+A.+Jaitinauthor=M.+Klepfishauthor=E.+Davidauthor=A.+Zhuravlevauthor=H.+Keren-Shaulauthor=D.+R.+Winterauthor=I.+Gat-Viksauthor=M.+Mandelboimauthor=T.+Zivauthor=I.+Amitauthor=I.+Sagi&title=Extracellular+Matrix+Proteolysis+by+MT1-MMP+Contributes+to+Influenza-Related+Tissue+Damage+and+Mortality&doi=10.1016%2Fj.chom.2016.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality</span></div><div class="casAuthors">Talmi-Frank, Dalit; Altboum, Zeev; Solomonov, Inna; Udi, Yael; Jaitin, Diego Adhemar; Klepfish, Mordehay; David, Eyal; Zhuravlev, Alina; Keren-Shaul, Hadas; Winter, Deborah R.; Gat-Viks, Irit; Mandelboim, Michal; Ziv, Tamar; Amit, Ido; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-470</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mounting an effective immune response, while also protecting tissue integrity, is crit. for host survival.  We used a combined genomic and proteomic approach to investigate the role of extracellular matrix (ECM) proteolysis in achieving this balance in the lung during influenza virus infection.  We identified the membrane-tethered matrix metalloprotease MT1-MMP as a prominent host-ECM-remodeling collagenase in influenza infection.  Selective inhibition of MT1-MMP protected the tissue from infection-related structural and compositional tissue damage.  MT1-MMP inhibition did not significantly alter the immune response or cytokine expression.  The available flu therapeutic Oseltamivir did not prevent lung ECM damage and was less effective than anti-MT1-MMP in influenza virus Streptococcus pneumoniae coinfection paradigms.  Combination therapy of Oseltamivir with anti-MT1-MMP showed a strong synergistic effect and resulted in complete recovery of infected mice.  This study highlights the importance of tissue resilience in surviving infection and the potential of such host-pathogen therapy combinations for respiratory infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8wWOP13TwlLVg90H21EOLACvtfcHk0lgs1BIRjhxx8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Wntr7F&md5=4fb9e04a619ea4175a3ae478b5c8c63d</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2016.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2016.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DTalmi-Frank%26aufirst%3DD.%26aulast%3DAltboum%26aufirst%3DZ.%26aulast%3DSolomonov%26aufirst%3DI.%26aulast%3DUdi%26aufirst%3DY.%26aulast%3DJaitin%26aufirst%3DD.%2BA.%26aulast%3DKlepfish%26aufirst%3DM.%26aulast%3DDavid%26aufirst%3DE.%26aulast%3DZhuravlev%26aufirst%3DA.%26aulast%3DKeren-Shaul%26aufirst%3DH.%26aulast%3DWinter%26aufirst%3DD.%2BR.%26aulast%3DGat-Viks%26aufirst%3DI.%26aulast%3DMandelboim%26aufirst%3DM.%26aulast%3DZiv%26aufirst%3DT.%26aulast%3DAmit%26aufirst%3DI.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DExtracellular%2520Matrix%2520Proteolysis%2520by%2520MT1-MMP%2520Contributes%2520to%2520Influenza-Related%2520Tissue%2520Damage%2520and%2520Mortality%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2016%26volume%3D20%26issue%3D4%26spage%3D458%26epage%3D470%26doi%3D10.1016%2Fj.chom.2016.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blázquez-Prieto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amado-Rodriguez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Alonso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batalla-Solís, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-López, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Pérez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayoral-Garcia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaiceta, G. M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-14 Triggers an Anti-Inflammatory Proteolytic Cascade in Endotoxemia</span>. <i>J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1007/s00109-017-1510-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00109-017-1510-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28120021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2017&pages=487-497&issue=5&author=A.+Aguirreauthor=J.+Bl%C3%A1zquez-Prietoauthor=L.+Amado-Rodriguezauthor=I.+L%C3%B3pez-Alonsoauthor=E.+Batalla-Sol%C3%ADsauthor=A.+Gonz%C3%A1lez-L%C3%B3pezauthor=M.+S%C3%A1nchez-P%C3%A9rezauthor=C.+Mayoral-Garciaauthor=A.+Guti%C3%A9rrez-Fern%C3%A1ndezauthor=G.+M.+Albaiceta&title=Matrix+Metalloproteinase-14+Triggers+an+Anti-Inflammatory+Proteolytic+Cascade+in+Endotoxemia&doi=10.1007%2Fs00109-017-1510-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-14 triggers an anti-inflammatory proteolytic cascade in endotoxemia</span></div><div class="casAuthors">Aguirre, Alina; Blazquez-Prieto, Jorge; Amado-Rodriguez, Laura; Lopez-Alonso, Ines; Batalla-Solis, Estefania; Gonzalez-Lopez, Adrian; Sanchez-Perez, Moises; Mayoral-Garcia, Carlos; Gutierrez-Fernandez, Ana; Albaiceta, Guillermo M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">487-497</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Matrix metalloproteinases can modulate the inflammatory response through processing of cyto- and chemokines.  Among them, MMP-14 is a non-dispensable collagenase responsible for the activation of other enzymes, triggering a proteolytic cascade.  To identify the role of MMP-14 during the pro-inflammatory response, wildtype and Mmp14-/- mice were challenged with lipopolysaccharide.  MMP-14 levels decreased after endotoxemia.  Mutant animals showed 100% mortality, compared to 50% in wildtype mice.  The increased mortality was related to a more severe lung injury, an impaired lung MMP-2 activation, and increased levels of the alarmin S100A9.  There were no differences in the expression of other mediators including Il6, Cxcl2, Tgfb, Il10, or S100a8.  A similar result was obsd. in lung explants of both genotypes cultured in presence of lipopolysaccharide.  In this ex vivo model, exogenous activated MMP-2 ameliorated the obsd. increase in alarmins.  Samples from septic patients showed a decrease in serum MMP-14 and activated MMP-2 compared to non-septic critically ill patients.  These results demonstrate that the MMP-14-MMP-2 axis is downregulated during sepsis, leading to a proinflammatory response involving S100A9 and a more severe lung injury.  This anti-inflammatory role of MMP-14 could have a therapeutic value in sepsis.  Key messages: MMP-14 levels decrease in lungs from endotoxemic mice and serum from septic patients.  Mmp14-/- mice show increased lung injury and mortality following endotoxemia.  Absence of Mmp14 decreases activated MMP-2 and increases S100A9 levels in lung tissue.  MMP-14 ameliorates inflammation by promoting S100A9 cleavage by activated MMP-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuq9NZ18PZtbVg90H21EOLACvtfcHk0lgs1BIRjhxx8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeitLk%253D&md5=24edaa0fdd631eb7816f92e8abe89a5a</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1007%2Fs00109-017-1510-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-017-1510-z%26sid%3Dliteratum%253Aachs%26aulast%3DAguirre%26aufirst%3DA.%26aulast%3DBl%25C3%25A1zquez-Prieto%26aufirst%3DJ.%26aulast%3DAmado-Rodriguez%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez-Alonso%26aufirst%3DI.%26aulast%3DBatalla-Sol%25C3%25ADs%26aufirst%3DE.%26aulast%3DGonz%25C3%25A1lez-L%25C3%25B3pez%26aufirst%3DA.%26aulast%3DS%25C3%25A1nchez-P%25C3%25A9rez%26aufirst%3DM.%26aulast%3DMayoral-Garcia%26aufirst%3DC.%26aulast%3DGuti%25C3%25A9rrez-Fern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DAlbaiceta%26aufirst%3DG.%2BM.%26atitle%3DMatrix%2520Metalloproteinase-14%2520Triggers%2520an%2520Anti-Inflammatory%2520Proteolytic%2520Cascade%2520in%2520Endotoxemia%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2017%26volume%3D95%26issue%3D5%26spage%3D487%26epage%3D497%26doi%3D10.1007%2Fs00109-017-1510-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span> <span> </span><span class="NLM_article-title">Cytoplasmic Tail of MT1-MMP Regulates Macrophage Motility Independently from Its Protease Activity</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2443.2009.01293.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fj.1365-2443.2009.01293.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19371380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVCmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=617-626&issue=5&author=T.+Sakamotoauthor=M.+Seiki&title=Cytoplasmic+Tail+of+MT1-MMP+Regulates+Macrophage+Motility+Independently+from+Its+Protease+Activity&doi=10.1111%2Fj.1365-2443.2009.01293.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity</span></div><div class="casAuthors">Sakamoto, Takeharu; Seiki, Motoharu</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-626</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Membrane type-1 matrix metalloproteinase (MT1-MMP) is a pro-invasive protease that regulates various cellular functions as evidenced by myriad defects in different types of cells and tissues in MT1-MMP-deficient (MT1-/-) mice.  Here, the authors demonstrate that MT1-/- mice exhibit fewer infiltrating macrophages into sites of inflammation.  MT1-/- macrophages exhibited a reduced ability to invade reconstituted basement membrane (Matrigel) and invasion by wild-type (WT) macrophages was inhibited by a synthetic MMP inhibitor (BB94) to a level similar to that of MT1-/- cells.  The rate of migration of MT1-/- macrophages was also low compared to that of the WT cells and re-expression of MT1-MMP in MT1-/- macrophages reconstituted their migratory activity.  Unexpectedly, however, BB94 did not inhibit the migration of WT macrophages.  The migration-boosting activity of MT1-MMP was retained in a mutant that lacked most of the extracellular portion including the catalytic and hemopexin-like domains.  In contrast, deletion of the cytoplasmic (CP) tail abolished the activity completely.  Thus, the authors demonstrate that MT1-MMP regulates macrophages via its invasion-promoting protease activity as well as its CP-dependent non-proteolytic activity to boost cell migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryBdh4aP_b7LVg90H21EOLACvtfcHk0lh2ZnlLX7m5Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVCmu7w%253D&md5=b313e733dfaf6e370a70120000cf024b</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2009.01293.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2009.01293.x%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DT.%26aulast%3DSeiki%26aufirst%3DM.%26atitle%3DCytoplasmic%2520Tail%2520of%2520MT1-MMP%2520Regulates%2520Macrophage%2520Motility%2520Independently%2520from%2520Its%2520Protease%2520Activity%26jtitle%3DGenes%2520Cells%26date%3D2009%26volume%3D14%26issue%3D5%26spage%3D617%26epage%3D626%26doi%3D10.1111%2Fj.1365-2443.2009.01293.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchalant, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouzin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrete, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paumier, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Py, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">MT5-MMP Is a New pro-Amyloidogenic Proteinase That Promotes Amyloid Pathology and Cognitive Decline in a Transgenic Mouse Model of Alzheimer’s Disease</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1007/s00018-015-1992-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-015-1992-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26202697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1aksrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=217-236&issue=1&author=K.+Barangerauthor=Y.+Marchalantauthor=A.+E.+Bonnetauthor=N.+Crouzinauthor=A.+Carreteauthor=J.-M.+Paumierauthor=N.+A.+Pyauthor=A.+Bernardauthor=C.+Bauerauthor=E.+Charratauthor=K.+Moschkeauthor=M.+Seikiauthor=M.+Vignesauthor=S.+F.+Lichtenthalerauthor=F.+Checlerauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=MT5-MMP+Is+a+New+pro-Amyloidogenic+Proteinase+That+Promotes+Amyloid+Pathology+and+Cognitive+Decline+in+a+Transgenic+Mouse+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.1007%2Fs00018-015-1992-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease</span></div><div class="casAuthors">Baranger, Kevin; Marchalant, Yannick; Bonnet, Amandine E.; Crouzin, Nadine; Carrete, Alex; Paumier, Jean-Michel; Py, Nathalie A.; Bernard, Anne; Bauer, Charlotte; Charrat, Eliane; Moschke, Katrin; Seiki, Mothoharu; Vignes, Michel; Lichtenthaler, Stefan F.; Checler, Frederic; Khrestchatisky, Michel; Rivera, Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-236</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Membrane-type 5-matrix metalloproteinase (MT5-MMP) is a proteinase mainly expressed in the nervous system with emerging roles in brain pathophysiol.  The implication of MT5-MMP in Alzheimer's disease (AD), notably its interplay with the amyloidogenic process, remains elusive.  Accordingly, we crossed the genetically engineered 5xFAD mouse model of AD with MT5-MMP-deficient mice and examd. the impact of MT5-MMP deficiency in bigenic 5xFAD/MT5-MMP-/- mice.  At early stages (4 mo) of the pathol., the levels of amyloid beta peptide (Aβ) and its amyloid precursor protein (APP) C-terminal fragment C99 were largely reduced in the cortex and hippocampus of 5xFAD/MT5-MMP-/-, compared to 5xFAD mice.  Reduced amyloidosis in bigenic mice was concomitant with decreased glial reactivity and interleukin-1β (IL-1β) levels, and the preservation of long-term potentiation (LTP) and spatial learning, without changes in the activity of α-, β- and γ-secretases.  The pos. impact of MT5-MMP deficiency was still noticeable at 16 mo of age, as illustrated by reduced amyloid burden and gliosis, and a better preservation of the cortical neuronal network and synaptophysin levels in bigenic mice.  MT5-MMP expressed in HEKswe cells colocalized and co-immunopptd. with APP and significantly increased the levels of Aβ and C99.  MT5-MMP also promoted the release of a sol. APP fragment of 95 kDa (sAPP95) in HEKswe cells. sAPP95 levels were significantly reduced in brain homogenates of 5xFAD/MT5-MMP-/- mice, supporting altogether the idea that MT5-MMP influences APP processing.  MT5-MMP emerges as a new pro-amyloidogenic regulator of APP metab., whose deficiency alleviates amyloid pathol., neuroinflammation and cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH_5t3Z1acubVg90H21EOLACvtfcHk0lh2ZnlLX7m5Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1aksrjP&md5=e4e622d44965b44f298497aca7119f0f</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1007%2Fs00018-015-1992-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-015-1992-1%26sid%3Dliteratum%253Aachs%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DMarchalant%26aufirst%3DY.%26aulast%3DBonnet%26aufirst%3DA.%2BE.%26aulast%3DCrouzin%26aufirst%3DN.%26aulast%3DCarrete%26aufirst%3DA.%26aulast%3DPaumier%26aufirst%3DJ.-M.%26aulast%3DPy%26aufirst%3DN.%2BA.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DC.%26aulast%3DCharrat%26aufirst%3DE.%26aulast%3DMoschke%26aufirst%3DK.%26aulast%3DSeiki%26aufirst%3DM.%26aulast%3DVignes%26aufirst%3DM.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DMT5-MMP%2520Is%2520a%2520New%2520pro-Amyloidogenic%2520Proteinase%2520That%2520Promotes%2520Amyloid%2520Pathology%2520and%2520Cognitive%2520Decline%2520in%2520a%2520Transgenic%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26issue%3D1%26spage%3D217%26epage%3D236%26doi%3D10.1007%2Fs00018-015-1992-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paumier, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-González, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmanaa, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">MT5-MMP Promotes Alzheimer’s Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in Vitro</span>. <i>Front. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.3389/fnmol.2016.00163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3389%2Ffnmol.2016.00163" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1-17&issue=1&author=K.+Barangerauthor=A.+E.+Bonnetauthor=S.+D.+Girardauthor=J.-M.+Paumierauthor=L.+Garc%C3%ADa-Gonz%C3%A1lezauthor=W.+Elmanaaauthor=A.+Bernardauthor=E.+Charratauthor=D.+Stephanauthor=C.+Bauerauthor=K.+Moschkeauthor=S.+F.+Lichtenthalerauthor=F.+S.+Romanauthor=F.+Checlerauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=MT5-MMP+Promotes+Alzheimer%E2%80%99s+Pathogenesis+in+the+Frontal+Cortex+of+5xFAD+Mice+and+APP+Trafficking+in+Vitro&doi=10.3389%2Ffnmol.2016.00163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2016.00163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2016.00163%26sid%3Dliteratum%253Aachs%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DBonnet%26aufirst%3DA.%2BE.%26aulast%3DGirard%26aufirst%3DS.%2BD.%26aulast%3DPaumier%26aufirst%3DJ.-M.%26aulast%3DGarc%25C3%25ADa-Gonz%25C3%25A1lez%26aufirst%3DL.%26aulast%3DElmanaa%26aufirst%3DW.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DCharrat%26aufirst%3DE.%26aulast%3DStephan%26aufirst%3DD.%26aulast%3DBauer%26aufirst%3DC.%26aulast%3DMoschke%26aufirst%3DK.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DRoman%26aufirst%3DF.%2BS.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DMT5-MMP%2520Promotes%2520Alzheimer%25E2%2580%2599s%2520Pathogenesis%2520in%2520the%2520Frontal%2520Cortex%2520of%25205xFAD%2520Mice%2520and%2520APP%2520Trafficking%2520in%2520Vitro%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2017%26volume%3D9%26issue%3D1%26spage%3D1%26epage%3D17%26doi%3D10.3389%2Ffnmol.2016.00163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">MT5-MMP, Just a New APP Processing Proteinase in Alzheimer’s Disease?</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">167</span>, <span class="refDoi"> DOI: 10.1186/s12974-016-0633-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1186%2Fs12974-016-0633-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27349644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC2s7ktlehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=167&issue=1&author=K.+Barangerauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=MT5-MMP%2C+Just+a+New+APP+Processing+Proteinase+in+Alzheimer%E2%80%99s+Disease%3F&doi=10.1186%2Fs12974-016-0633-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">MT5-MMP, just a new APP processing proteinase in Alzheimer's disease?</span></div><div class="casAuthors">Baranger Kevin; Khrestchatisky Michel; Rivera Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">167</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We have recently identified in a transgenic mouse model of Alzheimer's disease (AD) membrane-type 5-MMP (MT5-MMP) as a new player in Alzheimer's pathogenesis, which displays pro-amyloidogenic features and proteolytic processing of amyloid precursor protein (APP).  Another group has reported that MT5-MMP processing of APP may release a novel neurotoxic APP fragment.  Although MT5-MMP-mediated APP processing appears to be a key pathogenic step, we hypothesize that MT5-MMP may also contribute to AD pathogenesis through complementary mechanisms that involve the activation of pro-inflammatory pathways and/or APP trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOwBKw6SCc_F1C8OJBvdfbfW6udTcc2ea5Yu4GKiMun7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7ktlehsA%253D%253D&md5=5a18b9baf232700092b506c0108cc689</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1186%2Fs12974-016-0633-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-016-0633-4%26sid%3Dliteratum%253Aachs%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DMT5-MMP%252C%2520Just%2520a%2520New%2520APP%2520Processing%2520Proteinase%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2016%26volume%3D13%26issue%3D1%26spage%3D167%26doi%3D10.1186%2Fs12974-016-0633-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahirovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busche, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovsepian, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kootar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornburg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, L. D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giudici, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenninger-Weinzierl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremmer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heneka, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giedraitis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livesey, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herms, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konnerth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span> <span> </span><span class="NLM_article-title">η-Secretase Processing of APP Inhibits Neuronal Activity in the Hippocampus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>526</i></span> (<span class="NLM_issue">7573</span>),  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1038/nature14864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnature14864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26322584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCis7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2015&pages=443-447&issue=7573&author=M.+Willemauthor=S.+Tahirovicauthor=M.+A.+Buscheauthor=S.+V.+Ovsepianauthor=M.+Chafaiauthor=S.+Kootarauthor=D.+Hornburgauthor=L.+D.+B.+Evansauthor=S.+Mooreauthor=A.+Dariaauthor=H.+Hampelauthor=V.+M%C3%BCllerauthor=C.+Giudiciauthor=B.+Nuscherauthor=A.+Wenninger-Weinzierlauthor=E.+Kremmerauthor=M.+T.+Henekaauthor=D.+R.+Thalauthor=V.+Giedraitisauthor=L.+Lannfeltauthor=U.+M%C3%BCllerauthor=F.+J.+Liveseyauthor=F.+Meissnerauthor=J.+Hermsauthor=A.+Konnerthauthor=H.+Marieauthor=C.+Haass&title=%CE%B7-Secretase+Processing+of+APP+Inhibits+Neuronal+Activity+in+the+Hippocampus&doi=10.1038%2Fnature14864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">η-Secretase processing of APP inhibits neuronal activity in the hippocampus</span></div><div class="casAuthors">Willem, Michael; Tahirovic, Sabina; Busche, Marc Aurel; Ovsepian, Saak V.; Chafai, Magda; Kootar, Scherazad; Hornburg, Daniel; Evans, Lewis D. B.; Moore, Steven; Daria, Anna; Hampel, Heike; Mueller, Veronika; Giudici, Camilla; Nuscher, Brigitte; Wenninger-Weinzierl, Andrea; Kremmer, Elisabeth; Heneka, Michael T.; Thal, Dietmar R.; Giedraitis, Vilmantas; Lannfelt, Lars; Mueller, Ulrike; Livesey, Frederick J.; Meissner, Felix; Herms, Jochen; Konnerth, Arthur; Marie, Helene; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue">7573</span>),
    <span class="NLM_cas:pages">443-447</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-β peptide.  Two principal physiol. pathways either prevent or promote amyloid-β generation from its precursor, β-amyloid precursor protein (APP), in a competitive manner.  Although APP processing has been studied in great detail, unknown proteolytic events seem to hinder stoichiometric analyses of APP metab. in vivo.  Here we describe a new physiol. APP processing pathway, which generates proteolytic fragments capable of inhibiting neuronal activity within the hippocampus.  We identify higher mol. mass carboxy-terminal fragments (CTFs) of APP, termed CTF-η, in addn. to the long-known CTF-α and CTF-β fragments generated by the α- and β-secretases ADAM10 (a disintegrin and metalloproteinase 10) and BACE1 (β-site APP cleaving enzyme 1), resp.  CTF-η generation is mediated in part by membrane-bound matrix metalloproteinases such as MT5-MMP, referred to as η-secretase activity.  η-Secretase cleavage occurs primarily at amino acids 504-505 of APP695, releasing a truncated ectodomain.  After shedding of this ectodomain, CTF-η is further processed by ADAM10 and BACE1 to release long and short Aη peptides (termed Aη-α and Aη-β).  CTFs produced by η-secretase are enriched in dystrophic neurites in an AD mouse model and in human AD brains.  Genetic and pharmacol. inhibition of BACE1 activity results in robust accumulation of CTF-η and Aη-α.  In mice treated with a potent BACE1 inhibitor, hippocampal long-term potentiation was reduced.  Notably, when recombinant or synthetic Aη-α was applied on hippocampal slices ex vivo, long-term potentiation was lowered.  Furthermore, in vivo single-cell two-photon calcium imaging showed that hippocampal neuronal activity was attenuated by Aη-α.  These findings not only demonstrate a major functionally relevant APP processing pathway, but may also indicate potential translational relevance for therapeutic strategies targeting APP processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_5ub5j4eaRbVg90H21EOLACvtfcHk0lioMQnKp6ZIpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCis7%252FN&md5=e56ae17f893de088e80fe973d4885930</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fnature14864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14864%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DTahirovic%26aufirst%3DS.%26aulast%3DBusche%26aufirst%3DM.%2BA.%26aulast%3DOvsepian%26aufirst%3DS.%2BV.%26aulast%3DChafai%26aufirst%3DM.%26aulast%3DKootar%26aufirst%3DS.%26aulast%3DHornburg%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DL.%2BD.%2BB.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DDaria%26aufirst%3DA.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DV.%26aulast%3DGiudici%26aufirst%3DC.%26aulast%3DNuscher%26aufirst%3DB.%26aulast%3DWenninger-Weinzierl%26aufirst%3DA.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DGiedraitis%26aufirst%3DV.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DM%25C3%25BCller%26aufirst%3DU.%26aulast%3DLivesey%26aufirst%3DF.%2BJ.%26aulast%3DMeissner%26aufirst%3DF.%26aulast%3DHerms%26aufirst%3DJ.%26aulast%3DKonnerth%26aufirst%3DA.%26aulast%3DMarie%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3D%25CE%25B7-Secretase%2520Processing%2520of%2520APP%2520Inhibits%2520Neuronal%2520Activity%2520in%2520the%2520Hippocampus%26jtitle%3DNature%26date%3D2015%26volume%3D526%26issue%3D7573%26spage%3D443%26epage%3D447%26doi%3D10.1038%2Fnature14864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashita-Kinoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, a</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yana, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span> <span> </span><span class="NLM_article-title">Membrane-Type 5 Matrix Metalloproteinase Is Expressed in Differentiated Neurons and Regulates Axonal Growth</span>. <i>Cell Growth Differ.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11714638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1KksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=573-580&issue=11&author=H.+Hayashita-Kinohauthor=H.+Kinohauthor=a+Okadaauthor=K.+Komoriauthor=Y.+Itohauthor=T.+Chibaauthor=M.+Kajitaauthor=I.+Yanaauthor=M.+Seiki&title=Membrane-Type+5+Matrix+Metalloproteinase+Is+Expressed+in+Differentiated+Neurons+and+Regulates+Axonal+Growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth</span></div><div class="casAuthors">Hayashita-Kinoh, Hiromi; Kinoh, Hiroaki; Okada, Akiko; Komori, Kiyoshi; Itoh, Yoshifumi; Chiba, Tadashige; Kajita, Masahiro; Yana, Ikuo; Seiki, Motoharu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Growth & Differentiation</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">573-580</span>CODEN:
                <span class="NLM_cas:coden">CGDIE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-9523</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of membrane-type (MT) 5 matrix metalloproteinase (MMP) in the mouse brain was examd.  MT5-MMP was expressed in the cerebrum in embryos, but it declined after birth.  In contrast, expression in the cerebellum started to increase postnatally and continued thereafter.  The cells expressing MT5-MMP were postmitotic neurons that showed gelatinolytic activities.  Specific expression of MT5-MMP was obsd. in the neurons but not in the glial cells when embryonal mouse carcinoma P19 cells were differentiated in vitro by retinoic acid treatment.  Neurons isolated from dorsal root ganglia also expressed MT5-MMP, and it was localized at the edge of growth cone.  Proteoglycans inhibit neurite extension and regulate synaptogenesis.  The inhibitory effect of the proteoglycans on neurite extension of dorsal root ganglia neurons was effectively eliminated by recombinant MT5-MMP.  Thus, MT5-MMP expressed in neurons may play a role in axonal growth that contributes to the regulation of neural network formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKTa4_mQT9dbVg90H21EOLACvtfcHk0lioMQnKp6ZIpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1KksLY%253D&md5=001445893412ef6feb5f808818ba5f77</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashita-Kinoh%26aufirst%3DH.%26aulast%3DKinoh%26aufirst%3DH.%26aulast%3DOkada%26aufirst%3Da%26aulast%3DKomori%26aufirst%3DK.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DKajita%26aufirst%3DM.%26aulast%3DYana%26aufirst%3DI.%26aulast%3DSeiki%26aufirst%3DM.%26atitle%3DMembrane-Type%25205%2520Matrix%2520Metalloproteinase%2520Is%2520Expressed%2520in%2520Differentiated%2520Neurons%2520and%2520Regulates%2520Axonal%2520Growth%26jtitle%3DCell%2520Growth%2520Differ.%26date%3D2001%26volume%3D12%26issue%3D11%26spage%3D573%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashita-Kinoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yana, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span> <span> </span><span class="NLM_article-title">Absence of Mechanical Allodynia and Aβ-Fiber Sprouting after Sciatic Nerve Injury in Mice Lacking Membrane-Type 5 Matrix Metalloproteinase</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>557</i></span> (<span class="NLM_issue">1–3</span>),  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(03)01458-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0014-5793%2803%2901458-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=14741353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltV2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=557&publication_year=2004&pages=125-128&issue=1%E2%80%933&author=K.+Komoriauthor=T.+Nonakaauthor=A.+Okadaauthor=H.+Kinohauthor=H.+Hayashita-Kinohauthor=N.+Yoshidaauthor=I.+Yanaauthor=M.+Seiki&title=Absence+of+Mechanical+Allodynia+and+A%CE%B2-Fiber+Sprouting+after+Sciatic+Nerve+Injury+in+Mice+Lacking+Membrane-Type+5+Matrix+Metalloproteinase&doi=10.1016%2FS0014-5793%2803%2901458-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Absence of mechanical allodynia and Aβ-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase</span></div><div class="casAuthors">Komori, Kiyoshi; Nonaka, Takahiro; Okada, Akiko; Kinoh, Hiroaki; Hayashita-Kinoh, Hiromi; Yoshida, Nobuaki; Yana, Ikuo; Seiki, Motoharu</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">557</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">125-128</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are a family of endopeptidases that degrade extracellular matrix components.  Membrane-type 5 MMP (MT5-MMP/MMP-24) was identified as neuron-specific, and is believed to contribute to neuronal circuit formation and plasticity.  To elucidate its function in vivo, we have generated mice lacking MT5-MMP by gene targeting.  MT5-MMP-deficient mice were born without obvious morphol. abnormalities.  No apparent histol. defects were obsd. in the nervous system either.  However, MT5-MMP-deficient mice did not develop neuropathic pain with mech. allodynia after sciatic nerve injury, though responses to acute noxious stimuli were normal.  Neuropathic pain induced by peripheral nerve lesions is known to accompany structural reorganization of the nervous system.  Intraneural injection of cholera toxin B subunit, a transganglionic tracer, into the injured sciatic nerve of wild-type mice revealed that the myelinated Aβ-fiber primary afferents sprouted from laminae III-VI of the dorsal horn of the spinal cord and invaded lamina II.  However, no such sprouting and invasion of Aβ-fibers were obsd. in MT5-MMP-deficient mice.  These findings suggest that MT5-MMP is essential for the development of mech. allodynia and plays an important role in neuronal plasticity in this mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocUJuiIjhdirVg90H21EOLACvtfcHk0lgwNhLN3jHi0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltV2qtw%253D%253D&md5=f727b61980024717fcc7c4b6331264ef</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2803%2901458-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252803%252901458-3%26sid%3Dliteratum%253Aachs%26aulast%3DKomori%26aufirst%3DK.%26aulast%3DNonaka%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DA.%26aulast%3DKinoh%26aufirst%3DH.%26aulast%3DHayashita-Kinoh%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DYana%26aufirst%3DI.%26aulast%3DSeiki%26aufirst%3DM.%26atitle%3DAbsence%2520of%2520Mechanical%2520Allodynia%2520and%2520A%25CE%25B2-Fiber%2520Sprouting%2520after%2520Sciatic%2520Nerve%2520Injury%2520in%2520Mice%2520Lacking%2520Membrane-Type%25205%2520Matrix%2520Metalloproteinase%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D557%26issue%3D1%25E2%2580%25933%26spage%3D125%26epage%3D128%26doi%3D10.1016%2FS0014-5793%2803%2901458-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Folgueras, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdes-Sanchez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menendez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baamonde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denlinger, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmonte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juarez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lastra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Suarez, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astudillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendas, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinas, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Otin, C.</span></span> <span> </span><span class="NLM_article-title">Metalloproteinase MT5-MMP Is an Essential Modulator of Neuro-Immune Interactions in Thermal Pain Stimulation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">16451</span>– <span class="NLM_lpage">16456</span>, <span class="refDoi"> DOI: 10.1073/pnas.0908507106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1073%2Fpnas.0908507106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19805319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Ojtr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16451-16456&issue=38&author=A.+R.+Folguerasauthor=T.+Valdes-Sanchezauthor=E.+Llanoauthor=L.+Menendezauthor=A.+Baamondeauthor=B.+L.+Denlingerauthor=C.+Belmonteauthor=L.+Juarezauthor=A.+Lastraauthor=O.+Garcia-Suarezauthor=A.+Astudilloauthor=M.+Kirsteinauthor=A.+M.+Pendasauthor=I.+Farinasauthor=C.+Lopez-Otin&title=Metalloproteinase+MT5-MMP+Is+an+Essential+Modulator+of+Neuro-Immune+Interactions+in+Thermal+Pain+Stimulation&doi=10.1073%2Fpnas.0908507106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation</span></div><div class="casAuthors">Folgueras, Alicia R.; Valdes-Sanchez, Teresa; Llano, Elena; Menendez, Luis; Baamonde, Ana; Denlinger, Bristol L.; Belmonte, Carlos; Juarez, Lucia; Lastra, Ana; Garcia-Suarez, Olivia; Kirstein, Martina; Pendas, Alberto M.; Farinas, Isabel; Lopez-Otin, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">16451-16456, S16451/1-S16451/12</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Peripheral interactions between nociceptive fibers and mast cells contribute to inflammatory pain, but little is known about mechanisms mediating neuroimmune communication.  Here we show that metalloproteinase MT5-MMP (MMP-24) is an essential mediator of peripheral thermal nociception and inflammatory hyperalgesia.  We report that MT5-MMP is expressed by CGRP-contg. peptidergic nociceptors in dorsal root ganglia and that Mmp24-deficient mice display enhanced sensitivity to noxious thermal stimuli under basal conditions.  Consistently, mutant peptidergic sensory neurons hyperinnervate the skin, a phenotype that correlates with changes in the regulated cleavage of the cell-cell adhesion mol. N-cadherin.  In contrast to basal nociception, Mmp24-/- mice do not develop thermal hyperalgesia during inflammation, a phenotype that appears assocd. with alterations in N-cadherin-mediated cell-cell interactions between mast cells and sensory fibers.  Collectively, our findings demonstrate an essential role of MT5-MMP in the development of dermal neuro-immune synapses and suggest that this metalloproteinase may be a target for pain control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmN1iKK3OrYrVg90H21EOLACvtfcHk0lgwNhLN3jHi0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Ojtr7M&md5=b03c677c89f1c57351838b39f4aff61f</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908507106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908507106%26sid%3Dliteratum%253Aachs%26aulast%3DFolgueras%26aufirst%3DA.%2BR.%26aulast%3DValdes-Sanchez%26aufirst%3DT.%26aulast%3DLlano%26aufirst%3DE.%26aulast%3DMenendez%26aufirst%3DL.%26aulast%3DBaamonde%26aufirst%3DA.%26aulast%3DDenlinger%26aufirst%3DB.%2BL.%26aulast%3DBelmonte%26aufirst%3DC.%26aulast%3DJuarez%26aufirst%3DL.%26aulast%3DLastra%26aufirst%3DA.%26aulast%3DGarcia-Suarez%26aufirst%3DO.%26aulast%3DAstudillo%26aufirst%3DA.%26aulast%3DKirstein%26aufirst%3DM.%26aulast%3DPendas%26aufirst%3DA.%2BM.%26aulast%3DFarinas%26aufirst%3DI.%26aulast%3DLopez-Otin%26aufirst%3DC.%26atitle%3DMetalloproteinase%2520MT5-MMP%2520Is%2520an%2520Essential%2520Modulator%2520of%2520Neuro-Immune%2520Interactions%2520in%2520Thermal%2520Pain%2520Stimulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D38%26spage%3D16451%26epage%3D16456%26doi%3D10.1073%2Fpnas.0908507106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okimoto, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitenbuecher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivas, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asthana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrustanovic, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulpule, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakely, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haringsma, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bivona, T. G.</span></span> <span> </span><span class="NLM_article-title">Inactivation of Capicua Drives Cancer Metastasis</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1038/ng.3728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fng.3728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27869830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGqu7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=87-96&issue=1&author=R.+A.+Okimotoauthor=F.+Breitenbuecherauthor=V.+R.+Olivasauthor=W.+Wuauthor=B.+Giniauthor=M.+Hofreeauthor=S.+Asthanaauthor=G.+Hrustanovicauthor=J.+Flanaganauthor=A.+Tulpuleauthor=C.+M.+Blakelyauthor=H.+J.+Haringsmaauthor=A.+D.+Simmonsauthor=K.+Gowenauthor=J.+Suhauthor=V.+A.+Millerauthor=S.+Aliauthor=M.+Schulerauthor=T.+G.+Bivona&title=Inactivation+of+Capicua+Drives+Cancer+Metastasis&doi=10.1038%2Fng.3728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Capicua drives cancer metastasis</span></div><div class="casAuthors">Okimoto, Ross A.; Breitenbuecher, Frank; Olivas, Victor R.; Wu, Wei; Gini, Beatrice; Hofree, Matan; Asthana, Saurabh; Hrustanovic, Gorjan; Flanagan, Jennifer; Tulpule, Asmin; Blakely, Collin M.; Haringsma, Henry J.; Simmons, Andrew D.; Gowen, Kyle; Suh, James; Miller, Vincent A.; Ali, Siraj; Schuler, Martin; Bivona, Trever G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metastasis is the leading cause of death in people with lung cancer, yet the mol. effectors underlying tumor dissemination remain poorly defined.  Through the development of an in vivo spontaneous lung cancer metastasis model, we show that the developmentally regulated transcriptional repressor Capicua (CIC) suppresses invasion and metastasis.  Inactivation of CIC relieves repression of its effector ETV4, driving ETV4-mediated upregulation of MMP24, which is necessary and sufficient for metastasis.  Loss of CIC, or an increase in levels of its effectors ETV4 and MMP24, is a biomarker of tumor progression and worse outcomes in people with lung and/or gastric cancer.  Our findings reveal CIC as a conserved metastasis suppressor, highlighting new anti-metastatic strategies that could potentially improve patient outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq810YPLfE1rVg90H21EOLACvtfcHk0lixTjukpd2xew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGqu7bO&md5=42666b56b3deb9d8f58546fe56d096b8</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1038%2Fng.3728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3728%26sid%3Dliteratum%253Aachs%26aulast%3DOkimoto%26aufirst%3DR.%2BA.%26aulast%3DBreitenbuecher%26aufirst%3DF.%26aulast%3DOlivas%26aufirst%3DV.%2BR.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DGini%26aufirst%3DB.%26aulast%3DHofree%26aufirst%3DM.%26aulast%3DAsthana%26aufirst%3DS.%26aulast%3DHrustanovic%26aufirst%3DG.%26aulast%3DFlanagan%26aufirst%3DJ.%26aulast%3DTulpule%26aufirst%3DA.%26aulast%3DBlakely%26aufirst%3DC.%2BM.%26aulast%3DHaringsma%26aufirst%3DH.%2BJ.%26aulast%3DSimmons%26aufirst%3DA.%2BD.%26aulast%3DGowen%26aufirst%3DK.%26aulast%3DSuh%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DV.%2BA.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DSchuler%26aufirst%3DM.%26aulast%3DBivona%26aufirst%3DT.%2BG.%26atitle%3DInactivation%2520of%2520Capicua%2520Drives%2520Cancer%2520Metastasis%26jtitle%3DNat.%2520Genet.%26date%3D2017%26volume%3D49%26issue%3D1%26spage%3D87%26epage%3D96%26doi%3D10.1038%2Fng.3728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Llano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendás, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freije, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knäuper, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Otin, C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Identification and Characterization of Human MT5-MMP, a New Membrane-Bound Activator of Progelatinase A Overexpressed in Brain Tumors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2570</span>– <span class="NLM_lpage">2576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10363975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1ymsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2570-2576&author=E.+Llanoauthor=A.+M.+Pend%C3%A1sauthor=J.+P.+Freijeauthor=A.+Nakanoauthor=V.+Kn%C3%A4uperauthor=G.+Murphyauthor=C.+L%C3%B3pez-Otin&title=Identification+and+Characterization+of+Human+MT5-MMP%2C+a+New+Membrane-Bound+Activator+of+Progelatinase+A+Overexpressed+in+Brain+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors</span></div><div class="casAuthors">Llano, Elena; Pendas, Alberto M.; Freije, Jose P.; Nakano, Atsuhisa; Knauper, Vera; Murphy, Gillian; Lopez-Otin, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2570-2576</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">A cDNA encoding a new member of the membrane-type (MT) matrix metalloproteinase (MMP) family has been identified and cloned from a human brain cDNA library.  The isolated cDNA encodes a polypeptide of 645 amino acids that displays a similar domain organization as other MMPs, including a predomain with the activation locus, a zinc-binding site, and a hemopexin domain.  The deduced amino acid sequence contains a COOH-terminal extension, rich in hydrophobic residues and similar in size to the equiv. domains identified in MT-MMPs.  Immunofluorescence and Western blot anal. of COS-7 cells transfected with the isolated cDNA revealed that the encoded protein is localized in the plasma membrane.  On the basis of these features, this novel human MMP has been called MT5-MMP because it represents the fifth member of the MT-MMP subfamily of MMPs.  Fluorescent in situ hybridization expts. showed that the human MT5-MMP gene (MMP-24) maps to 20q11.2, a region frequently amplified in tumors from diverse sources.  Northern blot anal. demonstrated that MT5-MMP is predominantly expressed in brain, kidney, pancreas, and lung.  In addn., MT5-MMP transcripts were detected at high levels compared to normal brain tissue in a series of brain tumors, including astrocytomas and glioblastomas.  The catalytic domain of MT5-MMP, produced in Escherichia coli as a fusion protein with glutathione S-transferase, exhibits a potent proteolytic activity against progelatinase A, leading to the generation of the Mr 62,000 active form of this enzyme.  These data suggest that MT5-MMP may contribute to the activation of progelatinase A in tumor tissues, in which it is overexpressed, thereby facilitating tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpadhPHN2JP-LVg90H21EOLACvtfcHk0lixTjukpd2xew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1ymsb4%253D&md5=d6f6fbcef15d7ff4aa03dfb95706ba33</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlano%26aufirst%3DE.%26aulast%3DPend%25C3%25A1s%26aufirst%3DA.%2BM.%26aulast%3DFreije%26aufirst%3DJ.%2BP.%26aulast%3DNakano%26aufirst%3DA.%26aulast%3DKn%25C3%25A4uper%26aufirst%3DV.%26aulast%3DMurphy%26aufirst%3DG.%26aulast%3DL%25C3%25B3pez-Otin%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520Human%2520MT5-MMP%252C%2520a%2520New%2520Membrane-Bound%2520Activator%2520of%2520Progelatinase%2520A%2520Overexpressed%2520in%2520Brain%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2570%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Restituito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziff, E. B.</span></span> <span> </span><span class="NLM_article-title">Synaptic Autoregulation by Metalloproteases and -Secretase</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">12083</span>– <span class="NLM_lpage">12093</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2513-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.2513-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21865451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCisLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=12083-12093&issue=34&author=S.+Restituitoauthor=L.+Khatriauthor=I.+Ninanauthor=P.+M.+Mathewsauthor=X.+Liuauthor=R.+J.+Weinbergauthor=E.+B.+Ziff&title=Synaptic+Autoregulation+by+Metalloproteases+and+-Secretase&doi=10.1523%2FJNEUROSCI.2513-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic autoregulation by metalloproteases and γ-secretase</span></div><div class="casAuthors">Restituito, Sophie; Khatri, Latika; Ninan, Ipe; Mathews, Paul M.; Liu, Xin; Weinberg, Richard J.; Ziff, Edward B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12083-12093</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The proteolytic machinery comprising metalloproteases and γ-secretase, an intramembrane aspartyl protease involved in Alzheimer's disease, cleaves several substrates in addn. to the extensively studied amyloid precursor protein.  Some of these substrates, such as N-cadherin, are synaptic proteins involved in synapse remodeling and maintenance.  Here we show, in rats and mice, that metalloproteases and γ-secretase are physiol. regulators of synapses.  Both proteases are synaptic, with γ-secretase tethered at the synapse by δ-catenin, a synaptic scaffolding protein that also binds to N-cadherin and, through scaffolds, to AMPA receptor and a metalloprotease.  Activity-dependent proteolysis by metalloproteases and γ-secretase takes place at both sides of the synapse, with the metalloprotease cleavage being NMDA receptor-dependent.  This proteolysis decreases levels of synaptic proteins and diminishes synaptic transmission.  Our results suggest that activity-dependent substrate cleavage by synaptic metalloproteases and γ-secretase modifies synaptic transmission, providing a novel form of synaptic autoregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWcx4oOMJBpbVg90H21EOLACvtfcHk0lixTjukpd2xew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCisLjM&md5=fc8b3d49daee5290bd2393b4d0c12ce5</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2513-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2513-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DRestituito%26aufirst%3DS.%26aulast%3DKhatri%26aufirst%3DL.%26aulast%3DNinan%26aufirst%3DI.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWeinberg%26aufirst%3DR.%2BJ.%26aulast%3DZiff%26aufirst%3DE.%2BB.%26atitle%3DSynaptic%2520Autoregulation%2520by%2520Metalloproteases%2520and%2520-Secretase%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26issue%3D34%26spage%3D12083%26epage%3D12093%26doi%3D10.1523%2FJNEUROSCI.2513-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of the Fifth Membrane-Type Matrix Metalloproteinase MT5-MMP</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">8925</span>– <span class="NLM_lpage">8932</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.13.8925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.274.13.8925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10085137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK1MXitFyrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=8925-8932&issue=13&author=D.+Pei&title=Identification+and+Characterization+of+the+Fifth+Membrane-Type+Matrix+Metalloproteinase+MT5-MMP&doi=10.1074%2Fjbc.274.13.8925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP</span></div><div class="casAuthors">Pei, Duanqing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">8925-8932</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A new member of the membrane-type matrix metalloproteinase (MT-MMP) subfamily tentatively named MT5-MMP was isolated from mouse brain cDNA library.  It is predicted to contain (i) a candidate signal sequence, (ii) a propeptide region with the highly conserved PRCGVPD sequence, (iii) a potential furin recognition motif RRRRNKR, (iv) a zinc-binding catalytic domain, (v) a hemopexin-like domain, (vi) a 24-residue hydrophobic domain as a potential transmembrane domain, and (vii) a short cytosolic domain.  Reverse transcriptase-polymerase chain reaction anal. of its transcripts indicates that MT5-MMP is expressed in a brain-specific manner consistent with the origin of its EST clone from cerebellum.  It is also highly expressed during embryonic development at stages day 11 and 15.  Like other MT-MMPs, MT5-MMP specifically activates progelatinase A when co-expressed in Madin-Darby canine kidney cells.  Its ability to activate progelatinase A is dependent on its proteolytic activity since a mutation converting Glu to Ala in the zinc binding motif HE255LGH renders MT5-MMP inactive against progelatinase A.  In contrast to other MT-MMPs, MT5-MMP tends to shed from cell surface as sol. proteinases, thus offering flexibility as both a cell bound and sol. proteinase for extracellular matrix remodeling processes.  Taken together, these properties serve to distinguish MT5-MMP as a versatile MT-MMP playing an important role in extracellular matrix remodeling events in the brain and during embryonic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpReZMfJt6wrbVg90H21EOLACvtfcHk0lgHj1ejkWdZtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFyrtbo%253D&md5=c565022eb49b94e1e86fcdf77bc364fb</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.13.8925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.13.8925%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DD.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520the%2520Fifth%2520Membrane-Type%2520Matrix%2520Metalloproteinase%2520MT5-MMP%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D13%26spage%3D8925%26epage%3D8932%26doi%3D10.1074%2Fjbc.274.13.8925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, D. M.</span></span> <span> </span><span class="NLM_article-title">Developmental Regulation of Membrane Type-5 Matrix Metalloproteinase (MT5-MMP) Expression in the Rat Nervous System</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>860</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/S0006-8993(00)02035-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0006-8993%2800%2902035-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10727639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvV2mu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=860&publication_year=2000&pages=174-177&issue=1%E2%80%932&author=D.+M.+Jaworski&title=Developmental+Regulation+of+Membrane+Type-5+Matrix+Metalloproteinase+%28MT5-MMP%29+Expression+in+the+Rat+Nervous+System&doi=10.1016%2FS0006-8993%2800%2902035-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system</span></div><div class="casAuthors">Jaworski, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">860</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">174-177</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">An intricate balance between extracellular matrix (ECM) synthesis and degrdn. must be maintained during developmental tissue remodeling.  Matrix metalloproteinases (MMPs) are the main mediators of ECM degrdn.  A subset of MMPs, referred to as membrane-type MMPs, contains a transmembrane domain that restricts protease activity at the cell surface.  Membrane type-5 MMP is predominantly expressed in the brain.  The present report is the first to demonstrate the temporal regulation and spatial distribution of MT5-MMP mRNA during nervous system development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOJQZn-ovmxrVg90H21EOLACvtfcHk0lgHj1ejkWdZtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvV2mu7k%253D&md5=a03ceb57f3a57d7d8b6cb4c22ecde53b</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2800%2902035-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252800%252902035-7%26sid%3Dliteratum%253Aachs%26aulast%3DJaworski%26aufirst%3DD.%2BM.%26atitle%3DDevelopmental%2520Regulation%2520of%2520Membrane%2520Type-5%2520Matrix%2520Metalloproteinase%2520%2528MT5-MMP%2529%2520Expression%2520in%2520the%2520Rat%2520Nervous%2520System%26jtitle%3DBrain%2520Res.%26date%3D2000%26volume%3D860%26issue%3D1%25E2%2580%25932%26spage%3D174%26epage%3D177%26doi%3D10.1016%2FS0006-8993%2800%2902035-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSouza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziff, E. B.</span></span> <span> </span><span class="NLM_article-title">Membrane Localization of Membrane Type 5 Matrix Metalloproteinase by AMPA Receptor Binding Protein and Cleavage of Cadherins</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2300</span>– <span class="NLM_lpage">2312</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3521-05.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.3521-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16495457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFCms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2300-2312&issue=8&author=S.+Moneaauthor=B.+A.+Jordanauthor=S.+Srivastavaauthor=S.+DeSouzaauthor=E.+B.+Ziff&title=Membrane+Localization+of+Membrane+Type+5+Matrix+Metalloproteinase+by+AMPA+Receptor+Binding+Protein+and+Cleavage+of+Cadherins&doi=10.1523%2FJNEUROSCI.3521-05.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins</span></div><div class="casAuthors">Monea, Sara; Jordan, Bryen A.; Srivastava, Sapna; DeSouza, Sunita; Ziff, Edward B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2300-2312</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) have been proposed to remodel the extracellular environment of neurons.  Here, we report that the metalloproteinase membrane-type 5 MMP (MT5-MMP) binds to AMPA receptor binding protein (ABP) and GRIP (glutamate receptor interaction protein), two related postsynaptic d. (PSD) PDZ (postsynaptic d.-95/Disks large/zona occludens-1) domain proteins that target AMPA receptors to synapses.  The MT5-MMP C terminus binds ABP PDZ5 and the two proteins coimmunopptd. and colocalized in heterologous cells and neurons.  MT5-MMP localized in filopodia at the tips of growth cones in young [2-5 d in vitro (DIV)] cultured embryonic hippocampal neurons, and at synapses in mature (21 DIV) neurons.  Its enrichment in synaptosomes also indicated a synaptic localization in the mature brain.  Deletion of the PDZ binding site impaired membrane trafficking of MT5-MMP, whereas exogenous ABP splice forms that are assocd. either with the plasma membrane or with the cytosol, resp., colocalized with MT5-MMP in synaptic spines or recruited MT5-MMP to intracellular compartments.  We show that endogenous MT5-MMP is found in cultured neurons and brain lysates in a proenzyme form that is activated by furin and degraded by auto-proteolysis.  We also identify cadherins as MT5-MMP substrates.  These results suggest that ABP directs MT5-MMP proteolytic activity to growth cones and synaptic sites in neurons, where it may regulate axon pathfinding or synapse remodeling through proteolysis of cadherins or other ECM or cell adhesion mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLg9JNlTy6RbVg90H21EOLACvtfcHk0lgHj1ejkWdZtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFCms7k%253D&md5=1213afc2727ed6f2693fee8b509d6910</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3521-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3521-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DMonea%26aufirst%3DS.%26aulast%3DJordan%26aufirst%3DB.%2BA.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DDeSouza%26aufirst%3DS.%26aulast%3DZiff%26aufirst%3DE.%2BB.%26atitle%3DMembrane%2520Localization%2520of%2520Membrane%2520Type%25205%2520Matrix%2520Metalloproteinase%2520by%2520AMPA%2520Receptor%2520Binding%2520Protein%2520and%2520Cleavage%2520of%2520Cadherins%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26issue%3D8%26spage%3D2300%26epage%3D2312%26doi%3D10.1523%2FJNEUROSCI.3521-05.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García-González, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2019.00244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3389%2Ffnagi.2019.00244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30740048" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1-19&issue=1&author=L.+Garc%C3%ADa-Gonz%C3%A1lezauthor=D.+Pilatauthor=K.+Barangerauthor=S.+Rivera&title=Emerging+Alternative+Proteinases+in+APP+Metabolism+and+Alzheimer%E2%80%99s+Disease+Pathogenesis%3A+A+Focus+on+MT1-MMP+and+MT5-MMP&doi=10.3389%2Ffnagi.2019.00244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2019.00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2019.00244%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Gonz%25C3%25A1lez%26aufirst%3DL.%26aulast%3DPilat%26aufirst%3DD.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DEmerging%2520Alternative%2520Proteinases%2520in%2520APP%2520Metabolism%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Pathogenesis%253A%2520A%2520Focus%2520on%2520MT1-MMP%2520and%2520MT5-MMP%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2019%26volume%3D11%26issue%3D1%26spage%3D1%26epage%3D19%26doi%3D10.3389%2Ffnagi.2019.00244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekine-Aizawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai-Azuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase (MMP) System in Brain: Identification and Characterization of Brain-Specific MMP Highly Expressed in Cerebellum</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1046/j.0953-816x.2001.01462.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1046%2Fj.0953-816x.2001.01462.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11264666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD3M3ktVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=935-948&issue=5&author=Y.+Sekine-Aizawaauthor=E.+Hamaauthor=K.+Watanabeauthor=S.+Tsubukiauthor=M.+Kanai-Azumaauthor=Y.+Kanaiauthor=H.+Araiauthor=H.+Aizawaauthor=N.+Iwataauthor=T.+C.+Saido&title=Matrix+Metalloproteinase+%28MMP%29+System+in+Brain%3A+Identification+and+Characterization+of+Brain-Specific+MMP+Highly+Expressed+in+Cerebellum&doi=10.1046%2Fj.0953-816x.2001.01462.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum</span></div><div class="casAuthors">Sekine-Aizawa Y; Hama E; Watanabe K; Tsubuki S; Kanai-Azuma M; Kanai Y; Arai H; Aizawa H; Iwata N; Saido T C</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">935-48</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">The matrix metalloproteinase (MMP) family, comprising more than 20 isoforms, modulates the extracellular milieu by degrading extracellular matrix (ECM) proteins.  Because MMP is one of the few groups of proteinases capable of hydrolysing insoluble fibrillar proteins, they are likely to play crucial roles in regulating both normal and pathophysiological processes in the brain.  However, little is yet known about their possible neuronal functions due presumably to their unusual redundancy and to the absence of a complete catalogue of isoforms.  As an initial step in understanding the MMP system in the brain, we analysed an expression spectrum of MMP in rat brain using RT-PCR and discovered a novel brain-specific MMP, MT5-MMP.  MT5-MMP was the predominant species among the nongelatinase-type isoforms in brain.  MT5-MMP, present in all brain tissues examined, was most strongly expressed in cerebellum and was localized in the membranous structures of expressing neurons, as assessed biochemically and immunohistochemically.  In cerebellum, its expression was regulated developmentally and was closely associated with dendritic tree formation of Purkinje cells, suggesting that MT5-MMP may contribute to neuronal development.  Furthermore, its stable postdevelopmental expression and colocalization with senile plaques in Alzheimer brain indicates possible roles in neuronal remodeling naturally occurring in adulthood and in regulating pathophysiological processes associated with advanced age.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdYDB0v_Dquz0SWnHPWbmmfW6udTcc2eaRPlq5mKESDrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3ktVeitQ%253D%253D&md5=82e61ac5186bd838f44ec2eb5e98fe05</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1046%2Fj.0953-816x.2001.01462.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0953-816x.2001.01462.x%26sid%3Dliteratum%253Aachs%26aulast%3DSekine-Aizawa%26aufirst%3DY.%26aulast%3DHama%26aufirst%3DE.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DTsubuki%26aufirst%3DS.%26aulast%3DKanai-Azuma%26aufirst%3DM.%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DAizawa%26aufirst%3DH.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26atitle%3DMatrix%2520Metalloproteinase%2520%2528MMP%2529%2520System%2520in%2520Brain%253A%2520Identification%2520and%2520Characterization%2520of%2520Brain-Specific%2520MMP%2520Highly%2520Expressed%2520in%2520Cerebellum%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2001%26volume%3D13%26issue%3D5%26spage%3D935%26epage%3D948%26doi%3D10.1046%2Fj.0953-816x.2001.01462.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrew, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellett, K. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinakaran, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, N. M.</span></span> <span> </span><span class="NLM_article-title">A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">19235</span>– <span class="NLM_lpage">19244</span>, <span class="refDoi"> DOI: 10.1074/jbc.R116.746032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.R116.746032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27474742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2ju7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=19235-19244&issue=37&author=R.+J.+Andrewauthor=K.+A.+B.+Kellettauthor=G.+Thinakaranauthor=N.+M.+Hooper&title=A+Greek+Tragedy%3A+The+Growing+Complexity+of+Alzheimer+Amyloid+Precursor+Protein+Proteolysis&doi=10.1074%2Fjbc.R116.746032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">A Greek tragedy: The growing complexity of Alzheimer amyloid precursor protein proteolysis</span></div><div class="casAuthors">Andrew, Robert J.; Kellett, Katherine A. B.; Thinakaran, Gopal; Hooper, Nigel M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">19235-19244</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Proteolysis of the amyloid precursor protein (APP) liberates various fragments including the proposed initiator of Alzheimer disease-assocd. dysfunctions, amyloid-β.  However, recent evidence suggests that the accepted view of APP proteolysis by the canonical α-, β-, and γ-secretases is simplistic, with the discovery of a no. of novel APP secretases (including δ- and η-secretases, alternative β-secretases) and addnl. metabolites, some of which may also cause synaptic dysfunction.  Furthermore, various proteins have been identified that interact with APP and modulate its cleavage by the secretases.  Here, we give an overview of the increasingly complex picture of APP proteolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNPewvE58BkLVg90H21EOLACvtfcHk0ljmGlUphlhRhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2ju7zL&md5=c48d252ee26d606f805df02cadf17ae6</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R116.746032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R116.746032%26sid%3Dliteratum%253Aachs%26aulast%3DAndrew%26aufirst%3DR.%2BJ.%26aulast%3DKellett%26aufirst%3DK.%2BA.%2BB.%26aulast%3DThinakaran%26aufirst%3DG.%26aulast%3DHooper%26aufirst%3DN.%2BM.%26atitle%3DA%2520Greek%2520Tragedy%253A%2520The%2520Growing%2520Complexity%2520of%2520Alzheimer%2520Amyloid%2520Precursor%2520Protein%2520Proteolysis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26issue%3D37%26spage%3D19235%26epage%3D19244%26doi%3D10.1074%2Fjbc.R116.746032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagase, H.</span></span> <span> </span><span class="NLM_article-title">Substrate Specificity of MMPs</span>. In  <i>Matrix Metalloproteinase Inhibitors in Cancer Therapy. Cancer Drug Discovery and Development</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clendeninn, N. J.</span>, <span class="NLM_string-name">Appelt, K.</span></span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2001</span>; Chapter 2, pp  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">66</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=39-66&author=H.+Nagaseauthor=N.+J.+Clendeninn&author=K.+Appelt&title=Matrix+Metalloproteinase+Inhibitors+in+Cancer+Therapy.+Cancer+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DH.%26atitle%3DSubstrate%2520Specificity%2520of%2520MMPs%26btitle%3DMatrix%2520Metalloproteinase%2520Inhibitors%2520in%2520Cancer%2520Therapy.%2520Cancer%2520Drug%2520Discovery%2520and%2520Development%26aulast%3DClendeninn%26aufirst%3DN.%2BJ.%26pub%3DHumana%2520Press%26date%3D2001%26spage%3D39%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases: What Do They Not Do? New Substrates and Biological Roles Identified by Murine Models and Proteomics</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1803</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2009.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbamcr.2009.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19800373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1803&publication_year=2010&pages=39-54&issue=1&author=D.+Rodr%C3%ADguezauthor=C.+J.+Morrisonauthor=C.+M.+Overall&title=Matrix+Metalloproteinases%3A+What+Do+They+Not+Do%3F+New+Substrates+and+Biological+Roles+Identified+by+Murine+Models+and+Proteomics&doi=10.1016%2Fj.bbamcr.2009.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics</span></div><div class="casAuthors">Rodriguez, David; Morrison, Charlotte J.; Overall, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1803</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-54</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The biol. roles of the matrix metalloproteinases (MMPs) have been traditionally assocd. with the degrdn. and turnover of most of the components of the extracellular matrix (ECM).  This functional misconception has been used for years to explain the involvement of the MMP family in developmental processes, cell homeostasis, and disease, and led to clin. trials of MMP inhibitors for the treatment of cancer that failed to meet their endpoints and cast a shadow on MMPs as druggable targets.  Accumulated evidence from a great variety of post-trial MMP degradomics studies, ranging from transgenic models to recent state-of-the-art proteomics screens, is changing the dogma about MMP functions.  MMPs regulate cell behavior through finely tuned and tightly controlled proteolytic processing of a large variety of signaling mols. that can also have beneficial effects in disease resoln.  Moreover, net proteolytic activity relies upon direct interactions between the different protease and protease inhibitor families, interconnected in a complex protease web, with MMPs acting as key nodal components.  Such complexity renders simple interpretation of Mmp knockout mice very difficult.  Indeed, the phenotype of these models reveals the response of a complex system to the loss of one protease rather than necessarily a direct effect of the lack of functional activity of a protease.  Such a shift in the MMP functional paradigm, together with the difficulties assocd. with current methods of studying proteases thus highlights the need for new high content degradomics approaches to uncover and annotate MMP activities in vivo and identify novel interactions within the protease web.  Integration of these techniques with specifically designed animal models for final validation should lay the foundations for the development of new inhibitors that specifically target disease-related MMPs and/or their upstream effectors that cause deleterious effects in disease, while sparing MMP functions that are protective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxplhmF1lbo7Vg90H21EOLACvtfcHk0ljmGlUphlhRhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKitL8%253D&md5=d072b56c4c2be7f497be6af79a649443</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2009.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2009.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DD.%26aulast%3DMorrison%26aufirst%3DC.%2BJ.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DMatrix%2520Metalloproteinases%253A%2520What%2520Do%2520They%2520Not%2520Do%253F%2520New%2520Substrates%2520and%2520Biological%2520Roles%2520Identified%2520by%2520Murine%2520Models%2520and%2520Proteomics%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2010%26volume%3D1803%26issue%3D1%26spage%3D39%26epage%3D54%26doi%3D10.1016%2Fj.bbamcr.2009.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">Updated Biological Roles for Matrix Metalloproteinases and New “intracellular” substrates Revealed by Degradomics</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">10830</span>– <span class="NLM_lpage">10845</span>, <span class="refDoi"> DOI: 10.1021/bi901656f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi901656f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlaltbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=10830-10845&issue=46&author=G.+S.+Butlerauthor=C.+M.+Overall&title=Updated+Biological+Roles+for+Matrix+Metalloproteinases+and+New+%E2%80%9Cintracellular%E2%80%9D+substrates+Revealed+by+Degradomics&doi=10.1021%2Fbi901656f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Updated Biological Roles for Matrix Metalloproteinases and New "Intracellular" Substrates Revealed by Degradomics</span></div><div class="casAuthors">Butler, Georgina S.; Overall, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">10830-10845</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Shotgun proteomics techniques are conceptually unbiased, but data interpretation and follow-up expts. are often constrained by dogma, established beliefs that are accepted without question, that can dil. the power of proteomics and hinder scientific progress.  Proteomics and degradomics, the characterization of all proteases, inhibitors, and protease substrates by genomic and proteomic techniques, have exponentially expanded the known substrate repertoire of the matrix metalloproteinases (MMPs), even to include intracellular proteins with newly recognized extracellular functions.  Thus, the dogma that MMPs are dowdy degraders of extracellular matrix has been resolutely overturned, and the metamorphosis of MMPs into modulators of multiple signaling pathways has been facilitated.  Here we review progress made in the field of degradomics and present a current view of the MMP degradome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOI1zIjVErvbVg90H21EOLACvtfcHk0lgdKbmUSClV8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlaltbrO&md5=1568a3370819d7fd0a945e6340a3b49e</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fbi901656f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi901656f%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DG.%2BS.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DUpdated%2520Biological%2520Roles%2520for%2520Matrix%2520Metalloproteinases%2520and%2520New%2520%25E2%2580%259Cintracellular%25E2%2580%259D%2520substrates%2520Revealed%2520by%2520Degradomics%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26issue%3D46%26spage%3D10830%26epage%3D10845%26doi%3D10.1021%2Fbi901656f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maskos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, W.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases</span>. <i>Mol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1385/MB:25:3:241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1385%2FMB%3A25%3A3%3A241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=14668538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2003&pages=241-266&issue=3&author=K.+Maskosauthor=W.+Bode&title=Structural+Basis+of+Matrix+Metalloproteinases+and+Tissue+Inhibitors+of+Metalloproteinases&doi=10.1385%2FMB%3A25%3A3%3A241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases</span></div><div class="casAuthors">Maskos, Klaus; Bode, Wolfram</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-266</span>CODEN:
                <span class="NLM_cas:coden">MLBOEO</span>;
        ISSN:<span class="NLM_cas:issn">1073-6085</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) constitute a family of secreted/cell-surface-anchored multidomain Zn endopeptidases, all of which exhibit a catalytic domain of a common metzincin-like topol., and which are involved in the degrdn. of the extracellular matrix but also in a no. of other biol. processes.  Normally, the proteolytic activity of the MMPs is precisely regulated by their main endogenous protein inhibitors, in particular the tissue inhibitors of metalloproteinases (TIMPs).  Disruption of this balance results in serious diseases such as arthritis, tumor growth, and tumor metastasis, rendering the MMPs attractive targets for inhibition therapy.  Knowledge of their tertiary structures is crucial for a full understanding of their functional properties and their assocns. with dysfunctions.  Since the reports of the 1st at. structures of MMPs and TIMPs in 1994, considerable structural information has become available about both of these families of substances.  Many of the MMP structures have been detd. as complexes with synthetic inhibitors, facilitating knowledge-based drug design.  This review focuses on the currently available 3-dimensional structural information about MMPs and TIMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3tLSdkDbU1LVg90H21EOLACvtfcHk0lgdKbmUSClV8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cnsb4%253D&md5=5782531e69bea3a0bacf95137aad7925</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1385%2FMB%3A25%3A3%3A241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FMB%253A25%253A3%253A241%26sid%3Dliteratum%253Aachs%26aulast%3DMaskos%26aufirst%3DK.%26aulast%3DBode%26aufirst%3DW.%26atitle%3DStructural%2520Basis%2520of%2520Matrix%2520Metalloproteinases%2520and%2520Tissue%2520Inhibitors%2520of%2520Metalloproteinases%26jtitle%3DMol.%2520Biotechnol.%26date%3D2003%26volume%3D25%26issue%3D3%26spage%3D241%26epage%3D266%26doi%3D10.1385%2FMB%3A25%3A3%3A241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bode, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomis-Rüth, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stöckler, W.</span></span> <span> </span><span class="NLM_article-title">Astacins, Serralysins, Snake Venom and Matrix Metalloproteinases Exhibit Identical Zinc-Binding Environments (HEXXHXXGXXH and Met-Turn) and Topologies and Should Be Grouped into a Common Family, the “Metzincins.</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>331</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(93)80312-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2F0014-5793%2893%2980312-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=8405391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK2cXis1aqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1993&pages=134-140&issue=1%E2%80%932&author=W.+Bodeauthor=F.+X.+Gomis-R%C3%BCthauthor=W.+St%C3%B6ckler&title=Astacins%2C+Serralysins%2C+Snake+Venom+and+Matrix+Metalloproteinases+Exhibit+Identical+Zinc-Binding+Environments+%28HEXXHXXGXXH+and+Met-Turn%29+and+Topologies+and+Should+Be+Grouped+into+a+Common+Family%2C+the+%E2%80%9CMetzincins.&doi=10.1016%2F0014-5793%2893%2980312-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'</span></div><div class="casAuthors">Bode, Wolfram; Gomis-Rueth, Franz-Xaver; Stoeckler, Walter</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">134-40</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The X-ray crystal structures of two zinc endopeptidases, astacin from crayfish, and adamalysin II from snake venom, reveal a strong overall topol. equivalence and virtually identical extended HEXXHXXGXXH zinc-binding segments, but in addn. a methionine-contg. turn of similar conformation (the 'Met-turn'), which forms a hydrophobic basis for the zinc ion and the three liganding histidine residues.  These two features are also present in a similar arrangement in the matrix metalloproteinases (matrixins) and in the large bacterial Serratia proteinase-like peptidases (serralysins).  The authors suggest that these four proteinases represent members of distinct subfamilies which can be grouped together in a family, for which the authors propose the designation, metzincins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq9YhUaYiBDLVg90H21EOLACvtfcHk0lhLkGmKd1GPTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1aqsA%253D%253D&md5=e9926789857268493a3948d4c6bb76e4</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2893%2980312-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252893%252980312-I%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DW.%26aulast%3DGomis-R%25C3%25BCth%26aufirst%3DF.%2BX.%26aulast%3DSt%25C3%25B6ckler%26aufirst%3DW.%26atitle%3DAstacins%252C%2520Serralysins%252C%2520Snake%2520Venom%2520and%2520Matrix%2520Metalloproteinases%2520Exhibit%2520Identical%2520Zinc-Binding%2520Environments%2520%2528HEXXHXXGXXH%2520and%2520Met-Turn%2529%2520and%2520Topologies%2520and%2520Should%2520Be%2520Grouped%2520into%2520a%2520Common%2520Family%252C%2520the%2520%25E2%2580%259CMetzincins.%26jtitle%3DFEBS%2520Lett.%26date%3D1993%26volume%3D331%26issue%3D1%25E2%2580%25932%26spage%3D134%26epage%3D140%26doi%3D10.1016%2F0014-5793%2893%2980312-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomis-Rüth, F. X.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases: Fold and Function of Their Catalytic Domains</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1803</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2009.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbamcr.2009.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19374923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1803&publication_year=2010&pages=20-28&issue=1&author=C.+Tallantauthor=A.+Marreroauthor=F.+X.+Gomis-R%C3%BCth&title=Matrix+Metalloproteinases%3A+Fold+and+Function+of+Their+Catalytic+Domains&doi=10.1016%2Fj.bbamcr.2009.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases: Fold and function of their catalytic domains</span></div><div class="casAuthors">Tallant, Cynthia; Marrero, Aniebrys; Gomis-Rueth, F. Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1803</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-28</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are Zn-dependent protein and peptide hydrolases.  They have been almost exclusively studied in vertebrates and 23 paralogs are present in humans.  They are widely involved in metab. regulation through both extensive protein degrdn. and selective peptide-bond hydrolysis.  If MMPs are not subjected to exquisite spatial and temporal control, they become destructive, which can lead to pathologies such as arthritis, inflammation, and cancer.  The main therapeutic strategy to combat the dysregulation of MMPs is the design of drugs to target their catalytic domains, for which purpose detailed structural knowledge is essential.  The catalytic domains of 13 MMPs have been structurally analyzed so far and they belong to the "metzincin" clan of metalloendopeptidases.  These compact, spherical, ∼165-residue mols. are divided by a shallow substrate-binding crevice into an upper and a lower subdomain.  The mols. have an extended Zn-binding motif, HEXXHXXGXXH, which contains 3 Zn-binding His residues and a Glu residue that acts as a general base/acid during catalysis.  In addn., a conserved Met residue lying within a "Met-turn" provides a hydrophobic base for the Zn-binding site.  Further earmarks of MMPs are 3 α-helixes and a 5-stranded β-sheet, as well as at least 2 Ca2+ sites and a 2nd Zn2+ with structural functions.  Most MMPs are secreted as inactive zymogens with an N-terminal ∼80-residue pro-domain, which folds into a 3-helix globular domain and inhibits the catalytic Zn through a Cys residue imbedded in a conserved motif, PRCGXPD.  Removal of the pro-domain enables access of a catalytic solvent mol. and substrate mols. to the active site cleft, which harbors a hydrophobic S1'-pocket as main determinant of specificity.  Together with the catalytic Zn2+ ion, this pocket has been targeted since the onset of drug development against MMPs.  However, the inability of 1st- and 2nd-generation inhibitors to distinguish between different MMPs has led to failures in clin. trials.  More recent approaches have produced highly specific inhibitors to tackle selected MMPs, thus anticipating the development of more successful drugs in the near future.  Further strategies should include the detailed structural characterization of the remaining 10 MMPs to assist in achieving higher drug selectivity.  Here, the authors discuss the general architecture of MMP catalytic domains and its implication in function, zymogenic activation, and drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ2E3a08DbpbVg90H21EOLACvtfcHk0lhLkGmKd1GPTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKit7g%253D&md5=2bc4aa7e4f23c51da4404bf725c1bf30</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2009.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2009.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DMarrero%26aufirst%3DA.%26aulast%3DGomis-R%25C3%25BCth%26aufirst%3DF.%2BX.%26atitle%3DMatrix%2520Metalloproteinases%253A%2520Fold%2520and%2520Function%2520of%2520Their%2520Catalytic%2520Domains%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2010%26volume%3D1803%26issue%3D1%26spage%3D20%26epage%3D28%26doi%3D10.1016%2Fj.bbamcr.2009.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aureli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gioia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerbara, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasciglione, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascenzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coletta, M.</span></span> <span> </span><span class="NLM_article-title">Structural Bases for Substrate and Inhibitor Recognition by Matrix Metalloproteinases</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">2192</span>– <span class="NLM_lpage">2222</span>, <span class="refDoi"> DOI: 10.2174/092986708785747490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F092986708785747490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=18781944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFCksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2192-2222&issue=22&author=L.+Aureliauthor=M.+Gioiaauthor=I.+Cerbaraauthor=S.+Monacoauthor=G.+Fasciglioneauthor=S.+Mariniauthor=P.+Ascenziauthor=A.+Topaiauthor=M.+Coletta&title=Structural+Bases+for+Substrate+and+Inhibitor+Recognition+by+Matrix+Metalloproteinases&doi=10.2174%2F092986708785747490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Structural bases for substrate and inhibitor recognition by matrix metalloproteinases</span></div><div class="casAuthors">Aureli, Loretta; Gioia, Magda; Cerbara, Ilaria; Monaco, Susanna; Fasciglione, Giovanni Francesco; Marini, Stefano; Ascenzi, Paolo; Topai, Alessandra; Coletta, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2192-2222</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of Zn-dependent metalloproteinases which are involved in the proteolytic processing of several components of the extracellular matrix.  As a consequence, MMPs are implicated in several physiol. and pathol. processes, such as skeletal growth and remodeling, wound healing, cancer, arthritis, and multiple sclerosis, raising very widespread interest toward this class of enzymes as potential therapeutic targets.  Here, structure-function relations are discussed to highlight the role of different MMP domains on substrate/inhibitor recognition and processing and to attempt the formulation of advanced guidelines, based on natural substrates, for the design of inhibitors more efficient in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-8qHgMffS-LVg90H21EOLACvtfcHk0lhLkGmKd1GPTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFCksbg%253D&md5=9e7ee25ffcf16877cca6463b6f5559c3</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.2174%2F092986708785747490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785747490%26sid%3Dliteratum%253Aachs%26aulast%3DAureli%26aufirst%3DL.%26aulast%3DGioia%26aufirst%3DM.%26aulast%3DCerbara%26aufirst%3DI.%26aulast%3DMonaco%26aufirst%3DS.%26aulast%3DFasciglione%26aufirst%3DG.%26aulast%3DMarini%26aufirst%3DS.%26aulast%3DAscenzi%26aufirst%3DP.%26aulast%3DTopai%26aufirst%3DA.%26aulast%3DColetta%26aufirst%3DM.%26atitle%3DStructural%2520Bases%2520for%2520Substrate%2520and%2520Inhibitor%2520Recognition%2520by%2520Matrix%2520Metalloproteinases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26issue%3D22%26spage%3D2192%26epage%3D2222%26doi%3D10.2174%2F092986708785747490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A.</span></span> <span> </span><span class="NLM_article-title">On the Size of the Active Site in Proteases. I. Papain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(67)80055-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0006-291X%2867%2980055-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=6035483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=157-162&issue=2&author=I.+Schechterauthor=A.+Berger&title=On+the+Size+of+the+Active+Site+in+Proteases.+I.+Papain&doi=10.1016%2FS0006-291X%2867%2980055-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">On the size of the active site in proteases.  I.  Papain</span></div><div class="casAuthors">Schechter, Israel; Berger, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-62</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The action of papain on 40 diastereoisomeric peptides of alanine, ranging in length from Ala2 to Ala6, was studied to investigate the size of the active site.  The variations observed in the rates of hydrolysis lead to the conclusion that papain has a large active site which extends over ∼25 A. and can be divided into 7 "subsites," each accommodating 1 amino acid residue of the peptide substrate.  The subsites are located on both sides of the catalytic site, 4 on the one side and 3 on the other.  It is postulated that a long "groove" analogous to that found by x-ray analysis in lysozyme is present.  The substrate is believed to fit into the groove, binding to several subsites of specific geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_kZeRVAOVyrVg90H21EOLACvtfcHk0li1OkXAiem6xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D&md5=a58ceccdbb5cc5c021af06912835f77c</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2867%2980055-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252867%252980055-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DOn%2520the%2520Size%2520of%2520the%2520Active%2520Site%2520in%2520Proteases.%2520I.%2520Papain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1967%26volume%3D27%26issue%3D2%26spage%3D157%26epage%3D162%26doi%3D10.1016%2FS0006-291X%2867%2980055-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span> <i>PyMOL Molecular
Graphics
System</i>, <span class="NLM_edition">version 2.3.2</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>, <span class="NLM_year">2020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+PyMOL+Molecular%0AGraphics%0ASystem%2C+version+2.3.2%3B+Schr%C3%B6dinger%2C+LLC%2C+2020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DPyMOL%2520Molecular%250AGraphics%250ASystem%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pascual-Teresa, B.</span></span> <span> </span><span class="NLM_article-title">Targeting Matrix Metalloproteinases: Exploring the Dynamics of the S1′ Pocket in the Design of Selective, Small Molecule Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">10205</span>– <span class="NLM_lpage">10219</span>, <span class="refDoi"> DOI: 10.1021/jm500505f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500505f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10205-10219&issue=24&author=B.+Fabreauthor=A.+Ramosauthor=B.+De+Pascual-Teresa&title=Targeting+Matrix+Metalloproteinases%3A+Exploring+the+Dynamics+of+the+S1%E2%80%B2+Pocket+in+the+Design+of+Selective%2C+Small+Molecule+Inhibitors&doi=10.1021%2Fjm500505f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Matrix Metalloproteinases: Exploring the Dynamics of the S1' Pocket in the Design of Selective, Small Molecule Inhibitors</span></div><div class="casAuthors">Fabre, Benjamin; Ramos, Ana; de Pascual-Teresa, Beatriz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10205-10219</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are important targets for pathol. conditions such as arthritis, chronic obstructive pulmonary disease, and cancer.  The failure of the first broad-spectrum MMP inhibitors in clin. trials has led researchers to address the selectivity as one of their main objectives.  The S1' pocket has been widely used to modulate the selectivity of these enzymes because it displays the highest variability in length and shape among MMPs.  In this review, we encourage medicinal chemists to also consider the dynamics of this pocket as an important parameter to achieve the desired selectivity.  To support this proposal, we collect examples from the literature where the flexibility of the S1' pocket was highlighted as a relevant and significant issue affecting selectivity.  We also review the exptl. studies on the dynamics of this pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVMrlJGwAibrVg90H21EOLACvtfcHk0li1OkXAiem6xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrnF&md5=7ad8fad793d1bff66bf6e5c7275834ca</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjm500505f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500505f%26sid%3Dliteratum%253Aachs%26aulast%3DFabre%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DDe%2BPascual-Teresa%26aufirst%3DB.%26atitle%3DTargeting%2520Matrix%2520Metalloproteinases%253A%2520Exploring%2520the%2520Dynamics%2520of%2520the%2520S1%25E2%2580%25B2%2520Pocket%2520in%2520the%2520Design%2520of%2520Selective%252C%2520Small%2520Molecule%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D24%26spage%3D10205%26epage%3D10219%26doi%3D10.1021%2Fjm500505f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, B.</span></span> <span> </span><span class="NLM_article-title">Recent Developments in the Design of Specific Matrix Metalloproteinase Inhibitors Aided by Structural and Computational Studies</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.2174/1381612053382115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F1381612053382115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15723627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVKnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=295-322&issue=3&author=B.+Rao&title=Recent+Developments+in+the+Design+of+Specific+Matrix+Metalloproteinase+Inhibitors+Aided+by+Structural+and+Computational+Studies&doi=10.2174%2F1381612053382115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the design of specific matrix metalloproteinase inhibitors aided by structural and computational studies</span></div><div class="casAuthors">Rao, B. Govinda</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-322</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It was 10 years since a 3-dimensional structure of the catalytic domain of a Matrix Metalloprotease (MMP) was revealed for the 1st time in 1994.  More than 80 structures of different MMPs in apo and inhibited forms, detd. by x-ray crystallog. and NMR methods, were published by the end of year 2003.  A large no. of very potent inhibitors were disclosed in published and patent literature.  Several MMP inhibitors entered clin. trials for the treatment of cancer and arthritis.  Most of the 1st generation inhibitors have hydroxamic acid as the Zinc-binding group and have limited specificity.  With the failure of these inhibitors in clin. trials, more efforts were directed to the design of specific inhibitors with different Zn-binding groups in recent years.  This review will summarize all the published structural information and focus on the inhibitors that were designed to take advantage of the nonprime side of the MMP active site using structural information and computational anal.  Representative structures from all MMPs are aligned to a target structure to provide a better understanding of the similarities and differences of the active site pockets.  This anal. supports the view that the differences in the nonprime side pockets provide better opportunities for designing inhibitors with higher specificity.  Published information on all the Zinc-binding groups of MMP inhibitors is reviewed for the 1st time.  Pros and cons of inhibitors with non-hydroxamate Zinc-binding groups in terms of specificity, toxicity, and pharmacokinetic properties are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4xnMcPhOoqrVg90H21EOLACvtfcHk0li1OkXAiem6xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVKnsrw%253D&md5=db7c6b330cdce553acaca12dd3a1d1f8</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.2174%2F1381612053382115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612053382115%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DB.%26atitle%3DRecent%2520Developments%2520in%2520the%2520Design%2520of%2520Specific%2520Matrix%2520Metalloproteinase%2520Inhibitors%2520Aided%2520by%2520Structural%2520and%2520Computational%2520Studies%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2005%26volume%3D11%26issue%3D3%26spage%3D295%26epage%3D322%26doi%3D10.2174%2F1381612053382115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nation, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagare, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Orazio, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachicano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepehrband, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buennagel, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benzinger, T. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toga, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">Blood-brain Barrier Breakdown Is an Early Biomarker of Human Cognitive Dysfunction</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1038/s41591-018-0297-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fs41591-018-0297-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30643288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvFSguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=270-276&issue=2&author=D.+A.+Nationauthor=M.+D.+Sweeneyauthor=A.+Montagneauthor=A.+P.+Sagareauthor=L.+M.+D%E2%80%99Orazioauthor=M.+Pachicanoauthor=F.+Sepehrbandauthor=A.+R.+Nelsonauthor=D.+P.+Buennagelauthor=M.+G.+Harringtonauthor=T.+L.+S.+Benzingerauthor=A.+M.+Faganauthor=J.+M.+Ringmanauthor=L.+S.+Schneiderauthor=J.+C.+Morrisauthor=H.+C.+Chuiauthor=M.+Lawauthor=A.+W.+Togaauthor=B.+V.+Zlokovic&title=Blood-brain+Barrier+Breakdown+Is+an+Early+Biomarker+of+Human+Cognitive+Dysfunction&doi=10.1038%2Fs41591-018-0297-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction</span></div><div class="casAuthors">Nation, Daniel A.; Sweeney, Melanie D.; Montagne, Axel; Sagare, Abhay P.; D'Orazio, Lina M.; Pachicano, Maricarmen; Sepehrband, Farshid; Nelson, Amy R.; Buennagel, David P.; Harrington, Michael G.; Benzinger, Tammie L. S.; Fagan, Anne M.; Ringman, John M.; Schneider, Lon S.; Morris, John C.; Chui, Helena C.; Law, Meng; Toga, Arthur W.; Zlokovic, Berislav V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">270-276</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Vascular contributions to cognitive impairment are increasingly recognized1-5 as shown by neuropathol.6,7, neuroimaging4,8-11, and cerebrospinal fluid biomarker4,12 studies.  Moreover, small vessel disease of the brain has been estd. to contribute to approx. 50% of all dementias worldwide, including those caused by Alzheimer's disease (AD)3,4,13.  Vascular changes in AD have been typically attributed to the vasoactive and/or vasculotoxic effects of amyloid-β (Aβ)3,11,14, and more recently tau15.  Animal studies suggest that Aβ and tau lead to blood vessel abnormalities and blood-brain barrier (BBB) breakdown14-16.  Although neurovascular dysfunction3,11 and BBB breakdown develop early in AD1,4,5,8-10,12,13, how they relate to changes in the AD classical biomarkers Aβ and tau, which also develop before dementia17, remains unknown.  To address this question, we studied brain capillary damage using a novel cerebrospinal fluid biomarker of BBB-assocd. capillary mural cell pericyte, sol. platelet-derived growth factor receptor-β8,18, and regional BBB permeability using dynamic contrast-enhanced magnetic resonance imaging8-10.  Our data show that individuals with early cognitive dysfunction develop brain capillary damage and BBB breakdown in the hippocampus irresp. of Alzheimer's Aβ and/or tau biomarker changes, suggesting that BBB breakdown is an early biomarker of human cognitive dysfunction independent of Aβ and tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvlm03Rnw7FrVg90H21EOLACvtfcHk0lgSVSzGA3IgiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvFSguro%253D&md5=cea06fe825ac40408c4e224601c92d10</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1038%2Fs41591-018-0297-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-018-0297-y%26sid%3Dliteratum%253Aachs%26aulast%3DNation%26aufirst%3DD.%2BA.%26aulast%3DSweeney%26aufirst%3DM.%2BD.%26aulast%3DMontagne%26aufirst%3DA.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DD%25E2%2580%2599Orazio%26aufirst%3DL.%2BM.%26aulast%3DPachicano%26aufirst%3DM.%26aulast%3DSepehrband%26aufirst%3DF.%26aulast%3DNelson%26aufirst%3DA.%2BR.%26aulast%3DBuennagel%26aufirst%3DD.%2BP.%26aulast%3DHarrington%26aufirst%3DM.%2BG.%26aulast%3DBenzinger%26aufirst%3DT.%2BL.%2BS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DRingman%26aufirst%3DJ.%2BM.%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DChui%26aufirst%3DH.%2BC.%26aulast%3DLaw%26aufirst%3DM.%26aulast%3DToga%26aufirst%3DA.%2BW.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DBlood-brain%2520Barrier%2520Breakdown%2520Is%2520an%2520Early%2520Biomarker%2520of%2520Human%2520Cognitive%2520Dysfunction%26jtitle%3DNat.%2520Med.%26date%3D2019%26volume%3D25%26issue%3D2%26spage%3D270%26epage%3D276%26doi%3D10.1038%2Fs41591-018-0297-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montagne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s Disease: A Matter of Blood-brain Barrier Dysfunction?</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>214</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3151</span>– <span class="NLM_lpage">3169</span>, <span class="refDoi"> DOI: 10.1084/jem.20171406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1084%2Fjem.20171406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29061693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWmt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2017&pages=3151-3169&issue=11&author=A.+Montagneauthor=Z.+Zhaoauthor=B.+V.+Zlokovic&title=Alzheimer%E2%80%99s+Disease%3A+A+Matter+of+Blood-brain+Barrier+Dysfunction%3F&doi=10.1084%2Fjem.20171406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: a matter of blood-brain barrier dysfunction?</span></div><div class="casAuthors">Montagne, Axel; Zhao, Zhen; Zlokovic, Berislav V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3151-3169</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">1540-9538</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) keeps neurotoxic plasma-derived components, cells, and pathogens out of the brain.  An early BBB breakdown and/or dysfunction have been shown in Alzheimer's disease (AD) before dementia, neurodegeneration and/or brain atrophy occur.  However, the role of BBB breakdown in neurodegenerative disorders is still not fully understood.  Here, we examine BBB breakdown in animal models frequently used to study the pathophysiol. of AD, including transgenic mice expressing human amyloid-β precursor protein, presenilin 1, and tau mutations, and apolipoprotein E, the strongest genetic risk factor for AD.  We discuss the role of BBB breakdown and dysfunction in neurodegenerative process, pitfalls in BBB measurements, and how targeting the BBB can influence the course of neurol. disorder.  Finally, we comment on future approaches and models to better define, at the cellular and mol. level, the underlying mechanisms between BBB breakdown and neurodegeneration as a basis for developing new therapies for BBB repair to control neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq41vuMCIwSUbVg90H21EOLACvtfcHk0lgSVSzGA3IgiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWmt7zJ&md5=eb18daf55d05460948c3065c92861f0c</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1084%2Fjem.20171406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20171406%26sid%3Dliteratum%253Aachs%26aulast%3DMontagne%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Matter%2520of%2520Blood-brain%2520Barrier%2520Dysfunction%253F%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2017%26volume%3D214%26issue%3D11%26spage%3D3151%26epage%3D3169%26doi%3D10.1084%2Fjem.20171406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rempe, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartz, A. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, B.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases in the Brain and Blood-brain Barrier: Versatile Breakers and Makers</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1481</span>– <span class="NLM_lpage">1507</span>, <span class="refDoi"> DOI: 10.1177/0271678X16655551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1177%2F0271678X16655551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27323783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVyrsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=1481-1507&issue=9&author=R.+G.+Rempeauthor=A.+M.+S.+Hartzauthor=B.+Bauer&title=Matrix+Metalloproteinases+in+the+Brain+and+Blood-brain+Barrier%3A+Versatile+Breakers+and+Makers&doi=10.1177%2F0271678X16655551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers</span></div><div class="casAuthors">Rempe, Ralf G.; Hartz, Anika M. S.; Bauer, Bjoern</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1481-1507</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Matrix metalloproteinases are versatile endopeptidases with many different functions in the body in health and disease.  In the brain, matrix metalloproteinases are crit. for tissue formation, neuronal network remodeling, and blood-brain barrier integrity.  Many reviews have been published on matrix metalloproteinases before, most of which focus on the two best studied matrix metalloproteinases, the gelatinases MMP-2 and MMP-9, and their role in one or two diseases.  In this review, we provide a broad overview of the role various matrix metalloproteinases play in brain disorders.  We summarize and review current knowledge and understanding of matrix metalloproteinases in the brain and at the blood-brain barrier in neuroinflammation, multiple sclerosis, cerebral aneurysms, stroke, epilepsy, Alzheimer's disease, Parkinson's disease, and brain cancer.  We discuss the detrimental effects matrix metalloproteinases can have in these conditions, contributing to blood-brain barrier leakage, neuroinflammation, neurotoxicity, demyelination, tumor angiogenesis, and cancer metastasis.  We also discuss the beneficial role matrix metalloproteinases can play in neuroprotection and anti-inflammation.  Finally, we address matrix metalloproteinases as potential therapeutic targets.  Together, in this comprehensive review, we summarize current understanding and knowledge of matrix metalloproteinases in the brain and at the blood-brain barrier in brain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoybuTHruCv67Vg90H21EOLACvtfcHk0lgSVSzGA3IgiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVyrsbjP&md5=e1c7f23e71b3b8a06bdcd99ff652cbb5</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1177%2F0271678X16655551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0271678X16655551%26sid%3Dliteratum%253Aachs%26aulast%3DRempe%26aufirst%3DR.%2BG.%26aulast%3DHartz%26aufirst%3DA.%2BM.%2BS.%26aulast%3DBauer%26aufirst%3DB.%26atitle%3DMatrix%2520Metalloproteinases%2520in%2520the%2520Brain%2520and%2520Blood-brain%2520Barrier%253A%2520Versatile%2520Breakers%2520and%2520Makers%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2016%26volume%3D36%26issue%3D9%26spage%3D1481%26epage%3D1507%26doi%3D10.1177%2F0271678X16655551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span> <span> </span><span class="NLM_article-title">MMP-9 Inhibition: A Therapeutic Strategy in Ischemic Stroke</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1007/s12035-013-8538-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs12035-013-8538-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24026771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCitrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=563-573&issue=1&author=M.+Chaturvediauthor=L.+Kaczmarek&title=MMP-9+Inhibition%3A+A+Therapeutic+Strategy+in+Ischemic+Stroke&doi=10.1007%2Fs12035-013-8538-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke</span></div><div class="casAuthors">Chaturvedi, Mayank; Kaczmarek, Leszek</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">563-573</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Ischemic stroke is a leading cause of disability worldwide.  In cerebral ischemia there is an enhanced expression of matrix metallo-proteinase-9 (MMP-9), which has been assocd. with various complications including excitotoxicity, neuronal damage, apoptosis, blood-brain barrier (BBB) opening leading to cerebral edema, and hemorrhagic transformation.  Moreover, the tissue plasminogen activator (tPA), which is the only US-FDA approved treatment of ischemic stroke, has a brief 3 to 4 h time window and it has been proposed that detrimental effects of tPA beyond the 3 h since the onset of stroke are derived from its ability to activate MMP-9 that in turn contributes to the breakdown of BBB.  Therefore, the available literature suggests that MMP-9 inhibition can be of therapeutic importance in ischemic stroke.  Hence, combination therapies of MMP-9 inhibitor along with tPA can be beneficial in ischemic stroke.  In this review we will discuss the current status of various strategies which have shown neuroprotection and extension of thrombolytic window by directly or indirectly inhibiting MMP-9 activity.  In the introductory part of the review, we briefly provide an overview on ischemic stroke, commonly used models of ischemic stroke and a role of MMP-9 in ischemia.  In next part, the literature is organized as various approaches which have proven neuroprotective effects through direct or indirect decrease in MMP-9 activity, namely, using biotherapeutics, involving MMP-9 gene inhibition using viral vectors; using endogenous inhibitor of MMP-9, repurposing of old drugs such as minocycline, new chem. entities like DP-b99, and finally other approaches like therapeutic hypothermia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2kGS9IvaXvrVg90H21EOLACvtfcHk0lgk6JDF5PU9FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCitrvP&md5=21828bf3861b708e60c7d90e367aff33</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1007%2Fs12035-013-8538-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-013-8538-z%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DM.%26aulast%3DKaczmarek%26aufirst%3DL.%26atitle%3DMMP-9%2520Inhibition%253A%2520A%2520Therapeutic%2520Strategy%2520in%2520Ischemic%2520Stroke%26jtitle%3DMol.%2520Neurobiol.%26date%3D2014%26volume%3D49%26issue%3D1%26spage%3D563%26epage%3D573%26doi%3D10.1007%2Fs12035-013-8538-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ahmady, Z. S.</span></span> <span> </span><span class="NLM_article-title">Selective Drug Delivery Approaches to Lesioned Brain through Blood Brain Barrier Disruption</span>. <i>Expert Opin. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1080/17425247.2018.1444601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1080%2F17425247.2018.1444601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29466890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks1Gqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=335-349&issue=4&author=Z.+S.+Al-Ahmady&title=Selective+Drug+Delivery+Approaches+to+Lesioned+Brain+through+Blood+Brain+Barrier+Disruption&doi=10.1080%2F17425247.2018.1444601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Selective drug delivery approaches to lesioned brain through blood brain barrier disruption</span></div><div class="casAuthors">Al-Ahmady, Zahraa S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Delivery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">335-349</span>CODEN:
                <span class="NLM_cas:coden">EODDAW</span>;
        ISSN:<span class="NLM_cas:issn">1742-5247</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: The development of therapeutics for central nervous system (CNS) disorders is still considered a challenging area in drug development due to insufficient translocation through the blood-brain barrier (BBB).  Under normal conditions, BBB restrict the penetration of more than 98% of blood-borne mols. including drugs to the CNS.  However, recent research findings have proven that the nature of the BBB is altered in several neurol. conditions.  This complexity encourages revisiting drug delivery strategies to the CNS as this can give a wide range of opportunities for CNS drug development.: This review focuses on nanotechnol.-based drug delivery platforms designed for selective recruitment into the lesioned brain by taking advantages of BBB disruption that is assocd. with certain neurol. conditions.: Current CNS therapeutic strategies do not fully address the pathophysiol. adaptation of BBB in their design.  The lack of selective delivery to the brain lesions has been the culprit behind the failure of many CNS therapeutics.  This highlighted the need for smart designs of advanced drug delivery systems that take advantage of BBB structural changes in CNS diseases.  Recently, promising examples have been reported in this area, however, more work is still required beyond the preclin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2cT7q9jWEZLVg90H21EOLACvtfcHk0lgk6JDF5PU9FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks1Gqtbc%253D&md5=ed6d813b6f146befb1e20bbb6744ea6b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1080%2F17425247.2018.1444601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425247.2018.1444601%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Ahmady%26aufirst%3DZ.%2BS.%26atitle%3DSelective%2520Drug%2520Delivery%2520Approaches%2520to%2520Lesioned%2520Brain%2520through%2520Blood%2520Brain%2520Barrier%2520Disruption%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2018%26volume%3D15%26issue%3D4%26spage%3D335%26epage%3D349%26doi%3D10.1080%2F17425247.2018.1444601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priestley, R. D.</span></span> <span> </span><span class="NLM_article-title">Nanomedicine as a Non-Invasive Strategy for Drug Delivery across the Blood Brain Barrier</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>515</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2016.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.ijpharm.2016.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27769885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslans7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=515&publication_year=2016&pages=331-342&issue=1%E2%80%932&author=V.+H.+Tamauthor=C.+Sosaauthor=R.+Liuauthor=N.+Yaoauthor=R.+D.+Priestley&title=Nanomedicine+as+a+Non-Invasive+Strategy+for+Drug+Delivery+across+the+Blood+Brain+Barrier&doi=10.1016%2Fj.ijpharm.2016.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier</span></div><div class="casAuthors">Tam, Vivienne H.; Sosa, Chris; Liu, Rui; Yao, Nan; Priestley, Rodney D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">515</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">331-342</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The blood brain barrier (BBB) is a major obstacle to drug delivery for diseases of the central nervous system (CNS).  This brief review highlights the current invasive and non-invasive technologies available to address this problem.  In particular, nanomedicine has shown much promise as a non-invasive strategy due to its drug loading capabilities, ease of targeting to the BBB, and small size.  The versatility of this technol. in terms of type of drug and imaging agent, carrier material, and targeting mechanism is highlighted in this review.  The recent inclusion of imaging agents in the nanocarriers has important consequences for the field of theranostics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbTTspDc8UJ7Vg90H21EOLACvtfcHk0lgk6JDF5PU9FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslans7jN&md5=8b94abd6a8c4015169fc0215baabe252</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2016.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2016.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DV.%2BH.%26aulast%3DSosa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPriestley%26aufirst%3DR.%2BD.%26atitle%3DNanomedicine%2520as%2520a%2520Non-Invasive%2520Strategy%2520for%2520Drug%2520Delivery%2520across%2520the%2520Blood%2520Brain%2520Barrier%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2016%26volume%3D515%26issue%3D1%25E2%2580%25932%26spage%3D331%26epage%3D342%26doi%3D10.1016%2Fj.ijpharm.2016.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilken-Resman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boroumand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, R. G.</span></span> <span> </span><span class="NLM_article-title">Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3937</span>– <span class="NLM_lpage">3966</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00548</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00548" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWit77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=3937-3966&issue=12&author=N.+N.+Kumarauthor=M.+E.+Pizzoauthor=G.+Nehraauthor=B.+Wilken-Resmanauthor=S.+Boroumandauthor=R.+G.+Thorne&title=Passive+Immunotherapies+for+Central+Nervous+System+Disorders%3A+Current+Delivery+Challenges+and+New+Approaches&doi=10.1021%2Facs.bioconjchem.8b00548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches</span></div><div class="casAuthors">Kumar, Niyanta N.; Pizzo, Michelle E.; Nehra, Geetika; Wilken-Resman, Brynna; Boroumand, Sam; Thorne, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3937-3966</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Passive immunotherapy, i.e., the administration of exogenous antibodies that recognize a specific target antigen, has gained significant momentum as a potential treatment strategy for several central nervous system (CNS) disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and brain cancer, among others.  Advances in antibody engineering to create therapeutic antibody fragments or antibody conjugates have introduced new strategies that may also be applied to treat CNS disorders.  However, drug delivery to the CNS for antibodies and other macromols. has thus far proven challenging, due in large part to the blood-brain barrier (BBB) and blood-cerebrospinal fluid barriers (BCSFBs) that greatly restrict transport of peripherally administered mols. from the systemic circulation into the CNS.  Here, we summarize the various passive immunotherapy approaches under study for the treatment of CNS disorders, with a primary focus on disease-specific and target site-specific challenges to drug delivery and new, cutting edge methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLRWkTz_J0DLVg90H21EOLACvtfcHk0lgk6JDF5PU9FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWit77K&md5=02fd78cf1cb2cfcdcc29975194c88be1</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00548%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DN.%2BN.%26aulast%3DPizzo%26aufirst%3DM.%2BE.%26aulast%3DNehra%26aufirst%3DG.%26aulast%3DWilken-Resman%26aufirst%3DB.%26aulast%3DBoroumand%26aufirst%3DS.%26aulast%3DThorne%26aufirst%3DR.%2BG.%26atitle%3DPassive%2520Immunotherapies%2520for%2520Central%2520Nervous%2520System%2520Disorders%253A%2520Current%2520Delivery%2520Challenges%2520and%2520New%2520Approaches%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26issue%3D12%26spage%3D3937%26epage%3D3966%26doi%3D10.1021%2Facs.bioconjchem.8b00548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourseif, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omidi, Y.</span></span> <span> </span><span class="NLM_article-title">Blood-Brain Barrier Transport Machineries and Targeted Therapy of Brain Diseases</span>. <i>BioImpacts</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.15171/bi.2016.30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.15171%2Fbi.2016.30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28265539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVaqtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=225-248&issue=4&author=J.+Bararauthor=M.+A.+Rafiauthor=M.+M.+Pourseifauthor=Y.+Omidi&title=Blood-Brain+Barrier+Transport+Machineries+and+Targeted+Therapy+of+Brain+Diseases&doi=10.15171%2Fbi.2016.30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier transport machineries and targeted therapy of brain diseases</span></div><div class="casAuthors">Barar, Jaleh; Rafi, Mohammad A.; Pourseif, Mohammad M.; Omidi, Yadollah</div><div class="citationInfo"><span class="NLM_cas:title">BioImpacts</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">225-248</span>CODEN:
                <span class="NLM_cas:coden">BIOICT</span>;
        ISSN:<span class="NLM_cas:issn">2228-5660</span>.
    
            (<span class="NLM_cas:orgname">Tabriz University of Medical Sciences</span>)
        </div><div class="casAbstract">Introduction: Desired clin. outcome of pharmacotherapy of brain diseases largely depends upon the safe drug delivery into the brain parenchyma.  However, due to the robust blockade function of the blood-brain barrier (BBB), drug transport into the brain is selectively controlled by the BBB formed by brain capillary endothelial cells and supported by astrocytes and pericytes.  Methods: In the current study, we have reviewed the most recent literature on the subject to provide an insight upon the role and impacts of BBB on brain drug delivery and targeting.  Results: All drugs, either small mols. or macromols., designated to treat brain diseases must adequately cross the BBB to provide their therapeutic properties on biol. targets within the central nervous system (CNS).  However, most of these pharmaceuticals do not sufficiently penetrate into CNS, failing to meet the intended therapeutic outcomes.  Most lipophilic drugs capable of penetrating BBB are prone to the efflux functionality of BBB.  In contrast, all hydrophilic drugs are facing severe infiltration blockage imposed by the tight cellular junctions of the BBB.  Hence, a no. of strategies have been devised to improve the efficiency of brain drug delivery and targeted therapy of CNS disorders using multimodal nanosystems (NSs).  Conclusions: In order to improve the therapeutic outcomes of CNS drug transfer and targeted delivery, the discriminatory permeability of BBB needs to be taken under control.  The carrier-mediated transport machineries of brain capillary endothelial cells (BCECs) can be exploited for the discovery, development and delivery of small mols. into the brain.  Further, the receptor-mediated transport systems can be recruited for the delivery of macromol. biologics and multimodal NSs into the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr7E4mzJJc37Vg90H21EOLACvtfcHk0lhIN9TnZT14yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVaqtbrE&md5=1181e875fafa634642ef67f9c49498c8</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.15171%2Fbi.2016.30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15171%252Fbi.2016.30%26sid%3Dliteratum%253Aachs%26aulast%3DBarar%26aufirst%3DJ.%26aulast%3DRafi%26aufirst%3DM.%2BA.%26aulast%3DPourseif%26aufirst%3DM.%2BM.%26aulast%3DOmidi%26aufirst%3DY.%26atitle%3DBlood-Brain%2520Barrier%2520Transport%2520Machineries%2520and%2520Targeted%2520Therapy%2520of%2520Brain%2520Diseases%26jtitle%3DBioImpacts%26date%3D2016%26volume%3D6%26issue%3D4%26spage%3D225%26epage%3D248%26doi%3D10.15171%2Fbi.2016.30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabathuler, R.</span></span> <span> </span><span class="NLM_article-title">Approaches to Transport Therapeutic Drugs across the Blood-brain Barrier to Treat Brain Diseases</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2009.07.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.nbd.2009.07.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19664710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=48-57&issue=1&author=R.+Gabathuler&title=Approaches+to+Transport+Therapeutic+Drugs+across+the+Blood-brain+Barrier+to+Treat+Brain+Diseases&doi=10.1016%2Fj.nbd.2009.07.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases</span></div><div class="casAuthors">Gabathuler, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-57</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The central nervous system is protected by barriers which control the entry of compds. into the brain, thereby regulating brain homeostasis.  The blood-brain barrier, formed by the endothelial cells of the brain capillaries, restricts access to brain cells of blood-borne compds. and facilitates nutrients essential for normal metab. to reach brain cells.  This very tight regulation of the brain homeostasis results in the inability of some small and large therapeutic compds. to cross the blood-brain barrier (BBB).  Therefore, various strategies are being developed to enhance the amt. and concn. of therapeutic compds. in the brain.  In this review, we will address the different approaches used to increase the transport of therapeutics from blood into the brain parenchyma.  We will mainly conc. on the physiol. approach which takes advantage of specific receptors already expressed on the capillary endothelial cells forming the BBB and necessary for the survival of brain cells.  Among all the approaches used for increasing brain delivery of therapeutics, the most accepted method is the use of the physiol. approach which takes advantage of the transcytosis capacity of specific receptors expressed at the BBB.  The low d. lipoprotein receptor related protein (LRP) is the most adapted for such use with the engineered peptide compd. (EPiC) platform incorporating the Angiopep peptide in new therapeutics the most advanced with promising data in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXnM4hn2vGGrVg90H21EOLACvtfcHk0lhIN9TnZT14yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7jE&md5=ede4d80cd5fabc1080289b5446072d07</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.07.028%26sid%3Dliteratum%253Aachs%26aulast%3DGabathuler%26aufirst%3DR.%26atitle%3DApproaches%2520to%2520Transport%2520Therapeutic%2520Drugs%2520across%2520the%2520Blood-brain%2520Barrier%2520to%2520Treat%2520Brain%2520Diseases%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D37%26issue%3D1%26spage%3D48%26epage%3D57%26doi%3D10.1016%2Fj.nbd.2009.07.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golub, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannobile, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorsa, T.</span></span> <span> </span><span class="NLM_article-title">Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms</span>. <i>Adv. Dent. Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1177/08959374980120010501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1177%2F08959374980120010501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=9972117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADyaK1M7jvVSltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=12-26&issue=1&author=L.+M.+Golubauthor=H.-M.+Leeauthor=M.+E.+Ryanauthor=W.+V.+Giannobileauthor=J.+Payneauthor=T.+Sorsa&title=Tetracyclines+Inhibit+Connective+Tissue+Breakdown+by+Multiple+Non-Antimicrobial+Mechanisms&doi=10.1177%2F08959374980120010501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms</span></div><div class="casAuthors">Golub L M; Lee H M; Ryan M E; Giannobile W V; Payne J; Sorsa T</div><div class="citationInfo"><span class="NLM_cas:title">Advances in dental research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">12-26</span>
        ISSN:<span class="NLM_cas:issn">0895-9374</span>.
    </div><div class="casAbstract">A seminal experiment involving a germ-free rat model of connective tissue breakdown (followed soon thereafter by a series of in vitro studies) identified an unexpected non-antimicrobial property of tetracyclines (TCs).  This ability of TCs to inhibit matrix metalloproteinases (MMPs) such as collagenase was found to reflect multiple direct and indirect mechanisms of action, and to be therapeutically useful in a variety of dental (e.g., adult periodontitis) and medical (e.g., arthritis, osteoporosis, cancer) diseases.  The site on the TC molecule responsible for its MMP-inhibitory activity was identified which led to the development of a series of chemically modified non-antimicrobial analogs, called CMTs, which also have therapeutic potential but do not appear to induce antibiotic side-effects.  Longitudinal double-blind studies on humans with adult periodontitis have demonstrated that a sub-antimicrobial dose of doxycycline (previously reported to suppress collagenase activity in the periodontal pocket) is safe and effective and has recently been approved by the FDA as an adjunct to scaling and root planing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS67MxfhHdRnAHqQV89nF-2fW6udTcc2ebwl0zkUesKnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7jvVSltg%253D%253D&md5=d4a1a1d96883c4e662854f18c3ae12e4</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1177%2F08959374980120010501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F08959374980120010501%26sid%3Dliteratum%253Aachs%26aulast%3DGolub%26aufirst%3DL.%2BM.%26aulast%3DLee%26aufirst%3DH.-M.%26aulast%3DRyan%26aufirst%3DM.%2BE.%26aulast%3DGiannobile%26aufirst%3DW.%2BV.%26aulast%3DPayne%26aufirst%3DJ.%26aulast%3DSorsa%26aufirst%3DT.%26atitle%3DTetracyclines%2520Inhibit%2520Connective%2520Tissue%2520Breakdown%2520by%2520Multiple%2520Non-Antimicrobial%2520Mechanisms%26jtitle%3DAdv.%2520Dent.%2520Res.%26date%3D1998%26volume%3D12%26issue%3D1%26spage%3D12%26epage%3D26%26doi%3D10.1177%2F08959374980120010501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chtarto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenenbaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brotchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levivier, M.</span></span> <span> </span><span class="NLM_article-title">Clinical Potential of Minocycline for Neurodegenerative Disorders</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2004.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.nbd.2004.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15571972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVansbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=359-366&issue=3&author=D.+Blumauthor=A.+Chtartoauthor=L.+Tenenbaumauthor=J.+Brotchiauthor=M.+Levivier&title=Clinical+Potential+of+Minocycline+for+Neurodegenerative+Disorders&doi=10.1016%2Fj.nbd.2004.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical potential of minocycline for neurodegenerative disorders</span></div><div class="casAuthors">Blum, David; Chtarto, Abdelwahed; Tenenbaum, Liliane; Brotchi, Jacques; Levivier, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-366</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Minocycline, an antibiotic of the tetracycline family, has been shown to display neurorestorative or neuroprotective properties in various models of neurodegenerative diseases.  In particular, it has been shown to delay motor alterations, inflammation and apoptosis in models of Huntington's disease, amyotrophic lateral sclerosis and Parkinson's disease.  Despite controversies about its efficacy, the relative safety and tolerability of minocycline have led to the launching of various clin. trials.  The present review summarizes the available data supporting the clin. testing of minocycline for these neurodegenerative disorders.  In addn., the authors extend the authors' discussion to the potential applications of minocycline for combining this treatment with cellular and mol. therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRD0d9GE-PnrVg90H21EOLACvtfcHk0liyj4H6MVGYFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVansbvI&md5=0760d1b014e761b686709d01aa341b35</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2004.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2004.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DChtarto%26aufirst%3DA.%26aulast%3DTenenbaum%26aufirst%3DL.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DLevivier%26aufirst%3DM.%26atitle%3DClinical%2520Potential%2520of%2520Minocycline%2520for%2520Neurodegenerative%2520Disorders%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2004%26volume%3D17%26issue%3D3%26spage%3D359%26epage%3D366%26doi%3D10.1016%2Fj.nbd.2004.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teronen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heikkilä, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konttinen, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanemaaijer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teronen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorsa, T.</span></span> <span> </span><span class="NLM_article-title">MMP Inhibition and Downregulation by Bisphosphonates</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>878</i></span> (<span class="NLM_issue">358</span>),  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.1999.tb07702.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fj.1749-6632.1999.tb07702.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10415748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK1MXkslemsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=878&publication_year=1999&pages=453-465&issue=358&author=O.+Teronenauthor=P.+Heikkil%C3%A4author=Y.+T.+Konttinenauthor=M.+Laitinenauthor=T.+Saloauthor=R.+Hanemaaijerauthor=A.+Teronenauthor=P.+Maisiauthor=T.+Sorsa&title=MMP+Inhibition+and+Downregulation+by+Bisphosphonates&doi=10.1111%2Fj.1749-6632.1999.tb07702.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">MMP inhibition and downregulation by bisphosphonates</span></div><div class="casAuthors">Teronen, Olli; Heikkila, Pia; Konttinen, Yrjo T.; Laitinen, Minna; Salo, Tuula; Hanemaaijer, Roeland; Teronen, Anneli; Maisi, Paivi; Sorsa, Timo</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">878</span>
        (<span class="NLM_cas:issue">Inhibition of Matrix Metalloproteinases</span>),
    <span class="NLM_cas:pages">453-465</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">Bisphosphonates are a group of drugs capable of inhibiting bone resorption, and are thus used for the treatment of bone diseases, such as Paget's disease, osteoporosis, and for bone metastases of malignant tumors.  Their primary cellular target is considered to be the osteoclast.  The mol. mechanisms responsible for the downregulation of bone resorption by bisphosphonates have remain unclear.  We have discovered that various matrix metalloproteinases (MMPs) are inhibited in vitro by several bisphosphonates.  This novel finding may, in part, explain the efficacy of bisphosphonates in their current indications in humans.  In enzyme activity tests using purified and recombinant enzymes, we have obsd. the inhibition of MMP-1, -2, -3, -7, -8, -9, -12, -13, and -14 by clondronate, alendronate, pamidronate, zolendronate, nedrinate, and clodrinate.  The IC50s range from 50 to 150 μM.  We have also shown that clondronate can downregulate the expression of MT1-MMP protein and mRNA in several cell lines.  Addnl., several bisphosphonates decrease the degree of invasion of malignant melanoma (C8161) and fibrosarcoma (HT1080) cells through artificial basement membrane (Matrigel) in cell cultures at IC50s of 50-150 μM and below.  Having low toxicity and proven to be well tolerated after several years in human use, bisphosphonates have the potential to become one of the main MMP-inhibitors for MMP-related human soft and hard tissue-destructive diseases in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX5dePnWitWrVg90H21EOLACvtfcHk0liyj4H6MVGYFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslemsL0%253D&md5=fe3c87d4da0524727b9ddcbcdf86dc3e</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1999.tb07702.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1999.tb07702.x%26sid%3Dliteratum%253Aachs%26aulast%3DTeronen%26aufirst%3DO.%26aulast%3DHeikkil%25C3%25A4%26aufirst%3DP.%26aulast%3DKonttinen%26aufirst%3DY.%2BT.%26aulast%3DLaitinen%26aufirst%3DM.%26aulast%3DSalo%26aufirst%3DT.%26aulast%3DHanemaaijer%26aufirst%3DR.%26aulast%3DTeronen%26aufirst%3DA.%26aulast%3DMaisi%26aufirst%3DP.%26aulast%3DSorsa%26aufirst%3DT.%26atitle%3DMMP%2520Inhibition%2520and%2520Downregulation%2520by%2520Bisphosphonates%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1999%26volume%3D878%26issue%3D358%26spage%3D453%26epage%3D465%26doi%3D10.1111%2Fj.1749-6632.1999.tb07702.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Izidoro-Toledo, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belo, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanus-Santos, J. E.</span></span> <span> </span><span class="NLM_article-title">Effects of Statins on Matrix Metalloproteinases and Their Endogenous Inhibitors in Human Endothelial Cells</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>383</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1007/s00210-011-0623-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00210-011-0623-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21448567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFWitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2011&pages=547-554&issue=6&author=T.+C.+Izidoro-Toledoauthor=D.+A.+Guimaraesauthor=V.+A.+Beloauthor=R.+F.+Gerlachauthor=J.+E.+Tanus-Santos&title=Effects+of+Statins+on+Matrix+Metalloproteinases+and+Their+Endogenous+Inhibitors+in+Human+Endothelial+Cells&doi=10.1007%2Fs00210-011-0623-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells</span></div><div class="casAuthors">Izidoro-Toledo, Tatiane C.; Guimaraes, Danielle A.; Belo, Vanessa A.; Gerlach, Raquel F.; Tanus-Santos, Jose Eduardo</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">547-554</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Statins exert anti-inflammatory effects and downregulate matrix metalloproteinases (MMPs) expression, thus contributing to restore cardiovascular homeostasis in cardiovascular diseases.  We aimed at comparing the effects of different statins (simvastatin, atorvastatin, and pravastatin) on MMP-2, MMP-9, tissue inhibitors of metalloproteinases (TIMP)-1, TIMP-2, and MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios released by human umbilical vein endothelial cells (HUVEC) stimulated by phorbol myristate acetate (PMA).  HUVECs were incubated with statins (0.1-10 μM) for 12 h before stimulation with PMA 100 nM.  Monolayers were used to perform cell viability assays and the supernatants were collected to det. MMPs and TIMPs levels by gelatin zymog. and/or enzyme immunoassay.  While treatment with PMA increased MMP-9 and TIMP-1 levels (by 556% and 159%, resp.; both P < 0.05), it exerted no effects on MMP-2 and TIMP-2 levels.  Simvastatin and atorvastatin, but not pravastatin, attenuated PMA-induced increases in MMP-9 levels (P < 0.05).  Only atorvastatin decreased baseline MMP-2 levels significantly (P < 0.05).  We found no effects on TIMP-2 levels.  Simvastatin and atorvastatin, but not pravastatin, decreased MMP-9/TIMP-1 ratio significantly (both P < 0.05), whereas atorvastatin and pravastatin, but not simvastatin, decreased MMP-2/TIMP-2 ratio significantly (both P < 0.05).  Our data support the notion that statins with different physicochem. features exert variable effects on MMP/TIMP ratios (which reflect net MMP activity).  Our results suggest that more lipophilic statins (simvastatin and atorvastatin), but not the hydrophilic statin pravastatin, downregulate net MMP-9 activity.  However, atorvastatin and pravastatin may downregulate net MMP-2 activity.  The clin. implications of the present findings deserve further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeUewGHR2nArVg90H21EOLACvtfcHk0liyj4H6MVGYFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFWitr8%253D&md5=47c9ed06738531d3595250bd0ba66abd</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1007%2Fs00210-011-0623-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-011-0623-0%26sid%3Dliteratum%253Aachs%26aulast%3DIzidoro-Toledo%26aufirst%3DT.%2BC.%26aulast%3DGuimaraes%26aufirst%3DD.%2BA.%26aulast%3DBelo%26aufirst%3DV.%2BA.%26aulast%3DGerlach%26aufirst%3DR.%2BF.%26aulast%3DTanus-Santos%26aufirst%3DJ.%2BE.%26atitle%3DEffects%2520of%2520Statins%2520on%2520Matrix%2520Metalloproteinases%2520and%2520Their%2520Endogenous%2520Inhibitors%2520in%2520Human%2520Endothelial%2520Cells%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2011%26volume%3D383%26issue%3D6%26spage%3D547%26epage%3D554%26doi%3D10.1007%2Fs00210-011-0623-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piura, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyomin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huleihel, M.</span></span> <span> </span><span class="NLM_article-title">Thalidomide Distinctly Affected TNF-A, IL-6 and MMP Secretion by an Ovarian Cancer Cell Line (SKOV-3) and Primary Ovarian Cancer Cells</span>. <i>Eur. Cytokine Netw.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1684/ecn.2013.0342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1684%2Fecn.2013.0342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24284039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVygsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=122-129&issue=3&author=B.+Piuraauthor=L.+Medinaauthor=A.+Rabinovichauthor=V.+Dyominauthor=M.+Huleihel&title=Thalidomide+Distinctly+Affected+TNF-A%2C+IL-6+and+MMP+Secretion+by+an+Ovarian+Cancer+Cell+Line+%28SKOV-3%29+and+Primary+Ovarian+Cancer+Cells&doi=10.1684%2Fecn.2013.0342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Thalidomide distinctly affected TNF-α, IL-6 and MMP secretion by an ovarian cancer cell line (SKOV-3) and primary ovarian cancer cells</span></div><div class="casAuthors">Piura, Benjamin; Medina, Liat; Rabinovich, Alex; Dyomin, Victor; Huleihel, Mahmoud</div><div class="citationInfo"><span class="NLM_cas:title">European Cytokine Network</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">122-129</span>CODEN:
                <span class="NLM_cas:coden">ECYNEJ</span>;
        ISSN:<span class="NLM_cas:issn">1952-4005</span>.
    
            (<span class="NLM_cas:orgname">John Libbey Eurotext</span>)
        </div><div class="casAbstract">Background. Thalidomide inhibits TNF-α prodn. in lipopolysaccharide-stimulated monocytes.  The aim of this study was to evaluate the effect of thalidomide on TNF-α, IL-6 and MMP secretion in epithelial ovarian carcinoma cells.  Materials and methods. SKOV-3 cells and primary epithelial ovarian carcinoma cells were cultured in the presence of various concns. of thalidomide.  Cell proliferation was examd. by MTT proliferation assay.  TNF-α and IL-6 levels were detd. in the supernatants of the cell cultures by ELISA, and MMP activity was examd. by gelatin zymog.  Results. Thalidomide did not significantly affect the proliferation and growth of SKOV-3 cells.  However, it decreased significantly the capacity of SKOV-3 cells and primary epithelial ovarian carcinoma cells to secrete TNF-α.  Thalidomide also significantly decreased the capacity of SKOV-3 cells, but not primary epithelial ovarian carcinoma cells, to secrete MMP-9 and MMP-2.  However, thalidomide did not affect IL-6 secretion in SKOV-3 cells or primary epithelial ovarian carcinoma cells.  Conclusion. Our study suggests that thalidomide distinctly affected TNF-α, IL-6 and MMPs secretion by an ovarian carcinoma cell line (SKOV-3) and primary ovarian cancer cells.  This might suggest a different susceptibility of these two types of cells to thalidomide, and/or that the mechanisms of secretion of the factors examd. are differently regulated in these cells.  Our results may deepen our understanding the mechanism/s of action of thalidomide in ovarian carcinoma cells.  The results might have important implications in future therapeutic strategies that will incorporate thalidomide and other cytokine inhibitors in the treatment of epithelial ovarian carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroZ0pUkj08a7Vg90H21EOLACvtfcHk0lieQ6FVBCJmbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVygsLrI&md5=5ef240f565728a9320a754ba3779847c</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1684%2Fecn.2013.0342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1684%252Fecn.2013.0342%26sid%3Dliteratum%253Aachs%26aulast%3DPiura%26aufirst%3DB.%26aulast%3DMedina%26aufirst%3DL.%26aulast%3DRabinovich%26aufirst%3DA.%26aulast%3DDyomin%26aufirst%3DV.%26aulast%3DHuleihel%26aufirst%3DM.%26atitle%3DThalidomide%2520Distinctly%2520Affected%2520TNF-A%252C%2520IL-6%2520and%2520MMP%2520Secretion%2520by%2520an%2520Ovarian%2520Cancer%2520Cell%2520Line%2520%2528SKOV-3%2529%2520and%2520Primary%2520Ovarian%2520Cancer%2520Cells%26jtitle%3DEur.%2520Cytokine%2520Netw.%26date%3D2013%26volume%3D24%26issue%3D3%26spage%3D122%26epage%3D129%26doi%3D10.1684%2Fecn.2013.0342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gearing, A. J. H.</span></span> <span> </span><span class="NLM_article-title">Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2735</span>– <span class="NLM_lpage">2776</span>, <span class="refDoi"> DOI: 10.1021/cr9804543</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9804543" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK1MXls1Kku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2735-2776&issue=9&author=M.+Whittakerauthor=C.+D.+Floydauthor=P.+Brownauthor=A.+J.+H.+Gearing&title=Design+and+Therapeutic+Application+of+Matrix+Metalloproteinase+Inhibitors&doi=10.1021%2Fcr9804543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors</span></div><div class="casAuthors">Whittaker, Mark; Floyd, Christopher D.; Brown, Peter; Gearing, Andrew J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2735-2776</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 389 refs.  MMP inhibitors may be an important new class of therapeutic agents for the treatment of diseases characterized by excessive extracellular matrix degrdn. and/or remodelling, such as cancer and chronic inflammatory diseases such as rheumatoid arthritis, atherosclerosis, and MS.  This review describes progress in the design of MMP inhibitors and outlines the results of early clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGACjaK8AEZbVg90H21EOLACvtfcHk0lieQ6FVBCJmbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXls1Kku7c%253D&md5=e226080188f791f5d1ce8c61b64ad33a</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Fcr9804543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9804543%26sid%3Dliteratum%253Aachs%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DFloyd%26aufirst%3DC.%2BD.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DGearing%26aufirst%3DA.%2BJ.%2BH.%26atitle%3DDesign%2520and%2520Therapeutic%2520Application%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26issue%3D9%26spage%3D2735%26epage%3D2776%26doi%3D10.1021%2Fcr9804543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coussens, L. M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase Inhibitors and Cancer: Trials and Tribulations</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>295</i></span> (<span class="NLM_issue">5564</span>),  <span class="NLM_fpage">2387</span>– <span class="NLM_lpage">2392</span>, <span class="refDoi"> DOI: 10.1126/science.1067100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1126%2Fscience.1067100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11923519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD38XisFSmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2002&pages=2387-2392&issue=5564&author=L.+M.+Coussens&title=Matrix+Metalloproteinase+Inhibitors+and+Cancer%3A+Trials+and+Tribulations&doi=10.1126%2Fscience.1067100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer therapy: matrix metalloproteinase inhibitors and cancer: trials and tribulations</span></div><div class="casAuthors">Coussens, Lisa M.; Fingleton, Barbara; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">5564</span>),
    <span class="NLM_cas:pages">2387-2392</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  For at least 30 yr, matrix metalloproteinases (MMPs) have been heralded as promising targets for cancer therapy on the basis of their massive up-regulation in malignant tissues and their unique ability to degrade all components of the extracellular matrix.  Preclin. studies testing the efficacy of MMP suppression in tumor models were so compelling that synthetic metalloproteinase inhibitors (MPI) were rapidly developed and routed into human clin. trials.  The results of these trials have been disappointing.  Here we review the studies that brought MPI into clin. testing and discuss the design and outcome of the trials in light of new information about the cellular source, substrates, and mode of action of MMPs at different stages of tumor progression.  The important lessons learned from the MPI experience may be of great value for future studies of MPI and for cancer drug development in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquzqvwAiv5frVg90H21EOLACvtfcHk0lieQ6FVBCJmbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisFSmtb0%253D&md5=be0d4cfc46c6c451a2374e3545cb4ec6</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1126%2Fscience.1067100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1067100%26sid%3Dliteratum%253Aachs%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26atitle%3DMatrix%2520Metalloproteinase%2520Inhibitors%2520and%2520Cancer%253A%2520Trials%2520and%2520Tribulations%26jtitle%3DScience%26date%3D2002%26volume%3D295%26issue%3D5564%26spage%3D2387%26epage%3D2392%26doi%3D10.1126%2Fscience.1067100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major Jourden, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">To Bind Zinc or Not to Bind Zinc: An Examination of Innovative Approaches to Improved Metalloproteinase Inhibition</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1803</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2009.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbamcr.2009.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19712708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1803&publication_year=2010&pages=72-94&issue=1&author=J.+A.+Jacobsenauthor=J.+L.+Major+Jourdenauthor=M.+T.+Millerauthor=S.+M.+Cohen&title=To+Bind+Zinc+or+Not+to+Bind+Zinc%3A+An+Examination+of+Innovative+Approaches+to+Improved+Metalloproteinase+Inhibition&doi=10.1016%2Fj.bbamcr.2009.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition</span></div><div class="casAuthors">Jacobsen, Jennifer A.; Major Jourden, Jody L.; Miller, Melissa T.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1803</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-94</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This short review highlights some recent advances in matrix metalloproteinase inhibitor (MMPi) design and development.  Three distinct approaches to improved MMP inhibition are discussed: (1) the identification and investigation of novel zinc-binding groups (ZBGs), (2) the study of non-zinc-binding MMPi, and (3) mechanism-based MMPi that form covalent adducts with the protein.  Each of these strategies is discussed and their resp. advantages and remaining challenges are highlighted.  The studies discussed here bode well for the development of ever more selective, potent, and well-tolerated MMPi for treating several important disease pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbxHz-QbzTTrVg90H21EOLACvtfcHk0ljBQB6vwrC4oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKitLg%253D&md5=ad63d40149284ff3051de5bed442fbcd</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2009.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2009.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DJ.%2BA.%26aulast%3DMajor%2BJourden%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BT.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DTo%2520Bind%2520Zinc%2520or%2520Not%2520to%2520Bind%2520Zinc%253A%2520An%2520Examination%2520of%2520Innovative%2520Approaches%2520to%2520Improved%2520Metalloproteinase%2520Inhibition%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2010%26volume%3D1803%26issue%3D1%26spage%3D72%26epage%3D94%26doi%3D10.1016%2Fj.bbamcr.2009.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullagar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1021/jm101266s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101266s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WqtLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=591-602&issue=2&author=J.+A.+Jacobsenauthor=J.+L.+Fullagarauthor=M.+T.+Millerauthor=S.+M.+Cohen&title=Identifying+Chelators+for+Metalloprotein+Inhibitors+Using+a+Fragment-Based+Approach&doi=10.1021%2Fjm101266s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach</span></div><div class="casAuthors">Jacobsen, Jennifer A.; Fullagar, Jessica L.; Miller, Melissa T.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for metalloenzyme inhibitors.  When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compds. produced hit rates ranging from 29% to 43% for five matrix metalloproteases (MMPs), 24% for anthrax lethal factor (LF), 49% for 5-lipoxygenase (5-LO), and 60% for tyrosinase (TY).  The ligand efficiencies (LE) of the fragment hits are excellent, in the range of 0.4-0.8 kcal/mol.  The MMP enzymes all generally elicit the same chelators as hits from CFL-1.1; however, the chelator fragments that inhibit structurally unrelated metalloenzymes (LF, 5-LO, TY) vary considerably.  To develop more advanced hits, one hit from CFL-1.1, 8-hydroxyquinoline, was elaborated at four different positions around the ring system to generate new fragments. 8-Hydroxyquinoline fragments substituted at either the 5- or 7-positions gave potent hits against MMP-2, with IC50 values in the low micromolar range.  The 8-hydroxyquinoline represents a promising new chelator scaffold for the development of MMP inhibitors that was discovered by use of a metalloprotein-focused chelator fragment library.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEhMn4K1QBJLVg90H21EOLACvtfcHk0ljBQB6vwrC4oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WqtLvE&md5=1ef31ce8e5939f7d1c69aed8a409cd8d</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Fjm101266s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101266s%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DJ.%2BA.%26aulast%3DFullagar%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BT.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DIdentifying%2520Chelators%2520for%2520Metalloprotein%2520Inhibitors%2520Using%2520a%2520Fragment-Based%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D2%26spage%3D591%26epage%3D602%26doi%3D10.1021%2Fjm101266s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Perez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarreal, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Zinc-Binding Groups Modulate Selective Inhibition of MMPs</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">812</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fcmdc.200700290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=18181119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1emtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=812-820&issue=5&author=A.+Agrawalauthor=D.+Romero-Perezauthor=J.+A.+Jacobsenauthor=F.+J.+Villarrealauthor=S.+M.+Cohen&title=Zinc-Binding+Groups+Modulate+Selective+Inhibition+of+MMPs&doi=10.1002%2Fcmdc.200700290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc-binding groups modulate selective inhibition of MMPs</span></div><div class="casAuthors">Agrawal, Arpita; Romero-Perez, Diego; Jacobsen, Jennifer A.; Villarreal, Francisco J.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">812-820</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The need for selective matrix metalloproteinase (MMP) inhibition is of interest because of the range of pathologies mediated by different MMP isoforms.  The development of more selective MMP inhibitors (MMPi) may help to overcome some of the undesired side effects that have hindered the clin. success of these compds.  In an effort to devise new approaches to selective inhibitors, herein the authors describe several novel MMPi and show that their selectivity is dependent on the nature of the zinc-binding group (ZBG).  This is in contrast to most current MMPi, which obtain isoform selectivity solely from the peptidomimetic backbone portion of the compd.  In the present study, six different hydroxypyrone and hydroxypyridinone ZBGs were appended to a common biphenyl backbone and the inhibition efficiency of each inhibitor was detd. in vitro (IC50 values) against MMP-1, -2, -3, -7, -8, -9, -12, and -13.  The results show that the selectivity profile of each inhibitor is different as a result of the various ZBGs.  Computational modeling studies were used to explain some trends in the obsd. selectivity profiles.  To assess the importance of the ZBG in a biol. model, two of the semiselective, potent MMPi (and one control) were evaluated using an isolated perfused rat heart system.  Hearts were subjected to ischemia reperfusion injury, and recovery of contractile function was examd.  In this model, only one of the two MMPi showed significant and sustained heart recovery, demonstrating that the choice of ZBG can have a significant effect in a relevant pathophysiol. endpoint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmDxoMI4DNj7Vg90H21EOLACvtfcHk0ljBQB6vwrC4oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1emtL8%253D&md5=6e0c84c04d315c9a7ee827e558849e0a</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700290%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DRomero-Perez%26aufirst%3DD.%26aulast%3DJacobsen%26aufirst%3DJ.%2BA.%26aulast%3DVillarreal%26aufirst%3DF.%2BJ.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DZinc-Binding%2520Groups%2520Modulate%2520Selective%2520Inhibition%2520of%2520MMPs%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26issue%3D5%26spage%3D812%26epage%3D820%26doi%3D10.1002%2Fcmdc.200700290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skiles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonnella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, A.</span></span> <span> </span><span class="NLM_article-title">The Design, Structure, and Clinical Update of Small Molecular Weight Matrix Metalloproteinase Inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">2911</span>– <span class="NLM_lpage">2977</span>, <span class="refDoi"> DOI: 10.2174/0929867043364018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F0929867043364018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15544483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVyntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=2911-2977&issue=22&author=J.+Skilesauthor=N.+Gonnellaauthor=A.+Jeng&title=The+Design%2C+Structure%2C+and+Clinical+Update+of+Small+Molecular+Weight+Matrix+Metalloproteinase+Inhibitors&doi=10.2174%2F0929867043364018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Skiles, Jerry W.; Gonnella, Nina C.; Jeng, Arco Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2911-2977</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of zinc-contg. enzymes involved in the degrdn. and remodeling of extracellular matrix proteins.  Under normal physiol. conditions, the activities of these enzymes are well-regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs).  Chronic stimulation of MMP activities due to an imbalance in the levels of MMPs and TIMPs was implicated in the pathogenesis of a variety of diseases such as cancer, osteoarthritis, and rheumatoid arthritis.  Thus, MMP inhibitors are expected to be useful for the treatment of these disorders.  Because of their importance in a variety of pathol. conditions, a no. of small mol. wt. MMP inhibitors have entered clin. trials in humans.  However, the results of these trials were extremely disappointing and have led many investigators to conclude that MMP inhibitors have no therapeutic benefit in human cancer.  To date, the 1st generation MMP inhibitors exhibited poor bioavailability while 2nd-generation compds. revealed that prolonged treatment caused musculoskeletal pain and inflammation or had a lack of efficacy.  This article describes the design of small mol. wt. MMP inhibitors, a brief description of available 3-dimensional MMP structures, a review of the proposed therapeutic utility of MMP inhibitors, and a clin. update of compds. that have entered clin. trials in humans.  The exptl. detd. structures used in the structure-based design of MMP inhibitors are thoroughly covered.  Major emphasis is on recently published and/or patented potent MMP inhibitors, from approx. Jan. 2000 to Apr. 2003, and their pharmacol. properties.  Protein inhibitors of these proteolytic enzymes, i.e. TIMPs, will not be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0LYPCikT-orVg90H21EOLACvtfcHk0li3nF2z_J53bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVyntbg%253D&md5=10e7288182d59fadf4691d1bf3795533</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.2174%2F0929867043364018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364018%26sid%3Dliteratum%253Aachs%26aulast%3DSkiles%26aufirst%3DJ.%26aulast%3DGonnella%26aufirst%3DN.%26aulast%3DJeng%26aufirst%3DA.%26atitle%3DThe%2520Design%252C%2520Structure%252C%2520and%2520Clinical%2520Update%2520of%2520Small%2520Molecular%2520Weight%2520Matrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26issue%3D22%26spage%3D2911%26epage%3D2977%26doi%3D10.2174%2F0929867043364018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Third Generation of Matrix Metalloprotease Inhibitors: Gain in Selectivity by Targeting the Depth of the S1’ Cavity</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1508</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2010.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.biochi.2010.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20696203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2isLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1501-1508&issue=11&author=L.+Develauthor=B.+Czarnyauthor=F.+Beauauthor=D.+Georgiadisauthor=E.+Sturaauthor=V.+Dive&title=Third+Generation+of+Matrix+Metalloprotease+Inhibitors%3A+Gain+in+Selectivity+by+Targeting+the+Depth+of+the+S1%E2%80%99+Cavity&doi=10.1016%2Fj.biochi.2010.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity</span></div><div class="casAuthors">Devel, Laurent; Czarny, Bertrand; Beau, Fabrice; Georgiadis, Dimitris; Stura, Enrico; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1501-1508</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Following the disappointment of clin. trials with early broad-spectrum synthetic inhibitors of matrix metalloproteases (MMPs), the field is now resurging with a new focus on the development of more selective inhibitors.  Compds. able to fully discriminate between different members of the MMP family are sorely needed for therapeutic applications.  Chem. efforts over the past years have led to very few selective inhibitors of MMPs.  The over-exploitation of the hydroxamate function, or other strong zinc-binding groups, might be responsible for this failure.  By resorting to weaker zinc-chelating groups, like phosphoryl or carboxylic groups, inhibitors with improved selectivity profiles have been developed.  However, the most encouraging results have been obtained with compds. that avoid targeting the zinc but gain their affinity from plunging deeper into the MMP S1' cavity.  Analyses of the crystal structures of MMP-13 and MMP-8 complexes with such compds. provide novel insights for the design of more selective inhibitors for other members of the MMP family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAZawXfNu_tLVg90H21EOLACvtfcHk0lijemrosvZa2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2isLrE&md5=e7c5a03fbf3ff95b904430458a1c804c</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2010.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2010.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DStura%26aufirst%3DE.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DThird%2520Generation%2520of%2520Matrix%2520Metalloprotease%2520Inhibitors%253A%2520Gain%2520in%2520Selectivity%2520by%2520Targeting%2520the%2520Depth%2520of%2520the%2520S1%25E2%2580%2599%2520Cavity%26jtitle%3DBiochimie%26date%3D2010%26volume%3D92%26issue%3D11%26spage%3D1501%26epage%3D1508%26doi%3D10.1016%2Fj.biochi.2010.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuccinardi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossello, A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2100</span>, <span class="refDoi"> DOI: 10.2174/138161207781039706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F138161207781039706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17627541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Ogu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=2087-2100&issue=20&author=E.+Nutiauthor=T.+Tuccinardiauthor=A.+Rossello&title=Matrix+Metalloproteinase+Inhibitors%3A+New+Challenges+in+the+Era+of+Post+Broad-Spectrum+Inhibitors&doi=10.2174%2F138161207781039706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors</span></div><div class="casAuthors">Nuti, Elisa; Tuccinardi, Tiziano; Rossello, Armando</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2087-2100</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  More than two decades have been spent to develop many families of synthetic matrix metalloproteinases inhibitors (MMPI) as therapeutical agents for serious pathologies.  Unfortunately, clin. trials conducted on broad-spectrum inhibitors have yielded disappointing results, esp. in the cancer pathol. area.  Despite these outcomes, some small synthetic MMPI are in advanced trials or launched in clin. ones for cancer, arthritis, periodontal diseases.  Today many groups are developing intensive efforts to find new classes of inhibitors characterized by improved potency and, above all, high selectivity against the specific MMP involved in each targeted pathol.  The new challenges include the development of new MMPI bearing more effective ZBGs and the development of new allosteric non-zinc binding inhibitors, devoid of ZBGs.  An anal. of more recent results in this field reported on journals and patents will be developed, to consider some of the more interesting new highly selective synthetic MMPI, their SARs, the new theor. approaches used for modeling and the results of their biol. evaluations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMCtqrLRJtEbVg90H21EOLACvtfcHk0lijemrosvZa2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Ogu7w%253D&md5=011104d90447c23592ff58e5c09cdf91</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.2174%2F138161207781039706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161207781039706%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DMatrix%2520Metalloproteinase%2520Inhibitors%253A%2520New%2520Challenges%2520in%2520the%2520Era%2520of%2520Post%2520Broad-Spectrum%2520Inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2007%26volume%3D13%26issue%3D20%26spage%3D2087%26epage%3D2100%26doi%3D10.2174%2F138161207781039706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dormán, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cseh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdú, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kónya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovács, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferdinandy, P.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase Inhibitors</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">964</span>, <span class="refDoi"> DOI: 10.2165/11318390-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2165%2F11318390-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20481653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlalsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=949-964&issue=8&author=G.+Dorm%C3%A1nauthor=S.+Csehauthor=I.+Hajd%C3%BAauthor=L.+Barnaauthor=D.+K%C3%B3nyaauthor=K.+Kupaiauthor=L.+Kov%C3%A1csauthor=P.+Ferdinandy&title=Matrix+Metalloproteinase+Inhibitors&doi=10.2165%2F11318390-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility</span></div><div class="casAuthors">Dorman, Gyorgy; Cseh, Sandor; Hajdu, Istvan; Barna, Laszlo; Konya, Denes; Kupai, Krisztina; Kovacs, Laszlo; Ferdinandy, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">949-964</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis Data Information BV</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) play an important role in tissue remodelling assocd. with various physiol. and pathol. processes, such as morphogenesis, angiogenesis, tissue repair, arthritis, chronic heart failure, chronic obstructive pulmonary disease, chronic inflammation and cancer metastasis.  As a result, MMPs are considered to be viable drug targets in the therapy of these diseases.  Despite the high therapeutic potential of MMP inhibitors (MMPIs), all clin. trials have failed to date, except for doxycycline for periodontal disease.  This can be attributed to (i) poor selectivity of the MMPIs, (ii) poor target validation for the targeted therapy and (iii) poorly defined predictive preclin. animal models for safety and efficacy.  Lessons from previous failures, such as recent discoveries of oxidative/nitrosative activation and phosphorylation of MMPs, as well as novel non-matrix related intra- and extracellular targets of MMP, give new hope for MMPI development for both chronic and acute diseases.  In this article we critically review the major structural determinants of the selectivity and the milestones of past design efforts of MMPIs where 2-/3-dimensional structure-based methods were intensively applied.  We also analyze the in vitro screening and preclin./clin. pharmacol. approaches, with particular emphasis on drawing conclusions on how to overcome efficacy and safety problems through better target validation and design of preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr90df3aVC2rVg90H21EOLACvtfcHk0ljiBr5aAfh4Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlalsb8%253D&md5=a3ef6e419599ae64a7165d1b3eca5e4a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.2165%2F11318390-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11318390-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DDorm%25C3%25A1n%26aufirst%3DG.%26aulast%3DCseh%26aufirst%3DS.%26aulast%3DHajd%25C3%25BA%26aufirst%3DI.%26aulast%3DBarna%26aufirst%3DL.%26aulast%3DK%25C3%25B3nya%26aufirst%3DD.%26aulast%3DKupai%26aufirst%3DK.%26aulast%3DKov%25C3%25A1cs%26aufirst%3DL.%26aulast%3DFerdinandy%26aufirst%3DP.%26atitle%3DMatrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26issue%3D8%26spage%3D949%26epage%3D964%26doi%3D10.2165%2F11318390-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in MMP Inhibitor Design</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1007/s10555-006-7894-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs10555-006-7894-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16680577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=115-136&issue=1&author=J.+F.+Fisherauthor=S.+Mobashery&title=Recent+Advances+in+MMP+Inhibitor+Design&doi=10.1007%2Fs10555-006-7894-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in MMP inhibitor design</span></div><div class="casAuthors">Fisher, Jed F.; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-136</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The search for an MMP inhibitor with anticancer efficacy is a nearly three-decade endeavor.  This inhibitor is yet to be found.  The reasons for this failure include shortcomings in the chem. of these compds. (including broad MMP sub-type selectivity, metabolic lability, and toxicity) as well as the emerging, and arguably extraordinary, complexity of MMP cell (and cancer) biol.  Together these suggest that the successful anticancer inhibitor must possess MMP selectivity against the MMP subtype whose involvement is crit., yet highly temporally (with respect to metastatic progression) and mechanistically (with respect to matrix degrdn.) regulated.  This review summarizes the progression of chem. structure and mechanistic thinking toward these objectives, with emphasis on the disappointment, the perseverance, and the resilient optimism that such an inhibitor is there to be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgy2dldRRXLVg90H21EOLACvtfcHk0ljiBr5aAfh4Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D&md5=ceed8438ad533dac294e22102e5ba8bf</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1007%2Fs10555-006-7894-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-006-7894-9%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DRecent%2520Advances%2520in%2520MMP%2520Inhibitor%2520Design%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2006%26volume%3D25%26issue%3D1%26spage%3D115%26epage%3D136%26doi%3D10.1007%2Fs10555-006-7894-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">Progress in the Development of Matrix Metalloproteinase Inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">1388</span>– <span class="NLM_lpage">1395</span>, <span class="refDoi"> DOI: 10.2174/092986708784567680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F092986708784567680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=18537616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1388-1395&issue=14&author=G.+Tuauthor=W.+Xuauthor=H.+Huangauthor=S.+Li&title=Progress+in+the+Development+of+Matrix+Metalloproteinase+Inhibitors&doi=10.2174%2F092986708784567680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Tu, GuoGang; Xu, WenFang; Huang, HuiMing; Li, ShaoHua</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1388-1395</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteinases involved in the degrdn. and remodeling of extracellular matrix proteins that are assocd. with the tumorigenic process.  MMPs promote tumor invasion and metastasis, regulating host defense mechanisms and normal cell function.  Thus, MMP inhibitors (MMPIs) are expected to be useful for the treatment of diseases such as cancer, osteoarthritis, and rheumatoid arthritis.  A vast no. of MMPIs have been developed in recent years.  With the failure of these inhibitors in clin. trials, more efforts have been directed to the design of specific inhibitors with different Zn-binding groups.  This review summarizes the current status of MMPIs, the design of small mol. wt. MMPIs, a brief description of available three-dimensional MMP structures, a review of the proposed therapeutic utility of MMPIs, and a clin. update of compds. that have entered clin. trials in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofpnHvDcAn-rVg90H21EOLACvtfcHk0ljiBr5aAfh4Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVyhs7w%253D&md5=2cf2aff42def16a2b76a363d1d498daa</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.2174%2F092986708784567680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708784567680%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DProgress%2520in%2520the%2520Development%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26issue%3D14%26spage%3D1388%26epage%3D1395%26doi%3D10.2174%2F092986708784567680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, R.</span></span> <span> </span><span class="NLM_article-title">Design and Structural Evolution of Matrix Metalloproteinase Inhibitors</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">7960</span>– <span class="NLM_lpage">7980</span>, <span class="refDoi"> DOI: 10.1002/chem.201805361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fchem.201805361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30720221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXos1WitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=7960-7980&issue=34&author=T.+Fischerauthor=N.+Sennauthor=R.+Riedl&title=Design+and+Structural+Evolution+of+Matrix+Metalloproteinase+Inhibitors&doi=10.1002%2Fchem.201805361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Structural Evolution of Matrix Metalloproteinase Inhibitors</span></div><div class="casAuthors">Fischer, Thomas; Senn, Nicole; Riedl, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7960-7980</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are involved in a multitude of severe diseases.  Despite MMPs being considered druggable targets, past drug-discovery programs have not delivered the anticipated clin. benefits.  This review examines the latest structural evolution of small-mol. inhibitors of MMPs, with a focus on the development of novel chem. entities with improved affinity and selectivity profiles.  X-ray crystallog. data of the protein targets and cocrystal structures with inhibitors proved to be key for the success achieved during this ambitious endeavor.  An evolutionary view on the structural diversity generated for this class of mols. is provided.  This encouraging development paves the way for the clin. utilization of this class of highly relevant therapeutic targets.  The structure-based design of superior MMP inhibitors highlights the power of this technique and displays strategies for the development of treatment options based on the modulation of challenging drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnxijtyd8uL7Vg90H21EOLACvtfcHk0ljiBr5aAfh4Vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXos1WitbY%253D&md5=366df24421036cc428d37c7c905271d1</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1002%2Fchem.201805361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201805361%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DT.%26aulast%3DSenn%26aufirst%3DN.%26aulast%3DRiedl%26aufirst%3DR.%26atitle%3DDesign%2520and%2520Structural%2520Evolution%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2019%26volume%3D25%26issue%3D34%26spage%3D7960%26epage%3D7980%26doi%3D10.1002%2Fchem.201805361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saravanan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span> <span> </span><span class="NLM_article-title">Sulphonamides: Deserving Class as MMP Inhibitors?</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.ejmech.2012.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23287054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVeiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=89-100&author=P.+Jainauthor=C.+Saravananauthor=S.+K.+Singh&title=Sulphonamides%3A+Deserving+Class+as+MMP+Inhibitors%3F&doi=10.1016%2Fj.ejmech.2012.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Sulphonamides: Deserving class as MMP inhibitors?</span></div><div class="casAuthors">Jain, Pranjali; Saravanan, Chinnadurai; Singh, Sushil Kumar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The importance of sulfonamide moiety in medicinal chem. cannot be ignored as it constitutes an important class of extensively used drugs.  Recently, sulfonamides have also been reported for their matrix metalloproteinase (MMP) inhibitory activity.  MMPs are calcium- and zinc-dependent endopeptidases, involved in both inter- and intra-cellular activity.  This review documents the emergence of sulfonamides as matrix metalloproteinase inhibitors (MMPIs) from the first generation to the recent third generation MMPIs, their mode of action - how sulfonamides act on MMPs as well as the structure activity relationship along with their therapeutic uses in chronic obstructive pulmonary disease (COPD), ulcer, asthma, arthritis and cancer.  From this review, readers can get answer for the question- is sulfonamides a potential class of MMPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1FEujtONsfbVg90H21EOLACvtfcHk0lhDbgGet1L7yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVeiu7o%253D&md5=10dc47ad65684dad2cd3622b82378d2b</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DP.%26aulast%3DSaravanan%26aufirst%3DC.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26atitle%3DSulphonamides%253A%2520Deserving%2520Class%2520as%2520MMP%2520Inhibitors%253F%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D60%26spage%3D89%26epage%3D100%26doi%3D10.1016%2Fj.ejmech.2012.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuffaro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosalia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepshi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camodeca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciccone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossello, A.</span></span> <span> </span><span class="NLM_article-title">Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1626</span>– <span class="NLM_lpage">1637</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fcmdc.201600235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27356908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyhsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1626-1637&author=E.+Nutiauthor=D.+Cuffaroauthor=F.+D%E2%80%99Andreaauthor=L.+Rosaliaauthor=L.+Tepshiauthor=M.+Fabbiauthor=G.+Carbottiauthor=S.+Ferriniauthor=S.+Santamariaauthor=C.+Camodecaauthor=L.+Cicconeauthor=E.+Orlandiniauthor=S.+Nencettiauthor=E.+A.+Sturaauthor=V.+Diveauthor=A.+Rossello&title=Sugar-Based+Arylsulfonamide+Carboxylates+as+Selective+and+Water-Soluble+Matrix+Metalloproteinase-12+Inhibitors&doi=10.1002%2Fcmdc.201600235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors</span></div><div class="casAuthors">Nuti, Elisa; Cuffaro, Doretta; D'Andrea, Felicia; Rosalia, Lea; Tepshi, Livia; Fabbi, Marina; Carbotti, Grazia; Ferrini, Silvano; Santamaria, Salvatore; Camodeca, Caterina; Ciccone, Lidia; Orlandini, Elisabetta; Nencetti, Susanna; Stura, Enrico A.; Dive, Vincent; Rossello, Armando</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1626-1637</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-12 (MMP-12) can be considered an attractive target to study selective inhibitors useful in the development of new therapies for lung and cardiovascular diseases.  .In this study, a new series of arylsulfonamide carboxylates, with increased hydrophilicity resulting from conjugation with a β-N-acetyl-D-glucosamine moiety, were designed and synthesized as MMP-12 selective inhibitors.  Their inhibitory activity was evaluated on human MMPs by using the fluorimetric assay, and a crystallog. anal. was performed to characterize their binding mode.  Among these glycoconjugates, a nanomolar MMP-12 inhibitor with improved water soly., compd. I was identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiqGwhIwzturVg90H21EOLACvtfcHk0lhDbgGet1L7yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyhsbbK&md5=bc140624b010a1bca6bb7dfc7365eea3</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600235%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DCuffaro%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DF.%26aulast%3DRosalia%26aufirst%3DL.%26aulast%3DTepshi%26aufirst%3DL.%26aulast%3DFabbi%26aufirst%3DM.%26aulast%3DCarbotti%26aufirst%3DG.%26aulast%3DFerrini%26aufirst%3DS.%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3DCamodeca%26aufirst%3DC.%26aulast%3DCiccone%26aufirst%3DL.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DStura%26aufirst%3DE.%2BA.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DSugar-Based%2520Arylsulfonamide%2520Carboxylates%2520as%2520Selective%2520and%2520Water-Soluble%2520Matrix%2520Metalloproteinase-12%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1626%26epage%3D1637%26doi%3D10.1002%2Fcmdc.201600235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuffaro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camodeca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piragine, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossello, A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-12 Inhibitors: Synthesis, Structure-Activity Relationships and Intestinal Absorption of Novel Sugar-Based Biphenylsulfonamide Carboxylates</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">5804</span>– <span class="NLM_lpage">5815</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bmc.2018.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30429099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKmt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=5804-5815&issue=22&author=D.+Cuffaroauthor=C.+Camodecaauthor=F.+D%E2%80%99Andreaauthor=E.+Piragineauthor=L.+Testaiauthor=V.+Calderoneauthor=E.+Orlandiniauthor=E.+Nutiauthor=A.+Rossello&title=Matrix+Metalloproteinase-12+Inhibitors%3A+Synthesis%2C+Structure-Activity+Relationships+and+Intestinal+Absorption+of+Novel+Sugar-Based+Biphenylsulfonamide+Carboxylates&doi=10.1016%2Fj.bmc.2018.10.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates</span></div><div class="casAuthors">Cuffaro, Doretta; Camodeca, Caterina; D'Andrea, Felicia; Piragine, Eugenia; Testai, Lara; Calderone, Vincenzo; Orlandini, Elisabetta; Nuti, Elisa; Rossello, Armando</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5804-5815</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">MMP-12 is a validated target in pulmonary and cardiovascular diseases.  The principal obstacles to clin. development of MMP-12 inhibitors are an inadequate selectivity for the target enzyme and a poor water soly., with consequent poor oral bioavailability.  We recently reported a new class of sugar-based arylsulfonamide carboxylates with a nanomolar activity for MMP-12, a good selectivity and an improved water soly.  In this study, we designed and synthesized new derivs. to characterize the structure-activity relationship (SAR) within this class of glycoconjugate inhibitors.  All the new derivs. were tested on human recombinant MMP-12 and MMP-9 in order to evaluate their affinity and the selectivity for the target enzyme.  Among them, the four most promising compds. were selected to assess their intestinal permeability using an ex vivo everted gut sac model.  Given the high polarity and structural similarity to glucose, compd. 3 was demonstrated to cross the intestinal membrane by using the facilitative GLUT2 transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr39tPCiDpjGLVg90H21EOLACvtfcHk0lhDbgGet1L7yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKmt7jN&md5=dde01819969c8d6baac4d21340abb598</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DCuffaro%26aufirst%3DD.%26aulast%3DCamodeca%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DF.%26aulast%3DPiragine%26aufirst%3DE.%26aulast%3DTestai%26aufirst%3DL.%26aulast%3DCalderone%26aufirst%3DV.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DMatrix%2520Metalloproteinase-12%2520Inhibitors%253A%2520Synthesis%252C%2520Structure-Activity%2520Relationships%2520and%2520Intestinal%2520Absorption%2520of%2520Novel%2520Sugar-Based%2520Biphenylsulfonamide%2520Carboxylates%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26issue%3D22%26spage%3D5804%26epage%3D5815%26doi%3D10.1016%2Fj.bmc.2018.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuffaro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camodeca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciccone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepshi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossello, A.</span></span> <span> </span><span class="NLM_article-title">Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4421</span>– <span class="NLM_lpage">4435</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00096</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00096" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVWis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4421-4435&author=E.+Nutiauthor=D.+Cuffaroauthor=E.+Bernardiniauthor=C.+Camodecaauthor=L.+Panelliauthor=S.+Chavesauthor=L.+Cicconeauthor=L.+Tepshiauthor=L.+Veraauthor=E.+Orlandiniauthor=S.+Nencettiauthor=E.+A.+Sturaauthor=M.+A.+Santosauthor=V.+Diveauthor=A.+Rossello&title=Development+of+Thioaryl-Based+Matrix+Metalloproteinase-12+Inhibitors+with+Alternative+Zinc-Binding+Groups%3A+Synthesis%2C+Potentiometric%2C+NMR%2C+and+Crystallographic+Studies&doi=10.1021%2Facs.jmedchem.8b00096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies</span></div><div class="casAuthors">Nuti, Elisa; Cuffaro, Doretta; Bernardini, Elisa; Camodeca, Caterina; Panelli, Laura; Chaves, Silvia; Ciccone, Lidia; Tepshi, Livia; Vera, Laura; Orlandini, Elisabetta; Nencetti, Susanna; Stura, Enrico A.; Santos, M. Amelia; Dive, Vincent; Rossello, Armando</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4421-4435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-12 (MMP-12) selective inhibitors could play a role in the treatment of lung inflammatory and cardiovascular diseases.  In the present study, the previously reported 4-methoxybiphenylsulfonyl hydroxamate and carboxylate based inhibitors (I and II) were modified to enhance their selectivity for MMP-12.  In the newly synthesized thioaryl derivs., the nature of the zinc binding group (ZBG) and the sulfur oxidn. state were changed.  Biol. assays carried out in vitro on human MMPs with the resulting compds. led to identification of a sulfide, III, bearing an N-1-hydroxypiperidine-2,6-dione (HPD) group as new ZBG.  Compd. III is a promising hit compd. since it displayed a nanomolar affinity for MMP-12 with a marked selectivity over MMP-9, MMP-1, and MMP-14.  Soln. complexation studies with Zn2+ were performed to characterize the chelating abilities of the new compds. and confirmed the bidentate binding mode of HPD derivs.  X-ray crystallog. studies using MMP-12 and MMP-9 catalytic domains were carried out to rationalize the biol. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGompUvE-tYWNLVg90H21EOLACvtfcHk0lgln2PgJAj7jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVWis7Y%253D&md5=2b8d3c42ee0eb148735605580ae9172d</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00096%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DCuffaro%26aufirst%3DD.%26aulast%3DBernardini%26aufirst%3DE.%26aulast%3DCamodeca%26aufirst%3DC.%26aulast%3DPanelli%26aufirst%3DL.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DCiccone%26aufirst%3DL.%26aulast%3DTepshi%26aufirst%3DL.%26aulast%3DVera%26aufirst%3DL.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DStura%26aufirst%3DE.%2BA.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520Thioaryl-Based%2520Matrix%2520Metalloproteinase-12%2520Inhibitors%2520with%2520Alternative%2520Zinc-Binding%2520Groups%253A%2520Synthesis%252C%2520Potentiometric%252C%2520NMR%252C%2520and%2520Crystallographic%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4421%26epage%3D4435%26doi%3D10.1021%2Facs.jmedchem.8b00096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardo, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotra, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span> <span> </span><span class="NLM_article-title">Potent and Selective Mechanism-Based Inhibition of Gelatinases</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">6799</span>– <span class="NLM_lpage">6800</span>, <span class="refDoi"> DOI: 10.1021/ja001461n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja001461n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlOqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=6799-6800&issue=12&author=S.+Brownauthor=M.+M.+Bernardoauthor=Z.+Liauthor=L.+P.+Kotraauthor=Y.+Tanakaauthor=R.+Fridmanauthor=S.+Mobashery&title=Potent+and+Selective+Mechanism-Based+Inhibition+of+Gelatinases&doi=10.1021%2Fja001461n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Mechanism-Based Inhibition of Gelatinases</span></div><div class="casAuthors">Brown, Stephen; Bernardo, M. Margarida; Li, Zhi-Hong; Kotra, Lakshmi P.; Tanaka, Yasuhiro; Fridman, Rafael; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6799-6800</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Increased level of activity for human gelatinases, MMP-2 and MMP-9, has been implicated in the process of tumor metastasis and angiogenesis.  As a result, we have been interested in the selective inhibition of these two key MMPs.  For this purpose, we have resorted to the design of mechanism-based inhibitors (also known as "kcat inhibitors" or "suicide substrates").  This type of inhibitor has the potential to impart high selectivity in inhibition of closely related enzymes, such as MMPs.  Our strategy for mechanism-based inhibition of MMPs by compd. I is depicted in Scheme 1.  The strategy envisions that coordination of the thiirane with the active-site zinc ion would activate it for modification by a nucleophile in the enzyme active site.  The biphenyl moiety in compds. 1-6 would fit in the P1' subsite of gelatinases, which is a deep hydrophobic pocket.  Energy-minimized complexes of MMP-2 and MMP-9 with compd. I indicated that the biphenyl group would fit in the active site analogously to the same group in reversible inhibitors of MMP-2 and MMP-9.  This binding mode would bring the sulfur of the thiirane in I into the coordination sphere of the zinc ion.  The models indicated that the thiirane moiety in compds. 2 and 3, with longer carbon backbones, would not be able to coordinate with the zinc ion, but would fit in an extended conformation in the active site.  Compds. I-6 were evaluated with MMPs.  Whereas inhibitors 2-6 showed either no inhibition or relatively poor inhibition of the MMPs (Ki values of micromolar at best), the behavior of inhibitor I was different.  Inhibitor I showed a dual behavior.  It served as a mechanism-based inhibitor with a partition ratio of 79 + 10 (i.e., kcat/kinac) for MMP-2 and of 416 + 63 for MMP-9.  Furthermore, it also behaved as a slow-binding inhibitor, for which the rate consts. for the on-set of inhibition (kon) and recovery of activity from inhibition (koff) were evaluated.  It would appear that coordination of the thiirane with the zinc ion (as seen in the energy-minimized computational models) would set in motion a conformational change, which is presumed from the slow-binding kinetic behavior.  The kinetic data fit the model for slow-binding inhibition.  Covalent modification of the enzymes ensued this conformational change.  We incubated inhibitor I with MMP-2 to the point that less than 5% activity remained.  This inhibitor-enzyme complex was dialyzed over 3 days, which resulted in recovery of approx. 50% of the activity.  This observation is consistent with modification of the active site Glu-404, via the formation of an ester bond, which is a relatively labile covalent linkage.  We observe selectivity in inhibition of gelatinases by inhibitor I.  The Ki values are 13.9 ± 0.4 and 600 ± 200 nM for MMP-2 and MMP-9, resp.  In contrast, the corresponding Ki values for the other MMPs tested, including MMP-3, which does show the slow-binding mechanism-based inhibition profile, are in the micromolar range.  Interestingly, the values for kon, are 611- and 78-fold larger for MMP-2 and MMP-9, resp., than that for MMP-3.  Collectively, these kinetic parameters make inhibitor I a potent and selective inhibitor for both MMP-2 and MMP-9, more so for MMP-2.  We have detd. previously that two mols. of either TIMP-1 or TIMP-2 bind to activated MMP-2 and MMP-9.  One binding event is high affinity and would appear physiol. relevant, whereas the second binding event takes place with relatively lower affinity (micromolar).  Inhibition of MMP-2 and MMP-9 by TIMP-2 and TIMP-1, resp., also follows slow-binding kinetics.  The kinetic parameters for these interactions at the high affinity site are presented.  We find it noteworthy that the kinetic parameters for the slow-binding component of inhibition of MMP-2 and MMP-9 by inhibitor I (kon and koff) approach closely the same parameters for those of the TIMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_leOdGm4bBrVg90H21EOLACvtfcHk0lgln2PgJAj7jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlOqt7Y%253D&md5=15101fcf9ff6340558e63b181b62a6dd</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Fja001461n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja001461n%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DBernardo%26aufirst%3DM.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DKotra%26aufirst%3DL.%2BP.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DPotent%2520and%2520Selective%2520Mechanism-Based%2520Inhibition%2520of%2520Gelatinases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26issue%3D12%26spage%3D6799%26epage%3D6800%26doi%3D10.1021%2Fja001461n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleifeld, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotra, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gervasi, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardo, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">X-Ray Absorption Studies of Human Matrix Metalloproteinase-2 (MMP-2) Bound to a Highly Selective Mechanism-Based Inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">17125</span>– <span class="NLM_lpage">17131</span>, <span class="refDoi"> DOI: 10.1074/jbc.M011604200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M011604200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11278946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvFGitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=17125-17131&issue=20&author=O.+Kleifeldauthor=L.+P.+Kotraauthor=D.+C.+Gervasiauthor=S.+Brownauthor=M.+M.+Bernardoauthor=R.+Fridmanauthor=S.+Mobasheryauthor=I.+Sagi&title=X-Ray+Absorption+Studies+of+Human+Matrix+Metalloproteinase-2+%28MMP-2%29+Bound+to+a+Highly+Selective+Mechanism-Based+Inhibitor&doi=10.1074%2Fjbc.M011604200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanism-based inhibitor. Comparison with the latent and active forms of the enzyme</span></div><div class="casAuthors">Kleifeld, Oded; Kotra, Lakshmi P.; Gervasi, David C.; Brown, Stephen; Bernardo, M. Margarida; Fridman, Rafael; Mobashery, Shahriar; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">17125-17131</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Malignant tumors express high levels of zinc-dependent endopeptidases called matrix metalloproteinases (MMPs), which are thought to facilitate tumor metastasis and angiogenesis by hydrolyzing components of the extracellular matrix.  Of these enzymes, gelatinases A (MMP-2) and B (MMP-9), have esp. been implicated in malignant processes, and thus, they have been a target for drugs designed to block their activity.  Therefore, understanding their mol. structure is key for a rational approach to inhibitor design.  Here, the authors have conducted x-ray absorption spectroscopy of the full-length human MMP-2 in its latent, active, and inhibited states and report the structural changes at the zinc ion site upon enzyme activation and inhibition.  The authors have also examd. the mol. structure of MMP-2 in complex with SB-3CT, a recently reported novel mechanism-based synthetic inhibitor that was designed to be highly selective in gelatinases.  It is shown that SB-3CT directly binds the catalytic zinc ion of MMP-2.  Interestingly, the novel mode of binding of the inhibitor to the catalytic zinc reconstructs the conformational environment around the active site metal ion back to that of the proenzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKUVKfewB1R7Vg90H21EOLACvtfcHk0lgln2PgJAj7jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvFGitrY%253D&md5=cb92e0e1e44d1c636a840140c115c4b6</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M011604200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M011604200%26sid%3Dliteratum%253Aachs%26aulast%3DKleifeld%26aufirst%3DO.%26aulast%3DKotra%26aufirst%3DL.%2BP.%26aulast%3DGervasi%26aufirst%3DD.%2BC.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DBernardo%26aufirst%3DM.%2BM.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DX-Ray%2520Absorption%2520Studies%2520of%2520Human%2520Matrix%2520Metalloproteinase-2%2520%2528MMP-2%2529%2520Bound%2520to%2520a%2520Highly%2520Selective%2520Mechanism-Based%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D20%26spage%3D17125%26epage%3D17131%26doi%3D10.1074%2Fjbc.M011604200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gooyit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckow, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolter, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span> <span> </span><span class="NLM_article-title">Selective Gelatinase Inhibitor Neuroprotective Agents Cross the Blood-Brain Barrier</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1021/cn300062w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300062w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWhsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=730-736&issue=10&author=M.+Gooyitauthor=M.+A.+Suckowauthor=V.+A.+Schroederauthor=W.+R.+Wolterauthor=S.+Mobasheryauthor=M.+Chang&title=Selective+Gelatinase+Inhibitor+Neuroprotective+Agents+Cross+the+Blood-Brain+Barrier&doi=10.1021%2Fcn300062w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Gelatinase Inhibitor Neuroprotective Agents Cross the Blood-Brain Barrier</span></div><div class="casAuthors">Gooyit, Major; Suckow, Mark A.; Schroeder, Valerie A.; Wolter, William R.; Mobashery, Shahriar; Chang, Mayland</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">730-736</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SB-3CT, a potent and selective inhibitor of matrix metalloproteinase-2 and -9, has shown efficacy in several animal models of neurol. diseases.  One of the greatest challenges in the development of therapeutics for neurol. diseases is the inability of drugs to cross the blood-brain barrier.  A sensitive bioanal. method based on ultraperformance liq. chromatog. with multiple-reaction monitoring detection was developed to measure levels of SB-3CT, its active metabolite, the α-Me analog, and its p-hydroxy metabolite in plasma and brain.  The compds. are rapidly absorbed and are readily distributed to the brain.  The pharmacokinetic properties of these gelatinase inhibitors and the efficacy shown by SB-3CT in animal models of stroke, subarachnoid hemorrhage, and spinal cord injury indicate that this class of compds. holds considerable promise in the treatment of diseases of the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmol4U6a2bIbVg90H21EOLACvtfcHk0lhNgWSN6YFqMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWhsrfE&md5=05f147cd30e827b2d81b155af8a6c418</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Fcn300062w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300062w%26sid%3Dliteratum%253Aachs%26aulast%3DGooyit%26aufirst%3DM.%26aulast%3DSuckow%26aufirst%3DM.%2BA.%26aulast%3DSchroeder%26aufirst%3DV.%2BA.%26aulast%3DWolter%26aufirst%3DW.%2BR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DSelective%2520Gelatinase%2520Inhibitor%2520Neuroprotective%2520Agents%2520Cross%2520the%2520Blood-Brain%2520Barrier%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26issue%3D10%26spage%3D730%26epage%3D736%26doi%3D10.1021%2Fcn300062w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ranasinghe, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheepens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirimanne, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of MMP-9 Activity Following Hypoxic Ischemia in the Developing Brain Using a Highly Specific Inhibitor</span>. <i>Dev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1159/000343257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1159%2F000343257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23171520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2012&pages=417-427&issue=5&author=H.+S.+Ranasingheauthor=A.+Scheepensauthor=E.+Sirimanneauthor=M.+D.+Mitchellauthor=C.+E.+Williamsauthor=M.+Fraser&title=Inhibition+of+MMP-9+Activity+Following+Hypoxic+Ischemia+in+the+Developing+Brain+Using+a+Highly+Specific+Inhibitor&doi=10.1159%2F000343257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MMP-9 Activity following Hypoxic Ischemia in the Developing Brain Using a Highly Specific Inhibitor</span></div><div class="casAuthors">Ranasinghe, Himani S.; Scheepens, Arjan; Sirimanne, Ernest; Mitchell, Murray D.; Williams, Christopher E.; Fraser, Mhoyra</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Neuroscience (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">417-427</span>CODEN:
                <span class="NLM_cas:coden">DENED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-5866</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Perinatal hypoxic ischemic (HI) brain injury is a leading cause of long-term neurol. handicap in newborn babies.  Recently, excessive activity of matrix metalloproteinases (MMPs), and in particular MMP-9, has been implicated in the etiol. of HI injuries to the immature brain.  Our previous study suggested that MMP-9 may be involved in the development of the delayed injury processes following HI injury to the developing brain.  Given this, we therefore propose that MMP-9 may be a useful target for rescue therapies in the injured developing brain.  To address this, we chose to use SB-3CT, a highly selective inhibitor that is known to target only MMP-2 and MMP-9, to attenuate the elevated MMP-9 activity seen following HI injury to the developing brain.  Twenty-one-day-old postnatal Wistar rats were subjected to unilateral carotid artery occlusion followed by exposure to hypoxia (8% oxygen for 1 h).  SB-3CT (50 mg/kg body wt. in 25% DMSO/75% polyethylene glycol) or an equal vol. of vehicle or saline diluent was then administered i.p. at 2, 5 and 14 h following the insult.  Gelatin zymog. revealed that pro-MMP-9 levels were significantly reduced at 6 h following hypoxic ischemia (p ≤ 0.05).  However, our results showed that despite significantly inhibiting brain pro-MMP-9 activity after hypoxic ischemia, SB-3CT failed to confer significant neuroprotection in postnatal day 21 rats 3 days after an HI insult.  Further investigations are warranted using a recently reported selective water-sol. version of SB-3CT or another MMP-9 selective inhibitor to resolve the role of MMP-9 in the etiol. of HI injury in the developing brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxpRv7eWe3D7Vg90H21EOLACvtfcHk0lhNgWSN6YFqMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyqs78%253D&md5=429fef8bd3080501a530b4d34cfce258</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1159%2F000343257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000343257%26sid%3Dliteratum%253Aachs%26aulast%3DRanasinghe%26aufirst%3DH.%2BS.%26aulast%3DScheepens%26aufirst%3DA.%26aulast%3DSirimanne%26aufirst%3DE.%26aulast%3DMitchell%26aufirst%3DM.%2BD.%26aulast%3DWilliams%26aufirst%3DC.%2BE.%26aulast%3DFraser%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520MMP-9%2520Activity%2520Following%2520Hypoxic%2520Ischemia%2520in%2520the%2520Developing%2520Brain%2520Using%2520a%2520Highly%2520Specific%2520Inhibitor%26jtitle%3DDev.%2520Neurosci.%26date%3D2012%26volume%3D34%26issue%3D5%26spage%3D417%26epage%3D427%26doi%3D10.1159%2F000343257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gooyit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahasenan, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenwalter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckow, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolter, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span> <span> </span><span class="NLM_article-title">O -Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors That Cross the Blood-Brain Barrier</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8139</span>– <span class="NLM_lpage">8150</span>, <span class="refDoi"> DOI: 10.1021/jm401217d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401217d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeksbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8139-8150&issue=20&author=M.+Gooyitauthor=W.+Songauthor=K.+V.+Mahasenanauthor=K.+Lichtenwalterauthor=M.+A.+Suckowauthor=V.+A.+Schroederauthor=W.+R.+Wolterauthor=S.+Mobasheryauthor=M.+Chang&title=O+-Phenyl+Carbamate+and+Phenyl+Urea+Thiiranes+as+Selective+Matrix+Metalloproteinase-2+Inhibitors+That+Cross+the+Blood-Brain+Barrier&doi=10.1021%2Fjm401217d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">O-Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors that Cross the Blood-Brain Barrier</span></div><div class="casAuthors">Gooyit, Major; Song, Wei; Mahasenan, Kiran V.; Lichtenwalter, Katerina; Suckow, Mark A.; Schroeder, Valerie A.; Wolter, William R.; Mobashery, Shahriar; Chang, Mayland</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8139-8150</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Brain metastasis occurs in 20-40% of cancer patients.  Treatment is mostly palliative, and the inability of most drugs to penetrate the brain presents one of the greatest challenges in the development of therapeutics for brain metastasis.  Matrix metalloproteinase-2 (MMP-2) plays important roles in invasion and vascularization of the central nervous system and represents a potential target for treatment of brain metastasis.  Carbonate, O-Ph carbamate, urea, and N-Ph carbamate derivs. of SB-3CT, a selective and potent gelatinase inhibitor, were synthesized and evaluated.  The O-Ph carbamate and urea variants were selective and potent inhibitors of MMP-2.  Carbamate (I) was metabolized to a potent gelatinase inhibitor, which was present at therapeutic concns. in the brain.  In contrast, Ph urea (II) crossed the blood-brain barrier, however, higher doses would result in therapeutic brain concns.  Carbamate I and urea II show potential for intervention of MMP-2-dependent diseases such as brain metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxJd0iAL1uYrVg90H21EOLACvtfcHk0lhNgWSN6YFqMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeksbrF&md5=f84950242a75d2c2c947eeee5630fc64</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1021%2Fjm401217d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401217d%26sid%3Dliteratum%253Aachs%26aulast%3DGooyit%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DMahasenan%26aufirst%3DK.%2BV.%26aulast%3DLichtenwalter%26aufirst%3DK.%26aulast%3DSuckow%26aufirst%3DM.%2BA.%26aulast%3DSchroeder%26aufirst%3DV.%2BA.%26aulast%3DWolter%26aufirst%3DW.%2BR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DO%2520-Phenyl%2520Carbamate%2520and%2520Phenyl%2520Urea%2520Thiiranes%2520as%2520Selective%2520Matrix%2520Metalloproteinase-2%2520Inhibitors%2520That%2520Cross%2520the%2520Blood-Brain%2520Barrier%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D20%26spage%3D8139%26epage%3D8150%26doi%3D10.1021%2Fjm401217d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span> <span> </span><span class="NLM_article-title">MMP-9 Inhibitor SB-3CT Attenuates Behavioral Impairments and Hippocampal Loss after Traumatic Brain Injury in Rat</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1234</span>, <span class="refDoi"> DOI: 10.1089/neu.2013.3230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1089%2Fneu.2013.3230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24661104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC2crmslWitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=1225-1234&issue=13&author=F.+Jiaauthor=Y.+H.+Yinauthor=G.+Y.+Gaoauthor=Y.+Wangauthor=L.+Cenauthor=J.+Jiang&title=MMP-9+Inhibitor+SB-3CT+Attenuates+Behavioral+Impairments+and+Hippocampal+Loss+after+Traumatic+Brain+Injury+in+Rat&doi=10.1089%2Fneu.2013.3230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat</span></div><div class="casAuthors">Jia Feng; Yin Yu Hua; Gao Guo Yi; Wang Yu; Cen Lian; Jiang Ji-Yao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1225-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this study was to evaluate the potential efficacy of SB-3CT, a matrix metallopeptidase 9 inhibitor, on behavioral and histological outcomes after traumatic brain injury (TBI) in rats.  Adult male Sprague-Dawley rats were randomly divided into three groups (n=15/group): TBI with SB-3CT treatment, TBI with saline, and sham injury.  The TBI model was induced by a fluid percussion TBI device.  SB-3CT (50 mg/kg in 10% dimethyl sulfoxide) was administered intraperitoneally at 30 min, 6 h, and 12 h after the TBI.  Motor function (beam-balance/beam-walk tests) and spatial learning/memory (Morris water maze) were assessed on post-operative Days 1-5 and 11-15, respectively.  Fluoro-Jade staining, immunofluorescence, and cresyl violet-staining were carried out for histopathological evaluation at 24 h, 72 h, and 15 days after TBI, respectively.  It was shown that TBI can result in significant behavioral deficit induced by acute neurodegeneration, increased expression of cleaved caspase-3, and long-term neuronal loss.  SB-3CT intervention via the current regime provides robust behavioral protection and hippocampal neurons preservation from the deleterious effects of TBI.  Hence, the efficacy of SB-3CT on TBI prognosis could be ascertained.  It is believed that the current study adds to the growing literature in identifying SB-3CT as a potential therapy for human brain injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRF6ppVsbFbvJcXNb62YGmbfW6udTcc2ebSw9Px1j0F17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crmslWitg%253D%253D&md5=fc658ed558d1253792292a130e3dcca4</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1089%2Fneu.2013.3230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2013.3230%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DF.%26aulast%3DYin%26aufirst%3DY.%2BH.%26aulast%3DGao%26aufirst%3DG.%2BY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCen%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DJ.%26atitle%3DMMP-9%2520Inhibitor%2520SB-3CT%2520Attenuates%2520Behavioral%2520Impairments%2520and%2520Hippocampal%2520Loss%2520after%2520Traumatic%2520Brain%2520Injury%2520in%2520Rat%26jtitle%3DJ.%2520Neurotrauma%26date%3D2014%26volume%3D31%26issue%3D13%26spage%3D1225%26epage%3D1234%26doi%3D10.1089%2Fneu.2013.3230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogakos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makaritis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuniasse, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yiotakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">11152</span>– <span class="NLM_lpage">11160</span>, <span class="refDoi"> DOI: 10.1074/jbc.M600222200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M600222200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16481329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFWjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=11152-11160&issue=16&author=L.+Develauthor=V.+Rogakosauthor=A.+Davidauthor=A.+Makaritisauthor=F.+Beauauthor=P.+Cuniasseauthor=A.+Yiotakisauthor=V.+Dive&title=Development+of+Selective+Inhibitors+and+Substrate+of+Matrix+Metalloproteinase-12&doi=10.1074%2Fjbc.M600222200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12</span></div><div class="casAuthors">Devel, Laurent; Rogakos, Vassilis; David, Arnaud; Makaritis, Anastasios; Beau, Fabrice; Cuniasse, Philippe; Yiotakis, Athanasios; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">11152-11160</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Four phosphinic peptide libraries with compds. having the general formula p-Br-Ph-(PO2-CH2)-Xaa'-Yaa'-Zaa'-NH2 have been prepd. and screened against 10 matrix metalloproteinases (MMPs).  We identified two phosphinic peptides with Ki values of 0.19 and 4.4 nM toward MMP-12 (macrophage elastase) that are more than 2-3 orders of magnitude less potent toward the other MMPs tested.  These highly selective MMP-12 inhibitors contain a Glu-Glu motif in their Yaa'-Zaa' positions.  Incorporation of this Glu-Glu motif into the sequence of a nonspecific fluorogenic peptide cleaved by MMPs provides a highly selective substrate for MMP-12.  A model of one of these inhibitors interacting with MMP-12 suggests that the selectivity obsd. might be due, in part, to the presence of two unique polar residues in MMP-12, Thr239 and Lys177.  These MMP-12-selective inhibitors may have important therapeutic applications to diseases in which MMP-12 has been suggested to play a key role, such as in emphysema, atherosclerosis, and aortic abdominal aneurysm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCB87ECATf7bVg90H21EOLACvtfcHk0lidpElzccHVCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFWjsLs%253D&md5=ef003d08431c8bccda87c29e1aa32b26</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M600222200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M600222200%26sid%3Dliteratum%253Aachs%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DRogakos%26aufirst%3DV.%26aulast%3DDavid%26aufirst%3DA.%26aulast%3DMakaritis%26aufirst%3DA.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DCuniasse%26aufirst%3DP.%26aulast%3DYiotakis%26aufirst%3DA.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DDevelopment%2520of%2520Selective%2520Inhibitors%2520and%2520Substrate%2520of%2520Matrix%2520Metalloproteinase-12%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D16%26spage%3D11152%26epage%3D11160%26doi%3D10.1074%2Fjbc.M600222200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassar-Lajeunesse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchinat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Molecular Determinants of a Selective Matrix Metalloprotease-12 Inhibitor: Insights from Crystallography and Thermodynamic Studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.1021/jm301574d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301574d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlelsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1149-1159&issue=3&author=B.+Czarnyauthor=E.+A.+Sturaauthor=L.+Develauthor=L.+Veraauthor=E.+Cassar-Lajeunesseauthor=F.+Beauauthor=V.+Calderoneauthor=M.+Fragaiauthor=C.+Luchinatauthor=V.+Dive&title=Molecular+Determinants+of+a+Selective+Matrix+Metalloprotease-12+Inhibitor%3A+Insights+from+Crystallography+and+Thermodynamic+Studies&doi=10.1021%2Fjm301574d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of a Selective Matrix Metalloprotease-12 Inhibitor: Insights from Crystallography and Thermodynamic Studies</span></div><div class="casAuthors">Czarny, Bertrand; Stura, Enrico A.; Devel, Laurent; Vera, Laura; Cassar-Lajeunesse, Evelyne; Beau, Fabrice; Calderone, Vito; Fragai, Marco; Luchinat, Claudio; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1149-1159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mol. determinants responsible for the potency of the RXP470.1 phosphinic peptide inhibitor toward matrix metalloprotease-12 (MMP-12) remain elusive.  To address this issue, structure-activity study, X-ray crystallog., and isothermal titrn. calorimetry (ITC) expts. were performed.  The crystal structure of MMP-12/inhibitor complex (1.15 Å) reveals that the inhibitor establishes multiple interactions with the MMP-12 active site, with its long P1' side chain filling most of the S1' deep cavity.  ITC expts. indicate that the binding of this inhibitor to MMP-12 is mostly entropy driven (ΔG° = -13.1 kcal/mol, ΔH° = -2.53 kcal/mol, and -TΔS° = -10.60 kcal/mol) and involves a proton uptake from the buffer.  Comparing phosphinic vs. hydroxamate inhibitors reveals that the chelation of the zinc ion is slightly different, leading the inhibitor backbone to adopt a position in which the hydrogen bonding with the MMP-12 active site is less favorable in phosphinic inhibitor while maintaining high affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonVg7l2QsQ_bVg90H21EOLACvtfcHk0lhxU7rKtP4cGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlelsrc%253D&md5=481c06c2374ff4204e2793874a589ec3</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1021%2Fjm301574d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301574d%26sid%3Dliteratum%253Aachs%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DStura%26aufirst%3DE.%2BA.%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DVera%26aufirst%3DL.%26aulast%3DCassar-Lajeunesse%26aufirst%3DE.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DCalderone%26aufirst%3DV.%26aulast%3DFragai%26aufirst%3DM.%26aulast%3DLuchinat%26aufirst%3DC.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DMolecular%2520Determinants%2520of%2520a%2520Selective%2520Matrix%2520Metalloprotease-12%2520Inhibitor%253A%2520Insights%2520from%2520Crystallography%2520and%2520Thermodynamic%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D3%26spage%3D1149%26epage%3D1159%26doi%3D10.1021%2Fjm301574d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rouanet-Mehouas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassar-Lajeunesse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span> <span> </span><span class="NLM_article-title">Zinc-Metalloproteinase Inhibitors: Evaluation of the Complex Role Played by the Zinc-Binding Group on Potency and Selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01420</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01420" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWmsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=403-414&issue=1&author=C.+Rouanet-Mehouasauthor=B.+Czarnyauthor=F.+Beauauthor=E.+Cassar-Lajeunesseauthor=E.+A.+Sturaauthor=V.+Diveauthor=L.+Devel&title=Zinc-Metalloproteinase+Inhibitors%3A+Evaluation+of+the+Complex+Role+Played+by+the+Zinc-Binding+Group+on+Potency+and+Selectivity&doi=10.1021%2Facs.jmedchem.6b01420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc-metalloproteinase inhibitors: Evaluation of the complex role played by the zinc-binding group on potency and selectivity</span></div><div class="casAuthors">Rouanet-Mehouas, Cecile; Czarny, Bertrand; Beau, Fabrice; Cassar-Lajeunesse, Evelyne; Stura, Enrico A.; Dive, Vincent; Devel, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">403-414</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The most exploited strategy to develop potent Zn-metalloprotease inhibitors relies on a core Zn chelator and a peptidic or nonpeptidic scaffold that provides supplementary interactions for optimized potency and selectivity.  Applied to matrix metalloproteases (MMPs) with highly conserved catalytic domains, this strategy failed to identify inhibitors with the desired selectivity profiles.  To question the precise role of the Zn-binding group (ZBG), the authors carried out a study on MMP-12 inhibitors with a common peptidic core but different ZBGs.  The authors found that exchanging the ZBG modified inhibitor positioning and affected its dynamics and selectivity.  The binding properties of these compds. were compared through biochem., structural, and calorimetric studies, showing a complex interplay between cooperative interactions and dynamics dictated by the ZBG.  Improving selectivity will require expanding the ZBG repertoire within inhibitor libraries, since relying on a single ZBG significantly decreases the chance to identify effective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_v2xSUupLKLVg90H21EOLACvtfcHk0lhxU7rKtP4cGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWmsr7L&md5=d6ec22a45611ef6bb28e18cefb9f7264</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01420%26sid%3Dliteratum%253Aachs%26aulast%3DRouanet-Mehouas%26aufirst%3DC.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DCassar-Lajeunesse%26aufirst%3DE.%26aulast%3DStura%26aufirst%3DE.%2BA.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DDevel%26aufirst%3DL.%26atitle%3DZinc-Metalloproteinase%2520Inhibitors%253A%2520Evaluation%2520of%2520the%2520Complex%2520Role%2520Played%2520by%2520the%2520Zinc-Binding%2520Group%2520on%2520Potency%2520and%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D1%26spage%3D403%26epage%3D414%26doi%3D10.1021%2Facs.jmedchem.6b01420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajeunesse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Insights from Selective Non-Phosphinic Inhibitors of MMP-12 Tailored to Fit with an S1′ Loop Canonical Conformation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">35900</span>– <span class="NLM_lpage">35909</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.139634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M110.139634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20817735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyntb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=35900-35909&issue=46&author=L.+Develauthor=S.+Garciaauthor=B.+Czarnyauthor=F.+Beauauthor=E.+Lajeunesseauthor=L.+Veraauthor=D.+Georgiadisauthor=E.+Sturaauthor=V.+Dive&title=Insights+from+Selective+Non-Phosphinic+Inhibitors+of+MMP-12+Tailored+to+Fit+with+an+S1%E2%80%B2+Loop+Canonical+Conformation&doi=10.1074%2Fjbc.M110.139634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Insights from Selective Non-phosphinic Inhibitors of MMP-12 Tailored to Fit with an S1' Loop Canonical Conformation</span></div><div class="casAuthors">Devel, Laurent; Garcia, Sandra; Czarny, Bertrand; Beau, Fabrice; Lajeunesse, Evelyne; Vera, Laura; Georgiadis, Dimitris; Stura, Enrico; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">35900-35909</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">After the disappointment of clin. trials with early broad spectrum synthetic inhibitors of matrix metalloproteinases (MMPs), the field is now resurging with a new focus on the development of selective inhibitors that fully discriminate between different members of the MMP family with several therapeutic applications in perspective.  Here, we report a novel class of highly selective MMP-12 inhibitors, without a phosphinic zinc-binding group, designed to plunge deeper into the S1' cavity of the enzyme.  The best inhibitor from this series, identified through a systematic chem. exploration, displays nanomolar potency toward MMP-12 and selectivity factors that range between 2 and 4 orders of magnitude toward a large set of MMPs.  Comparison of the high resoln. x-ray structures of MMP-12 in free state or bound to this new MMP-12 selective inhibitor reveals that this compd. fits deeply within the S1' specificity cavity, maximizing surface/vol. ratios, without perturbing the S1' loop conformation.  This is in contrast with highly selective MMP-13 inhibitors that were shown to select a particular S1' loop conformation.  The search for such compds. that fit precisely to preponderant S1' loop conformation of a particular MMP may prove to be an alternative effective strategy for developing selective inhibitors of MMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ8qFgfjdCB7Vg90H21EOLACvtfcHk0lgwrDchbr9zdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyntb7N&md5=ce4a49985e0a8906820e879c154bb91a</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.139634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.139634%26sid%3Dliteratum%253Aachs%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DGarcia%26aufirst%3DS.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DLajeunesse%26aufirst%3DE.%26aulast%3DVera%26aufirst%3DL.%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DStura%26aufirst%3DE.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DInsights%2520from%2520Selective%2520Non-Phosphinic%2520Inhibitors%2520of%2520MMP-12%2520Tailored%2520to%2520Fit%2520with%2520an%2520S1%25E2%2580%25B2%2520Loop%2520Canonical%2520Conformation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D46%26spage%3D35900%26epage%3D35909%26doi%3D10.1074%2Fjbc.M110.139634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassar-Lajeunesse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Simple Pseudo-Dipeptides with a P2′ Glutamate: A Novel Inhibitor Family of Matrix Metalloproteases and Other Metzincins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">32</span>),  <span class="NLM_fpage">26647</span>– <span class="NLM_lpage">26656</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.380782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M112.380782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=22689580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFaqsbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=26647-26656&issue=32&author=L.+Develauthor=F.+Beauauthor=M.+Amouraauthor=L.+Veraauthor=E.+Cassar-Lajeunesseauthor=S.+Garciaauthor=B.+Czarnyauthor=E.+A.+Sturaauthor=V.+Dive&title=Simple+Pseudo-Dipeptides+with+a+P2%E2%80%B2+Glutamate%3A+A+Novel+Inhibitor+Family+of+Matrix+Metalloproteases+and+Other+Metzincins&doi=10.1074%2Fjbc.M112.380782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Simple Pseudo-dipeptides with a P2' Glutamate</span></div><div class="casAuthors">Devel, Laurent; Beau, Fabrice; Amoura, Mehdi; Vera, Laura; Cassar-Lajeunesse, Evelyne; Garcia, Sandra; Czarny, Bertrand; Stura, Enrico A.; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">26647-26656</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A series of pseudo-peptides with general formula X-L-Glu-NH2 (with X corresponding to an acyl moiety with a long aryl-alkyl side chain) have been synthesized, evaluated as inhibitors of matrix metalloproteases (MMPs), and found to display remarkable nanomolar affinity.  The loss in potency assocd. with a substitution of the P2' L-glutamate by a L-glutamine corroborates the importance of a carboxylate at this position.  The binding mode of some of these inhibitors was characterized in soln. and by X-ray crystallog. in complex with various MMPs.  The X-ray crystal structures reveal an unusual binding mode with the glutamate side chain chelating the active site zinc ion.  Competition expts. between these inhibitors and acetohydroxamic acid, a small zinc-binding mol., are in accord with the crystallog. results.  One of these pseudo-dipeptides displays potency and selectivity toward MMP-12 similar to the best MMP-12 inhibitors reported to date.  This novel family of pseudo peptides opens new opportunities to develop potent and selective inhibitors for several metzincins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrbDIuByI17Vg90H21EOLACvtfcHk0lgwrDchbr9zdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFaqsbjJ&md5=071a0d7c5dfafb512449997e929f6d9d</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.380782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.380782%26sid%3Dliteratum%253Aachs%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DAmoura%26aufirst%3DM.%26aulast%3DVera%26aufirst%3DL.%26aulast%3DCassar-Lajeunesse%26aufirst%3DE.%26aulast%3DGarcia%26aufirst%3DS.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DStura%26aufirst%3DE.%2BA.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DSimple%2520Pseudo-Dipeptides%2520with%2520a%2520P2%25E2%2580%25B2%2520Glutamate%253A%2520A%2520Novel%2520Inhibitor%2520Family%2520of%2520Matrix%2520Metalloproteases%2520and%2520Other%2520Metzincins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D32%26spage%3D26647%26epage%3D26656%26doi%3D10.1074%2Fjbc.M112.380782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nury, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassar-Lajeunesse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Detection of Endogenous Matrix Metalloprotease-12 Active Form with a Novel Broad Spectrum Activity-Based Probe</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">5636</span>– <span class="NLM_lpage">5644</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.419499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M112.419499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23271741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVGlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=5636-5644&issue=8&author=C.+Nuryauthor=S.+Bregantauthor=B.+Czarnyauthor=F.+Berthonauthor=E.+Cassar-Lajeunesseauthor=V.+Dive&title=Detection+of+Endogenous+Matrix+Metalloprotease-12+Active+Form+with+a+Novel+Broad+Spectrum+Activity-Based+Probe&doi=10.1074%2Fjbc.M112.419499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of Endogenous Matrix Metalloprotease-12 Active Form with a Novel Broad Spectrum Activity-based Probe</span></div><div class="casAuthors">Nury, Catherine; Bregant, Sarah; Czarny, Bertrand; Berthon, Fannely; Cassar-Lajeunesse, Evelyne; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5636-5644</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Matrix metalloproteases (MMPs) have attracted considerable attention as crit. mediators of pathol. tissue remodeling processes.  However it remains an unresolved challenge to detect their active forms in biol. samples.  To prove the efficacy of a recently developed MMP activity-based probe, we examd. the content in MMP active forms of bronchoalveolar lavage fluids (BALf) from male C57BL/6 mice exposed to ultrafine carbon black nanoparticles, a model of chronic obstructive pulmonary disease (COPD).  This probe was shown to label proteins, mostly expressed in BALf of mice exposed to nanoparticles.  Using competition assays with a selective MMP-12 inhibitor as well as MMP-12 knock-out mice, one of these proteins was identified as the active form of the catalytic domain of MMP-12.  This new probe can detect the active form of MMP-12 down to a threshold of 1 fmol.  Radioactive counting showed the concn. of the active form of MMP-12 to be around 1 fmol/μl in BALf from nanoparticle-treated mice.  A less sensitive probe would therefore not have detected MMP-12.  As the probe can detect other MMPs in the femtomolar range, it is a potentially powerful tool for monitoring the levels of MMP active forms in various diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9O4lT6P-B_rVg90H21EOLACvtfcHk0lgwrDchbr9zdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVGlsL4%253D&md5=8fe1b32d9845b045823f2766b9c3ee93</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.419499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.419499%26sid%3Dliteratum%253Aachs%26aulast%3DNury%26aufirst%3DC.%26aulast%3DBregant%26aufirst%3DS.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DBerthon%26aufirst%3DF.%26aulast%3DCassar-Lajeunesse%26aufirst%3DE.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DDetection%2520of%2520Endogenous%2520Matrix%2520Metalloprotease-12%2520Active%2520Form%2520with%2520a%2520Novel%2520Broad%2520Spectrum%2520Activity-Based%2520Probe%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D8%26spage%3D5636%26epage%3D5644%26doi%3D10.1074%2Fjbc.M112.419499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khomiak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konopka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rejmak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarragó, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prades, R.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Selective and Blood-Brain Barrier-Permeable Hydroxamate-Based Gelatinase Inhibitors</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">103365</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.103365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bioorg.2019.103365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31676116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2htbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2020&pages=103365&author=A.+Bertranauthor=D.+Khomiakauthor=A.+Konopkaauthor=E.+Rejmakauthor=E.+Bulskaauthor=J.+Secoauthor=L.+Kaczmarekauthor=T.+Tarrag%C3%B3author=R.+Prades&title=Design+and+Synthesis+of+Selective+and+Blood-Brain+Barrier-Permeable+Hydroxamate-Based+Gelatinase+Inhibitors&doi=10.1016%2Fj.bioorg.2019.103365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors</span></div><div class="casAuthors">Bertran, Alexandra; Khomiak, Danylo; Konopka, Anna; Rejmak, Emilia; Bulska, Ewa; Seco, Jesus; Kaczmarek, Leszek; Tarrago, Teresa; Prades, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103365</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs), a family of zinc-contg. endopeptidases involved in the degrdn. of the extracellular matrix, make a major contribution to the progression of a vast no. of diseases, such cancer or epilepsy.  Although several MMP inhibitors (MMPi) have been developed to date for the treatment of cancer, they have all failed in clin. trials due to lack of efficacy and, most importantly, the presence of severe side effects.  The latter can be explained by their lack of selectivity of these inhibitors.  In this regard, MMPs' family members have a high structural homol., which challenge the development of selective inhibitors for a specific MMP.  Here, we have used in silico calcns. and in vitro data to design MMPi that selectively target gelatinases (MMP-2 and MMP-9) and have the capacity to cross the blood-brain barrier.  Following this approach, we obtained compd. 40 that shows high proteolytic stability and low cytotoxicity.  This compd. may be of particular interest for the treatment of central nervous diseases such epilepsy or Alzheimer's disease, where gelatinase activity is increased.  Our data show the specificity of compd. 40 for recombinant MMP-9 and MMP-2 and endogenous MMP-9 from rat hippocampal cell cultures, and reveals its permeability across the blood-brain barrier in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRv1ljGyR_9bVg90H21EOLACvtfcHk0ljOP-PaQ-hj0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2htbbI&md5=50252efc3de6b7340e227af13638997a</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.103365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.103365%26sid%3Dliteratum%253Aachs%26aulast%3DBertran%26aufirst%3DA.%26aulast%3DKhomiak%26aufirst%3DD.%26aulast%3DKonopka%26aufirst%3DA.%26aulast%3DRejmak%26aufirst%3DE.%26aulast%3DBulska%26aufirst%3DE.%26aulast%3DSeco%26aufirst%3DJ.%26aulast%3DKaczmarek%26aufirst%3DL.%26aulast%3DTarrag%25C3%25B3%26aufirst%3DT.%26aulast%3DPrades%26aufirst%3DR.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Selective%2520and%2520Blood-Brain%2520Barrier-Permeable%2520Hydroxamate-Based%2520Gelatinase%2520Inhibitors%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D94%26spage%3D103365%26doi%3D10.1016%2Fj.bioorg.2019.103365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sela-Passwell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Bases for Allosteric Control of MMP Activities: Can It Pave the Path for Selective Inhibition?</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1803</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2009.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbamcr.2009.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1803&publication_year=2010&pages=29-38&issue=1&author=N.+Sela-Passwellauthor=G.+Rosenblumauthor=T.+Shohamauthor=I.+Sagi&title=Structural+and+Functional+Bases+for+Allosteric+Control+of+MMP+Activities%3A+Can+It+Pave+the+Path+for+Selective+Inhibition%3F&doi=10.1016%2Fj.bbamcr.2009.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional bases for allosteric control of MMP activities: Can it pave the path for selective inhibition?</span></div><div class="casAuthors">Sela-Passwell, Netta; Rosenblum, Gabriel; Shoham, Tsipi; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1803</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-38</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Zn-dependent matrix metalloproteinases (MMPs) belong to a large family of structurally homologous enzymes.  These enzymes are involved in a wide variety of biol. processes ranging from physiol. cell proliferation and differentiation to pathol. states assocd. with tumor metastasis, inflammation, tissue degeneration, and cell death.  Controlling the enzymic activity of specific individual MMPs by antagonist mols. is highly desirable, 1st, for studying their individual roles, and 2nd as potential therapeutic agents.  However, blocking the enzymic activity with synthetic small inhibitors appears to be an extremely difficult task.  Thus, this is an unmet need presumably due to the high structural homol. between MMP catalytic domains.  Recent reports have recognized a potential role for exosite or allosteric protein regions, distinct from the extended catalytic pocket, in mediating MMP activation and substrate hydrolysis.  This raises the possibility that MMP enzymic and nonenzymic activities may be modified via antagonist mols. targeted to such allosteric sites or to alternative enzyme domains.  Here, the authors discuss the structural and functional bases for potential allosteric control of MMPs and highlight potential alternative enzyme domains as targets for designing highly selective MMP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBcsEfeLnJsbVg90H21EOLACvtfcHk0ljOP-PaQ-hj0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKit7Y%253D&md5=19792cf064947626de1ed92c7e3ddddb</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2009.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2009.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DSela-Passwell%26aufirst%3DN.%26aulast%3DRosenblum%26aufirst%3DG.%26aulast%3DShoham%26aufirst%3DT.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DStructural%2520and%2520Functional%2520Bases%2520for%2520Allosteric%2520Control%2520of%2520MMP%2520Activities%253A%2520Can%2520It%2520Pave%2520the%2520Path%2520for%2520Selective%2520Inhibition%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2010%26volume%3D1803%26issue%3D1%26spage%3D29%26epage%3D38%26doi%3D10.1016%2Fj.bbamcr.2009.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Udi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitternacht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arad-Yellin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melikian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toccafondi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezovsky, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchinat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Unraveling Hidden Regulatory Sites in Structurally Homologous Metalloproteases</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>425</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2330</span>– <span class="NLM_lpage">2346</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2013.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.jmb.2013.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23583775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsleqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2013&pages=2330-2346&issue=13&author=Y.+Udiauthor=M.+Fragaiauthor=M.+Grossmanauthor=S.+Mitternachtauthor=R.+Arad-Yellinauthor=V.+Calderoneauthor=M.+Melikianauthor=M.+Toccafondiauthor=I.+N.+Berezovskyauthor=C.+Luchinatauthor=I.+Sagi&title=Unraveling+Hidden+Regulatory+Sites+in+Structurally+Homologous+Metalloproteases&doi=10.1016%2Fj.jmb.2013.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling hidden regulatory sites in structurally homologous metalloproteases</span></div><div class="casAuthors">Udi, Yael; Fragai, Marco; Grossman, Moran; Mitternacht, Simon; Arad-Yellin, Rina; Calderone, Vito; Melikian, Maxime; Toccafondi, Mirco; Berezovsky, Igor N.; Luchinat, Claudio; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2330-2346</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Monitoring enzymic activity in vivo of individual homologous enzymes such as the matrix metalloproteinases (MMPs) by antagonist mols. is highly desired for defining physiol. and pathophysiol. pathways.  However, the rational design of antagonists targeting enzyme catalytic moieties specific to one of the homologous enzymes often appears to be an extremely difficult task.  This is mainly due to the high structural homol. at the enzyme active sites shared by members of the protein family.  Accordingly, controlling enzymic activity via alternative allosteric sites has become an attractive proposition for drug design targeting individual homologous enzymes.  Yet, the challenge remains to identify such regulatory alternative sites that are often hidden and scattered over different locations on the protein's surface.  We have designed branched amphiphilic mols. exhibiting specific inhibitory activity towards individual members of the MMP family.  These amphiphilic isomers share the same chem. nature, providing versatile nonspecific binding reactivity that allows to probe hidden regulatory residues on a given protein surface.  Using the advantage provided by amphiphilic ligands, here we explore a new approach for detg. hidden regulatory sites.  This approach includes diverse exptl. anal., such as structural spectroscopic analyses, NMR, and protein crystallog. combined with computational prediction of effector binding sites.  We demonstrate how our approach works by analyzing members of the MMP family that possess a unique set of such sites.  Our work provides a proof of principle for using ligand effectors to unravel hidden regulatory sites specific to members of the structurally homologous MMP family.  This approach may be exploited for the design of novel mol. effectors and therapeutic agents affecting protein catalytic function via interactions with structure-specific regulatory sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg66HKNxyp5LVg90H21EOLACvtfcHk0lgGHFe_p-qBew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsleqsbk%253D&md5=dfde6f555846dab0c8729ea3b64b6ac4</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2013.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2013.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DUdi%26aufirst%3DY.%26aulast%3DFragai%26aufirst%3DM.%26aulast%3DGrossman%26aufirst%3DM.%26aulast%3DMitternacht%26aufirst%3DS.%26aulast%3DArad-Yellin%26aufirst%3DR.%26aulast%3DCalderone%26aufirst%3DV.%26aulast%3DMelikian%26aufirst%3DM.%26aulast%3DToccafondi%26aufirst%3DM.%26aulast%3DBerezovsky%26aufirst%3DI.%2BN.%26aulast%3DLuchinat%26aufirst%3DC.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DUnraveling%2520Hidden%2520Regulatory%2520Sites%2520in%2520Structurally%2520Homologous%2520Metalloproteases%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D425%26issue%3D13%26spage%3D2330%26epage%3D2346%26doi%3D10.1016%2Fj.jmb.2013.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span> <span> </span><span class="NLM_article-title">New Strategies for Targeting Matrix Metalloproteinases</span>. <i>Matrix Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44–46</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1016/j.matbio.2015.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.matbio.2015.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25595836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2gu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44%E2%80%9346&publication_year=2015&pages=239-246&author=G.+B.+Fields&title=New+Strategies+for+Targeting+Matrix+Metalloproteinases&doi=10.1016%2Fj.matbio.2015.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">New strategies for targeting matrix metalloproteinases</span></div><div class="casAuthors">Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Matrix Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44-46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">239-246</span>CODEN:
                <span class="NLM_cas:coden">MTBOEC</span>;
        ISSN:<span class="NLM_cas:issn">0945-053X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The development of matrix metalloproteinase (MMP) inhibitors has often been frustrated by a lack of specificity and subsequent off-target effects.  More recently, inhibitor design has considered secondary binding sites (exosites) to improve specificity.  Small mols. and peptides have been developed that bind exosites in the catalytic (CAT) domain of MMP-13, the CAT or hemopexin-like (HPX) domain of MT1-MMP, and the collagen binding domain (CBD) of MMP-2 and MMP-9.  Antibody-based approaches have resulted in selective inhibitors for MMP-9 and MT1-MMP that target CAT domain exosites.  Triple-helical "mini-proteins" have taken advantage of collagen binding exosites, producing a family of novel probes.  A variety of non-traditional approaches that incorporate exosite binding into the design process has yielded inhibitors with desirable selectivities within the MMP family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGHejEGVH3rVg90H21EOLACvtfcHk0lgDdd61RWtkPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2gu74%253D&md5=ef3430aa5d044a91b3ab115f26667119</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.matbio.2015.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.matbio.2015.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DG.%2BB.%26atitle%3DNew%2520Strategies%2520for%2520Targeting%2520Matrix%2520Metalloproteinases%26jtitle%3DMatrix%2520Biol.%26date%3D2015%26volume%3D44%25E2%2580%259346%26spage%3D239%26epage%3D246%26doi%3D10.1016%2Fj.matbio.2015.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. P.</span></span> <span> </span><span class="NLM_article-title">Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1168</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fcmdc.201700349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28722301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFynsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1157-1168&issue=15&author=X.+W.+Xieauthor=R.+Z.+Wanauthor=Z.+P.+Liu&title=Recent+Research+Advances+in+Selective+Matrix+Metalloproteinase-13+Inhibitors+as+Anti-Osteoarthritis+Agents&doi=10.1002%2Fcmdc.201700349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents</span></div><div class="casAuthors">Xie, Xin-Wen; Wan, Ren-Zhong; Liu, Zhao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1157-1168</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP-13) plays a key role in the degrdn. of type II collagen in cartilage and bone in osteoarthritis (OA).  The subtle differences between the S1' loop of MMP-13 and that of other MMPs offer a structural base for the design of selective MMP-13 inhibitors to mitigate the unperceived risk assocd. with inhibiting other MMP isoforms.  In this review, we summarize zinc-binding and non-zinc-binding selective MMP-13 inhibitors.  The zinc-binding MMP-13 inhibitors contain a small set of zinc-binding groups (ZBGs), including hydroxamic acid, pyrimidinetrione, reversed hydroxamic acid and hydantoin, carboxylic acid, 1,2,4,-triazole, and 1,2,4,-triazolone.  The non-zinc-binding MMP-13 inhibitors have different structural scaffolds, including di-Ph ethers, biaryls (aryltetrazoliums, arylfurans, pyrazole-indoles), pyrimidines, and aryl/cycloalkyl-fused pyrimidines.  This review provides a systematic overview of recent developments in MMP-13 inhibitors for the treatment of OA, with emphasis on their enzyme inhibitory potency, selectivity, and biol. activities, and highlights the various binding modes of typical inhibitors with MMP-13.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_kElEBU8rt7Vg90H21EOLACvtfcHk0lj4V9iVMh5xpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFynsbrI&md5=96433c8ec608829c497d471d7aceab13</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700349%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DX.%2BW.%26aulast%3DWan%26aufirst%3DR.%2BZ.%26aulast%3DLiu%26aufirst%3DZ.%2BP.%26atitle%3DRecent%2520Research%2520Advances%2520in%2520Selective%2520Matrix%2520Metalloproteinase-13%2520Inhibitors%2520as%2520Anti-Osteoarthritis%2520Agents%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26issue%3D15%26spage%3D1157%26epage%3D1168%26doi%3D10.1002%2Fcmdc.201700349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauer-Fields, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillargeon, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saldanha, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stawikowska, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span> <span> </span><span class="NLM_article-title">High Throughput Screening of Potentially Selective MMP-13 Exosite Inhibitors Utilizing a Triple-Helical FRET Substrate</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">1005</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bmc.2008.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=18358729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=990-1005&issue=3&author=J.+L.+Lauer-Fieldsauthor=D.+Minondauthor=P.+S.+Chaseauthor=P.+E.+Baillargeonauthor=S.+A.+Saldanhaauthor=R.+Stawikowskaauthor=P.+Hodderauthor=G.+B.+Fields&title=High+Throughput+Screening+of+Potentially+Selective+MMP-13+Exosite+Inhibitors+Utilizing+a+Triple-Helical+FRET+Substrate&doi=10.1016%2Fj.bmc.2008.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate</span></div><div class="casAuthors">Lauer-Fields, Janelle L.; Minond, Dmitriy; Chase, Peter S.; Baillargeon, Pierre E.; Saldanha, S. Adrian; Stawikowska, Roma; Hodder, Peter; Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">990-1005</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The major components of the cartilage extracellular matrix are type II collagen and aggrecan.  Matrix metalloproteinase 13 (MMP-13) has been implicated as the protease responsible for collagen degrdn. in cartilage during osteoarthritis (OA).  In the present study, a triple-helical FRET substrate has been utilized for high throughput screening (HTS) of MMP-13 with the MLSCN compd. library (n ∼ 65,000).  Thirty-four compds. from the HTS produced pharmacol. dose-response curves.  A secondary screen using RP-HPLC validated 25 compds. as MMP-13 inhibitors.  Twelve of these compds. were selected for counter-screening with 6 representative MMP family members.  Five compds. were found to be broad-spectrum MMP inhibitors, 3 inhibited MMP-13 and one other MMP, and 4 were selective for MMP-13.  One of the selective inhibitors was more active against MMP-13 triple-helical peptidase activity compared with single-stranded peptidase activity.  Since the THP FRET substrate has distinct conformational features that may interact with MMP secondary binding sites (exosites), novel non-active site-binding inhibitors may be identified via HTS protocols utilizing such assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc6QPfFleUqrVg90H21EOLACvtfcHk0lj4V9iVMh5xpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOhur0%253D&md5=4fb566e532ff6271ba60771cc6453eb3</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DLauer-Fields%26aufirst%3DJ.%2BL.%26aulast%3DMinond%26aufirst%3DD.%26aulast%3DChase%26aufirst%3DP.%2BS.%26aulast%3DBaillargeon%26aufirst%3DP.%2BE.%26aulast%3DSaldanha%26aufirst%3DS.%2BA.%26aulast%3DStawikowska%26aufirst%3DR.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DFields%26aufirst%3DG.%2BB.%26atitle%3DHigh%2520Throughput%2520Screening%2520of%2520Potentially%2520Selective%2520MMP-13%2520Exosite%2520Inhibitors%2520Utilizing%2520a%2520Triple-Helical%2520FRET%2520Substrate%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D3%26spage%3D990%26epage%3D1005%26doi%3D10.1016%2Fj.bmc.2008.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darout, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel, Exosite-Binding Matrix Metalloproteinase-13 Inhibitor Scaffolds</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">7180</span>– <span class="NLM_lpage">7184</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bmcl.2011.09.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=22018790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7180-7184&issue=23&author=J.+Rothauthor=D.+Minondauthor=E.+Daroutauthor=Q.+Liuauthor=J.+Lauerauthor=P.+Hodderauthor=G.+B.+Fieldsauthor=W.+R.+Roush&title=Identification+of+Novel%2C+Exosite-Binding+Matrix+Metalloproteinase-13+Inhibitor+Scaffolds&doi=10.1016%2Fj.bmcl.2011.09.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds</span></div><div class="casAuthors">Roth, Joshua; Minond, Dmitriy; Darout, Etzer; Liu, Qin; Lauer, Janelle; Hodder, Peter; Fields, Gregg B.; Roush, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7180-7184</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP-13) has been implicated as the protease responsible for collagen degrdn. in cartilage during osteoarthritis (OA).  Compds. that inhibit the metalloproteinase at the Zn binding site typically lack specificity among MMP family members.  Analogs of the low-micromolar lead MMP-13 inhibitor (I), discovered through high-throughput screening, were synthesized to investigate structure-activity relationships in this inhibitor series.  Systematic modifications of I led to the discovery of MMP-13 inhibitors II and III which are more selective than I against other MMPs.  Compd. II is also approx. fivefold more potent as an MMP-13 inhibitor than the original HTS-derived lead compd. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopP_zkFk8mibVg90H21EOLACvtfcHk0lj4V9iVMh5xpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7E&md5=cfde0e006c073edab16683e478bab78a</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.077%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DMinond%26aufirst%3DD.%26aulast%3DDarout%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLauer%26aufirst%3DJ.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DFields%26aufirst%3DG.%2BB.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DIdentification%2520of%2520Novel%252C%2520Exosite-Binding%2520Matrix%2520Metalloproteinase-13%2520Inhibitor%2520Scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D23%26spage%3D7180%26epage%3D7184%26doi%3D10.1016%2Fj.bmcl.2011.09.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spicer, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodder, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minond, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9598</span>– <span class="NLM_lpage">9611</span>, <span class="refDoi"> DOI: 10.1021/jm501284e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501284e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOgsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9598-9611&issue=22&author=T.+P.+Spicerauthor=J.+Jiangauthor=A.+B.+Taylorauthor=J.+Y.+Choiauthor=P.+J.+Hartauthor=W.+R.+Roushauthor=G.+B.+Fieldsauthor=P.+S.+Hodderauthor=D.+Minond&title=Characterization+of+Selective+Exosite-Binding+Inhibitors+of+Matrix+Metalloproteinase+13+That+Prevent+Articular+Cartilage+Degradation+in+Vitro&doi=10.1021%2Fjm501284e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro</span></div><div class="casAuthors">Spicer, Timothy P.; Jiang, Jianwen; Taylor, Alexander B.; Choi, Jun Yong; Hart, P. John; Roush, William R.; Fields, Gregg B.; Hodder, Peter S.; Minond, Dmitriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9598-9611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matrix metalloproteinase 13 (MMP-13) has been shown to be the main collagenase responsible for degrdn. of articular cartilage during osteoarthritis and therefore represents a target for drug development.  As a result of high-throughput screening and structure-activity relationship studies, the authors identified a novel, highly selective class of MMP-13 inhibitors.  Mechanistic characterization revealed a noncompetitive nature of these inhibitors with binding consts. in the low micromolar range.  Crystallog. analyses revealed two binding modes for compd. I in the MMP-13 S1' subsite and in an S1/S2* subsite.  Type II collagen- and cartilage-protective effects exhibited by the 3 compds. suggested that these compds. might be efficacious in future in vivo studies.  Finally, these compds. were also highly selective when tested against a panel of 30 proteases, which, in combination with a good CYP inhibition profile, suggested low off-target toxicity and drug-drug interactions in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCW6fx0sdNp7Vg90H21EOLACvtfcHk0ljmrYn_zp2aoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOgsrvF&md5=11b482b88311bf59b842995dd23d2b6a</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Fjm501284e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501284e%26sid%3Dliteratum%253Aachs%26aulast%3DSpicer%26aufirst%3DT.%2BP.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DA.%2BB.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DHart%26aufirst%3DP.%2BJ.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DFields%26aufirst%3DG.%2BB.%26aulast%3DHodder%26aufirst%3DP.%2BS.%26aulast%3DMinond%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520Selective%2520Exosite-Binding%2520Inhibitors%2520of%2520Matrix%2520Metalloproteinase%252013%2520That%2520Prevent%2520Articular%2520Cartilage%2520Degradation%2520in%2520Vitro%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D22%26spage%3D9598%26epage%3D9611%26doi%3D10.1021%2Fjm501284e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuerst, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapinska, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5816</span>– <span class="NLM_lpage">5825</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00514</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGmt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5816-5825&issue=13&author=J.+Y.+Choiauthor=R.+Fuerstauthor=A.+M.+Knapinskaauthor=A.+B.+Taylorauthor=L.+Smithauthor=X.+Caoauthor=P.+J.+Hartauthor=G.+B.+Fieldsauthor=W.+R.+Roush&title=Structure-Based+Design+and+Synthesis+of+Potent+and+Selective+Matrix+Metalloproteinase+13+Inhibitors&doi=10.1021%2Facs.jmedchem.7b00514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors</span></div><div class="casAuthors">Choi, Jun Yong; Fuerst, Rita; Knapinska, Anna M.; Taylor, Alexander B.; Smith, Lyndsay; Cao, Xiaohang; Hart, P. John; Fields, Gregg B.; Roush, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5816-5825</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the use of comparative structural anal. and structure-guided mol. design to develop potent and selective inhibitors of matrix metalloproteinase 13 (MMP-13).  The authors applied a three-step process, starting with a comparative anal. of the x-ray crystallog. structure of compd. 5 (III) in complex with MMP-13 with published structures of known MMP-13 inhibitor complexes followed by mol. design and synthesis of potent but nonselective zinc-chelating MMP inhibitors.  After demonstrating that the pharmacophores of the chelating inhibitors were binding within the MMP-13 active site, the Zn2+ chelating unit was replaced with nonchelating polar residues that bridged over the Zn2+ binding site and reached into a solvent accessible area.  After two rounds of structural optimization, these design approaches led to small mol. MMP-13 inhibitors 10d (I)and (S)-17b (II), which bind within the substrate-binding site of MMP-13 and surround the catalytically active Zn2+ ion without chelating to the metal.  These compds. exhibit at least 500-fold selectivity vs. other MMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Tr2dWc11W7Vg90H21EOLACvtfcHk0ljmrYn_zp2aoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGmt7fM&md5=9006603b13358fa670d43575c24b9ede</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00514%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DFuerst%26aufirst%3DR.%26aulast%3DKnapinska%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DA.%2BB.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DHart%26aufirst%3DP.%2BJ.%26aulast%3DFields%26aufirst%3DG.%2BB.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DStructure-Based%2520Design%2520and%2520Synthesis%2520of%2520Potent%2520and%2520Selective%2520Matrix%2520Metalloproteinase%252013%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5816%26epage%3D5825%26doi%3D10.1021%2Facs.jmedchem.7b00514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mototani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanzaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terauchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kori, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel, Highly Potent, and Selective Quinazoline-2-Carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">8886</span>– <span class="NLM_lpage">8902</span>, <span class="refDoi"> DOI: 10.1021/jm500981k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500981k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8886-8902&issue=21&author=H.+Naraauthor=K.+Satoauthor=T.+Naitoauthor=H.+Mototaniauthor=H.+Okiauthor=Y.+Yamamotoauthor=H.+Kunoauthor=T.+Santouauthor=N.+Kanzakiauthor=J.+Terauchiauthor=O.+Uchikawaauthor=M.+Kori&title=Discovery+of+Novel%2C+Highly+Potent%2C+and+Selective+Quinazoline-2-Carboxamide-Based+Matrix+Metalloproteinase+%28MMP%29-13+Inhibitors+without+a+Zinc+Binding+Group+Using+a+Structure-Based+Design+Approach&doi=10.1021%2Fjm500981k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach</span></div><div class="casAuthors">Nara, Hiroshi; Sato, Kenjiro; Naito, Takako; Mototani, Hideyuki; Oki, Hideyuki; Yamamoto, Yoshio; Kuno, Haruhiko; Santou, Takashi; Kanzaki, Naoyuki; Terauchi, Jun; Uchikawa, Osamu; Kori, Masakuni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8886-8902</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP-13) has been implicated to play a key role in the pathol. of osteoarthritis.  On the basis of X-ray crystallog., we designed a series of potent MMP-13 selective inhibitors optimized to occupy the distinct deep S1' pocket including an adjacent branch.  Among them, carboxylic acid inhibitor 21k exhibited excellent potency and selectivity for MMP-13 over other MMPs.  An effort to convert compd. 21k to the mono sodium salt 38 was promising in all animal species studied.  Moreover, no overt toxicity was obsd. in a preliminary repeat dose oral toxicity study of compd. 21k in rats.  A single oral dose of compd. 38 significantly reduced degrdn. products (CTX-II) released from articular cartilage into the joint cavity in a rat MIA model in vivo.  In this article, we report the discovery of highly potent, selective, and orally bioavailable MMP-13 inhibitors as well as their detailed structure-activity data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGzMIFSbDatLVg90H21EOLACvtfcHk0ljmrYn_zp2aoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrvP&md5=087e338412a2daeb1006a48e08d67bbd</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1021%2Fjm500981k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500981k%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DNaito%26aufirst%3DT.%26aulast%3DMototani%26aufirst%3DH.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuno%26aufirst%3DH.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Novel%252C%2520Highly%2520Potent%252C%2520and%2520Selective%2520Quinazoline-2-Carboxamide-Based%2520Matrix%2520Metalloproteinase%2520%2528MMP%2529-13%2520Inhibitors%2520without%2520a%2520Zinc%2520Binding%2520Group%2520Using%2520a%2520Structure-Based%2520Design%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D21%26spage%3D8886%26epage%3D8902%26doi%3D10.1021%2Fjm500981k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaieda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mototani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanzaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terauchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kori, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-Yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2nurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=608-626&issue=2&author=H.+Naraauthor=A.+Kaiedaauthor=K.+Satoauthor=T.+Naitoauthor=H.+Mototaniauthor=H.+Okiauthor=Y.+Yamamotoauthor=H.+Kunoauthor=T.+Santouauthor=N.+Kanzakiauthor=J.+Terauchiauthor=O.+Uchikawaauthor=M.+Kori&title=Discovery+of+Novel%2C+Highly+Potent%2C+and+Selective+Matrix+Metalloproteinase+%28MMP%29-13+Inhibitors+with+a+1%2C2%2C4-Triazol-3-Yl+Moiety+as+a+Zinc+Binding+Group+Using+a+Structure-Based+Design+Approach&doi=10.1021%2Facs.jmedchem.6b01007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach</span></div><div class="casAuthors">Nara, Hiroshi; Kaieda, Akira; Sato, Kenjiro; Naito, Takako; Mototani, Hideyuki; Oki, Hideyuki; Yamamoto, Yoshio; Kuno, Haruhiko; Santou, Takashi; Kanzaki, Naoyuki; Terauchi, Jun; Uchikawa, Osamu; Kori, Masakuni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">608-626</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of a superposition study of x-ray crystal structures of complexes of quinazoline deriv. I and triazole deriv. II with matrix metalloproteinase (MMP)-13 catalytic domain, a novel series of fused pyrimidine compds. which possess a 1,2,4-triazol-3-yl group as a zinc binding group (ZBG) was designed.  Among the herein described and evaluated compds., 5-(3-fluorophenyl)-4-oxo-N-{3-[2-[1H-1,2,4-triazol-3-yloxy]ethoxy]benzyl}-3,4-dihydrothieno[2,3-d]-pyrimidine-2-carboxamide (31f) exhibited excellent potency for MMP-13 (IC50 = 0.036 nM) and selectivities (greater than 1500-fold) over other MMPs (MMP-1, 2, 3, 7, 8, 9, 10, and 14) and tumor necrosis factor-α converting enzyme (TACE).  Furthermore, the inhibitor was shown to protect bovine nasal cartilage explants against degrdn. induced by interleukin-1 and oncostatin M.  In this article, the authors report the discovery of extremely potent, highly selective, and orally bioavailable fused pyrimidine derivs. that possess a 1,2,4-triazol-3-yl group as a novel ZBG for selective MMP-13 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ8Gj9214XrLVg90H21EOLACvtfcHk0lisOUfOF8h0PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2nurvE&md5=2965566ea0c85df0bc5f806ef5650627</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01007%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DH.%26aulast%3DKaieda%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DNaito%26aufirst%3DT.%26aulast%3DMototani%26aufirst%3DH.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuno%26aufirst%3DH.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Novel%252C%2520Highly%2520Potent%252C%2520and%2520Selective%2520Matrix%2520Metalloproteinase%2520%2528MMP%2529-13%2520Inhibitors%2520with%2520a%25201%252C2%252C4-Triazol-3-Yl%2520Moiety%2520as%2520a%2520Zinc%2520Binding%2520Group%2520Using%2520a%2520Structure-Based%2520Design%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D2%26spage%3D608%26epage%3D626%26doi%3D10.1021%2Facs.jmedchem.6b01007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuscu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzo, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLeon, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaber, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">4977</span>– <span class="NLM_lpage">4988</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-4552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1158%2F0008-5472.CAN-10-4552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21646471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFartrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=4977-4988&issue=14&author=A.+Dufourauthor=N.+S.+Sampsonauthor=J.+Liauthor=C.+Kuscuauthor=R.+C.+Rizzoauthor=J.+L.+DeLeonauthor=J.+Zhiauthor=N.+Jaberauthor=E.+Liuauthor=S.+Zuckerauthor=J.+Cao&title=Small-Molecule+Anticancer+Compounds+Selectively+Target+the+Hemopexin+Domain+of+Matrix+Metalloproteinase-9&doi=10.1158%2F0008-5472.CAN-10-4552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9</span></div><div class="casAuthors">Dufour, Antoine; Sampson, Nicole S.; Li, Jian; Kuscu, Cem; Rizzo, Robert C.; DeLeon, Jennifer L.; Zhi, Jizu; Jaber, Nadia; Liu, Eric; Zucker, Stanley; Cao, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4977-4988</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Lack of target specificity by existing matrix metalloproteinase (MMP) inhibitors has hindered antimetastatic cancer drug discovery.  Inhibitors that bind to noncatalytic sites of MMPs and disrupt protease signaling function have the potential to be more specific and selective.  In this work, compds. that target the hemopexin (PEX) domain of MMP-9 were identified using an in silico docking approach and evaluated using biochem. and biol. approaches.  Two of the selected compds. interfere with MMP-9-mediated cancer cell migration and proliferation in cells expressing exogenous or endogenous MMP-9.  Furthermore, these inhibitors do not modulate MMP-9 catalytic activity.  The lead compd., N-[4-(difluoromethoxy)phenyl]-2-[(4-oxo-6-propyl-1H-pyrimidin-2-yl)sulfanyl]-acetamide, specifically binds to the PEX domain of MMP-9, but not other MMPs.  This interaction between the compd. and the PEX domain results in the abrogation of MMP-9 homodimerization and leads to blockage of a downstream signaling pathway required for MMP-9-mediated cell migration.  In a tumor xenograft model, this pyrimidinone retarded MDA-MB-435 tumor growth and inhibited lung metastasis.  Thus, we have shown for the first time that a novel small-mol. interacts specifically with the PEX domain of MMP-9 and inhibits tumor growth and metastasis by reducing cell migration and proliferation.  Cancer Res; 71(14); 4977-88.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN0dKAuaguzbVg90H21EOLACvtfcHk0li2XmCHsknIbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFartrc%253D&md5=fcb7ef8db5fd4f2dd93e340600c670a7</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-4552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-4552%26sid%3Dliteratum%253Aachs%26aulast%3DDufour%26aufirst%3DA.%26aulast%3DSampson%26aufirst%3DN.%2BS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DKuscu%26aufirst%3DC.%26aulast%3DRizzo%26aufirst%3DR.%2BC.%26aulast%3DDeLeon%26aufirst%3DJ.%2BL.%26aulast%3DZhi%26aufirst%3DJ.%26aulast%3DJaber%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DZucker%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DJ.%26atitle%3DSmall-Molecule%2520Anticancer%2520Compounds%2520Selectively%2520Target%2520the%2520Hemopexin%2520Domain%2520of%2520Matrix%2520Metalloproteinase-9%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D14%26spage%3D4977%26epage%3D4988%26doi%3D10.1158%2F0008-5472.CAN-10-4552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remacle, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golubkov, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiryaev, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheltsov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strongin, A. Y.</span></span> <span> </span><span class="NLM_article-title">Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2339</span>– <span class="NLM_lpage">2349</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-4149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1158%2F0008-5472.CAN-11-4149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=22406620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1ymtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2339-2349&issue=9&author=A.+G.+Remacleauthor=V.+S.+Golubkovauthor=S.+A.+Shiryaevauthor=R.+Dahlauthor=J.+L.+Stebbinsauthor=A.+V.+Chernovauthor=A.+V.+Cheltsovauthor=M.+Pellecchiaauthor=A.+Y.+Strongin&title=Novel+MT1-MMP+Small-Molecule+Inhibitors+Based+on+Insights+into+Hemopexin+Domain+Function+in+Tumor+Growth&doi=10.1158%2F0008-5472.CAN-11-4149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth</span></div><div class="casAuthors">Remacle, Albert G.; Golubkov, Vladislav S.; Shiryaev, Sergey A.; Dahl, Russell; Stebbins, John L.; Chernov, Andrei V.; Cheltsov, Anton V.; Pellecchia, Maurizio; Strongin, Alex Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2339-2349</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Membrane type-1 matrix metalloproteinase (MT1-MMP) is a promising drug target in malignancy.  The structure of MT1-MMP includes the hemopexin domain (PEX) that is distinct from and addnl. to the catalytic domain.  Current MMP inhibitors target the conserved active site in the catalytic domain and, as a result, repress the proteolytic activity of multiple MMPs instead of MT1-MMP alone.  In our search for noncatalytic inhibitors of MT1-MMP, we compared the protumorigenic activity of wild-type MT1-MMP with an MT1-MMP mutant lacking PEX (ΔPEX).  In contrast to MT1-MMP, ΔPEX did not support tumor growth in vivo, and its expression resulted in small fibrotic tumors that contained increased levels of collagen.  Because these findings suggested an important role for PEX in tumor growth, we carried out an inhibitor screen to identify small mols. targeting the PEX domain of MT1-MMP.  Using the Developmental Therapeutics Program (National Cancer Institute/NIH), virtual ligand screening compd. library as a source and the X-ray crystal structure of PEX as a target, we identified and validated a novel PEX inhibitor.  Low dosage, intratumoral injections of PEX inhibitor repressed tumor growth and caused a fibrotic, ΔPEX-like tumor phenotype in vivo.  Together, our findings provide a preclin. proof of principle rationale for the development of novel and selective MT1-MMP inhibitors that specifically target the PEX domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokdpmWy18oyrVg90H21EOLACvtfcHk0li2XmCHsknIbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1ymtL0%253D&md5=aac476734e061847f75ad5e0f5e89907</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-4149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-4149%26sid%3Dliteratum%253Aachs%26aulast%3DRemacle%26aufirst%3DA.%2BG.%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26aulast%3DShiryaev%26aufirst%3DS.%2BA.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DStebbins%26aufirst%3DJ.%2BL.%26aulast%3DChernov%26aufirst%3DA.%2BV.%26aulast%3DCheltsov%26aufirst%3DA.%2BV.%26aulast%3DPellecchia%26aufirst%3DM.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26atitle%3DNovel%2520MT1-MMP%2520Small-Molecule%2520Inhibitors%2520Based%2520on%2520Insights%2520into%2520Hemopexin%2520Domain%2520Function%2520in%2520Tumor%2520Growth%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26issue%3D9%26spage%3D2339%26epage%3D2349%26doi%3D10.1158%2F0008-5472.CAN-11-4149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haarlander, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewandowski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devine, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzordzorme, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tounge, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayoumy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalk-Hihi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, K. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Highly Selective Chemical Inhibitor of Matrix Metalloproteinase-9 (MMP-9) That Allosterically Inhibits Zymogen Activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">17963</span>– <span class="NLM_lpage">17974</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.806075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M117.806075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28860188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehs7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=17963-17974&issue=43&author=R.+H.+Scannevinauthor=R.+Alexanderauthor=T.+M.+Haarlanderauthor=S.+L.+Burkeauthor=M.+Singerauthor=C.+Huoauthor=Y.+M.+Zhangauthor=D.+Maguireauthor=J.+Spurlinoauthor=I.+Deckmanauthor=K.+I.+Carrollauthor=F.+Lewandowskiauthor=E.+Devineauthor=K.+Dzordzormeauthor=B.+Toungeauthor=C.+Milliganauthor=S.+Bayoumyauthor=R.+Williamsauthor=C.+Schalk-Hihiauthor=K.+Leonardauthor=P.+Jacksonauthor=M.+Toddauthor=L.+C.+Kuoauthor=K.+J.+Rhodes&title=Discovery+of+a+Highly+Selective+Chemical+Inhibitor+of+Matrix+Metalloproteinase-9+%28MMP-9%29+That+Allosterically+Inhibits+Zymogen+Activation&doi=10.1074%2Fjbc.M117.806075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation</span></div><div class="casAuthors">Scannevin, Robert H.; Alexander, Richard; Haarlander, Tara Mezzasalma; Burke, Sharon L.; Singer, Monica; Huo, Cuifen; Zhang, Yue-Mei; Maguire, Diane; Spurlino, John; Deckman, Ingrid; Carroll, Karen I.; Lewandowski, Frank; Devine, Eric; Dzordzorme, Keli; Tounge, Brett; Milligan, Cindy; Bayoumy, Shariff; Williams, Robyn; Schalk-Hihi, Celine; Leonard, Kristi; Jackson, Paul; Todd, Matthew; Kuo, Lawrence C.; Rhodes, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">17963-17974</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant activation of matrix metalloproteinases (MMPs) is a common feature of pathol. cascades obsd. in diverse disorders, such as cancer, fibrosis, immune dysregulation, and neurodegenerative diseases.  MMP-9, in particular, is highly dynamically regulated in several pathol. processes.  Development of MMP inhibitors has therefore been an attractive strategy for therapeutic intervention.  However, a long history of failed clin. trials has demonstrated that broad-spectrum MMP inhibitors have limited clin. utility, which has spurred the development of inhibitors selective for individual MMPs.  Attaining selectivity has been tech. challenging because of sequence and structural conservation across the various MMPs.  Here, through a biochem. and structural screening paradigm, the authors have identified JNJ0966, a highly selective compd. that inhibited activation of MMP-9 zymogen and subsequent generation of catalytically active enzyme.  JNJ0966 had no effect on MMP-1, MMP-2, MMP-3, MMP-9, or MMP-14 catalytic activity and did not inhibit activation of the highly related MMP-2 zymogen.  The mol. basis for this activity was characterized as an interaction of JNJ0966 with a structural pocket in proximity to the MMP-9 zymogen cleavage site near Arg 106, which is distinct from the catalytic domain.  JNJ0966 was efficacious in reducing disease severity in a mouse exptl. autoimmune encephalomyelitis model, demonstrating the viability of this therapeutic approach.  This discovery reveals an unprecedented pharmacol. approach to MMP inhibition, providing an opportunity to improve selectivity of future clin. drug candidates.  Targeting zymogen activation in this manner may also allow for pharmaceutical exploration of other enzymes previously viewed as intractable drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRTVPKDSQkOrVg90H21EOLACvtfcHk0ljLyqUIIxZ-Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehs7%252FP&md5=56f8b03dbe9b59d85224fb8464732734</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.806075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.806075%26sid%3Dliteratum%253Aachs%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DHaarlander%26aufirst%3DT.%2BM.%26aulast%3DBurke%26aufirst%3DS.%2BL.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DHuo%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%2BM.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DDeckman%26aufirst%3DI.%26aulast%3DCarroll%26aufirst%3DK.%2BI.%26aulast%3DLewandowski%26aufirst%3DF.%26aulast%3DDevine%26aufirst%3DE.%26aulast%3DDzordzorme%26aufirst%3DK.%26aulast%3DTounge%26aufirst%3DB.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DBayoumy%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DSchalk-Hihi%26aufirst%3DC.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%26aulast%3DTodd%26aufirst%3DM.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DRhodes%26aufirst%3DK.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Highly%2520Selective%2520Chemical%2520Inhibitor%2520of%2520Matrix%2520Metalloproteinase-9%2520%2528MMP-9%2529%2520That%2520Allosterically%2520Inhibits%2520Zymogen%2520Activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D43%26spage%3D17963%26epage%3D17974%26doi%3D10.1074%2Fjbc.M117.806075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alford, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeliger, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojima, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, N. S.</span></span> <span> </span><span class="NLM_article-title">Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2788</span>– <span class="NLM_lpage">2803</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00758</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00758" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFCrtLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2788-2803&issue=11&author=V.+M.+Alfordauthor=A.+Kamathauthor=X.+Renauthor=K.+Kumarauthor=Q.+Ganauthor=M.+Awwaauthor=M.+Tongauthor=M.+A.+Seeligerauthor=J.+Caoauthor=I.+Ojimaauthor=N.+S.+Sampson&title=Targeting+the+Hemopexin-like+Domain+of+Latent+Matrix+Metalloproteinase-9+%28proMMP-9%29+with+a+Small+Molecule+Inhibitor+Prevents+the+Formation+of+Focal+Adhesion+Junctions&doi=10.1021%2Facschembio.7b00758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions</span></div><div class="casAuthors">Alford, Vincent M.; Kamath, Anushree; Ren, Xiaodong; Kumar, Kunal; Gan, Qianwen; Awwa, Monaf; Tong, Michael; Seeliger, Markus A.; Cao, Jian; Ojima, Iwao; Sampson, Nicole S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2788-2803</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A lack of target specificity has greatly hindered the success of inhibitor development against matrix metalloproteinases (MMPs) for the treatment of various cancers.  The MMP catalytic domains are highly conserved, whereas the hemopexin-like domain of MMPs are unique to each family member.  The hemopexin-like domain of MMP-9 enhances cancer cell migration through self-interaction and hetero-interactions with cell surface proteins including CD44 and α4β1 integrin.  These interactions activate EGFR-MAP kinase dependent signaling that leads to cell migration.  In this work, we generated a library of compds., based on hit mol., N-[4-(difluoromethoxy)phenyl]-2-[(4-oxo-6-propyl-1H-pyrimidin-2-yl)sulfanyl]-acetamide, that target the hemopexin-like domain of MMP-9.  We identify N-(4-fluorophenyl)-4-(4-oxo-3,4,5,6,7,8-hexahydroquinazolin-2-ylthio)butanamide, 3c, as a potent lead (Kd = 320 nM) that is specific for binding to proMMP-9 hemopexin-like domain.  We demonstrate that I disruption of MMP-9 homodimerization prevents assocn. of proMMP-9 with both α4β1 integrin and CD44 and results in dissocn. of EGFR.  This disruption results in decreased phosphorylation of Src and its downstream target proteins focal adhesion kinase (FAK) and paxillin (PAX), which are implicated in promoting tumor cell growth, migration, and invasion.  Using a chicken chorioallantoic membrane in vivo assay, we demonstrate that 500 nM I blocks cancer cell invasion of the basement membrane and reduces angiogenesis.  In conclusion, we present a mechanism of action for 3c whereby targeting the hemopexin domain results in decreased cancer cell migration through simultaneous disruption of α4β1 integrin and EGFR signaling pathways, thereby preventing signaling bypass.  Targeting through the hemopexin-like domain is a powerful approach to anti-metastatic drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPnLsccijPtrVg90H21EOLACvtfcHk0ljLyqUIIxZ-Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFCrtLfM&md5=0ba3d1fbf04f7e998b26abaf926b05e0</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00758%26sid%3Dliteratum%253Aachs%26aulast%3DAlford%26aufirst%3DV.%2BM.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DGan%26aufirst%3DQ.%26aulast%3DAwwa%26aufirst%3DM.%26aulast%3DTong%26aufirst%3DM.%26aulast%3DSeeliger%26aufirst%3DM.%2BA.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DOjima%26aufirst%3DI.%26aulast%3DSampson%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520the%2520Hemopexin-like%2520Domain%2520of%2520Latent%2520Matrix%2520Metalloproteinase-9%2520%2528proMMP-9%2529%2520with%2520a%2520Small%2520Molecule%2520Inhibitor%2520Prevents%2520the%2520Formation%2520of%2520Focal%2520Adhesion%2520Junctions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26issue%3D11%26spage%3D2788%26epage%3D2803%26doi%3D10.1021%2Facschembio.7b00758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talmi-Frank, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkadash, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, V.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase Protein Inhibitors: Hightlighting a New Beginning for Metalloproteinases in Medicine</span>. <i>Met. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.2147/MNM.S65143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2147%2FMNM.S65143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=31-47&author=I.+Sagiauthor=D.+Talmi-Frankauthor=V.+Arkadashauthor=N.+Papoauthor=V.+Mohan&title=Matrix+Metalloproteinase+Protein+Inhibitors%3A+Hightlighting+a+New+Beginning+for+Metalloproteinases+in+Medicine&doi=10.2147%2FMNM.S65143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.2147%2FMNM.S65143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FMNM.S65143%26sid%3Dliteratum%253Aachs%26aulast%3DSagi%26aufirst%3DI.%26aulast%3DTalmi-Frank%26aufirst%3DD.%26aulast%3DArkadash%26aufirst%3DV.%26aulast%3DPapo%26aufirst%3DN.%26aulast%3DMohan%26aufirst%3DV.%26atitle%3DMatrix%2520Metalloproteinase%2520Protein%2520Inhibitors%253A%2520Hightlighting%2520a%2520New%2520Beginning%2520for%2520Metalloproteinases%2520in%2520Medicine%26jtitle%3DMet.%2520Med.%26date%3D2016%26volume%3D3%26spage%3D31%26epage%3D47%26doi%3D10.2147%2FMNM.S65143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span> <span> </span><span class="NLM_article-title">The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">984</span>, <span class="refDoi"> DOI: 10.3390/cells8090984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3390%2Fcells8090984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=984&issue=9&author=G.+B.+Fields&title=The+Rebirth+of+Matrix+Metalloproteinase+Inhibitors%3A+Moving+Beyond+the+Dogma&doi=10.3390%2Fcells8090984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma</span></div><div class="casAuthors">Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">984</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago.  Initial clin. trials were disappointing, resulting in a neg. view of MMPs as therapeutic targets.  As a better understanding of MMP biol. and inhibitor pharmacokinetic properties emerged, it became clear that initial MMP inhibitor clin. trials were held prematurely.  Further complicating matters were problematic conclusions drawn from animal model studies.  The most recent generation of MMP inhibitors have desirable selectivities and improved pharmacokinetics, resulting in improved toxicity profiles.  Application of selective MMP inhibitors led to the conclusion that MMP-2, MMP-9, MMP-13, and MT1-MMP are not involved in musculoskeletal syndrome, a common side effect obsd. with broad spectrum MMP inhibitors.  Specific activities within a single MMP can now be inhibited.  Better definition of the roles of MMPs in immunol. responses and inflammation will help inform clinic trials, and multiple studies indicate that modulating MMP activity can improve immunotherapy.  There is a U.S.  Food and Drug Administration (FDA)-approved MMP inhibitor for periodontal disease, and several MMP inhibitors are in clinic trials, targeting a variety of maladies including gastric cancer, diabetic foot ulcers, and multiple sclerosis.  It is clearly time to move on from the dogma of viewing MMP inhibition as intractable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY8YcT4Rj5RLVg90H21EOLACvtfcHk0lhFpKYBVLfufQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D&md5=4ff4b435717c123cd5043df32587c853</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.3390%2Fcells8090984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells8090984%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DG.%2BB.%26atitle%3DThe%2520Rebirth%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%253A%2520Moving%2520Beyond%2520the%2520Dogma%26jtitle%3DCells%26date%3D2019%26volume%3D8%26issue%3D9%26spage%3D984%26doi%3D10.3390%2Fcells8090984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yiu, C. K. Y.</span></span> <span> </span><span class="NLM_article-title">The Past, Present and Future Perspectives of Matrix Metalloproteinase Inhibitors</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">107465</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2019.107465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.pharmthera.2019.107465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31863819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVyrurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2020&pages=107465&author=K.+Liauthor=F.+R.+Tayauthor=C.+K.+Y.+Yiu&title=The+Past%2C+Present+and+Future+Perspectives+of+Matrix+Metalloproteinase+Inhibitors&doi=10.1016%2Fj.pharmthera.2019.107465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">The past, present and future perspectives of matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Li, Kang; Tay, Franklin R.; Yiu, Cynthia Kar Yung</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107465</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a large family of enzymes that degrade the extracellular matrix (ECM).  Under pathol. conditions, overexpression of MMPs or insufficient control by tissue inhibitors of MMPs (TIMPs) results in the dysregulation of tissue remodeling and causes a variety of diseases such as encephalomyelitis, rheumatoid arthritis, Alzheimer's disease and tumors.  Therefore, the high affinity of MMPs for biomols. renders them attractive targets for inhibition when homeostasis breaks down in the ECM.  There are 4 generations of MMP inhibitors (MMPIs), ranging from small mols. or peptides to antibodies and protein-engineered inhibitors of metalloproteinase.  Although a plethora of MMPIs has been synthesized, most of them have failed in clin. trials or are still in the lab. stage of development.  The present review summarizes the development of MMPIs, their assocd. problems and discusses future directions for the development of the future generations of MMPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruRCapSoUsk7Vg90H21EOLACvtfcHk0lif-kTpHlb8LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVyrurrO&md5=bbcac8e8bc77198311c39604ed653dc1</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2019.107465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2019.107465%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DK.%26aulast%3DTay%26aufirst%3DF.%2BR.%26aulast%3DYiu%26aufirst%3DC.%2BK.%2BY.%26atitle%3DThe%2520Past%252C%2520Present%2520and%2520Future%2520Perspectives%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2020%26volume%3D207%26spage%3D107465%26doi%3D10.1016%2Fj.pharmthera.2019.107465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, R.</span></span> <span> </span><span class="NLM_article-title">Monoclonal Antibodies against Metzincin Targets</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1111/bph.14186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fbph.14186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29488211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVems74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=52-66&issue=1&author=S.+Santamariaauthor=R.+de+Groot&title=Monoclonal+Antibodies+against+Metzincin+Targets&doi=10.1111%2Fbph.14186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Monoclonal antibodies against metzincin targets</span></div><div class="casAuthors">Santamaria, Salvatore; de Groot, Rens</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-66</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The metzincin clan of metalloproteinases includes the MMP, disintegrin and metalloproteinase (ADAM) and ADAM with thrombospondin motifs families, which cleave extracellular targets in a wide range of (patho)physiol. processes.  Antibodies constitute a powerful tool to modulate the activity of these enzymes for both therapeutic and research purposes.  In this review, we give an overview of monoclonal antibodies (mAbs) that have been tested in preclin. disease models, human trials and important studies of metzincin structure and function.  Initial attempts to develop therapeutic small mol. inhibitors against MMPs were hampered by structural similarities between metzincin active sites and, consequently, off-target effects.  Therefore, more recently, mAbs have been developed that do not bind to the active site but bind to surface-exposed loops that are poorly conserved in closely related family members.  Inhibition of protease activity by these mAbs occurs through a variety of mechanisms, including (i) barring access to the active site, (ii) disruption of exosite binding, and (iii) prevention of protease activation.  These different modes of inhibition are discussed in the context of the antibodies' potency, selectivity and, importantly, the effects in models of disease and clin. trials.  In addn., various innovative strategies that were used to generate anti-metzincin mAbs are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyGrQwnEmcRLVg90H21EOLACvtfcHk0ljaGCbbzxZGbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVems74%253D&md5=30fa232b6ff5f312b56af1bb68b7d23a</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1111%2Fbph.14186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14186%26sid%3Dliteratum%253Aachs%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3Dde%2BGroot%26aufirst%3DR.%26atitle%3DMonoclonal%2520Antibodies%2520against%2520Metzincin%2520Targets%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D176%26issue%3D1%26spage%3D52%26epage%3D66%26doi%3D10.1111%2Fbph.14186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nam, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remacle, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strongin, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span> <span> </span><span class="NLM_article-title">Active-Site MMP-Selective Antibody Inhibitors Discovered from Convex Paratope Synthetic Libraries</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">52</span>),  <span class="NLM_fpage">14970</span>– <span class="NLM_lpage">14975</span>, <span class="refDoi"> DOI: 10.1073/pnas.1609375114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1073%2Fpnas.1609375114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27965386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyisrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=14970-14975&issue=52&author=D.+H.+Namauthor=C.+Rodriguezauthor=A.+G.+Remacleauthor=A.+Y.+Stronginauthor=X.+Ge&title=Active-Site+MMP-Selective+Antibody+Inhibitors+Discovered+from+Convex+Paratope+Synthetic+Libraries&doi=10.1073%2Fpnas.1609375114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries</span></div><div class="casAuthors">Nam, Dong Hyun; Rodriguez, Carlos; Remacle, Albert G.; Strongin, Alex Y.; Ge, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">14970-14975</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Proteases are frequent pharmacol. targets, and their inhibitors are valuable drugs in multiple pathologies.  The catalytic mechanism and the active-site fold, however, are largely conserved among the protease classes, making the development of the selective inhibitors exceedingly challenging.  In the authors' departure from the conventional strategies, the authors reviewed the structure of known camelid inhibitory antibodies, which block enzyme activities via their unusually long, convex-shaped paratopes.  The authors synthesized the human Fab antibody library (over 1.25×109 individual variants) that carried the extended 23-27-residue complementarity-detg. region (CDR)-H3 segments.  As a proof of principle, the authors used the catalytic domain of matrix metalloproteinase-14 (MMP-14), a promalignant protease and a drug target in cancer, as bait.  In the authors' screens, the authors identified 20 binders, of which 14 performed as potent and selective inhibitors of MMP-14 rather than as broad-specificity antagonists.  Specifically, Fab 3A2 bound to MMP-14 in the vicinity of the active pocket with a high 4.8 nM affinity and was similarly efficient (9.7 nM) in inhibiting the protease cleavage activity.  The authors suggest that the convex paratope antibody libraries described here could be readily generalized to facilitate the design of the antibody inhibitors to many addnl. enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr__N9kyl6nprVg90H21EOLACvtfcHk0ljaGCbbzxZGbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyisrvE&md5=3e86c573d3ca022cefcc8a32777b4cbe</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1609375114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1609375114%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DD.%2BH.%26aulast%3DRodriguez%26aufirst%3DC.%26aulast%3DRemacle%26aufirst%3DA.%2BG.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26aulast%3DGe%26aufirst%3DX.%26atitle%3DActive-Site%2520MMP-Selective%2520Antibody%2520Inhibitors%2520Discovered%2520from%2520Convex%2520Paratope%2520Synthetic%2520Libraries%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D52%26spage%3D14970%26epage%3D14975%26doi%3D10.1073%2Fpnas.1609375114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustafa, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benitez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, R.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span> <span> </span><span class="NLM_article-title">Functional Selection of Protease Inhibitory Antibodies</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">16314</span>– <span class="NLM_lpage">16319</span>, <span class="refDoi"> DOI: 10.1073/pnas.1903330116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1073%2Fpnas.1903330116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31363054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFylsLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=16314-16319&issue=33&author=T.+Lopezauthor=Z.+Mustafaauthor=C.+Chenauthor=K.+B.+Leeauthor=A.+Ramirezauthor=C.+Benitezauthor=X.+Luoauthor=R.-R.+Jiauthor=X.+Ge&title=Functional+Selection+of+Protease+Inhibitory+Antibodies&doi=10.1073%2Fpnas.1903330116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selection of protease inhibitory antibodies</span></div><div class="casAuthors">Lopez, Tyler; Mustafa, Zahid; Chen, Chuan; Lee, Ki Baek; Ramirez, Aaron; Benitez, Chris; Luo, Xin; Ji, Ru-Rong; Ge, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">16314-16319</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Crit. for diverse biol. processes, proteases represent one of the largest families of pharmaceutical targets.  To inhibit pathogenic proteases with desired selectivity, monoclonal antibodies (mAbs) hold great promise as research tools and therapeutic agents.  However, identification of mAbs with inhibitory functions is challenging because current antibody discovery methods rely on binding rather than inhibition.  This study developed a highly efficient selection method for protease inhibitory mAbs by coexpressing 3 recombinant proteins in the periplasmic space of Escherichia coli-an antibody clone, a protease of interest, and a β-lactamase modified by insertion of a protease cleavable peptide sequence.  During functional selection, inhibitory antibodies prevent the protease from cleaving the modified β-lactamase, thereby allowing the cell to survive in the presence of ampicillin.  Using this method to select from synthetic human antibody libraries, we isolated panels of mAbs inhibiting 5 targets of 4 main protease classes: matrix metalloproteinases (MMP-14, a predominant target in metastasis; MMP-9, in neuropathic pain), β-secretase 1 (BACE-1, an aspartic protease in Alzheimer's disease), cathepsin B (a cysteine protease in cancer), and Alp2 (a serine protease in aspergillosis).  Notably, 37 of 41 identified binders were inhibitory.  Isolated mAb inhibitors exhibited nanomolar potency, exclusive selectivity, excellent proteolytic stability, and desired biol. functions.  Particularly, anti-Alp2 Fab A4A1 had a binding affinity of 11 nM and inhibition potency of 14 nM, anti-BACE1 IgG B2B2 reduced amyloid beta (Aβ40) prodn. by 80% in cellular assays, and IgG L13 inhibited MMP-9 but not MMP-2/-12/-14 and significantly relieved neuropathic pain development in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoExtbIbbqGyrVg90H21EOLACvtfcHk0ljaGCbbzxZGbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFylsLrK&md5=b3adfa90935908131cf63be184c3125d</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1903330116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1903330116%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DT.%26aulast%3DMustafa%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DK.%2BB.%26aulast%3DRamirez%26aufirst%3DA.%26aulast%3DBenitez%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DR.-R.%26aulast%3DGe%26aufirst%3DX.%26atitle%3DFunctional%2520Selection%2520of%2520Protease%2520Inhibitory%2520Antibodies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26issue%3D33%26spage%3D16314%26epage%3D16319%26doi%3D10.1073%2Fpnas.1903330116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogakos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yiotakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">A Selective Matrix Metalloproteinase-12 Inhibitor Retards Atherosclerotic Plaque Development in Apolipoprotein E-Knockout Mice</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.110.219147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1161%2FATVBAHA.110.219147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21212406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitVOgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=528-535&issue=3&author=J.+L.+Johnsonauthor=L.+Develauthor=B.+Czarnyauthor=S.+J.+Georgeauthor=C.+L.+Jacksonauthor=V.+Rogakosauthor=F.+Beauauthor=A.+Yiotakisauthor=A.+C.+Newbyauthor=V.+Dive&title=A+Selective+Matrix+Metalloproteinase-12+Inhibitor+Retards+Atherosclerotic+Plaque+Development+in+Apolipoprotein+E-Knockout+Mice&doi=10.1161%2FATVBAHA.110.219147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice</span></div><div class="casAuthors">Johnson, Jason L.; Devel, Laurent; Czarny, Bertrand; George, Sarah J.; Jackson, Christopher L.; Rogakos, Vassilis; Beau, Fabrice; Yiotakis, Athanasios; Newby, Andrew C.; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">528-535</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">OBJECTIVE: Matrix metalloproteinase (MMP)-12 has been implicated in plaque progression and instability and is also amenable to selective inhibition.  In this study, we investigated the influence of a greater than 10-fold selective synthetic MMP-12 inhibitor on plaque progression in the apolipoprotein E knockout mouse model of atherosclerosis.  METHODS AND RESULTS: A phosphinic peptide (RXP470.1) that is a potent, selective murine MMP-12 inhibitor significantly reduced atherosclerotic plaque cross-sectional area by approx. 50% at 4 different vascular sites in male and female apolipoprotein E knockout mice fed a Western diet.  Furthermore, RXP470.1 treatment resulted in less complex plaques with increased smooth muscle cell:macrophage ratio, less macrophage apoptosis, increased cap thickness, smaller necrotic cores, and decreased incidence of calcification.  Addnl. in vitro and in vivo findings indicate that attenuated monocyte/macrophage invasion and reduced macrophage apoptosis probably underlie the beneficial effects obsd. on atherosclerotic plaque progression with MMP-12 inhibitor treatment.  CONCLUSION: Our data demonstrate that a selective MMP-12 inhibitor retards atherosclerosis development and results in a more fibrous plaque phenotype in mice.  Our study provides proof of principle to motivate translational work on MMP-12 inhibitor therapy in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo74SZTSfuG57Vg90H21EOLACvtfcHk0lj5zlJW1SmnMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitVOgtbk%253D&md5=9cd9e21179e9182bede144c02da7d858</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.110.219147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.110.219147%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BL.%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DGeorge%26aufirst%3DS.%2BJ.%26aulast%3DJackson%26aufirst%3DC.%2BL.%26aulast%3DRogakos%26aufirst%3DV.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DYiotakis%26aufirst%3DA.%26aulast%3DNewby%26aufirst%3DA.%2BC.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DA%2520Selective%2520Matrix%2520Metalloproteinase-12%2520Inhibitor%2520Retards%2520Atherosclerotic%2520Plaque%2520Development%2520in%2520Apolipoprotein%2520E-Knockout%2520Mice%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2011%26volume%3D31%26issue%3D3%26spage%3D528%26epage%3D535%26doi%3D10.1161%2FATVBAHA.110.219147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nahra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, W.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, C.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baragi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyer, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.-K.</span></span> <span> </span><span class="NLM_article-title">Quinazolinones and Pyrido[3,4- D ]Pyrimidin-4-Ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1021/jm701274v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701274v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFehsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=835-841&issue=4&author=J.+J.+Liauthor=J.+Nahraauthor=A.+R.+Johnsonauthor=A.+Bunkerauthor=P.+O%E2%80%99Brienauthor=W.-S.+Yueauthor=D.+F.+Ortwineauthor=C.-F.+Manauthor=V.+Baragiauthor=K.+Kilgoreauthor=R.+D.+Dyerauthor=H.-K.+Han&title=Quinazolinones+and+Pyrido%5B3%2C4-+D+%5DPyrimidin-4-Ones+as+Orally+Active+and+Specific+Matrix+Metalloproteinase-13+Inhibitors+for+the+Treatment+of+Osteoarthritis&doi=10.1021%2Fjm701274v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Quinazolinones and Pyrido[3,4-d]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis</span></div><div class="casAuthors">Li, Jie Jack; Nahra, Joe; Johnson, Adam R.; Bunker, Amy; O'Brien, Patrick; Yue, Wen-Song; Ortwine, Daniel F.; Man, Chiu-Fai; Baragi, Vijay; Kilgore, Kenneth; Dyer, Richard D.; Han, Hyo-Kyung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">835-841</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinazolinones 8 and pyrido[3,4-d]pyrimidin-4-ones 9 as orally active and specific matrix metalloproteinase-13 inhibitors were discovered for the treatment of osteoarthritis.  Starting from a high-through-put screening (HTS) hit thizolopyrimidin-dione (I), the authors obtained two chemotypes, using computer-aided drug design (CADD) and methodical structure-activity relationship (SAR) studies.  They occupy the unique S1'-specificity pocket and do not bind to the Zn2+ ion.  Some pyrido[3,4-d]pyrimidin-4-ones, such as (II), possess favorable absorption, distribution, metab., and elimination (ADME) and safety profiles.  The compd. II effectively prevents cartilage damage in rabbit animal models of osteoarthritis without inducing musculoskeletal side effects when given at extremely high doses to rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYnmhx10vW57Vg90H21EOLACvtfcHk0lhmaKglfw2JIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFehsr0%253D&md5=b24d7f6aad20e14333ecf13610b2794a</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1021%2Fjm701274v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701274v%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DNahra%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DBunker%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%26aulast%3DYue%26aufirst%3DW.-S.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DMan%26aufirst%3DC.-F.%26aulast%3DBaragi%26aufirst%3DV.%26aulast%3DKilgore%26aufirst%3DK.%26aulast%3DDyer%26aufirst%3DR.%2BD.%26aulast%3DHan%26aufirst%3DH.-K.%26atitle%3DQuinazolinones%2520and%2520Pyrido%255B3%252C4-%2520D%2520%255DPyrimidin-4-Ones%2520as%2520Orally%2520Active%2520and%2520Specific%2520Matrix%2520Metalloproteinase-13%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Osteoarthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D835%26epage%3D841%26doi%3D10.1021%2Fjm701274v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref217"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref217'); return false;" data-citation="" class="refNumLink">217</a></strong><div class="NLM_citation" id="cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Settle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemirovskiy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidmar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruminski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnute, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunyer, T.</span></span> <span> </span><span class="NLM_article-title">Cartilage Degradation Biomarkers Predict Efficacy of a Novel, Highly Selective Matrix Metalloproteinase 13 Inhibitor in a Dog Model of Osteoarthritis: Confirmation by Multivariate Analysis That Modulation of Type Ii Collagen and Aggrecan Degradation Pepti</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3006</span>– <span class="NLM_lpage">3015</span>, <span class="refDoi"> DOI: 10.1002/art.27596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fart.27596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20533541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=3006-3015&issue=10&author=S.+Settleauthor=L.+Vickeryauthor=O.+Nemirovskiyauthor=T.+Vidmarauthor=A.+Bendeleauthor=D.+Messingauthor=P.+Ruminskiauthor=M.+Schnuteauthor=T.+Sunyer&title=Cartilage+Degradation+Biomarkers+Predict+Efficacy+of+a+Novel%2C+Highly+Selective+Matrix+Metalloproteinase+13+Inhibitor+in+a+Dog+Model+of+Osteoarthritis%3A+Confirmation+by+Multivariate+Analysis+That+Modulation+of+Type+Ii+Collagen+and+Aggrecan+Degradation+Pepti&doi=10.1002%2Fart.27596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis</span></div><div class="casAuthors">Settle, Steven; Vickery, Lillian; Nemirovskiy, Olga; Vidmar, Tom; Bendele, Alison; Messing, Dean; Ruminski, Peter; Schnute, Mark; Sunyer, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3006-3015</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To demonstrate that the novel highly selective matrix metalloproteinase 13 (MMP-13) inhibitor PF152 reduces joint lesions in adult dogs with osteoarthritis (OA) and decreases biomarkers of cartilage degrdn.  Methods: The potency and selectivity of PF152 were evaluated in vitro using 16 MMPs, TACE, and ADAMTS-4 and ADAMTS-5, as well as ex vivo in human cartilage explants.  In vivo effects were evaluated at 3 concns. in mature beagles with partial medial meniscectomy.  Gross and histol. changes in the femorotibial joints were evaluated using various measures of cartilage degeneration.  Biomarkers of cartilage turnover were examd. in serum, urine, or synovial fluid.  Results were analyzed individually and in combination using multivariate anal.  Results: The potent and selective MMP-13 inhibitor PF152 decreased human cartilage degrdn. ex vivo in a dose-dependent manner.  PF152 treatment of dogs with OA reduced cartilage lesions and decreased biomarkers of type II collagen (type II collagen neoepitope) and aggrecan (peptides ending in ARGN or AGEG) degrdn.  The dose required for significant inhibition varied with the measure used, but multivariate anal. of 6 gross and histol. measures indicated that all doses differed significantly from vehicle but not from each other.  Combined anal. of cartilage degrdn. markers showed similar results.  Conclusion: This highly selective MMP-13 inhibitor exhibits chondroprotective effects in mature animals.  Biomarkers of cartilage degrdn., when evaluated in combination, parallel the joint structural changes induced by the MMP-13 inhibitor.  These data support the potential therapeutic value of selective MMP-13 inhibitors and the use of a set of appropriate biomarkers to predict efficacy in OA clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFetQBLK-edLVg90H21EOLACvtfcHk0li6_GysPckk4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrvL&md5=83b761d6731b0287d78bbee6263f4df5</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1002%2Fart.27596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27596%26sid%3Dliteratum%253Aachs%26aulast%3DSettle%26aufirst%3DS.%26aulast%3DVickery%26aufirst%3DL.%26aulast%3DNemirovskiy%26aufirst%3DO.%26aulast%3DVidmar%26aufirst%3DT.%26aulast%3DBendele%26aufirst%3DA.%26aulast%3DMessing%26aufirst%3DD.%26aulast%3DRuminski%26aufirst%3DP.%26aulast%3DSchnute%26aufirst%3DM.%26aulast%3DSunyer%26aufirst%3DT.%26atitle%3DCartilage%2520Degradation%2520Biomarkers%2520Predict%2520Efficacy%2520of%2520a%2520Novel%252C%2520Highly%2520Selective%2520Matrix%2520Metalloproteinase%252013%2520Inhibitor%2520in%2520a%2520Dog%2520Model%2520of%2520Osteoarthritis%253A%2520Confirmation%2520by%2520Multivariate%2520Analysis%2520That%2520Modulation%2520of%2520Type%2520Ii%2520Collagen%2520and%2520Aggrecan%2520Degradation%2520Pepti%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26issue%3D10%26spage%3D3006%26epage%3D3015%26doi%3D10.1002%2Fart.27596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref218"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref218'); return false;" data-citation="" class="refNumLink">218</a></strong><div class="NLM_citation" id="cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlovsky, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornemeier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banotai, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baragi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roark, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyer, R. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">27781</span>– <span class="NLM_lpage">27791</span>, <span class="refDoi"> DOI: 10.1074/jbc.M703286200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M703286200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17623656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVeju7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=27781-27791&issue=38&author=A.+R.+Johnsonauthor=A.+G.+Pavlovskyauthor=D.+F.+Ortwineauthor=F.+Priorauthor=C.+F.+Manauthor=D.+A.+Bornemeierauthor=C.+A.+Banotaiauthor=W.+T.+Muellerauthor=P.+McConnellauthor=C.+Yanauthor=V.+Baragiauthor=C.+Leschauthor=W.+H.+Roarkauthor=M.+Wilsonauthor=K.+Dattaauthor=R.+Guzmanauthor=H.+K.+Hanauthor=R.+D.+Dyer&title=Discovery+and+Characterization+of+a+Novel+Inhibitor+of+Matrix+Metalloprotease-13+That+Reduces+Cartilage+Damage+in+Vivo+without+Joint+Fibroplasia+Side+Effects&doi=10.1074%2Fjbc.M703286200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects</span></div><div class="casAuthors">Johnson, Adam R.; Pavlovsky, Alexander G.; Ortwine, Daniel F.; Prior, Faith; Man, Chiu-Fai; Bornemeier, Dirk A.; Banotai, Craig A.; Mueller, W. Thomas; McConnell, Patrick; Yan, Chunhong; Baragi, Vijay; Lesch, Charles; Roark, W. Howard; Wilson, Michael; Datta, Kaushik; Guzman, Roberto; Han, Hyo-Kyung; Dyer, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">27781-27791</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP13) is a Zn2+-dependent protease that catalyzes the cleavage of type II collagen, the main structural protein in articular cartilage.  Excess MMP13 activity causes cartilage degrdn. in osteoarthritis, making this protease an attractive therapeutic target.  However, clin. tested MMP inhibitors have been assocd. with a painful, joint-stiffening musculoskeletal side effect that may be due to their lack of selectivity.  In our efforts to develop a disease-modifying osteoarthritis drug, we have discovered MMP13 inhibitors that differ greatly from previous MMP inhibitors; they do not bind to the catalytic zinc ion, they are noncompetitive with respect to substrate binding, and they show extreme selectivity for inhibiting MMP13.  By structure-based drug design, we generated an orally active MMP13 inhibitor that effectively reduces cartilage damage in vivo and does not induce joint fibroplasias in a rat model of musculoskeletal syndrome side effects.  Thus, highly selective inhibition of MMP13 in patients may overcome the major safety and efficacy challenges that have limited previously tested non-selective MMP inhibitors.  MMP13 inhibitors such as the ones described here will help further define the role of this protease in arthritis and other diseases and may soon lead to drugs that safely halt cartilage damage in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCiHwTVRtp7bVg90H21EOLACvtfcHk0li6_GysPckk4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVeju7nP&md5=9cc5d9b2edff3847141f21c42f86faf8</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M703286200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M703286200%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DPavlovsky%26aufirst%3DA.%2BG.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPrior%26aufirst%3DF.%26aulast%3DMan%26aufirst%3DC.%2BF.%26aulast%3DBornemeier%26aufirst%3DD.%2BA.%26aulast%3DBanotai%26aufirst%3DC.%2BA.%26aulast%3DMueller%26aufirst%3DW.%2BT.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DBaragi%26aufirst%3DV.%26aulast%3DLesch%26aufirst%3DC.%26aulast%3DRoark%26aufirst%3DW.%2BH.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DDatta%26aufirst%3DK.%26aulast%3DGuzman%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DH.%2BK.%26aulast%3DDyer%26aufirst%3DR.%2BD.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520a%2520Novel%2520Inhibitor%2520of%2520Matrix%2520Metalloprotease-13%2520That%2520Reduces%2520Cartilage%2520Damage%2520in%2520Vivo%2520without%2520Joint%2520Fibroplasia%2520Side%2520Effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D38%26spage%3D27781%26epage%3D27791%26doi%3D10.1074%2Fjbc.M703286200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref219"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref219'); return false;" data-citation="" class="refNumLink">219</a></strong><div class="NLM_citation" id="cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Botkjaer, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terp, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karatt-Vellatt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCafferty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreasen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditzel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, G.</span></span> <span> </span><span class="NLM_article-title">Development of a Specific Affinity-Matured Exosite Inhibitor to MT1-MMP That Efficiently Inhibits Tumor Cell Invasion in Vitro and Metastasis in Vivo</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">16773</span>– <span class="NLM_lpage">16792</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.18632%2Foncotarget.7780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26934448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC28jmsFWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=16773-16792&issue=13&author=K.+A.+Botkjaerauthor=H.+F.+Kwokauthor=M.+G.+Terpauthor=A.+Karatt-Vellattauthor=S.+Santamariaauthor=J.+McCaffertyauthor=P.+A.+Andreasenauthor=Y.+Itohauthor=H.+J.+Ditzelauthor=G.+Murphy&title=Development+of+a+Specific+Affinity-Matured+Exosite+Inhibitor+to+MT1-MMP+That+Efficiently+Inhibits+Tumor+Cell+Invasion+in+Vitro+and+Metastasis+in+Vivo&doi=10.18632%2Foncotarget.7780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo</span></div><div class="casAuthors">Botkjaer Kenneth A; Kwok Hang Fai; Murphy Gillian; Kwok Hang Fai; Terp Mikkel G; Ditzel Henrik J; Karatt-Vellatt Aneesh; McCafferty John; Santamaria Salvatore; Itoh Yoshifumi; Andreasen Peter A; Andreasen Peter A; Ditzel Henrik J</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">16773-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The membrane-associated matrix metalloproteinase-14, MT1-MMP, has been implicated in pericellular proteolysis with an important role in cellular invasion of collagenous tissues.  It is substantially upregulated in various cancers and rheumatoid arthritis, and has been considered as a potential therapeutic target.  Here, we report the identification of antibody fragments to MT1-MMP that potently and specifically inhibit its cell surface functions.  Lead antibody clones displayed inhibitory activity towards pro-MMP-2 activation, collagen-film degradation and gelatin-film degradation, and were shown to bind to the MT1-MMP catalytic domain outside the active site cleft, inhibiting binding to triple helical collagen.  Affinity maturation using CDR3 randomization created a second generation of antibody fragments with dissociation constants down to 0.11 nM, corresponding to an improved affinity of 332-fold with the ability to interfere with cell-surface MT1-MMP functions, displaying IC50 values down to 5 nM.  Importantly, the new inhibitors were able to inhibit collagen invasion by tumor-cells in vitro and in vivo primary tumor growth and metastasis of MDA-MB-231 cells in a mouse orthotopic xenograft model.  Herein is the first demonstration that an inhibitory antibody targeting sites outside the catalytic cleft of MT1-MMP can effectively abrogate its in vivo activity during tumorigenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuEBmqbwQOv7HHuJhbyicZfW6udTcc2eZfP-8hV1Bswrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jmsFWksA%253D%253D&md5=60cb2ede64bdf8853ad4eca9c5599bca</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7780%26sid%3Dliteratum%253Aachs%26aulast%3DBotkjaer%26aufirst%3DK.%2BA.%26aulast%3DKwok%26aufirst%3DH.%2BF.%26aulast%3DTerp%26aufirst%3DM.%2BG.%26aulast%3DKaratt-Vellatt%26aufirst%3DA.%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3DMcCafferty%26aufirst%3DJ.%26aulast%3DAndreasen%26aufirst%3DP.%2BA.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DDitzel%26aufirst%3DH.%2BJ.%26aulast%3DMurphy%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520Specific%2520Affinity-Matured%2520Exosite%2520Inhibitor%2520to%2520MT1-MMP%2520That%2520Efficiently%2520Inhibits%2520Tumor%2520Cell%2520Invasion%2520in%2520Vitro%2520and%2520Metastasis%2520in%2520Vivo%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26issue%3D13%26spage%3D16773%26epage%3D16792%26doi%3D10.18632%2Foncotarget.7780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref220"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref220'); return false;" data-citation="" class="refNumLink">220</a></strong><div class="NLM_citation" id="cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanamandra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieters, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frans, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhove, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gool, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rank, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazmany, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonbroodt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladner, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderikx, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TenHoor, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbani, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentino, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dransfield, D. T.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1517</span>– <span class="NLM_lpage">1526</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-3255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1158%2F0008-5472.CAN-08-3255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19208838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslynsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=1517-1526&issue=4&author=L.+Devyauthor=L.+Huangauthor=L.+Naaauthor=N.+Yanamandraauthor=H.+Pietersauthor=N.+Fransauthor=E.+Changauthor=Q.+Taoauthor=M.+Vanhoveauthor=A.+Lejeuneauthor=R.+van+Goolauthor=D.+J.+Sextonauthor=G.+Kuangauthor=D.+Rankauthor=S.+Hoganauthor=C.+Pazmanyauthor=Y.+L.+Maauthor=S.+Schoonbroodtauthor=A.+E.+Nixonauthor=R.+C.+Ladnerauthor=R.+Hoetauthor=P.+Henderikxauthor=C.+TenHoorauthor=S.+A.+Rabbaniauthor=M.+L.+Valentinoauthor=C.+R.+Woodauthor=D.+T.+Dransfield&title=Selective+Inhibition+of+Matrix+Metalloproteinase-14+Blocks+Tumor+Growth%2C+Invasion%2C+and+Angiogenesis&doi=10.1158%2F0008-5472.CAN-08-3255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis</span></div><div class="casAuthors">Devy, Laetitia; Huang, Lili; Naa, Laurent; Yanamandra, Niranjan; Pieters, Henk; Frans, Nicolas; Chang, Edward; Tao, Qingfeng; Vanhove, Marc; Lejeune, Annabelle; van Gool, Reinoud; Sexton, Daniel J.; Kuang, Guannan; Rank, Douglas; Hogan, Shannon; Pazmany, Csaba; Ma, Yu Lu; Schoonbroodt, Sonia; Nixon, Andrew E.; Ladner, Robert C.; Hoet, Rene; Henderikx, Paula; TenHoor, Chris; Rabbani, Shafaat A.; Valentino, Maria Luisa; Wood, Clive R.; Dransfield, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1517-1526</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of specific matrix metalloproteinases (MMP) is an attractive noncytotoxic approach to cancer therapy.  MMP-14, a membrane-bound zinc endopeptidase, has been proposed to play a central role in tumor growth, invasion, and neovascularization.  Besides cleaving matrix proteins, MMP-14 activates proMMP-2 leading to an amplification of pericellular proteolytic activity.  To examine the contribution of MMP-14 to tumor growth and angiogenesis, the authors used DX-2400, a highly selective fully human MMP-14 inhibitory antibody discovered using phage display technol.  DX-2400 blocked proMMP-2 processing on tumor and endothelial cells, inhibited angiogenesis, and slowed tumor progression and formation of metastatic lesions.  The combination of potency, selectivity, and robust in vivo activity shows the potential of a selective MMP-14 inhibitor for the treatment of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9CyBaO8dtwbVg90H21EOLACvtfcHk0lit-01LWhV4zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslynsLg%253D&md5=e21aa828522a8711d432d171613c919a</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-3255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-3255%26sid%3Dliteratum%253Aachs%26aulast%3DDevy%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DNaa%26aufirst%3DL.%26aulast%3DYanamandra%26aufirst%3DN.%26aulast%3DPieters%26aufirst%3DH.%26aulast%3DFrans%26aufirst%3DN.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DTao%26aufirst%3DQ.%26aulast%3DVanhove%26aufirst%3DM.%26aulast%3DLejeune%26aufirst%3DA.%26aulast%3Dvan%2BGool%26aufirst%3DR.%26aulast%3DSexton%26aufirst%3DD.%2BJ.%26aulast%3DKuang%26aufirst%3DG.%26aulast%3DRank%26aufirst%3DD.%26aulast%3DHogan%26aufirst%3DS.%26aulast%3DPazmany%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DY.%2BL.%26aulast%3DSchoonbroodt%26aufirst%3DS.%26aulast%3DNixon%26aufirst%3DA.%2BE.%26aulast%3DLadner%26aufirst%3DR.%2BC.%26aulast%3DHoet%26aufirst%3DR.%26aulast%3DHenderikx%26aufirst%3DP.%26aulast%3DTenHoor%26aufirst%3DC.%26aulast%3DRabbani%26aufirst%3DS.%2BA.%26aulast%3DValentino%26aufirst%3DM.%2BL.%26aulast%3DWood%26aufirst%3DC.%2BR.%26aulast%3DDransfield%26aufirst%3DD.%2BT.%26atitle%3DSelective%2520Inhibition%2520of%2520Matrix%2520Metalloproteinase-14%2520Blocks%2520Tumor%2520Growth%252C%2520Invasion%252C%2520and%2520Angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26issue%3D4%26spage%3D1517%26epage%3D1526%26doi%3D10.1158%2F0008-5472.CAN-08-3255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref221"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref221'); return false;" data-citation="" class="refNumLink">221</a></strong><div class="NLM_citation" id="cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ager, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodack, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Askoxylakis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snuderl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzikansky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkelstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dransfield, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span> <span> </span><span class="NLM_article-title">Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy</span>. <i>JNCI J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>107</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1093/jnci/djv017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1093%2Fjnci%2Fdjv017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2015&pages=1-12&issue=4&author=E.+I.+Agerauthor=S.+V.+Kozinauthor=N.+D.+Kirkpatrickauthor=G.+Seanoauthor=D.+P.+Kodackauthor=V.+Askoxylakisauthor=Y.+Huangauthor=S.+Goelauthor=M.+Snuderlauthor=A.+Muzikanskyauthor=D.+M.+Finkelsteinauthor=D.+T.+Dransfieldauthor=L.+Devyauthor=Y.+Boucherauthor=D.+Fukumuraauthor=R.+K.+Jain&title=Blockade+of+MMP14+Activity+in+Murine+Breast+Carcinomas%3A+Implications+for+Macrophages%2C+Vessels%2C+and+Radiotherapy&doi=10.1093%2Fjnci%2Fdjv017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjv017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjv017%26sid%3Dliteratum%253Aachs%26aulast%3DAger%26aufirst%3DE.%2BI.%26aulast%3DKozin%26aufirst%3DS.%2BV.%26aulast%3DKirkpatrick%26aufirst%3DN.%2BD.%26aulast%3DSeano%26aufirst%3DG.%26aulast%3DKodack%26aufirst%3DD.%2BP.%26aulast%3DAskoxylakis%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DGoel%26aufirst%3DS.%26aulast%3DSnuderl%26aufirst%3DM.%26aulast%3DMuzikansky%26aufirst%3DA.%26aulast%3DFinkelstein%26aufirst%3DD.%2BM.%26aulast%3DDransfield%26aufirst%3DD.%2BT.%26aulast%3DDevy%26aufirst%3DL.%26aulast%3DBoucher%26aufirst%3DY.%26aulast%3DFukumura%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DBlockade%2520of%2520MMP14%2520Activity%2520in%2520Murine%2520Breast%2520Carcinomas%253A%2520Implications%2520for%2520Macrophages%252C%2520Vessels%252C%2520and%2520Radiotherapy%26jtitle%3DJNCI%2520J.%2520Natl.%2520Cancer%2520Inst.%26date%3D2015%26volume%3D107%26issue%3D4%26spage%3D1%26epage%3D12%26doi%3D10.1093%2Fjnci%2Fdjv017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref222"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref222'); return false;" data-citation="" class="refNumLink">222</a></strong><div class="NLM_citation" id="cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dransfield, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1002/art.39414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fart.39414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26315469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslSgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=521-531&issue=2&author=K.+Kanekoauthor=R.+O.+Williamsauthor=D.+T.+Dransfieldauthor=A.+E.+Nixonauthor=A.+Sandisonauthor=Y.+Itoh&title=Selective+Inhibition+of+Membrane+Type+1+Matrix+Metalloproteinase+Abrogates+Progression+of+Experimental+Inflammatory+Arthritis%3A+Synergy+With+Tumor+Necrosis+Factor+Blockade&doi=10.1002%2Fart.39414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade</span></div><div class="casAuthors">Kaneko, Kazuyo; Williams, Richard O.; Dransfield, Daniel T.; Nixon, Andrew E.; Sandison, Ann; Itoh, Yoshifumi</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">521-531</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : In rheumatoid arthritis (RA), destruction of articular cartilage by the inflamed synovium is considered to be driven by increased activities of proteolytic enzymes, including matrix metalloproteinases (MMPs).  The purpose of this study was to investigate the therapeutic potential of selective inhibition of membrane type 1 MMP (MT1-MMP) and its combination with tumor necrosis factor (TNF) blockage in mice with collagen-induced arthritis (CIA).  Methods : CIA was induced in DBA/1 mice by immunization with bovine type II collagen.  From the onset of clin. arthritis, mice were treated with MT1-MMP selective inhibitory antibody DX-2400 and/or TNFR-Fc fusion protein.  Disease progression was monitored daily, and serum, lymph nodes, and affected paws were collected at the end of the study for cytokine and histol. analyses.  For in vitro anal., bone marrow-derived macrophages were stimulated with lipopolysaccharide for 24 h in the presence of DX-2400 and/or TNFR-Fc to analyze cytokine prodn. and phenotype.  Results : DX-2400 treatment significantly reduced cartilage degrdn. and disease progression in mice with CIA.  Importantly, when combined with TNF blockade, DX-2400 acted synergistically, inducing long-term benefit.  DX-2400 also inhibited the up-regulation of interleukin-12 (IL-12)/IL-23 p40 via polarization toward an M2 phenotype in bone marrow-derived macrophages.  Increased prodn. of IL-17 induced by anti-TNF, which correlated with an incomplete response to anti-TNF, was abrogated by combined treatment with DX-2400 in CIA.  Conclusion : Targeting MT1-MMP provides a potential strategy for joint protection, and its combination with TNF blockade may be particularly beneficial in RA patients with an inadequate response to anti-TNF therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH7BAkTfRak7Vg90H21EOLACvtfcHk0lgwbH-9GbsXEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslSgsL0%253D&md5=60c7ae76bed70c0e2b3c2124b57dbd43</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1002%2Fart.39414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39414%26sid%3Dliteratum%253Aachs%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26aulast%3DDransfield%26aufirst%3DD.%2BT.%26aulast%3DNixon%26aufirst%3DA.%2BE.%26aulast%3DSandison%26aufirst%3DA.%26aulast%3DItoh%26aufirst%3DY.%26atitle%3DSelective%2520Inhibition%2520of%2520Membrane%2520Type%25201%2520Matrix%2520Metalloproteinase%2520Abrogates%2520Progression%2520of%2520Experimental%2520Inflammatory%2520Arthritis%253A%2520Synergy%2520With%2520Tumor%2520Necrosis%2520Factor%2520Blockade%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26issue%3D2%26spage%3D521%26epage%3D531%26doi%3D10.1002%2Fart.39414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref223"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref223'); return false;" data-citation="" class="refNumLink">223</a></strong><div class="NLM_citation" id="cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, R.</span></span> <span> </span><span class="NLM_article-title">Development of a Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-7/-13 Inhibitor</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1548</span>, <span class="refDoi"> DOI: 10.3390/molecules22091548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3390%2Fmolecules22091548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaiur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1548&author=T.+Fischerauthor=R.+Riedl&title=Development+of+a+Non-Hydroxamate+Dual+Matrix+Metalloproteinase+%28MMP%29-7%2F-13+Inhibitor&doi=10.3390%2Fmolecules22091548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a non-hydroxamate dual matrix metalloproteinase (MMP)-7/-13 inhibitor</span></div><div class="casAuthors">Fischer, Thomas; Riedl, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1548/1-1548/27</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Matrix metalloproteinase 7 (MMP-7) is a member of the MMP superfamily and is able to degrade extracellular matrix proteins such as casein, gelatin, fibronectin and proteoglycan.  MMP-7 is a validated target for the development of small mol. drugs against cancer.  MMP-13 is within the enzyme class the most efficient contributor to type II collagen degeneration and is a validated target in arthritis and cancer.  We have developed the dual MMP-7/-13 inhibitor ZHAWOC6941 with IC50-values of 2.2 μM (MMP-7) and 1.2 μM (MMP-13) that is selective over a broad range of MMP isoforms.  It spares MMP-1, -2, -3, -8, -9, -12 and -14, making it a valuable modulator for targeted polypharmacol. approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUe3LxiuAsWLVg90H21EOLACvtfcHk0lgwbH-9GbsXEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaiur%252FF&md5=f7f10191eada9a280279de822c0487d4</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22091548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22091548%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DT.%26aulast%3DRiedl%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520a%2520Non-Hydroxamate%2520Dual%2520Matrix%2520Metalloproteinase%2520%2528MMP%2529-7%252F-13%2520Inhibitor%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D1548%26doi%3D10.3390%2Fmolecules22091548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref224"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref224'); return false;" data-citation="" class="refNumLink">224</a></strong><div class="NLM_citation" id="cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gall, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frasson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermelinger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittl, P. R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sievers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, R.</span></span> <span> </span><span class="NLM_article-title">Drug Design Inspired by Nature: Crystallographic Detection of an Auto-Tailored Protease Inhibitor Template</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4051</span>– <span class="NLM_lpage">4055</span>, <span class="refDoi"> DOI: 10.1002/anie.201812348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fanie.201812348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVansL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=4051-4055&issue=12&author=F.+M.+Gallauthor=D.+Hohlauthor=D.+Frassonauthor=T.+Wermelingerauthor=P.+R.+E.+Mittlauthor=M.+Sieversauthor=R.+Riedl&title=Drug+Design+Inspired+by+Nature%3A+Crystallographic+Detection+of+an+Auto-Tailored+Protease+Inhibitor+Template&doi=10.1002%2Fanie.201812348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Design Inspired by Nature: Crystallographic Detection of an Auto-Tailored Protease Inhibitor Template</span></div><div class="casAuthors">Gall, Flavio M.; Hohl, Deborah; Frasson, David; Wermelinger, Tobias; Mittl, Peer R. E.; Sievers, Martin; Riedl, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4051-4055</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">De novo drug discovery is still a challenge in the search for potent and selective modulators of therapeutically relevant target proteins.  Here, we disclose the unexpected discovery of a peptidic ligand 1 by X-ray crystallog., which was auto-tailored by the therapeutic target MMP-13 through partial self-degrdn. and subsequent structure-based optimization to a highly potent and selective β-sheet peptidomimetic inhibitor derived from the endogenous tissue inhibitors of metalloproteinases (TIMPs).  The incorporation of non-proteinogenic amino acids in combination with a cyclization strategy proved to be key for the de novo design of TIMP peptidomimetics.  The optimized cyclic peptide 4 (ZHAWOC7726) is membrane permeable with an IC50 of 21 nm for MMP-13 and an attractive selectivity profile with respect to a polypharmacol. approach including the anticancer targets MMP-2 (IC50: 170 nm) and MMP-9 (IC50: 140 nm).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfsjNPNOrK2LVg90H21EOLACvtfcHk0lgwbH-9GbsXEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVansL0%253D&md5=01c3b9232b54eee221917b570ecc5b3a</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1002%2Fanie.201812348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201812348%26sid%3Dliteratum%253Aachs%26aulast%3DGall%26aufirst%3DF.%2BM.%26aulast%3DHohl%26aufirst%3DD.%26aulast%3DFrasson%26aufirst%3DD.%26aulast%3DWermelinger%26aufirst%3DT.%26aulast%3DMittl%26aufirst%3DP.%2BR.%2BE.%26aulast%3DSievers%26aufirst%3DM.%26aulast%3DRiedl%26aufirst%3DR.%26atitle%3DDrug%2520Design%2520Inspired%2520by%2520Nature%253A%2520Crystallographic%2520Detection%2520of%2520an%2520Auto-Tailored%2520Protease%2520Inhibitor%2520Template%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26issue%3D12%26spage%3D4051%26epage%3D4055%26doi%3D10.1002%2Fanie.201812348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref225"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref225'); return false;" data-citation="" class="refNumLink">225</a></strong><div class="NLM_citation" id="cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El Ashry, E. S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teleb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Serie, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abd Al Moaty, M. N.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design and Optimization of Pyrimidine- and 1,2,4-triazolo[4,3-A]pyrimidine-Based Matrix Metalloproteinase-10/13 Inhibitors via Dimroth Rearrangement towards Targeted Polypharmacology</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">103616</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bioorg.2020.103616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=32032847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisV2hu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2020&pages=103616&author=E.+S.+H.+El+Ashryauthor=L.+F.+Awadauthor=M.+Telebauthor=N.+A.+Ibrahimauthor=M.+M.+Abu-Serieauthor=M.+N.+Abd+Al+Moaty&title=Structure-Based+Design+and+Optimization+of+Pyrimidine-+and+1%2C2%2C4-triazolo%5B4%2C3-A%5Dpyrimidine-Based+Matrix+Metalloproteinase-10%2F13+Inhibitors+via+Dimroth+Rearrangement+towards+Targeted+Polypharmacology&doi=10.1016%2Fj.bioorg.2020.103616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology</span></div><div class="casAuthors">El Ashry, El Sayed Helmy; Awad, Laila Fathy; Teleb, Mohamed; Ibrahim, Nihal Ahmed; Abu-Serie, Marwa M.; Abd Al Moaty, Mohamed Nabil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103616pp.</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study described the design, synthesis and optimization of novel MMP-10/13 inhibitors with enhanced MMP-10 potency and selectivity towards polypharmacol.  Firstly, a series of 6-Me pyrimidinone hydrazones I [Ar = 4-MeOC6H4, 4-ClC6H4, 4-BrC6H4, etc.] was synthesized via conventional and ultrasonic-assisted methods, then evaluated for MMP-10/13 inhibition.  The most active deriv., compd. I [Ar = 4-MeOC6H4] exhibited acceptable dual potency with 7-fold selectivity for MMP-10 (IC50 = 53 nM) over MMP-13.  Such hydrazones were then cyclized to the corresponding isomeric 1,2,4-triazolo[4,3-a]pyrimidines II and III and their MMP-10/13 inhibition assay revealed, in most cases, superior dual activities with general MMP-10 selectivity compared to the corresponding precursors I.  In addn., a clear structure activity relationship trend was deduced within the identified regioisomers, where compds. II [Ar = 4-ClC6H4, 4-BrC6H4] were far more active against MMP-10/13 than their regioisomers III [Ar = 4-ClC6H4, 4-BrC6H4].  Remarkably, compd. II [Ar = 4-BrC6H4] exhibited the highest MMP-10 inhibition (IC50 = 24 nM), whereas compd. II [Ar = 4-MeOC6H4] was the most potent MMP-13 inhibitor (IC50 = 294 nM).  Moreover, compd. II [Ar = 4-BrC6H4] exhibited 19-fold selectivity for MMP-10 over MMP-13, 10-fold over MMP-9 and 29-fold over MMP-7.  Docking studies were performed to provide reasonable explanation for structure-activity relationships and isoform selectivity.  Compds. II [Ar = 4-BrC6H4, 4-MeOC6H4] were then evaluated for their anticancer activities against three human cancers to assess their therapeutic potential at cellular level via MTT assay and both compds. exhibited superior anticancer activities compared to quercetin.  Their in silico ligand efficiency metrics, physicochem. properties and ADME parameters were drug-like.  Guided by such findings that pointed to compd. II [Ar = 4-BrC6H4] as the most promising compd. in this study, further structure optimization was carried out via photoirradn.-mediated Dimroth rearrangement of the inactive triazolopyrimidine compd. III [Ar = 4-BrC6H4] to its potent regioisomer compd. II [Ar = 4-BrC6H4].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqml1aUujQox7Vg90H21EOLACvtfcHk0ljW57ZYTHjuFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisV2hu7k%253D&md5=749009ed7909329c61c7b3766c3b5c76</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103616%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BAshry%26aufirst%3DE.%2BS.%2BH.%26aulast%3DAwad%26aufirst%3DL.%2BF.%26aulast%3DTeleb%26aufirst%3DM.%26aulast%3DIbrahim%26aufirst%3DN.%2BA.%26aulast%3DAbu-Serie%26aufirst%3DM.%2BM.%26aulast%3DAbd%2BAl%2BMoaty%26aufirst%3DM.%2BN.%26atitle%3DStructure-Based%2520Design%2520and%2520Optimization%2520of%2520Pyrimidine-%2520and%25201%252C2%252C4-triazolo%255B4%252C3-A%255Dpyrimidine-Based%2520Matrix%2520Metalloproteinase-10%252F13%2520Inhibitors%2520via%2520Dimroth%2520Rearrangement%2520towards%2520Targeted%2520Polypharmacology%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D96%26spage%3D103616%26doi%3D10.1016%2Fj.bioorg.2020.103616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref226"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref226'); return false;" data-citation="" class="refNumLink">226</a></strong><div class="NLM_citation" id="cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swetha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganeshpurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span> <span> </span><span class="NLM_article-title">Multifunctional Hybrid Sulfonamides as Novel Therapeutic Agents for Alzheimer’s Disease</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">3161</span>– <span class="NLM_lpage">3178</span>, <span class="refDoi"> DOI: 10.4155/fmc-2019-0106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.4155%2Ffmc-2019-0106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31838895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlygurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=3161-3178&issue=24&author=R.+Swethaauthor=D.+Kumarauthor=S.+K.+Guptaauthor=A.+Ganeshpurkarauthor=R.+Singhauthor=G.+Guttiauthor=D.+Kumarauthor=S.+Janaauthor=S.+Krishnamurthyauthor=S.+K.+Singh&title=Multifunctional+Hybrid+Sulfonamides+as+Novel+Therapeutic+Agents+for+Alzheimer%E2%80%99s+Disease&doi=10.4155%2Ffmc-2019-0106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer's disease</span></div><div class="casAuthors">Swetha, Rayala; Kumar, Devendra; Gupta, Sukesh K.; Ganeshpurkar, Ankit; Singh, Ravi; Gutti, Gopichand; Kumar, Dileep; Jana, Srabanti; Krishnamurthy, Sairam; Singh, Sushil K.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3161-3178</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: A breakthrough in modern medicine, in terms of treatment of Alzheimer's disease, is yet to be seen, as the scene is currently plagued with numerous clin. trial failures.  Here, we are exploring multifunctional hybrid sulfonamides for their anti-Alzheimer activity due to the complex nature of the disease.  Results & methodol.: Compd. 41 showed significant inhibition of MMP-2 (IC50: 18.24 ± 1.62 nM), AChE (IC50: 4.28 ± 0.15μM) and BuChE (IC50: 1.32 ± 0.02μM).  It also exhibited a metal-chelating property, as validated by an in vitro metal-induced Aβ aggregation assay using confocal fluorescence imaging.  Whereas, MTT and DPPH assays revealed it to be nontoxic and neuroprotective with substantial antioxidant property.  Conclusion: The present study puts forth potent yet nontoxic lead mols., which foray into the field of multitargeted agents for the treatment of Alzheimer's disease.  Graphical abstr. :.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1hLG6EnH_2bVg90H21EOLACvtfcHk0ljW57ZYTHjuFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlygurnK&md5=39172cb2b65e602d591f323fccf422b7</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2019-0106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2019-0106%26sid%3Dliteratum%253Aachs%26aulast%3DSwetha%26aufirst%3DR.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DGaneshpurkar%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DGutti%26aufirst%3DG.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DJana%26aufirst%3DS.%26aulast%3DKrishnamurthy%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26atitle%3DMultifunctional%2520Hybrid%2520Sulfonamides%2520as%2520Novel%2520Therapeutic%2520Agents%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2019%26volume%3D11%26issue%3D24%26spage%3D3161%26epage%3D3178%26doi%3D10.4155%2Ffmc-2019-0106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216'],'ref217':['cit217'],'ref218':['cit218'],'ref219':['cit219'],'ref220':['cit220'],'ref221':['cit221'],'ref222':['cit222'],'ref223':['cit223'],'ref224':['cit224'],'ref225':['cit225'],'ref226':['cit226']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 9 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Yue</span>, <span class="hlFld-ContribAuthor ">Yaojie  Shi</span>, <span class="hlFld-ContribAuthor ">Xingping  Su</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Tinghong  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Matrix metalloproteinases inhibitors in idiopathic pulmonary fibrosis: Medicinal chemistry perspectives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113714. <a href="https://doi.org/10.1016/j.ejmech.2021.113714" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113714%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMatrix%252Bmetalloproteinases%252Binhibitors%252Bin%252Bidiopathic%252Bpulmonary%252Bfibrosis%25253A%252BMedicinal%252Bchemistry%252Bperspectives%26aulast%3DYue%26aufirst%3DLin%26date%3D2021%26volume%3D224%26spage%3D113714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  García‐González</span>, <span class="hlFld-ContribAuthor ">Jean‐Michel  Paumier</span>, <span class="hlFld-ContribAuthor ">Laurence  Louis</span>, <span class="hlFld-ContribAuthor ">Dominika  Pilat</span>, <span class="hlFld-ContribAuthor ">Anne  Bernard</span>, <span class="hlFld-ContribAuthor ">Delphine  Stephan</span>, <span class="hlFld-ContribAuthor ">Nicolas  Jullien</span>, <span class="hlFld-ContribAuthor ">Frédéric  Checler</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Nivet</span>, <span class="hlFld-ContribAuthor ">Michel  Khrestchatisky</span>, <span class="hlFld-ContribAuthor ">Kévin  Baranger</span>, <span class="hlFld-ContribAuthor ">Santiago  Rivera</span>. </span><span class="cited-content_cbyCitation_article-title">MT5‐MMP controls APP and β‐CTF/C99 metabolism through proteolytic‐dependent and ‐independent mechanisms relevant for Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2021,</strong> <em>35 </em>
                                    (7)
                                     <a href="https://doi.org/10.1096/fj.202100593R" title="DOI URL">https://doi.org/10.1096/fj.202100593R</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.202100593R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.202100593R%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DMT5%2525E2%252580%252590MMP%252Bcontrols%252BAPP%252Band%252B%2525CE%2525B2%2525E2%252580%252590CTF%25252FC99%252Bmetabolism%252Bthrough%252Bproteolytic%2525E2%252580%252590dependent%252Band%252B%2525E2%252580%252590independent%252Bmechanisms%252Brelevant%252Bfor%252BAlzheimer%252527s%252Bdisease%26aulast%3DGarc%25C3%25ADa%25E2%2580%2590Gonz%25C3%25A1lez%26aufirst%3DLaura%26date%3D2021%26date%3D2021%26volume%3D35%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikita  Arnst</span>, <span class="hlFld-ContribAuthor ">Pedro  Belio-Mairal</span>, <span class="hlFld-ContribAuthor ">Laura  García-González</span>, <span class="hlFld-ContribAuthor ">Laurie  Arnaud</span>, <span class="hlFld-ContribAuthor ">Louise  Greetham</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Nivet</span>, <span class="hlFld-ContribAuthor ">Santiago  Rivera</span>, <span class="hlFld-ContribAuthor ">Alexander  Dityatev</span>. </span><span class="cited-content_cbyCitation_article-title">Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (7)
                                     , 1705. <a href="https://doi.org/10.3390/cells10071705" title="DOI URL">https://doi.org/10.3390/cells10071705</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10071705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10071705%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DDeficiency%252Bin%252BMT5-MMP%252BSupports%252BBranching%252Bof%252BHuman%252BiPSCs-Derived%252BNeurons%252Band%252BReduces%252BExpression%252Bof%252BGLAST%25252FS100%252Bin%252BiPSCs-Derived%252BAstrocytes%26aulast%3DArnst%26aufirst%3DNikita%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D7%26spage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Lenci</span>, <span class="hlFld-ContribAuthor ">Lucrezia  Cosottini</span>, <span class="hlFld-ContribAuthor ">Andrea  Trabocchi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel matrix metalloproteinase inhibitors: an updated patent review (2014 - 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (6)
                                     , 509-523. <a href="https://doi.org/10.1080/13543776.2021.1881481" title="DOI URL">https://doi.org/10.1080/13543776.2021.1881481</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1881481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1881481%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNovel%252Bmatrix%252Bmetalloproteinase%252Binhibitors%25253A%252Ban%252Bupdated%252Bpatent%252Breview%252B%2525282014%252B-%252B2020%252529%26aulast%3DLenci%26aufirst%3DElena%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D6%26spage%3D509%26epage%3D523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  García-Viñuales</span>, <span class="hlFld-ContribAuthor ">Michele F.M.  Sciacca</span>, <span class="hlFld-ContribAuthor ">Valeria  Lanza</span>, <span class="hlFld-ContribAuthor ">Anna Maria  Santoro</span>, <span class="hlFld-ContribAuthor ">Giulia  Grasso</span>, <span class="hlFld-ContribAuthor ">Grazia R.  Tundo</span>, <span class="hlFld-ContribAuthor ">Diego  Sbardella</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Coletta</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Grasso</span>, <span class="hlFld-ContribAuthor ">Carmelo  La Rosa</span>, <span class="hlFld-ContribAuthor ">Danilo  Milardi</span>. </span><span class="cited-content_cbyCitation_article-title">The interplay between lipid and Aβ amyloid homeostasis in Alzheimer’s Disease: risk factors and therapeutic opportunities. </span><span class="cited-content_cbyCitation_journal-name">Chemistry and Physics of Lipids</span><span> <strong>2021,</strong> <em>236 </em>, 105072. <a href="https://doi.org/10.1016/j.chemphyslip.2021.105072" title="DOI URL">https://doi.org/10.1016/j.chemphyslip.2021.105072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chemphyslip.2021.105072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chemphyslip.2021.105072%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520and%2520Physics%2520of%2520Lipids%26atitle%3DThe%252Binterplay%252Bbetween%252Blipid%252Band%252BA%2525CE%2525B2%252Bamyloid%252Bhomeostasis%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252Brisk%252Bfactors%252Band%252Btherapeutic%252Bopportunities%26aulast%3DGarc%25C3%25ADa-Vi%25C3%25B1uales%26aufirst%3DSara%26date%3D2021%26volume%3D236%26spage%3D105072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tapan  Behl</span>, <span class="hlFld-ContribAuthor ">Gagandeep  Kaur</span>, <span class="hlFld-ContribAuthor ">Aayush  Sehgal</span>, <span class="hlFld-ContribAuthor ">Shaveta  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Sukhbir  Singh</span>, <span class="hlFld-ContribAuthor ">Camelia  Buhas</span>, <span class="hlFld-ContribAuthor ">Claudia  Judea-Pusta</span>, <span class="hlFld-ContribAuthor ">Diana  Uivarosan</span>, <span class="hlFld-ContribAuthor ">Mihai Alexandru  Munteanu</span>, <span class="hlFld-ContribAuthor ">Simona  Bungau</span>. </span><span class="cited-content_cbyCitation_article-title">Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (3)
                                     , 1413. <a href="https://doi.org/10.3390/ijms22031413" title="DOI URL">https://doi.org/10.3390/ijms22031413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22031413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22031413%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMultifaceted%252BRole%252Bof%252BMatrix%252BMetalloproteinases%252Bin%252BNeurodegenerative%252BDiseases%25253A%252BPathophysiological%252Band%252BTherapeutic%252BPerspectives%26aulast%3DBehl%26aufirst%3DTapan%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D3%26spage%3D1413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lidia  Ciccone</span>, <span class="hlFld-ContribAuthor ">Jennifer  Vandooren</span>, <span class="hlFld-ContribAuthor ">Susanna  Nencetti</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Orlandini</span>. </span><span class="cited-content_cbyCitation_article-title">Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (2)
                                     , 86. <a href="https://doi.org/10.3390/ph14020086" title="DOI URL">https://doi.org/10.3390/ph14020086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14020086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14020086%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DNatural%252BMarine%252Band%252BTerrestrial%252BCompounds%252Bas%252BModulators%252Bof%252BMatrix%252BMetalloproteinases-2%252B%252528MMP-2%252529%252Band%252BMMP-9%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DCiccone%26aufirst%3DLidia%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D2%26spage%3D86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darcy R  Denner</span>, <span class="hlFld-ContribAuthor ">Maria LD  Udan-Johns</span>, <span class="hlFld-ContribAuthor ">Michael R  Nichols</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of matrix metalloproteinase-9 secretion by dimethyl sulfoxide and cyclic adenosine monophosphate in human monocytes. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 1-14. <a href="https://doi.org/10.4331/wjbc.v12.i1.1" title="DOI URL">https://doi.org/10.4331/wjbc.v12.i1.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4331/wjbc.v12.i1.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4331%2Fwjbc.v12.i1.1%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Biological%2520Chemistry%26atitle%3DInhibition%252Bof%252Bmatrix%252Bmetalloproteinase-9%252Bsecretion%252Bby%252Bdimethyl%252Bsulfoxide%252Band%252Bcyclic%252Badenosine%252Bmonophosphate%252Bin%252Bhuman%252Bmonocytes%26aulast%3DDenner%26aufirst%3DDarcy%2BR%26date%3D2021%26volume%3D12%26issue%3D1%26spage%3D1%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Asif Hassan  Syed</span>, <span class="hlFld-ContribAuthor ">Tabrej  Khan</span>, <span class="hlFld-ContribAuthor ">Atif  Hassan</span>, <span class="hlFld-ContribAuthor ">Nashwan A.  Alromema</span>, <span class="hlFld-ContribAuthor ">Muhammad  Binsawad</span>, <span class="hlFld-ContribAuthor ">Alhuseen Omar  Alsayed</span>. </span><span class="cited-content_cbyCitation_article-title">An Ensemble-Learning Based Application to Predict the Earlier Stages of Alzheimer’s Disease (AD). </span><span class="cited-content_cbyCitation_journal-name">IEEE Access</span><span> <strong>2020,</strong> <em>8 </em>, 222126-222143. <a href="https://doi.org/10.1109/ACCESS.2020.3043715" title="DOI URL">https://doi.org/10.1109/ACCESS.2020.3043715</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1109/ACCESS.2020.3043715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1109%2FACCESS.2020.3043715%26sid%3Dliteratum%253Aachs%26jtitle%3DIEEE%2520Access%26atitle%3DAn%252BEnsemble-Learning%252BBased%252BApplication%252Bto%252BPredict%252Bthe%252BEarlier%252BStages%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%252B%252528AD%252529%26aulast%3DSyed%26aufirst%3DAsif%2BHassan%26date%3D2020%26volume%3D8%26spage%3D222126%26epage%3D222143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of the two classical APP processing pathways. In blue, the nonamyloidogenic pathway, which mainly occurs at the plasma membrane level, and in red, the amyloidogenic pathway, which mainly occurs in the endosomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of APP processing by η-secretase. Aη-α is neurotoxic, but Aη-β is not.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic representation of the two newly described disease pathways involving MT5-MMP in the pathogenesis of AD. A third synergistic/complementary pathway would be the role of MT5-MMP in the regulation of inflammatory processes in the CNS, but data are still needed to demonstrate this.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Schematic representation of substrate binding in a MMP catalytic site, with the implication of different subsites S<i>n</i> of the MMP for the accommodation of various amino acids P<i>n</i> of the substrate. In yellow, the zinc cation (Zn) is essential for the cleavage of the peptide bond (indicated by the arrow between P1–P1′). This cartoon has been generated with PyMOL software from the crystal structure of MT3-MMP available in the PDB Data Bank (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RM8">1RM8</a>).<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Schematic representation of the general catalytic site of MMPs, illustrated by MT3-MMP crystal structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RM8">1RM8</a>). The S1′ pocket (in red), close to Zn cation (in yellow) is deep, hydrophobic, and variable in size and shape among the MMPs. The S2′ shallow pocket (in green) is very similar among MMPs and is partially exposed to solvent. This image has been generated with PyMOL software.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Schematic representation of physiological and pharmacological regulation of MMP activity. Physiological regulation is represented in the blue box with proMMP-3 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SLM">1SLM</a>), active MMP-3 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CAQ">1CAQ</a>), and the MMP-3/TIMP-1 complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UEA">1UEA</a>). Pharmacological regulation is presented in red by a zinc-chelating inhibitor <b>11</b> complexed with MMP-12 catalytic site (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GQL">4GQL</a>) and by GS-5745 exosite-based mAb of MMP-9 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TH9">5TH9</a>). Surface representation of MMP catalytic site with the secondary structure highlighted in gray, catalytic zinc ion in yellow. The image has been generated with PyMOL software.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Examples of structures of nonselective MMPs inhibitors. (A) Marketed compounds (B) first generation, peptides/peptidomimetics; (C) second generation, nonpeptidomimetics. *Yellow spheres indicate the zinc binding group (ZBG) on designed MMP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Crystal structure of the catalytic domain of MT3-MMP complexed with the nonselective inhibitor batimastat <b>5</b> in blue (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RM8">1RM8</a>). Surface representation of the protein with the secondary structure is highlighted in gray, the S1′ pocket in red and the catalytic zinc ion in yellow. The inset shows a zoom of the catalytic site with ligand–protein interactions represented as yellow dashed lines. The image has been generated with PyMOL software.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> (B) Schematic representation of the binding mode of batimastat <b>5</b> in the catalytic site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Development of various ZBGs over time, represented with their pros and cons.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Examples of third generation of selective inhibitors with catalytic site interactions represented (pockets S<i>n</i>). Yellow spheres indicate the ZBG. (A) Nonpeptidomimetic, (B) mechanism-based, and (C) peptidomimetic inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/medium/jm0c00352_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Examples of the fourth-generation exosite-based MMP inhibitors. (A) MMP-13 inhibitors with protein–inhibitor interactions represented (MMP pockets S<i>n</i>′ are visualized and yellow spheres indicate the ZBG). (B) Other exosite-based MMP inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.0c00352/20201001/images/large/jm0c00352_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00352&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 226 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, C.</span></span> <i>World Alzheimer Report 2018. The State of the Art of Dementia Research: New Frontiers</i>; <span class="NLM_publisher-name">London Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2018</span>; <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2018.pdf</a> (accessed 2020-02-08).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=C.+Patterson&title=World+Alzheimer+Report+2018.+The+State+of+the+Art+of+Dementia+Research%3A+New+Frontiers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DPatterson%26aufirst%3DC.%26jtitle%3DWorld%2520Alzheimer%2520Report%25202018.%2520The%2520State%2520of%2520the%2520Art%2520of%2520Dementia%2520Research%253A%2520New%2520Frontiers%26pub%3DLondon%2520Alzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vandenbroucke, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span> <span> </span><span class="NLM_article-title">Is There New Hope for Therapeutic Matrix Metalloproteinase Inhibition?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">904</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1038/nrd4390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrd4390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25376097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2jtb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=904-927&issue=12&author=R.+E.+Vandenbrouckeauthor=C.+Libert&title=Is+There+New+Hope+for+Therapeutic+Matrix+Metalloproteinase+Inhibition%3F&doi=10.1038%2Fnrd4390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Is there new hope for therapeutic matrix metalloproteinase inhibition?</span></div><div class="casAuthors">Vandenbroucke, Roosmarijn E.; Libert, Claude</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">904-927</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that form a family of 24 members in mammals.  Evidence of the pathol. roles of MMPs in various diseases, combined with their druggability, has made them attractive therapeutic targets.  Initial drug discovery efforts focused on the roles of MMPs in cancer progression, and more than 50 MMP inhibitors have been investigated in clin. trials in various cancers.  However, all of these trials failed.  Reasons for failure include the lack of inhibitor specificity and insufficient knowledge about the complexity of the disease biol.  MMPs are also known to be involved in several inflammatory processes, and there are new therapeutic opportunities for MMP inhibitors to treat such diseases.  In this Review, we discuss the recent advances made in understanding the role of MMPs in inflammatory diseases and the therapeutic potential of MMP inhibition in those conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpua2GBt8P5b7Vg90H21EOLACvtfcHk0lhCD-RhInkqEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2jtb3I&md5=032265fe59e9f7567e4d3c7d072b3cde</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd4390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4390%26sid%3Dliteratum%253Aachs%26aulast%3DVandenbroucke%26aufirst%3DR.%2BE.%26aulast%3DLibert%26aufirst%3DC.%26atitle%3DIs%2520There%2520New%2520Hope%2520for%2520Therapeutic%2520Matrix%2520Metalloproteinase%2520Inhibition%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26issue%3D12%26spage%3D904%26epage%3D927%26doi%3D10.1038%2Fnrd4390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maskos, K.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of MMPs in Complex with Physiological and Pharmacological Inhibitors</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>87</i></span> (<span class="NLM_issue">3–4</span>),  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2004.11.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.biochi.2004.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15781312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2005&pages=249-263&issue=3%E2%80%934&author=K.+Maskos&title=Crystal+Structures+of+MMPs+in+Complex+with+Physiological+and+Pharmacological+Inhibitors&doi=10.1016%2Fj.biochi.2004.11.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of MMPs in complex with physiological and pharmacological inhibitors</span></div><div class="casAuthors">Maskos, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">249-263</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of multidomain Zn-endopeptidases that function in the extracellular space or attached to the cell membrane.  Their proteolytic activity is controlled by the presence of endogenous inhibitors, including TIMPs, α-macroglobulin, and others.  Disruption of the proteinase-inhibitor balance is obsd. in serious diseases such as arthritis, tumor growth, and metastasis, rendering the MMPs attractive targets for drug intervention by pharmacol. inhibitors.  The detn. of MMP structures is of crit. importance in order to understand their substrate preferences, dimerization events, and their assocn. with matrix components and inhibitors.  Thus, MMP structures may contribute significantly to the development of specific MMP inhibitors, which should allow precise control of individual members of the MMP family without affecting all members or the closely related metalloproteinases such as ADAMs and ADAMTSs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN46VmWEyg47Vg90H21EOLACvtfcHk0lhPcyhc5pT4OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVWqt7o%253D&md5=4e8015d72053e021c29d75b817326f67</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2004.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2004.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DMaskos%26aufirst%3DK.%26atitle%3DCrystal%2520Structures%2520of%2520MMPs%2520in%2520Complex%2520with%2520Physiological%2520and%2520Pharmacological%2520Inhibitors%26jtitle%3DBiochimie%26date%3D2005%26volume%3D87%26issue%3D3%25E2%2580%25934%26spage%3D249%26epage%3D263%26doi%3D10.1016%2Fj.biochi.2004.11.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagase, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, G.</span></span> <span> </span><span class="NLM_article-title">Structure and Function of Matrix Metalloproteinases and TIMPs</span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1016/j.cardiores.2005.12.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.cardiores.2005.12.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16405877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2006&pages=562-573&issue=3&author=H.+Nagaseauthor=R.+Visseauthor=G.+Murphy&title=Structure+and+Function+of+Matrix+Metalloproteinases+and+TIMPs&doi=10.1016%2Fj.cardiores.2005.12.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of matrix metalloproteinases and TIMPs</span></div><div class="casAuthors">Nagase, Hideaki; Visse, Robert; Murphy, Gillian</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">562-573</span>CODEN:
                <span class="NLM_cas:coden">CVREAU</span>;
        ISSN:<span class="NLM_cas:issn">0008-6363</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs), also called matrixins, function in the extracellular environment of cells and degrade both matrix and non-matrix proteins.  They play central roles in morphogenesis, wound healing, tissue repair and remodelling in response to injury, e.g. after myocardial infarction, and in progression of diseases such as atheroma, arthritis, cancer and chronic tissue ulcers.  They are multi-domain proteins and their activities are regulated by tissue inhibitors of metalloproteinases (TIMPs).  This review introduces the members of the MMP family and discusses their domain structure and function, proenyme activation, the mechanism of inhibition by TIMPs and their significance in physiol. and pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo77sy3-HPv0rVg90H21EOLACvtfcHk0lhPcyhc5pT4OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVKitg%253D%253D&md5=2c9b99a424f3a604cc4dc899ddc41cd7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cardiores.2005.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cardiores.2005.12.002%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DH.%26aulast%3DVisse%26aufirst%3DR.%26aulast%3DMurphy%26aufirst%3DG.%26atitle%3DStructure%2520and%2520Function%2520of%2520Matrix%2520Metalloproteinases%2520and%2520TIMPs%26jtitle%3DCardiovasc.%2520Res.%26date%3D2006%26volume%3D69%26issue%3D3%26spage%3D562%26epage%3D573%26doi%3D10.1016%2Fj.cardiores.2005.12.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, D. M.</span></span> <span> </span><span class="NLM_article-title">Metzincin Proteases and Their Inhibitors: Foes or Friends in Nervous System Physiology?</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">15337</span>– <span class="NLM_lpage">15357</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3467-10.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.3467-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21084591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWitbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=15337-15357&issue=46&author=S.+Riveraauthor=M.+Khrestchatiskyauthor=L.+Kaczmarekauthor=G.+A.+Rosenbergauthor=D.+M.+Jaworski&title=Metzincin+Proteases+and+Their+Inhibitors%3A+Foes+or+Friends+in+Nervous+System+Physiology%3F&doi=10.1523%2FJNEUROSCI.3467-10.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?</span></div><div class="casAuthors">Rivera, Santiago; Khrestchatisky, Michel; Kaczmarek, Leszek; Rosenberg, Gary A.; Jaworski, Diane M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">15337-15357</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  Members of the metzincin family of metalloproteinases have long been considered merely degradative enzymes for extracellular matrix mols.  Recently, however, there was growing appreciation for these proteinases and their endogenous inhibitors, tissue inhibitors of metalloproteinases (TIMPs), as fine modulators of nervous system physiol. and pathol.  Present all along the phylogenetic tree, in all neural cell types, from the nucleus to the synapse and in the extracellular space, metalloproteinases exhibit a complex spatiotemporal profile of expression in the nervous parenchyma and at the neurovascular interface.  The irreversibility of their proteolytic activity on numerous biofactors (e.g., growth factors, cytokines, receptors, DNA repair enzymes, matrix proteins) is ideally suited to sustain structural changes that are involved in physiol. or postlesion remodeling of neural networks, learning consolidation or impairment, neurodegenerative and neuroinflammatory processes, or progression of malignant gliomas.  The present review provides a state of the art overview of the involvement of the metzincin/TIMP system in these processes and the prospects of new therapeutic strategies based on the control of metalloproteinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfLsAcOVia_LVg90H21EOLACvtfcHk0lhPcyhc5pT4OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWitbzN&md5=4100fcb2749bca6f8e1ebdd5ac0dfc66</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3467-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3467-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DKaczmarek%26aufirst%3DL.%26aulast%3DRosenberg%26aufirst%3DG.%2BA.%26aulast%3DJaworski%26aufirst%3DD.%2BM.%26atitle%3DMetzincin%2520Proteases%2520and%2520Their%2520Inhibitors%253A%2520Foes%2520or%2520Friends%2520in%2520Nervous%2520System%2520Physiology%253F%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26issue%3D46%26spage%3D15337%26epage%3D15357%26doi%3D10.1523%2FJNEUROSCI.3467-10.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, D. B. C.</span></span> <span> </span><span class="NLM_article-title">Recent Insights into Natural Product Inhibitors of Matrix Metalloproteinases</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2024</span>– <span class="NLM_lpage">2037</span>, <span class="refDoi"> DOI: 10.1039/C9MD00165D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1039%2FC9MD00165D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=32904148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFSqu7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2024-2037&issue=12&author=G.+B.+Kumarauthor=B.+G.+Nairauthor=J.+J.+P.+Perryauthor=D.+B.+C.+Martin&title=Recent+Insights+into+Natural+Product+Inhibitors+of+Matrix+Metalloproteinases&doi=10.1039%2FC9MD00165D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent insights into natural product inhibitors of matrix metalloproteinases</span></div><div class="casAuthors">Kumar, Geetha B.; Nair, Bipin G.; Perry, J. Jefferson P.; Martin, David B. C.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2024-2037</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Members of the matrix metalloproteinase (MMP) family have biol. functions that are central to human health and disease, and MMP inhibitors have been investigated for the treatment of cardiovascular disease, cancer and neurodegenerative disorders.  The outcomes of initial clin. trials with the first generation of MMP inhibitors proved disappointing.  However, our growing understanding of the complexities of the MMP function in disease, and an increased understanding of MMP protein architecture and control of activity now provide new opportunities and avenues to develop MMP-focused therapies.  Natural products that affect MMP activities have been of strong interest as templates for drug discovery, and for their use as chem. tools to help delineate the roles of MMPs that still remain to be defined.  Herein, we highlight the most recent discoveries of structurally diverse natural product inhibitors to these proteases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5GeivYWCCS7Vg90H21EOLACvtfcHk0lgXUnE9TvqoLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFSqu7%252FF&md5=66bb0d887885b178dc5246e1adeec2dd</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1039%2FC9MD00165D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9MD00165D%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DG.%2BB.%26aulast%3DNair%26aufirst%3DB.%2BG.%26aulast%3DPerry%26aufirst%3DJ.%2BJ.%2BP.%26aulast%3DMartin%26aufirst%3DD.%2BB.%2BC.%26atitle%3DRecent%2520Insights%2520into%2520Natural%2520Product%2520Inhibitors%2520of%2520Matrix%2520Metalloproteinases%26jtitle%3DMedChemComm%26date%3D2019%26volume%3D10%26issue%3D12%26spage%3D2024%26epage%3D2037%26doi%3D10.1039%2FC9MD00165D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sternlicht, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werb, Z.</span></span> <span> </span><span class="NLM_article-title">How Matrix Metalloproteinases Regulate Cell Behavior</span>. <i>Annu. Rev. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1146/annurev.cellbio.17.1.463</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1146%2Fannurev.cellbio.17.1.463" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11687497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1Omsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2001&pages=463-516&issue=1&author=M.+D.+Sternlichtauthor=Z.+Werb&title=How+Matrix+Metalloproteinases+Regulate+Cell+Behavior&doi=10.1146%2Fannurev.cellbio.17.1.463"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">How matrix metalloproteinases regulate cell behavior</span></div><div class="casAuthors">Sternlicht, Mark D.; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Cell and Developmental Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">463-516</span>CODEN:
                <span class="NLM_cas:coden">ARDBF8</span>;
        ISSN:<span class="NLM_cas:issn">1081-0706</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) constitute a multigene family of over 25 secreted and cell surface enzymes that process or degrade numerous pericellular substrates.  Their targets include other proteinases, proteinase inhibitors, clotting factors, chemotactic mols., latent growth factors, growth factor-binding proteins, cell surface receptors, cell-cell adhesion mols., and virtually all structural extracellular matrix proteins.  Thus MMPs are able to regulate many biol. processes and are closely regulated themselves.  We review recent advances that help to explain how MMPs work, how they are controlled, and how they influence biol. behavior.  These advances shed light on how the structure and function of the MMPs are related and on how their transcription, secretion, activation, inhibition, localization, and clearance are controlled.  MMPs participate in numerous normal and abnormal processes, and there are new insights into the key substrates and mechanisms responsible for regulating some of these processes in vivo.  Our knowledge in the field of MMP biol. is rapidly expanding, yet we still do not fully understand how these enzymes regulate most processes of development, homeostasis, and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzwWw3I6HsLLVg90H21EOLACvtfcHk0lgXUnE9TvqoLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1Omsbs%253D&md5=5af2db8479b20df72e8a9d083c92ae2b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1146%2Fannurev.cellbio.17.1.463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.cellbio.17.1.463%26sid%3Dliteratum%253Aachs%26aulast%3DSternlicht%26aufirst%3DM.%2BD.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DHow%2520Matrix%2520Metalloproteinases%2520Regulate%2520Cell%2520Behavior%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2001%26volume%3D17%26issue%3D1%26spage%3D463%26epage%3D516%26doi%3D10.1146%2Fannurev.cellbio.17.1.463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Page-McCaw, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewald, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werb, Z.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases and the Regulation of Tissue Remodelling</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/nrm2125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrm2125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17318226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitVGrs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=221-233&issue=3&author=A.+Page-McCawauthor=A.+J.+Ewaldauthor=Z.+Werb&title=Matrix+Metalloproteinases+and+the+Regulation+of+Tissue+Remodelling&doi=10.1038%2Fnrm2125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and the regulation of tissue remodelling</span></div><div class="casAuthors">Page-McCaw, Andrea; Ewald, Andrew J.; Werb, Zena</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-233</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) were discovered because of their role in amphibian metamorphosis, yet they have attracted more attention because of their roles in disease.  Despite intensive scrutiny in vitro, in cell culture and in animal models, the normal physiol. roles of these extracellular proteases have been elusive.  Recent studies in mice and flies point to essential roles of MMPs as mediators of change and phys. adaptation in tissues, whether developmentally regulated, environmentally induced or disease assocd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruFGsYuEMGL7Vg90H21EOLACvtfcHk0lgXUnE9TvqoLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitVGrs74%253D&md5=8c3655e653939cd016e2949c6b017e93</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrm2125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2125%26sid%3Dliteratum%253Aachs%26aulast%3DPage-McCaw%26aufirst%3DA.%26aulast%3DEwald%26aufirst%3DA.%2BJ.%26aulast%3DWerb%26aufirst%3DZ.%26atitle%3DMatrix%2520Metalloproteinases%2520and%2520the%2520Regulation%2520of%2520Tissue%2520Remodelling%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2007%26volume%3D8%26issue%3D3%26spage%3D221%26epage%3D233%26doi%3D10.1038%2Fnrm2125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaffney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomonov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehorai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Multilevel Regulation of Matrix Metalloproteinases in Tissue Homeostasis Indicates Their Molecular Specificity in Vivo</span>. <i>Matrix Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44–46</i></span> (<span class="NLM_issue">Ldl</span>),  <span class="NLM_fpage">191</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/j.matbio.2015.01.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.matbio.2015.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25622911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXisFChsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44%E2%80%9346&publication_year=2015&pages=191-199&issue=Ldl&author=J.+Gaffneyauthor=I.+Solomonovauthor=E.+Zehoraiauthor=I.+Sagi&title=Multilevel+Regulation+of+Matrix+Metalloproteinases+in+Tissue+Homeostasis+Indicates+Their+Molecular+Specificity+in+Vivo&doi=10.1016%2Fj.matbio.2015.01.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Multilevel regulation of matrix metalloproteinases in tissue homeostasis indicates their molecular specificity in vivo</span></div><div class="casAuthors">Gaffney, Jean; Solomonov, Inna; Zehorai, Eldar; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Matrix Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44-46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">191-199</span>CODEN:
                <span class="NLM_cas:coden">MTBOEC</span>;
        ISSN:<span class="NLM_cas:issn">0945-053X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) play a crucial role in irreversible remodeling of the extracellular matrix (ECM) in normal homeostasis and pathol. states.  Accumulating data from various studies strongly suggest that MMPs are tightly regulated, starting from the level of gene expression all the way to zymogen activation and endogenous inhibition, with each level controlled by multiple factors.  Recent in vivo findings indicate that cell-ECM and cell-cell interactions, as well as ECM bio-active products, contribute an addnl. layer of regulation at all levels, indicating that individual MMP expression and activity in vivo are highly coordinated and tissue specific processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoczmX5xOgBnbVg90H21EOLACvtfcHk0lizMz3hz446OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXisFChsL0%253D&md5=b2e2f0a1a371681655144defe7d2375b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.matbio.2015.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.matbio.2015.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DGaffney%26aufirst%3DJ.%26aulast%3DSolomonov%26aufirst%3DI.%26aulast%3DZehorai%26aufirst%3DE.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DMultilevel%2520Regulation%2520of%2520Matrix%2520Metalloproteinases%2520in%2520Tissue%2520Homeostasis%2520Indicates%2520Their%2520Molecular%2520Specificity%2520in%2520Vivo%26jtitle%3DMatrix%2520Biol.%26date%3D2015%26volume%3D44%25E2%2580%259346%26issue%3DLdl%26spage%3D191%26epage%3D199%26doi%3D10.1016%2Fj.matbio.2015.01.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span>; <span class="NLM_string-name">Rivera, S.</span>; <span class="NLM_string-name">Liechti, F. D.</span>; <span class="NLM_string-name">Grandgirard, D.</span>; <span class="NLM_string-name">Bigas, J.</span>; <span class="NLM_string-name">Seco, J.</span>; <span class="NLM_string-name">Tarrago, T.</span>; <span class="NLM_string-name">Leib, S. L.</span>; <span class="NLM_string-name">Khrestchatisky, M.</span></span> <span> </span><span class="NLM_article-title">Endogenous and Synthetic MMP Inhibitors in CNS Physiopathology</span>; In <span class="NLM_publisher-loc">Progress in Brain Research</span>, <span class="NLM_year">2014</span>; Chapter 214, pp  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">351</span><span class="refDoi"> DOI: 10.1016/B978-0-444-63486-3.00014-1</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FB978-0-444-63486-3.00014-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Baranger%2C+K.%3B+Rivera%2C+S.%3B+Liechti%2C+F.+D.%3B+Grandgirard%2C+D.%3B+Bigas%2C+J.%3B+Seco%2C+J.%3B+Tarrago%2C+T.%3B+Leib%2C+S.+L.%3B+Khrestchatisky%2C+M.+Endogenous+and+Synthetic+MMP+Inhibitors+in+CNS+Physiopathology%3B+In+Progress+in+Brain+Research%2C+2014%3B+Chapter+214%2C+pp+313%E2%80%93351+10.1016%2FB978-0-444-63486-3.00014-1."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FB978-0-444-63486-3.00014-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-444-63486-3.00014-1%26sid%3Dliteratum%253Aachs%26aulast%3DBaranger%26aufirst%3DK.%26atitle%3DEndogenous%2520and%2520Synthetic%2520MMP%2520Inhibitors%2520in%2520CNS%2520Physiopathology%26date%3D2014%26spage%3D313%26epage%3D351%26doi%3D10.1016%2FB978-0-444-63486-3.00014-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brew, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinakarpandian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagase, H.</span></span> <span> </span><span class="NLM_article-title">Tissue Inhibitors of Metalloproteinases: Evolution, Structure and Function</span>. <i>Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>1477</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">283</span>, <span class="refDoi"> DOI: 10.1016/S0167-4838(99)00279-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0167-4838%2899%2900279-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10708863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsFGktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1477&publication_year=2000&pages=267-283&issue=1%E2%80%932&author=K.+Brewauthor=D.+Dinakarpandianauthor=H.+Nagase&title=Tissue+Inhibitors+of+Metalloproteinases%3A+Evolution%2C+Structure+and+Function&doi=10.1016%2FS0167-4838%2899%2900279-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue inhibitors of metalloproteinases: evolution, structure and function</span></div><div class="casAuthors">Brew, K.; Dinakarpandian, D.; Nagase, H.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1477</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">267-283</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review with 74 refs.  Matrix metalloproteinases (MMPs) play a key role in the normal physiol. of connective tissue during development, morphogenesis, and wound healing, but their unregulated activity has been implicated in numerous disease processes including arthritis, tumor cell metastasis, and atherosclerosis.  An important mechanism for the regulation of the activity of MMPs is via binding to a family of homologous proteins referred to as TIMPs (TIMP-1 to TIMP-4).  The 2-domain TIMPs are of relatively small size, yet have been found to exhibit several biochem. and physiol./biol. functions, including inhibition of active MMPs, proMMP activation, cell growth promotion, matrix binding, inhibition of angiogenesis, and the induction of apoptosis.  Mutations in TIMP-3 are the cause of Sorsby's fundus dystrophy in humans, a disease that results in early onset macular degeneration.  This review highlights the evolution of TIMPs, the recently elucidated high-resoln. structures of TIMPs and their complexes with metalloproteinases, and the results of mutational and other studies of structure-function relations that have enhanced the understanding of the mechanism and specificity of the inhibition of MMPs by TIMPs.  Several intriguing questions, such as the basis of the multiple biol. functions of TIMPs, the kinetics of TIMP-MMP interactions, and the differences in binding in some TIMP-metalloproteinase pairs are discussed which, although not fully resolved, serve to illustrate the kind of issues that are important for a full understanding of the interactions between families of mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKocbVzzBH47Vg90H21EOLACvtfcHk0lizMz3hz446OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsFGktbs%253D&md5=f797232a6ea04d3d5e5f9e983477da8b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2899%2900279-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252899%252900279-4%26sid%3Dliteratum%253Aachs%26aulast%3DBrew%26aufirst%3DK.%26aulast%3DDinakarpandian%26aufirst%3DD.%26aulast%3DNagase%26aufirst%3DH.%26atitle%3DTissue%2520Inhibitors%2520of%2520Metalloproteinases%253A%2520Evolution%252C%2520Structure%2520and%2520Function%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%2520Mol.%2520Enzymol.%26date%3D2000%26volume%3D1477%26issue%3D1%25E2%2580%25932%26spage%3D267%26epage%3D283%26doi%3D10.1016%2FS0167-4838%2899%2900279-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stamenkovic, I.</span></span> <span> </span><span class="NLM_article-title">Extracellular Matrix Remodelling: The Role of Matrix Metalloproteinases</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>200</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">448</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1002/path.1400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fpath.1400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12845612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvF2ns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2003&pages=448-464&issue=4&author=I.+Stamenkovic&title=Extracellular+Matrix+Remodelling%3A+The+Role+of+Matrix+Metalloproteinases&doi=10.1002%2Fpath.1400"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular matrix remodelling: the role of matrix metalloproteinases</span></div><div class="casAuthors">Stamenkovic, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">448-464</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a growing family of metalloendopeptidases that cleave the protein components of the extracellular matrix and thereby play a central role in tissue remodelling.  For many years following their discovery, MMPs were believed to function primarily as regulators of ECM compn. and to facilitate cell migration simply by removing barriers such as collagen.  It is becoming increasingly clear, however, that MMPs are implicated in the functional regulation of a host of non-ECM mols. that include growth factors and their receptors, cytokines and chemokines, adhesion receptors and cell surface proteoglycans, and a variety of enzymes.  MMPs therefore play an important role in the control of cellular interactions with and response to their environment in conditions that promote tissue turnover, be they physiol., such as normal development, or pathol., such as inflammation and cancer.  This review summarizes some of the recent discoveries that have shed new light on the role of MMPs in physiol. and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAyYsJuRleu7Vg90H21EOLACvtfcHk0lhru8U5hmpp-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvF2ns7g%253D&md5=b0c96583501213ed146c9396563361cd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fpath.1400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.1400%26sid%3Dliteratum%253Aachs%26aulast%3DStamenkovic%26aufirst%3DI.%26atitle%3DExtracellular%2520Matrix%2520Remodelling%253A%2520The%2520Role%2520of%2520Matrix%2520Metalloproteinases%26jtitle%3DJ.%2520Pathol.%26date%3D2003%26volume%3D200%26issue%3D4%26spage%3D448%26epage%3D464%26doi%3D10.1002%2Fpath.1400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parks, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Boado, Y. S.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases as Modulators of Inflammation and Innate Immunity</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1038/nri1418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnri1418" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15286728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=617-629&issue=8&author=W.+C.+Parksauthor=C.+L.+Wilsonauthor=Y.+S.+L%C3%B3pez-Boado&title=Matrix+Metalloproteinases+as+Modulators+of+Inflammation+and+Innate+Immunity&doi=10.1038%2Fnri1418"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases as modulators of inflammation and innate immunity</span></div><div class="casAuthors">Parks, William C.; Wilson, Carole L.; Lopez-Boado, Yolanda S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">617-629</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  As their name implies, matrix metalloproteinases are thought to be responsible for the turnover and degrdn. of the extracellular matrix.  However, matrix degrdn. is neither the sole nor the main function of these proteinases.  Indeed, as the authors discuss here, recent findings indicate that matrix metalloproteinases act on pro-inflammatory cytokines, chemokines and other proteins to regulate varied aspects of inflammation and immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBtb_YA4ZbNbVg90H21EOLACvtfcHk0lhru8U5hmpp-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWktrc%253D&md5=2f0172ac025916666fda425f6869c360</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnri1418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1418%26sid%3Dliteratum%253Aachs%26aulast%3DParks%26aufirst%3DW.%2BC.%26aulast%3DWilson%26aufirst%3DC.%2BL.%26aulast%3DL%25C3%25B3pez-Boado%26aufirst%3DY.%2BS.%26atitle%3DMatrix%2520Metalloproteinases%2520as%2520Modulators%2520of%2520Inflammation%2520and%2520Innate%2520Immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2004%26volume%3D4%26issue%3D8%26spage%3D617%26epage%3D629%26doi%3D10.1038%2Fnri1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Levin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomonov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Next Generation Matrix Metalloproteinase Inhibitors — Novel Strategies Bring New Prospects</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1864</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1927</span>– <span class="NLM_lpage">1939</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2017.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbamcr.2017.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28636874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCrtbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1864&publication_year=2017&pages=1927-1939&issue=11&author=M.+Levinauthor=Y.+Udiauthor=I.+Solomonovauthor=I.+Sagi&title=Next+Generation+Matrix+Metalloproteinase+Inhibitors+%E2%80%94+Novel+Strategies+Bring+New+Prospects&doi=10.1016%2Fj.bbamcr.2017.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects</span></div><div class="casAuthors">Levin, Maxim; Udi, Yael; Solomonov, Inna; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1864</span>
        (<span class="NLM_cas:issue">11_Part_A</span>),
    <span class="NLM_cas:pages">1927-1939</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enzymic proteolysis of cell surface proteins and extracellular matrix (ECM) is crit. for tissue homeostasis and cell signaling.  These proteolytic activities are mediated predominantly by a family of proteases termed matrix metalloproteinases (MMPs).  The growing evidence in recent years that ECM and non-ECM bioactive mols. (e.g., growth factors, cytokines, chemokines, on top of matrikines and matricryptins) have versatile functions redefines our view on the roles matrix remodeling enzymes play in many physiol. and pathol. processes, and underscores the notion that ECM proteolytic reaction mechanisms represent master switches in the regulation of crit. biol. processes and govern cell behavior.  Accordingly, MMPs are not only responsible for direct degrdn. of ECM mols. but are also key modulators of cardinal bioactive factors.  Many attempts were made to manipulate ECM degrdn. by targeting MMPs using small peptidic and org. inhibitors.  However, due to the high structural homol. shared by these enzymes, the majority of the developed compds. are broad-spectrum inhibitors affecting the proteolytic activity of various MMPs and other zinc-related proteases.  These inhibitors, in many cases, failed as therapeutic agents, mainly due to the bilateral role of MMPs in pathol. conditions such as cancer, in which MMPs have both pro- and anti-tumorigenic effects.  Despite the important role of MMPs in many human diseases, none of the broad-range synthetic MMP inhibitors that were designed have successfully passed clin. trials.  It appears that, designing highly selective MMP inhibitors that are also effective in vivo, is not trivial.  The challenges related to designing selective and effective metalloprotease inhibitors, are assocd. in part with the aforesaid high structural homol. and the dynamic nature of their protein scaffolds.  Great progress was achieved in the last decade in understanding the biochem. and biol. of MMPs activity.  This knowledge, combined with lessons from the past has drawn new "boundaries" for the development of the next-generation MMP inhibitors.  These novel agents are currently designed to be highly specific, capable to discriminate between the homologous MMPs and ideally administered as a short-term topical treatment.  In this review we discuss the latest progress in the fields of MMP inhibitors in terms of structure, function and their specific activity.  The development of novel highly specific inhibitors targeting MMPs paves the path to study complex biol. processes assocd. with ECM proteolysis in health and disease.  This article is part of a Special Issue entitled: Matrix Metalloproteinases edited by Rafael Fridman.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoxMizX3oHyrVg90H21EOLACvtfcHk0lh-u0PBwADIXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCrtbjL&md5=245b0e34dd6cedaf2b301400dded146f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2017.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2017.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DM.%26aulast%3DUdi%26aufirst%3DY.%26aulast%3DSolomonov%26aufirst%3DI.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DNext%2520Generation%2520Matrix%2520Metalloproteinase%2520Inhibitors%2520%25E2%2580%2594%2520Novel%2520Strategies%2520Bring%2520New%2520Prospects%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2017%26volume%3D1864%26issue%3D11%26spage%3D1927%26epage%3D1939%26doi%3D10.1016%2Fj.bbamcr.2017.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleifeld, O.</span></span> <span> </span><span class="NLM_article-title">Validating Matrix Metalloproteinases as Drug Targets and Anti-Targets for Cancer Therapy</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.1038/nrc1821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrc1821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16498445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=227-239&issue=3&author=C.+M.+Overallauthor=O.+Kleifeld&title=Validating+Matrix+Metalloproteinases+as+Drug+Targets+and+Anti-Targets+for+Cancer+Therapy&doi=10.1038%2Fnrc1821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour microenvironment - Opinion: Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy</span></div><div class="casAuthors">Overall, Christopher M.; Kleifeld, Oded</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-239</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) mediate homeostasis of the extracellular environment.  They have multiple signaling activities that are commonly altered during tumorigenesis and that might serve as intervention points for anticancer drugs.  However, there are many criteria to consider in validating MMPs as drug targets and for the development of MMP inhibitors.  The inhibition of some MMPs could have pro-tumorigenic effects (making them anti-targets), counterbalancing the benefits of target inhibition.  These effects might partially account for the failure of MMP inhibitors in clin. trials.  What are the major challenges in MMP target validation and MMP-inhibitor-drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc3iBQEggRc7Vg90H21EOLACvtfcHk0lh-u0PBwADIXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslelt70%253D&md5=3edfeca153a62c759443d0893a6212e2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnrc1821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1821%26sid%3Dliteratum%253Aachs%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DKleifeld%26aufirst%3DO.%26atitle%3DValidating%2520Matrix%2520Metalloproteinases%2520as%2520Drug%2520Targets%2520and%2520Anti-Targets%2520for%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26issue%3D3%26spage%3D227%26epage%3D239%26doi%3D10.1038%2Fnrc1821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fingleton, B.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases as Valid Clinical Targets</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">333</span>– <span class="NLM_lpage">346</span>, <span class="refDoi"> DOI: 10.2174/138161207779313551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F138161207779313551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17313364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlWhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=333-346&issue=3&author=B.+Fingleton&title=Matrix+Metalloproteinases+as+Valid+Clinical+Targets&doi=10.2174%2F138161207779313551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases as valid clinical targets</span></div><div class="casAuthors">Fingleton, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">333-346</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinase family of enzymes was a pharmaceutical target for over 20 years.  In that time, many drugs were developed but none have successfully passed clin. trials.  A significant problem was development of dose-limiting side-effects that were revealed during long-term clin. trials in diseases such as arthritis and various cancers.  There are, however, other clin. settings where evidence for MMP function contributing to the pathophysiol. of disease is strong.  A no. of these settings will be discussed here together with evidence from animal models that MMP inhibition is a valid strategy to be considered.  A major advantage with many of these settings is that drug exposure may not have to be long-term and/or systemic thus reducing the possibility that side-effects will stymie MMPI-based therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYKVax9TQ4HrVg90H21EOLACvtfcHk0lh-u0PBwADIXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlWhsLo%253D&md5=0023ab6fa8337c8bbac5e21029ff47e6</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F138161207779313551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161207779313551%26sid%3Dliteratum%253Aachs%26aulast%3DFingleton%26aufirst%3DB.%26atitle%3DMatrix%2520Metalloproteinases%2520as%2520Valid%2520Clinical%2520Targets%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2007%26volume%3D13%26issue%3D3%26spage%3D333%26epage%3D346%26doi%3D10.2174%2F138161207779313551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brkic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balusu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenbroucke, R. E.</span></span> <span> </span><span class="NLM_article-title">Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2015</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1155/2015/620581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1155%2F2015%2F620581" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2015&publication_year=2015&pages=1-27&author=M.+Brkicauthor=S.+Balusuauthor=C.+Libertauthor=R.+E.+Vandenbroucke&title=Friends+or+Foes%3A+Matrix+Metalloproteinases+and+Their+Multifaceted+Roles+in+Neurodegenerative+Diseases&doi=10.1155%2F2015%2F620581"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1155%2F2015%2F620581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2015%252F620581%26sid%3Dliteratum%253Aachs%26aulast%3DBrkic%26aufirst%3DM.%26aulast%3DBalusu%26aufirst%3DS.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DVandenbroucke%26aufirst%3DR.%2BE.%26atitle%3DFriends%2520or%2520Foes%253A%2520Matrix%2520Metalloproteinases%2520and%2520Their%2520Multifaceted%2520Roles%2520in%2520Neurodegenerative%2520Diseases%26jtitle%3DMediators%2520Inflammation%26date%3D2015%26volume%3D2015%26spage%3D1%26epage%3D27%26doi%3D10.1155%2F2015%2F620581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-González, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span> <span> </span><span class="NLM_article-title">Metalloproteinases and Their Tissue Inhibitors in Alzheimer’s Disease and Other Neurodegenerative Disorders</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3167</span>– <span class="NLM_lpage">3191</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03178-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03178-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31197405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFKqtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3167-3191&issue=16&author=S.+Riveraauthor=L.+Garc%C3%ADa-Gonz%C3%A1lezauthor=M.+Khrestchatiskyauthor=K.+Baranger&title=Metalloproteinases+and+Their+Tissue+Inhibitors+in+Alzheimer%E2%80%99s+Disease+and+Other+Neurodegenerative+Disorders&doi=10.1007%2Fs00018-019-03178-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders</span></div><div class="casAuthors">Rivera, Santiago; Garcia-Gonzalez, Laura; Khrestchatisky, Michel; Baranger, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3167-3191</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  As life expectancy increases worldwide, age-related neurodegenerative diseases will increase in parallel.  The lack of effective treatment strategies may soon lead to an unprecedented health, social and economic crisis.  Any attempt to halt the progression of these diseases requires a thorough knowledge of the pathophysiol. mechanisms involved to facilitate the identification of new targets and the application of innovative therapeutic strategies.  The metzincin superfamily of metalloproteinases includes matrix metalloproteinases (MMP), a disintegrin and metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS).  These multigenic and multifunctional proteinase families regulate the functions of an increasing no. of signalling and scaffolding mols. involved in neuroinflammation, blood-brain barrier disruption, protein misfolding, synaptic dysfunction or neuronal death.  Metalloproteinases and their physiol. inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), are therefore, at the crossroads of mol. and cellular mechanisms that support neurodegenerative processes, and emerge as potential new therapeutic targets.  We provide an overview of current knowledge on the role and regulation of metalloproteinases and TIMPs in four major neurodegenerative diseases: Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and Huntington's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkTuzJDrAsULVg90H21EOLACvtfcHk0lgPcoGivy-Opw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFKqtLvF&md5=673f1fa0c8e5a9d7ccf09e36f101d64b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03178-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03178-2%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DGarc%25C3%25ADa-Gonz%25C3%25A1lez%26aufirst%3DL.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DBaranger%26aufirst%3DK.%26atitle%3DMetalloproteinases%2520and%2520Their%2520Tissue%2520Inhibitors%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Other%2520Neurodegenerative%2520Disorders%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3167%26epage%3D3191%26doi%3D10.1007%2Fs00018-019-03178-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dzwonek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rylski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases and Their Endogenous Inhibitors in Neuronal Physiology of the Adult Brain</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>567</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">129</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2004.03.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.febslet.2004.03.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15165905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVGhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=567&publication_year=2004&pages=129-135&issue=1&author=J.+Dzwonekauthor=M.+Rylskiauthor=L.+Kaczmarek&title=Matrix+Metalloproteinases+and+Their+Endogenous+Inhibitors+in+Neuronal+Physiology+of+the+Adult+Brain&doi=10.1016%2Fj.febslet.2004.03.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain</span></div><div class="casAuthors">Dzwonek, Joanna; Rylski, Marcin; Kaczmarek, Leszek</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">567</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">129-135</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  More than 20 matrix metalloproteinases (MMPs) and four of their endogenous tissue inhibitors (TIMPs) act together to control tightly temporally restricted, focal proteolysis of extracellular matrix.  In the neurons of the adult brain several components of the TIMP/MMP system are expressed and are responsive to changes in neuronal activity.  Furthermore, functional studies, esp. involving blocking of MMP activities, along with the identification of MMP substrates in the brain strongly suggest that this enzymic system plays an important physiol. role in adult brain neurons, possibly being pivotal for neuronal plasticity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1-hrHbZhH-LVg90H21EOLACvtfcHk0lgPcoGivy-Opw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVGhtL8%253D&md5=4cad884f15616d01706fb4372c292929</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2004.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2004.03.070%26sid%3Dliteratum%253Aachs%26aulast%3DDzwonek%26aufirst%3DJ.%26aulast%3DRylski%26aufirst%3DM.%26aulast%3DKaczmarek%26aufirst%3DL.%26atitle%3DMatrix%2520Metalloproteinases%2520and%2520Their%2520Endogenous%2520Inhibitors%2520in%2520Neuronal%2520Physiology%2520of%2520the%2520Adult%2520Brain%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D567%26issue%3D1%26spage%3D129%26epage%3D135%26doi%3D10.1016%2Fj.febslet.2004.03.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lau, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V.</span></span> <span> </span><span class="NLM_article-title">MMPs in the Central Nervous System: Where the Good Guys Go Bad</span>. <i>Semin. Cell Dev. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">42</span>– <span class="NLM_lpage">51</span>, <span class="refDoi"> DOI: 10.1016/j.semcdb.2007.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.semcdb.2007.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17646116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=42-51&issue=1&author=S.+Agrawalauthor=L.+Lauauthor=V.+Yong&title=MMPs+in+the+Central+Nervous+System%3A+Where+the+Good+Guys+Go+Bad&doi=10.1016%2Fj.semcdb.2007.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">MMPs in the central nervous system: Where the good guys go bad</span></div><div class="casAuthors">Agrawal, Smriti M.; Lau, Lorraine; Yong, V. Wee</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Cell & Developmental Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-51</span>CODEN:
                <span class="NLM_cas:coden">SCDBFX</span>;
        ISSN:<span class="NLM_cas:issn">1084-9521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are expressed in the developing, healthy adult and diseased CNS.  We emphasize the regulation of neurogenesis and oligodendrogenesis by MMPs during CNS development, and highlight physiol. roles of MMPs in the healthy adult CNS, such as in synaptic plasticity, learning and memory.  Nonetheless, MMPs as "the good guys" go bad in neurol. conditions, likely aided by the sudden and massive upregulation of several MMP members.  We stress the necessity of drawing a fine balance in the treatment of neurol. diseases, and we suggest that MMP inhibitors do have therapeutic potential early after CNS injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIq75CDeMzKrVg90H21EOLACvtfcHk0lg3RCe9qCdt4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVeqtLbM&md5=420efe9ae3a47284b9b6c578f86a9dc8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2007.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2007.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DLau%26aufirst%3DL.%26aulast%3DYong%26aufirst%3DV.%26atitle%3DMMPs%2520in%2520the%2520Central%2520Nervous%2520System%253A%2520Where%2520the%2520Good%2520Guys%2520Go%2520Bad%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2008%26volume%3D19%26issue%3D1%26spage%3D42%26epage%3D51%26doi%3D10.1016%2Fj.semcdb.2007.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brzdak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiera, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mozrzymas, J. W.</span></span> <span> </span><span class="NLM_article-title">Multifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative Disorders</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.3389/fncel.2017.00178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3389%2Ffncel.2017.00178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28154525" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=1-22&author=P.+Brzdakauthor=D.+Nowakauthor=G.+Wieraauthor=J.+W.+Mozrzymas&title=Multifaceted+Roles+of+Metzincins+in+CNS+Physiology+and+Pathology%3A+From+Synaptic+Plasticity+and+Cognition+to+Neurodegenerative+Disorders&doi=10.3389%2Ffncel.2017.00178"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2017.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2017.00178%26sid%3Dliteratum%253Aachs%26aulast%3DBrzdak%26aufirst%3DP.%26aulast%3DNowak%26aufirst%3DD.%26aulast%3DWiera%26aufirst%3DG.%26aulast%3DMozrzymas%26aufirst%3DJ.%2BW.%26atitle%3DMultifaceted%2520Roles%2520of%2520Metzincins%2520in%2520CNS%2520Physiology%2520and%2520Pathology%253A%2520From%2520Synaptic%2520Plasticity%2520and%2520Cognition%2520to%2520Neurodegenerative%2520Disorders%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2017%26volume%3D11%26spage%3D1%26epage%3D22%26doi%3D10.3389%2Ffncel.2017.00178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beroun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaluk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pijet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefaniuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span> <span> </span><span class="NLM_article-title">MMPs in Learning and Memory and Neuropsychiatric Disorders</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3207</span>– <span class="NLM_lpage">3228</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03180-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03180-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31172215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3207-3228&issue=16&author=A.+Berounauthor=S.+Mitraauthor=P.+Michalukauthor=B.+Pijetauthor=M.+Stefaniukauthor=L.+Kaczmarek&title=MMPs+in+Learning+and+Memory+and+Neuropsychiatric+Disorders&doi=10.1007%2Fs00018-019-03180-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">MMPs in learning and memory and neuropsychiatric disorders</span></div><div class="casAuthors">Beroun, Anna; Mitra, Shiladitya; Michaluk, Piotr; Pijet, Barbara; Stefaniuk, Marzena; Kaczmarek, Leszek</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3207-3228</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are a group of over twenty proteases, operating chiefly extracellularly to cleave components of the extracellular matrix, cell adhesion mols. as well as cytokines and growth factors.  By virtue of their expression and activity patterns in animal models and clin. investigations, as well as functional studies with gene knockouts and enzyme inhibitors, MMPs have been demonstrated to play a paramount role in many physiol. and pathol. processes in the brain.  In particular, they have been shown to influence learning and memory processes, as well as major neuropsychiatric disorders such as schizophrenia, various kinds of addiction, epilepsy, fragile X syndrome, and depression.  A possible link connecting all those conditions is either physiol. or aberrant synaptic plasticity where some MMPs, e.g., MMP-9, have been demonstrated to contribute to the structural and functional reorganization of excitatory synapses that are located on dendritic spines.  Another common theme linking the aforementioned pathol. conditions is neuroinflammation and MMPs have also been shown to be important mediators of immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvmSrkxQ1bZbVg90H21EOLACvtfcHk0lg3RCe9qCdt4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtb3N&md5=b9f915c9a3c7d3455a22107e055e721e</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03180-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03180-8%26sid%3Dliteratum%253Aachs%26aulast%3DBeroun%26aufirst%3DA.%26aulast%3DMitra%26aufirst%3DS.%26aulast%3DMichaluk%26aufirst%3DP.%26aulast%3DPijet%26aufirst%3DB.%26aulast%3DStefaniuk%26aufirst%3DM.%26aulast%3DKaczmarek%26aufirst%3DL.%26atitle%3DMMPs%2520in%2520Learning%2520and%2520Memory%2520and%2520Neuropsychiatric%2520Disorders%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3207%26epage%3D3228%26doi%3D10.1007%2Fs00018-019-03180-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kacervosky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salesse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowing, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rambaldi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaubien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmbeck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloutier, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, A. E.</span></span> <span> </span><span class="NLM_article-title">MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">518</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0962-17.2017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.0962-17.2017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29196321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsF2rtL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=518-529&issue=3&author=R.+L.+Sanzauthor=G.+B.+Ferraroauthor=J.+Kacervoskyauthor=C.+Salesseauthor=E.+Gowingauthor=L.+Huaauthor=I.+Rambaldiauthor=F.+Beaubienauthor=K.+Holmbeckauthor=J.+F.+Cloutierauthor=M.+Levesqueauthor=K.+Muraiauthor=A.+E.+Fournier&title=MT3-MMP+Promotes+Excitatory+Synapse+Formation+by+Promoting+Nogo-66+Receptor+Ectodomain+Shedding&doi=10.1523%2FJNEUROSCI.0962-17.2017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">MT3-MMP promotes excitatory synapse formation by promoting Nogo-66 receptor ectodomain shedding</span></div><div class="casAuthors">Sanz, Ricardo L.; Ferraro, Gino B.; Kacervosky, Johannes; Salesse, Charleen; Gowing, Elizabeth; Hua, Luyang; Rambaldi, Isabel; Beaubien, Francois; Holmbeck, Kenn; Cloutier, J. F.; Levesque, Martin; Murai, Keith; Fournier, Alyson E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">518-529</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">1529-2401</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Cell-surface mols. are dynamically regulated at the synapse to assemble and disassemble adhesive contacts that are important for synaptogenesis and for tuning synaptic transmission.  Metalloproteinases dynamically regulate cellular behaviors through the processing of cell surface mols.  In the present study, we evaluated the role of membrane-type metalloproteinases (MT-MMPs) in excitatory synaptogenesis.  We find that MT3-MMP and MT5-MMP are broadly expressed in the mouse cerebral cortex and that MT3-MMP loss-of-function interferes with excitatory synapse development in dissocd. cortical neurons and in vivo.  We identify Nogo-66 receptor (NgR1) as an MT3-MMP substrate that is required for MT3-MMP-dependent synapse formation.  Introduction of the shed ectodomain of NgR1 is sufficient to accelerate excitatory synapse formation in dissocd. cortical neurons and in vivo.  Together, our findings support a role for MT3-MMP-dependent shedding of NgR1 in regulating excitatory synapse development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQE96Le1Qn4rVg90H21EOLACvtfcHk0lht5LaAPFXuTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2rtL7L&md5=8a29dd05ed2c3fe61b80e7261da83fad</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0962-17.2017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0962-17.2017%26sid%3Dliteratum%253Aachs%26aulast%3DSanz%26aufirst%3DR.%2BL.%26aulast%3DFerraro%26aufirst%3DG.%2BB.%26aulast%3DKacervosky%26aufirst%3DJ.%26aulast%3DSalesse%26aufirst%3DC.%26aulast%3DGowing%26aufirst%3DE.%26aulast%3DHua%26aufirst%3DL.%26aulast%3DRambaldi%26aufirst%3DI.%26aulast%3DBeaubien%26aufirst%3DF.%26aulast%3DHolmbeck%26aufirst%3DK.%26aulast%3DCloutier%26aufirst%3DJ.%2BF.%26aulast%3DLevesque%26aufirst%3DM.%26aulast%3DMurai%26aufirst%3DK.%26aulast%3DFournier%26aufirst%3DA.%2BE.%26atitle%3DMT3-MMP%2520Promotes%2520Excitatory%2520Synapse%2520Formation%2520by%2520Promoting%2520Nogo-66%2520Receptor%2520Ectodomain%2520Shedding%26jtitle%3DJ.%2520Neurosci.%26date%3D2018%26volume%3D38%26issue%3D3%26spage%3D518%26epage%3D529%26doi%3D10.1523%2FJNEUROSCI.0962-17.2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Powell, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, L. L.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1615</span>– <span class="NLM_lpage">1631</span>, <span class="refDoi"> DOI: 10.1089/neu.2018.5994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1089%2Fneu.2018.5994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30444175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BB3crhsFyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2019&pages=1615-1631&issue=10&author=M.+A.+Powellauthor=R.+T.+Blackauthor=T.+L.+Smithauthor=T.+M.+Reevesauthor=L.+L.+Phillips&title=Matrix+Metalloproteinase+9+and+Osteopontin+Interact+to+Support+Synaptogenesis+in+the+Olfactory+Bulb+after+Mild+Traumatic+Brain+Injury&doi=10.1089%2Fneu.2018.5994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury</span></div><div class="casAuthors">Powell Melissa A; Black Raiford T; Smith Terry L; Reeves Thomas M; Phillips Linda L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1615-1631</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Olfactory receptor axons reinnervate the olfactory bulb (OB) after chemical or transection lesion.  Diffuse brain injury damages the same axons, but the time course and regulators of OB reinnervation are unknown.  Gelatinases (matrix metalloproteinase [MMP]2, MMP9) and their substrate osteopontin (OPN) are candidate mediators of synaptogenesis after central nervous system (CNS) insult, including olfactory axon damage.  Here, we examined the time course of MMP9, OPN, and OPN receptor CD44 response to diffuse OB injury.  FVBV/NJ mice received mild midline fluid percussion insult (mFPI), after which MMP9 activity and both OPN and CD44 protein expression were measured.  Diffuse mFPI induced time-dependent increase in OB MMP9 activity and elevated the cell signaling 48-kD OPN fragment.  This response was bimodal at 1 and 7 days post-injury.  MMP9 activity was also correlated with 7-day reduction in a second 32-kD OPN peptide.  CD44 increase peaked at 3 days, delayed relative to MMP9/OPN response.  MMP9 and OPN immunohistochemistry suggested that deafferented tufted and mitral neurons were the principal sites for these molecular interactions.  Analysis of injured MMP9 knockout (KO) mice showed that 48-kD OPN production was dependent on OB MMP9 activity, but with no KO effect on CD44 induction.  Olfactory marker protein (OMP), used to identify injured olfactory axons, revealed persistent axon damage in the absence of MMP9.  MMP9 KO ultrastructure at 21 days post-injury indicated that persistent OMP reduction was paired with delayed removal of degenerated axons.  These results provide evidence that diffuse, concussive brain trauma induces a post-injury interaction between MMP9, OPN, and CD44, which mediates synaptic plasticity and reinnervation within the OB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzRtA6ZuEPHcyail4HZd-ifW6udTcc2eYuVRiDtoCPKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3crhsFyhtQ%253D%253D&md5=f8a38773f5f794704c9ef4faad061e00</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1089%2Fneu.2018.5994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2018.5994%26sid%3Dliteratum%253Aachs%26aulast%3DPowell%26aufirst%3DM.%2BA.%26aulast%3DBlack%26aufirst%3DR.%2BT.%26aulast%3DSmith%26aufirst%3DT.%2BL.%26aulast%3DReeves%26aufirst%3DT.%2BM.%26aulast%3DPhillips%26aufirst%3DL.%2BL.%26atitle%3DMatrix%2520Metalloproteinase%25209%2520and%2520Osteopontin%2520Interact%2520to%2520Support%2520Synaptogenesis%2520in%2520the%2520Olfactory%2520Bulb%2520after%2520Mild%2520Traumatic%2520Brain%2520Injury%26jtitle%3DJ.%2520Neurotrauma%26date%3D2019%26volume%3D36%26issue%3D10%26spage%3D1615%26epage%3D1631%26doi%3D10.1089%2Fneu.2018.5994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollet, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Diguardher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanessian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-2 (MMP-2) Regulates Astrocyte Motility in Connection with the Actin Cytoskeleton and Integrins</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">272</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1002/glia.20349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fglia.20349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16845676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD28rhtFSrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=272-284&issue=4&author=C.+Ogierauthor=A.+Bernardauthor=A.-M.+Cholletauthor=T.+Le+Diguardherauthor=S.+Hanessianauthor=G.+Chartonauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=Matrix+Metalloproteinase-2+%28MMP-2%29+Regulates+Astrocyte+Motility+in+Connection+with+the+Actin+Cytoskeleton+and+Integrins&doi=10.1002%2Fglia.20349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins</span></div><div class="casAuthors">Ogier Crystel; Bernard Anne; Chollet Anne-Marie; LE Diguardher Thierry; Hanessian Stephen; Charton Gerard; Khrestchatisky Michel; Rivera Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">272-84</span>
        ISSN:<span class="NLM_cas:issn">0894-1491</span>.
    </div><div class="casAbstract">Matrix Metalloproteinases (MMPs) play a role in migration of many cell types outside the central nervous system (CNS).  Among neural cells, astrocytes are one of the main sources of MMPs in physiological and postlesional conditions.  However, no data are available on the possible role of MMPs in astrocyte motility.  Using an in vitro model of 2D migration and broad spectrum and selective MMP inhibitors, the authors demonstrated that MMP-2, but not MMP-9, is a key enzyme for astrocyte migration.  In support of these data, the authors found constitutive expression of MMP-2 in astrocytes, while MMP-9 was nearly undetectable by gel zymography and immunocytochemical methods.  The inhibition of migration by MMP inhibitors correlated with changes in cell morphology and in the organization of the actin cytoskeleton.  In parallel, the characteristic focalized distribution of MMP-2 at the migration front observed in control cells became more diffuse and internalized by treatments that inhibited migration.  The disruption of actin by cytochalasin D caused the partial recruitment of MMP-2 and gelatinolytic activity into actin aggregates, indicating a connection between the proteinase and the actin cytoskeleton.  Finally, the authors found a co-localization of beta1-integrin with MMP-2 at the leading edge of migrating astrocytes.  Altogether, these data provide the first evidence for the implication of MMP-2 in astrocyte motility, probably through the interaction of the proteinase with beta1-integrin that could act as a linker between pericellular proteolysis and the actin cytoskeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT2YOB1XGyB6Rgd2Wuil24tfW6udTcc2ea-PqZw72HB7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rhtFSrsw%253D%253D&md5=30bdc476c4dd2c4f2998e3abe91a7059</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fglia.20349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20349%26sid%3Dliteratum%253Aachs%26aulast%3DOgier%26aufirst%3DC.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DChollet%26aufirst%3DA.-M.%26aulast%3DLe%2BDiguardher%26aufirst%3DT.%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DCharton%26aufirst%3DG.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DMatrix%2520Metalloproteinase-2%2520%2528MMP-2%2529%2520Regulates%2520Astrocyte%2520Motility%2520in%2520Connection%2520with%2520the%2520Actin%2520Cytoskeleton%2520and%2520Integrins%26jtitle%3DGlia%26date%3D2006%26volume%3D54%26issue%3D4%26spage%3D272%26epage%3D284%26doi%3D10.1002%2Fglia.20349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ould-Yahoui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbai, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clément, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gigmes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Féron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Role of Matrix Metalloproteinases in Migration and Neurotrophic Properties of Nasal Olfactory Stem and Ensheathing Cells</span>. <i>Cell Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">993</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.3727/096368912X657468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3727%2F096368912X657468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23043957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252Fjt1Gjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=993-1010&issue=6&author=A.+Ould-Yahouiauthor=O.+Sbaiauthor=K.+Barangerauthor=A.+Bernardauthor=Y.+Gueyeauthor=E.+Charratauthor=B.+Cl%C3%A9mentauthor=D.+Gigmesauthor=V.+Diveauthor=S.+D.+Girardauthor=F.+F%C3%A9ronauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=Role+of+Matrix+Metalloproteinases+in+Migration+and+Neurotrophic+Properties+of+Nasal+Olfactory+Stem+and+Ensheathing+Cells&doi=10.3727%2F096368912X657468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells</span></div><div class="casAuthors">Ould-Yahoui Adlane; Sbai Oualid; Baranger Kevin; Bernard Anne; Gueye Yatma; Charrat Eliane; Clement Benoit; Gigmes Didier; Dive Vincent; Girard Stephane D; Feron Francois; Khrestchatisky Michel; Rivera Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Cell transplantation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">993-1010</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Adult olfactory ectomesenchymal stem cells (OE-MSCs) and olfactory ensheathing cells (OECs), both from the nasal olfactory lamina propria, display robust regenerative properties when transplanted into the nervous system, but the mechanisms supporting such therapeutic effects remain unknown.  Matrix metalloproteinases (MMPs) are an important family of proteinases contributing to cell motility and axonal outgrowth across the extracellular matrix (ECM) in physiological and pathological conditions.  In this study, we have characterized for the first time in nasal human OE-MSCs the expression profile of some MMPs currently associated with cell migration and invasiveness.  We demonstrate different patterns of expression for MMP-1, MMP-2, MMP-9, and MT1-MMP upon cell migration when compared with nonmigrating cells.  Our results establish a correspondence between the localization of these proteinases in the migration front with the ability of cells to migrate.  Using various modulators of MMP activity, we also show that at least MMP-2, MMP-9, and MT1-MMP contribute to OE-MSC migration in an in vitro 3D test.  Furthermore, we demonstrate under the same conditions of culture used for in vivo transplantation that OE-MSCs and OECs secrete neurotrophic factors that promote neurite outgrowth of cortical and dorsal root ganglia (DRG) neurons, as well as axo-dendritic differentiation of cortical neurons.  These effects were abolished by the depletion of MMP-2 and MMP-9 from the culture conditioned media.  Altogether, our results provide the first evidence that MMPs may contribute to the therapeutic features of OE-MSCs and OECs through the control of their motility and/or their neurotrophic properties.  Our data provide new insight into the mechanisms of neuroregeneration and will contribute to optimization of cell therapy strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXZWHF9AnWD0HdcurJClFcfW6udTcc2ebekMeVxjGEH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252Fjt1Gjtg%253D%253D&md5=3a5aee22d272446314649e8d77d82315</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3727%2F096368912X657468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3727%252F096368912X657468%26sid%3Dliteratum%253Aachs%26aulast%3DOuld-Yahoui%26aufirst%3DA.%26aulast%3DSbai%26aufirst%3DO.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DGueye%26aufirst%3DY.%26aulast%3DCharrat%26aufirst%3DE.%26aulast%3DCl%25C3%25A9ment%26aufirst%3DB.%26aulast%3DGigmes%26aufirst%3DD.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DGirard%26aufirst%3DS.%2BD.%26aulast%3DF%25C3%25A9ron%26aufirst%3DF.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DRole%2520of%2520Matrix%2520Metalloproteinases%2520in%2520Migration%2520and%2520Neurotrophic%2520Properties%2520of%2520Nasal%2520Olfactory%2520Stem%2520and%2520Ensheathing%2520Cells%26jtitle%3DCell%2520Transplant.%26date%3D2013%26volume%3D22%26issue%3D6%26spage%3D993%26epage%3D1010%26doi%3D10.3727%2F096368912X657468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gueye, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferhat, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbai, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ould-Yahoui, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauvin, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risso, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Féron, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span> <span> </span><span class="NLM_article-title">Trafficking and Secretion of Matrix Metalloproteinase-2 in Olfactory Ensheathing Glial Cells: A Role in Cell Migration?</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">770</span>, <span class="refDoi"> DOI: 10.1002/glia.21146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fglia.21146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21360755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC3M3nsVelsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=750-770&issue=5&author=Y.+Gueyeauthor=L.+Ferhatauthor=O.+Sbaiauthor=J.+Biancoauthor=A.+Ould-Yahouiauthor=A.+Bernardauthor=E.+Charratauthor=J.-P.+Chauvinauthor=J.-J.+Rissoauthor=F.+F%C3%A9ronauthor=S.+Riveraauthor=M.+Khrestchatisky&title=Trafficking+and+Secretion+of+Matrix+Metalloproteinase-2+in+Olfactory+Ensheathing+Glial+Cells%3A+A+Role+in+Cell+Migration%3F&doi=10.1002%2Fglia.21146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Trafficking and secretion of matrix metalloproteinase-2 in olfactory ensheathing glial cells: A role in cell migration?</span></div><div class="casAuthors">Gueye Yatma; Ferhat Lotfi; Sbai Oualid; Bianco John; Ould-Yahoui Adlane; Bernard Anne; Charrat Eliane; Chauvin Jean-Paul; Risso Jean-Jacques; Feron Francois; Rivera Santiago; Khrestchatisky Michel</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">750-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Olfactory ensheathing cells (OECs) are unique glia found only in the olfactory system.  They retain exceptional plasticity and support olfactory neurogenesis and retargeting across the PNS:CNS boundary in the olfactory system.  OECs have been shown to improve functional outcome when transplanted into rodents with spinal cord injury.  The growth-promoting properties of implanted OECs encompass their ability to migrate through the scar tissue and render it more permissive for axonal outgrowth, but the underlying molecular mechanisms remain poorly understood.  OECs appear to regulate molecules of the extracellular matrix (ECM) that inhibit axonal growth.  Among the proteins that have the potential to promote cell migration, axonal regeneration and remodeling of the ECM are matrix metalloproteinases (MMPs), a family of endopeptidases that cleave matrix, soluble, and membrane-bound proteins and that are regulated by their endogenous inhibitors, the tissue inhibitors of MMPs (TIMPs).  Little is known about MMP/TIMP trafficking, secretion, and role in OECs.  Using a combination of cell biology, biochemistry, pharmacology, and imaging techniques, we show that MMP-2 and MMP-9 are expressed and proteolytically active in the olfactory epithelium and in particular in the OECs of the lamina propria.  These proteinases and regulatory proteins such as MT1-MMP and TIMP-2 are expressed in cultured OECs.  MMPs exhibit nuclear localization and vesicular trafficking and secretion, with distribution along microtubules and microfilaments and co-localization with the molecular motor protein kinesin.  Finally, we show that MMPs are involved in migration of OECs in vitro on different ECM substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJoWRA2BTI_7JzI8owOhpDfW6udTcc2ebekMeVxjGEH7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3nsVelsw%253D%253D&md5=1ed5499efb20313bb8c428bf34b62662</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fglia.21146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.21146%26sid%3Dliteratum%253Aachs%26aulast%3DGueye%26aufirst%3DY.%26aulast%3DFerhat%26aufirst%3DL.%26aulast%3DSbai%26aufirst%3DO.%26aulast%3DBianco%26aufirst%3DJ.%26aulast%3DOuld-Yahoui%26aufirst%3DA.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DCharrat%26aufirst%3DE.%26aulast%3DChauvin%26aufirst%3DJ.-P.%26aulast%3DRisso%26aufirst%3DJ.-J.%26aulast%3DF%25C3%25A9ron%26aufirst%3DF.%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26atitle%3DTrafficking%2520and%2520Secretion%2520of%2520Matrix%2520Metalloproteinase-2%2520in%2520Olfactory%2520Ensheathing%2520Glial%2520Cells%253A%2520A%2520Role%2520in%2520Cell%2520Migration%253F%26jtitle%3DGlia%26date%3D2011%26volume%3D59%26issue%3D5%26spage%3D750%26epage%3D770%26doi%3D10.1002%2Fglia.21146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warren, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, L. L.</span></span> <span> </span><span class="NLM_article-title">MT5-MMP, ADAM-10, and N-Cadherin Act in Concert To Facilitate Synapse Reorganization after Traumatic Brain Injury</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1922</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.1089/neu.2012.2383</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1089%2Fneu.2012.2383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=22489706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC38rjslWktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2012&pages=1922-1940&issue=10&author=K.+M.+Warrenauthor=T.+M.+Reevesauthor=L.+L.+Phillips&title=MT5-MMP%2C+ADAM-10%2C+and+N-Cadherin+Act+in+Concert+To+Facilitate+Synapse+Reorganization+after+Traumatic+Brain+Injury&doi=10.1089%2Fneu.2012.2383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injury</span></div><div class="casAuthors">Warren Kelly M; Reeves Thomas M; Phillips Linda L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1922-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Matrix metalloproteinases (MMPs) influence synaptic recovery following traumatic brain injury (TBI).  Membrane type 5-matrix metalloproteinase (MT5-MMP) and a distintegrin and metalloproteinase-10 (ADAM-10) are membrane-bound MMPs that cleave N-cadherin, a protein critical to synapse stabilization.  This study examined protein and mRNA expression of MT5-MMP, ADAM-10, and N-cadherin after TBI, contrasting adaptive and maladaptive synaptogenesis.  The effect of MMP inhibition on MT5-MMP, ADAM-10, and N-cadherin was assessed during maladaptive plasticity and correlated with synaptic function.  Rats were subjected to adaptive unilateral entorhinal cortical lesion (UEC) or maladaptive fluid percussion TBI+bilateral entorhinal cortical lesion (TBI+BEC).  Hippocampal MT5-MMP and ADAM-10 protein was significantly elevated 2 and 7 days post-injury.  At 15 days after UEC, each MMP returned to control level, while TBI+BEC ADAM-10 remained elevated.  At 2 and 7 days, N-cadherin protein was below control.  By the 15-day synapse stabilization phase, UEC N-cadherin rose above control, a shift not seen for TBI+BEC.  At 7 days, increased TBI+BEC ADAM-10 transcript correlated with protein elevation.  UEC ADAM-10 mRNA did not change, and no differences in MT5-MMP or N-cadherin mRNA were detected.  Confocal imaging showed MT5-MMP, ADAM-10, and N-cadherin localization within reactive astrocytes.  MMP inhibition attenuated ADAM-10 protein 15 days after TBI+BEC and increased N-cadherin.  This inhibition partially restored long-term potentiation induction, but did not affect paired-pulse facilitation.  Our results confirm time- and injury-dependent expression of MT5-MMP, ADAM-10, and N-cadherin during reactive synaptogenesis.  Persistent ADAM-10 expression was correlated with attenuated N-cadherin level and reduced functional recovery.  MMP inhibition shifted ADAM-10 and N-cadherin toward adaptive expression and improved synaptic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQSwaFZpur1YCSm0e6ZOaemfW6udTcc2ebBWiNTnAKeq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rjslWktQ%253D%253D&md5=cb8b4e709e1c613b9af8eaecd0ee5995</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1089%2Fneu.2012.2383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2012.2383%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DK.%2BM.%26aulast%3DReeves%26aufirst%3DT.%2BM.%26aulast%3DPhillips%26aufirst%3DL.%2BL.%26atitle%3DMT5-MMP%252C%2520ADAM-10%252C%2520and%2520N-Cadherin%2520Act%2520in%2520Concert%2520To%2520Facilitate%2520Synapse%2520Reorganization%2520after%2520Traumatic%2520Brain%2520Injury%26jtitle%3DJ.%2520Neurotrauma%26date%3D2012%26volume%3D29%26issue%3D10%26spage%3D1922%26epage%3D1940%26doi%3D10.1089%2Fneu.2012.2383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huntley, G. W.</span></span> <span> </span><span class="NLM_article-title">Synaptic Circuit Remodelling by Matrix Metalloproteinases in Health and Disease</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">743</span>– <span class="NLM_lpage">757</span>, <span class="refDoi"> DOI: 10.1038/nrn3320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrn3320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23047773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVOgtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=743-757&issue=11&author=G.+W.+Huntley&title=Synaptic+Circuit+Remodelling+by+Matrix+Metalloproteinases+in+Health+and+Disease&doi=10.1038%2Fnrn3320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic circuit remodelling by matrix metalloproteinases in health and disease</span></div><div class="casAuthors">Huntley, George W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">743-757</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are extracellularly acting enzymes that have long been known to have deleterious roles in brain injury and disease.  In particular, widespread and protracted MMP activity can contribute to neuronal loss and synaptic dysfunction.  However, recent studies show that rapid and focal MMP-mediated proteolysis proactively drives synaptic structural and functional remodelling that is crucial for ongoing cognitive processes.  Deficits in synaptic remodelling are assocd. with psychiatric and neurol. disorders, and aberrant MMP expression or function may contribute to the mol. mechanisms underlying these deficits.  This Review explores the paradigm shift in our understanding of the contribution of MMPs to normal and abnormal synaptic plasticity and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4dGOLqydN2rVg90H21EOLACvtfcHk0li6Fd223o_Dsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVOgtrjM&md5=a42ae1fe3253ee329628845e623ef13f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fnrn3320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3320%26sid%3Dliteratum%253Aachs%26aulast%3DHuntley%26aufirst%3DG.%2BW.%26atitle%3DSynaptic%2520Circuit%2520Remodelling%2520by%2520Matrix%2520Metalloproteinases%2520in%2520Health%2520and%2520Disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2012%26volume%3D13%26issue%3D11%26spage%3D743%26epage%3D757%26doi%3D10.1038%2Fnrn3320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, P. H.</span></span> <span> </span><span class="NLM_article-title">Myelin Formation during Development of the CNS Is Delayed in Matrix Metalloproteinase-9 and −12 Null Mice</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2207</span>– <span class="NLM_lpage">2214</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1880-05.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.1880-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16495447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFCmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2207-2214&issue=8&author=P.+H.+Larsen&title=Myelin+Formation+during+Development+of+the+CNS+Is+Delayed+in+Matrix+Metalloproteinase-9+and+%E2%88%9212+Null+Mice&doi=10.1523%2FJNEUROSCI.1880-05.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice</span></div><div class="casAuthors">Larsen, Peter H.; DaSilva, Angelika Goncalves; Conant, Katherine; Yong, V. Wee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2207-2214</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We have addressed whether and how matrix metalloproteinases (MMPs) might be required for myelin formation in normal ontogeny.  Using a probe for multiple MMPs and the developing mouse optic nerve, we found 2 members, MMP-9 and -12, to be upregulated during the period of myelin formation.  These MMPs partake in myelinogenesis because myelination in the corpus callosum of MMP-9 and(or) MMP-12 null mice was deficient from postnatal days 7 to 14 compared with that of wild-type mice.  The deficient myelination was correlated with fewer mature oligodendrocytes, but similar precursor cell nos., in MMP null animals compared with wild type.  Because an important growth factor for oligodendrocyte maturation is insulin-like growth factor-1 (IGF-1), we addressed whether this was involved in the deficient myelination in MMP null mice.  Indeed, the addn. of IGF-1 normalized the lack of maturation of oligodendrocytes that occurred in cultures from MMP-12 null mice.  Furthermore, we detd. that IGF binding protein 6 (IGFBP-6), which sequesters IGF-1, was a substrate for MMP processing.  Finally, we found IGFBP-6 levels to remain high in MMP-deficient mice.  These results reveal a novel function for MMP-9 and -12 in developmental myelination likely through regulating IGF-1 bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMnPNy0rTJOrVg90H21EOLACvtfcHk0li6Fd223o_Dsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFCmsrY%253D&md5=7cc05c8fa6bf91b6ff7937a9a8ac46a9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1880-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1880-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DP.%2BH.%26atitle%3DMyelin%2520Formation%2520during%2520Development%2520of%2520the%2520CNS%2520Is%2520Delayed%2520in%2520Matrix%2520Metalloproteinase-9%2520and%2520%25E2%2588%259212%2520Null%2520Mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26issue%3D8%26spage%3D2207%26epage%3D2214%26doi%3D10.1523%2FJNEUROSCI.1880-05.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, J.-Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKeon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goussev, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werb, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble-Haeusslein, L. J.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-2 Facilitates Wound Healing Events That Promote Functional Recovery after Spinal Cord Injury</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">9841</span>– <span class="NLM_lpage">9850</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1993-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.1993-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17005848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=9841-9850&issue=39&author=J.-Y.+C.+Hsuauthor=R.+McKeonauthor=S.+Goussevauthor=Z.+Werbauthor=J.-U.+Leeauthor=A.+Trivediauthor=L.+J.+Noble-Haeusslein&title=Matrix+Metalloproteinase-2+Facilitates+Wound+Healing+Events+That+Promote+Functional+Recovery+after+Spinal+Cord+Injury&doi=10.1523%2FJNEUROSCI.1993-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury</span></div><div class="casAuthors">Hsu, Jung-Yu C.; McKeon, Robert; Goussev, Staci; Werb, Zena; Lee, Jung-Uek; Trivedi, Alpa; Noble-Haeusslein, Linda J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9841-9850</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are proteolytic enzymes that are involved in both injury and repair mechanisms in the CNS.  Pharmacol. blockade of MMPs, limited to the first several days after spinal cord injury, improves locomotor recovery.  This beneficial response is, however, lost when treatment is extended beyond the acutely injured cord to include wound healing and tissue remodeling.  This suggests that some MMPs play a beneficial role in wound healing.  To test this hypothesis, we investigated the role of MMP-2, which is actively expressed during wound healing, in white matter sparing and axonal plasticity, the formation of a glial scar, and locomotor recovery after spinal cord injury.  MMP-2 increased between 7 and 14 d after injury, where it was immunolocalized in reactive astrocytes bordering the lesion epicenter.  There was reduced white matter sparing and fewer serotonergic fibers, caudal to the lesion in injured MMP-2 null animals.  MMP-2 deficiency also resulted in increased immunoreactivity to chondroitin sulfate proteoglycans and a more extensive astrocytic scar.  Most importantly, locomotion in an open field, performance on a rotarod, and grid walking were significantly impaired in injured MMP-2 null mice.  Our findings suggest that MMP-2 promotes functional recovery after injury by regulating the formation of a glial scar and white matter sparing and/or axonal plasticity.  Thus, strategies exploiting MMPs as therapeutic targets must balance these beneficial effects during wound healing with their adverse interactions in the acutely injured spinal cord.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphjd-RTmz7UrVg90H21EOLACvtfcHk0li6Fd223o_Dsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOmtLjE&md5=771b194d45103ab319d78ba6c397a036</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1993-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1993-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DHsu%26aufirst%3DJ.-Y.%2BC.%26aulast%3DMcKeon%26aufirst%3DR.%26aulast%3DGoussev%26aufirst%3DS.%26aulast%3DWerb%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DJ.-U.%26aulast%3DTrivedi%26aufirst%3DA.%26aulast%3DNoble-Haeusslein%26aufirst%3DL.%2BJ.%26atitle%3DMatrix%2520Metalloproteinase-2%2520Facilitates%2520Wound%2520Healing%2520Events%2520That%2520Promote%2520Functional%2520Recovery%2520after%2520Spinal%2520Cord%2520Injury%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26issue%3D39%26spage%3D9841%26epage%3D9850%26doi%3D10.1523%2FJNEUROSCI.1993-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stallcup, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opdenakker, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">35</span>),  <span class="NLM_fpage">11127</span>– <span class="NLM_lpage">11135</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.23-35-11127.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.23-35-11127.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=14657171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=11127-11135&issue=35&author=P.+H.+Larsenauthor=J.+E.+Wellsauthor=W.+B.+Stallcupauthor=G.+Opdenakkerauthor=V.+W.+Yong&title=Matrix+Metalloproteinase-9+Facilitates+Remyelination+in+Part+by+Processing+the+Inhibitory+NG2+Proteoglycan&doi=10.1523%2FJNEUROSCI.23-35-11127.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan</span></div><div class="casAuthors">Larsen, Peter H.; Wells, Jennifer E.; Stallcup, William B.; Opdenakker, Ghislain; Yong, V. Wee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">11127-11135</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Remyelination is a crit. repair process that is initiated after a demyelinating insult.  The failure to remyelinate contributes to neurol. diseases such as multiple sclerosis.  Here, we test the hypothesis that proteinase activity is required for the extensive remodeling of the extracellular matrix that occurs during remyelination.  We show that mice lacking matrix metalloproteinase (MMP)-9 are impaired in myelin reformation after lysolecithin-induced demyelination.  This deficiency may be explained at least in part by the failure to clear the accumulation of NG2, an inhibitory proteoglycan that retards the maturation and differentiation of oligodendrocytes that are needed for remyelination.  These results emphasize for the first time that upregulation of MMP activity can be important for facilitating regeneration from some types of CNS injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtnQwqRVH0_7Vg90H21EOLACvtfcHk0li6Fd223o_Dsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvV2gtb8%253D&md5=135805c7644c2e867f01ce2bc4b4841d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.23-35-11127.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.23-35-11127.2003%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DP.%2BH.%26aulast%3DWells%26aufirst%3DJ.%2BE.%26aulast%3DStallcup%26aufirst%3DW.%2BB.%26aulast%3DOpdenakker%26aufirst%3DG.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DMatrix%2520Metalloproteinase-9%2520Facilitates%2520Remyelination%2520in%2520Part%2520by%2520Processing%2520the%2520Inhibitory%2520NG2%2520Proteoglycan%26jtitle%3DJ.%2520Neurosci.%26date%3D2003%26volume%3D23%26issue%3D35%26spage%3D11127%26epage%3D11135%26doi%3D10.1523%2FJNEUROSCI.23-35-11127.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deb, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottschall, P. E.</span></span> <span> </span><span class="NLM_article-title">Regional and Age-Related Expression of Gelatinases in the Brains of Young and Old Rats after Treatment with Kainic Acid</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>295</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/S0304-3940(00)01582-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0304-3940%2800%2901582-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11078924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVCkt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=9-12&issue=1%E2%80%932&author=J.+W.+Zhangauthor=S.+Debauthor=P.+E.+Gottschall&title=Regional+and+Age-Related+Expression+of+Gelatinases+in+the+Brains+of+Young+and+Old+Rats+after+Treatment+with+Kainic+Acid&doi=10.1016%2FS0304-3940%2800%2901582-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Regional and age-related expression of gelatinases in the brains of young and old rats after treatment with kainic acid</span></div><div class="casAuthors">Zhang, J. W.; Deb, S.; Gottschall, P. E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">9-12</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Due to the possible detrimental impact of local inflammatory responses in neurodegenerative disease, it was of interest to measure the expression of extracellular matrix-degrading enzymes, a group of proteases that are induced during an inflammatory response, in the brains of old and young animals in a model of neuronal death.  Doses of kainic acid were administered that resulted in comparable hippocampal pyramidal neuron loss in young and old F344/BN hybrid rats, even though each age group received widely differing doses.  Two matrix metalloproteinases (MMPs), MMP-2 and MMP-9, were differentially induced with respect to time after kainic acid in sensitive brain regions in both young and old rats.  However, the elevation of MMP-9 in the temporal lobe 12 h after injection in old rats was significantly greater than that obsd. in young animals.  These results suggest that early and late induction of MMPs may play a role in neuronal death and repair mechanisms, resp., and that inflammatory mechanisms in the central nervous system (CNS) of old rats are exaggerated compared to young rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnJzOvs3yq_rVg90H21EOLACvtfcHk0li4AU67yQpMmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVCkt7Y%253D&md5=daf5532e29dd5adcc79adf570592a9a8</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2800%2901582-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252800%252901582-2%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BW.%26aulast%3DDeb%26aufirst%3DS.%26aulast%3DGottschall%26aufirst%3DP.%2BE.%26atitle%3DRegional%2520and%2520Age-Related%2520Expression%2520of%2520Gelatinases%2520in%2520the%2520Brains%2520of%2520Young%2520and%2520Old%2520Rats%2520after%2520Treatment%2520with%2520Kainic%2520Acid%26jtitle%3DNeurosci.%2520Lett.%26date%3D2000%26volume%3D295%26issue%3D1%25E2%2580%25932%26spage%3D9%26epage%3D12%26doi%3D10.1016%2FS0304-3940%2800%2901582-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jourquin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decanis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanessian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollet, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Diguardher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Neuronal Activity-Dependent Increase of Net Matrix Metalloproteinase Activity Is Associated with MMP-9 Neurotoxicity after Kainate</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1507</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1046/j.1460-9568.2003.02876.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1046%2Fj.1460-9568.2003.02876.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=14511330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD3svpt1Cjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=1507-1517&issue=6&author=J.+Jourquinauthor=E.+Tremblayauthor=N.+Decanisauthor=G.+Chartonauthor=S.+Hanessianauthor=A.-M.+Cholletauthor=T.+Le+Diguardherauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=Neuronal+Activity-Dependent+Increase+of+Net+Matrix+Metalloproteinase+Activity+Is+Associated+with+MMP-9+Neurotoxicity+after+Kainate&doi=10.1046%2Fj.1460-9568.2003.02876.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate</span></div><div class="casAuthors">Jourquin Jerome; Tremblay Evelyne; Decanis Nadege; Charton Gerard; Hanessian Stephen; Chollet Anne-Marie; Le Diguardher Thierry; Khrestchatisky Michel; Rivera Santiago</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1507-17</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Matrix metalloproteinases (MMPs) and the tissue inhibitors of MMPs (TIMPs) are emerging as important modulators of brain physiopathology.  Dramatic changes in the expression of MMPs and TIMPs occur during excitotoxic/neuroinflammatory processes.  However, only the measurement of net protease activity is relevant physiologically, and the functional consequences of MMP/TIMP ratio modifications in the brain remain elusive.  In order to assess MMP activity and effects in brain tissue, we combined in vivo and organotypic culture models of kainate (KA)-induced excitotoxicity to provoke selective neuronal death and neuroinflammation in the hippocampus.  Using in situ zymography, we show that KA-induced excitotoxic seizures in rats increase net MMP activity in hippocampal neurons 8 h after seizures, before their death, and that this increase is neuronal activity-dependent.  Three days after KA, proteolytic activity increases in blood vessels and reactive glial cells of vulnerable areas, in relation with neuroinflammation.  At 7 and 15 days, proteolysis remains high in blood vessels whereas it is reduced in glia.  In organotypic hippocampal cultures, which lack blood cell-mediated inflammation and extrinsic connections, a broad-spectrum inhibitor of MMPs (MMPI), but also a selective MMP-9 inhibitor, protect hippocampal neurons against KA-induced excitotoxicity.  Moreover, recombinant MMP-9, but not MMP-2, induces selective pyramidal cell death in these cultures and KA-induced neuronal activity exacerbates the neuronal death promoting effects of MMP-9.  These data strongly implicate MMPs, and MMP-9 in particular, in both excitotoxic neuronal damage and subsequent neuroinflammatory processes, and suggest that selective MMPIs could be therapeutically relevant in related neurological disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROkTDnPFyF0RWfpMXQLRstfW6udTcc2eZprbLrxT5vdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3svpt1Cjtg%253D%253D&md5=d2f68cccdafec7c518902ca815627c4a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.2003.02876.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.2003.02876.x%26sid%3Dliteratum%253Aachs%26aulast%3DJourquin%26aufirst%3DJ.%26aulast%3DTremblay%26aufirst%3DE.%26aulast%3DDecanis%26aufirst%3DN.%26aulast%3DCharton%26aufirst%3DG.%26aulast%3DHanessian%26aufirst%3DS.%26aulast%3DChollet%26aufirst%3DA.-M.%26aulast%3DLe%2BDiguardher%26aufirst%3DT.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DNeuronal%2520Activity-Dependent%2520Increase%2520of%2520Net%2520Matrix%2520Metalloproteinase%2520Activity%2520Is%2520Associated%2520with%2520MMP-9%2520Neurotoxicity%2520after%2520Kainate%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2003%26volume%3D18%26issue%3D6%26spage%3D1507%26epage%3D1517%26doi%3D10.1046%2Fj.1460-9568.2003.02876.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gasche, Y.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases and Diseases of the Central Nervous System with a Special Emphasis on Ischemic Brain</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1289</span>– <span class="NLM_lpage">1301</span>, <span class="refDoi"> DOI: 10.2741/1883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2741%2F1883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16368516" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2006&pages=1289-1301&issue=1&author=Y.+Gasche&title=Matrix+Metalloproteinases+and+Diseases+of+the+Central+Nervous+System+with+a+Special+Emphasis+on+Ischemic+Brain&doi=10.2741%2F1883"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.2741%2F1883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F1883%26sid%3Dliteratum%253Aachs%26aulast%3DGasche%26aufirst%3DY.%26atitle%3DMatrix%2520Metalloproteinases%2520and%2520Diseases%2520of%2520the%2520Central%2520Nervous%2520System%2520with%2520a%2520Special%2520Emphasis%2520on%2520Ischemic%2520Brain%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2006%26volume%3D11%26issue%3D1%26spage%3D1289%26epage%3D1301%26doi%3D10.2741%2F1883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jourquin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timsit, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szklarczyk, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gearing, A. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span> <span> </span><span class="NLM_article-title">Gelatinase B and TIMP-1 Are Regulated in a Cell- and Time-Dependent Manner in Association with Neuronal Death and Glial Reactivity after Global Forebrain Ischemia</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1046/j.0953-816x.2001.01838.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1046%2Fj.0953-816x.2001.01838.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11860503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD387ktFymtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=19-32&issue=1&author=S.+Riveraauthor=C.+Ogierauthor=J.+Jourquinauthor=S.+Timsitauthor=A.+W.+Szklarczykauthor=K.+Millerauthor=A.+J.+H.+Gearingauthor=L.+Kaczmarekauthor=M.+Khrestchatisky&title=Gelatinase+B+and+TIMP-1+Are+Regulated+in+a+Cell-+and+Time-Dependent+Manner+in+Association+with+Neuronal+Death+and+Glial+Reactivity+after+Global+Forebrain+Ischemia&doi=10.1046%2Fj.0953-816x.2001.01838.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia</span></div><div class="casAuthors">Rivera Santiago; Ogier Crystel; Jourquin Jerome; Timsit Serge; Szklarczyk Arkadius W; Miller Karen; Gearing Andrew J H; Kaczmarek Leszek; Khrestchatisky Michel</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-32</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Matrix metalloproteinases (MMPs) belong to a large family of endopeptidases that regulate the pericellular environment through the cleavage of protein components of the extracellular matrix, membrane receptors and cytokines.  MMP activity is controlled by the multifunctional tissue inhibitors of metalloproteinases (TIMPs).  Proteases and their inhibitors are critically involved in developmental and pathological processes in numerous organs, including the brain.  Global transient cerebral ischemia induces selective delayed neuronal death and neuroinflammation.  We compared, in discrete vulnerable and resistant areas of the ischemic rat hippocampus, the kinetics and cellular distribution of gelatinase B and its principal inhibitor TIMP-1 and we assessed by in situ zymography, the net gelatinolytic activity at the cellular level.  We show that gelatinases are expressed and active in neurons, suggesting that MMPs play a role in maintaining neural homeostasis.  In the ischemic rat brain, expression and activity of gelatinase B, and expression of TIMP-1 are altered in a time-, region- and cell-dependent manner.  Gelatinase B is induced first in reactive microglia and subsequently in reactive astrocytes.  In situ, increases in gelatinase activity accompanied the progression of neuronal death and glial reactivity.  Our results suggest that MMPs and TIMPs are involved in cell viability and tissue remodelling in the ischemic brain, and reinforces the idea that the MMP/TIMP system contributes both to neuronal demise and tissue repair in the context of glial reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR2N4CuMIbAh2K_SFaaT9INfW6udTcc2eaouJ2o_nwGNbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ktFymtw%253D%253D&md5=b81eb3cb819d7cdbccf51b6fed3cf026</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1046%2Fj.0953-816x.2001.01838.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0953-816x.2001.01838.x%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DOgier%26aufirst%3DC.%26aulast%3DJourquin%26aufirst%3DJ.%26aulast%3DTimsit%26aufirst%3DS.%26aulast%3DSzklarczyk%26aufirst%3DA.%2BW.%26aulast%3DMiller%26aufirst%3DK.%26aulast%3DGearing%26aufirst%3DA.%2BJ.%2BH.%26aulast%3DKaczmarek%26aufirst%3DL.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26atitle%3DGelatinase%2520B%2520and%2520TIMP-1%2520Are%2520Regulated%2520in%2520a%2520Cell-%2520and%2520Time-Dependent%2520Manner%2520in%2520Association%2520with%2520Neuronal%2520Death%2520and%2520Glial%2520Reactivity%2520after%2520Global%2520Forebrain%2520Ischemia%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2002%26volume%3D15%26issue%3D1%26spage%3D19%26epage%3D32%26doi%3D10.1046%2Fj.0953-816x.2001.01838.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Z.</span></span> <span> </span><span class="NLM_article-title">S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell Death</span>. <i>Science (Washington, DC, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span> (<span class="NLM_issue">5584</span>),  <span class="NLM_fpage">1186</span>– <span class="NLM_lpage">1190</span>, <span class="refDoi"> DOI: 10.1126/science.1073634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1126%2Fscience.1073634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12183632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVOhtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=1186-1190&issue=5584&author=Z.+Gu&title=S-Nitrosylation+of+Matrix+Metalloproteinases%3A+Signaling+Pathway+to+Neuronal+Cell+Death&doi=10.1126%2Fscience.1073634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">S-Nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death</span></div><div class="casAuthors">Gu, Zezong; Kaul, Marcus; Yan, Boxu; Kridel, Steven J.; Cui, Jiankun; Strongin, Alex; Smith, Jeffrey W.; Liddington, Robert C.; Lipton, Stuart A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5584</span>),
    <span class="NLM_cas:pages">1186-1190</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of neurodegenerative diseases and stroke.  However, the mechanism of MMP activation remains unclear.  We report that MMP activation involves S-nitrosylation.  During cerebral ischemia in vivo, MMP-9 colocalized with neuronal nitric oxide synthase.  S-Nitrosylation activated MMP-9 in vitro and induced neuronal apoptosis.  Mass spectrometry identified the active deriv. of MMP-9, both in vitro and in vivo, as a stable sulfinic or sulfonic acid, whose formation was triggered by S-nitrosylation.  These findings suggest a potential extracellular proteolysis pathway to neuronal cell death in which S-nitrosylation activates MMPs, and further oxidn. results in a stable posttranslational modification with pathol. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrXst1UtWNrVg90H21EOLACvtfcHk0li2MXfZ57roMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVOhtL8%253D&md5=367fff24338ee8628f875afdf45dab24</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscience.1073634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1073634%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DZ.%26atitle%3DS-Nitrosylation%2520of%2520Matrix%2520Metalloproteinases%253A%2520Signaling%2520Pathway%2520to%2520Neuronal%2520Cell%2520Death%26jtitle%3DScience%2520%2528Washington%252C%2520DC%252C%2520U.%2520S.%2529%26date%3D2002%26volume%3D297%26issue%3D5584%26spage%3D1186%26epage%3D1190%26doi%3D10.1126%2Fscience.1073634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leppert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandgirard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leib, S. L.</span></span> <span> </span><span class="NLM_article-title">MMPs and ADAMs in Neurological Infectious Diseases and Multiple Sclerosis</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3097</span>– <span class="NLM_lpage">3116</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03174-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03174-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31172218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3097-3116&issue=16&author=L.+Muriauthor=D.+Leppertauthor=D.+Grandgirardauthor=S.+L.+Leib&title=MMPs+and+ADAMs+in+Neurological+Infectious+Diseases+and+Multiple+Sclerosis&doi=10.1007%2Fs00018-019-03174-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">MMPs and ADAMs in neurological infectious diseases and multiple sclerosis</span></div><div class="casAuthors">Muri, Lukas; Leppert, David; Grandgirard, Denis; Leib, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3097-3116</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Metalloproteinases-such as matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinases (ADAMs)-are involved in various diseases of the nervous system but also contribute to nervous system development, synaptic plasticity and neuroregeneration upon injury.  MMPs and ADAMs proteolytically cleave many substrates including extracellular matrix components but also signaling mols. and receptors.  During neuroinfectious disease with assocd. neuroinflammation, MMPs and ADAMs regulate blood-brain barrier breakdown, bacterial invasion, neutrophil infiltration and cytokine signaling.  Specific and broad-spectrum inhibitors for MMPs and ADAMs have exptl. been shown to decrease neuroinflammation and brain damage in diseases with excessive neuroinflammation as a common denominator, such as pneumococcal meningitis and multiple sclerosis, thereby improving the disease outcome.  Timing of metalloproteinase inhibition appears to be crit. to effectively target the cascade of pathophysiol. processes leading to brain damage without inhibiting the neuroregenerative effects of metalloproteinases.  As the crit. role of metalloproteinases in neuronal repair mechanisms and regeneration was only lately recognized, the original idea of chronic MMP inhibition needs to be conceptually revised.  Recently accumulated research urges for a second chance of metalloproteinase inhibitors, which-when correctly applied and dosed-harbor the potential to improve the outcome of different neuroinflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNTkbwv59ML7Vg90H21EOLACvtfcHk0lhF-wujTnWbsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtb3K&md5=8c5982c714d4efa05479dcc87890d6f9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03174-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03174-6%26sid%3Dliteratum%253Aachs%26aulast%3DMuri%26aufirst%3DL.%26aulast%3DLeppert%26aufirst%3DD.%26aulast%3DGrandgirard%26aufirst%3DD.%26aulast%3DLeib%26aufirst%3DS.%2BL.%26atitle%3DMMPs%2520and%2520ADAMs%2520in%2520Neurological%2520Infectious%2520Diseases%2520and%2520Multiple%2520Sclerosis%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3097%26epage%3D3116%26doi%3D10.1007%2Fs00018-019-03174-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramiro, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simats, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Guillamon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bustamante, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosell, A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases and ADAMs in Stroke</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3117</span>– <span class="NLM_lpage">3140</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03175-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03175-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31165904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3117-3140&issue=16&author=J.+Montanerauthor=L.+Ramiroauthor=A.+Simatsauthor=M.+Hern%C3%A1ndez-Guillamonauthor=P.+Delgadoauthor=A.+Bustamanteauthor=A.+Rosell&title=Matrix+Metalloproteinases+and+ADAMs+in+Stroke&doi=10.1007%2Fs00018-019-03175-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and ADAMs in stroke</span></div><div class="casAuthors">Montaner, Joan; Ramiro, Laura; Simats, Alba; Hernandez-Guillamon, Mar; Delgado, Pilar; Bustamante, Alejandro; Rosell, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3117-3140</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Stroke is a leading cause of death and disability worldwide.  However, after years of in-depth research, the pathophysiol. of stroke is still not fully understood.  Increasing evidence shows that matrix metalloproteinases (MMPs) and "a disintegrin and metalloproteinase" (ADAMs) participate in the neuro-inflammatory cascade that is triggered during stroke but also in recovery phases of the disease.  This review covers the involvement of these proteins in brain injury following cerebral ischemia which has been widely studied in recent years, with efforts to modulate this group of proteins in neuroprotective therapies, together with their implication in neurorepair mechanisms.  Moreover, the review also discusses the role of these proteins in specific forms of neurovascular disease, such as small vessel diseases and intracerebral hemorrhage.  Finally, the potential use of MMPs and ADAMs as guiding biomarkers of brain injury and repair for decision-making in cases of stroke is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRW7-MAdUcWrVg90H21EOLACvtfcHk0lhF-wujTnWbsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtbbP&md5=d5177f9d70e49ef9800be878f1b9070c</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03175-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03175-5%26sid%3Dliteratum%253Aachs%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DRamiro%26aufirst%3DL.%26aulast%3DSimats%26aufirst%3DA.%26aulast%3DHern%25C3%25A1ndez-Guillamon%26aufirst%3DM.%26aulast%3DDelgado%26aufirst%3DP.%26aulast%3DBustamante%26aufirst%3DA.%26aulast%3DRosell%26aufirst%3DA.%26atitle%3DMatrix%2520Metalloproteinases%2520and%2520ADAMs%2520in%2520Stroke%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3117%26epage%3D3140%26doi%3D10.1007%2Fs00018-019-03175-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, G. A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases in Neuroinflammation</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1002/glia.10108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fglia.10108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12203394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD38vksVWqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2002&pages=279-291&issue=3&author=G.+A.+Rosenberg&title=Matrix+Metalloproteinases+in+Neuroinflammation&doi=10.1002%2Fglia.10108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases in neuroinflammation</span></div><div class="casAuthors">Rosenberg Gary A</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-91</span>
        ISSN:<span class="NLM_cas:issn">0894-1491</span>.
    </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are a gene family of neutral proteases that are important in normal development, wound healing, and a wide variety of pathological processes, including the spread of metastatic cancer cells, arthritic destruction of joints, atherosclerosis, and neuroinflammation.  In the central nervous system (CNS), MMPs have been shown to degrade components of the basal lamina, leading to disruption of the blood-brain barrier (BBB), and to contribute to the neuroinflammatory response in many neurological diseases.  Brain cells express both constitutive and inducible MMPs in response to cellular stress.  MMPs are tightly regulated to avoid unwanted proteolysis.  Secreted as inactive enzymes, the MMPs require activation by other proteases and free radicals.  The MMPs are part of a larger class of metalloproteinases (MPs), which includes the recently discovered ADAMs (a disintegrin and metalloproteinase domain) and ADAMTS (a disintegrin and metalloproteinase thrombospondin) families.  MPs have complex roles at the cell surface and within the extracellular matrix.  At the cell surface, they act as sheddases, releasing growth factors, death receptors, and death-inducing ligands, making them important in cell survival and death.  Tissue inhibitors of metalloproteinases (TIMPs) are endogenous inhibitors that regulate the activity of the MMPs.  Synthetic inhibitors have been developed for the treatment of arthritis and cancer.  These hydroxymate-based compounds have been shown to reduce injury in experimental allergic encephalomyelitis (EAE), experimental allergic neuritis (EAN), cerebral ischemia, intracerebral hemorrhage, and viral and bacterial infections.  MPs have both beneficial and detrimental roles; understanding their expression in various CNS insults will allow for the use of MMP inhibitors in the treatment of neurological disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQqaNxQnG0x0zC850By6mxpfW6udTcc2eZpQW5QTDgkubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38vksVWqtQ%253D%253D&md5=eca79ccb4df70f06593ab5796ec1c17f</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fglia.10108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.10108%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DG.%2BA.%26atitle%3DMatrix%2520Metalloproteinases%2520in%2520Neuroinflammation%26jtitle%3DGlia%26date%3D2002%26volume%3D39%26issue%3D3%26spage%3D279%26epage%3D291%26doi%3D10.1002%2Fglia.10108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chopra, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases in the CNS: Interferons Get Nervous</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3083</span>– <span class="NLM_lpage">3095</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03171-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03171-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31165203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2hs7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3083-3095&issue=16&author=S.+Chopraauthor=C.+M.+Overallauthor=A.+Dufour&title=Matrix+Metalloproteinases+in+the+CNS%3A+Interferons+Get+Nervous&doi=10.1007%2Fs00018-019-03171-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases in the CNS: interferons get nervous</span></div><div class="casAuthors">Chopra, Sameeksha; Overall, Christopher M.; Dufour, Antoine</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3083-3095</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) have been investigated in context of chronic inflammatory diseases and demonstrated to degrade multiple components of the extracellular matrix (ECM).  However, following several disappointing MMP clin. trials, recent studies have demonstrated unexpected novel functions of MMPs in viral infections and autoimmune inflammatory diseases in unanticipated locations.  Thus, MMPs play addnl. functions in inflammation than just ECM degrdn.  They can regulate the activity of chemokines and cytokines of the immune response by precise proteolytic processing resulting in activation or inactivation of signaling pathways.  MMPs have been demonstrated to cleave multiple substrates of the central nervous systems (CNS) and contribute to promoting and dampening diseases of the CNS.  Initially, believed to be solely promoting pathologies, more than 10 MMPs to date have been shown to have protective functions.  Here, we present some of the beneficial and destructive roles of MMPs in CNS pathologies and discuss strategies for the use of MMP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqylHe7Yphs1LVg90H21EOLACvtfcHk0liMweJ_XtuZIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2hs7%252FE&md5=0709b7ad3fb4ad6352085106573587ad</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03171-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03171-9%26sid%3Dliteratum%253Aachs%26aulast%3DChopra%26aufirst%3DS.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26aulast%3DDufour%26aufirst%3DA.%26atitle%3DMatrix%2520Metalloproteinases%2520in%2520the%2520CNS%253A%2520Interferons%2520Get%2520Nervous%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3083%26epage%3D3095%26doi%3D10.1007%2Fs00018-019-03171-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, J.</span></span> <span> </span><span class="NLM_article-title">The Role of Matrix Metalloproteinases in Glioma Invasion</span>. <i>Front. Biosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e261</span>, <span class="refDoi"> DOI: 10.2741/1016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2741%2F1016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12456313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitFygtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=e261&author=M.+Nakadaauthor=Y.+Okadaauthor=J.+Yamashita&title=The+Role+of+Matrix+Metalloproteinases+in+Glioma+Invasion&doi=10.2741%2F1016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The role of matrix metalloproteinases in glioma invasion</span></div><div class="casAuthors">Nakada, Mitsutoshi; Okada, Yasunori; Yamashita, Junkoh</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">E261-E269</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinase (MMP) family plays an important role in the degrdn. of extracellular matrix (ECM) in various physiol. and pathol. conditions.  Accumulated evidence has suggested that MMPs contribute to cancer cell invasion of the surrounding normal tissues and metastasis through the cell-surface ECM degrdn.  Strong correlations have been reported between elevated MMP levels and tumor cell invasiveness in human gliomas.  Among them, attention has been focused on gelatinases (MMP-2 and MMP-9) and membrane type MMPs (MT-MMPs).  We discuss here the biol. significance of these MMP's in the glioblastoma invasion processes.  A better understanding of cell-ECM interactions will help in developing therapeutic strategies to decrease the invasion of gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDqAKkp7DVCrVg90H21EOLACvtfcHk0liMweJ_XtuZIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitFygtbY%253D&md5=f406f06276196ac7e70aa7fa20f841f5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2741%2F1016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F1016%26sid%3Dliteratum%253Aachs%26aulast%3DNakada%26aufirst%3DM.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DJ.%26atitle%3DThe%2520Role%2520of%2520Matrix%2520Metalloproteinases%2520in%2520Glioma%2520Invasion%26jtitle%3DFront.%2520Biosci.%26date%3D2003%26volume%3D8%26spage%3De261%26doi%3D10.2741%2F1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreira, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonçalves, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, M. J.</span></span> <span> </span><span class="NLM_article-title">MMP-14 Overexpression Correlates with the Neurodegenerative Process in Familial Amyloidotic Polyneuropathy</span>. <i>Dis. Models &amp; Mech.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1253</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1242/dmm.028571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1242%2Fdmm.028571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28993312" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2017&pages=1253-1260&issue=10&author=D.+Martinsauthor=J.+Moreiraauthor=N.+P.+Gon%C3%A7alvesauthor=M.+J.+Saraiva&title=MMP-14+Overexpression+Correlates+with+the+Neurodegenerative+Process+in+Familial+Amyloidotic+Polyneuropathy&doi=10.1242%2Fdmm.028571"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1242%2Fdmm.028571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdmm.028571%26sid%3Dliteratum%253Aachs%26aulast%3DMartins%26aufirst%3DD.%26aulast%3DMoreira%26aufirst%3DJ.%26aulast%3DGon%25C3%25A7alves%26aufirst%3DN.%2BP.%26aulast%3DSaraiva%26aufirst%3DM.%2BJ.%26atitle%3DMMP-14%2520Overexpression%2520Correlates%2520with%2520the%2520Neurodegenerative%2520Process%2520in%2520Familial%2520Amyloidotic%2520Polyneuropathy%26jtitle%3DDis.%2520Models%2520%2526amp%253B%2520Mech.%26date%3D2017%26volume%3D10%26issue%3D10%26spage%3D1253%26epage%3D1260%26doi%3D10.1242%2Fdmm.028571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, G. A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases and Their Multiple Roles in Neurodegenerative Diseases</span>. <i>Lancet Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1016/S1474-4422(09)70016-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS1474-4422%2809%2970016-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19161911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFCgu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=205-216&issue=2&author=G.+A.+Rosenberg&title=Matrix+Metalloproteinases+and+Their+Multiple+Roles+in+Neurodegenerative+Diseases&doi=10.1016%2FS1474-4422%2809%2970016-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases and their multiple roles in neurodegenerative diseases</span></div><div class="casAuthors">Rosenberg, Gary A.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-216</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) and proteins contg. a disintegrin and metalloproteinase domain (ADAM) are important in neuroinflammation, and recent studies have linked their actions to neurodegenerative disorders.  MMPs act as cell-surface sheddases and can affect cell signalling initiated by growth factors or death receptors.  Four tissue inhibitors of metalloproteinases (TIMPs) regulate metalloproteinase activity.  These proteases increase the permeability of the blood-brain barrier, which can cause edema, hemorrhage, and cell death.  MMPs also participate in tissue repair by promoting angiogenesis and neurogenesis.  In vascular cognitive impairment, MMPs change permeability of the blood-brain barrier and might contribute to white matter damage.  MMPs and ADAMs might contribute to the formation and degrdn. of amyloid proteins in Alzheimer's disease and cause death of dopaminergic neurons in Parkinson's disease.  In this Review, by examg. the effects of neuroinflammation, we try to understand the role that MMPs might have in neurodegenerative diseases.  Therapeutic strategies that use inhibitors of MMPs could represent potential novel treatments for neurol. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEXuGYramRwrVg90H21EOLACvtfcHk0lj9JX1hNqwYSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFCgu7k%253D&md5=e84c6afbc8da51b37c834ef478b7c7ec</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2809%2970016-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252809%252970016-X%26sid%3Dliteratum%253Aachs%26aulast%3DRosenberg%26aufirst%3DG.%2BA.%26atitle%3DMatrix%2520Metalloproteinases%2520and%2520Their%2520Multiple%2520Roles%2520in%2520Neurodegenerative%2520Diseases%26jtitle%3DLancet%2520Neurol.%26date%3D2009%26volume%3D8%26issue%3D2%26spage%3D205%26epage%3D216%26doi%3D10.1016%2FS1474-4422%2809%2970016-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble-Haeusslein, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, L. L.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase Signals Following Neurotrauma Are Right on Cue</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">3141</span>– <span class="NLM_lpage">3156</span>, <span class="refDoi"> DOI: 10.1007/s00018-019-03176-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-019-03176-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31168660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2019&pages=3141-3156&issue=16&author=A.+Trivediauthor=L.+J.+Noble-Haeussleinauthor=J.+M.+Levineauthor=A.+D.+Santucciauthor=T.+M.+Reevesauthor=L.+L.+Phillips&title=Matrix+Metalloproteinase+Signals+Following+Neurotrauma+Are+Right+on+Cue&doi=10.1007%2Fs00018-019-03176-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase signals following neurotrauma are right on cue</span></div><div class="casAuthors">Trivedi, Alpa; Noble-Haeusslein, Linda J.; Levine, Jonathan M.; Santucci, Alison D.; Reeves, Thomas M.; Phillips, Linda L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3141-3156</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Neurotrauma, a term referencing both traumatic brain and spinal cord injuries, is unique to neurodegeneration in that onset is clearly defined.  From the perspective of matrix metalloproteinases (MMPs), there is opportunity to define their temporal participation in injury and recovery beginning at the level of the synapse.  Here we examine the diverse roles of MMPs in the context of targeted insults (optic nerve lesion and hippocampal and olfactory bulb deafferentation), and clin. relevant focal models of traumatic brain and spinal cord injuries.  Time-specific MMP postinjury signaling is crit. to synaptic recovery after focal axonal injuries; members of the MMP family exhibit a signature temporal profile corresponding to axonal degeneration and regrowth, where they direct postinjury reorganization and synaptic stabilization.  In both traumatic brain and spinal cord injuries, MMPs mediate early secondary pathogenesis including disruption of the blood-brain barrier, creating an environment that may be hostile to recovery.  They are also crit. players in wound healing including angiogenesis and the formation of an inhibitory glial scar.  Exptl. strategies to reduce their activity in the acute phase result in long-term neurol. recovery after neurotrauma and have led to the first clin. trial in spinal cord injured pet dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxJl5ChtEOH7Vg90H21EOLACvtfcHk0lj9JX1hNqwYSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFWqtbbJ&md5=bd3be350964cc8e703d84dd6bbd1e142</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs00018-019-03176-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-019-03176-4%26sid%3Dliteratum%253Aachs%26aulast%3DTrivedi%26aufirst%3DA.%26aulast%3DNoble-Haeusslein%26aufirst%3DL.%2BJ.%26aulast%3DLevine%26aufirst%3DJ.%2BM.%26aulast%3DSantucci%26aufirst%3DA.%2BD.%26aulast%3DReeves%26aufirst%3DT.%2BM.%26aulast%3DPhillips%26aufirst%3DL.%2BL.%26atitle%3DMatrix%2520Metalloproteinase%2520Signals%2520Following%2520Neurotrauma%2520Are%2520Right%2520on%2520Cue%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2019%26volume%3D76%26issue%3D16%26spage%3D3141%26epage%3D3156%26doi%3D10.1007%2Fs00018-019-03176-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leake, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whateley, J.</span></span> <span> </span><span class="NLM_article-title">Brain Matrix Metalloproteinase 1 Levels Are Elevated in Alzheimer’s Disease</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1016/S0304-3940(00)01418-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0304-3940%2800%2901418-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10984641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtlGrtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2000&pages=201-203&issue=3&author=A.+Leakeauthor=C.+Morrisauthor=J.+Whateley&title=Brain+Matrix+Metalloproteinase+1+Levels+Are+Elevated+in+Alzheimer%E2%80%99s+Disease&doi=10.1016%2FS0304-3940%2800%2901418-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease</span></div><div class="casAuthors">Leake, A.; Morris, C. M.; Whateley, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">201-203</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Several lines of evidence indicate that there may be an inflammatory component to the pathol. of Alzheimer's disease (AD), the major form of degenerative dementia in the elderly.  Activity of inflammatory cells, and the elaboration of toxic mols. by such cells may be a significant factor in disease progression.  In peripheral inflammatory states, the increased activity of matrix metalloproteinase (MMP) enzymes are a major cause of tissue breakdown and secondary damage in diseases such as rheumatoid arthritis.  The activity of such enzymes in the normal or diseased central nervous system is, however, not well characterized.  We have therefore detd. the levels of MMP 1 (collagenase) in the normal human brain and in AD.  MMP1 levels were relatively low though were significantly elevated by approx. 50% in AD in all cortical areas examd.  Given the activity towards collagen of MMP1, it is possible that enhanced MMP1 activity in AD, may contribute to the blood-brain barrier dysfunction seen in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLLIi5Trl5fbVg90H21EOLACvtfcHk0lj9JX1hNqwYSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtlGrtLk%253D&md5=a66d1cb72b51558511e4988a59f1679b</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2800%2901418-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252800%252901418-X%26sid%3Dliteratum%253Aachs%26aulast%3DLeake%26aufirst%3DA.%26aulast%3DMorris%26aufirst%3DC.%26aulast%3DWhateley%26aufirst%3DJ.%26atitle%3DBrain%2520Matrix%2520Metalloproteinase%25201%2520Levels%2520Are%2520Elevated%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeurosci.%2520Lett.%26date%3D2000%26volume%3D291%26issue%3D3%26spage%3D201%26epage%3D203%26doi%3D10.1016%2FS0304-3940%2800%2901418-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Py, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchalant, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Differential Spatio-Temporal Regulation of MMPs in the 5xFAD Mouse Model of Alzheimer’s Disease: Evidence for a pro-Amyloidogenic Role of MT1-MMP</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2014.00247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3389%2Ffnagi.2014.00247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24478697" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1-17&author=N.+A.+Pyauthor=A.+E.+Bonnetauthor=A.+Bernardauthor=Y.+Marchalantauthor=E.+Charratauthor=F.+Checlerauthor=M.+Khrestchatiskyauthor=K.+Barangerauthor=S.+Rivera&title=Differential+Spatio-Temporal+Regulation+of+MMPs+in+the+5xFAD+Mouse+Model+of+Alzheimer%E2%80%99s+Disease%3A+Evidence+for+a+pro-Amyloidogenic+Role+of+MT1-MMP&doi=10.3389%2Ffnagi.2014.00247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2014.00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2014.00247%26sid%3Dliteratum%253Aachs%26aulast%3DPy%26aufirst%3DN.%2BA.%26aulast%3DBonnet%26aufirst%3DA.%2BE.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DMarchalant%26aufirst%3DY.%26aulast%3DCharrat%26aufirst%3DE.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DDifferential%2520Spatio-Temporal%2520Regulation%2520of%2520MMPs%2520in%2520the%25205xFAD%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Evidence%2520for%2520a%2520pro-Amyloidogenic%2520Role%2520of%2520MT1-MMP%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2014%26volume%3D6%26spage%3D1%26epage%3D17%26doi%3D10.3389%2Ffnagi.2014.00247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoshiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asahina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span> <span> </span><span class="NLM_article-title">Selective Distribution of Matrix Metalloproteinase-3 (MMP-3) in Alzheimer’s Disease Brain</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1007/PL00007428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2FPL00007428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10672313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotl2k" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2000&pages=91-95&issue=2&author=Y.+Yoshiyamaauthor=M.+Asahinaauthor=T.+Hattori&title=Selective+Distribution+of+Matrix+Metalloproteinase-3+%28MMP-3%29+in+Alzheimer%E2%80%99s+Disease+Brain&doi=10.1007%2FPL00007428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain</span></div><div class="casAuthors">Yoshiyama, Yasumasa; Asahina, Masato; Hattori, Takamichi</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-95</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A growing amt. of evidence indicates that matrix metalloproteinases (MMPs) may play an important role in the pathogenesis of Alzheimer's disease (AD).  Stromelysin-1 (MMP-3) plays a central role in activating latent-type MMPs, which are originally secreted as proenzymes.  We examd. MMP-3 immunoreactivity in the brains of patients who had suffered from Alzheimer's disease and in those of neurol. normal persons.  The interstitium between myelinated axons and astrocytes in the white matter of all brain tissues, and senile plaques in the gray matter of the patients with AD were stained with a monoclonal antibody to MMP-3.  Comparison of the no. of senile plaques stained with the antibody against MMP-3 in the parietal cortex with that in the hippocampus showed that fewer plaques were stained in the hippocampus.  The selective distribution of MMP-3 in the human brain suggests that MMP-3 might play an important role in the pathogenesis of AD, esp. in the degrdn. of β-amyloid protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzYKovp_zFrVg90H21EOLACvtfcHk0ljsEH8cWx5WNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotl2k&md5=147796511ba3dff92d1a81a4400cd8e5</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1007%2FPL00007428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00007428%26sid%3Dliteratum%253Aachs%26aulast%3DYoshiyama%26aufirst%3DY.%26aulast%3DAsahina%26aufirst%3DM.%26aulast%3DHattori%26aufirst%3DT.%26atitle%3DSelective%2520Distribution%2520of%2520Matrix%2520Metalloproteinase-3%2520%2528MMP-3%2529%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Brain%26jtitle%3DActa%2520Neuropathol.%26date%3D2000%26volume%3D99%26issue%3D2%26spage%3D91%26epage%3D95%26doi%3D10.1007%2FPL00007428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.-J.</span></span> <span> </span><span class="NLM_article-title">MMP13 Inhibition Rescues Cognitive Decline in Alzheimer Transgenic Mice via BACE1 Regulation</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>142</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">192</span>, <span class="refDoi"> DOI: 10.1093/brain/awy305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1093%2Fbrain%2Fawy305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30596903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BB3cnmvVShtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2019&pages=176-192&issue=1&author=B.+L.+Zhuauthor=Y.+Longauthor=W.+Luoauthor=Z.+Yanauthor=Y.+J.+Laiauthor=L.+G.+Zhaoauthor=W.+H.+Zhouauthor=Y.+J.+Wangauthor=L.+L.+Shenauthor=L.+Liuauthor=X.-J.+Dengauthor=X.-F.+Wangauthor=F.+Sunauthor=G.-J.+Chen&title=MMP13+Inhibition+Rescues+Cognitive+Decline+in+Alzheimer+Transgenic+Mice+via+BACE1+Regulation&doi=10.1093%2Fbrain%2Fawy305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">MMP13 inhibition rescues cognitive decline in Alzheimer transgenic mice via BACE1 regulation</span></div><div class="casAuthors">Zhu Bing-Lin; Long Yan; Lai Yu-Jie; Zhao Li-Ge; Liu Lu; Deng Xiao-Juan; Wang Xue-Feng; Chen Guo-Jun; Luo Wei; Yan Zhen; Zhou Wei-Hui; Wang Yan-Jiang; Shen Lin-Lin; Sun Fei</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-192</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MMP13 (matrix metallopeptidase 13) plays a key role in bone metabolism and cancer development, but has no known functions in Alzheimer's disease.  In this study, we used high-throughput small molecule screening in SH-SY5Y cells that stably expressed a luciferase reporter gene driven by the BACE1 (β-site amyloid precursor protein cleaving enzyme 1) promoter, which included a portion of the 5' untranslated region (5'UTR).  We identified that CL82198, a selective inhibitor of MMP13, decreased BACE1 protein levels in cultured neuronal cells.  This effect was dependent on PI3K (phosphatidylinositide 3-kinase) signalling, and was unrelated to BACE1 gene transcription and protein degradation.  Further, we found that eukaryotic translation initiation factor 4B (eIF4B) played a key role, as the mutation of eIF4B at serine 422 (S422R) or deletion of the BACE1 5'UTR attenuated MMP13-mediated BACE1 regulation.  In APPswe/PS1E9 mice, an animal model of Alzheimer's disease, hippocampal Mmp13 knockdown or intraperitoneal CL82198 administration reduced BACE1 protein levels and the related amyloid-β precursor protein processing, amyloid-β load and eIF4B phosphorylation, whereas spatial and associative learning and memory performances were improved.  Collectively, MMP13 inhibition/CL82198 treatment exhibited therapeutic potential for Alzheimer's disease, via the translational regulation of BACE1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT3joSWYgUFxEcLvDNbOD4DfW6udTcc2eZeV6hp4c25W7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cnmvVShtg%253D%253D&md5=06bf76e7aea2af9ad9ede52073fb4035</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawy305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawy305%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DB.%2BL.%26aulast%3DLong%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DLai%26aufirst%3DY.%2BJ.%26aulast%3DZhao%26aufirst%3DL.%2BG.%26aulast%3DZhou%26aufirst%3DW.%2BH.%26aulast%3DWang%26aufirst%3DY.%2BJ.%26aulast%3DShen%26aufirst%3DL.%2BL.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DX.-J.%26aulast%3DWang%26aufirst%3DX.-F.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DG.-J.%26atitle%3DMMP13%2520Inhibition%2520Rescues%2520Cognitive%2520Decline%2520in%2520Alzheimer%2520Transgenic%2520Mice%2520via%2520BACE1%2520Regulation%26jtitle%3DBrain%26date%3D2019%26volume%3D142%26issue%3D1%26spage%3D176%26epage%3D192%26doi%3D10.1093%2Fbrain%2Fawy305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Langenfurth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinnenthal, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinnakota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prinz, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlo, A.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stadelmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siffrin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peaschke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heppner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kettenmann, H.</span></span> <span> </span><span class="NLM_article-title">Membrane-Type 1 Metalloproteinase Is Upregulated in Microglia/brain Macrophages in Neurodegenerative and Neuroinflammatory Diseases</span>. <i>J. Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1002/jnr.23288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fjnr.23288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24323769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2014&pages=275-286&issue=3&author=A.+Langenfurthauthor=J.+L.+Rinnenthalauthor=K.+Vinnakotaauthor=V.+Prinzauthor=A.-S.+Carloauthor=C.+Stadelmannauthor=V.+Siffrinauthor=S.+Peaschkeauthor=M.+Endresauthor=F.+Heppnerauthor=R.+Glassauthor=S.+A.+Wolfauthor=H.+Kettenmann&title=Membrane-Type+1+Metalloproteinase+Is+Upregulated+in+Microglia%2Fbrain+Macrophages+in+Neurodegenerative+and+Neuroinflammatory+Diseases&doi=10.1002%2Fjnr.23288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases</span></div><div class="casAuthors">Langenfurth, Anika; Rinnenthal, Jan Leo; Vinnakota, Katyayni; Prinz, Vincent; Carlo, Anne-Sophie; Stadelmann, Christine; Siffrin, Volker; Peaschke, Susann; Endres, Matthias; Heppner, Frank; Glass, Rainer; Wolf, Susanne A.; Kettenmann, Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-286</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">We previously reported that glioma cells induce the expression of membrane-type 1 metalloproteinase (MT1-MMP or MMP-14) in tumor-assocd. microglia/macrophages and promote tumor growth, whereas MMP-14 expression in microglia under physiol. conditions is very low.  Here, we show that the increase in MMP-14 expression is also found in microglia/macrophages assocd. with neurodegenerative and neuroinflammatory pathologies in mouse models as well as in human biopsies or post-mortem tissue.  We found that microglial/macrophage MMP-14 expression was upregulated in Alzheimer's disease tissue, in active lesions of multiple sclerosis, and in tissue from stage II stroke as well as in the corresponding mouse models for the human diseases.  In contrast, we obsd. no upregulation for MMP-14 in microglia/macrophages in the early phase of stroke or in the corresponding mouse model, in human amyotrophic lateral sclerosis (ALS) tissue or in a mouse model of ALS as well as in human cases of acute brain trauma.  These data indicate that MMP-14 expression is not a general marker for activated microglia/macrophages but is upregulated in defined stages of neuroinflammatory and neurodegenerative diseases and that there is generally a good match between mouse models and human brain pathologies.  © 2013 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyk7U-94DwprVg90H21EOLACvtfcHk0liI3p--uIhD_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvV2hsbbN&md5=45856ef31c1982645c4bc9c12c7f0e6d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fjnr.23288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.23288%26sid%3Dliteratum%253Aachs%26aulast%3DLangenfurth%26aufirst%3DA.%26aulast%3DRinnenthal%26aufirst%3DJ.%2BL.%26aulast%3DVinnakota%26aufirst%3DK.%26aulast%3DPrinz%26aufirst%3DV.%26aulast%3DCarlo%26aufirst%3DA.-S.%26aulast%3DStadelmann%26aufirst%3DC.%26aulast%3DSiffrin%26aufirst%3DV.%26aulast%3DPeaschke%26aufirst%3DS.%26aulast%3DEndres%26aufirst%3DM.%26aulast%3DHeppner%26aufirst%3DF.%26aulast%3DGlass%26aufirst%3DR.%26aulast%3DWolf%26aufirst%3DS.%2BA.%26aulast%3DKettenmann%26aufirst%3DH.%26atitle%3DMembrane-Type%25201%2520Metalloproteinase%2520Is%2520Upregulated%2520in%2520Microglia%252Fbrain%2520Macrophages%2520in%2520Neurodegenerative%2520and%2520Neuroinflammatory%2520Diseases%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2014%26volume%3D92%26issue%3D3%26spage%3D275%26epage%3D286%26doi%3D10.1002%2Fjnr.23288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dawkins, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, D. H.</span></span> <span> </span><span class="NLM_article-title">Insights into the Physiological Function of the β-Amyloid Precursor Protein: Beyond Alzheimer’s Disease</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>129</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">756</span>– <span class="NLM_lpage">769</span>, <span class="refDoi"> DOI: 10.1111/jnc.12675</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fjnc.12675" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24517464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotFentbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2014&pages=756-769&issue=5&author=E.+Dawkinsauthor=D.+H.+Small&title=Insights+into+the+Physiological+Function+of+the+%CE%B2-Amyloid+Precursor+Protein%3A+Beyond+Alzheimer%E2%80%99s+Disease&doi=10.1111%2Fjnc.12675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease</span></div><div class="casAuthors">Dawkins, Edgar; Small, David H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">756-769</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The β-amyloid precursor protein (APP) has been extensively studied for its role as the precursor of the β-amyloid protein (Aβ) of Alzheimer's disease.  However, the normal function of APP remains largely unknown.  This article reviews studies on the structure, expression and post-translational processing of APP, as well as studies on the effects of APPin vitro and in vivo.  We conclude that the published data provide strong evidence that APP has a trophic function.  APP is likely to be involved in neural stem cell development, neuronal survival, neurite outgrowth and neurorepair.  However, the mechanisms by which APP exerts its actions remain to be elucidated.  The available evidence suggests that APP interacts both intracellularly and extracellularly to regulate various signal transduction mechanisms.  This article reviews studies on the structure, expression and post-translational processing of β-amyloid precursor protein (APP), as well as studies on the effects of APP in vitro and in vivo.  We conclude that the published data provide strong evidence that APP has a trophic function.  APP is likely to be involved in neural stem cell development, neuronal survival, neurite outgrowth and neurorepair.  However, the mechanisms by which APP exerts its actions remain to be elucidated.  The available evidence suggests that APP interacts both intracellularly and extracellularly to regulate various signal transduction mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9em4KObLccLVg90H21EOLACvtfcHk0liI3p--uIhD_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotFentbY%253D&md5=0e8bf111322cb475ee2e799038e1aeb9</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12675%26sid%3Dliteratum%253Aachs%26aulast%3DDawkins%26aufirst%3DE.%26aulast%3DSmall%26aufirst%3DD.%2BH.%26atitle%3DInsights%2520into%2520the%2520Physiological%2520Function%2520of%2520the%2520%25CE%25B2-Amyloid%2520Precursor%2520Protein%253A%2520Beyond%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D129%26issue%3D5%26spage%3D756%26epage%3D769%26doi%3D10.1111%2Fjnc.12675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Müller, U. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korte, M.</span></span> <span> </span><span class="NLM_article-title">Not Just Amyloid: Physiological Functions of the Amyloid Precursor Protein Family</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1038/nrn.2017.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrn.2017.29" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28360418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXltl2itr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=281-298&issue=5&author=U.+C.+M%C3%BCllerauthor=T.+Dellerauthor=M.+Korte&title=Not+Just+Amyloid%3A+Physiological+Functions+of+the+Amyloid+Precursor+Protein+Family&doi=10.1038%2Fnrn.2017.29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Not just amyloid: physiological functions of the amyloid precursor protein family</span></div><div class="casAuthors">Mueller, Ulrike C.; Deller, Thomas; Korte, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">281-298</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Amyloid precursor protein (APP) gives rise to the amyloid-β peptide and thus has a key role in the pathogenesis of Alzheimer disease.  By contrast, the physiol. functions of APP and the closely related APP-like proteins (APLPs) remain less well understood.  Studying these physiol. functions has been challenging and has required a careful long-term strategy, including the anal. of different App-knockout and Aplp-knockout mice.  In this Review, we summarize these findings, focusing on the in vivo roles of APP family members and their processing products for CNS development, synapse formation and function, brain injury and neuroprotection, as well as ageing.  In addn., we discuss the implications of APP physiol. for therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptIVhbzrwCcrVg90H21EOLACvtfcHk0liI3p--uIhD_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXltl2itr8%253D&md5=9fae9ec257825e9cf70ed14389ccbbb9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1038%2Fnrn.2017.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn.2017.29%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DU.%2BC.%26aulast%3DDeller%26aufirst%3DT.%26aulast%3DKorte%26aufirst%3DM.%26atitle%3DNot%2520Just%2520Amyloid%253A%2520Physiological%2520Functions%2520of%2520the%2520Amyloid%2520Precursor%2520Protein%2520Family%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2017%26volume%3D18%26issue%3D5%26spage%3D281%26epage%3D298%26doi%3D10.1038%2Fnrn.2017.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span> <span> </span><span class="NLM_article-title">APP Processing in Alzheimer’s Disease</span>. <i>Mol. Brain</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1186/1756-6606-4-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1186%2F1756-6606-4-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21214928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpt1ahtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=3&issue=1&author=Y.+Zhangauthor=R.+Thompsonauthor=H.+Zhangauthor=H.+Xu&title=APP+Processing+in+Alzheimer%E2%80%99s+Disease&doi=10.1186%2F1756-6606-4-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">APP processing in Alzheimer's disease</span></div><div class="casAuthors">Zhang, Yun-wu; Thompson, Robert; Zhang, Han; Xu, Huaxi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>CODEN:
                <span class="NLM_cas:coden">MBORAO</span>;
        ISSN:<span class="NLM_cas:issn">1756-6606</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  An important pathol. feature of Alzheimer's disease (AD) is the presence of extracellular senile plaques in the brain.  Senile plaques are composed of aggregations of small peptides called β-amyloid (Aβ).  Multiple lines of evidence demonstrate that overprodn./aggregation of Aβ in the brain is a primary cause of AD and inhibition of Aβ generation has become a hot topic in AD research.  Aβ is generated from β-amyloid precursor protein (APP) through sequential cleavages first by β-secretase and then by gamma:-secretase complex.  Alternatively, APP can be cleaved by α-secretase within the Aβ domain to release sol. APPα and preclude Aβ generation.  Cleavage of APP by caspases may also contribute to AD pathologies.  Therefore, understanding the metab./processing of APP is crucial for AD therapeutics.  Here we review current knowledge of APP processing regulation as well as the pathophysiol. functions of APP and its metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7EtjtYnHM3rVg90H21EOLACvtfcHk0lgFKOsRL42uJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpt1ahtQ%253D%253D&md5=53536166472a4503c3e71dfc2db605f1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1186%2F1756-6606-4-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-6606-4-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DThompson%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DXu%26aufirst%3DH.%26atitle%3DAPP%2520Processing%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DMol.%2520Brain%26date%3D2011%26volume%3D4%26issue%3D1%26spage%3D3%26doi%3D10.1186%2F1756-6606-4-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coronel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernabeu-Zornoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñiz-Moreno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zambrano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liste, I.</span></span> <span> </span><span class="NLM_article-title">Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">7107</span>– <span class="NLM_lpage">7117</span>, <span class="refDoi"> DOI: 10.1007/s12035-018-0914-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs12035-018-0914-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29383688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVaisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2018&pages=7107-7117&issue=9&author=R.+Coronelauthor=A.+Bernabeu-Zornozaauthor=C.+Palmerauthor=M.+Mu%C3%B1iz-Morenoauthor=A.+Zambranoauthor=E.+Canoauthor=I.+Liste&title=Role+of+Amyloid+Precursor+Protein+%28APP%29+and+Its+Derivatives+in+the+Biology+and+Cell+Fate+Specification+of+Neural+Stem+Cells&doi=10.1007%2Fs12035-018-0914-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells</span></div><div class="casAuthors">Coronel, Raquel; Bernabeu-Zornoza, Adela; Palmer, Charlotte; Muniz-Moreno, Mar; Zambrano, Alberto; Cano, Eva; Liste, Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">7107-7117</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Amyloid precursor protein (APP) is a member of the APP family of proteins, and different enzymic processing leads to the prodn. of several derivs. that are shown to have distinct biol. functions.  APP is involved in the pathol. of Alzheimer's disease (AD), the most common neurodegenerative disorder causing dementia.  Furthermore, it is believed that individuals with Down syndrome (DS) have increased APP expression, due to an extra copy of chromosome 21 (Hsa21), that contains the gene for APP.  Nevertheless, the physiol. function of APP remains unclear.  It is known that APP plays an important role in neural growth and maturation during brain development, possibly by influencing proliferation, cell fate specification and neurogenesis of neural stem cells (NSCs).  Proteolytic cleavage of APP occurs mainly via two mutually exclusive pathways, the non-amyloidogenic pathway or the amyloidogenic pathway.  Other alternative pathways (η-secretase, δ-secretase and meprin pathways) have also been described for the physiol. processing of APP.  The different metabolites generated from these pathways, including sol. APPα (sAPPα), sol. APPβ (sAPPβ), β-amyloid (Aβ) peptides and the APP intracellular domain (AICD), have different functions detd. by their structural differences, equil. and concn. with respect to other fragments derived from APP.  This review discusses recent observations regarding possible functions of APP and its proteolytic derivs. in the biol. and phenotypic specification of NSCs.  This can be important for a better understanding of the pathogenesis and the development of future therapeutic applications for AD and/or DS, diseases in which alterations in neurogenesis have been described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpE0PhCosTk8bVg90H21EOLACvtfcHk0lgFKOsRL42uJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVaisL4%253D&md5=8c320dc5edb2db739b0b59cfb4dc94a8</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1007%2Fs12035-018-0914-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-018-0914-2%26sid%3Dliteratum%253Aachs%26aulast%3DCoronel%26aufirst%3DR.%26aulast%3DBernabeu-Zornoza%26aufirst%3DA.%26aulast%3DPalmer%26aufirst%3DC.%26aulast%3DMu%25C3%25B1iz-Moreno%26aufirst%3DM.%26aulast%3DZambrano%26aufirst%3DA.%26aulast%3DCano%26aufirst%3DE.%26aulast%3DListe%26aufirst%3DI.%26atitle%3DRole%2520of%2520Amyloid%2520Precursor%2520Protein%2520%2528APP%2529%2520and%2520Its%2520Derivatives%2520in%2520the%2520Biology%2520and%2520Cell%2520Fate%2520Specification%2520of%2520Neural%2520Stem%2520Cells%26jtitle%3DMol.%2520Neurobiol.%26date%3D2018%26volume%3D55%26issue%3D9%26spage%3D7107%26epage%3D7117%26doi%3D10.1007%2Fs12035-018-0914-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauritzen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardossi-Piquard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brigham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, J.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranaldi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">St-George-Hyslop, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Thuc, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chami, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunys, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span> <span> </span><span class="NLM_article-title">The β-Secretase-Derived C-Terminal Fragment of APP, C99, But Not A, Is a Key Contributor to Early Intraneuronal Lesions in Triple-Transgenic Mouse Hippocampus</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">16243</span>– <span class="NLM_lpage">16255</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2775-12.2012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.2775-12.2012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23152608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslagurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2012&pages=16243-16255&issue=46&author=I.+Lauritzenauthor=R.+Pardossi-Piquardauthor=C.+Bauerauthor=E.+Brighamauthor=J.-D.+Abrahamauthor=S.+Ranaldiauthor=P.+Fraserauthor=P.+St-George-Hyslopauthor=O.+Le+Thucauthor=V.+Espinauthor=L.+Chamiauthor=J.+Dunysauthor=F.+Checler&title=The+%CE%B2-Secretase-Derived+C-Terminal+Fragment+of+APP%2C+C99%2C+But+Not+A%2C+Is+a+Key+Contributor+to+Early+Intraneuronal+Lesions+in+Triple-Transgenic+Mouse+Hippocampus&doi=10.1523%2FJNEUROSCI.2775-12.2012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase-derived C-terminal fragment of βAPP, C99, but not Aβ, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus</span></div><div class="casAuthors">Lauritzen, Inger; Pardossi-Piquard, Raphaelle; Bauer, Charlotte; Brigham, Elizabeth; Abraham, Jean-Daniel; Ranaldi, Sebastien; Fraser, Paul; St-George-Hyslop, Peter; Le Thuc, Ophelia; Espin, Vanessa; Chami, Linda; Dunys, Julie; Checler, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16243-16255</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Triple-transgenic mice (3xTgAD) overexpressing Swedish-mutated β-amyloid precursor protein (βAPPswe), P310L-Tau (TauP301L), and physiol. levels of M146V-presenilin-1 (PS1M146V) display extracellular amyloid-β peptides (Aβ) deposits and Tau tangles.  More disputed is the observation that these mice accumulate intraneuronal Aβ that has been linked to synaptic dysfunction and cognitive deficits.  Here, we provide immunohistol., genetic, and pharmacol. evidences for early, age-dependent, and hippocampus-specific accumulation of the β-secretase-derived βAPP fragment C99 that is obsd. from 3 mo of age and enhanced by pharmacol. blockade of γ-secretase.  Notably, intracellular Aβ is only detectable several months later and appears, as is the case of C99, in enlarged cathepsin B-pos. structures, while extracellular Aβ deposits are detected ∼12 mo of age and beyond.  Early C99 prodn. occurs mainly in the CA1/subicular interchange area of the hippocampus corresponding to the first region exhibiting plaques and tangles in old mice.  Furthermore, the comparison of 3xTgAD mice with double-transgenic mice bearing the βAPPswe and TauP301L mutations but expressing endogenous PS1 (2xTgAD) demonstrate that C99 accumulation is not accounted for by a loss of function triggered by PS1 mutation that would have prevented C99 secondary cleavage by γ-secretase.  Together, our work identifies C99 as the earliest βAPP catabolite and main contributor to the intracellular βAPP-related immunoreactivity in 3xTgAD mice, suggesting its implication as an initiator of the neurodegenerative process and cognitive alterations taking place in this mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDXJ9_L4EulrVg90H21EOLACvtfcHk0lgFKOsRL42uJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslagurzF&md5=891ceec67b06650dc91133376298f38a</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2775-12.2012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2775-12.2012%26sid%3Dliteratum%253Aachs%26aulast%3DLauritzen%26aufirst%3DI.%26aulast%3DPardossi-Piquard%26aufirst%3DR.%26aulast%3DBauer%26aufirst%3DC.%26aulast%3DBrigham%26aufirst%3DE.%26aulast%3DAbraham%26aufirst%3DJ.-D.%26aulast%3DRanaldi%26aufirst%3DS.%26aulast%3DFraser%26aufirst%3DP.%26aulast%3DSt-George-Hyslop%26aufirst%3DP.%26aulast%3DLe%2BThuc%26aufirst%3DO.%26aulast%3DEspin%26aufirst%3DV.%26aulast%3DChami%26aufirst%3DL.%26aulast%3DDunys%26aufirst%3DJ.%26aulast%3DChecler%26aufirst%3DF.%26atitle%3DThe%2520%25CE%25B2-Secretase-Derived%2520C-Terminal%2520Fragment%2520of%2520APP%252C%2520C99%252C%2520But%2520Not%2520A%252C%2520Is%2520a%2520Key%2520Contributor%2520to%2520Early%2520Intraneuronal%2520Lesions%2520in%2520Triple-Transgenic%2520Mouse%2520Hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D2012%26volume%3D32%26issue%3D46%26spage%3D16243%26epage%3D16255%26doi%3D10.1523%2FJNEUROSCI.2775-12.2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bukhari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glotzbach, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolbe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonhardt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loosse, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T.</span></span> <span> </span><span class="NLM_article-title">Small Things Matter: Implications of APP Intracellular Domain AICD Nuclear Signaling in the Progression and Pathogenesis of Alzheimer’s Disease</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1016/j.pneurobio.2017.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.pneurobio.2017.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28587768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCiu7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2017&pages=189-213&author=H.+Bukhariauthor=A.+Glotzbachauthor=K.+Kolbeauthor=G.+Leonhardtauthor=C.+Loosseauthor=T.+M%C3%BCller&title=Small+Things+Matter%3A+Implications+of+APP+Intracellular+Domain+AICD+Nuclear+Signaling+in+the+Progression+and+Pathogenesis+of+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.pneurobio.2017.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Small things matter: Implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Bukhari, Hassan; Glotzbach, Annika; Kolbe, Katharina; Leonhardt, Gregor; Loosse, Christina; Mueller, Thorsten</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">189-213</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common neurodegenerative disease with tens of millions of people affected worldwide.  The pathogenesis is still poorly understood and various therapeutical approaches targeting the amyloid β (Aβ) peptide, a product of the amyloidogenic cleavage of the amyloid precursor protein (APP), failed.  Moreover, a couple of studies critically questioned the relevance of Aβ in the pathogenesis of AD.  Thus, new ideas need to be studied and one highly interesting hypothesis is the APP mediated signal transduction to the nucleus.  As a consequence nuclear -potentially toxic- structures emerge, which were recently found to a high extent in human AD tissue and thus, may contribute to neurodegeneration.  Relevant for the signaling machinery are modifications at the very C-terminal end of the precursor protein, the APP intracellular domain (AICD).  In this review we update the knowledge on mechanisms on AICD referring to our 2008 article: The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-Relevance for Alzheimer's disease (T. Muller, et al., 2008).  We summarize how AICD is generated and degraded, we describe its intramol. motifs, translational modifications, and how those as well as APP dimerization influence AICD generation and function.  Moreover, we resume the AICD interactome and elucidate AICDs involvement in nuclear signaling, transcriptional regulation, cell death, DNA repair and cell cycle re-entry and we give insights in its physiol. function.  Results are summarized in the comprehensive poster "The world of AICD".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-9zXleK9M27Vg90H21EOLACvtfcHk0ljdRrlg-R095w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCiu7jP&md5=cb30208ad0c6b447bca1caeeeaf9ec7a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2017.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2017.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DBukhari%26aufirst%3DH.%26aulast%3DGlotzbach%26aufirst%3DA.%26aulast%3DKolbe%26aufirst%3DK.%26aulast%3DLeonhardt%26aufirst%3DG.%26aulast%3DLoosse%26aufirst%3DC.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%26atitle%3DSmall%2520Things%2520Matter%253A%2520Implications%2520of%2520APP%2520Intracellular%2520Domain%2520AICD%2520Nuclear%2520Signaling%2520in%2520the%2520Progression%2520and%2520Pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2017%26volume%3D156%26spage%3D189%26epage%3D213%26doi%3D10.1016%2Fj.pneurobio.2017.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, A. J.</span></span> <span> </span><span class="NLM_article-title">β-Amyloid Catabolism: Roles for Neprilysin (NEP) and Other Metallopeptidases?</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>81</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1046/j.1471-4159.2002.00855.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1046%2Fj.1471-4159.2002.00855.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12067222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD38XivVensL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2002&pages=1-8&issue=1&author=J.+A.+Carsonauthor=A.+J.+Turner&title=%CE%B2-Amyloid+Catabolism%3A+Roles+for+Neprilysin+%28NEP%29+and+Other+Metallopeptidases%3F&doi=10.1046%2Fj.1471-4159.2002.00855.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">β-Amyloid catabolism: Roles for neprilysin (NEP) and other metallopeptidases?</span></div><div class="casAuthors">Carson, Julie A.; Turner, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The steady-state level of amyloid β-peptide (Aβ) represents a balance between its biosynthesis from the amyloid precursor protein (APP) through the action of the β- and γ-secretases and its catabolism by a variety of proteolytic enzymes.  Recent attention has focused on members of the neprilysin (NEP) family of zinc metalloproteinases in amyloid metab.  NEP itself degrades both Aβ1-40 and Aβ1-42 in vitro and in vivo, and this metab. is prevented by NEP inhibitors.  Other NEP family members, for example endothelin-converting enzyme, may contribute to amyloid catabolism and may also play a role in neuroprotection.  Another metalloproteinase, insulysin (insulin-degrading enzyme) has also been advocated as an amyloid-degrading enzyme and may contribute more generally to metab. of amyloid-forming peptides.  Other candidate enzymes proposed include angiotensin-converting enzyme, some matrix metalloproteinases, plasmin and, indirectly, thimet oligopeptidase (endopeptidase-24.15).  This review critically evaluates the evidence relating to proteinases implicated in amyloid catabolism.  Therapeutic strategies aimed at promoting Aβ degrdn. may provide a novel approach to the therapy of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1hGDjPTnKErVg90H21EOLACvtfcHk0ljdRrlg-R095w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivVensL4%253D&md5=b6dd1e3da2676578cd6e7ecbf044e84b</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2002.00855.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2002.00855.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarson%26aufirst%3DJ.%2BA.%26aulast%3DTurner%26aufirst%3DA.%2BJ.%26atitle%3D%25CE%25B2-Amyloid%2520Catabolism%253A%2520Roles%2520for%2520Neprilysin%2520%2528NEP%2529%2520and%2520Other%2520Metallopeptidases%253F%26jtitle%3DJ.%2520Neurochem.%26date%3D2002%26volume%3D81%26issue%3D1%26spage%3D1%26epage%3D8%26doi%3D10.1046%2Fj.1471-4159.2002.00855.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span> <span> </span><span class="NLM_article-title">Amyloid Precursor Protein Processing and Alzheimer’s Disease</span>. <i>Annu. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">185</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1146/annurev-neuro-061010-113613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1146%2Fannurev-neuro-061010-113613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21456963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpvVyju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2011&pages=185-204&issue=1&author=R.+J.+O%E2%80%99Brienauthor=P.+C.+Wong&title=Amyloid+Precursor+Protein+Processing+and+Alzheimer%E2%80%99s+Disease&doi=10.1146%2Fannurev-neuro-061010-113613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid precursor protein processing and Alzheimer's disease</span></div><div class="casAuthors">O'Brien, Richard J.; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">185-204</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated and cleaved forms of the microtubule-assocd. protein tau.  Genetic, biochem., and behavioral research suggest that physiol. generation of the neurotoxic Aβ peptide from sequential amyloid precursor protein (APP) proteolysis is the crucial step in the development of AD.  APP is a single-pass transmembrane protein expressed at high levels in the brain and metabolized in a rapid and highly complex fashion by a series of sequential proteases, including the intramembranous γ-secretase complex, which also process other key regulatory mols.  Why Aβ accumulates in the brains of elderly individuals is unclear but could relate to changes in APP metab. or Aβ elimination.  Lessons learned from biochem. and genetic studies of APP processing will be crucial to the development of therapeutic targets to treat AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVXA7Il6AlxLVg90H21EOLACvtfcHk0ljdRrlg-R095w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpvVyju7k%253D&md5=6d186f110797eb5472fbc30fd9d397a6</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1146%2Fannurev-neuro-061010-113613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-neuro-061010-113613%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DR.%2BJ.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DAmyloid%2520Precursor%2520Protein%2520Processing%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2011%26volume%3D34%26issue%3D1%26spage%3D185%26epage%3D204%26doi%3D10.1146%2Fannurev-neuro-061010-113613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasunic, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woods, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotter, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, R.</span></span> <span> </span><span class="NLM_article-title">Proteolysis of Aβ Peptide from Alzheimer Disease Brain by Gelatinase A</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>205</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1755</span>– <span class="NLM_lpage">1761</span>, <span class="refDoi"> DOI: 10.1006/bbrc.1994.2872</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1006%2Fbbrc.1994.2872" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=7811262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK2MXivV2rurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1994&pages=1755-1761&issue=3&author=A.+E.+Roherauthor=T.+C.+Kasunicauthor=A.+S.+Woodsauthor=R.+J.+Cotterauthor=M.+J.+Ballauthor=R.+Fridman&title=Proteolysis+of+A%CE%B2+Peptide+from+Alzheimer+Disease+Brain+by+Gelatinase+A&doi=10.1006%2Fbbrc.1994.2872"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Proteolysis of Aβ peptide from Alzheimer disease brain by gelatinase A</span></div><div class="casAuthors">Roher, A. E.; Kasunic, T. C.; Woods, A. S.; Cotter, R. J.; Ball, M. J.; Bridman, R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1755-61</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">It has been recently reported that the 72 kDa proteolytic enzyme gelatinase A/type IV collagenase/matrix metalloproteinase 2 (MMP2) hydrolyzed the Lys 16-Leu 17 peptide bond of a synthetic decapeptide (YEVHHQKLVFF) representing the sol. Aβ sequence of amino acid residues 10-20.  The aim was to test if this enzyme could also degrade the insol. 40-42 residues long Aβ peptides purified from Alzheimer Disease brain.  The results indicate that MMP2 hydrolyzes Aβ1-40 and Aβ1-42 peptides at Lys 16-Leu 17, at Leu 34-Met 35, and Met 35-Val 36 peptide bonds.  These results suggest that MMP2 has the ability of degrading Aβ of AD in vitro.  If this hydrolysis also occurs in the brain's extracellular matrix, the enzymic action of gelatinase A could prevent the generation of amyloidogenic Aβ1-40(42).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrY2naFWxJm17Vg90H21EOLACvtfcHk0ljdRrlg-R095w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXivV2rurs%253D&md5=4b59b56e98cb4bd7ca28ac3588e03f78</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.1994.2872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.1994.2872%26sid%3Dliteratum%253Aachs%26aulast%3DRoher%26aufirst%3DA.%2BE.%26aulast%3DKasunic%26aufirst%3DT.%2BC.%26aulast%3DWoods%26aufirst%3DA.%2BS.%26aulast%3DCotter%26aufirst%3DR.%2BJ.%26aulast%3DBall%26aufirst%3DM.%2BJ.%26aulast%3DFridman%26aufirst%3DR.%26atitle%3DProteolysis%2520of%2520A%25CE%25B2%2520Peptide%2520from%2520Alzheimer%2520Disease%2520Brain%2520by%2520Gelatinase%2520A%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1994%26volume%3D205%26issue%3D3%26spage%3D1755%26epage%3D1761%26doi%3D10.1006%2Fbbrc.1994.2872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Backstrom, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tökés, Z. A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-β Peptide (1–40)</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">7910</span>– <span class="NLM_lpage">7919</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.16-24-07910.1996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.16-24-07910.1996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=8987819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK28XnsF2nt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=7910-7919&issue=24&author=J.+R.+Backstromauthor=G.+P.+Limauthor=M.+J.+Cullenauthor=Z.+A.+T%C3%B6k%C3%A9s&title=Matrix+Metalloproteinase-9+%28MMP-9%29+Is+Synthesized+in+Neurons+of+the+Human+Hippocampus+and+Is+Capable+of+Degrading+the+Amyloid-%CE%B2+Peptide+%281%E2%80%9340%29&doi=10.1523%2FJNEUROSCI.16-24-07910.1996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40)</span></div><div class="casAuthors">Backstrom, Jon R.; Lim, Giselle P.; Cullen, Michael J.; Toekes, Zoltan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7910-7919</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We reported earlier that the levels of Ca2+-dependent metalloproteinases are increased in Alzheimer's disease (AD) specimens, relative to control specimens.  Here we show that these enzymes are forms of the matrix metalloproteinase MMP-9 (EC 3.4.24.35) and are expressed in the human hippocampus.  Affinity-purified antibodies to MMP-9 labeled pyramidal neurons, but not granular neurons or glial cells.  MMP-9 mRNA is expressed in pyramidal neurons, as detd. with digoxigenin-labeled MMP-9 riboprobes, and the presence of this mRNA is confirmed with reverse transcriptase PCR.  The cellular distribution of MMP-9 is altered in AD because 76% of the total 100 kDa enzyme activity is found in the sol. fraction of control specimens, whereas only 51% is detectable in the same fraction from AD specimens.  The accumulated 100 kDa enzyme from AD brain is latent and can be converted to an active form with aminophenylmercuric acetate.  MMP-9 also is detected in close proximity to extracellular amyloid plaques.  Because a major constituent of plaques is the 4 kDa β-amyloid peptide, synthetic Aβ1-40 was incubated with activated MMP-9.  The enzyme cleaves the peptide at several sites, predominantly at Leu34-Met35 within the membrane-spanning domain.  These results establish that neurons have the capacity to synthesize MMP-9, which, on activation, may degrade extracellular substrates such as β-amyloid.  Because the latent form of MMP-9 accumulates in AD brain, it is hypothesized that the lack of enzyme activation contributes to the accumulation of insol. β-amyloid peptides in plaques.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpADNH9q_TcxbVg90H21EOLACvtfcHk0lg21AO1I21tZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnsF2nt7c%253D&md5=2fd7f6e68d94bc5a5ddcd94f3611e6da</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.16-24-07910.1996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.16-24-07910.1996%26sid%3Dliteratum%253Aachs%26aulast%3DBackstrom%26aufirst%3DJ.%2BR.%26aulast%3DLim%26aufirst%3DG.%2BP.%26aulast%3DCullen%26aufirst%3DM.%2BJ.%26aulast%3DT%25C3%25B6k%25C3%25A9s%26aufirst%3DZ.%2BA.%26atitle%3DMatrix%2520Metalloproteinase-9%2520%2528MMP-9%2529%2520Is%2520Synthesized%2520in%2520Neurons%2520of%2520the%2520Human%2520Hippocampus%2520and%2520Is%2520Capable%2520of%2520Degrading%2520the%2520Amyloid-%25CE%25B2%2520Peptide%2520%25281%25E2%2580%259340%2529%26jtitle%3DJ.%2520Neurosci.%26date%3D1996%26volume%3D16%26issue%3D24%26spage%3D7910%26epage%3D7919%26doi%3D10.1523%2FJNEUROSCI.16-24-07910.1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirrito, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">24566</span>– <span class="NLM_lpage">24574</span>, <span class="refDoi"> DOI: 10.1074/jbc.M602440200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M602440200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16787929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1eqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=24566-24574&issue=34&author=P.+Yanauthor=X.+Huauthor=H.+Songauthor=K.+Yinauthor=R.+J.+Batemanauthor=J.+R.+Cirritoauthor=Q.+Xiaoauthor=F.+F.+Hsuauthor=J.+W.+Turkauthor=J.+Xuauthor=C.+Y.+Hsuauthor=D.+M.+Holtzmanauthor=J.-M.+Lee&title=Matrix+Metalloproteinase-9+Degrades+Amyloid-%CE%B2+Fibrils+in+Vitro+and+Compact+Plaques+in+Situ&doi=10.1074%2Fjbc.M602440200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ</span></div><div class="casAuthors">Yan, Ping; Hu, Xiaoyan; Song, Haowei; Yin, Kejie; Bateman, Randall J.; Cirrito, John R.; Xiao, Qingli; Hsu, Fong F.; Turk, John W.; Xu, Jan; Hsu, Chung Y.; Holtzman, David M.; Lee, Jin-Moo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">24566-24574</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The pathol. hallmark of Alzheimer disease is the senile plaque principally composed of tightly aggregated amyloid-β fibrils (fAβ), which are thought to be resistant to degrdn. and clearance.  In this study, we explored whether proteases capable of degrading sol. Aβ (sAβ) could degrade fAβ as well.  We demonstrate that matrix metalloproteinase-9 (MMP-9) can degrade fAβ and that this ability is not shared by other sAβ-degrading enzymes examd., including endothelin-converting enzyme, insulin-degrading enzyme, and neprilysin. fAβ was decreased in samples incubated with MMP-9 compared with other proteases, assessed using thioflavin-T.  Furthermore, fAβ breakdown with MMP-9 but not with other proteases was demonstrated by TEM.  Proteolytic digests of purified fAβ were analyzed with matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify sites of Aβ that are cleaved during its degrdn.  Only MMP-9 digests contained fragments (Aβ1-20 and Aβ1-30) from fAβ1-42 substrate; the corresponding cleavage sites are thought to be important for β-pleated sheet formation.  To det. whether MMP-9 can degrade plaques formed in vivo, fresh brain slices from aged APP/PS1 mice were incubated with proteases.  MMP-9 digestion resulted in a decrease in thioflavin-S (ThS) staining.  Consistent with a role for endogenous MMP-9 in this process in vivo, MMP-9 immunoreactivity was detected in astrocytes surrounding amyloid plaques in the brains of aged APP/PS1 and APPsw mice, and increased MMP activity was selectively obsd. in compact ThS-pos. plaques.  These findings suggest that MMP-9 can degrade fAβ and may contribute to ongoing clearance of plaques from amyloid-laden brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphNEml788nF7Vg90H21EOLACvtfcHk0lg21AO1I21tZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1eqtrc%253D&md5=e70cd7fec515ff195e0fff84a25fa1f8</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M602440200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M602440200%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DK.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DCirrito%26aufirst%3DJ.%2BR.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DHsu%26aufirst%3DF.%2BF.%26aulast%3DTurk%26aufirst%3DJ.%2BW.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DHsu%26aufirst%3DC.%2BY.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DJ.-M.%26atitle%3DMatrix%2520Metalloproteinase-9%2520Degrades%2520Amyloid-%25CE%25B2%2520Fibrils%2520in%2520Vitro%2520and%2520Compact%2520Plaques%2520in%2520Situ%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D34%26spage%3D24566%26epage%3D24574%26doi%3D10.1074%2Fjbc.M602440200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Guillamon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawhirt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blais, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostagno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghiso, J.</span></span> <span> </span><span class="NLM_article-title">Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">15078</span>– <span class="NLM_lpage">15091</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.610931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M114.610931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25897080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvV2nt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=15078-15091&issue=24&author=M.+Hernandez-Guillamonauthor=S.+Mawhirtauthor=S.+Blaisauthor=J.+Montanerauthor=T.+A.+Neubertauthor=A.+Rostagnoauthor=J.+Ghiso&title=Sequential+Amyloid-%CE%B2+Degradation+by+the+Matrix+Metalloproteases+MMP-2+and+MMP-9&doi=10.1074%2Fjbc.M114.610931"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9</span></div><div class="casAuthors">Hernandez-Guillamon, Mar; Mawhirt, Stephanie; Blais, Steven; Montaner, Joan; Neubert, Thomas A.; Rostagno, Agueda; Ghiso, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15078-15091</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Matrix metalloproteases (MMPs) MMP-2 and MMP-9 have been implicated in the physiol. catabolism of Alzheimer's amyloid-β (Aβ).  Conversely, their assocn. with vascular amyloid deposits, blood-brain barrier disruption, and hemorrhagic transformations after ischemic stroke also highlights their involvement in pathol. processes.  To better understand this dichotomy, recombinant human (rh) MMP-2 and MMP-9 were incubated with Aβ40 and Aβ42, and the resulting proteolytic fragments were assessed via immunopptn. and quant. mass spectrometry.  Both MMPs generated Aβ fragments truncated only at the C terminus, ending at positions 34, 30, and 16.  Using deuterated homologues as internal stds., we obsd. limited and relatively slow degrdn. of Aβ42 by rhMMP-2, although the enzyme cleaved >80% of Aβ40 during the 1st h of incubation.  RhMMP-9 was significantly less effective, particularly in degrading Aβ(1-42), although the targeted peptide bonds were identical.  Using Aβ(1-34) and Aβ(1-30), we demonstrated that these peptides are also substrates for both MMPs, cleaving Aβ(1-34) to produce Aβ(1-30) first and Aβ(1-16) subsequently.  Consistent with the kinetics obsd. with full-length Aβ, rhMMP-9 degraded only a minute fraction of Aβ(1-34) and was even less effective in producing Aβ(1-16).  Further degrdn. of Aβ(1-16) by either MMP-2 or MMP-9 was not obsd. even after prolonged incubation times.  Notably, all MMP-generated C-terminally truncated Aβ fragments were highly sol. and did not exhibit fibrillogenic properties or induce cytotoxicity in human cerebral microvascular endothelial or neuronal cells supporting the notion that these truncated Aβ species are assocd. with clearance mechanisms rather than being key elements in the fibrillogenesis process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZOL0ljnEWorVg90H21EOLACvtfcHk0liELLVFEow1ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvV2nt7k%253D&md5=f72014b81c4af7000f34b608d13f12af</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.610931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.610931%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Guillamon%26aufirst%3DM.%26aulast%3DMawhirt%26aufirst%3DS.%26aulast%3DBlais%26aufirst%3DS.%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DNeubert%26aufirst%3DT.%2BA.%26aulast%3DRostagno%26aufirst%3DA.%26aulast%3DGhiso%26aufirst%3DJ.%26atitle%3DSequential%2520Amyloid-%25CE%25B2%2520Degradation%2520by%2520the%2520Matrix%2520Metalloproteases%2520MMP-2%2520and%2520MMP-9%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26issue%3D24%26spage%3D15078%26epage%3D15091%26doi%3D10.1074%2Fjbc.M114.610931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirrito, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, F.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-Beta Peptide Catabolism</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">10939</span>– <span class="NLM_lpage">10948</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2085-06.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.2085-06.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17065436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFymsLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=10939-10948&issue=43&author=K.-J.+Yinauthor=J.+R.+Cirritoauthor=P.+Yanauthor=X.+Huauthor=Q.+Xiaoauthor=X.+Panauthor=R.+Batemanauthor=H.+Songauthor=F.-F.+Hsuauthor=J.+Turkauthor=J.+Xuauthor=C.+Y.+Hsuauthor=J.+C.+Millsauthor=D.+M.+Holtzmanauthor=J.-M.+Lee&title=Matrix+Metalloproteinases+Expressed+by+Astrocytes+Mediate+Extracellular+Amyloid-Beta+Peptide+Catabolism&doi=10.1523%2FJNEUROSCI.2085-06.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism</span></div><div class="casAuthors">Yin, Ke-Jie; Cirrito, John R.; Yan, Ping; Hu, Xiaoyan; Xiao, Qingli; Pan, Xiaoou; Bateman, Randall; Song, Haowei; Hsu, Fong-Fu; Turk, John; Xu, Jan; Hsu, Chung Y.; Mills, Jason C.; Holtzman, David M.; Lee, Jin-Moo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">10939-10948</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">It has been postulated that the development of amyloid plaques in Alzheimer's disease (AD) may result from an imbalance between the generation and clearance of the amyloid-β peptide (Aβ).  Although familial AD appears to be caused by Aβ over-prodn., sporadic AD (the most prevalent form) may result from impairment in clearance.  Recent evidence suggests that several proteases may contribute to the degrdn. of Aβ.  Furthermore, astrocytes have recently been implicated as a potential cellular mediator of Aβ degrdn.  In this study, we examd. the possibility that matrix metalloproteinases (MMPs), proteases known to be expressed and secreted by astrocytes, could play a role in extracellular Aβ degrdn.  We found that astrocytes surrounding amyloid plaques showed enhanced expression of MMP-2 and MMP-9 in aged amyloid precursor protein (APP)/presenilin 1 mice.  Moreover, astrocyte-conditioned medium (ACM) degraded Aβ, lowering levels and producing several fragments after incubation with synthetic human Aβ1-40 and Aβ1-42.  This activity was attenuated with specific inhibitors of MMP-2 and -9, as well as in ACM derived from mmp-2 or -9 knock-out (KO) mice.  In vivo, significant increases in the steady-state levels of Aβ were found in the brains of mmp-2 and -9 KO mice compared with wild-type controls.  Furthermore, pharmacol. inhibition of the MMPs with N-[(2R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl]-L- tryptophan methylamide (GM 6001) increased brain interstitial fluid Aβ levels and elimination of half-life in APPsw mice.  These results suggest that MMP-2 and -9 may contribute to extracellular brain Aβ clearance by promoting Aβ catabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSWJwEblOMLLVg90H21EOLACvtfcHk0liELLVFEow1ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFymsLjM&md5=0e8675a83cfeb4f9344a37ff47d44e20</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2085-06.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2085-06.2006%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DK.-J.%26aulast%3DCirrito%26aufirst%3DJ.%2BR.%26aulast%3DYan%26aufirst%3DP.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DPan%26aufirst%3DX.%26aulast%3DBateman%26aufirst%3DR.%26aulast%3DSong%26aufirst%3DH.%26aulast%3DHsu%26aufirst%3DF.-F.%26aulast%3DTurk%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DHsu%26aufirst%3DC.%2BY.%26aulast%3DMills%26aufirst%3DJ.%2BC.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DLee%26aufirst%3DJ.-M.%26atitle%3DMatrix%2520Metalloproteinases%2520Expressed%2520by%2520Astrocytes%2520Mediate%2520Extracellular%2520Amyloid-Beta%2520Peptide%2520Catabolism%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26issue%3D43%26spage%3D10939%26epage%3D10948%26doi%3D10.1523%2FJNEUROSCI.2085-06.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koronyo-Hamaoui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koronyo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azoulay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seksenyan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakhsheshian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogeri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farkas, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, M.</span></span> <span> </span><span class="NLM_article-title">Attenuation of AD-like Neuropathology by Harnessing Peripheral Immune Cells: Local Elevation of IL-10 and MMP-9</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1424</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2009.06402.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fj.1471-4159.2009.06402.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19780903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGqtrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2009&pages=1409-1424&issue=6&author=M.+Koronyo-Hamaouiauthor=M.+K.+Koauthor=Y.+Koronyoauthor=D.+Azoulayauthor=A.+Seksenyanauthor=G.+Kunisauthor=M.+Phamauthor=J.+Bakhsheshianauthor=P.+Rogeriauthor=K.+L.+Blackauthor=D.+L.+Farkasauthor=M.+Schwartz&title=Attenuation+of+AD-like+Neuropathology+by+Harnessing+Peripheral+Immune+Cells%3A+Local+Elevation+of+IL-10+and+MMP-9&doi=10.1111%2Fj.1471-4159.2009.06402.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of AD-like neuropathology by harnessing peripheral immune cells: local elevation of IL-10 and MMP-9</span></div><div class="casAuthors">Koronyo-Hamaoui, Maya; Ko, MinHee K.; Koronyo, Yosef; Azoulay, David; Seksenyan, Akop; Kunis, Gilad; Pham, Michael; Bakhsheshian, Joshua; Rogeri, Patricia; Black, Keith L.; Farkas, Daniel L.; Schwartz, Michal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1409-1424</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Immunization with an altered myelin-derived peptide (MOG45D) improves recovery from acute CNS insults, partially via recruitment of monocyte-derived macrophages that locally display a regulatory activity.  Here, we investigated the local alterations in the cellular and mol. immunol. milieu assocd. with attenuation of Alzheimer's disease-like pathol. following immunotherapy.  We found that immunization of amyloid precursor protein/presenilin 1 double-transgenic mice with MOG45D peptide, loaded on dendritic cells, led to a substantial redn. of parenchymal and perivascular amyloid beta (Aβ)-plaque burden and sol. Aβ(1-42) peptide levels as well as reduced astrogliosis and levels of a key glial scar protein (chondroitin sulfate proteoglycan).  These changes were assocd. with a shift in the local innate immune response, manifested by increased Iba1+/CD45high macrophages that engulfed Aβ, reduced pro-inflammatory (tumor necrosis factor-α) and increased anti-inflammatory (interleukin-10) cytokines, as well as a significant increase in growth factors (IGF-1 and TGFβ) in the brain.  Furthermore, the levels of matrix metalloproteinase-9, an enzyme shown to degrade Aβ and is assocd. with glial scar formation, were significantly elevated in the brain following immunization.  Altogether, these results indicate that boosting systemic immune cells leads to a local immunomodulation manifested by elevated levels of anti-inflammatory cytokines and metalloproteinases that contribute to ameliorating Alzheimer's disease pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru6rP_iiSL6LVg90H21EOLACvtfcHk0lgDFAMl8lrOow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGqtrjP&md5=cda5be12bdac04ebe4fb719087b8b0ae</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.06402.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.06402.x%26sid%3Dliteratum%253Aachs%26aulast%3DKoronyo-Hamaoui%26aufirst%3DM.%26aulast%3DKo%26aufirst%3DM.%2BK.%26aulast%3DKoronyo%26aufirst%3DY.%26aulast%3DAzoulay%26aufirst%3DD.%26aulast%3DSeksenyan%26aufirst%3DA.%26aulast%3DKunis%26aufirst%3DG.%26aulast%3DPham%26aufirst%3DM.%26aulast%3DBakhsheshian%26aufirst%3DJ.%26aulast%3DRogeri%26aufirst%3DP.%26aulast%3DBlack%26aufirst%3DK.%2BL.%26aulast%3DFarkas%26aufirst%3DD.%2BL.%26aulast%3DSchwartz%26aufirst%3DM.%26atitle%3DAttenuation%2520of%2520AD-like%2520Neuropathology%2520by%2520Harnessing%2520Peripheral%2520Immune%2520Cells%253A%2520Local%2520Elevation%2520of%2520IL-10%2520and%2520MMP-9%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D111%26issue%3D6%26spage%3D1409%26epage%3D1424%26doi%3D10.1111%2Fj.1471-4159.2009.06402.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fragkouli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsilibary, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tzinia, A. K.</span></span> <span> </span><span class="NLM_article-title">Neuroprotective Role of MMP-9 Overexpression in the Brain of Alzheimer’s 5xFAD Mice</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2014.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.nbd.2014.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25008761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlCjsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2014&pages=179-189&author=A.+Fragkouliauthor=E.+C.+Tsilibaryauthor=A.+K.+Tzinia&title=Neuroprotective+Role+of+MMP-9+Overexpression+in+the+Brain+of+Alzheimer%E2%80%99s+5xFAD+Mice&doi=10.1016%2Fj.nbd.2014.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice</span></div><div class="casAuthors">Fragkouli, Apostolia; Tsilibary, Effie C.; Tzinia, Athina K.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">179-189</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Accumulation of amyloid-β (Αβ) peptide is believed to play a central role in the pathogenesis of Alzheimer's disease (AD).  Lowering Aβ levels in the brain may thus improve synaptic and cognitive deficits obsd. in AD patients.  In the non-amyloidogenic pathway, the amyloid-β precursor protein (APP) is cleaved within the Aβ peptide sequence by α-secretases, giving rise to the potent neurotrophic N-terminal fragment sΑPPα.  We have previously reported that gelatinase B/matrix metalloproteinase 9 (MMP-9), a matrix metalloproteinase critically involved in neuronal plasticity, acts as α-secretase both in vitro and in vivo and reduces Aβ levels in vitro.  In the present study, we demonstrate that neuronal overexpression of MMP-9 in a transgenic AD mouse model harboring five familial AD-related mutations (5xFAD) resulted in increased sAPPα levels and decreased Aβ oligomers without affecting amyloid plaque load in the brain.  Functionally, overexpression of MMP-9 prevented the cognitive deficits displayed by 5xFAD mice, an improvement that was accompanied by increased levels of the pre-synaptic protein synaptophysin and mature brain-derived neurotrophic factor (BDNF) in the brain.  These results suggest that in vivo activation of endogenous MMP-9 could be a promising target for interference with development and/or progression of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBRqVJAyoPBbVg90H21EOLACvtfcHk0lgDFAMl8lrOow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlCjsbnF&md5=59028958f6f956f9880a2c67b78e5432</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2014.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2014.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DFragkouli%26aufirst%3DA.%26aulast%3DTsilibary%26aufirst%3DE.%2BC.%26aulast%3DTzinia%26aufirst%3DA.%2BK.%26atitle%3DNeuroprotective%2520Role%2520of%2520MMP-9%2520Overexpression%2520in%2520the%2520Brain%2520of%2520Alzheimer%25E2%2580%2599s%25205xFAD%2520Mice%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2014%26volume%3D70%26spage%3D179%26epage%3D189%26doi%3D10.1016%2Fj.nbd.2014.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruno, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mufson, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuello, A. C.</span></span> <span> </span><span class="NLM_article-title">Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment</span>. <i>J. Neuropathol. Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1309</span>– <span class="NLM_lpage">1318</span>, <span class="refDoi"> DOI: 10.1097/NEN.0b013e3181c22569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1097%2FNEN.0b013e3181c22569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19915485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVOhtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2009&pages=1309-1318&issue=12&author=M.+A.+Brunoauthor=E.+J.+Mufsonauthor=J.+Wuuauthor=A.+C.+Cuello&title=Increased+Matrix+Metalloproteinase+9+Activity+in+Mild+Cognitive+Impairment&doi=10.1097%2FNEN.0b013e3181c22569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment</span></div><div class="casAuthors">Bruno, Martin A.; Mufson, Elliott J.; Wuu, Joanne; Cuello, A. Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuropathology & Experimental Neurology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1309-1318</span>CODEN:
                <span class="NLM_cas:coden">JNENAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-3069</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Nerve growth factor (NGF)-dependent cholinergic basal forebrain neurons degenerate during the progression of Alzheimer disease (AD).  Elevated proNGF and reduced levels of the TrkA high-affinity NGF receptor occur in prodromal and advanced stages of AD.  We recently described a protease cascade responsible for the conversion of proNGF to mature NGF (mNGF) in which matrix metalloproteinase 9 (MMP-9) degrades mNGF in the extracellular space.  To det. whether this proteolytic cascade is altered during the progression of AD, we examd. human frontal and parietal cortex tissues from aged subjects with a clin. diagnosis of AD, mild cognitive impairment, or no cognitive impairment.  The anal. demonstrated greater MMP-9 activity in both AD and mild cognitive impairment compared with no cognitive impairment brain samples (p < 0.01), which supports the notion that a metabolic failure in the NGF-maturation/degrdn. pathway may be assocd. with an exacerbated degrdn. of mNGF in the cerebral cortex in early AD.  Moreover, there were inverse correlations between Global Cognitive Score and Mini-Mental State Examn. score and MMP-9 activity.  These findings suggest that a redn. in mNGF as a consequence of MMP-9-mediated degrdn. may in part underlie the pathogenesis of cognitive deficits in mild cognitive impairment and AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwo15Y4xpt27Vg90H21EOLACvtfcHk0ljIGwVX0ConOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVOhtLvL&md5=fa3e9f900180eaa2c11397038542f971</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1097%2FNEN.0b013e3181c22569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNEN.0b013e3181c22569%26sid%3Dliteratum%253Aachs%26aulast%3DBruno%26aufirst%3DM.%2BA.%26aulast%3DMufson%26aufirst%3DE.%2BJ.%26aulast%3DWuu%26aufirst%3DJ.%26aulast%3DCuello%26aufirst%3DA.%2BC.%26atitle%3DIncreased%2520Matrix%2520Metalloproteinase%25209%2520Activity%2520in%2520Mild%2520Cognitive%2520Impairment%26jtitle%3DJ.%2520Neuropathol.%2520Exp.%2520Neurol.%26date%3D2009%26volume%3D68%26issue%3D12%26spage%3D1309%26epage%3D1318%26doi%3D10.1097%2FNEN.0b013e3181c22569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilcock, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ridnour, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wink, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colton, C. A.</span></span> <span> </span><span class="NLM_article-title">Activation of Matrix Metalloproteinases Following Anti-Aβ Immunotherapy; Implications for Microhemorrhage Occurrence</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">115</span>, <span class="refDoi"> DOI: 10.1186/1742-2094-8-115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1186%2F1742-2094-8-115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21906275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlajs77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=115&author=D.+M.+Wilcockauthor=D.+Morganauthor=M.+N.+Gordonauthor=T.+L.+Taylorauthor=L.+A.+Ridnourauthor=D.+A.+Winkauthor=C.+A.+Colton&title=Activation+of+Matrix+Metalloproteinases+Following+Anti-A%CE%B2+Immunotherapy%3B+Implications+for+Microhemorrhage+Occurrence&doi=10.1186%2F1742-2094-8-115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of matrix metalloproteinases following anti-Aβ immunotherapy; implications for microhemorrhage occurrence</span></div><div class="casAuthors">Wilcock, Donna M.; Morgan, Dave; Gordon, Marcia N.; Taylor, Tiffany L.; Ridnour, Lisa A.; Wink, David A.; Colton, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Anti-Aβ immunotherapy is a promising approach to the prevention and treatment of Alzheimer's disease (AD) currently in clin. trials.  There is extensive evidence, both in mice and humans that a significant adverse event is the occurrence of microhemorrhages.  Also, vasogenic edema was reported in phase 2 of a passive immunization clin. trial.  In order to overcome these vascular adverse effects it is crit. that we understand the mechanism(s) by which they occur.  Methods: We have examd. the matrix metalloproteinase (MMP) protein degrdn. system in two previously published anti-Aβ immunotherapy studies.  The first was a passive immunization study in which we examd. 22 mo old APPSw mice that had received anti-Aβ antibodies for 1, 2 or 3 mo.  The second is an active vaccination study in which we examd. 16 mo old APPSw/NOS2-/- mice treated with Aβ vaccination for 4 mo.  Results: There is a significant activation of the MMP2 and MMP9 proteinase degrdn. systems by anti-Aβ immunotherapy, regardless of whether this is delivered through active vaccination or passive immunization.  We have characterized this activation by gene expression, protein expression and zymog. assessment of MMP activity.  Conclusions: Since the MMP2 and MMP9 systems are heavily implicated in the pathophysiol. of intracerbral hemorrhage, these data may provide a potential mechanism of microhemorrhage due to immunotherapy.  Increased activity of the MMP system, therefore, is likely to be a major factor in increased microhemorrhage occurrence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTafVW7HjmrLVg90H21EOLACvtfcHk0ljIGwVX0ConOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlajs77I&md5=39c3a215f1c8fbac9e68c09415b2c26b</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-8-115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-8-115%26sid%3Dliteratum%253Aachs%26aulast%3DWilcock%26aufirst%3DD.%2BM.%26aulast%3DMorgan%26aufirst%3DD.%26aulast%3DGordon%26aufirst%3DM.%2BN.%26aulast%3DTaylor%26aufirst%3DT.%2BL.%26aulast%3DRidnour%26aufirst%3DL.%2BA.%26aulast%3DWink%26aufirst%3DD.%2BA.%26aulast%3DColton%26aufirst%3DC.%2BA.%26atitle%3DActivation%2520of%2520Matrix%2520Metalloproteinases%2520Following%2520Anti-A%25CE%25B2%2520Immunotherapy%253B%2520Implications%2520for%2520Microhemorrhage%2520Occurrence%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2011%26volume%3D8%26spage%3D115%26doi%3D10.1186%2F1742-2094-8-115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bell, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagare, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deane, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holtzman, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betsholtz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armulik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sallstrom, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berk, B. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">Apolipoprotein E Controls Cerebrovascular Integrity via Cyclophilin A</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span> (<span class="NLM_issue">7399</span>),  <span class="NLM_fpage">512</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1038/nature11087</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnature11087" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=22622580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38Xntl2js78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=512-516&issue=7399&author=R.+D.+Bellauthor=E.+A.+Winklerauthor=I.+Singhauthor=A.+P.+Sagareauthor=R.+Deaneauthor=Z.+Wuauthor=D.+M.+Holtzmanauthor=C.+Betsholtzauthor=A.+Armulikauthor=J.+Sallstromauthor=B.+C.+Berkauthor=B.+V.+Zlokovic&title=Apolipoprotein+E+Controls+Cerebrovascular+Integrity+via+Cyclophilin+A&doi=10.1038%2Fnature11087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Apolipoprotein E controls cerebrovascular integrity via cyclophilin A</span></div><div class="casAuthors">Bell, Robert D.; Winkler, Ethan A.; Singh, Itender; Sagare, Abhay P.; Deane, Rashid; Wu, Zhenhua; Holtzman, David M.; Betsholtz, Christer; Armulik, Annika; Sallstrom, Jan; Berk, Bradford C.; Zlokovic, Berislav V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7399</span>),
    <span class="NLM_cas:pages">512-516</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human apolipoprotein E has three isoforms: APOE2, APOE3 and APOE4.  APOE4 is a major genetic risk factor for Alzheimer's disease and is assocd. with Down's syndrome dementia and poor neurol. outcome after traumatic brain injury and hemorrhage.  Neurovascular dysfunction is present in normal APOE4 carriers and individuals with APOE4-assocd. disorders.  In mice, lack of Apoe leads to blood-brain barrier (BBB) breakdown, whereas APOE4 increases BBB susceptibility to injury.  How APOE genotype affects brain microcirculation remains elusive.  Using different APOE transgenic mice, including mice with ablation and/or inhibition of cyclophilin A (CypA), here we show that expression of APOE4 and lack of murine Apoe, but not APOE2 and APOE3, leads to BBB breakdown by activating a proinflammatory CypA-nuclear factor-κB-matrix-metalloproteinase-9 pathway in pericytes.  This, in turn, leads to neuronal uptake of multiple blood-derived neurotoxic proteins, and microvascular and cerebral blood flow redns.  We show that the vascular defects in Apoe-deficient and APOE4-expressing mice precede neuronal dysfunction and can initiate neurodegenerative changes.  Astrocyte-secreted APOE3, but not APOE4, suppressed the CypA-nuclear factor-κB-matrix-metalloproteinase-9 pathway in pericytes through a lipoprotein receptor.  Our data suggest that CypA is a key target for treating APOE4-mediated neurovascular injury and the resulting neuronal dysfunction and degeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVs8RaZyMcF7Vg90H21EOLACvtfcHk0ljIGwVX0ConOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xntl2js78%253D&md5=bc9f5173cc57165193023091edb70d89</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnature11087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11087%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DR.%2BD.%26aulast%3DWinkler%26aufirst%3DE.%2BA.%26aulast%3DSingh%26aufirst%3DI.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DDeane%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DBetsholtz%26aufirst%3DC.%26aulast%3DArmulik%26aufirst%3DA.%26aulast%3DSallstrom%26aufirst%3DJ.%26aulast%3DBerk%26aufirst%3DB.%2BC.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DApolipoprotein%2520E%2520Controls%2520Cerebrovascular%2520Integrity%2520via%2520Cyclophilin%2520A%26jtitle%3DNature%26date%3D2012%26volume%3D485%26issue%3D7399%26spage%3D512%26epage%3D516%26doi%3D10.1038%2Fnature11087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Nostrand, W. E.</span></span> <span> </span><span class="NLM_article-title">Degradation of Soluble and Fibrillar Amyloid β-Protein by Matrix Metalloproteinase (MT1-MMP) in Vitro</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1127</span>– <span class="NLM_lpage">1136</span>, <span class="refDoi"> DOI: 10.1021/bi901994d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi901994d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnvFSkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=1127-1136&issue=6&author=M.+C.+Liaoauthor=W.+E.+Van+Nostrand&title=Degradation+of+Soluble+and+Fibrillar+Amyloid+%CE%B2-Protein+by+Matrix+Metalloproteinase+%28MT1-MMP%29+in+Vitro&doi=10.1021%2Fbi901994d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Degradation of soluble and fibrillar amyloid β-protein by matrix metalloproteinase (MT1-MMP) in vitro</span></div><div class="casAuthors">Liao, Mei-Chen; Van Nostrand, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1127-1136</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The progressive accumulation of β-amyloid (Aβ) in senile plaques and in the cerebral vasculature is the hallmark of Alzheimer's disease and related disorders.  Degrdn. of Aβ by specific proteolytic enzymes is an important process that regulates its levels in brain.  Matrix metalloproteinase 2 (MMP2) was shown to be expressed in reactive astrocytes surrounding amyloid plaques and may contribute to Aβ degrdn.  Membrane type 1 (MT1) MMP is the physiol. activator for the zymogen pro-MMP2.  Here, we show that, in addn. to MMP2, its activator MT1-MMP is also expressed in reactive astrocytes in regions with amyloid deposits in transgenic mice.  Using a Cos-1 cell expression system, we demonstrated that MT1-MMP can degrade exogenous Aβ40 and Aβ42.  A purified sol. form of MT1-MMP degraded both sol. and fibrillar Aβ peptides in a time-dependent manner, yielding specific degrdn. products.  Mass spectrometry anal. identified multiple MT1-MMP cleavage sites on sol. Aβ40 and Aβ42.  MT1-MMP-mediated Aβ degrdn. was inhibited with the general MMP inhibitor GM6001 or the specific MT1-MMP inhibitor tissue inhibitor of metalloproteinases 2.  Furthermore, in situ expts. showed that purified MT1-MMP degraded parenchymal fibrillar amyloid plaques that form in the brains of Aβ precursor protein transgenic mice.  Together, these findings indicate that MT1-MMP possesses Aβ degrading activity in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9nRa-vya6C7Vg90H21EOLACvtfcHk0lgt8Bw5TLOb-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnvFSkug%253D%253D&md5=09b9144ae8f1a1999f397c3cc81e97be</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fbi901994d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi901994d%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DM.%2BC.%26aulast%3DVan%2BNostrand%26aufirst%3DW.%2BE.%26atitle%3DDegradation%2520of%2520Soluble%2520and%2520Fibrillar%2520Amyloid%2520%25CE%25B2-Protein%2520by%2520Matrix%2520Metalloproteinase%2520%2528MT1-MMP%2529%2520in%2520Vitro%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26issue%3D6%26spage%3D1127%26epage%3D1136%26doi%3D10.1021%2Fbi901994d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poteet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.-H.</span></span> <span> </span><span class="NLM_article-title">Regulation of Matrix Metalloproteinase 2 by Oligomeric Amyloid β Protein</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1387</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2011.02.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.brainres.2011.02.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21376707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXksFensLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1387&publication_year=2011&pages=141-148&author=W.+Liauthor=E.+Poteetauthor=L.+Xieauthor=R.+Liuauthor=Y.+Wenauthor=S.-H.+Yang&title=Regulation+of+Matrix+Metalloproteinase+2+by+Oligomeric+Amyloid+%CE%B2+Protein&doi=10.1016%2Fj.brainres.2011.02.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein</span></div><div class="casAuthors">Li, Wenjun; Poteet, Ethan; Xie, Luokun; Liu, Ran; Wen, Yi; Yang, Shao-Hua</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1387</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">141-148</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are a group of proteinases that degrade components of the extracellular matrix (ECM).  There is increasing evidence for a link between the activation of MMPs and Alzheimer's disease (AD) pathogenesis, in which both beneficial and detrimental actions of MMPs have been suggested.  It has been demonstrated that MMPs could degrade amyloid β (Aβ) and play important roles in the extracellular Aβ catabolism and clearance.  On the other hand, MMPs could contribute to AD pathogenesis by compromising the blood brain barrier and promoting neurodegeneration.  In the present study, we obsd. that oligomeric Aβ regulates MMP2 expression in a paradoxical manner.  In rat primary astrocyte cultures, oligomeric Aβ down-regulated MMP2 transcription and reduced its extracellular activity.  However, in a widely used mouse model for AD, immunohistochem. demonstrated an increase of MMP2 expression in astrocytes surrounding senile plaques in APP/PS1 transgenic mice brains.  Using real-time PCR, we found that the MMP2 mRNA level was elevated in APP/PS1 transgenic mice brains.  In addn., elevated mRNA levels of MMP stimulating cytokines such as IL-1β and TGFβ were found in the brains of APP/PS1 mice.  Our study suggests a complex regulation of MMP2 expression by oligomeric Aβ in astrocytes.  While oligomeric Aβ directly down-regulates MMP2 expression and activation in astrocytes, it induces prodn. of proinflammatory cytokines which could serve as strong stimulators for MMP2.  Therefore, the ultimate outcome of the oligomeric Aβ on MMP2 activation in astrocytes might be the combination of its direct inhibitory action on astrocyte MMP2 expression and the secondary action of inducing inflammatory cytokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJsMP3gCEirLVg90H21EOLACvtfcHk0lgt8Bw5TLOb-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXksFensLY%253D&md5=4d71423312854581a412f0359a040652</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2011.02.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2011.02.078%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DW.%26aulast%3DPoteet%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DWen%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DS.-H.%26atitle%3DRegulation%2520of%2520Matrix%2520Metalloproteinase%25202%2520by%2520Oligomeric%2520Amyloid%2520%25CE%25B2%2520Protein%26jtitle%3DBrain%2520Res.%26date%3D2011%26volume%3D1387%26spage%3D141%26epage%3D148%26doi%3D10.1016%2Fj.brainres.2011.02.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shlosberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benifla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaufer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, A.</span></span> <span> </span><span class="NLM_article-title">Blood-brain Barrier Breakdown as a Therapeutic Target in Traumatic Brain Injury</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">403</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2010.74</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrneurol.2010.74" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20551947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovFKgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=393-403&issue=7&author=D.+Shlosbergauthor=M.+Beniflaauthor=D.+Kauferauthor=A.+Friedman&title=Blood-brain+Barrier+Breakdown+as+a+Therapeutic+Target+in+Traumatic+Brain+Injury&doi=10.1038%2Fnrneurol.2010.74"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury</span></div><div class="casAuthors">Shlosberg, Dan; Benifla, Mony; Kaufer, Daniela; Friedman, Alon</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">393-403</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Many individuals who survive traumatic brain injury (TBI) experience long-term complications.  The prevention and management of such complications, however, remain challenging goals for clinicians.  Here, Shlosberg and colleague examine the role of blood-brain barrier (BBB) breakdown in the pathophysiol. of TBI, particularly in the development of delayed TBI-related conditions.  The authors also discuss novel BBB-targeted therapeutic strategies that might be explored to counter or prevent long-term complications in patients.  Traumatic brain injury (TBI) is the leading cause of death in young adults and children.  The treatment of TBI in the acute phase has improved substantially; however, the prevention and management of long-term complications remain a challenge.  Blood-brain barrier (BBB) breakdown has often been documented in patients with TBI, but the role of such vascular pathol. in neurol. dysfunction has only recently been explored.  Animal studies have demonstrated that BBB breakdown is involved in the initiation of transcriptional changes in the neurovascular network that ultimately lead to delayed neuronal dysfunction and degeneration.  Brain imaging data have confirmed the high incidence of BBB breakdown in patients with TBI and suggest that such pathol. could be used as a biomarker in the clinic and in drug trials.  Here, we review the neurol. consequences of TBI, focusing on the long-term complications of such injuries.  We present the clin. evidence for involvement of BBB breakdown in TBI and examine the primary and secondary mechanisms that underlie such pathol.  We go on to consider the consequences of BBB injury, before analyzing potential mechanisms linking vascular pathol. to neuronal dysfunction and degeneration, and exploring possible targets for treatment.  Finally, we highlight areas for future basic research and clin. studies into TBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzyKlkmddfl7Vg90H21EOLACvtfcHk0lhjgxz-DlG_vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovFKgt7g%253D&md5=dfe95442a1bdf7c56253656e78890b6c</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2010.74&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2010.74%26sid%3Dliteratum%253Aachs%26aulast%3DShlosberg%26aufirst%3DD.%26aulast%3DBenifla%26aufirst%3DM.%26aulast%3DKaufer%26aufirst%3DD.%26aulast%3DFriedman%26aufirst%3DA.%26atitle%3DBlood-brain%2520Barrier%2520Breakdown%2520as%2520a%2520Therapeutic%2520Target%2520in%2520Traumatic%2520Brain%2520Injury%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2010%26volume%3D6%26issue%3D7%26spage%3D393%26epage%3D403%26doi%3D10.1038%2Fnrneurol.2010.74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagare, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">Blood-brain Barrier Breakdown in Alzheimer Disease and Other Neurodegenerative Disorders</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">133</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2017.188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnrneurol.2017.188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29377008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVeqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=133-150&issue=3&author=M.+D.+Sweeneyauthor=A.+P.+Sagareauthor=B.+V.+Zlokovic&title=Blood-brain+Barrier+Breakdown+in+Alzheimer+Disease+and+Other+Neurodegenerative+Disorders&doi=10.1038%2Fnrneurol.2017.188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders</span></div><div class="casAuthors">Sweeney, Melanie D.; Sagare, Abhay P.; Zlokovic, Berislav V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">133-150</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The blood-brain barrier (BBB) is a continuous endothelial membrane within brain microvessels that has sealed cell-to-cell contacts and is sheathed by mural vascular cells and perivascular astrocyte end-feet.  The BBB protects neurons from factors present in the systemic circulation and maintains the highly regulated CNS internal milieu, which is required for proper synaptic and neuronal functioning.  BBB disruption allows influx into the brain of neurotoxic blood-derived debris, cells and microbial pathogens and is assocd. with inflammatory and immune responses, which can initiate multiple pathways of neurodegeneration.  This Review discusses neuroimaging studies in the living human brain and post-mortem tissue as well as biomarker studies demonstrating BBB breakdown in Alzheimer disease, Parkinson disease, Huntington disease, amyotrophic lateral sclerosis, multiple sclerosis, HIV-1-assocd. dementia and chronic traumatic encephalopathy.  The pathogenic mechanisms by which BBB breakdown leads to neuronal injury, synaptic dysfunction, loss of neuronal connectivity and neurodegeneration are described.  The importance of a healthy BBB for therapeutic drug delivery and the adverse effects of disease-initiated, pathol. BBB breakdown in relation to brain delivery of neuropharmaceuticals are briefly discussed.  Finally, future directions, gaps in the field and opportunities to control the course of neurol. diseases by targeting the BBB are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpthNnwB5Wnc7Vg90H21EOLACvtfcHk0lhjgxz-DlG_vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVeqtbk%253D&md5=2756dc089ed4b6595e4aca5eb6cd9314</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2017.188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2017.188%26sid%3Dliteratum%253Aachs%26aulast%3DSweeney%26aufirst%3DM.%2BD.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DBlood-brain%2520Barrier%2520Breakdown%2520in%2520Alzheimer%2520Disease%2520and%2520Other%2520Neurodegenerative%2520Disorders%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2018%26volume%3D14%26issue%3D3%26spage%3D133%26epage%3D150%26doi%3D10.1038%2Fnrneurol.2017.188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giannoni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango-Lievano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das Neves, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rousset, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanneteau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claeysen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchi, N.</span></span> <span> </span><span class="NLM_article-title">Cerebrovascular Pathology during the Progression of Experimental Alzheimer’s Disease</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2016.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.nbd.2016.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26774030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2016&pages=107-117&author=P.+Giannoniauthor=M.+Arango-Lievanoauthor=I.+Das+Nevesauthor=M.-C.+Roussetauthor=K.+Barangerauthor=S.+Riveraauthor=F.+Jeanneteauauthor=S.+Claeysenauthor=N.+Marchi&title=Cerebrovascular+Pathology+during+the+Progression+of+Experimental+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.nbd.2016.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrovascular pathology during the progression of experimental Alzheimer's disease</span></div><div class="casAuthors">Giannoni, Patrizia; Arango-Lievano, Margarita; Neves, Ines Das; Rousset, Marie-Claude; Baranger, Kevin; Rivera, Santiago; Jeanneteau, Freddy; Claeysen, Sylvie; Marchi, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Clin. and exptl. evidence point to a possible role of cerebrovascular dysfunction in Alzheimer's disease (AD).  The 5xFAD mouse model of AD expresses human amyloid precursor protein and presenilin genes with mutations found in AD patients.  It remains unknown whether amyloid deposition driven by these mutations is assocd. with cerebrovascular changes.  5XFAD and wild type mice (2 to 12 mo old; M2 to M12) were used.  Thinned skull in vivo 2-photon microscopy was used to det. Aβ accumulation on leptomeningeal or superficial cortical vessels over time.  Parenchymal microvascular damage was assessed using FITC-microangiog.  Collagen-IV and CD31 were used to stain basal lamina and endothelial cells.  Methoxy-XO4, Thioflavin-S or 6E10 were used to visualize Aβ accumulation in living mice or in fixed brain tissues.  Positioning of reactive IBA1 microglia and GFAP astrocytes at the vasculature was rendered using confocal microscopy.  Platelet-derived growth factor receptor beta (PDGFRβ) staining was used to visualize perivascular pericytes.  In vivo 2-photon microscopy revealed Methoxy-XO4+ amyloid perivascular deposits on leptomeningeal and penetrating cortical vessels in 5xFAD mice, typical of cerebral amyloid angiopathy (CAA).  Amyloid deposits were visible in vivo at M3 and aggravated over time.  Progressive microvascular damage was concomitant to parenchymal Aβ plaque accumulation in 5xFAD mice.  Microvascular inflammation in 5xFAD mice presented with sporadic FITC-albumin leakages at M4 becoming more prevalent at M9 and M12. 3D colocalization showed inflammatory IBA1+ microglia proximal to microvascular FITC-albumin leaks.  The no. of perivascular PDGFRβ+ pericytes was significantly decreased at M4 in the fronto-parietal cortices, with a trend decrease obsd. in the other structures.  At M9-M12, PDGFRβ+ pericytes displayed hypertrophic perivascular ramifications contiguous to reactive microglia.  Cerebral amyloid angiopathy and microvascular inflammation occur in 5xFAD mice concomitantly to parenchymal plaque deposition.  The prospect of cerebrovascular pharmacol. in AD is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphspRxMza3jrVg90H21EOLACvtfcHk0lhjgxz-DlG_vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSntL8%253D&md5=55e32de8e42e02aec08cf6314867ba54</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2016.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2016.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DGiannoni%26aufirst%3DP.%26aulast%3DArango-Lievano%26aufirst%3DM.%26aulast%3DDas%2BNeves%26aufirst%3DI.%26aulast%3DRousset%26aufirst%3DM.-C.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DS.%26aulast%3DJeanneteau%26aufirst%3DF.%26aulast%3DClaeysen%26aufirst%3DS.%26aulast%3DMarchi%26aufirst%3DN.%26atitle%3DCerebrovascular%2520Pathology%2520during%2520the%2520Progression%2520of%2520Experimental%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2016%26volume%3D88%26spage%3D107%26epage%3D117%26doi%3D10.1016%2Fj.nbd.2016.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terni, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span> <span> </span><span class="NLM_article-title">Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer’s Disease-Related Pathology</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">469</span>, <span class="refDoi"> DOI: 10.3233/JAD-142460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3233%2FJAD-142460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26402409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps12ls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2015&pages=461-469&issue=2&author=B.+Terniauthor=I.+Ferrer&title=Abnormal+Expression+and+Distribution+of+MMP2+at+Initial+Stages+of+Alzheimer%E2%80%99s+Disease-Related+Pathology&doi=10.3233%2FJAD-142460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology</span></div><div class="casAuthors">Terni, Beatrice; Ferrer, Isidro; Alafuzoff, Irina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">461-469</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Previous studies have shown that metalloproteinases (MMPs) participate in the clearance of amyloid-β (Aβ) in Alzheimer's disease (AD); MMP2 and MMP3 cleave sol. Aβ, and both MMP9 and MT1-MMP are able to degrade sol. and fibrillar forms of Aβ.  The present study shows increased expression levels of active MMP2 in the entorhinal cortex at early stages of AD-related pathol. (Braak and Braak stages I/II-0 and III/IV-A) as revealed by western blotting and gelatin zymog.  Confocal microscopy discloses co-localization of MMP2 and phospho-tau in neurofibrillary tangles and dystrophic neurites.  MMP2 has the capacity to cleave recombinant tau in vitro in a dose-dependent manner, consistent with a physiol. function of MMP2 in normal tau proteolysis.  However, MMP2 does not cleave hyperphosphorylated and dephosphorylated tau from enriched paired helical filament fractions.  These observations raise the possibility that accumulation of MMP2 in neurofibrillary tangles and concomitant loss of proteolytic capacity on tau protein is a response geared to eliminating prodn. of toxic truncated tau species in AD brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok7_8G24KdHrVg90H21EOLACvtfcHk0lhjgxz-DlG_vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps12ls7c%253D&md5=1dc3e0459a65c3dbaabb80f76a8a5c8d</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.3233%2FJAD-142460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-142460%26sid%3Dliteratum%253Aachs%26aulast%3DTerni%26aufirst%3DB.%26aulast%3DFerrer%26aufirst%3DI.%26atitle%3DAbnormal%2520Expression%2520and%2520Distribution%2520of%2520MMP2%2520at%2520Initial%2520Stages%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease-Related%2520Pathology%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2015%26volume%3D46%26issue%3D2%26spage%3D461%26epage%3D469%26doi%3D10.3233%2FJAD-142460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asahina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshiyama, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, T.</span></span> <span> </span><span class="NLM_article-title">Expression of Matrix Metalloproteinase-9 and Urinary-Type Plasminogen Activator in Alzheimer’s Disease Brain</span>. <i>Clin. Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11327298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD3MvotlGrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=60-63&author=M.+Asahinaauthor=Y.+Yoshiyamaauthor=T.+Hattori&title=Expression+of+Matrix+Metalloproteinase-9+and+Urinary-Type+Plasminogen+Activator+in+Alzheimer%E2%80%99s+Disease+Brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain</span></div><div class="casAuthors">Asahina M; Yoshiyama Y; Hattori T</div><div class="citationInfo"><span class="NLM_cas:title">Clinical neuropathology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">60-3</span>
        ISSN:<span class="NLM_cas:issn">0722-5091</span>.
    </div><div class="casAbstract">OBJECTIVE:  Urinary-type plasminogen activator (uPA) binding to uPA receptor (uPAR) promotes the activation of matrix metalloproteinase-9 (MMP-9), which degrades amyloid beta protein (Abeta) in vitro.  We investigated the expression of MMP-9, uPA, and uPAR in post-mortem brains from patients with Alzheimer's disease (AD) and those with vascular dementia (VD).  MATERIAL AND METHODS:  We used immunohistochemistry to examine the sections of the parietal lobe and hippocampus from 4 AD and 3 VD patients.  The anti-MMP-9 antibody, anti-uPA antibody, and anti-uPAR antibody were used to perform immunohistological analysis.  RESULTS:  In the brain tissues from the AD patients, we found expression of MMP-9 in the cytoplasm of neurons, neurofibrillary tangles, senile plaques, vascular walls and uPAR expression in the cytoplasm of neurons and vascular walls. uPA was detected only in the vascular walls.  On the other hand, we could not find expression of MMP-9, uPAR and uPA in the brain tissues of the VD patients, except for the vascular walls.  CONCLUSION:  The neurons in the AD brains expressed MMP-9 and uPAR.  MMP-9 may be produced for the degradation of Abeta, but uPA, which activates MMP-9, was not immunolocalized to the neurons in the AD brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkH5aHebIOkkEksK8CslK8fW6udTcc2ebgZqIK1Y-nbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvotlGrtA%253D%253D&md5=3d944cdeb80618d7031ef919cf241e89</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsahina%26aufirst%3DM.%26aulast%3DYoshiyama%26aufirst%3DY.%26aulast%3DHattori%26aufirst%3DT.%26atitle%3DExpression%2520of%2520Matrix%2520Metalloproteinase-9%2520and%2520Urinary-Type%2520Plasminogen%2520Activator%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Brain%26jtitle%3DClin.%2520Neuropathol.%26date%3D2001%26volume%3D20%26spage%3D60%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, C.</span></span> <span> </span><span class="NLM_article-title">Systemic Infection, Interleukin 1beta, and Cognitive Decline in Alzheimer’s Disease</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">789</span>, <span class="refDoi"> DOI: 10.1136/jnnp.74.6.788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1136%2Fjnnp.74.6.788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12754353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD3s3jtFGksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2003&pages=788-789&issue=6&author=C.+Holmes&title=Systemic+Infection%2C+Interleukin+1beta%2C+and+Cognitive+Decline+in+Alzheimer%E2%80%99s+Disease&doi=10.1136%2Fjnnp.74.6.788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease</span></div><div class="casAuthors">Holmes C; El-Okl M; Williams A L; Cunningham C; Wilcockson D; Perry V H</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">788-9</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">Activated microglia, the resident macrophages of the brain, are a feature of Alzheimer's disease.  Animal models suggest that when activated microglia are further activated by a subsequent systemic infection this results in significantly raised levels of interleukin 1beta within the CNS, which may in turn potentiate neurodegeneration.  This prospective pilot study in Alzheimer's disease subjects showed that cognitive function can be impaired for at least two months after the resolution of a systemic infection and that cognitive impairment is preceded by raised serum levels of interleukin 1beta.  These relations were not confounded by the presence of any subsequent systemic infection or by baseline cognitive scores.  Further research is needed to determine whether recurrent systemic infections drive cognitive decline in Alzheimer's disease subjects through a cytokine mediated pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSoMTnUmk96gjQLBVDQn4bCfW6udTcc2ebgZqIK1Y-nbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3jtFGksA%253D%253D&md5=3fd7ba7ccf45e045f370afe15209206b</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.74.6.788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.74.6.788%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DC.%26atitle%3DSystemic%2520Infection%252C%2520Interleukin%25201beta%252C%2520and%2520Cognitive%2520Decline%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2003%26volume%3D74%26issue%3D6%26spage%3D788%26epage%3D789%26doi%3D10.1136%2Fjnnp.74.6.788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paumier, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Py, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-González, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Proamyloidogenic Effects of Membrane Type 1 Matrix Metalloproteinase Involve MMP-2 and BACE-1 Activities, and the Modulation of APP Trafficking</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">2910</span>– <span class="NLM_lpage">2927</span>, <span class="refDoi"> DOI: 10.1096/fj.201801076R</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1096%2Ffj.201801076R" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30332299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFCls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2019&pages=2910-2927&issue=2&author=J.-M.+Paumierauthor=N.+A.+Pyauthor=L.+Garc%C3%ADa-Gonz%C3%A1lezauthor=A.+Bernardauthor=D.+Stephanauthor=L.+Louisauthor=F.+Checlerauthor=M.+Khrestchatiskyauthor=K.+Barangerauthor=S.+Rivera&title=Proamyloidogenic+Effects+of+Membrane+Type+1+Matrix+Metalloproteinase+Involve+MMP-2+and+BACE-1+Activities%2C+and+the+Modulation+of+APP+Trafficking&doi=10.1096%2Ffj.201801076R"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking</span></div><div class="casAuthors">Paumier, Jean-Michel; Py, Nathalie A.; Garcia-Gonzalez, Laura; Bernard, Anne; Stephan, Delphine; Louis, Laurence; Checler, Frederic; Khrestchatisky, Michel; Baranger, Kevin; Rivera, Santiago</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">2910-2927</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">We previously demonstrated that membrane type 1 (MT1) matrix metalloproteinase (MMP) was up-regulated in the hippocampus of the model of transgenic mice bearing 5 familial mutations on human amyloid precursor protein (APP) and presenilin 1 of Alzheimer disease (AD), and that the proteinase increased the levels of amyloid β peptide (Aβ) and its APP C-terminal fragment of 99 aa in a heterologous cell system.  Here we provide further evidence that MT1-MMP interacts with APP and promotes amyloidogenesis in a proteolytic-dependent manner in Swedish APP-expressing human embryonic kidney 293 (HEKswe) cells.  MT1-MMP-mediated processing of APP releases a sol. APP fragment, sAPP95.  This process partly requires the activation of endogenous MMP-2 but is independent of β-site APP cleaving enzyme 1 (BACE-1) or α-secretase activities.  In contrast, MT1-MMP-mediated increase of Aβ levels involved BACE-1 activity and was inhibited by tissue inhibitor of MMP-2, a natural inhibitor of both MT1-MMP and MMP-2.  Interestingly, near abolishment of basal Aβ prodn. upon BACE-1 inhibition was rescued by MT1-MMP, indicating that the latter could mimic β-secretase-like activity.  Moreover, MT1-MMP promoted APP/Aβ localization in endosomes, where Aβ prodn. mainly occurs.  These data unveil new mechanistic insights to support the proamyloidogenic role of MT1-MMP based on APP processing and trafficking, and reinforce the idea that this proteinase may become a new potential therapeutic target in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbgnsLRQx7n7Vg90H21EOLACvtfcHk0lj0qCfYc3ZnMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFCls7o%253D&md5=a15528450b75c49e8fec40cff97030c6</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1096%2Ffj.201801076R&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.201801076R%26sid%3Dliteratum%253Aachs%26aulast%3DPaumier%26aufirst%3DJ.-M.%26aulast%3DPy%26aufirst%3DN.%2BA.%26aulast%3DGarc%25C3%25ADa-Gonz%25C3%25A1lez%26aufirst%3DL.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DStephan%26aufirst%3DD.%26aulast%3DLouis%26aufirst%3DL.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DProamyloidogenic%2520Effects%2520of%2520Membrane%2520Type%25201%2520Matrix%2520Metalloproteinase%2520Involve%2520MMP-2%2520and%2520BACE-1%2520Activities%252C%2520and%2520the%2520Modulation%2520of%2520APP%2520Trafficking%26jtitle%3DFASEB%2520J.%26date%3D2019%26volume%3D33%26issue%3D2%26spage%3D2910%26epage%3D2927%26doi%3D10.1096%2Ffj.201801076R" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holmbeck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caterina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kromer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuznetsov, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehron Robey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poole, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pidoux, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkedal-Hansen, H.</span></span> <span> </span><span class="NLM_article-title">MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">92</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80064-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0092-8674%2800%2980064-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10520996" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK1MXmsleqs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=81-92&issue=1&author=K.+Holmbeckauthor=P.+Biancoauthor=J.+Caterinaauthor=S.+Yamadaauthor=M.+Kromerauthor=S.+A.+Kuznetsovauthor=M.+Mankaniauthor=P.+Gehron+Robeyauthor=A.+R.+Pooleauthor=I.+Pidouxauthor=J.+M.+Wardauthor=H.+Birkedal-Hansen&title=MT1-MMP-Deficient+Mice+Develop+Dwarfism%2C+Osteopenia%2C+Arthritis%2C+and+Connective+Tissue+Disease+due+to+Inadequate+Collagen+Turnover&doi=10.1016%2FS0092-8674%2800%2980064-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover</span></div><div class="casAuthors">Holmbeck, Kenn; Bianco, Paolo; Caterina, John; Yamada, Susan; Kromer, Mark; Kuznetsov, Sergei A.; Mankani, Mahesh; Robey, Pamela Gehron; Poole, A. Robin; Pidoux, Isabelle; Ward, Jerrold M.; Birkedal-Hansen, Henning</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-92</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">MT1-MMP is a membrane-bound matrix metalloproteinase (MT-MMP) capable of mediating pericellular proteolysis of extracellular matrix components.  MT1-MMP is therefore thought to be an important mol. tool for cellular remodeling of the surrounding matrix.  To establish the biol. role of this membrane proteinase we generated MT1-MMP-deficient mice by gene targeting.  MT1-MMP deficiency causes craniofacial dysmorphism, arthritis, osteopenia, dwarfism, and fibrosis of soft tissues due to ablation of a collagenolytic activity that is essential for modeling of skeletal and extraskeletal connective tissues.  Our findings demonstrate the pivotal function of MT1-MMP in connective tissue metab., and illustrate that modeling of the soft connective tissue matrix by resident cells is essential for the development and maintenance of the hard tissues of the skeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5giSKp25jUbVg90H21EOLACvtfcHk0ljoEmwKT_9CpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsleqs7c%253D&md5=8ecbc7d88158e67867a11ba99edd5679</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980064-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980064-1%26sid%3Dliteratum%253Aachs%26aulast%3DHolmbeck%26aufirst%3DK.%26aulast%3DBianco%26aufirst%3DP.%26aulast%3DCaterina%26aufirst%3DJ.%26aulast%3DYamada%26aufirst%3DS.%26aulast%3DKromer%26aufirst%3DM.%26aulast%3DKuznetsov%26aufirst%3DS.%2BA.%26aulast%3DMankani%26aufirst%3DM.%26aulast%3DGehron%2BRobey%26aufirst%3DP.%26aulast%3DPoole%26aufirst%3DA.%2BR.%26aulast%3DPidoux%26aufirst%3DI.%26aulast%3DWard%26aufirst%3DJ.%2BM.%26aulast%3DBirkedal-Hansen%26aufirst%3DH.%26atitle%3DMT1-MMP-Deficient%2520Mice%2520Develop%2520Dwarfism%252C%2520Osteopenia%252C%2520Arthritis%252C%2520and%2520Connective%2520Tissue%2520Disease%2520due%2520to%2520Inadequate%2520Collagen%2520Turnover%26jtitle%3DCell%26date%3D1999%26volume%3D99%26issue%3D1%26spage%3D81%26epage%3D92%26doi%3D10.1016%2FS0092-8674%2800%2980064-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apte, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soininen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baaklini, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauser, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tryggvason, K.</span></span> <span> </span><span class="NLM_article-title">Impaired Endochondral Ossification and Angiogenesis in Mice Deficient in Membrane-Type Matrix Metalloproteinase I</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4052</span>– <span class="NLM_lpage">4057</span>, <span class="refDoi"> DOI: 10.1073/pnas.060037197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1073%2Fpnas.060037197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10737763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXislSgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=4052-4057&issue=8&author=Z.+Zhouauthor=S.+S.+Apteauthor=R.+Soininenauthor=R.+Caoauthor=G.+Y.+Baakliniauthor=R.+W.+Rauserauthor=J.+Wangauthor=Y.+Caoauthor=K.+Tryggvason&title=Impaired+Endochondral+Ossification+and+Angiogenesis+in+Mice+Deficient+in+Membrane-Type+Matrix+Metalloproteinase+I&doi=10.1073%2Fpnas.060037197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I</span></div><div class="casAuthors">Zhou, Zhongjun; Apte, Suneel S.; Soininen, Raija; Cao, Renhai; Baaklini, George Y.; Rauser, Richard W.; Wang, Jianming; Cao, Yihai; Tryggvason, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4052-4057</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Membrane-type matrix metalloproteinase I (MT1-MMP)-deficient mice were found to have severe defects in skeletal development and angiogenesis.  The craniofacial, axial, and appendicular skeletons were severely affected, leading to a short and domed skull, marked deceleration of postnatal growth, and death by 3 wk of age.  Shortening of bones is a consequence of decreased chondrocyte proliferation in the proliferative zone of the growth plates.  Defective vascular invasion of cartilage leads to enlargement of hypertrophic zones of growth plates and delayed formation of secondary ossification centers in long bones.  In an in vivo corneal angiogenesis assay, null mice did not have angiogenic response to implanted FGF-2, suggesting that the defect in angiogenesis is not restricted to cartilage alone.  In tissues from null mice, activation of latent matrix metalloproteinase 2 was deficient, suggesting that MT1-MMP is essential for its activation in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphY4S7v353E7Vg90H21EOLACvtfcHk0ljoEmwKT_9CpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXislSgtLo%253D&md5=3304017873fed4c2541fdba8f3bd4882</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1073%2Fpnas.060037197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.060037197%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DApte%26aufirst%3DS.%2BS.%26aulast%3DSoininen%26aufirst%3DR.%26aulast%3DCao%26aufirst%3DR.%26aulast%3DBaaklini%26aufirst%3DG.%2BY.%26aulast%3DRauser%26aufirst%3DR.%2BW.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DTryggvason%26aufirst%3DK.%26atitle%3DImpaired%2520Endochondral%2520Ossification%2520and%2520Angiogenesis%2520in%2520Mice%2520Deficient%2520in%2520Membrane-Type%2520Matrix%2520Metalloproteinase%2520I%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26issue%3D8%26spage%3D4052%26epage%3D4057%26doi%3D10.1073%2Fpnas.060037197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remacle, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieplak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiryaev, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strongin, A. Y.</span></span> <span> </span><span class="NLM_article-title">Selective Function-Blocking Monoclonal Human Antibody Highlights the Important Role of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) in Metastasis</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">2781</span>– <span class="NLM_lpage">2799</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.18632%2Foncotarget.13157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27835863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC2snlt1KktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2781-2799&issue=2&author=A.+G.+Remacleauthor=P.+Cieplakauthor=D.+H.+Namauthor=S.+A.+Shiryaevauthor=X.+Geauthor=A.+Y.+Strongin&title=Selective+Function-Blocking+Monoclonal+Human+Antibody+Highlights+the+Important+Role+of+Membrane+Type-1+Matrix+Metalloproteinase+%28MT1-MMP%29+in+Metastasis&doi=10.18632%2Foncotarget.13157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis</span></div><div class="casAuthors">Remacle Albert G; Cieplak Piotr; Shiryaev Sergey A; Strongin Alex Y; Nam Dong Hyun; Ge Xin</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">2781-2799</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The invasion-promoting MT1-MMP is a cell surface-associated collagenase with a plethora of critical cellular functions.  There is a consensus that MT1-MMP is a key protease in aberrant pericellular proteolysis in migrating cancer cells and, accordingly, a promising drug target.  Because of high homology in the MMP family and a limited success in the design of selective small-molecule inhibitors, it became evident that the inhibitor specificity is required for selective and successful MT1-MMP therapies.  Using the human Fab antibody library (over 1.25×109 individual variants) that exhibited the extended, 23-27 residue long, VH CDR-H3 segments, we isolated a panel of the inhibitory antibody fragments, from which the 3A2 Fab outperformed others as a specific and potent, low nanomolar range, inhibitor of MT1-MMP.  Here, we report the in-depth characterization of the 3A2 antibody.  Our multiple in vitro and cell-based tests and assays, and extensive structural modeling of the antibody/protease interactions suggest that the antibody epitope involves the residues proximal to the protease catalytic site and that, in contrast with tissue inhibitor-2 of MMPs (TIMP-2), the 3A2 Fab inactivates the protease functionality by binding to the catalytic domain outside the active site cavity.  In agreement with the studies in metastasis by others, our animal studies in acute pulmonary melanoma metastasis support a key role of MT1-MMP in metastatic process.  Conversely, the selective anti-MT1-MMP monotherapy significantly alleviated melanoma metastatic burden.  It is likely that further affinity maturation of the 3A2 Fab will result in the lead inhibitor and a proof-of-concept for MT1-MMP targeting in metastatic cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVH4TOmGh3kny-c-E1v-fmfW6udTcc2ebbB4ROiUzsyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snlt1KktA%253D%253D&md5=487e5d594fd55b5981ad0c79e581f3cb</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13157%26sid%3Dliteratum%253Aachs%26aulast%3DRemacle%26aufirst%3DA.%2BG.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DNam%26aufirst%3DD.%2BH.%26aulast%3DShiryaev%26aufirst%3DS.%2BA.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26atitle%3DSelective%2520Function-Blocking%2520Monoclonal%2520Human%2520Antibody%2520Highlights%2520the%2520Important%2520Role%2520of%2520Membrane%2520Type-1%2520Matrix%2520Metalloproteinase%2520%2528MT1-MMP%2529%2520in%2520Metastasis%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26issue%3D2%26spage%3D2781%26epage%3D2799%26doi%3D10.18632%2Foncotarget.13157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Udi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomonov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dym, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozenberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuniasse, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arroyo, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Inhibition Mechanism of Membrane Metalloprotease by an Exosite-Swiveling Conformational Antibody</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">104</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1016/j.str.2014.10.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.str.2014.10.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25482542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrtLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=104-115&issue=1&author=Y.+Udiauthor=M.+Grossmanauthor=I.+Solomonovauthor=O.+Dymauthor=H.+Rozenbergauthor=V.+Morenoauthor=P.+Cuniasseauthor=V.+Diveauthor=A.+G.+Arroyoauthor=I.+Sagi&title=Inhibition+Mechanism+of+Membrane+Metalloprotease+by+an+Exosite-Swiveling+Conformational+Antibody&doi=10.1016%2Fj.str.2014.10.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition mechanism of membrane metalloprotease by an exosite-swiveling conformational antibody</span></div><div class="casAuthors">Udi, Yael; Grossman, Moran; Solomonov, Inna; Dym, Orly; Rozenberg, Haim; Moreno, Vanessa; Cuniasse, Philippe; Dive, Vincent; Arroyo, Alicia Garcia; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">104-115</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Membrane type 1 metalloprotease (MT1-MMP) is a membrane-anchored, Zn-dependent protease.  MT1-MMP is an important mediator of cell migration and invasion, and overexpression of this enzyme has been correlated with the malignancy of various tumor types.  Therefore, modulators of MT1-MMP activity have been proposed to possess therapeutic potential in numerous invasive diseases.  Here, the authors report the inhibition mode of MT1-MMP by the LEM-2/15 monoclonal antibody fragment, which targets a surface epitope of MT1-MMP.  Specifically, the crystal structures of Fab LEM-2/15 in complex with the MT1-MMP surface antigen suggested that conformational swiveling of the enzyme surface loop was required for effective binding and consequent inhibition of MT1-MMP activity on the cell membrane.  This inhibition mechanism appears to be effective in controlling active MT1-MMP in endothelial cells and at the leading edge of migratory cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ViuLsV_tirVg90H21EOLACvtfcHk0lhOolH7yyP0jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrtLnN&md5=054384bf26885067fb6eb18540682748</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2014.10.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2014.10.012%26sid%3Dliteratum%253Aachs%26aulast%3DUdi%26aufirst%3DY.%26aulast%3DGrossman%26aufirst%3DM.%26aulast%3DSolomonov%26aufirst%3DI.%26aulast%3DDym%26aufirst%3DO.%26aulast%3DRozenberg%26aufirst%3DH.%26aulast%3DMoreno%26aufirst%3DV.%26aulast%3DCuniasse%26aufirst%3DP.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DArroyo%26aufirst%3DA.%2BG.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DInhibition%2520Mechanism%2520of%2520Membrane%2520Metalloprotease%2520by%2520an%2520Exosite-Swiveling%2520Conformational%2520Antibody%26jtitle%3DStructure%26date%3D2015%26volume%3D23%26issue%3D1%26spage%3D104%26epage%3D115%26doi%3D10.1016%2Fj.str.2014.10.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funahashi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umeda, M.</span></span> <span> </span><span class="NLM_article-title">A Metalloproteinase Inhibitor Domain in Alzheimer Amyloid Protein Precursor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>362</i></span> (<span class="NLM_issue">6423</span>),  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1038/362839a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2F362839a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=8479521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK3sXltFCktbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1993&pages=839-841&issue=6423&author=K.+Miyazakiauthor=M.+Hasegawaauthor=K.+Funahashiauthor=M.+Umeda&title=A+Metalloproteinase+Inhibitor+Domain+in+Alzheimer+Amyloid+Protein+Precursor&doi=10.1038%2F362839a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor</span></div><div class="casAuthors">Miyazaki, Kaoru; Hasegawa, Miki; Funahashi, Kayano; Umeda, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">6423</span>),
    <span class="NLM_cas:pages">839-41</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Extracellular deposition of amyloid β-protein (β-AP), or A4 protein (Mr 4,000), is assocd. with Alzheimer's disease and with Down's syndrome (trisomy for chromosome 21).  The large membrane-bound precursor protein (APP) of β-AP is normally cleaved within the β-AP region by a putative proteinase (APP secretase) to release its extracellular portion; β-AP is produced by an alternative proteolytic processing.  Here the authors demonstrate that APP contains a proteinase inhibitor domain for the matrix metalloproteinase gelatinase A, which is located in the C-terminal glycosylated region of the secretory forms of APP.  In addn., the authors show that the gelatinase has an APp secretase-like activity, which hydrolyses the Lys16-Leu17 bond in the β-AP sequence.  These results indicate that the proteinase inhibitor domain of APP and gelatinase A may be involved in the formation of β-AP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLvhVS9kMRfrVg90H21EOLACvtfcHk0lhOolH7yyP0jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltFCktbo%253D&md5=c4c2c24887ae6e7e56a1d7d3213309c8</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2F362839a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F362839a0%26sid%3Dliteratum%253Aachs%26aulast%3DMiyazaki%26aufirst%3DK.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DFunahashi%26aufirst%3DK.%26aulast%3DUmeda%26aufirst%3DM.%26atitle%3DA%2520Metalloproteinase%2520Inhibitor%2520Domain%2520in%2520Alzheimer%2520Amyloid%2520Protein%2520Precursor%26jtitle%3DNature%26date%3D1993%26volume%3D362%26issue%3D6423%26spage%3D839%26epage%3D841%26doi%3D10.1038%2F362839a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span> <span> </span><span class="NLM_article-title">Identification of a Region of β-Amyloid Precursor Protein Essential for Its Gelatinase A Inhibitory Activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">14020</span>– <span class="NLM_lpage">14028</span>, <span class="refDoi"> DOI: 10.1074/jbc.M212264200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M212264200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=12586836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtVSiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=14020-14028&issue=16&author=S.+Higashiauthor=K.+Miyazaki&title=Identification+of+a+Region+of+%CE%B2-Amyloid+Precursor+Protein+Essential+for+Its+Gelatinase+A+Inhibitory+Activity&doi=10.1074%2Fjbc.M212264200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Region of β-Amyloid Precursor Protein Essential for Its Gelatinase A Inhibitory Activity</span></div><div class="casAuthors">Higashi, Shouichi; Miyazaki, Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">14020-14028</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Because β-amyloid precursor protein (APP) has the abilities both to interact with extracellular matrix and to inhibit gelatinase A activity, this mol. is assumed to play a regulatory role in the gelatinase A-catalyzed degrdn. of extracellular matrix.  To det. a region of APP essential for the inhibitory activity, we prepd. various derivs. of APP.  Functional analyses of proteolytic fragments of sol. APP (sAPP) and glutathione S-transferase fusion proteins, which contain various C-terminal parts of sAPP, showed that a site contg. residues 579-601 of APP770 is essential for the inhibitory activity.  Moreover, a synthetic decapeptide contg. the ISYGNDALMP sequence corresponding to residues 586-595 of APP770 had a gelatinase A inhibitory activity slightly higher than that of sAPP.  Studies of deletion of the NH2- and C-terminal residues and alanine replacement of internal residues of the decapeptide further revealed that Tyr588, Asp591, and Leu593 of APP mainly stabilize the interaction between gelatinase A and the inhibitor.  We also found that the residues of Ile586, Met594, and Pro595 modestly contribute to the inhibitory activity.  The APP-derived decapeptide efficiently inhibited the activity of gelatinase A (IC50 = 30 nM), whereas its inhibitory activity toward membrane type 1 matrix metalloproteinase was much weaker (IC50 = 2 μM).  The decapeptide had poor inhibitory activity toward gelatinase B, matrilysin, and stromelysin (IC50 > 10 μM).  The APP-derived inhibitor formed a complex with active gelatinase A but not with progelatinase A, and the complex formation was prevented completely by a hydroxamate-based synthetic inhibitor.  Therefore, the decapeptide region of APP is likely an active site-directed inhibitor that has high selectivity toward gelatinase A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpErgWhUIbiUbVg90H21EOLACvtfcHk0lhOolH7yyP0jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtVSiurs%253D&md5=aca3047fb1e3e6c146e9153e80bffc90</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M212264200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M212264200%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DS.%26aulast%3DMiyazaki%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520a%2520Region%2520of%2520%25CE%25B2-Amyloid%2520Precursor%2520Protein%2520Essential%2520for%2520Its%2520Gelatinase%2520A%2520Inhibitory%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26issue%3D16%26spage%3D14020%26epage%3D14028%26doi%3D10.1074%2Fjbc.M212264200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span> <span> </span><span class="NLM_article-title">Identification of Amino Acid Residues of the Matrix Metalloproteinase-2 Essential for Its Selective Inhibition by β-Amyloid Precursor Protein-Derived Inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>283</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">10068</span>– <span class="NLM_lpage">10078</span>, <span class="refDoi"> DOI: 10.1074/jbc.M709509200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M709509200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=18238779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkt1alu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=10068-10078&issue=15&author=S.+Higashiauthor=K.+Miyazaki&title=Identification+of+Amino+Acid+Residues+of+the+Matrix+Metalloproteinase-2+Essential+for+Its+Selective+Inhibition+by+%CE%B2-Amyloid+Precursor+Protein-Derived+Inhibitor&doi=10.1074%2Fjbc.M709509200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Amino Acid Residues of the Matrix Metalloproteinase-2 Essential for Its Selective Inhibition by β-Amyloid Precursor Protein-derived Inhibitor</span></div><div class="casAuthors">Higashi, Shouichi; Miyazaki, Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">10068-10078</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The extracellular domain of β-amyloid precursor protein (APP) contains an inhibitor against matrix metalloproteinase-2 (MMP-2, gelatinase A).  Our previous study demonstrated that the inhibitor is localized within the ISYGN-DALMP sequence of APP, and a synthetic decapeptide contg. this sequence (named APP-derived inhibitory peptide, APP-IP) selectively inhibits the activity of MMP-2.  To det. the region of interaction that correlates with the selective inhibition, we constructed various MMP-2 mutants.  An MMP-2 mutant, which had the hemopexin-like domain and three fibronectin-like type II domains of MMP-2 deleted, and native MMP-2 showed similar affinities for APP-IP, suggesting that only the catalytic domain of MMP-2 is essential for the interaction.  Studies of chimeric proteases, consisting of various parts of the MMP-2 catalytic domain and those of MMP-7 (matrilysin) or MMP-9 (gelatinase B), further revealed that Ala88 and Gly94 in the non-prime side and Tyr145 and Thr146 in the prime side of the substrate-binding cleft of MMP-2 contribute sep. to the selective inhibition.  Replacement of the amino acid residue at position 94 of a chimeric MMP mutant affected its interaction with the C-terminal Pro10 of APP-IP, whereas that of residues 145-148 affected the interaction with Tyr3 of the inhibitor, suggesting that the N to C direction of APP-IP relative to the substrate-binding cleft of MMP is analogous to that of propeptide in proMMP, and opposite to that of substrate.  When the APP-IP sequence was added to the N terminus of the catalytic domain of MMP-2, the activity of the protease was intramolecularly inhibited.  We speculate that the direction of interaction makes the active site-bound APP-IP resistant to cleavage, thereby supporting the inhibitory action of the peptide inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6URu4T6RQerVg90H21EOLACvtfcHk0lh-XogFWbzf4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkt1alu74%253D&md5=31f48dd9b93faa418ee728393a40944c</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M709509200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M709509200%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DS.%26aulast%3DMiyazaki%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520Amino%2520Acid%2520Residues%2520of%2520the%2520Matrix%2520Metalloproteinase-2%2520Essential%2520for%2520Its%2520Selective%2520Inhibition%2520by%2520%25CE%25B2-Amyloid%2520Precursor%2520Protein-Derived%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26issue%3D15%26spage%3D10068%26epage%3D10078%26doi%3D10.1074%2Fjbc.M709509200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, S.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Matrix Metalloproteinase-2 (MMP-2)-Selective Inhibitory Action of β-Amyloid Precursor Protein-Derived Inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">33236</span>– <span class="NLM_lpage">33243</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.264176</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M111.264176" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21813640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFOit7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=33236-33243&issue=38&author=H.+Hashimotoauthor=T.+Takeuchiauthor=K.+Komatsuauthor=K.+Miyazakiauthor=M.+Satoauthor=S.+Higashi&title=Structural+Basis+for+Matrix+Metalloproteinase-2+%28MMP-2%29-Selective+Inhibitory+Action+of+%CE%B2-Amyloid+Precursor+Protein-Derived+Inhibitor&doi=10.1074%2Fjbc.M111.264176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Matrix Metalloproteinase-2 (MMP-2)-selective Inhibitory Action of β-Amyloid Precursor Protein-derived Inhibitor</span></div><div class="casAuthors">Hashimoto, Hiroshi; Takeuchi, Tomoka; Komatsu, Kyoko; Miyazaki, Kaoru; Sato, Mamoru; Higashi, Shou-Ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">33236-33243</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Unlike other synthetic or physiol. inhibitors for matrix metalloproteinases (MMPs), the β-amyloid precursor protein-derived inhibitory peptide (APP-IP) having an ISYGNDALMP sequence has a high selectivity toward MMP-2.  Our previous study identified amino acid residues of MMP-2 essential for its selective inhibition by APP-IP and demonstrated that the N to C direction of the decapeptide inhibitor relative to the substrate-binding cleft of MMP-2 is opposite that of substrate.  However, detailed interactions between the two mols. remained to be clarified.  Here, we detd. the crystal structure of the catalytic domain of MMP-2 in complex with APP-IP.  We found that APP-IP in the complex is indeed embedded into the substrate-binding cleft of the catalytic domain in the N to C direction opposite that of substrate.  With the crystal structure, it was first clarified that the arom. side chain of Tyr3 of the inhibitor is accommodated into the S1' pocket of the protease, and the carboxylate group of Asp6 of APP-IP coordinates bidentately to the catalytic zinc of the enzyme.  The Ala7 to Pro10 and Tyr3 to Ile1 strands of the inhibitor extend into the nonprime and the prime sides of the cleft, resp.  Therefore, the decapeptide inhibitor has long range contact with the substrate-binding cleft of the protease.  This mode of interaction is probably essential for the high MMP-2 selectivity of the inhibitor because MMPs share a common architecture in the vicinity of the catalytic center, but whole structures of their substrate-binding clefts have sufficient variety for the inhibitor to distinguish MMP-2 from other MMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp-w8bRwhBtbVg90H21EOLACvtfcHk0lh-XogFWbzf4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFOit7zE&md5=c65c71687ad8cf41e092ffb9f1b7853c</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.264176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.264176%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DKomatsu%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DS.%26atitle%3DStructural%2520Basis%2520for%2520Matrix%2520Metalloproteinase-2%2520%2528MMP-2%2529-Selective%2520Inhibitory%2520Action%2520of%2520%25CE%25B2-Amyloid%2520Precursor%2520Protein-Derived%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26issue%3D38%26spage%3D33236%26epage%3D33243%26doi%3D10.1074%2Fjbc.M111.264176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirose, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span> <span> </span><span class="NLM_article-title">Molecular Design of a Highly Selective and Strong Protein Inhibitor against Matrix Metalloproteinase-2 (MMP-2)</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">9066</span>– <span class="NLM_lpage">9076</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.441758</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M112.441758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23395821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkvF2ltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=9066-9076&issue=13&author=S.+Higashiauthor=T.+Hiroseauthor=T.+Takeuchiauthor=K.+Miyazaki&title=Molecular+Design+of+a+Highly+Selective+and+Strong+Protein+Inhibitor+against+Matrix+Metalloproteinase-2+%28MMP-2%29&doi=10.1074%2Fjbc.M112.441758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Design of a Highly Selective and Strong Protein Inhibitor against Matrix Metalloproteinase-2 (MMP-2)</span></div><div class="casAuthors">Higashi, Shouichi; Hirose, Tomokazu; Takeuchi, Tomoka; Miyazaki, Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">9066-9076</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Synthetic inhibitors of matrix metalloproteinases (MMPs), designed previously, as well as tissue inhibitors of metalloproteinases (TIMPs) lack enzyme selectivity, which has been a major obstacle for developing inhibitors into safe and effective MMP-targeted drugs.  Here we designed a fusion protein named APP-IP-TIMP-2, in which the ten amino acid residue sequence of APP-derived MMP-2 selective inhibitory peptide (APP-IP) is added to the N terminus of TIMP-2.  The APP-IP and TIMP-2 regions of the fusion protein are designed to interact with the active site and the hemopexin-like domain of MMP-2, resp.  The reactive site of the TIMP-2 region, which has broad specificity against MMPs, is blocked by the APP-IP adduct.  The recombinant APP-IP-TIMP-2 showed strong inhibitory activity toward MMP-2 (Kiapp = 0.68 pm), whereas its inhibitory activity toward MMP-1, MMP-3, MMP-7, MMP-8, MMP-9, or MT1-MMP was six orders of magnitude or more weaker (IC50>1 μm).  The fusion protein inhibited the activation of pro-MMP-2 in the Con A-stimulated HT1080 cells, degrdn. of type IV collagen by the cells, and the migration of stimulated cells.  Compared with the decapeptide APP-IP (t1/2 = 30 min), APP-IP-TIMP-2 (t1/2 » 96h) showed a much longer half-life in cultured tumor cells.  Therefore, the fusion protein may be a useful tool to evaluate contributions of proteolytic activity of MMP-2 in various pathophysiol. processes.  It may also be developed as an effective antitumor drug with restricted side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJmnNeOz2f2rVg90H21EOLACvtfcHk0lh-XogFWbzf4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkvF2ltrs%253D&md5=2475403197343ae9f5662727a028fa35</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.441758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.441758%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DS.%26aulast%3DHirose%26aufirst%3DT.%26aulast%3DTakeuchi%26aufirst%3DT.%26aulast%3DMiyazaki%26aufirst%3DK.%26atitle%3DMolecular%2520Design%2520of%2520a%2520Highly%2520Selective%2520and%2520Strong%2520Protein%2520Inhibitor%2520against%2520Matrix%2520Metalloproteinase-2%2520%2528MMP-2%2529%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D13%26spage%3D9066%26epage%3D9076%26doi%3D10.1074%2Fjbc.M112.441758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, K.</span></span> <span> </span><span class="NLM_article-title">Novel Processing of β-Amyloid Precursor Protein Catalyzed by Membrane Type 1 Matrix Metalloproteinase Releases a Fragment Lacking the Inhibitor Domain against Gelatinase A †</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6514</span>– <span class="NLM_lpage">6526</span>, <span class="refDoi"> DOI: 10.1021/bi020643m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi020643m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVOjur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=6514-6526&issue=21&author=S.+Higashiauthor=K.+Miyazaki&title=Novel+Processing+of+%CE%B2-Amyloid+Precursor+Protein+Catalyzed+by+Membrane+Type+1+Matrix+Metalloproteinase+Releases+a+Fragment+Lacking+the+Inhibitor+Domain+against+Gelatinase+A+%E2%80%A0&doi=10.1021%2Fbi020643m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Processing of β-Amyloid Precursor Protein Catalyzed by Membrane Type 1 Matrix Metalloproteinase Releases a Fragment Lacking the Inhibitor Domain against Gelatinase A</span></div><div class="casAuthors">Higashi, Shouichi; Miyazaki, Kaoru</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6514-6526</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In various mammalian cell lines, β-amyloid precursor protein (APP) is proteolytically processed to release its NH2-terminal extracellular domain as a sol. APP (sAPP) that contains the inhibitor domain against gelatinase A.  To investigate the roles of sAPP in the regulation of gelatinase A activity, we examd. the correlation between the activation of progelatinase A and processing of APP.  We found that stimulation of HT1080 fibrosarcoma cells with Con A led to an activation of endogenous progelatinase A and to a novel processing of APP, which releases a COOH-terminally truncated form of sAPP (sAPPtrc) into the culture medium.  Reverse zymog. anal. showed that sAPPtrc lacked an inhibitory activity against gelatinase A.  Analyses of prodn. of sAPPtrc in the presence of various metalloproteinase inhibitors showed that membrane type 1 matrix metalloproteinase (MT1-MMP), an activator of progelatinase A, is most likely responsible for the prodn. of sAPPtrc.  When the Con A-stimulated HT1080 cells were cultured in the condition that inhibited MT1-MMP activity, sAPP and APP were assocd. with the extracellular matrix deposited by the cells, whereas these gelatinase A inhibitors in the matrix were displaced by sAPPtrc after exertion of MT1-MMP activity.  Taken together, these data support a model in which MT1-MMP-catalyzed release of sAPPtrc leads to redn. of the extracellular matrix-assocd. gelatinase A inhibitor, sAPP, thus making it feasible for gelatinase A to exert proteolytic activity only near its activator, MT1-MMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYsfjRvMkSgrVg90H21EOLACvtfcHk0lhNkzgREQN6bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVOjur0%253D&md5=50e7e5b7929f585d7bfd8c67777d7916</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1021%2Fbi020643m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi020643m%26sid%3Dliteratum%253Aachs%26aulast%3DHigashi%26aufirst%3DS.%26aulast%3DMiyazaki%26aufirst%3DK.%26atitle%3DNovel%2520Processing%2520of%2520%25CE%25B2-Amyloid%2520Precursor%2520Protein%2520Catalyzed%2520by%2520Membrane%2520Type%25201%2520Matrix%2520Metalloproteinase%2520Releases%2520a%2520Fragment%2520Lacking%2520the%2520Inhibitor%2520Domain%2520against%2520Gelatinase%2520A%2520%25E2%2580%25A0%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26issue%3D21%26spage%3D6514%26epage%3D6526%26doi%3D10.1021%2Fbi020643m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoshita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stetler Stevenson, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span> <span> </span><span class="NLM_article-title">Cell Surface Binding and Activation of Gelatinase A Induced by Expression of Membrane-Type-1-Matrix Metalloproteinase (MT1-MMP)</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>385</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(96)00389-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2F0014-5793%2896%2900389-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=8647259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK28XivFOhs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=1996&pages=238-240&issue=3&author=H.+Satoauthor=T.+Takinoauthor=T.+Kinoshitaauthor=K.+Imaiauthor=Y.+Okadaauthor=W.+G.+Stetler+Stevensonauthor=M.+Seiki&title=Cell+Surface+Binding+and+Activation+of+Gelatinase+A+Induced+by+Expression+of+Membrane-Type-1-Matrix+Metalloproteinase+%28MT1-MMP%29&doi=10.1016%2F0014-5793%2896%2900389-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP)</span></div><div class="casAuthors">Sato, Hiroshi; Takino, Takahisa; Kinoshita, Takeshi; Imai, Kazushi; Okada, Yasunori; Stetler Stevenson, William G.; Seiki, Motoharu</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">238-240</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Gelatinase A is secreted as a proenzyme (progelatinase A) which is activated and bound on the surface of tumor and normal cells.  We have reported that the expression of a membrane-type-1-matrix metalloproteinase (MT1-MMP) induces activation of progelatinase A. Here we demonstrate that the expression of MT1-MMP in COS-1 cells induces cell-surface binding of progelatinase A which is consequently processed to an intermediate form.  Processing from the intermediate to the fully active form is dependent on the gelatinase A concn.  These results suggest that the cell-surface binding concs. the gelatinase A intermediate form locally to allow autoproteolytic processing to the fully active form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrluoSxfvDUR7Vg90H21EOLACvtfcHk0lhNkzgREQN6bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFOhs7c%253D&md5=e50faabd7aff5b8be0ab6ec62f0e8f7a</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2896%2900389-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252896%252900389-4%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DH.%26aulast%3DTakino%26aufirst%3DT.%26aulast%3DKinoshita%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DK.%26aulast%3DOkada%26aufirst%3DY.%26aulast%3DStetler%2BStevenson%26aufirst%3DW.%2BG.%26aulast%3DSeiki%26aufirst%3DM.%26atitle%3DCell%2520Surface%2520Binding%2520and%2520Activation%2520of%2520Gelatinase%2520A%2520Induced%2520by%2520Expression%2520of%2520Membrane-Type-1-Matrix%2520Metalloproteinase%2520%2528MT1-MMP%2529%26jtitle%3DFEBS%2520Lett.%26date%3D1996%26volume%3D385%26issue%3D3%26spage%3D238%26epage%3D240%26doi%3D10.1016%2F0014-5793%2896%2900389-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haapasalo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, D. M.</span></span> <span> </span><span class="NLM_article-title">The Many Substrates of Presenilin/γ-Secretase</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.3233/JAD-2011-101065</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3233%2FJAD-2011-101065" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21335653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsVSisbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=3-28&issue=1&author=A.+Haapasaloauthor=D.+M.+Kovacs&title=The+Many+Substrates+of+Presenilin%2F%CE%B3-Secretase&doi=10.3233%2FJAD-2011-101065"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">The Many Substrates of Presenilin/γ-Secretase</span></div><div class="casAuthors">Haapasalo, Annakaisa; Kovacs, Dora M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-28</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The Alzheimer's disease (AD)-assocd. amyloid-β protein precursor (AβPP) is cleaved by α-, β-, and presenilin (PS)/γ-secretases through sequential regulated proteolysis.  These proteolytic events control the generation of the pathogenic amyloid-β (Aβ) peptide, which excessively accumulates in the brains of individuals afflicted by AD.  A growing no. of addnl. proteins cleaved by PS/γ-secretase continue to be discovered.  Similarly to AβPP, most of these proteins are type-I transmembrane proteins involved in vital signaling functions regulating cell fate, adhesion, migration, neurite outgrowth, or synaptogenesis.  All the identified proteins share common structural features, which are typical for their proteolysis.  The consequences of the PS/γ-secretase-mediated cleavage on the function of many of these proteins are largely unknown.  Here, we review the current literature on the proteolytic processing mediated by the versatile PS/γ-secretase complex.  We begin by discussing the steps of AβPP processing and PS/γ-secretase complex compn. and localization, which give clues to how and where the processing of other PS/γ-secretase substrates may take place.  Then we summarize the typical features of PS/γ-secretase-mediated protein processing.  Finally, we recapitulate the current knowledge on the possible physiol. function of PS/γ-secretase-mediated cleavage of specific substrate proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphYizFVw4_A7Vg90H21EOLACvtfcHk0lhNkzgREQN6bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsVSisbY%253D&md5=22ce56939b97019e5c130556f9db7d5f</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.3233%2FJAD-2011-101065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2011-101065%26sid%3Dliteratum%253Aachs%26aulast%3DHaapasalo%26aufirst%3DA.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26atitle%3DThe%2520Many%2520Substrates%2520of%2520Presenilin%252F%25CE%25B3-Secretase%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2011%26volume%3D25%26issue%3D1%26spage%3D3%26epage%3D28%26doi%3D10.3233%2FJAD-2011-101065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paumier, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinakaran, G.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase 13, a New Target for Therapy in Alzheimer’s Disease</span>. <i>Genes Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">2</span>, <span class="refDoi"> DOI: 10.1016/j.gendis.2019.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.gendis.2019.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30906825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjs1ahu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2019&pages=1-2&issue=1&author=J.+M.+Paumierauthor=G.+Thinakaran&title=Matrix+Metalloproteinase+13%2C+a+New+Target+for+Therapy+in+Alzheimer%E2%80%99s+Disease&doi=10.1016%2Fj.gendis.2019.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase 13, a new target for therapy in Alzheimer's disease</span></div><div class="casAuthors">Paumier, Jean-Michel; Thinakaran, Gopal</div><div class="citationInfo"><span class="NLM_cas:title">Genes and Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-2</span>CODEN:
                <span class="NLM_cas:coden">GDEIAV</span>;
        ISSN:<span class="NLM_cas:issn">2352-3042</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOyGK4Ipe1UbVg90H21EOLACvtfcHk0lgogE6MRzvQ9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjs1ahu74%253D&md5=c6c383f8331bd2cc0f84926122156f5c</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.gendis.2019.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gendis.2019.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DPaumier%26aufirst%3DJ.%2BM.%26aulast%3DThinakaran%26aufirst%3DG.%26atitle%3DMatrix%2520Metalloproteinase%252013%252C%2520a%2520New%2520Target%2520for%2520Therapy%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DGenes%2520Dis.%26date%3D2019%26volume%3D6%26issue%3D1%26spage%3D1%26epage%3D2%26doi%3D10.1016%2Fj.gendis.2019.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haneda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, K.</span></span> <span> </span><span class="NLM_article-title">Induction of Matrix Metalloproteinases (MMP3, MMP12 and MMP13) Expression in the Microglia by Amyloid-β Stimulation via the PI3K/Akt Pathway</span>. <i>Exp. Gerontol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">532</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1016/j.exger.2006.11.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.exger.2006.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17198748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsF2htb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=532-537&issue=6&author=S.+Itoauthor=K.+Kimuraauthor=M.+Hanedaauthor=Y.+Ishidaauthor=M.+Sawadaauthor=K.+Isobe&title=Induction+of+Matrix+Metalloproteinases+%28MMP3%2C+MMP12+and+MMP13%29+Expression+in+the+Microglia+by+Amyloid-%CE%B2+Stimulation+via+the+PI3K%2FAkt+Pathway&doi=10.1016%2Fj.exger.2006.11.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-β stimulation via the PI3K/Akt pathway</span></div><div class="casAuthors">Ito, Sachiko; Kimura, Kenya; Haneda, Masataka; Ishida, Yoshiyuki; Sawada, Makoto; Isobe, Ken-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Gerontology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">532-537</span>CODEN:
                <span class="NLM_cas:coden">EXGEAB</span>;
        ISSN:<span class="NLM_cas:issn">0531-5565</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease is characterized by the presence of senile plaques in the brain composed primarily of amyloid-β peptide.  Microglia have been reported to surround these Aβ plaques, which have opposite roles, provoking a microglia-mediated inflammatory response that contributes to neuronal cell loss or the removal of Aβ and damaged neurons.  We herein analyzed the process of expression of Matrix metalloproteinases induced by Aβ stimulation.  We found that Aβ1-42 induces a high level of MMP3, MMP12 and MMP13 in the microglia.  The signal transduction pathway for the expression of these MMPs mRNA induced by Aβ1-42 depends on PI3K/Akt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvhGbb9ohGfbVg90H21EOLACvtfcHk0lgogE6MRzvQ9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsF2htb0%253D&md5=ec289ea527da6cfee357727db14bc71e</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.exger.2006.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exger.2006.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DK.%26aulast%3DHaneda%26aufirst%3DM.%26aulast%3DIshida%26aufirst%3DY.%26aulast%3DSawada%26aufirst%3DM.%26aulast%3DIsobe%26aufirst%3DK.%26atitle%3DInduction%2520of%2520Matrix%2520Metalloproteinases%2520%2528MMP3%252C%2520MMP12%2520and%2520MMP13%2529%2520Expression%2520in%2520the%2520Microglia%2520by%2520Amyloid-%25CE%25B2%2520Stimulation%2520via%2520the%2520PI3K%252FAkt%2520Pathway%26jtitle%3DExp.%2520Gerontol.%26date%3D2007%26volume%3D42%26issue%3D6%26spage%3D532%26epage%3D537%26doi%3D10.1016%2Fj.exger.2006.11.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lue, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalsing-Hernandez, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyes, B. E.</span></span> <span> </span><span class="NLM_article-title">Gene Expression Changes by Amyloid β Peptide-Stimulated Human Postmortem Brain Microglia Identify Activation of Multiple Inflammatory Processes</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">596</span>– <span class="NLM_lpage">610</span>, <span class="refDoi"> DOI: 10.1189/jlb.0705377</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1189%2Fjlb.0705377" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16365156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFKmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2006&pages=596-610&issue=3&author=D.+G.+Walkerauthor=J.+Linkauthor=L.+Lueauthor=J.+E.+Dalsing-Hernandezauthor=B.+E.+Boyes&title=Gene+Expression+Changes+by+Amyloid+%CE%B2+Peptide-Stimulated+Human+Postmortem+Brain+Microglia+Identify+Activation+of+Multiple+Inflammatory+Processes&doi=10.1189%2Fjlb.0705377"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression changes by amyloid β peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes</span></div><div class="casAuthors">Walker, Douglas G.; Link, John; Lue, Lih-Fen; Dalsing-Hernandez, Jessica E.; Boyes, Barry E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">596-610</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">A central feature of the inflammatory pathol. in Alzheimer's disease is activated microglia clustered around aggregated amyloid β (Aβ) peptide-contg. plaques.  In vitro-cultured microglia can be activated to an inflammatory state by aggregated Aβ with the induction of a range of different neurotoxic factors and provide a model system for studying microglia Aβ interactions.  Gene expression responses of human postmortem brain-derived microglia to aggregated Aβ were measured using whole genome microarrays to address the hypothesis that Aβ interactions with human microglia primarily induce proinflammatory genes and not activation of genes involved in Aβ phagocytosis and removal.  The results demonstrated that Aβ activation of microglia induced a large alteration in gene transcription including activation of many proinflammatory cytokines and chemokines, most notably, interleukin (IL)-1β, IL-8, and matrix metalloproteinases (MMP), including MMP1, MMP3, MMP9, MMP10, and MMP12.  All of these genes could amplify ongoing inflammation, resulting in further neuronal loss.  Changes in expression of receptors assocd. with Aβ phagocytosis did not match the changes in proinflammatory gene expression.  Time-course gene expression profiling, along with real-time polymerase chain reaction validation of expression changes, demonstrated an acute phase of gene induction for many proinflammatory genes but also chronic activation for many other potentially toxic products.  These chronically activated genes included indoleamine 2,3-dioxygenase and kynureninase, which are involved in formation of the neurotoxin quinolinic acid, and S100A8, a potential proinflammatory chemokine.  These studies show that activation of microglia by Aβ induces multiple genes that could be involved in inflammatory responses contributing to neurodegenerative processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI1Qa73eVxQbVg90H21EOLACvtfcHk0li_CJaBut9bfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFKmsr4%253D&md5=b56e7e4f40bc1afc185de0b9820b176e</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1189%2Fjlb.0705377&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.0705377%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DD.%2BG.%26aulast%3DLink%26aufirst%3DJ.%26aulast%3DLue%26aufirst%3DL.%26aulast%3DDalsing-Hernandez%26aufirst%3DJ.%2BE.%26aulast%3DBoyes%26aufirst%3DB.%2BE.%26atitle%3DGene%2520Expression%2520Changes%2520by%2520Amyloid%2520%25CE%25B2%2520Peptide-Stimulated%2520Human%2520Postmortem%2520Brain%2520Microglia%2520Identify%2520Activation%2520of%2520Multiple%2520Inflammatory%2520Processes%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2006%26volume%3D79%26issue%3D3%26spage%3D596%26epage%3D610%26doi%3D10.1189%2Fjlb.0705377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ierusalimsky, V. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuleshova, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaban, P. M.</span></span> <span> </span><span class="NLM_article-title">Expression of the Type 1 Metalloproteinase in the Rat Hippocampus after the Intracerebroventricular Injection of β-Amyloid Peptide (25–35)</span>. <i>Acta Neurobiol. Exp. (Wars).</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">571</span>– <span class="NLM_lpage">578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24457647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC2czovFSnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=571-578&author=V.+N.+Ierusalimskyauthor=E.+P.+Kuleshovaauthor=P.+M.+Balaban&title=Expression+of+the+Type+1+Metalloproteinase+in+the+Rat+Hippocampus+after+the+Intracerebroventricular+Injection+of+%CE%B2-Amyloid+Peptide+%2825%E2%80%9335%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the type 1 metalloproteinase in the rat hippocampus after the intracerebroventricular injection of β-amyloid peptide (25-35)</span></div><div class="casAuthors">Ierusalimsky Victor N; Kuleshova Elena P; Balaban Pavel M</div><div class="citationInfo"><span class="NLM_cas:title">Acta neurobiologiae experimentalis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">571-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The expression of matrix metalloproteinase of the first type was studied in frontal sections of the adult rat brain one month after a single intracerebroventricular injection of beta-amyloid peptide (25-35), which is known to be a well-known model of the development of Alzheimer's disease.  Brain sections were stained immunocytochemically to detect MMP-1 expression, and histologically to reveal the state of hippocampal neurons.  Administration of beta-amyloid peptide induced a significant degeneration of cells in the dorsal hippocampus.  This was demonstrated by a significant decrease in the total number of cells and by the appearance of acidophilic neurons of altered (often triangular) shape.  Altered cells were most often found in the hippocampal field CA3, and in a smaller quantity in the CA1 field.  MMP-1-like immunoreactivity was found in the same hippocampal areas, the staining being restricted to the cells of altered shape (staining of somata and primary neurites).  The data suggest possible involvement of the type 1 metalloproteinase in the development of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqkSBNX-MlXmx8TEN9K18QfW6udTcc2ea6Vn14hoVuVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czovFSnsg%253D%253D&md5=596092e68faf81c906daa72915e25ecd</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIerusalimsky%26aufirst%3DV.%2BN.%26aulast%3DKuleshova%26aufirst%3DE.%2BP.%26aulast%3DBalaban%26aufirst%3DP.%2BM.%26atitle%3DExpression%2520of%2520the%2520Type%25201%2520Metalloproteinase%2520in%2520the%2520Rat%2520Hippocampus%2520after%2520the%2520Intracerebroventricular%2520Injection%2520of%2520%25CE%25B2-Amyloid%2520Peptide%2520%252825%25E2%2580%259335%2529%26jtitle%3DActa%2520Neurobiol.%2520Exp.%2520%2528Wars%2529.%26date%3D2013%26volume%3D73%26spage%3D571%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakkar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span> <span> </span><span class="NLM_article-title">Impact of Matrix Metalloproteinases on Atherosclerosis</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">442</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.2174/1389450115666140211115805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F1389450115666140211115805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24517161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXksFShu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=442-453&issue=4&author=J.+Linauthor=V.+Kakkarauthor=X.+Lu&title=Impact+of+Matrix+Metalloproteinases+on+Atherosclerosis&doi=10.2174%2F1389450115666140211115805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Matrix Metalloproteinases on Atherosclerosis</span></div><div class="casAuthors">Lin, Juntang; Kakkar, Vijay; Lu, Xinjie</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">442-453</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Atherosclerosis is now widely recognized as a chronic inflammatory disease that involves innate and adaptive immune responses.  Both cellular and humoral components of the immune system have been implicated in atherogenesis.  Growing evidence suggests that immune cells play crucial roles in atherogenic plaque formation.  Vulnerability of the plaque probably plays an important role in rupture.  Most ruptures occur at the periphery of the fibrous cap that covers the lipid-rich core-points where the cap is usually thinnest and most heavily infiltrated by macrophage foam cells.  Sudden rupture of a plaque triggers unstable angina, acute myocardial infarction, and sudden cardiac death.  Initiation of collagen breakdown in plaques requires matrix metalloproteinase (MMP) family members including MMP-1, MMP-8, and MMP- 13.  In addn., other MMPs such as MMP-2, -3, -9, -10 and -12 have also been reported to play roles in atherosclerosis.  This review aims to focus on description of general structural features of MMPs and their roles in atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZlAue_n8tWbVg90H21EOLACvtfcHk0li1CfdYVW0G8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXksFShu74%253D&md5=017aae726ec8344e3f0b5c5541e69ce3</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.2174%2F1389450115666140211115805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450115666140211115805%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DKakkar%26aufirst%3DV.%26aulast%3DLu%26aufirst%3DX.%26atitle%3DImpact%2520of%2520Matrix%2520Metalloproteinases%2520on%2520Atherosclerosis%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2014%26volume%3D15%26issue%3D4%26spage%3D442%26epage%3D453%26doi%3D10.2174%2F1389450115666140211115805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. L.</span></span> <span> </span><span class="NLM_article-title">Metalloproteinases in Atherosclerosis</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>816</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2017.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.ejphar.2017.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28893577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVOhur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=816&publication_year=2017&pages=93-106&issue=6&author=J.+L.+Johnson&title=Metalloproteinases+in+Atherosclerosis&doi=10.1016%2Fj.ejphar.2017.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloproteinases in atherosclerosis</span></div><div class="casAuthors">Johnson, Jason L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">816</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-106</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Atherosclerosis underlies most cardiovascular diseases, and is accepted as a primary cause of mortality worldwide.  Proteases have been implicated in the development and progression of atherosclerosis, due to their ability to provoke focal destruction of the vascular extracellular matrix.  Members of the metalloproteinase family, esp. matrix metalloproteinases (MMPs), and their endogenous tissue inhibitors (TIMPs) have been suggested to perform complex dual roles during late-stage progression and rupture of atherosclerotic plaques.  Proposed favorable actions of metalloproteinases include the promotion of vascular smooth muscle growth and survival which stabilizes plaques, while conversely extracellular matrix destruction alongside interminable monocyte/macrophage accumulation can encourage plaque rupture.  This review provides a summary of the cogent evidence connecting the contribution of individual metalloproteinases to atherosclerotic plaque development, progression, and instability.  Topics discussed include structural, functional and cell-specific diversity of MMP members; evidence from animal models of atherosclerosis and comparisons with findings in humans; the dual role of MMPs and the requirement to selectively target individual MMPs; and the need for efficient surrogate markers of MMP inhibition.  Accordingly, as our knowledge of the complex roles individual MMPs play esp. during the progression and rupture of atherosclerotic plaques expands, new impetus is required for clin. trials evaluating the therapeutic potential of selective MMP inhibition, which could limit cardiovascular morbidity and mortality worldwide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpo29nEs4jZ7Vg90H21EOLACvtfcHk0li1CfdYVW0G8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVOhur3O&md5=2084c3082b303fcd431eba4ebb95812a</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2017.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2017.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BL.%26atitle%3DMetalloproteinases%2520in%2520Atherosclerosis%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D816%26issue%3D6%26spage%3D93%26epage%3D106%26doi%3D10.1016%2Fj.ejphar.2017.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elkington, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiomi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuttall, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte-Gil, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraiva, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mauri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Armiento, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedland, J. S.</span></span> <span> </span><span class="NLM_article-title">MMP-1 Drives Immunopathology in Human Tuberculosis and Transgenic Mice</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1827</span>– <span class="NLM_lpage">1833</span>, <span class="refDoi"> DOI: 10.1172/JCI45666</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1172%2FJCI45666" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21519144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFKnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=1827-1833&issue=5&author=P.+Elkingtonauthor=T.+Shiomiauthor=R.+Breenauthor=R.+K.+Nuttallauthor=C.+A.+Ugarte-Gilauthor=N.+F.+Walkerauthor=L.+Saraivaauthor=B.+Pedersenauthor=F.+Mauriauthor=M.+Lipmanauthor=D.+R.+Edwardsauthor=B.+D.+Robertsonauthor=J.+D%E2%80%99Armientoauthor=J.+S.+Friedland&title=MMP-1+Drives+Immunopathology+in+Human+Tuberculosis+and+Transgenic+Mice&doi=10.1172%2FJCI45666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-1 drives immunopathology in human tuberculosis and transgenic mice</span></div><div class="casAuthors">Elkington, Paul; Shiomi, Takayuki; Breen, Ronan; Nuttall, Robert K.; Ugarte-Gil, Cesar Augusto; Walker, Naomi F.; Saraiva, Luisa; Pedersen, Bernadette; Mauri, Francesco; Lipman, Marc; Edwards, Dylan R.; Robertson, Brian D.; D'Armiento, Jeanine; Friedland, Jon S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1827-1833</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis can cause lung tissue damage to spread, but the mechanisms driving this immunopathol. are poorly understood.  The breakdown of lung matrix involves MMPs, which have a unique ability to degrade fibrillar collagens at neutral pH.  To det. whether MMPs play a role in the immunopathol. of tuberculosis (TB), we profiled MMPs and their inhibitors, the tissue inhibitor of metalloproteinases (TIMPs), in sputum and bronchoalveolar lavage fluid from patients with TB and symptomatic controls.  MMP-1 concns. were significantly increased in both HIV-neg. and HIV-pos. patients with TB, while TIMP concns. were lower in HIV-neg. TB patients.  In primary human monocytes, M. tuberculosis infection selectively upregulated MMP1 gene expression and secretion, and Ro32-3555, a specific MMP inhibitor, suppressed M. tuberculosis-driven MMP-1 activity.  Since the mouse MMP-1 ortholog is not expressed in the lung and mice infected with M. tuberculosis do not develop tissue destruction equiv. to humans, we infected transgenic mice expressing human MMP-1 with M. tuberculosis to investigate whether MMP-1 caused lung immunopathol.  In the MMP-1 transgenic mice, M. tuberculosis infection increased MMP-1 expression, resulting in alveolar destruction in lung granulomas and significantly greater collagen breakdown.  In summary, MMP-1 may drive tissue destruction in TB and represents a therapeutic target to limit immunopathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoklCcWsJLZhbVg90H21EOLACvtfcHk0lgvU7xOtWxQPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFKnt7s%253D&md5=05e4eb412ae0f166c78f3fa8565d73f2</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1172%2FJCI45666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI45666%26sid%3Dliteratum%253Aachs%26aulast%3DElkington%26aufirst%3DP.%26aulast%3DShiomi%26aufirst%3DT.%26aulast%3DBreen%26aufirst%3DR.%26aulast%3DNuttall%26aufirst%3DR.%2BK.%26aulast%3DUgarte-Gil%26aufirst%3DC.%2BA.%26aulast%3DWalker%26aufirst%3DN.%2BF.%26aulast%3DSaraiva%26aufirst%3DL.%26aulast%3DPedersen%26aufirst%3DB.%26aulast%3DMauri%26aufirst%3DF.%26aulast%3DLipman%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DD.%2BR.%26aulast%3DRobertson%26aufirst%3DB.%2BD.%26aulast%3DD%25E2%2580%2599Armiento%26aufirst%3DJ.%26aulast%3DFriedland%26aufirst%3DJ.%2BS.%26atitle%3DMMP-1%2520Drives%2520Immunopathology%2520in%2520Human%2520Tuberculosis%2520and%2520Transgenic%2520Mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26issue%3D5%26spage%3D1827%26epage%3D1833%26doi%3D10.1172%2FJCI45666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases: Inflammatory Regulators of Cell Behaviors in Vascular Formation and Remodeling</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1155/2013/928315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1155%2F2013%2F928315" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=1-14&author=Q.+Chenauthor=M.+Jinauthor=F.+Yangauthor=J.+Zhuauthor=Q.+Xiaoauthor=L.+Zhang&title=Matrix+Metalloproteinases%3A+Inflammatory+Regulators+of+Cell+Behaviors+in+Vascular+Formation+and+Remodeling&doi=10.1155%2F2013%2F928315"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1155%2F2013%2F928315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F928315%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DJin%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26atitle%3DMatrix%2520Metalloproteinases%253A%2520Inflammatory%2520Regulators%2520of%2520Cell%2520Behaviors%2520in%2520Vascular%2520Formation%2520and%2520Remodeling%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D14%26doi%3D10.1155%2F2013%2F928315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barichello, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Generoso, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelon, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simões, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuolo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comim, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal-Pizzol, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quevedo, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Matrix Metalloproteinases-2 and −9 Prevents Cognitive Impairment Induced by Pneumococcal Meningitis in Wistar Rats</span>. <i>Exp. Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>239</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1177/1535370213508354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1177%2F1535370213508354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFags7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=239&publication_year=2014&pages=225-231&issue=2&author=T.+Barichelloauthor=J.+S.+Generosoauthor=C.+M.+Michelonauthor=L.+R.+Sim%C3%B5esauthor=S.+G.+Eliasauthor=F.+Vuoloauthor=C.+M.+Comimauthor=F.+Dal-Pizzolauthor=J.+Quevedo&title=Inhibition+of+Matrix+Metalloproteinases-2+and+%E2%88%929+Prevents+Cognitive+Impairment+Induced+by+Pneumococcal+Meningitis+in+Wistar+Rats&doi=10.1177%2F1535370213508354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats</span></div><div class="casAuthors">Barichello, Tatiana; Generoso, Jaqueline S.; Michelon, Cleonice M.; Simoes, Lutiana R.; Elias, Samuel G.; Vuolo, Franciele; Comim, Clarissa M.; Dal-Pizzol, Felipe; Quevedo, Joao</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">239</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-231, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3699</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Pneumococcal meningitis is a relevant clin. disease characterized by an intense inflammatory reaction into the subarachnoid and ventricular spaces, leading to blood-brain barrier breakdown, hearing loss, and cognitive impairment.  Matrix metalloproteinases (MMPs) are capable of degrading components of the basal laminin, thus contributing to BBB damage and neuronal injury.  In the present study, we evaluated the effects of MMP-2, MMP-9, and MMP-2/9 inhibitors on BBB integrity, learning, and memory in Wistar rats subjected to pneumococcal meningitis.  The animals underwent a magna cistern tap and received either 10 μL sterile saline as a placebo or an equiv. vol. of a Streptococcus pneumoniae suspension at a concn. of 5 × 109 cfu/mL.  The rats were randomized into different groups that received adjuvant treatment with MMP-2, MMP-9 or MMP-2/9 inhibitors.  The BBB integrity was evaluated, and the animals were habituated to open-field and object recognition tasks 10 days after meningitis induction.  Adjuvant treatments with inhibitors of MMP-2 or MMP-2/9 prevented BBB breakdown in the hippocampus, and treatments with inhibitors of MMP-2, MMP-9 or MMP-2/9 prevented BBB breakdown in the cortex.  Ten days after meningitis induction, the animals that received adjuvant treatment with the inhibitor of MMP-2/9 demonstrated that animals habituated to the open-field task faster and enhanced memory during short-term and long-term retention test sessions in the object recognition task.  Further investigation is necessary to provide support for MMP inhibitors as an alternative treatment for bacterial meningitis; however, these findings suggest that the meningitis model could be a good research tool for studying the biol. mechanisms involved in the behavioral alterations assocd. with pneumococcal meningitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9hBIe9cGLkLVg90H21EOLACvtfcHk0lgvU7xOtWxQPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFags7fE&md5=651ff752d93696620d96b312cbd76fd0</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1177%2F1535370213508354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1535370213508354%26sid%3Dliteratum%253Aachs%26aulast%3DBarichello%26aufirst%3DT.%26aulast%3DGeneroso%26aufirst%3DJ.%2BS.%26aulast%3DMichelon%26aufirst%3DC.%2BM.%26aulast%3DSim%25C3%25B5es%26aufirst%3DL.%2BR.%26aulast%3DElias%26aufirst%3DS.%2BG.%26aulast%3DVuolo%26aufirst%3DF.%26aulast%3DComim%26aufirst%3DC.%2BM.%26aulast%3DDal-Pizzol%26aufirst%3DF.%26aulast%3DQuevedo%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520Matrix%2520Metalloproteinases-2%2520and%2520%25E2%2588%25929%2520Prevents%2520Cognitive%2520Impairment%2520Induced%2520by%2520Pneumococcal%2520Meningitis%2520in%2520Wistar%2520Rats%26jtitle%3DExp.%2520Biol.%2520Med.%26date%3D2014%26volume%3D239%26issue%3D2%26spage%3D225%26epage%3D231%26doi%3D10.1177%2F1535370213508354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hannocks, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerwien, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chashchina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burmeister, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korpos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorokin, L.</span></span> <span> </span><span class="NLM_article-title">The Gelatinases, MMP-2 and MMP-9, as Fine Tuners of Neuroinflammatory Processes</span>. <i>Matrix Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>75–76</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">113</span>, <span class="refDoi"> DOI: 10.1016/j.matbio.2017.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.matbio.2017.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29158162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVOitbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75%E2%80%9376&publication_year=2019&pages=102-113&author=M.-J.+Hannocksauthor=X.+Zhangauthor=H.+Gerwienauthor=A.+Chashchinaauthor=M.+Burmeisterauthor=E.+Korposauthor=J.+Songauthor=L.+Sorokin&title=The+Gelatinases%2C+MMP-2+and+MMP-9%2C+as+Fine+Tuners+of+Neuroinflammatory+Processes&doi=10.1016%2Fj.matbio.2017.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The gelatinases, MMP-2 and MMP-9, as fine tuners of neuroinflammatory processes</span></div><div class="casAuthors">Hannocks, M.-J.; Zhang, X.; Gerwien, H.; Chashchina, A.; Burmeister, M.; Korpos, E.; Song, J.; Sorokin, L.</div><div class="citationInfo"><span class="NLM_cas:title">Matrix Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">75-76</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">102-113</span>CODEN:
                <span class="NLM_cas:coden">MTBOEC</span>;
        ISSN:<span class="NLM_cas:issn">0945-053X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review focuses on the complementary roles of MMP-2 and MMP-9 in leukocyte migration into the brain in neuroinflammation, studied mainly in a murine model of exptl. autoimmune encephalomyelitis (EAE) that has similarity to the human disease multiple sclerosis.  We discuss the cellular sources of MMP-2/MMP-9 in EAE, their sites of activity, and how cleavage of the to-date identified MMP-2/MMP-9 substrates at the blood-brain barrier facilitate leukocyte filtration of the central nervous system (CNS).  Where necessary, comparisons are made to inflammatory processes in the periphery and to other MMPs relevant to neuroinflammation.  While the general principles concerning MMP-2 and MMP-9 function discussed here are relevant to all inflammatory situations, the details regarding substrates and mol. mechanisms of action are likely to be specific for neuroinflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD6C_B8JJ8ArVg90H21EOLACvtfcHk0liHDlQQWvxWDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVOitbjE&md5=0839dca25d3939f71992607de8ea3af5</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1016%2Fj.matbio.2017.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.matbio.2017.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DHannocks%26aufirst%3DM.-J.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGerwien%26aufirst%3DH.%26aulast%3DChashchina%26aufirst%3DA.%26aulast%3DBurmeister%26aufirst%3DM.%26aulast%3DKorpos%26aufirst%3DE.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DSorokin%26aufirst%3DL.%26atitle%3DThe%2520Gelatinases%252C%2520MMP-2%2520and%2520MMP-9%252C%2520as%2520Fine%2520Tuners%2520of%2520Neuroinflammatory%2520Processes%26jtitle%3DMatrix%2520Biol.%26date%3D2019%26volume%3D75%25E2%2580%259376%26spage%3D102%26epage%3D113%26doi%3D10.1016%2Fj.matbio.2017.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volitakis, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharples, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xilinas, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoke, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsinger, R. M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherny, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnham, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masters, C. L.</span></span> <span> </span><span class="NLM_article-title">Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-Dependent Up-Regulation of Metalloprotease Activity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">17670</span>– <span class="NLM_lpage">17680</span>, <span class="refDoi"> DOI: 10.1074/jbc.M602487200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M602487200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16648635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtFyksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=17670-17680&issue=26&author=A.+R.+Whiteauthor=T.+Duauthor=K.+M.+Laughtonauthor=I.+Volitakisauthor=R.+A.+Sharplesauthor=M.+E.+Xilinasauthor=D.+E.+Hokeauthor=R.+M.+D.+Holsingerauthor=G.+Evinauthor=R.+A.+Chernyauthor=A.+F.+Hillauthor=K.+J.+Barnhamauthor=Q.-X.+Liauthor=A.+I.+Bushauthor=C.+L.+Masters&title=Degradation+of+the+Alzheimer+Disease+Amyloid+%CE%B2-Peptide+by+Metal-Dependent+Up-Regulation+of+Metalloprotease+Activity&doi=10.1074%2Fjbc.M602487200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity</span></div><div class="casAuthors">White, Anthony R.; Du, Tai; Laughton, Katrina M.; Volitakis, Irene; Sharples, Robyn A.; Xilinas, Michel E.; Hoke, David E.; Holsinger, R. M. Damian; Evin, Genevieve; Cherny, Robert A.; Hill, Andrew F.; Barnham, Kevin J.; Li, Qiao-Xin; Bush, Ashley I.; Masters, Colin L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">17670-17680</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Biometals play an important role in Alzheimer disease, and recent reports have described the development of potential therapeutic agents based on modulation of metal bioavailability.  The metal ligand clioquinol (CQ) has shown promising results in animal models and small phase clin. trials; however, the actual mode of action in vivo has not been detd.  We now report a novel effect of CQ on amyloid β-peptide (Aβ) metab. in cell culture.  Treatment of Chinese hamster ovary cells overexpressing amyloid precursor protein with CQ and Cu2+ or Zn2+ resulted in an ∼85 - 90% redn. of secreted Aβ-(1-40) and Aβ-(1-42) compared with untreated controls.  Analogous effects were seen in amyloid precursor protein-overexpressing neuroblastoma cells.  The secreted Aβ was rapidly degraded through up-regulation of matrix metalloprotease (MMP)-2 and MMP-3 after addn. of CQ and Cu2+.  MMP activity was increased through activation of phosphoinositol 3-kinase and JNK.  CQ and Cu2+ also promoted phosphorylation of glycogen synthase kinase-3, and this potentiated activation of JNK and loss of Aβ-(1-40).  Our findings identify an alternative mechanism of action for CQ in the redn. of Aβ deposition in the brains of CQ-treated animals and potentially in Alzheimer disease patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphcWxR7vti2bVg90H21EOLACvtfcHk0liHDlQQWvxWDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtFyksLg%253D&md5=01082a7c6c94dba950d653b992119ded</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M602487200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M602487200%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DA.%2BR.%26aulast%3DDu%26aufirst%3DT.%26aulast%3DLaughton%26aufirst%3DK.%2BM.%26aulast%3DVolitakis%26aufirst%3DI.%26aulast%3DSharples%26aufirst%3DR.%2BA.%26aulast%3DXilinas%26aufirst%3DM.%2BE.%26aulast%3DHoke%26aufirst%3DD.%2BE.%26aulast%3DHolsinger%26aufirst%3DR.%2BM.%2BD.%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DCherny%26aufirst%3DR.%2BA.%26aulast%3DHill%26aufirst%3DA.%2BF.%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DLi%26aufirst%3DQ.-X.%26aulast%3DBush%26aufirst%3DA.%2BI.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26atitle%3DDegradation%2520of%2520the%2520Alzheimer%2520Disease%2520Amyloid%2520%25CE%25B2-Peptide%2520by%2520Metal-Dependent%2520Up-Regulation%2520of%2520Metalloprotease%2520Activity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D26%26spage%3D17670%26epage%3D17680%26doi%3D10.1074%2Fjbc.M602487200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brkic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balusu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wonterghem, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorle, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benilova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Hove, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moons, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Libert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenbroucke, R. E.</span></span> <span> </span><span class="NLM_article-title">Amyloid Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">12766</span>– <span class="NLM_lpage">12778</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.0006-15.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.0006-15.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26377465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVSqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=12766-12778&issue=37&author=M.+Brkicauthor=S.+Balusuauthor=E.+Van+Wonterghemauthor=N.+Gorleauthor=I.+Benilovaauthor=A.+Kremerauthor=I.+Van+Hoveauthor=L.+Moonsauthor=B.+De+Strooperauthor=S.+Kanazirauthor=C.+Libertauthor=R.+E.+Vandenbroucke&title=Amyloid+Oligomers+Disrupt+Blood-CSF+Barrier+Integrity+by+Activating+Matrix+Metalloproteinases&doi=10.1523%2FJNEUROSCI.0006-15.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid β oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases</span></div><div class="casAuthors">Brkic, Marjana; Balusu, Sriram; Van Wonterghem, Elien; Gorle, Nina; Benilova, Iryna; Kremer, Anna; Van Hove, Inge; Moons, Lieve; De Strooper, Bart; Kanazir, Selma; Libert, Claude; Vandenbroucke, Roosmarijn E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">12766-12778</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The blood-CSF barrier (BCSFB) consists of a monolayer of choroid plexus epithelial (CPE) cells that maintain CNS homeostasis by producing CSF and restricting the passage of undesirable mols. and pathogens into the brain.  Alzheimer's disease is the most common progressive neurodegenerative disorder and is characterized by the presence of amyloid β (Aβ) plaques and neurofibrillary tangles in the brain.  Recent research shows that Alzheimer's disease is assocd. with morphol. changes in CPE cells and compromised prodn. of CSF.  Here, we studied the direct effects of Aβ on the functionality of the BCSFB.  Intracerebroventricular injection of Aβ1-42 oligomers into the cerebral ventricles of mice, a validated Alzheimer's disease model, caused induction of a cascade of detrimental events, including increased inflammatory gene expression in CPE cells and increased levels of proinflammatory cytokines and chemokines in the CSF.  It also rapidly affected CPE cell morphol. and tight junction protein levels.  These changes were assocd. with loss of BCSFB integrity, as shown by an increase in BCSFB leakage.  Aβ1-42 oligomers also increased matrix metalloproteinase (MMP) gene expression in the CPE and its activity in CSF.  Interestingly, BCSFB disruption induced by Aβ1-42 oligomers did not occur in the presence of a broad-spectrum MMP inhibitor or in MMP3-deficient mice.  These data provide evidence that MMPs are essential for the BCSFB leakage induced by Aβ1-42 oligomers.  Our results reveal that Alzheimer's disease-assocd. sol. Aβ1-42 oligomers induce BCSFB dysfunction and suggest MMPs as a possible therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGg-ylkQBzrVg90H21EOLACvtfcHk0liHDlQQWvxWDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVSqt78%253D&md5=1b7cbd00c8353329f38a81215774253f</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0006-15.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0006-15.2015%26sid%3Dliteratum%253Aachs%26aulast%3DBrkic%26aufirst%3DM.%26aulast%3DBalusu%26aufirst%3DS.%26aulast%3DVan%2BWonterghem%26aufirst%3DE.%26aulast%3DGorle%26aufirst%3DN.%26aulast%3DBenilova%26aufirst%3DI.%26aulast%3DKremer%26aufirst%3DA.%26aulast%3DVan%2BHove%26aufirst%3DI.%26aulast%3DMoons%26aufirst%3DL.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DKanazir%26aufirst%3DS.%26aulast%3DLibert%26aufirst%3DC.%26aulast%3DVandenbroucke%26aufirst%3DR.%2BE.%26atitle%3DAmyloid%2520Oligomers%2520Disrupt%2520Blood-CSF%2520Barrier%2520Integrity%2520by%2520Activating%2520Matrix%2520Metalloproteinases%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26issue%3D37%26spage%3D12766%26epage%3D12778%26doi%3D10.1523%2FJNEUROSCI.0006-15.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillmore, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, L. L.</span></span> <span> </span><span class="NLM_article-title">Elevation of Hippocampal MMP-3 Expression and Activity during Trauma-Induced Synaptogenesis</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>192</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">72</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2004.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.expneurol.2004.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15698619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2005&pages=60-72&issue=1&author=H.+J.+Kimauthor=H.+L.+Fillmoreauthor=T.+M.+Reevesauthor=L.+L.+Phillips&title=Elevation+of+Hippocampal+MMP-3+Expression+and+Activity+during+Trauma-Induced+Synaptogenesis&doi=10.1016%2Fj.expneurol.2004.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Elevation of hippocampal MMP-3 expression and activity during trauma-induced synaptogenesis</span></div><div class="casAuthors">Kim, H. J.; Fillmore, H. L.; Reeves, T. M.; Phillips, L. L.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-72</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The matrix metalloproteinase (MMP) enzyme family contributes to the regulation of a variety of brain extracellular matrix mols.  In order to assess their role in synaptic plasticity following traumatic brain injury (TBI), we compared expression of stromelysin-1 (MMP-3) protein and mRNA in two rodent models of TBI exhibiting different levels of recovery: adaptive synaptic plasticity following central fluid percussion injury and maladaptive synaptic plasticity generated by combined TBI and bilateral entorhinal cortical lesion (TBI + BEC).  We sampled the hippocampus at 7 days postinjury, targeting a selectively vulnerable brain region and a survival interval exhibiting rapid synaptogenesis.  We report elevated expression of hippocampal MMP-3 mRNA and protein after TBI.  MMP-3 immunohistochem. staining showed increased protein levels relative to sham-injured controls, primarily localized to cell bodies within the deafferented dendritic laminae.  Injury-related differences in MMP-3 protein were also obsd.  TBI alone elevated MMP-3 immunobinding over the stratum lacunosum moleculare (SLM), inner mol. layer and hilus, while TBI + BEC generated more robust increases in MMP-3 reactivity within the deafferented SLM and dentate mol. layer (DML).  Double labeling with GFAP confirmed the presence of MMP-3 within reactive astrocytes induced by each injury model.  Semi-quant. RT-PCR revealed that MMP-3 mRNA also increased after each injury, however, the combined insult induced a much greater elevation than fluid percussion alone: 1.9-fold vs. 79%, resp.  In the TBI + BEC model, MMP-3 up-regulation was spatio-temporally correlated with increased enzyme activity, an effect which was attenuated with the neuroprotective compd. MK-801.  These results show that distinct pathol. conditions elicited by TBI can differentially affect MMP-3 expression during reactive synaptic plasticity.  Notably, these effects are both transcriptional and translational and are correlated with functionally active enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDEiPSZa0oArVg90H21EOLACvtfcHk0li6ocQapZBhpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKgsr4%253D&md5=e86e1fc5fbd58d9eea76cacca4a76063</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2004.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2004.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DFillmore%26aufirst%3DH.%2BL.%26aulast%3DReeves%26aufirst%3DT.%2BM.%26aulast%3DPhillips%26aufirst%3DL.%2BL.%26atitle%3DElevation%2520of%2520Hippocampal%2520MMP-3%2520Expression%2520and%2520Activity%2520during%2520Trauma-Induced%2520Synaptogenesis%26jtitle%3DExp.%2520Neurol.%26date%3D2005%26volume%3D192%26issue%3D1%26spage%3D60%26epage%3D72%26doi%3D10.1016%2Fj.expneurol.2004.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joh, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beal, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">Role of Matrix Metalloproteinase 3-Mediated α-Synuclein Cleavage in Dopaminergic Cell Death</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>286</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">14168</span>– <span class="NLM_lpage">14177</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.222430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M111.222430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21330369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslWju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=14168-14177&issue=16&author=D.+H.+Choiauthor=Y.+J.+Kimauthor=Y.+G.+Kimauthor=T.+H.+Johauthor=M.+F.+Bealauthor=Y.+S.+Kim&title=Role+of+Matrix+Metalloproteinase+3-Mediated+%CE%B1-Synuclein+Cleavage+in+Dopaminergic+Cell+Death&doi=10.1074%2Fjbc.M111.222430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death</span></div><div class="casAuthors">Choi, Dong-Hee; Kim, Youn-Jung; Kim, Young-Gun; Joh, Tong H.; Beal, M. Flint; Kim, Yoon-Seong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">14168-14177</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Evidence suggests that the C-terminal truncation of α-synuclein is equally important as aggregation of α-synuclein in Parkinson disease (PD).  Our previous results showed that an endopeptidase, matrix metalloproteinase-3 (MMP3), was induced and activated in dopaminergic (DA) cells upon stress conditions.  Here, we report that MMP3 cleaved α-synuclein in vitro and in vivo and that α-synuclein and MMP3 were co-localized in Lewy bodies (LB) in the postmortem brains of PD patients.  Incubation of α-synuclein with the catalytic domain of MMP3 (cMMP3) resulted in generation of several peptides, and the peptide profiles of WT α-synuclein (WTsyn) and A53T mutant (A53Tsyn) were different.  Combined anal. using mass spectrometry and N-terminal detn. revealed that MMP3 generated C-terminally truncated peptides of amino acids 1-78, 1-91, and 1-93 and that A53Tsyn produced significantly higher quantities of these peptides.  Similar sizes of peptides were detected in N27 DA cells under oxidative stress and RNA interference to knock down MMP3-attenuated peptide generation.  Co-overexpression of cMMP3 with either WTsyn or A53Tsyn led to a redn. in Triton X-100-insol. aggregates and an increase in protofibril-like small aggregates.  In addn., overexpression of the 1-93-amino acid peptide in the substantia nigra led to DA neuronal loss without LB-like aggregate formation.  The results strongly indicate that MMP3 digestion of α-synuclein in DA neurons plays a pivotal role in the progression of PD through modulation of α-synuclein in aggregation, LB formation, and neurotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7BjPuBR4vibVg90H21EOLACvtfcHk0li6ocQapZBhpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslWju70%253D&md5=c67b0e3fed2c0f2feeef2ad09e772ee0</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.222430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.222430%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DD.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DJoh%26aufirst%3DT.%2BH.%26aulast%3DBeal%26aufirst%3DM.%2BF.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DRole%2520of%2520Matrix%2520Metalloproteinase%25203-Mediated%2520%25CE%25B1-Synuclein%2520Cleavage%2520in%2520Dopaminergic%2520Cell%2520Death%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26issue%3D16%26spage%3D14168%26epage%3D14177%26doi%3D10.1074%2Fjbc.M111.222430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chung, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bok, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yune, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeng, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, B. K.</span></span> <span> </span><span class="NLM_article-title">MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson’s Disease</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">11</span>, <span class="refDoi"> DOI: 10.1155/2013/370526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1155%2F2013%2F370526" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=1-11&author=Y.+C.+Chungauthor=Y.-S.+Kimauthor=E.+Bokauthor=T.+Y.+Yuneauthor=S.+Maengauthor=B.+K.+Jin&title=MMP-3+Contributes+to+Nigrostriatal+Dopaminergic+Neuronal+Loss%2C+BBB+Damage%2C+and+Neuroinflammation+in+an+MPTP+Mouse+Model+of+Parkinson%E2%80%99s+Disease&doi=10.1155%2F2013%2F370526"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1155%2F2013%2F370526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F370526%26sid%3Dliteratum%253Aachs%26aulast%3DChung%26aufirst%3DY.%2BC.%26aulast%3DKim%26aufirst%3DY.-S.%26aulast%3DBok%26aufirst%3DE.%26aulast%3DYune%26aufirst%3DT.%2BY.%26aulast%3DMaeng%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DB.%2BK.%26atitle%3DMMP-3%2520Contributes%2520to%2520Nigrostriatal%2520Dopaminergic%2520Neuronal%2520Loss%252C%2520BBB%2520Damage%252C%2520and%2520Neuroinflammation%2520in%2520an%2520MPTP%2520Mouse%2520Model%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26jtitle%3DMediators%2520Inflammation%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D11%26doi%3D10.1155%2F2013%2F370526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stawarski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefaniuk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wlodarczyk, J.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-9 Involvement in the Structural Plasticity of Dendritic Spines</span>. <i>Front. Neuroanat.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.3389/fnana.2014.00068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3389%2Ffnana.2014.00068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24523676" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=1-15&issue=7&author=M.+Stawarskiauthor=M.+Stefaniukauthor=J.+Wlodarczyk&title=Matrix+Metalloproteinase-9+Involvement+in+the+Structural+Plasticity+of+Dendritic+Spines&doi=10.3389%2Ffnana.2014.00068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.3389%2Ffnana.2014.00068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnana.2014.00068%26sid%3Dliteratum%253Aachs%26aulast%3DStawarski%26aufirst%3DM.%26aulast%3DStefaniuk%26aufirst%3DM.%26aulast%3DWlodarczyk%26aufirst%3DJ.%26atitle%3DMatrix%2520Metalloproteinase-9%2520Involvement%2520in%2520the%2520Structural%2520Plasticity%2520of%2520Dendritic%2520Spines%26jtitle%3DFront.%2520Neuroanat.%26date%3D2014%26volume%3D8%26issue%3D7%26spage%3D1%26epage%3D15%26doi%3D10.3389%2Ffnana.2014.00068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murase, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantz, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stopfer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinlan, E. M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-9 Regulates Neuronal Circuit Development and Excitability</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>53</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">3477</span>– <span class="NLM_lpage">3493</span>, <span class="refDoi"> DOI: 10.1007/s12035-015-9295-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs12035-015-9295-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26093382" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVKhsrfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2016&pages=3477-3493&issue=5&author=S.+Muraseauthor=C.+L.+Lantzauthor=E.+Kimauthor=N.+Guptaauthor=R.+Higginsauthor=M.+Stopferauthor=D.+A.+Hoffmanauthor=E.+M.+Quinlan&title=Matrix+Metalloproteinase-9+Regulates+Neuronal+Circuit+Development+and+Excitability&doi=10.1007%2Fs12035-015-9295-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix Metalloproteinase-9 Regulates Neuronal Circuit Development and Excitability</span></div><div class="casAuthors">Murase, Sachiko; Lantz, Crystal L.; Kim, Eunyoung; Gupta, Nitin; Higgins, Richard; Stopfer, Mark; Hoffman, Dax A.; Quinlan, Elizabeth M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">3477-3493</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">In early postnatal development, naturally occurring cell death, dendritic outgrowth, and synaptogenesis sculpt neuronal ensembles into functional neuronal circuits.  Here, we demonstrate that deletion of the extracellular proteinase matrix metalloproteinase-9 (MMP-9) affects each of these processes, resulting in maladapted neuronal circuitry.  MMP-9 deletion increases the no. of CA1 pyramidal neurons but decreases dendritic length and complexity.  Parallel changes in neuronal morphol. are obsd. in primary visual cortex and persist into adulthood.  Individual CA1 neurons in MMP-9-/- mice have enhanced input resistance and a significant increase in the frequency, but not amplitude, of miniature excitatory postsynaptic currents (mEPSCs).  Addnl., deletion of MMP-9 significantly increases spontaneous neuronal activity in awake MMP-9-/- mice and enhances response to acute challenge by the excitotoxin kainate.  Our data document a novel role for MMP-9-dependent proteolysis: the regulation of several aspects of circuit maturation to constrain excitability throughout life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMOv1yVS2dd7Vg90H21EOLACvtfcHk0lhRuq3B9tSvow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVKhsrfJ&md5=69ad09d0ece8eb0b1ceaa4f9e093f1c6</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1007%2Fs12035-015-9295-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-015-9295-y%26sid%3Dliteratum%253Aachs%26aulast%3DMurase%26aufirst%3DS.%26aulast%3DLantz%26aufirst%3DC.%2BL.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DGupta%26aufirst%3DN.%26aulast%3DHiggins%26aufirst%3DR.%26aulast%3DStopfer%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DD.%2BA.%26aulast%3DQuinlan%26aufirst%3DE.%2BM.%26atitle%3DMatrix%2520Metalloproteinase-9%2520Regulates%2520Neuronal%2520Circuit%2520Development%2520and%2520Excitability%26jtitle%3DMol.%2520Neurobiol.%26date%3D2016%26volume%3D53%26issue%3D5%26spage%3D3477%26epage%3D3493%26doi%3D10.1007%2Fs12035-015-9295-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conant, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">Myelin Formation during Development of the CNS Is Delayed in Matrix Metalloproteinase-9 and −12 Null Mice</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2207</span>– <span class="NLM_lpage">2214</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.1880-05.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.1880-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16495447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFCmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2207-2214&issue=8&author=P.+H.+Larsenauthor=A.+G.+DaSilvaauthor=K.+Conantauthor=V.+W.+Yong&title=Myelin+Formation+during+Development+of+the+CNS+Is+Delayed+in+Matrix+Metalloproteinase-9+and+%E2%88%9212+Null+Mice&doi=10.1523%2FJNEUROSCI.1880-05.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice</span></div><div class="casAuthors">Larsen, Peter H.; DaSilva, Angelika Goncalves; Conant, Katherine; Yong, V. Wee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2207-2214</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">We have addressed whether and how matrix metalloproteinases (MMPs) might be required for myelin formation in normal ontogeny.  Using a probe for multiple MMPs and the developing mouse optic nerve, we found 2 members, MMP-9 and -12, to be upregulated during the period of myelin formation.  These MMPs partake in myelinogenesis because myelination in the corpus callosum of MMP-9 and(or) MMP-12 null mice was deficient from postnatal days 7 to 14 compared with that of wild-type mice.  The deficient myelination was correlated with fewer mature oligodendrocytes, but similar precursor cell nos., in MMP null animals compared with wild type.  Because an important growth factor for oligodendrocyte maturation is insulin-like growth factor-1 (IGF-1), we addressed whether this was involved in the deficient myelination in MMP null mice.  Indeed, the addn. of IGF-1 normalized the lack of maturation of oligodendrocytes that occurred in cultures from MMP-12 null mice.  Furthermore, we detd. that IGF binding protein 6 (IGFBP-6), which sequesters IGF-1, was a substrate for MMP processing.  Finally, we found IGFBP-6 levels to remain high in MMP-deficient mice.  These results reveal a novel function for MMP-9 and -12 in developmental myelination likely through regulating IGF-1 bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMnPNy0rTJOrVg90H21EOLACvtfcHk0lhRuq3B9tSvow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFCmsrY%253D&md5=7cc05c8fa6bf91b6ff7937a9a8ac46a9</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1880-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1880-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DLarsen%26aufirst%3DP.%2BH.%26aulast%3DDaSilva%26aufirst%3DA.%2BG.%26aulast%3DConant%26aufirst%3DK.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DMyelin%2520Formation%2520during%2520Development%2520of%2520the%2520CNS%2520Is%2520Delayed%2520in%2520Matrix%2520Metalloproteinase-9%2520and%2520%25E2%2588%259212%2520Null%2520Mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26issue%3D8%26spage%3D2207%26epage%3D2214%26doi%3D10.1523%2FJNEUROSCI.1880-05.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mihaljevic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fassbender, K.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-12 Contributes to Neuroinflammation in the Aged Brain</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1231</span>– <span class="NLM_lpage">1239</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2012.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.neurobiolaging.2012.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23159549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmu7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=1231-1239&issue=4&author=Y.+Liuauthor=M.+Zhangauthor=W.+Haoauthor=I.+Mihaljevicauthor=X.+Liuauthor=K.+Xieauthor=S.+Walterauthor=K.+Fassbender&title=Matrix+Metalloproteinase-12+Contributes+to+Neuroinflammation+in+the+Aged+Brain&doi=10.1016%2Fj.neurobiolaging.2012.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain</span></div><div class="casAuthors">Liu, Yang; Zhang, Min; Hao, Wenlin; Mihaljevic, Ivan; Liu, Xu; Xie, Kan; Walter, Silke; Fassbender, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1231-1239</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">During aging the brain displays an increased proinflammatory status, which is assocd. with the pathogenesis of aging-related diseases such as Alzheimer's and Parkinson diseases.  Matrix metalloproteinases (MMPs) facilitate the migration of inflammatory cells in tissues and modulate their inflammatory activity.  In this study, we screened expression of MMPs in 3-, 10-, and 18-mo-old mice and obsd. that cerebral MMP-12 expression was strongly upregulated during aging.  We compared the neuroinflammation of 3-, 10-, and 18-mo-old MMP-12-deficient vs. wild type mice by counting microglia and measuring inflammatory gene transcripts in the brain and obsd. that MMP-12 deficiency reduced neuroinflammation during aging.  In order to identify potential mechanisms, we analyzed the inflammatory activity of microglia directly isolated from adult mouse brains or cultured from newborn mice.  We obsd. that MMP-12 deficiency increased the inflammatory activity of adult brain-derived microglia, but did not affect cultured microglia.  We found greater nos. of CD11b/CD45high cells in the parenchyma of MMP-12 wild type than in the parenchyma of MMP-12-deficient mouse brains.  Thus, our study suggested that the upregulated cerebral MMP-12 during aging enhances aging-assocd. neuroinflammation by facilitating recruitment of bone marrow-derived microglia into the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN5JKQoFbEqrVg90H21EOLACvtfcHk0lhRuq3B9tSvow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmu7vO&md5=0dc055afbeef9c89a4bdf1401551d675</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2012.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2012.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DMihaljevic%26aufirst%3DI.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DFassbender%26aufirst%3DK.%26atitle%3DMatrix%2520Metalloproteinase-12%2520Contributes%2520to%2520Neuroinflammation%2520in%2520the%2520Aged%2520Brain%26jtitle%3DNeurobiol.%2520Aging%26date%3D2013%26volume%3D34%26issue%3D4%26spage%3D1231%26epage%3D1239%26doi%3D10.1016%2Fj.neurobiolaging.2012.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abuelnasr, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bi, X.</span></span> <span> </span><span class="NLM_article-title">Enhanced Expression of Matrix Metalloproteinase-12 Contributes to Npc1 Deficiency-Induced Axonal Degeneration</span>. <i>Exp. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>269</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/j.expneurol.2015.04.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.expneurol.2015.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25864931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVCiurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=2015&pages=67-74&author=G.+Liaoauthor=Z.+Wangauthor=E.+Leeauthor=S.+Morenoauthor=O.+Abuelnasrauthor=M.+Baudryauthor=X.+Bi&title=Enhanced+Expression+of+Matrix+Metalloproteinase-12+Contributes+to+Npc1+Deficiency-Induced+Axonal+Degeneration&doi=10.1016%2Fj.expneurol.2015.04.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration</span></div><div class="casAuthors">Liao, Guanghong; Wang, Zhuangjun; Lee, Erik; Moreno, Stephanie; Abuelnasr, Omar; Baudry, Michel; Bi, Xiaoning</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">269</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">67-74</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Niemann-Pick type C (NPC) disease is a genetic disorder assocd. with intracellular cholesterol accumulation in the brain and other organs, and neurodegeneration is generally believed to be the fatal cause of the disease.  In view of the emerging role of matrix metalloproteinase-12 (MMP-12) in neuronal injury, we investigated its expression and potential roles in axonal degeneration in Npc1 -/- mouse brain.  Microarray and quant. real-time reversed transcription PCR anal. indicated a marked increase in MMP-12 mRNA levels in cerebellum of 3 wk-old Npc1 -/- mice, as compared to wild-type littermates.  Western blots showed that the ratio of mature MMP-12 over pro-MMP-12 was significantly increased in cerebellum of Npc1 -/-, as compared to wild-type mice.  Immunohistochem. studies confirmed that MMP-12 expression was increased, esp. in the cell bodies of Purkinje neurons in Npc1 -/- mice.  Neuritic growth was significantly reduced by Npc1 siRNA knockdown in nerve growth factor-differentiated PC-12 cells, and this effect was completely reversed by treatment with an MMP-12 specific inhibitor.  Furthermore, in vivo expts. showed that chronic treatment with the MMP-12 inhibitor ameliorated Npc1 deficiency-induced axonal pathol. in the striatum.  Our results indicate that abnormal neuronal expression of MMP-12 may contribute to axonal degeneration in NPC disease, thus providing a potential novel target for treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNAgp5KMVr9LVg90H21EOLACvtfcHk0lhwcM_gTahUQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVCiurY%253D&md5=5789a94020fc44c23c7902c87f65e717</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2015.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2015.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DMoreno%26aufirst%3DS.%26aulast%3DAbuelnasr%26aufirst%3DO.%26aulast%3DBaudry%26aufirst%3DM.%26aulast%3DBi%26aufirst%3DX.%26atitle%3DEnhanced%2520Expression%2520of%2520Matrix%2520Metalloproteinase-12%2520Contributes%2520to%2520Npc1%2520Deficiency-Induced%2520Axonal%2520Degeneration%26jtitle%3DExp.%2520Neurol.%26date%3D2015%26volume%3D269%26spage%3D67%26epage%3D74%26doi%3D10.1016%2Fj.expneurol.2015.04.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves DaSilva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-12 Deficiency Worsens Relapsing-Remitting Experimental Autoimmune Encephalomyelitis in Association with Cytokine and Chemokine Dysregulation</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>174</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">909</span>, <span class="refDoi"> DOI: 10.2353/ajpath.2009.080952</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2353%2Fajpath.2009.080952" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19218336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ltFCrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2009&pages=898-909&issue=3&author=A.+Goncalves+DaSilvaauthor=V.+W.+Yong&title=Matrix+Metalloproteinase-12+Deficiency+Worsens+Relapsing-Remitting+Experimental+Autoimmune+Encephalomyelitis+in+Association+with+Cytokine+and+Chemokine+Dysregulation&doi=10.2353%2Fajpath.2009.080952"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-12 deficiency worsens relapsing-remitting experimental autoimmune encephalomyelitis in association with cytokine and chemokine dysregulation</span></div><div class="casAuthors">Goncalves DaSilva Angelika; Yong V Wee</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">898-909</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The elevation of several members of the matrix metalloproteinase (MMP) family promotes the pathophysiology of both multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis (EAE).  Nonetheless, given the multiple activities of MMPs, it remains possible that increased levels of a particular MMP may have beneficial functions during disease progression.  We reported previously that MMP-12(-/-) mice of the 129/SvEv strain had a poorer EAE outcome than wild-type controls.  However, we did not determine further differences in disease profiles between these groups.  Using the EAE model in 129/SvEv mice, we report that disease in both wild-type and MMP-12(-/-) mice follows a relapsing-remitting course.  Although both mouse groups had similar clinical onsets, subsequent relapses were more severe in MMP-12(-/-) mice; their residual disability at remission was also higher compared with wild-type controls.  The worsened relapses and remissions in MMP-12(-/-) mice occurred despite a deficiency of the antigen recall capacity of lymph node-derived cells as well as a reduction in the proportion of macrophages in the spinal cord during the chronic phase of EAE.  Significantly, large increases of levels of chemokines and cytokines were found in the spinal cords of MMP-12(-/-) mice during chronic EAE.  These results highlight MMP-12 as a beneficial enzyme in EAE and suggest that therapeutic interventions in multiple sclerosis should avoid targeting MMP-12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNjBFWHwNkMT0SWnHPWbmmfW6udTcc2eYc0UzVdGsC8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ltFCrtw%253D%253D&md5=e1f9fdfe133a0b73b208a52f8d47bb41</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2009.080952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2009.080952%26sid%3Dliteratum%253Aachs%26aulast%3DGoncalves%2BDaSilva%26aufirst%3DA.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DMatrix%2520Metalloproteinase-12%2520Deficiency%2520Worsens%2520Relapsing-Remitting%2520Experimental%2520Autoimmune%2520Encephalomyelitis%2520in%2520Association%2520with%2520Cytokine%2520and%2520Chemokine%2520Dysregulation%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2009%26volume%3D174%26issue%3D3%26spage%3D898%26epage%3D909%26doi%3D10.2353%2Fajpath.2009.080952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goncalves DaSilva, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liaw, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yong, V. W.</span></span> <span> </span><span class="NLM_article-title">Cleavage of Osteopontin by Matrix Metalloproteinase-12 Modulates Experimental Autoimmune Encephalomyelitis Disease in C57BL/6 Mice</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>177</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1458</span>, <span class="refDoi"> DOI: 10.2353/ajpath.2010.091081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2353%2Fajpath.2010.091081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20651245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC3cjosVehsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2010&pages=1448-1458&issue=3&author=A.+Goncalves+DaSilvaauthor=L.+Liawauthor=V.+W.+Yong&title=Cleavage+of+Osteopontin+by+Matrix+Metalloproteinase-12+Modulates+Experimental+Autoimmune+Encephalomyelitis+Disease+in+C57BL%2F6+Mice&doi=10.2353%2Fajpath.2010.091081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL/6 mice</span></div><div class="casAuthors">Goncalves DaSilva Angelika; Liaw Lucy; Yong V Wee</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of pathology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1448-58</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A role for osteopontin (OPN) in promoting disease activity of multiple sclerosis or its animal model experimental autoimmune encephalomyelitis (EAE) has recently been suggested.  As the biological activity of OPN is heavily influenced by posttranslational processing, we investigated the capacity of matrix metalloproteinase (MMP)-12 to cleave OPN and determined whether this influenced disease activity.  We found that OPN mRNA and protein expression in the spinal cord increased with EAE disease in C57BL/6 mice concurrently with MMP-12 expression.  A Western blot of EAE and control spinal cords revealed different OPN-immunoreactive bands, with a pattern that was similar to MMP-12 cleavage of recombinant OPN in vitro.  In addition, OPN fragments in the spinal cord of EAE-afflicted mice were reduced in MMP-12(-/-) mice compared with wild-type controls.  However, examination of OPN(-/-) mice in short- and long-term experiments revealed no difference in EAE outcomes from wild-type animals.  OPN/MMP-12 double null mice were generated, and it was revealed that MMP-12(-/-) mice had a worsening of disease compared with wild-type mice, which returned to wild-type levels in the OPN/MMP-12 double null mice.  These results suggest that EAE disease activity may be modulated by the cleavage of OPN by MMP-12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6YcDfkJ4bbKe0F5ixvZgXfW6udTcc2ebvCC-htT1XFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjosVehsQ%253D%253D&md5=603ea936e089019b3bf33abf2239f7fb</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2010.091081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2010.091081%26sid%3Dliteratum%253Aachs%26aulast%3DGoncalves%2BDaSilva%26aufirst%3DA.%26aulast%3DLiaw%26aufirst%3DL.%26aulast%3DYong%26aufirst%3DV.%2BW.%26atitle%3DCleavage%2520of%2520Osteopontin%2520by%2520Matrix%2520Metalloproteinase-12%2520Modulates%2520Experimental%2520Autoimmune%2520Encephalomyelitis%2520Disease%2520in%2520C57BL%252F6%2520Mice%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2010%26volume%3D177%26issue%3D3%26spage%3D1448%26epage%3D1458%26doi%3D10.2353%2Fajpath.2010.091081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellac, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhard, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappelhoff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortelny, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jobin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozmus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlidis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">C-Terminal Truncation of IFN-γ Inhibits Proinflammatory Macrophage Responses and Is Deficient in Autoimmune Disease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-04717-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fs41467-018-04717-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29317637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1yktLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1-18&issue=1&author=A.+Dufourauthor=C.+L.+Bellacauthor=U.+Eckhardauthor=N.+Solisauthor=T.+Kleinauthor=R.+Kappelhoffauthor=N.+Fortelnyauthor=P.+Jobinauthor=J.+Rozmusauthor=J.+Markauthor=P.+Pavlidisauthor=V.+Diveauthor=S.+J.+Barbourauthor=C.+M.+Overall&title=C-Terminal+Truncation+of+IFN-%CE%B3+Inhibits+Proinflammatory+Macrophage+Responses+and+Is+Deficient+in+Autoimmune+Disease&doi=10.1038%2Fs41467-018-04717-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Retraction Note: Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer</span></div><div class="casAuthors">Alioui, Anthony; Dufour, Julie; Leoni, Valerio; Loregger, Anke; Moeton, Martina; Iuliano, Luigi; Zerbinati, Chiara; Septier, Amandine; Val, Pierre; Fouache, Allan; Russo, Vincenzo; Volle, David H.; Lobaccaro, Jean-Marc A.; Zelcer, Noam; Baron, Silvere</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">This paper has been retracted at the request of the authors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru9R05NWL_C7Vg90H21EOLACvtfcHk0ljom6bGPDvH1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1yktLnP&md5=70f02b3fb4ba2e676f03508740e6bec6</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-04717-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-04717-4%26sid%3Dliteratum%253Aachs%26aulast%3DDufour%26aufirst%3DA.%26aulast%3DBellac%26aufirst%3DC.%2BL.%26aulast%3DEckhard%26aufirst%3DU.%26aulast%3DSolis%26aufirst%3DN.%26aulast%3DKlein%26aufirst%3DT.%26aulast%3DKappelhoff%26aufirst%3DR.%26aulast%3DFortelny%26aufirst%3DN.%26aulast%3DJobin%26aufirst%3DP.%26aulast%3DRozmus%26aufirst%3DJ.%26aulast%3DMark%26aufirst%3DJ.%26aulast%3DPavlidis%26aufirst%3DP.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DBarbour%26aufirst%3DS.%2BJ.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DC-Terminal%2520Truncation%2520of%2520IFN-%25CE%25B3%2520Inhibits%2520Proinflammatory%2520Macrophage%2520Responses%2520and%2520Is%2520Deficient%2520in%2520Autoimmune%2520Disease%26jtitle%3DNat.%2520Commun.%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D1%26epage%3D18%26doi%3D10.1038%2Fs41467-018-04717-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bellac, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krisinger, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loonchanta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Starr, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">auf dem Keller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebeler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kappelhoff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burtnick, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">Macrophage Matrix Metalloproteinase-12 Dampens Inflammation and Neutrophil Influx in Arthritis</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">618</span>– <span class="NLM_lpage">632</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2014.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.celrep.2014.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25310974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslels7vO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=618-632&issue=2&author=C.+L.+Bellacauthor=A.+Dufourauthor=M.+J.+Krisingerauthor=A.+Loonchantaauthor=A.+E.+Starrauthor=U.+auf+dem+Kellerauthor=P.+F.+Langeauthor=V.+Goebelerauthor=R.+Kappelhoffauthor=G.+S.+Butlerauthor=L.+D.+Burtnickauthor=E.+M.+Conwayauthor=C.+R.+Robertsauthor=C.+M.+Overall&title=Macrophage+Matrix+Metalloproteinase-12+Dampens+Inflammation+and+Neutrophil+Influx+in+Arthritis&doi=10.1016%2Fj.celrep.2014.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage Matrix Metalloproteinase-12 Dampens Inflammation and Neutrophil Influx in Arthritis</span></div><div class="casAuthors">Bellac, Caroline L.; Dufour, Antoine; Krisinger, Michael J.; Loonchanta, Anantasak; Starr, Amanda E.; auf dem Keller, Ulrich; Lange, Philipp F.; Goebeler, Verena; Kappelhoff, Reinhild; Butler, Georgina S.; Burtnick, Leslie D.; Conway, Edward M.; Roberts, Clive R.; Overall, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">618-632</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Resoln. of inflammation reduces pathol. tissue destruction and restores tissue homeostasis.  Here, we used a proteomic protease substrate discovery approach, terminal amine isotopic labeling of substrates (TAILS), to analyze the role of the macrophage-specific matrix metalloproteinase-12 (MMP12) in inflammation.  In murine peritonitis, MMP12 inactivates antithrombin and activates prothrombin, prolonging the activated partial thromboplastin time.  Furthermore, MMP12 inactivates complement C3 to reduce complement activation and inactivates the chemoattractant anaphylatoxins C3a and C5a, whereas iC3b and C3b opsonin cleavage increases phagocytosis.  Loss of these anti-inflammatory activities in collagen-induced arthritis in Mmp12-/- mice leads to unresolved synovitis and extensive articular inflammation.  Deep articular cartilage loss is assocd. with massive neutrophil infiltration and abnormal DNA neutrophil extracellular traps (NETs).  The NETs are rich in fibrin and extracellular actin, which TAILS identified as MMP12 substrates.  Thus, macrophage MMP12 in arthritis has multiple protective roles in countering neutrophil infiltration, clearing NETs, and dampening inflammatory pathways to prep. for the resoln. of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTQQA25RbqxrVg90H21EOLACvtfcHk0ljlpX0Meb6DzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslels7vO&md5=922ca3be888f3521dbc73c94fe86b333</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2014.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2014.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DBellac%26aufirst%3DC.%2BL.%26aulast%3DDufour%26aufirst%3DA.%26aulast%3DKrisinger%26aufirst%3DM.%2BJ.%26aulast%3DLoonchanta%26aufirst%3DA.%26aulast%3DStarr%26aufirst%3DA.%2BE.%26aulast%3Dauf%2Bdem%2BKeller%26aufirst%3DU.%26aulast%3DLange%26aufirst%3DP.%2BF.%26aulast%3DGoebeler%26aufirst%3DV.%26aulast%3DKappelhoff%26aufirst%3DR.%26aulast%3DButler%26aufirst%3DG.%2BS.%26aulast%3DBurtnick%26aufirst%3DL.%2BD.%26aulast%3DConway%26aufirst%3DE.%2BM.%26aulast%3DRoberts%26aufirst%3DC.%2BR.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DMacrophage%2520Matrix%2520Metalloproteinase-12%2520Dampens%2520Inflammation%2520and%2520Neutrophil%2520Influx%2520in%2520Arthritis%26jtitle%3DCell%2520Rep.%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3D618%26epage%3D632%26doi%3D10.1016%2Fj.celrep.2014.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartzell, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomis-Rüth, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, S. D.</span></span> <span> </span><span class="NLM_article-title">Macrophage Elastase Kills Bacteria within Murine Macrophages</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>460</i></span> (<span class="NLM_issue">7255</span>),  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1038/nature08181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnature08181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19536155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVagsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2009&pages=637-641&issue=7255&author=A.+M.+Houghtonauthor=W.+O.+Hartzellauthor=C.+S.+Robbinsauthor=F.+X.+Gomis-R%C3%BCthauthor=S.+D.+Shapiro&title=Macrophage+Elastase+Kills+Bacteria+within+Murine+Macrophages&doi=10.1038%2Fnature08181"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage elastase kills bacteria within murine macrophages</span></div><div class="casAuthors">Houghton, A. McGarry; Hartzell, William O.; Robbins, Clinton S.; Gomis-Rueth, F. Xavier; Shapiro, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">460</span>
        (<span class="NLM_cas:issue">7255</span>),
    <span class="NLM_cas:pages">637-641</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Macrophages are aptly positioned to function as the primary line of defense against invading pathogens in many organs, including the lung and peritoneum.  Their ability to phagocytose and clear microorganisms has been well documented.  Macrophages possess several substances with which they can kill bacteria, including reactive oxygen species, nitric oxide, and antimicrobial proteins.  The authors proposed that macrophage-derived proteinases may contribute to the antimicrobial properties of macrophages.  Macrophage elastase (also known as matrix metalloproteinase 12 or MMP12) is an enzyme predominantly expressed in mature tissue macrophages and is implicated in several disease processes, including emphysema.  Physiol. functions for MMP12 have not been described.  Here the authors show that Mmp12-/- mice exhibit impaired bacterial clearance and increased mortality when challenged with both Gram-neg. and Gram-pos. bacteria at macrophage-rich portals of entry, such as the peritoneum and lung.  Intracellular stores of MMP12 are mobilized to macrophage phagolysosomes after the ingestion of bacterial pathogens.  Once inside phagolysosomes, MMP12 adheres to bacterial cell walls where it disrupts cellular membranes resulting in bacterial death.  The antimicrobial properties of MMP12 do not reside within its catalytic domain, but rather within the C-terminal domain.  This domain contains a unique four amino acid sequence on an exposed β loop of the protein that is required for the obsd. antimicrobial activity.  The present study represents, to the authors' knowledge, the first report of direct antimicrobial activity by a matrix metallopeptidase, and describes a new antimicrobial peptide that is sequentially and structurally unique in nature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUaQpS82xsLrVg90H21EOLACvtfcHk0lgDGvjwwJLZYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVagsb8%253D&md5=68da572af1af203d98a198a19bf38d47</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnature08181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08181%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DA.%2BM.%26aulast%3DHartzell%26aufirst%3DW.%2BO.%26aulast%3DRobbins%26aufirst%3DC.%2BS.%26aulast%3DGomis-R%25C3%25BCth%26aufirst%3DF.%2BX.%26aulast%3DShapiro%26aufirst%3DS.%2BD.%26atitle%3DMacrophage%2520Elastase%2520Kills%2520Bacteria%2520within%2520Murine%2520Macrophages%26jtitle%3DNature%26date%3D2009%26volume%3D460%26issue%3D7255%26spage%3D637%26epage%3D641%26doi%3D10.1038%2Fnature08181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marchant, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellac, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadsworth, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilawchuk, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendry, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilbron, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucyk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karpov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegele, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granville, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McManus, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">A New Transcriptional Role for Matrix Metalloproteinase-12 in Antiviral Immunity</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.1038/nm.3508</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnm.3508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24784232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntlehs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=493-502&issue=5&author=D.+J.+Marchantauthor=C.+L.+Bellacauthor=T.+J.+Moraesauthor=S.+J.+Wadsworthauthor=A.+Dufourauthor=G.+S.+Butlerauthor=L.+M.+Bilawchukauthor=R.+G.+Hendryauthor=A.+G.+Robertsonauthor=C.+T.+Cheungauthor=J.+Ngauthor=L.+Angauthor=Z.+Luoauthor=K.+Heilbronauthor=M.+J.+Norrisauthor=W.+Duanauthor=T.+Bucykauthor=A.+Karpovauthor=L.+Develauthor=D.+Georgiadisauthor=R.+G.+Hegeleauthor=H.+Luoauthor=D.+J.+Granvilleauthor=V.+Diveauthor=B.+M.+McManusauthor=C.+M.+Overall&title=A+New+Transcriptional+Role+for+Matrix+Metalloproteinase-12+in+Antiviral+Immunity&doi=10.1038%2Fnm.3508"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity</span></div><div class="casAuthors">Marchant, David J.; Bellac, Caroline L.; Moraes, Theo J.; Wadsworth, Samuel J.; Dufour, Antoine; Butler, Georgina S.; Bilawchuk, Leanne M.; Hendry, Reid G.; Robertson, A. Gordon; Cheung, Caroline T.; Ng, Julie; Ang, Lisa; Luo, Zongshu; Heilbron, Karl; Norris, Michael J.; Duan, Wenming; Bucyk, Taylor; Karpov, Andrei; Devel, Laurent; Georgiadis, Dimitris; Hegele, Richard G.; Luo, Honglin; Granville, David J.; Dive, Vincent; McManus, Bruce M.; Overall, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">493-502</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Interferon-α (IFN-α) is essential for antiviral immunity, but in the absence of matrix metalloproteinase-12 (MMP-12) or IκBα (encoded by NFKBIA) we show that IFN-α is retained in the cytosol of virus-infected cells and is not secreted.  Our findings suggest that activated IκBα mediates the export of IFN-α from virus-infected cells and that the inability of cells in Mmp12-/- but not wild-type mice to express IκBα and thus export IFN-α makes coxsackievirus type B3 infection lethal and renders respiratory syncytial virus more pathogenic.  We show here that after macrophage secretion, MMP-12 is transported into virus-infected cells.  In HeLa cells MMP-12 is also translocated to the nucleus, where it binds to the NFKBIA promoter, driving transcription.  We also identified dual-regulated substrates that are repressed both by MMP-12 binding to the substrate's gene exons and by MMP-12-mediated cleavage of the substrate protein itself.  Whereas intracellular MMP-12 mediates NFKBIA transcription, leading to IFN-α secretion and host protection, extracellular MMP-12 cleaves off the IFN-α receptor 2 binding site of systemic IFN-α, preventing an unchecked immune response.  Consistent with an unexpected role for MMP-12 in clearing systemic IFN-α, treatment of coxsackievirus type B3-infected wild-type mice with a membrane-impermeable MMP-12 inhibitor elevates systemic IFN-α levels and reduces viral replication in pancreas while sparing intracellular MMP-12.  These findings suggest that inhibiting extracellular MMP-12 could be a new avenue for the development of antiviral treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOHUFHv6-8LVg90H21EOLACvtfcHk0lgDGvjwwJLZYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntlehs74%253D&md5=b82d045a6d78984630317c056f831baf</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2Fnm.3508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3508%26sid%3Dliteratum%253Aachs%26aulast%3DMarchant%26aufirst%3DD.%2BJ.%26aulast%3DBellac%26aufirst%3DC.%2BL.%26aulast%3DMoraes%26aufirst%3DT.%2BJ.%26aulast%3DWadsworth%26aufirst%3DS.%2BJ.%26aulast%3DDufour%26aufirst%3DA.%26aulast%3DButler%26aufirst%3DG.%2BS.%26aulast%3DBilawchuk%26aufirst%3DL.%2BM.%26aulast%3DHendry%26aufirst%3DR.%2BG.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DCheung%26aufirst%3DC.%2BT.%26aulast%3DNg%26aufirst%3DJ.%26aulast%3DAng%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DHeilbron%26aufirst%3DK.%26aulast%3DNorris%26aufirst%3DM.%2BJ.%26aulast%3DDuan%26aufirst%3DW.%26aulast%3DBucyk%26aufirst%3DT.%26aulast%3DKarpov%26aufirst%3DA.%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DHegele%26aufirst%3DR.%2BG.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DGranville%26aufirst%3DD.%2BJ.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DMcManus%26aufirst%3DB.%2BM.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DA%2520New%2520Transcriptional%2520Role%2520for%2520Matrix%2520Metalloproteinase-12%2520in%2520Antiviral%2520Immunity%26jtitle%3DNat.%2520Med.%26date%3D2014%26volume%3D20%26issue%3D5%26spage%3D493%26epage%3D502%26doi%3D10.1038%2Fnm.3508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Houghton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisolano, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hautamaki, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehring, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelius, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, S. D.</span></span> <span> </span><span class="NLM_article-title">Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung Metastases</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>66</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">6149</span>– <span class="NLM_lpage">6155</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-0297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1158%2F0008-5472.CAN-04-0297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16778188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVSksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=6149-6155&issue=12&author=A.+M.+Houghtonauthor=J.+L.+Grisolanoauthor=M.+L.+Baumannauthor=D.+K.+Kobayashiauthor=R.+D.+Hautamakiauthor=L.+C.+Nehringauthor=L.+A.+Corneliusauthor=S.+D.+Shapiro&title=Macrophage+Elastase+%28Matrix+Metalloproteinase-12%29+Suppresses+Growth+of+Lung+Metastases&doi=10.1158%2F0008-5472.CAN-04-0297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung Metastases</span></div><div class="casAuthors">Houghton, A. McGarry; Grisolano, Jay L.; Baumann, Mary L.; Kobayashi, Dale K.; Hautamaki, R. Dean; Nehring, Leslie C.; Cornelius, Lynn A.; Shapiro, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6149-6155</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMP) have been implicated in virtually all aspects of tumor progression.  However, the recent failure of clin. trials employing synthetic MMP inhibitors in cancer chemotherapy has led us to hypothesize that some MMPs may actually serve the host in its defense against tumor progression.  Here we show that mice deficient in macrophage elastase (MMP-12) develop significantly more gross Lewis lung carcinoma pulmonary metastases than their wild-type counterparts both in spontaneous and exptl. metastasis models.  The nos. of micrometastases between the two groups are equiv.; thus, it seems that MMP-12 affects lung tumor growth, and not metastasis formation, per se.  MMP-12 is solely macrophage derived in this model, being expressed by tumor-assocd. macrophages and not by tumor or stromal cells.  The presence of MMP-12 is assocd. with decreased tumor-assocd. microvessel d. in vivo and generates an angiostatic>angiogenic tumor microenvironment that retards lung tumor growth independent of the prodn. of angiostatin.  These data define a role for MMP-12 in suppressing the growth of lung metastases and suggest that inhibitors designed to specifically target tumor-promoting MMPs may yet prove effective as cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCb9UBIxa567Vg90H21EOLACvtfcHk0lhEvzi4YGE7Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVSksbw%253D&md5=bbbb7ec77f619e1964406698afdb7972</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-0297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-0297%26sid%3Dliteratum%253Aachs%26aulast%3DHoughton%26aufirst%3DA.%2BM.%26aulast%3DGrisolano%26aufirst%3DJ.%2BL.%26aulast%3DBaumann%26aufirst%3DM.%2BL.%26aulast%3DKobayashi%26aufirst%3DD.%2BK.%26aulast%3DHautamaki%26aufirst%3DR.%2BD.%26aulast%3DNehring%26aufirst%3DL.%2BC.%26aulast%3DCornelius%26aufirst%3DL.%2BA.%26aulast%3DShapiro%26aufirst%3DS.%2BD.%26atitle%3DMacrophage%2520Elastase%2520%2528Matrix%2520Metalloproteinase-12%2529%2520Suppresses%2520Growth%2520of%2520Lung%2520Metastases%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26issue%3D12%26spage%3D6149%26epage%3D6155%26doi%3D10.1158%2F0008-5472.CAN-04-0297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dandachi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radder, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leme, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, S. D.</span></span> <span> </span><span class="NLM_article-title">Macrophage Elastase Induces TRAIL-Mediated Tumor Cell Death through Its Carboxy-Terminal Domain</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>196</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1164/rccm.201606-1150OC</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1164%2Frccm.201606-1150OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28345958" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVShsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=196&publication_year=2017&pages=353-363&issue=3&author=N.+Dandachiauthor=N.+J.+Kellyauthor=J.+P.+Woodauthor=C.+L.+Burtonauthor=J.+E.+Radderauthor=A.+S.+Lemeauthor=A.+D.+Gregoryauthor=S.+D.+Shapiro&title=Macrophage+Elastase+Induces+TRAIL-Mediated+Tumor+Cell+Death+through+Its+Carboxy-Terminal+Domain&doi=10.1164%2Frccm.201606-1150OC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Macrophage elastase induces TRAIL-mediated tumor cell death through its carboxy-terminal domain</span></div><div class="casAuthors">Dandachi, Nadine; Kelly, Neil J.; Wood, John P.; Burton, Christine L.; Radder, Josiah E.; Leme, Adriana S.; Gregory, Alyssa D.; Shapiro, Steven D.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">196</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">353-363</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Macrophage elastase (matrix metalloproteinase [MMP]-12) is a potent protease that contributes to the lung destruction that accompanies cigarette smoking; it simultaneously inhibits lung tumor angiogenesis and metastasis by catalyzing the formation of antiangiogenic peptides.  Recent studies have revealed novel nonproteolytic functions of MMP12, including antimicrobial activity through a peptide within its C-terminal domain (CTD).  Objectives: To det. whether the MMP12 CTD contributes to its antitumor activity in lung cancer.  Methods: We used recombinant MMP12 peptide fragments, including its catalytic domain, CTD, and a 20 amino acid peptide within the CTD (SR20), in an in vitro system to delineate their effects on non-small cell lung cancer cell proliferation and apoptosis.  We translated our findings to two murine models of lung cancer, including orthotopic human xenograft and KrasLSL/G12D mouse models of lung cancer.  Measurements and Main Results: We show that SR20 triggers tumor apoptosis by up-regulation of gene expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptor, death receptor 4, sensitizing cells to an autocrine loop of TRAIL-mediated cell death.  We then demonstrate the therapeutic efficacy of SR20 against two murine models of lung cancer.  Conclusions: The MMP12 CTD initiates TRAIL-mediated tumor cell death through its conserved SR20 peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKg71B_S41HbVg90H21EOLACvtfcHk0lhEvzi4YGE7Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVShsr3J&md5=aa97658cc776c75bd36cf423dc5fbb02</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1164%2Frccm.201606-1150OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.201606-1150OC%26sid%3Dliteratum%253Aachs%26aulast%3DDandachi%26aufirst%3DN.%26aulast%3DKelly%26aufirst%3DN.%2BJ.%26aulast%3DWood%26aufirst%3DJ.%2BP.%26aulast%3DBurton%26aufirst%3DC.%2BL.%26aulast%3DRadder%26aufirst%3DJ.%2BE.%26aulast%3DLeme%26aufirst%3DA.%2BS.%26aulast%3DGregory%26aufirst%3DA.%2BD.%26aulast%3DShapiro%26aufirst%3DS.%2BD.%26atitle%3DMacrophage%2520Elastase%2520Induces%2520TRAIL-Mediated%2520Tumor%2520Cell%2520Death%2520through%2520Its%2520Carboxy-Terminal%2520Domain%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2017%26volume%3D196%26issue%3D3%26spage%3D353%26epage%3D363%26doi%3D10.1164%2Frccm.201606-1150OC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-San
Segundo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barceló, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morancho, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabriel-Salazar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giralt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosell, A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-13 Participates in Neuroprotection and Neurorepair after Cerebral Ischemia in Mice</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2016.03.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.nbd.2016.03.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27001146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2hurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2016&pages=236-246&author=F.+Maauthor=P.+Mart%C3%ADnez-San%0ASegundoauthor=V.+Barcel%C3%B3author=A.+Moranchoauthor=M.+Gabriel-Salazarauthor=D.+Giraltauthor=J.+Montanerauthor=A.+Rosell&title=Matrix+Metalloproteinase-13+Participates+in+Neuroprotection+and+Neurorepair+after+Cerebral+Ischemia+in+Mice&doi=10.1016%2Fj.nbd.2016.03.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-13 participates in neuroprotection and neurorepair after cerebral ischemia in mice</span></div><div class="casAuthors">Ma, Feifei; Martinez-San Segundo, Pablo; Barcelo, Veronica; Morancho, Anna; Gabriel-Salazar, Marina; Giralt, Dolors; Montaner, Joan; Rosell, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">236-246</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">New neuroreparative and neuroprotective therapies are being sought to treat stroke patients.  One approach is the remodeling of extracellular matrix, which participates in both brain injury and neurovascular repair when matrix metalloproteinases (MMPs) are thought to be key players.  Our aim was to investigate the role of MMP-13 (collagenase-3) in the acute (24 h and 3 days) and delayed (2 wk) phases of stroke.  Permanent and transient cerebral ischemia models involving the cortex were induced in MMP-13 knock-out (KO) and wild-type (WT) mice.  In the transient model, MMP-13 deficiency reduced the amt. of TTC-stained infarct tissue, reduced hemorrhagic events and improved functional outcomes (p < 0.01).  At two weeks, normal neuroblast (DCX +) migration from the subventricular zone toward the peri-infarct area was obsd.  However, MMP-13 deficiency significantly reduced the no. of newborn neuroblasts (DCX +/BrdU +) in the cortical peri-infarct area (p < 0.01).  This result occurred in parallel with aberrant cortical vascular remodeling: post-stroke peri-infarct vessel d. increased in the WT mice (p < 0.01) but this increase was blocked in the MMP-13 KO mice.  Prior to these vascular alterations, the levels of pro-angiogenic factors, including G-CSF, VEGF-A and angiopoietin-2, were lower in the ischemic cortex of MMP-13 KO mice than in WT mice (p < 0.05).  In vitro, gene-silencing of MMP-13 in endothelial progenitor cells (EPCs) confirmed the reduced ability of these cells to build tubulogenic networks in Matrigel substrate.  Together, our results indicate that MMP-13 is a central protease in infarct development and cortical remodeling during post-stroke neurorepair, which is crit. for optimal angiogenic and neurogenic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPU64FYnDIP7Vg90H21EOLACvtfcHk0lhEvzi4YGE7Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2hurY%253D&md5=1d825d5e2dc04a469e6b7f7c33d9d373</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2016.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2016.03.016%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DF.%26aulast%3DMart%25C3%25ADnez-San%2BSegundo%26aufirst%3DP.%26aulast%3DBarcel%25C3%25B3%26aufirst%3DV.%26aulast%3DMorancho%26aufirst%3DA.%26aulast%3DGabriel-Salazar%26aufirst%3DM.%26aulast%3DGiralt%26aufirst%3DD.%26aulast%3DMontaner%26aufirst%3DJ.%26aulast%3DRosell%26aufirst%3DA.%26atitle%3DMatrix%2520Metalloproteinase-13%2520Participates%2520in%2520Neuroprotection%2520and%2520Neurorepair%2520after%2520Cerebral%2520Ischemia%2520in%2520Mice%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2016%26volume%3D91%26spage%3D236%26epage%3D246%26doi%3D10.1016%2Fj.nbd.2016.03.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takino, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyamori, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span> <span> </span><span class="NLM_article-title">Cleavage of Amyloid-β Precursor Protein (APP) by Membrane-Type Matrix Metalloproteinases</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>139</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">517</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1093/jb/mvj054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1093%2Fjb%2Fmvj054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16567416" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XkslOnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2006&pages=517-526&issue=3&author=M.+Ahmadauthor=T.+Takinoauthor=H.+Miyamoriauthor=T.+Yoshizakiauthor=M.+Furukawaauthor=H.+Sato&title=Cleavage+of+Amyloid-%CE%B2+Precursor+Protein+%28APP%29+by+Membrane-Type+Matrix+Metalloproteinases&doi=10.1093%2Fjb%2Fmvj054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Cleavage of amyloid-β precursor protein (APP) by membrane-type matrix metalloproteinases</span></div><div class="casAuthors">Ahmad, Munirah; Takino, Takahisa; Miyamori, Hisashi; Yoshizaki, Tomokazu; Furukawa, Mitsuru; Sato, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">517-526</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Amyloid-β precursor protein (APP) was identified on expression cloning from a human placenta cDNA library as a gene product that modulates the activity of membrane-type matrix metalloproteinase-1 (MT1-MMP).  Co-expression of MT1-MMP with APP in HEK293T cells induced cleavage and shedding of the APP ectodomain when co-expressed with APP adaptor protein Fe65.  Among the MT-MMPs tested, MT3-MMP and MT5-MMP also caused efficient APP shedding.  The recombinant APP protein was cleaved by MT3-MMP in vitro at the A463-M464, N579-M580, H622-S623, and H685-Q686 peptide bonds, which included a cleavage site within the amyloid β peptide region known to produce a C-terminal fragment.  The Swedish-type mutant of APP, which produces a high level of amyloid β peptide, was more effectively cleaved by MT3-MMP than wild-type APP in both the presence and absence of Fe65; however, amyloid β peptide prodn. was not affected by MT3-MMP expression.  Expression of MT3-MMP enhanced Fe65-dependent transactivation by APP fused to the Gal4 DNA-binding and transactivation domains.  These results suggest that MT1-MMP, MT3-MMP and MT5-MMP should play an important role in the regulation of APP functions in tissues including the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom9ouPbCR5FbVg90H21EOLACvtfcHk0ljRSnboIvFs9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkslOnsrw%253D&md5=382d919de1ddb44cdd5b8377af15bffa</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvj054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvj054%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DM.%26aulast%3DTakino%26aufirst%3DT.%26aulast%3DMiyamori%26aufirst%3DH.%26aulast%3DYoshizaki%26aufirst%3DT.%26aulast%3DFurukawa%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DH.%26atitle%3DCleavage%2520of%2520Amyloid-%25CE%25B2%2520Precursor%2520Protein%2520%2528APP%2529%2520by%2520Membrane-Type%2520Matrix%2520Metalloproteinases%26jtitle%3DJ.%2520Biochem.%26date%3D2006%26volume%3D139%26issue%3D3%26spage%3D517%26epage%3D526%26doi%3D10.1093%2Fjb%2Fmvj054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulasov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarvaiya, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobbs, C.</span></span> <span> </span><span class="NLM_article-title">The Emerging Role of MMP14 in Brain Tumorigenesis and Future Therapeutics</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1846</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">113</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2014.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbcan.2014.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OqsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1846&publication_year=2014&pages=113-120&issue=1&author=I.+Ulasovauthor=R.+Yiauthor=D.+Guoauthor=P.+Sarvaiyaauthor=C.+Cobbs&title=The+Emerging+Role+of+MMP14+in+Brain+Tumorigenesis+and+Future+Therapeutics&doi=10.1016%2Fj.bbcan.2014.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of MMP14 in brain tumorigenesis and future therapeutics</span></div><div class="casAuthors">Ulasov, Ilya; Yi, Ruiyang; Guo, Donna; Sarvaiya, Purvaba; Cobbs, Charles</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1846</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-120</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Glioblastoma is a malignant brain tumor of glial origin.  These tumors are thought to be derived from astrocytic cells that undergo malignant transformation.  A growing body of evidence suggests that upregulation of MMP expression plays a significant role in promoting glioma pathogenesis.  Elevated expression of MMP14 not only promotes glioma invasion and tumor cell proliferation but also plays a role in angiogenesis.  Despite the fact that levels of MMP14 correlate with breast cancer progression, the controversial role of MMP14 in gliomagenesis needs to be elucidated.  In the present review, we discuss the role of MMP14 in glioma progression as well as the mechanisms of MMP14 regulation in the context of future therapeutic manipulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkjVoQGDlhkLVg90H21EOLACvtfcHk0ljRSnboIvFs9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OqsrzJ&md5=b6301880ace58fef3c8ff2cdb0eb9b23</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2014.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2014.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DUlasov%26aufirst%3DI.%26aulast%3DYi%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DD.%26aulast%3DSarvaiya%26aufirst%3DP.%26aulast%3DCobbs%26aufirst%3DC.%26atitle%3DThe%2520Emerging%2520Role%2520of%2520MMP14%2520in%2520Brain%2520Tumorigenesis%2520and%2520Future%2520Therapeutics%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2014%26volume%3D1846%26issue%3D1%26spage%3D113%26epage%3D120%26doi%3D10.1016%2Fj.bbcan.2014.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span> <span> </span><span class="NLM_article-title">Integrated Functions of Membrane-Type 1 Matrix Metalloproteinase in Regulating Cancer Malignancy: Beyond a Proteinase</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>108</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1095</span>– <span class="NLM_lpage">1100</span>, <span class="refDoi"> DOI: 10.1111/cas.13231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fcas.13231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28267240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVKnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2017&pages=1095-1100&issue=6&author=T.+Sakamotoauthor=M.+Seiki&title=Integrated+Functions+of+Membrane-Type+1+Matrix+Metalloproteinase+in+Regulating+Cancer+Malignancy%3A+Beyond+a+Proteinase&doi=10.1111%2Fcas.13231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated functions of membrane-type 1 matrix metalloproteinase in regulating cancer malignancy: Beyond a proteinase</span></div><div class="casAuthors">Sakamoto, Takeharu; Seiki, Motoharu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1095-1100</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Membrane-type 1 matrix metalloproteinase (MT1-MMP) is expressed in different types of invasive and proliferative cells, including cancer cells and stromal cells.  MT1-MMP cleaves extracellular matrix proteins, membrane proteins and other pericellular proteins, thereby changing the cellular microenvironment and regulating signal activation.  Crit. roles of protease activity in cancer cell proliferation, invasion and metastasis have been demonstrated by many groups.  MT1-MMP also has a non-protease activity in that it inhibits the oxygen-dependent suppression of hypoxia-inducible factors (HIFs) via Munc18-1-interacting protein 3 (Mint3) and thereby enhances the expression of HIF target genes.  Elevated HIF activity in MT1-MMP-expressing cancer cells is a fundamental mechanism underlying the Warburg effect, a well-known phenomenon where malignant cancer cells exhibit a higher rate of glucose metab.  Because specific intervention of HIF activation by MT1-MMP suppresses tumor formation by cancer cells in mice, both the proteolytic and non-proteolytic activities of MT1-MMP are important for tumor malignancy and function in an integrated manner.  In this review, we summarize recent findings relating to how MT1-MMP activates HIF and its effects on cancer cells and stromal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5zrhUXJIhbVg90H21EOLACvtfcHk0lisQaVMDheoHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVKnsLw%253D&md5=4efe8f5596e333f13bff1c098cd3dc4e</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1111%2Fcas.13231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13231%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DT.%26aulast%3DSeiki%26aufirst%3DM.%26atitle%3DIntegrated%2520Functions%2520of%2520Membrane-Type%25201%2520Matrix%2520Metalloproteinase%2520in%2520Regulating%2520Cancer%2520Malignancy%253A%2520Beyond%2520a%2520Proteinase%26jtitle%3DCancer%2520Sci.%26date%3D2017%26volume%3D108%26issue%3D6%26spage%3D1095%26epage%3D1100%26doi%3D10.1111%2Fcas.13231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talmi-Frank, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altboum, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomonov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaitin, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klepfish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuravlev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keren-Shaul, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gat-Viks, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandelboim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziv, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amit, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2016.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.chom.2016.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27736644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Wntr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=458-470&issue=4&author=D.+Talmi-Frankauthor=Z.+Altboumauthor=I.+Solomonovauthor=Y.+Udiauthor=D.+A.+Jaitinauthor=M.+Klepfishauthor=E.+Davidauthor=A.+Zhuravlevauthor=H.+Keren-Shaulauthor=D.+R.+Winterauthor=I.+Gat-Viksauthor=M.+Mandelboimauthor=T.+Zivauthor=I.+Amitauthor=I.+Sagi&title=Extracellular+Matrix+Proteolysis+by+MT1-MMP+Contributes+to+Influenza-Related+Tissue+Damage+and+Mortality&doi=10.1016%2Fj.chom.2016.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality</span></div><div class="casAuthors">Talmi-Frank, Dalit; Altboum, Zeev; Solomonov, Inna; Udi, Yael; Jaitin, Diego Adhemar; Klepfish, Mordehay; David, Eyal; Zhuravlev, Alina; Keren-Shaul, Hadas; Winter, Deborah R.; Gat-Viks, Irit; Mandelboim, Michal; Ziv, Tamar; Amit, Ido; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-470</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mounting an effective immune response, while also protecting tissue integrity, is crit. for host survival.  We used a combined genomic and proteomic approach to investigate the role of extracellular matrix (ECM) proteolysis in achieving this balance in the lung during influenza virus infection.  We identified the membrane-tethered matrix metalloprotease MT1-MMP as a prominent host-ECM-remodeling collagenase in influenza infection.  Selective inhibition of MT1-MMP protected the tissue from infection-related structural and compositional tissue damage.  MT1-MMP inhibition did not significantly alter the immune response or cytokine expression.  The available flu therapeutic Oseltamivir did not prevent lung ECM damage and was less effective than anti-MT1-MMP in influenza virus Streptococcus pneumoniae coinfection paradigms.  Combination therapy of Oseltamivir with anti-MT1-MMP showed a strong synergistic effect and resulted in complete recovery of infected mice.  This study highlights the importance of tissue resilience in surviving infection and the potential of such host-pathogen therapy combinations for respiratory infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8wWOP13TwlLVg90H21EOLACvtfcHk0lisQaVMDheoHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Wntr7F&md5=4fb9e04a619ea4175a3ae478b5c8c63d</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2016.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2016.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DTalmi-Frank%26aufirst%3DD.%26aulast%3DAltboum%26aufirst%3DZ.%26aulast%3DSolomonov%26aufirst%3DI.%26aulast%3DUdi%26aufirst%3DY.%26aulast%3DJaitin%26aufirst%3DD.%2BA.%26aulast%3DKlepfish%26aufirst%3DM.%26aulast%3DDavid%26aufirst%3DE.%26aulast%3DZhuravlev%26aufirst%3DA.%26aulast%3DKeren-Shaul%26aufirst%3DH.%26aulast%3DWinter%26aufirst%3DD.%2BR.%26aulast%3DGat-Viks%26aufirst%3DI.%26aulast%3DMandelboim%26aufirst%3DM.%26aulast%3DZiv%26aufirst%3DT.%26aulast%3DAmit%26aufirst%3DI.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DExtracellular%2520Matrix%2520Proteolysis%2520by%2520MT1-MMP%2520Contributes%2520to%2520Influenza-Related%2520Tissue%2520Damage%2520and%2520Mortality%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2016%26volume%3D20%26issue%3D4%26spage%3D458%26epage%3D470%26doi%3D10.1016%2Fj.chom.2016.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aguirre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blázquez-Prieto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amado-Rodriguez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Alonso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batalla-Solís, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-López, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Pérez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayoral-Garcia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-Fernández, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaiceta, G. M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-14 Triggers an Anti-Inflammatory Proteolytic Cascade in Endotoxemia</span>. <i>J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">497</span>, <span class="refDoi"> DOI: 10.1007/s00109-017-1510-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00109-017-1510-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28120021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFeitLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2017&pages=487-497&issue=5&author=A.+Aguirreauthor=J.+Bl%C3%A1zquez-Prietoauthor=L.+Amado-Rodriguezauthor=I.+L%C3%B3pez-Alonsoauthor=E.+Batalla-Sol%C3%ADsauthor=A.+Gonz%C3%A1lez-L%C3%B3pezauthor=M.+S%C3%A1nchez-P%C3%A9rezauthor=C.+Mayoral-Garciaauthor=A.+Guti%C3%A9rrez-Fern%C3%A1ndezauthor=G.+M.+Albaiceta&title=Matrix+Metalloproteinase-14+Triggers+an+Anti-Inflammatory+Proteolytic+Cascade+in+Endotoxemia&doi=10.1007%2Fs00109-017-1510-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-14 triggers an anti-inflammatory proteolytic cascade in endotoxemia</span></div><div class="casAuthors">Aguirre, Alina; Blazquez-Prieto, Jorge; Amado-Rodriguez, Laura; Lopez-Alonso, Ines; Batalla-Solis, Estefania; Gonzalez-Lopez, Adrian; Sanchez-Perez, Moises; Mayoral-Garcia, Carlos; Gutierrez-Fernandez, Ana; Albaiceta, Guillermo M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">487-497</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Matrix metalloproteinases can modulate the inflammatory response through processing of cyto- and chemokines.  Among them, MMP-14 is a non-dispensable collagenase responsible for the activation of other enzymes, triggering a proteolytic cascade.  To identify the role of MMP-14 during the pro-inflammatory response, wildtype and Mmp14-/- mice were challenged with lipopolysaccharide.  MMP-14 levels decreased after endotoxemia.  Mutant animals showed 100% mortality, compared to 50% in wildtype mice.  The increased mortality was related to a more severe lung injury, an impaired lung MMP-2 activation, and increased levels of the alarmin S100A9.  There were no differences in the expression of other mediators including Il6, Cxcl2, Tgfb, Il10, or S100a8.  A similar result was obsd. in lung explants of both genotypes cultured in presence of lipopolysaccharide.  In this ex vivo model, exogenous activated MMP-2 ameliorated the obsd. increase in alarmins.  Samples from septic patients showed a decrease in serum MMP-14 and activated MMP-2 compared to non-septic critically ill patients.  These results demonstrate that the MMP-14-MMP-2 axis is downregulated during sepsis, leading to a proinflammatory response involving S100A9 and a more severe lung injury.  This anti-inflammatory role of MMP-14 could have a therapeutic value in sepsis.  Key messages: MMP-14 levels decrease in lungs from endotoxemic mice and serum from septic patients.  Mmp14-/- mice show increased lung injury and mortality following endotoxemia.  Absence of Mmp14 decreases activated MMP-2 and increases S100A9 levels in lung tissue.  MMP-14 ameliorates inflammation by promoting S100A9 cleavage by activated MMP-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuq9NZ18PZtbVg90H21EOLACvtfcHk0ljUOl1YWA7Row"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFeitLk%253D&md5=24edaa0fdd631eb7816f92e8abe89a5a</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1007%2Fs00109-017-1510-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-017-1510-z%26sid%3Dliteratum%253Aachs%26aulast%3DAguirre%26aufirst%3DA.%26aulast%3DBl%25C3%25A1zquez-Prieto%26aufirst%3DJ.%26aulast%3DAmado-Rodriguez%26aufirst%3DL.%26aulast%3DL%25C3%25B3pez-Alonso%26aufirst%3DI.%26aulast%3DBatalla-Sol%25C3%25ADs%26aufirst%3DE.%26aulast%3DGonz%25C3%25A1lez-L%25C3%25B3pez%26aufirst%3DA.%26aulast%3DS%25C3%25A1nchez-P%25C3%25A9rez%26aufirst%3DM.%26aulast%3DMayoral-Garcia%26aufirst%3DC.%26aulast%3DGuti%25C3%25A9rrez-Fern%25C3%25A1ndez%26aufirst%3DA.%26aulast%3DAlbaiceta%26aufirst%3DG.%2BM.%26atitle%3DMatrix%2520Metalloproteinase-14%2520Triggers%2520an%2520Anti-Inflammatory%2520Proteolytic%2520Cascade%2520in%2520Endotoxemia%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2017%26volume%3D95%26issue%3D5%26spage%3D487%26epage%3D497%26doi%3D10.1007%2Fs00109-017-1510-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span> <span> </span><span class="NLM_article-title">Cytoplasmic Tail of MT1-MMP Regulates Macrophage Motility Independently from Its Protease Activity</span>. <i>Genes Cells</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2443.2009.01293.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fj.1365-2443.2009.01293.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19371380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVCmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=617-626&issue=5&author=T.+Sakamotoauthor=M.+Seiki&title=Cytoplasmic+Tail+of+MT1-MMP+Regulates+Macrophage+Motility+Independently+from+Its+Protease+Activity&doi=10.1111%2Fj.1365-2443.2009.01293.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoplasmic tail of MT1-MMP regulates macrophage motility independently from its protease activity</span></div><div class="casAuthors">Sakamoto, Takeharu; Seiki, Motoharu</div><div class="citationInfo"><span class="NLM_cas:title">Genes to Cells</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">617-626</span>CODEN:
                <span class="NLM_cas:coden">GECEFL</span>;
        ISSN:<span class="NLM_cas:issn">1356-9597</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Membrane type-1 matrix metalloproteinase (MT1-MMP) is a pro-invasive protease that regulates various cellular functions as evidenced by myriad defects in different types of cells and tissues in MT1-MMP-deficient (MT1-/-) mice.  Here, the authors demonstrate that MT1-/- mice exhibit fewer infiltrating macrophages into sites of inflammation.  MT1-/- macrophages exhibited a reduced ability to invade reconstituted basement membrane (Matrigel) and invasion by wild-type (WT) macrophages was inhibited by a synthetic MMP inhibitor (BB94) to a level similar to that of MT1-/- cells.  The rate of migration of MT1-/- macrophages was also low compared to that of the WT cells and re-expression of MT1-MMP in MT1-/- macrophages reconstituted their migratory activity.  Unexpectedly, however, BB94 did not inhibit the migration of WT macrophages.  The migration-boosting activity of MT1-MMP was retained in a mutant that lacked most of the extracellular portion including the catalytic and hemopexin-like domains.  In contrast, deletion of the cytoplasmic (CP) tail abolished the activity completely.  Thus, the authors demonstrate that MT1-MMP regulates macrophages via its invasion-promoting protease activity as well as its CP-dependent non-proteolytic activity to boost cell migration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryBdh4aP_b7LVg90H21EOLACvtfcHk0liF0PGyVAmZ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVCmu7w%253D&md5=b313e733dfaf6e370a70120000cf024b</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2443.2009.01293.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2443.2009.01293.x%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DT.%26aulast%3DSeiki%26aufirst%3DM.%26atitle%3DCytoplasmic%2520Tail%2520of%2520MT1-MMP%2520Regulates%2520Macrophage%2520Motility%2520Independently%2520from%2520Its%2520Protease%2520Activity%26jtitle%3DGenes%2520Cells%26date%3D2009%26volume%3D14%26issue%3D5%26spage%3D617%26epage%3D626%26doi%3D10.1111%2Fj.1365-2443.2009.01293.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchalant, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouzin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrete, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paumier, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Py, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vignes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">MT5-MMP Is a New pro-Amyloidogenic Proteinase That Promotes Amyloid Pathology and Cognitive Decline in a Transgenic Mouse Model of Alzheimer’s Disease</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1007/s00018-015-1992-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00018-015-1992-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26202697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1aksrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2016&pages=217-236&issue=1&author=K.+Barangerauthor=Y.+Marchalantauthor=A.+E.+Bonnetauthor=N.+Crouzinauthor=A.+Carreteauthor=J.-M.+Paumierauthor=N.+A.+Pyauthor=A.+Bernardauthor=C.+Bauerauthor=E.+Charratauthor=K.+Moschkeauthor=M.+Seikiauthor=M.+Vignesauthor=S.+F.+Lichtenthalerauthor=F.+Checlerauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=MT5-MMP+Is+a+New+pro-Amyloidogenic+Proteinase+That+Promotes+Amyloid+Pathology+and+Cognitive+Decline+in+a+Transgenic+Mouse+Model+of+Alzheimer%E2%80%99s+Disease&doi=10.1007%2Fs00018-015-1992-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease</span></div><div class="casAuthors">Baranger, Kevin; Marchalant, Yannick; Bonnet, Amandine E.; Crouzin, Nadine; Carrete, Alex; Paumier, Jean-Michel; Py, Nathalie A.; Bernard, Anne; Bauer, Charlotte; Charrat, Eliane; Moschke, Katrin; Seiki, Mothoharu; Vignes, Michel; Lichtenthaler, Stefan F.; Checler, Frederic; Khrestchatisky, Michel; Rivera, Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">217-236</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">Membrane-type 5-matrix metalloproteinase (MT5-MMP) is a proteinase mainly expressed in the nervous system with emerging roles in brain pathophysiol.  The implication of MT5-MMP in Alzheimer's disease (AD), notably its interplay with the amyloidogenic process, remains elusive.  Accordingly, we crossed the genetically engineered 5xFAD mouse model of AD with MT5-MMP-deficient mice and examd. the impact of MT5-MMP deficiency in bigenic 5xFAD/MT5-MMP-/- mice.  At early stages (4 mo) of the pathol., the levels of amyloid beta peptide (Aβ) and its amyloid precursor protein (APP) C-terminal fragment C99 were largely reduced in the cortex and hippocampus of 5xFAD/MT5-MMP-/-, compared to 5xFAD mice.  Reduced amyloidosis in bigenic mice was concomitant with decreased glial reactivity and interleukin-1β (IL-1β) levels, and the preservation of long-term potentiation (LTP) and spatial learning, without changes in the activity of α-, β- and γ-secretases.  The pos. impact of MT5-MMP deficiency was still noticeable at 16 mo of age, as illustrated by reduced amyloid burden and gliosis, and a better preservation of the cortical neuronal network and synaptophysin levels in bigenic mice.  MT5-MMP expressed in HEKswe cells colocalized and co-immunopptd. with APP and significantly increased the levels of Aβ and C99.  MT5-MMP also promoted the release of a sol. APP fragment of 95 kDa (sAPP95) in HEKswe cells. sAPP95 levels were significantly reduced in brain homogenates of 5xFAD/MT5-MMP-/- mice, supporting altogether the idea that MT5-MMP influences APP processing.  MT5-MMP emerges as a new pro-amyloidogenic regulator of APP metab., whose deficiency alleviates amyloid pathol., neuroinflammation and cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH_5t3Z1acubVg90H21EOLACvtfcHk0liF0PGyVAmZ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1aksrjP&md5=e4e622d44965b44f298497aca7119f0f</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1007%2Fs00018-015-1992-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-015-1992-1%26sid%3Dliteratum%253Aachs%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DMarchalant%26aufirst%3DY.%26aulast%3DBonnet%26aufirst%3DA.%2BE.%26aulast%3DCrouzin%26aufirst%3DN.%26aulast%3DCarrete%26aufirst%3DA.%26aulast%3DPaumier%26aufirst%3DJ.-M.%26aulast%3DPy%26aufirst%3DN.%2BA.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DC.%26aulast%3DCharrat%26aufirst%3DE.%26aulast%3DMoschke%26aufirst%3DK.%26aulast%3DSeiki%26aufirst%3DM.%26aulast%3DVignes%26aufirst%3DM.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DMT5-MMP%2520Is%2520a%2520New%2520pro-Amyloidogenic%2520Proteinase%2520That%2520Promotes%2520Amyloid%2520Pathology%2520and%2520Cognitive%2520Decline%2520in%2520a%2520Transgenic%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2016%26volume%3D73%26issue%3D1%26spage%3D217%26epage%3D236%26doi%3D10.1007%2Fs00018-015-1992-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paumier, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-González, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmanaa, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charrat, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moschke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roman, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Checler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">MT5-MMP Promotes Alzheimer’s Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in Vitro</span>. <i>Front. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.3389/fnmol.2016.00163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3389%2Ffnmol.2016.00163" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1-17&issue=1&author=K.+Barangerauthor=A.+E.+Bonnetauthor=S.+D.+Girardauthor=J.-M.+Paumierauthor=L.+Garc%C3%ADa-Gonz%C3%A1lezauthor=W.+Elmanaaauthor=A.+Bernardauthor=E.+Charratauthor=D.+Stephanauthor=C.+Bauerauthor=K.+Moschkeauthor=S.+F.+Lichtenthalerauthor=F.+S.+Romanauthor=F.+Checlerauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=MT5-MMP+Promotes+Alzheimer%E2%80%99s+Pathogenesis+in+the+Frontal+Cortex+of+5xFAD+Mice+and+APP+Trafficking+in+Vitro&doi=10.3389%2Ffnmol.2016.00163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2016.00163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2016.00163%26sid%3Dliteratum%253Aachs%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DBonnet%26aufirst%3DA.%2BE.%26aulast%3DGirard%26aufirst%3DS.%2BD.%26aulast%3DPaumier%26aufirst%3DJ.-M.%26aulast%3DGarc%25C3%25ADa-Gonz%25C3%25A1lez%26aufirst%3DL.%26aulast%3DElmanaa%26aufirst%3DW.%26aulast%3DBernard%26aufirst%3DA.%26aulast%3DCharrat%26aufirst%3DE.%26aulast%3DStephan%26aufirst%3DD.%26aulast%3DBauer%26aufirst%3DC.%26aulast%3DMoschke%26aufirst%3DK.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26aulast%3DRoman%26aufirst%3DF.%2BS.%26aulast%3DChecler%26aufirst%3DF.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DMT5-MMP%2520Promotes%2520Alzheimer%25E2%2580%2599s%2520Pathogenesis%2520in%2520the%2520Frontal%2520Cortex%2520of%25205xFAD%2520Mice%2520and%2520APP%2520Trafficking%2520in%2520Vitro%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2017%26volume%3D9%26issue%3D1%26spage%3D1%26epage%3D17%26doi%3D10.3389%2Ffnmol.2016.00163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khrestchatisky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">MT5-MMP, Just a New APP Processing Proteinase in Alzheimer’s Disease?</span>. <i>J. Neuroinflammation</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">167</span>, <span class="refDoi"> DOI: 10.1186/s12974-016-0633-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1186%2Fs12974-016-0633-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27349644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC2s7ktlehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=167&issue=1&author=K.+Barangerauthor=M.+Khrestchatiskyauthor=S.+Rivera&title=MT5-MMP%2C+Just+a+New+APP+Processing+Proteinase+in+Alzheimer%E2%80%99s+Disease%3F&doi=10.1186%2Fs12974-016-0633-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">MT5-MMP, just a new APP processing proteinase in Alzheimer's disease?</span></div><div class="casAuthors">Baranger Kevin; Khrestchatisky Michel; Rivera Santiago</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroinflammation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">167</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">We have recently identified in a transgenic mouse model of Alzheimer's disease (AD) membrane-type 5-MMP (MT5-MMP) as a new player in Alzheimer's pathogenesis, which displays pro-amyloidogenic features and proteolytic processing of amyloid precursor protein (APP).  Another group has reported that MT5-MMP processing of APP may release a novel neurotoxic APP fragment.  Although MT5-MMP-mediated APP processing appears to be a key pathogenic step, we hypothesize that MT5-MMP may also contribute to AD pathogenesis through complementary mechanisms that involve the activation of pro-inflammatory pathways and/or APP trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOwBKw6SCc_F1C8OJBvdfbfW6udTcc2ebuFRYQNeAa4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7ktlehsA%253D%253D&md5=5a18b9baf232700092b506c0108cc689</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1186%2Fs12974-016-0633-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12974-016-0633-4%26sid%3Dliteratum%253Aachs%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DKhrestchatisky%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DMT5-MMP%252C%2520Just%2520a%2520New%2520APP%2520Processing%2520Proteinase%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253F%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2016%26volume%3D13%26issue%3D1%26spage%3D167%26doi%3D10.1186%2Fs12974-016-0633-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willem, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahirovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busche, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ovsepian, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chafai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kootar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornburg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, L. D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daria, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giudici, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenninger-Weinzierl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremmer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heneka, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thal, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giedraitis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lannfelt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livesey, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meissner, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herms, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konnerth, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span> <span> </span><span class="NLM_article-title">η-Secretase Processing of APP Inhibits Neuronal Activity in the Hippocampus</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>526</i></span> (<span class="NLM_issue">7573</span>),  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">447</span>, <span class="refDoi"> DOI: 10.1038/nature14864</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fnature14864" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26322584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCis7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2015&pages=443-447&issue=7573&author=M.+Willemauthor=S.+Tahirovicauthor=M.+A.+Buscheauthor=S.+V.+Ovsepianauthor=M.+Chafaiauthor=S.+Kootarauthor=D.+Hornburgauthor=L.+D.+B.+Evansauthor=S.+Mooreauthor=A.+Dariaauthor=H.+Hampelauthor=V.+M%C3%BCllerauthor=C.+Giudiciauthor=B.+Nuscherauthor=A.+Wenninger-Weinzierlauthor=E.+Kremmerauthor=M.+T.+Henekaauthor=D.+R.+Thalauthor=V.+Giedraitisauthor=L.+Lannfeltauthor=U.+M%C3%BCllerauthor=F.+J.+Liveseyauthor=F.+Meissnerauthor=J.+Hermsauthor=A.+Konnerthauthor=H.+Marieauthor=C.+Haass&title=%CE%B7-Secretase+Processing+of+APP+Inhibits+Neuronal+Activity+in+the+Hippocampus&doi=10.1038%2Fnature14864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">η-Secretase processing of APP inhibits neuronal activity in the hippocampus</span></div><div class="casAuthors">Willem, Michael; Tahirovic, Sabina; Busche, Marc Aurel; Ovsepian, Saak V.; Chafai, Magda; Kootar, Scherazad; Hornburg, Daniel; Evans, Lewis D. B.; Moore, Steven; Daria, Anna; Hampel, Heike; Mueller, Veronika; Giudici, Camilla; Nuscher, Brigitte; Wenninger-Weinzierl, Andrea; Kremmer, Elisabeth; Heneka, Michael T.; Thal, Dietmar R.; Giedraitis, Vilmantas; Lannfelt, Lars; Mueller, Ulrike; Livesey, Frederick J.; Meissner, Felix; Herms, Jochen; Konnerth, Arthur; Marie, Helene; Haass, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue">7573</span>),
    <span class="NLM_cas:pages">443-447</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-β peptide.  Two principal physiol. pathways either prevent or promote amyloid-β generation from its precursor, β-amyloid precursor protein (APP), in a competitive manner.  Although APP processing has been studied in great detail, unknown proteolytic events seem to hinder stoichiometric analyses of APP metab. in vivo.  Here we describe a new physiol. APP processing pathway, which generates proteolytic fragments capable of inhibiting neuronal activity within the hippocampus.  We identify higher mol. mass carboxy-terminal fragments (CTFs) of APP, termed CTF-η, in addn. to the long-known CTF-α and CTF-β fragments generated by the α- and β-secretases ADAM10 (a disintegrin and metalloproteinase 10) and BACE1 (β-site APP cleaving enzyme 1), resp.  CTF-η generation is mediated in part by membrane-bound matrix metalloproteinases such as MT5-MMP, referred to as η-secretase activity.  η-Secretase cleavage occurs primarily at amino acids 504-505 of APP695, releasing a truncated ectodomain.  After shedding of this ectodomain, CTF-η is further processed by ADAM10 and BACE1 to release long and short Aη peptides (termed Aη-α and Aη-β).  CTFs produced by η-secretase are enriched in dystrophic neurites in an AD mouse model and in human AD brains.  Genetic and pharmacol. inhibition of BACE1 activity results in robust accumulation of CTF-η and Aη-α.  In mice treated with a potent BACE1 inhibitor, hippocampal long-term potentiation was reduced.  Notably, when recombinant or synthetic Aη-α was applied on hippocampal slices ex vivo, long-term potentiation was lowered.  Furthermore, in vivo single-cell two-photon calcium imaging showed that hippocampal neuronal activity was attenuated by Aη-α.  These findings not only demonstrate a major functionally relevant APP processing pathway, but may also indicate potential translational relevance for therapeutic strategies targeting APP processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_5ub5j4eaRbVg90H21EOLACvtfcHk0liCgfUzACZADA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCis7%252FN&md5=e56ae17f893de088e80fe973d4885930</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1038%2Fnature14864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14864%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DTahirovic%26aufirst%3DS.%26aulast%3DBusche%26aufirst%3DM.%2BA.%26aulast%3DOvsepian%26aufirst%3DS.%2BV.%26aulast%3DChafai%26aufirst%3DM.%26aulast%3DKootar%26aufirst%3DS.%26aulast%3DHornburg%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DL.%2BD.%2BB.%26aulast%3DMoore%26aufirst%3DS.%26aulast%3DDaria%26aufirst%3DA.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DM%25C3%25BCller%26aufirst%3DV.%26aulast%3DGiudici%26aufirst%3DC.%26aulast%3DNuscher%26aufirst%3DB.%26aulast%3DWenninger-Weinzierl%26aufirst%3DA.%26aulast%3DKremmer%26aufirst%3DE.%26aulast%3DHeneka%26aufirst%3DM.%2BT.%26aulast%3DThal%26aufirst%3DD.%2BR.%26aulast%3DGiedraitis%26aufirst%3DV.%26aulast%3DLannfelt%26aufirst%3DL.%26aulast%3DM%25C3%25BCller%26aufirst%3DU.%26aulast%3DLivesey%26aufirst%3DF.%2BJ.%26aulast%3DMeissner%26aufirst%3DF.%26aulast%3DHerms%26aufirst%3DJ.%26aulast%3DKonnerth%26aufirst%3DA.%26aulast%3DMarie%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3D%25CE%25B7-Secretase%2520Processing%2520of%2520APP%2520Inhibits%2520Neuronal%2520Activity%2520in%2520the%2520Hippocampus%26jtitle%3DNature%26date%3D2015%26volume%3D526%26issue%3D7573%26spage%3D443%26epage%3D447%26doi%3D10.1038%2Fnature14864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hayashita-Kinoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, a</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yana, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span> <span> </span><span class="NLM_article-title">Membrane-Type 5 Matrix Metalloproteinase Is Expressed in Differentiated Neurons and Regulates Axonal Growth</span>. <i>Cell Growth Differ.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">573</span>– <span class="NLM_lpage">580</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11714638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3MXos1KksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=573-580&issue=11&author=H.+Hayashita-Kinohauthor=H.+Kinohauthor=a+Okadaauthor=K.+Komoriauthor=Y.+Itohauthor=T.+Chibaauthor=M.+Kajitaauthor=I.+Yanaauthor=M.+Seiki&title=Membrane-Type+5+Matrix+Metalloproteinase+Is+Expressed+in+Differentiated+Neurons+and+Regulates+Axonal+Growth"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth</span></div><div class="casAuthors">Hayashita-Kinoh, Hiromi; Kinoh, Hiroaki; Okada, Akiko; Komori, Kiyoshi; Itoh, Yoshifumi; Chiba, Tadashige; Kajita, Masahiro; Yana, Ikuo; Seiki, Motoharu</div><div class="citationInfo"><span class="NLM_cas:title">Cell Growth & Differentiation</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">573-580</span>CODEN:
                <span class="NLM_cas:coden">CGDIE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-9523</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of membrane-type (MT) 5 matrix metalloproteinase (MMP) in the mouse brain was examd.  MT5-MMP was expressed in the cerebrum in embryos, but it declined after birth.  In contrast, expression in the cerebellum started to increase postnatally and continued thereafter.  The cells expressing MT5-MMP were postmitotic neurons that showed gelatinolytic activities.  Specific expression of MT5-MMP was obsd. in the neurons but not in the glial cells when embryonal mouse carcinoma P19 cells were differentiated in vitro by retinoic acid treatment.  Neurons isolated from dorsal root ganglia also expressed MT5-MMP, and it was localized at the edge of growth cone.  Proteoglycans inhibit neurite extension and regulate synaptogenesis.  The inhibitory effect of the proteoglycans on neurite extension of dorsal root ganglia neurons was effectively eliminated by recombinant MT5-MMP.  Thus, MT5-MMP expressed in neurons may play a role in axonal growth that contributes to the regulation of neural network formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKTa4_mQT9dbVg90H21EOLACvtfcHk0liCgfUzACZADA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXos1KksLY%253D&md5=001445893412ef6feb5f808818ba5f77</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHayashita-Kinoh%26aufirst%3DH.%26aulast%3DKinoh%26aufirst%3DH.%26aulast%3DOkada%26aufirst%3Da%26aulast%3DKomori%26aufirst%3DK.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DChiba%26aufirst%3DT.%26aulast%3DKajita%26aufirst%3DM.%26aulast%3DYana%26aufirst%3DI.%26aulast%3DSeiki%26aufirst%3DM.%26atitle%3DMembrane-Type%25205%2520Matrix%2520Metalloproteinase%2520Is%2520Expressed%2520in%2520Differentiated%2520Neurons%2520and%2520Regulates%2520Axonal%2520Growth%26jtitle%3DCell%2520Growth%2520Differ.%26date%3D2001%26volume%3D12%26issue%3D11%26spage%3D573%26epage%3D580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komori, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashita-Kinoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yana, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiki, M.</span></span> <span> </span><span class="NLM_article-title">Absence of Mechanical Allodynia and Aβ-Fiber Sprouting after Sciatic Nerve Injury in Mice Lacking Membrane-Type 5 Matrix Metalloproteinase</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>557</i></span> (<span class="NLM_issue">1–3</span>),  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">128</span>, <span class="refDoi"> DOI: 10.1016/S0014-5793(03)01458-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0014-5793%2803%2901458-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=14741353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltV2qtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=557&publication_year=2004&pages=125-128&issue=1%E2%80%933&author=K.+Komoriauthor=T.+Nonakaauthor=A.+Okadaauthor=H.+Kinohauthor=H.+Hayashita-Kinohauthor=N.+Yoshidaauthor=I.+Yanaauthor=M.+Seiki&title=Absence+of+Mechanical+Allodynia+and+A%CE%B2-Fiber+Sprouting+after+Sciatic+Nerve+Injury+in+Mice+Lacking+Membrane-Type+5+Matrix+Metalloproteinase&doi=10.1016%2FS0014-5793%2803%2901458-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Absence of mechanical allodynia and Aβ-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase</span></div><div class="casAuthors">Komori, Kiyoshi; Nonaka, Takahiro; Okada, Akiko; Kinoh, Hiroaki; Hayashita-Kinoh, Hiromi; Yoshida, Nobuaki; Yana, Ikuo; Seiki, Motoharu</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">557</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">125-128</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) are a family of endopeptidases that degrade extracellular matrix components.  Membrane-type 5 MMP (MT5-MMP/MMP-24) was identified as neuron-specific, and is believed to contribute to neuronal circuit formation and plasticity.  To elucidate its function in vivo, we have generated mice lacking MT5-MMP by gene targeting.  MT5-MMP-deficient mice were born without obvious morphol. abnormalities.  No apparent histol. defects were obsd. in the nervous system either.  However, MT5-MMP-deficient mice did not develop neuropathic pain with mech. allodynia after sciatic nerve injury, though responses to acute noxious stimuli were normal.  Neuropathic pain induced by peripheral nerve lesions is known to accompany structural reorganization of the nervous system.  Intraneural injection of cholera toxin B subunit, a transganglionic tracer, into the injured sciatic nerve of wild-type mice revealed that the myelinated Aβ-fiber primary afferents sprouted from laminae III-VI of the dorsal horn of the spinal cord and invaded lamina II.  However, no such sprouting and invasion of Aβ-fibers were obsd. in MT5-MMP-deficient mice.  These findings suggest that MT5-MMP is essential for the development of mech. allodynia and plays an important role in neuronal plasticity in this mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocUJuiIjhdirVg90H21EOLACvtfcHk0lhd03NWE21Y8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltV2qtw%253D%253D&md5=f727b61980024717fcc7c4b6331264ef</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2FS0014-5793%2803%2901458-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-5793%252803%252901458-3%26sid%3Dliteratum%253Aachs%26aulast%3DKomori%26aufirst%3DK.%26aulast%3DNonaka%26aufirst%3DT.%26aulast%3DOkada%26aufirst%3DA.%26aulast%3DKinoh%26aufirst%3DH.%26aulast%3DHayashita-Kinoh%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DN.%26aulast%3DYana%26aufirst%3DI.%26aulast%3DSeiki%26aufirst%3DM.%26atitle%3DAbsence%2520of%2520Mechanical%2520Allodynia%2520and%2520A%25CE%25B2-Fiber%2520Sprouting%2520after%2520Sciatic%2520Nerve%2520Injury%2520in%2520Mice%2520Lacking%2520Membrane-Type%25205%2520Matrix%2520Metalloproteinase%26jtitle%3DFEBS%2520Lett.%26date%3D2004%26volume%3D557%26issue%3D1%25E2%2580%25933%26spage%3D125%26epage%3D128%26doi%3D10.1016%2FS0014-5793%2803%2901458-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Folgueras, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdes-Sanchez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menendez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baamonde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denlinger, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belmonte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juarez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lastra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Suarez, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Astudillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirstein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendas, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinas, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Otin, C.</span></span> <span> </span><span class="NLM_article-title">Metalloproteinase MT5-MMP Is an Essential Modulator of Neuro-Immune Interactions in Thermal Pain Stimulation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">16451</span>– <span class="NLM_lpage">16456</span>, <span class="refDoi"> DOI: 10.1073/pnas.0908507106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1073%2Fpnas.0908507106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19805319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Ojtr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16451-16456&issue=38&author=A.+R.+Folguerasauthor=T.+Valdes-Sanchezauthor=E.+Llanoauthor=L.+Menendezauthor=A.+Baamondeauthor=B.+L.+Denlingerauthor=C.+Belmonteauthor=L.+Juarezauthor=A.+Lastraauthor=O.+Garcia-Suarezauthor=A.+Astudilloauthor=M.+Kirsteinauthor=A.+M.+Pendasauthor=I.+Farinasauthor=C.+Lopez-Otin&title=Metalloproteinase+MT5-MMP+Is+an+Essential+Modulator+of+Neuro-Immune+Interactions+in+Thermal+Pain+Stimulation&doi=10.1073%2Fpnas.0908507106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation</span></div><div class="casAuthors">Folgueras, Alicia R.; Valdes-Sanchez, Teresa; Llano, Elena; Menendez, Luis; Baamonde, Ana; Denlinger, Bristol L.; Belmonte, Carlos; Juarez, Lucia; Lastra, Ana; Garcia-Suarez, Olivia; Kirstein, Martina; Pendas, Alberto M.; Farinas, Isabel; Lopez-Otin, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">16451-16456, S16451/1-S16451/12</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Peripheral interactions between nociceptive fibers and mast cells contribute to inflammatory pain, but little is known about mechanisms mediating neuroimmune communication.  Here we show that metalloproteinase MT5-MMP (MMP-24) is an essential mediator of peripheral thermal nociception and inflammatory hyperalgesia.  We report that MT5-MMP is expressed by CGRP-contg. peptidergic nociceptors in dorsal root ganglia and that Mmp24-deficient mice display enhanced sensitivity to noxious thermal stimuli under basal conditions.  Consistently, mutant peptidergic sensory neurons hyperinnervate the skin, a phenotype that correlates with changes in the regulated cleavage of the cell-cell adhesion mol. N-cadherin.  In contrast to basal nociception, Mmp24-/- mice do not develop thermal hyperalgesia during inflammation, a phenotype that appears assocd. with alterations in N-cadherin-mediated cell-cell interactions between mast cells and sensory fibers.  Collectively, our findings demonstrate an essential role of MT5-MMP in the development of dermal neuro-immune synapses and suggest that this metalloproteinase may be a target for pain control.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmN1iKK3OrYrVg90H21EOLACvtfcHk0lj8XhG09wo0bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Ojtr7M&md5=b03c677c89f1c57351838b39f4aff61f</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0908507106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0908507106%26sid%3Dliteratum%253Aachs%26aulast%3DFolgueras%26aufirst%3DA.%2BR.%26aulast%3DValdes-Sanchez%26aufirst%3DT.%26aulast%3DLlano%26aufirst%3DE.%26aulast%3DMenendez%26aufirst%3DL.%26aulast%3DBaamonde%26aufirst%3DA.%26aulast%3DDenlinger%26aufirst%3DB.%2BL.%26aulast%3DBelmonte%26aufirst%3DC.%26aulast%3DJuarez%26aufirst%3DL.%26aulast%3DLastra%26aufirst%3DA.%26aulast%3DGarcia-Suarez%26aufirst%3DO.%26aulast%3DAstudillo%26aufirst%3DA.%26aulast%3DKirstein%26aufirst%3DM.%26aulast%3DPendas%26aufirst%3DA.%2BM.%26aulast%3DFarinas%26aufirst%3DI.%26aulast%3DLopez-Otin%26aufirst%3DC.%26atitle%3DMetalloproteinase%2520MT5-MMP%2520Is%2520an%2520Essential%2520Modulator%2520of%2520Neuro-Immune%2520Interactions%2520in%2520Thermal%2520Pain%2520Stimulation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D38%26spage%3D16451%26epage%3D16456%26doi%3D10.1073%2Fpnas.0908507106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Okimoto, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitenbuecher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivas, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asthana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrustanovic, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulpule, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blakely, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haringsma, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmons, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gowen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suh, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bivona, T. G.</span></span> <span> </span><span class="NLM_article-title">Inactivation of Capicua Drives Cancer Metastasis</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1038/ng.3728</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fng.3728" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27869830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGqu7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=87-96&issue=1&author=R.+A.+Okimotoauthor=F.+Breitenbuecherauthor=V.+R.+Olivasauthor=W.+Wuauthor=B.+Giniauthor=M.+Hofreeauthor=S.+Asthanaauthor=G.+Hrustanovicauthor=J.+Flanaganauthor=A.+Tulpuleauthor=C.+M.+Blakelyauthor=H.+J.+Haringsmaauthor=A.+D.+Simmonsauthor=K.+Gowenauthor=J.+Suhauthor=V.+A.+Millerauthor=S.+Aliauthor=M.+Schulerauthor=T.+G.+Bivona&title=Inactivation+of+Capicua+Drives+Cancer+Metastasis&doi=10.1038%2Fng.3728"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of Capicua drives cancer metastasis</span></div><div class="casAuthors">Okimoto, Ross A.; Breitenbuecher, Frank; Olivas, Victor R.; Wu, Wei; Gini, Beatrice; Hofree, Matan; Asthana, Saurabh; Hrustanovic, Gorjan; Flanagan, Jennifer; Tulpule, Asmin; Blakely, Collin M.; Haringsma, Henry J.; Simmons, Andrew D.; Gowen, Kyle; Suh, James; Miller, Vincent A.; Ali, Siraj; Schuler, Martin; Bivona, Trever G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-96</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Metastasis is the leading cause of death in people with lung cancer, yet the mol. effectors underlying tumor dissemination remain poorly defined.  Through the development of an in vivo spontaneous lung cancer metastasis model, we show that the developmentally regulated transcriptional repressor Capicua (CIC) suppresses invasion and metastasis.  Inactivation of CIC relieves repression of its effector ETV4, driving ETV4-mediated upregulation of MMP24, which is necessary and sufficient for metastasis.  Loss of CIC, or an increase in levels of its effectors ETV4 and MMP24, is a biomarker of tumor progression and worse outcomes in people with lung and/or gastric cancer.  Our findings reveal CIC as a conserved metastasis suppressor, highlighting new anti-metastatic strategies that could potentially improve patient outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq810YPLfE1rVg90H21EOLACvtfcHk0lgLuvow3gcy4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGqu7bO&md5=42666b56b3deb9d8f58546fe56d096b8</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1038%2Fng.3728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng.3728%26sid%3Dliteratum%253Aachs%26aulast%3DOkimoto%26aufirst%3DR.%2BA.%26aulast%3DBreitenbuecher%26aufirst%3DF.%26aulast%3DOlivas%26aufirst%3DV.%2BR.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DGini%26aufirst%3DB.%26aulast%3DHofree%26aufirst%3DM.%26aulast%3DAsthana%26aufirst%3DS.%26aulast%3DHrustanovic%26aufirst%3DG.%26aulast%3DFlanagan%26aufirst%3DJ.%26aulast%3DTulpule%26aufirst%3DA.%26aulast%3DBlakely%26aufirst%3DC.%2BM.%26aulast%3DHaringsma%26aufirst%3DH.%2BJ.%26aulast%3DSimmons%26aufirst%3DA.%2BD.%26aulast%3DGowen%26aufirst%3DK.%26aulast%3DSuh%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DV.%2BA.%26aulast%3DAli%26aufirst%3DS.%26aulast%3DSchuler%26aufirst%3DM.%26aulast%3DBivona%26aufirst%3DT.%2BG.%26atitle%3DInactivation%2520of%2520Capicua%2520Drives%2520Cancer%2520Metastasis%26jtitle%3DNat.%2520Genet.%26date%3D2017%26volume%3D49%26issue%3D1%26spage%3D87%26epage%3D96%26doi%3D10.1038%2Fng.3728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Llano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendás, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freije, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knäuper, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Otin, C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Identification and Characterization of Human MT5-MMP, a New Membrane-Bound Activator of Progelatinase A Overexpressed in Brain Tumors</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2570</span>– <span class="NLM_lpage">2576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10363975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1ymsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2570-2576&author=E.+Llanoauthor=A.+M.+Pend%C3%A1sauthor=J.+P.+Freijeauthor=A.+Nakanoauthor=V.+Kn%C3%A4uperauthor=G.+Murphyauthor=C.+L%C3%B3pez-Otin&title=Identification+and+Characterization+of+Human+MT5-MMP%2C+a+New+Membrane-Bound+Activator+of+Progelatinase+A+Overexpressed+in+Brain+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors</span></div><div class="casAuthors">Llano, Elena; Pendas, Alberto M.; Freije, Jose P.; Nakano, Atsuhisa; Knauper, Vera; Murphy, Gillian; Lopez-Otin, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2570-2576</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">A cDNA encoding a new member of the membrane-type (MT) matrix metalloproteinase (MMP) family has been identified and cloned from a human brain cDNA library.  The isolated cDNA encodes a polypeptide of 645 amino acids that displays a similar domain organization as other MMPs, including a predomain with the activation locus, a zinc-binding site, and a hemopexin domain.  The deduced amino acid sequence contains a COOH-terminal extension, rich in hydrophobic residues and similar in size to the equiv. domains identified in MT-MMPs.  Immunofluorescence and Western blot anal. of COS-7 cells transfected with the isolated cDNA revealed that the encoded protein is localized in the plasma membrane.  On the basis of these features, this novel human MMP has been called MT5-MMP because it represents the fifth member of the MT-MMP subfamily of MMPs.  Fluorescent in situ hybridization expts. showed that the human MT5-MMP gene (MMP-24) maps to 20q11.2, a region frequently amplified in tumors from diverse sources.  Northern blot anal. demonstrated that MT5-MMP is predominantly expressed in brain, kidney, pancreas, and lung.  In addn., MT5-MMP transcripts were detected at high levels compared to normal brain tissue in a series of brain tumors, including astrocytomas and glioblastomas.  The catalytic domain of MT5-MMP, produced in Escherichia coli as a fusion protein with glutathione S-transferase, exhibits a potent proteolytic activity against progelatinase A, leading to the generation of the Mr 62,000 active form of this enzyme.  These data suggest that MT5-MMP may contribute to the activation of progelatinase A in tumor tissues, in which it is overexpressed, thereby facilitating tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpadhPHN2JP-LVg90H21EOLACvtfcHk0ljOrJr42VOhrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1ymsb4%253D&md5=d6f6fbcef15d7ff4aa03dfb95706ba33</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlano%26aufirst%3DE.%26aulast%3DPend%25C3%25A1s%26aufirst%3DA.%2BM.%26aulast%3DFreije%26aufirst%3DJ.%2BP.%26aulast%3DNakano%26aufirst%3DA.%26aulast%3DKn%25C3%25A4uper%26aufirst%3DV.%26aulast%3DMurphy%26aufirst%3DG.%26aulast%3DL%25C3%25B3pez-Otin%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520Human%2520MT5-MMP%252C%2520a%2520New%2520Membrane-Bound%2520Activator%2520of%2520Progelatinase%2520A%2520Overexpressed%2520in%2520Brain%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2570%26epage%3D2576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Restituito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathews, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziff, E. B.</span></span> <span> </span><span class="NLM_article-title">Synaptic Autoregulation by Metalloproteases and -Secretase</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">12083</span>– <span class="NLM_lpage">12093</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2513-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.2513-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21865451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCisLjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=12083-12093&issue=34&author=S.+Restituitoauthor=L.+Khatriauthor=I.+Ninanauthor=P.+M.+Mathewsauthor=X.+Liuauthor=R.+J.+Weinbergauthor=E.+B.+Ziff&title=Synaptic+Autoregulation+by+Metalloproteases+and+-Secretase&doi=10.1523%2FJNEUROSCI.2513-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic autoregulation by metalloproteases and γ-secretase</span></div><div class="casAuthors">Restituito, Sophie; Khatri, Latika; Ninan, Ipe; Mathews, Paul M.; Liu, Xin; Weinberg, Richard J.; Ziff, Edward B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12083-12093</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The proteolytic machinery comprising metalloproteases and γ-secretase, an intramembrane aspartyl protease involved in Alzheimer's disease, cleaves several substrates in addn. to the extensively studied amyloid precursor protein.  Some of these substrates, such as N-cadherin, are synaptic proteins involved in synapse remodeling and maintenance.  Here we show, in rats and mice, that metalloproteases and γ-secretase are physiol. regulators of synapses.  Both proteases are synaptic, with γ-secretase tethered at the synapse by δ-catenin, a synaptic scaffolding protein that also binds to N-cadherin and, through scaffolds, to AMPA receptor and a metalloprotease.  Activity-dependent proteolysis by metalloproteases and γ-secretase takes place at both sides of the synapse, with the metalloprotease cleavage being NMDA receptor-dependent.  This proteolysis decreases levels of synaptic proteins and diminishes synaptic transmission.  Our results suggest that activity-dependent substrate cleavage by synaptic metalloproteases and γ-secretase modifies synaptic transmission, providing a novel form of synaptic autoregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWcx4oOMJBpbVg90H21EOLACvtfcHk0ljOrJr42VOhrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCisLjM&md5=fc8b3d49daee5290bd2393b4d0c12ce5</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2513-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2513-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DRestituito%26aufirst%3DS.%26aulast%3DKhatri%26aufirst%3DL.%26aulast%3DNinan%26aufirst%3DI.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWeinberg%26aufirst%3DR.%2BJ.%26aulast%3DZiff%26aufirst%3DE.%2BB.%26atitle%3DSynaptic%2520Autoregulation%2520by%2520Metalloproteases%2520and%2520-Secretase%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26issue%3D34%26spage%3D12083%26epage%3D12093%26doi%3D10.1523%2FJNEUROSCI.2513-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Identification and Characterization of the Fifth Membrane-Type Matrix Metalloproteinase MT5-MMP</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">8925</span>– <span class="NLM_lpage">8932</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.13.8925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.274.13.8925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10085137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK1MXitFyrtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=8925-8932&issue=13&author=D.+Pei&title=Identification+and+Characterization+of+the+Fifth+Membrane-Type+Matrix+Metalloproteinase+MT5-MMP&doi=10.1074%2Fjbc.274.13.8925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP</span></div><div class="casAuthors">Pei, Duanqing</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">8925-8932</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A new member of the membrane-type matrix metalloproteinase (MT-MMP) subfamily tentatively named MT5-MMP was isolated from mouse brain cDNA library.  It is predicted to contain (i) a candidate signal sequence, (ii) a propeptide region with the highly conserved PRCGVPD sequence, (iii) a potential furin recognition motif RRRRNKR, (iv) a zinc-binding catalytic domain, (v) a hemopexin-like domain, (vi) a 24-residue hydrophobic domain as a potential transmembrane domain, and (vii) a short cytosolic domain.  Reverse transcriptase-polymerase chain reaction anal. of its transcripts indicates that MT5-MMP is expressed in a brain-specific manner consistent with the origin of its EST clone from cerebellum.  It is also highly expressed during embryonic development at stages day 11 and 15.  Like other MT-MMPs, MT5-MMP specifically activates progelatinase A when co-expressed in Madin-Darby canine kidney cells.  Its ability to activate progelatinase A is dependent on its proteolytic activity since a mutation converting Glu to Ala in the zinc binding motif HE255LGH renders MT5-MMP inactive against progelatinase A.  In contrast to other MT-MMPs, MT5-MMP tends to shed from cell surface as sol. proteinases, thus offering flexibility as both a cell bound and sol. proteinase for extracellular matrix remodeling processes.  Taken together, these properties serve to distinguish MT5-MMP as a versatile MT-MMP playing an important role in extracellular matrix remodeling events in the brain and during embryonic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpReZMfJt6wrbVg90H21EOLACvtfcHk0lgkPvd0RPsmfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitFyrtbo%253D&md5=c565022eb49b94e1e86fcdf77bc364fb</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.13.8925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.13.8925%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DD.%26atitle%3DIdentification%2520and%2520Characterization%2520of%2520the%2520Fifth%2520Membrane-Type%2520Matrix%2520Metalloproteinase%2520MT5-MMP%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D13%26spage%3D8925%26epage%3D8932%26doi%3D10.1074%2Fjbc.274.13.8925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jaworski, D. M.</span></span> <span> </span><span class="NLM_article-title">Developmental Regulation of Membrane Type-5 Matrix Metalloproteinase (MT5-MMP) Expression in the Rat Nervous System</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>860</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">174</span>– <span class="NLM_lpage">177</span>, <span class="refDoi"> DOI: 10.1016/S0006-8993(00)02035-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0006-8993%2800%2902035-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10727639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvV2mu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=860&publication_year=2000&pages=174-177&issue=1%E2%80%932&author=D.+M.+Jaworski&title=Developmental+Regulation+of+Membrane+Type-5+Matrix+Metalloproteinase+%28MT5-MMP%29+Expression+in+the+Rat+Nervous+System&doi=10.1016%2FS0006-8993%2800%2902035-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental regulation of membrane type-5 matrix metalloproteinase (MT5-MMP) expression in the rat nervous system</span></div><div class="casAuthors">Jaworski, D. M.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">860</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">174-177</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">An intricate balance between extracellular matrix (ECM) synthesis and degrdn. must be maintained during developmental tissue remodeling.  Matrix metalloproteinases (MMPs) are the main mediators of ECM degrdn.  A subset of MMPs, referred to as membrane-type MMPs, contains a transmembrane domain that restricts protease activity at the cell surface.  Membrane type-5 MMP is predominantly expressed in the brain.  The present report is the first to demonstrate the temporal regulation and spatial distribution of MT5-MMP mRNA during nervous system development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOJQZn-ovmxrVg90H21EOLACvtfcHk0lgkPvd0RPsmfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvV2mu7k%253D&md5=a03ceb57f3a57d7d8b6cb4c22ecde53b</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1016%2FS0006-8993%2800%2902035-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-8993%252800%252902035-7%26sid%3Dliteratum%253Aachs%26aulast%3DJaworski%26aufirst%3DD.%2BM.%26atitle%3DDevelopmental%2520Regulation%2520of%2520Membrane%2520Type-5%2520Matrix%2520Metalloproteinase%2520%2528MT5-MMP%2529%2520Expression%2520in%2520the%2520Rat%2520Nervous%2520System%26jtitle%3DBrain%2520Res.%26date%3D2000%26volume%3D860%26issue%3D1%25E2%2580%25932%26spage%3D174%26epage%3D177%26doi%3D10.1016%2FS0006-8993%2800%2902035-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeSouza, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziff, E. B.</span></span> <span> </span><span class="NLM_article-title">Membrane Localization of Membrane Type 5 Matrix Metalloproteinase by AMPA Receptor Binding Protein and Cleavage of Cadherins</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2300</span>– <span class="NLM_lpage">2312</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3521-05.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1523%2FJNEUROSCI.3521-05.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16495457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFCms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2006&pages=2300-2312&issue=8&author=S.+Moneaauthor=B.+A.+Jordanauthor=S.+Srivastavaauthor=S.+DeSouzaauthor=E.+B.+Ziff&title=Membrane+Localization+of+Membrane+Type+5+Matrix+Metalloproteinase+by+AMPA+Receptor+Binding+Protein+and+Cleavage+of+Cadherins&doi=10.1523%2FJNEUROSCI.3521-05.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins</span></div><div class="casAuthors">Monea, Sara; Jordan, Bryen A.; Srivastava, Sapna; DeSouza, Sunita; Ziff, Edward B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2300-2312</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs) have been proposed to remodel the extracellular environment of neurons.  Here, we report that the metalloproteinase membrane-type 5 MMP (MT5-MMP) binds to AMPA receptor binding protein (ABP) and GRIP (glutamate receptor interaction protein), two related postsynaptic d. (PSD) PDZ (postsynaptic d.-95/Disks large/zona occludens-1) domain proteins that target AMPA receptors to synapses.  The MT5-MMP C terminus binds ABP PDZ5 and the two proteins coimmunopptd. and colocalized in heterologous cells and neurons.  MT5-MMP localized in filopodia at the tips of growth cones in young [2-5 d in vitro (DIV)] cultured embryonic hippocampal neurons, and at synapses in mature (21 DIV) neurons.  Its enrichment in synaptosomes also indicated a synaptic localization in the mature brain.  Deletion of the PDZ binding site impaired membrane trafficking of MT5-MMP, whereas exogenous ABP splice forms that are assocd. either with the plasma membrane or with the cytosol, resp., colocalized with MT5-MMP in synaptic spines or recruited MT5-MMP to intracellular compartments.  We show that endogenous MT5-MMP is found in cultured neurons and brain lysates in a proenzyme form that is activated by furin and degraded by auto-proteolysis.  We also identify cadherins as MT5-MMP substrates.  These results suggest that ABP directs MT5-MMP proteolytic activity to growth cones and synaptic sites in neurons, where it may regulate axon pathfinding or synapse remodeling through proteolysis of cadherins or other ECM or cell adhesion mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLg9JNlTy6RbVg90H21EOLACvtfcHk0lgkPvd0RPsmfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFCms7k%253D&md5=1213afc2727ed6f2693fee8b509d6910</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3521-05.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3521-05.2006%26sid%3Dliteratum%253Aachs%26aulast%3DMonea%26aufirst%3DS.%26aulast%3DJordan%26aufirst%3DB.%2BA.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DDeSouza%26aufirst%3DS.%26aulast%3DZiff%26aufirst%3DE.%2BB.%26atitle%3DMembrane%2520Localization%2520of%2520Membrane%2520Type%25205%2520Matrix%2520Metalloproteinase%2520by%2520AMPA%2520Receptor%2520Binding%2520Protein%2520and%2520Cleavage%2520of%2520Cadherins%26jtitle%3DJ.%2520Neurosci.%26date%3D2006%26volume%3D26%26issue%3D8%26spage%3D2300%26epage%3D2312%26doi%3D10.1523%2FJNEUROSCI.3521-05.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García-González, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilat, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baranger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, S.</span></span> <span> </span><span class="NLM_article-title">Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2019.00244</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3389%2Ffnagi.2019.00244" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30740048" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=1-19&issue=1&author=L.+Garc%C3%ADa-Gonz%C3%A1lezauthor=D.+Pilatauthor=K.+Barangerauthor=S.+Rivera&title=Emerging+Alternative+Proteinases+in+APP+Metabolism+and+Alzheimer%E2%80%99s+Disease+Pathogenesis%3A+A+Focus+on+MT1-MMP+and+MT5-MMP&doi=10.3389%2Ffnagi.2019.00244"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2019.00244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2019.00244%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Gonz%25C3%25A1lez%26aufirst%3DL.%26aulast%3DPilat%26aufirst%3DD.%26aulast%3DBaranger%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DS.%26atitle%3DEmerging%2520Alternative%2520Proteinases%2520in%2520APP%2520Metabolism%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Pathogenesis%253A%2520A%2520Focus%2520on%2520MT1-MMP%2520and%2520MT5-MMP%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2019%26volume%3D11%26issue%3D1%26spage%3D1%26epage%3D19%26doi%3D10.3389%2Ffnagi.2019.00244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sekine-Aizawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsubuki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai-Azuma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saido, T. C.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase (MMP) System in Brain: Identification and Characterization of Brain-Specific MMP Highly Expressed in Cerebellum</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1046/j.0953-816x.2001.01462.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1046%2Fj.0953-816x.2001.01462.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11264666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BD3M3ktVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2001&pages=935-948&issue=5&author=Y.+Sekine-Aizawaauthor=E.+Hamaauthor=K.+Watanabeauthor=S.+Tsubukiauthor=M.+Kanai-Azumaauthor=Y.+Kanaiauthor=H.+Araiauthor=H.+Aizawaauthor=N.+Iwataauthor=T.+C.+Saido&title=Matrix+Metalloproteinase+%28MMP%29+System+in+Brain%3A+Identification+and+Characterization+of+Brain-Specific+MMP+Highly+Expressed+in+Cerebellum&doi=10.1046%2Fj.0953-816x.2001.01462.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase (MMP) system in brain: identification and characterization of brain-specific MMP highly expressed in cerebellum</span></div><div class="casAuthors">Sekine-Aizawa Y; Hama E; Watanabe K; Tsubuki S; Kanai-Azuma M; Kanai Y; Arai H; Aizawa H; Iwata N; Saido T C</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">935-48</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">The matrix metalloproteinase (MMP) family, comprising more than 20 isoforms, modulates the extracellular milieu by degrading extracellular matrix (ECM) proteins.  Because MMP is one of the few groups of proteinases capable of hydrolysing insoluble fibrillar proteins, they are likely to play crucial roles in regulating both normal and pathophysiological processes in the brain.  However, little is yet known about their possible neuronal functions due presumably to their unusual redundancy and to the absence of a complete catalogue of isoforms.  As an initial step in understanding the MMP system in the brain, we analysed an expression spectrum of MMP in rat brain using RT-PCR and discovered a novel brain-specific MMP, MT5-MMP.  MT5-MMP was the predominant species among the nongelatinase-type isoforms in brain.  MT5-MMP, present in all brain tissues examined, was most strongly expressed in cerebellum and was localized in the membranous structures of expressing neurons, as assessed biochemically and immunohistochemically.  In cerebellum, its expression was regulated developmentally and was closely associated with dendritic tree formation of Purkinje cells, suggesting that MT5-MMP may contribute to neuronal development.  Furthermore, its stable postdevelopmental expression and colocalization with senile plaques in Alzheimer brain indicates possible roles in neuronal remodeling naturally occurring in adulthood and in regulating pathophysiological processes associated with advanced age.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdYDB0v_Dquz0SWnHPWbmmfW6udTcc2eZPWBzaVNNpS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3ktVeitQ%253D%253D&md5=82e61ac5186bd838f44ec2eb5e98fe05</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1046%2Fj.0953-816x.2001.01462.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0953-816x.2001.01462.x%26sid%3Dliteratum%253Aachs%26aulast%3DSekine-Aizawa%26aufirst%3DY.%26aulast%3DHama%26aufirst%3DE.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DTsubuki%26aufirst%3DS.%26aulast%3DKanai-Azuma%26aufirst%3DM.%26aulast%3DKanai%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DAizawa%26aufirst%3DH.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26atitle%3DMatrix%2520Metalloproteinase%2520%2528MMP%2529%2520System%2520in%2520Brain%253A%2520Identification%2520and%2520Characterization%2520of%2520Brain-Specific%2520MMP%2520Highly%2520Expressed%2520in%2520Cerebellum%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2001%26volume%3D13%26issue%3D5%26spage%3D935%26epage%3D948%26doi%3D10.1046%2Fj.0953-816x.2001.01462.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrew, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellett, K. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thinakaran, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, N. M.</span></span> <span> </span><span class="NLM_article-title">A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">19235</span>– <span class="NLM_lpage">19244</span>, <span class="refDoi"> DOI: 10.1074/jbc.R116.746032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.R116.746032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27474742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsV2ju7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=19235-19244&issue=37&author=R.+J.+Andrewauthor=K.+A.+B.+Kellettauthor=G.+Thinakaranauthor=N.+M.+Hooper&title=A+Greek+Tragedy%3A+The+Growing+Complexity+of+Alzheimer+Amyloid+Precursor+Protein+Proteolysis&doi=10.1074%2Fjbc.R116.746032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">A Greek tragedy: The growing complexity of Alzheimer amyloid precursor protein proteolysis</span></div><div class="casAuthors">Andrew, Robert J.; Kellett, Katherine A. B.; Thinakaran, Gopal; Hooper, Nigel M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">19235-19244</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Proteolysis of the amyloid precursor protein (APP) liberates various fragments including the proposed initiator of Alzheimer disease-assocd. dysfunctions, amyloid-β.  However, recent evidence suggests that the accepted view of APP proteolysis by the canonical α-, β-, and γ-secretases is simplistic, with the discovery of a no. of novel APP secretases (including δ- and η-secretases, alternative β-secretases) and addnl. metabolites, some of which may also cause synaptic dysfunction.  Furthermore, various proteins have been identified that interact with APP and modulate its cleavage by the secretases.  Here, we give an overview of the increasingly complex picture of APP proteolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNPewvE58BkLVg90H21EOLACvtfcHk0lh3-zEwc6u6Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsV2ju7zL&md5=c48d252ee26d606f805df02cadf17ae6</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R116.746032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R116.746032%26sid%3Dliteratum%253Aachs%26aulast%3DAndrew%26aufirst%3DR.%2BJ.%26aulast%3DKellett%26aufirst%3DK.%2BA.%2BB.%26aulast%3DThinakaran%26aufirst%3DG.%26aulast%3DHooper%26aufirst%3DN.%2BM.%26atitle%3DA%2520Greek%2520Tragedy%253A%2520The%2520Growing%2520Complexity%2520of%2520Alzheimer%2520Amyloid%2520Precursor%2520Protein%2520Proteolysis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26issue%3D37%26spage%3D19235%26epage%3D19244%26doi%3D10.1074%2Fjbc.R116.746032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagase, H.</span></span> <span> </span><span class="NLM_article-title">Substrate Specificity of MMPs</span>. In  <i>Matrix Metalloproteinase Inhibitors in Cancer Therapy. Cancer Drug Discovery and Development</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clendeninn, N. J.</span>, <span class="NLM_string-name">Appelt, K.</span></span>, Eds.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>, <span class="NLM_year">2001</span>; Chapter 2, pp  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">66</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=39-66&author=H.+Nagaseauthor=N.+J.+Clendeninn&author=K.+Appelt&title=Matrix+Metalloproteinase+Inhibitors+in+Cancer+Therapy.+Cancer+Drug+Discovery+and+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNagase%26aufirst%3DH.%26atitle%3DSubstrate%2520Specificity%2520of%2520MMPs%26btitle%3DMatrix%2520Metalloproteinase%2520Inhibitors%2520in%2520Cancer%2520Therapy.%2520Cancer%2520Drug%2520Discovery%2520and%2520Development%26aulast%3DClendeninn%26aufirst%3DN.%2BJ.%26pub%3DHumana%2520Press%26date%3D2001%26spage%3D39%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases: What Do They Not Do? New Substrates and Biological Roles Identified by Murine Models and Proteomics</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1803</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2009.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbamcr.2009.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19800373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1803&publication_year=2010&pages=39-54&issue=1&author=D.+Rodr%C3%ADguezauthor=C.+J.+Morrisonauthor=C.+M.+Overall&title=Matrix+Metalloproteinases%3A+What+Do+They+Not+Do%3F+New+Substrates+and+Biological+Roles+Identified+by+Murine+Models+and+Proteomics&doi=10.1016%2Fj.bbamcr.2009.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics</span></div><div class="casAuthors">Rodriguez, David; Morrison, Charlotte J.; Overall, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1803</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-54</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The biol. roles of the matrix metalloproteinases (MMPs) have been traditionally assocd. with the degrdn. and turnover of most of the components of the extracellular matrix (ECM).  This functional misconception has been used for years to explain the involvement of the MMP family in developmental processes, cell homeostasis, and disease, and led to clin. trials of MMP inhibitors for the treatment of cancer that failed to meet their endpoints and cast a shadow on MMPs as druggable targets.  Accumulated evidence from a great variety of post-trial MMP degradomics studies, ranging from transgenic models to recent state-of-the-art proteomics screens, is changing the dogma about MMP functions.  MMPs regulate cell behavior through finely tuned and tightly controlled proteolytic processing of a large variety of signaling mols. that can also have beneficial effects in disease resoln.  Moreover, net proteolytic activity relies upon direct interactions between the different protease and protease inhibitor families, interconnected in a complex protease web, with MMPs acting as key nodal components.  Such complexity renders simple interpretation of Mmp knockout mice very difficult.  Indeed, the phenotype of these models reveals the response of a complex system to the loss of one protease rather than necessarily a direct effect of the lack of functional activity of a protease.  Such a shift in the MMP functional paradigm, together with the difficulties assocd. with current methods of studying proteases thus highlights the need for new high content degradomics approaches to uncover and annotate MMP activities in vivo and identify novel interactions within the protease web.  Integration of these techniques with specifically designed animal models for final validation should lay the foundations for the development of new inhibitors that specifically target disease-related MMPs and/or their upstream effectors that cause deleterious effects in disease, while sparing MMP functions that are protective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxplhmF1lbo7Vg90H21EOLACvtfcHk0lh3-zEwc6u6Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKitL8%253D&md5=d072b56c4c2be7f497be6af79a649443</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2009.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2009.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DD.%26aulast%3DMorrison%26aufirst%3DC.%2BJ.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DMatrix%2520Metalloproteinases%253A%2520What%2520Do%2520They%2520Not%2520Do%253F%2520New%2520Substrates%2520and%2520Biological%2520Roles%2520Identified%2520by%2520Murine%2520Models%2520and%2520Proteomics%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2010%26volume%3D1803%26issue%3D1%26spage%3D39%26epage%3D54%26doi%3D10.1016%2Fj.bbamcr.2009.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overall, C. M.</span></span> <span> </span><span class="NLM_article-title">Updated Biological Roles for Matrix Metalloproteinases and New “intracellular” substrates Revealed by Degradomics</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">10830</span>– <span class="NLM_lpage">10845</span>, <span class="refDoi"> DOI: 10.1021/bi901656f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi901656f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlaltbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=10830-10845&issue=46&author=G.+S.+Butlerauthor=C.+M.+Overall&title=Updated+Biological+Roles+for+Matrix+Metalloproteinases+and+New+%E2%80%9Cintracellular%E2%80%9D+substrates+Revealed+by+Degradomics&doi=10.1021%2Fbi901656f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Updated Biological Roles for Matrix Metalloproteinases and New "Intracellular" Substrates Revealed by Degradomics</span></div><div class="casAuthors">Butler, Georgina S.; Overall, Christopher M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">10830-10845</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Shotgun proteomics techniques are conceptually unbiased, but data interpretation and follow-up expts. are often constrained by dogma, established beliefs that are accepted without question, that can dil. the power of proteomics and hinder scientific progress.  Proteomics and degradomics, the characterization of all proteases, inhibitors, and protease substrates by genomic and proteomic techniques, have exponentially expanded the known substrate repertoire of the matrix metalloproteinases (MMPs), even to include intracellular proteins with newly recognized extracellular functions.  Thus, the dogma that MMPs are dowdy degraders of extracellular matrix has been resolutely overturned, and the metamorphosis of MMPs into modulators of multiple signaling pathways has been facilitated.  Here we review progress made in the field of degradomics and present a current view of the MMP degradome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOI1zIjVErvbVg90H21EOLACvtfcHk0lgagm7Q7I74Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlaltbrO&md5=1568a3370819d7fd0a945e6340a3b49e</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Fbi901656f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi901656f%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DG.%2BS.%26aulast%3DOverall%26aufirst%3DC.%2BM.%26atitle%3DUpdated%2520Biological%2520Roles%2520for%2520Matrix%2520Metalloproteinases%2520and%2520New%2520%25E2%2580%259Cintracellular%25E2%2580%259D%2520substrates%2520Revealed%2520by%2520Degradomics%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26issue%3D46%26spage%3D10830%26epage%3D10845%26doi%3D10.1021%2Fbi901656f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maskos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, W.</span></span> <span> </span><span class="NLM_article-title">Structural Basis of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases</span>. <i>Mol. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1385/MB:25:3:241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1385%2FMB%3A25%3A3%3A241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=14668538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2003&pages=241-266&issue=3&author=K.+Maskosauthor=W.+Bode&title=Structural+Basis+of+Matrix+Metalloproteinases+and+Tissue+Inhibitors+of+Metalloproteinases&doi=10.1385%2FMB%3A25%3A3%3A241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases</span></div><div class="casAuthors">Maskos, Klaus; Bode, Wolfram</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Biotechnology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-266</span>CODEN:
                <span class="NLM_cas:coden">MLBOEO</span>;
        ISSN:<span class="NLM_cas:issn">1073-6085</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  The matrix metalloproteinases (MMPs) constitute a family of secreted/cell-surface-anchored multidomain Zn endopeptidases, all of which exhibit a catalytic domain of a common metzincin-like topol., and which are involved in the degrdn. of the extracellular matrix but also in a no. of other biol. processes.  Normally, the proteolytic activity of the MMPs is precisely regulated by their main endogenous protein inhibitors, in particular the tissue inhibitors of metalloproteinases (TIMPs).  Disruption of this balance results in serious diseases such as arthritis, tumor growth, and tumor metastasis, rendering the MMPs attractive targets for inhibition therapy.  Knowledge of their tertiary structures is crucial for a full understanding of their functional properties and their assocns. with dysfunctions.  Since the reports of the 1st at. structures of MMPs and TIMPs in 1994, considerable structural information has become available about both of these families of substances.  Many of the MMP structures have been detd. as complexes with synthetic inhibitors, facilitating knowledge-based drug design.  This review focuses on the currently available 3-dimensional structural information about MMPs and TIMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3tLSdkDbU1LVg90H21EOLACvtfcHk0lgagm7Q7I74Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cnsb4%253D&md5=5782531e69bea3a0bacf95137aad7925</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1385%2FMB%3A25%3A3%3A241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FMB%253A25%253A3%253A241%26sid%3Dliteratum%253Aachs%26aulast%3DMaskos%26aufirst%3DK.%26aulast%3DBode%26aufirst%3DW.%26atitle%3DStructural%2520Basis%2520of%2520Matrix%2520Metalloproteinases%2520and%2520Tissue%2520Inhibitors%2520of%2520Metalloproteinases%26jtitle%3DMol.%2520Biotechnol.%26date%3D2003%26volume%3D25%26issue%3D3%26spage%3D241%26epage%3D266%26doi%3D10.1385%2FMB%3A25%3A3%3A241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bode, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomis-Rüth, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stöckler, W.</span></span> <span> </span><span class="NLM_article-title">Astacins, Serralysins, Snake Venom and Matrix Metalloproteinases Exhibit Identical Zinc-Binding Environments (HEXXHXXGXXH and Met-Turn) and Topologies and Should Be Grouped into a Common Family, the “Metzincins.</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>331</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">140</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(93)80312-I</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2F0014-5793%2893%2980312-I" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=8405391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK2cXis1aqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1993&pages=134-140&issue=1%E2%80%932&author=W.+Bodeauthor=F.+X.+Gomis-R%C3%BCthauthor=W.+St%C3%B6ckler&title=Astacins%2C+Serralysins%2C+Snake+Venom+and+Matrix+Metalloproteinases+Exhibit+Identical+Zinc-Binding+Environments+%28HEXXHXXGXXH+and+Met-Turn%29+and+Topologies+and+Should+Be+Grouped+into+a+Common+Family%2C+the+%E2%80%9CMetzincins.&doi=10.1016%2F0014-5793%2893%2980312-I"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'</span></div><div class="casAuthors">Bode, Wolfram; Gomis-Rueth, Franz-Xaver; Stoeckler, Walter</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">134-40</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">The X-ray crystal structures of two zinc endopeptidases, astacin from crayfish, and adamalysin II from snake venom, reveal a strong overall topol. equivalence and virtually identical extended HEXXHXXGXXH zinc-binding segments, but in addn. a methionine-contg. turn of similar conformation (the 'Met-turn'), which forms a hydrophobic basis for the zinc ion and the three liganding histidine residues.  These two features are also present in a similar arrangement in the matrix metalloproteinases (matrixins) and in the large bacterial Serratia proteinase-like peptidases (serralysins).  The authors suggest that these four proteinases represent members of distinct subfamilies which can be grouped together in a family, for which the authors propose the designation, metzincins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq9YhUaYiBDLVg90H21EOLACvtfcHk0lgagm7Q7I74Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1aqsA%253D%253D&md5=e9926789857268493a3948d4c6bb76e4</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2893%2980312-I&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252893%252980312-I%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DW.%26aulast%3DGomis-R%25C3%25BCth%26aufirst%3DF.%2BX.%26aulast%3DSt%25C3%25B6ckler%26aufirst%3DW.%26atitle%3DAstacins%252C%2520Serralysins%252C%2520Snake%2520Venom%2520and%2520Matrix%2520Metalloproteinases%2520Exhibit%2520Identical%2520Zinc-Binding%2520Environments%2520%2528HEXXHXXGXXH%2520and%2520Met-Turn%2529%2520and%2520Topologies%2520and%2520Should%2520Be%2520Grouped%2520into%2520a%2520Common%2520Family%252C%2520the%2520%25E2%2580%259CMetzincins.%26jtitle%3DFEBS%2520Lett.%26date%3D1993%26volume%3D331%26issue%3D1%25E2%2580%25932%26spage%3D134%26epage%3D140%26doi%3D10.1016%2F0014-5793%2893%2980312-I" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomis-Rüth, F. X.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases: Fold and Function of Their Catalytic Domains</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1803</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2009.04.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbamcr.2009.04.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19374923" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1803&publication_year=2010&pages=20-28&issue=1&author=C.+Tallantauthor=A.+Marreroauthor=F.+X.+Gomis-R%C3%BCth&title=Matrix+Metalloproteinases%3A+Fold+and+Function+of+Their+Catalytic+Domains&doi=10.1016%2Fj.bbamcr.2009.04.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases: Fold and function of their catalytic domains</span></div><div class="casAuthors">Tallant, Cynthia; Marrero, Aniebrys; Gomis-Rueth, F. Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1803</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-28</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are Zn-dependent protein and peptide hydrolases.  They have been almost exclusively studied in vertebrates and 23 paralogs are present in humans.  They are widely involved in metab. regulation through both extensive protein degrdn. and selective peptide-bond hydrolysis.  If MMPs are not subjected to exquisite spatial and temporal control, they become destructive, which can lead to pathologies such as arthritis, inflammation, and cancer.  The main therapeutic strategy to combat the dysregulation of MMPs is the design of drugs to target their catalytic domains, for which purpose detailed structural knowledge is essential.  The catalytic domains of 13 MMPs have been structurally analyzed so far and they belong to the "metzincin" clan of metalloendopeptidases.  These compact, spherical, ∼165-residue mols. are divided by a shallow substrate-binding crevice into an upper and a lower subdomain.  The mols. have an extended Zn-binding motif, HEXXHXXGXXH, which contains 3 Zn-binding His residues and a Glu residue that acts as a general base/acid during catalysis.  In addn., a conserved Met residue lying within a "Met-turn" provides a hydrophobic base for the Zn-binding site.  Further earmarks of MMPs are 3 α-helixes and a 5-stranded β-sheet, as well as at least 2 Ca2+ sites and a 2nd Zn2+ with structural functions.  Most MMPs are secreted as inactive zymogens with an N-terminal ∼80-residue pro-domain, which folds into a 3-helix globular domain and inhibits the catalytic Zn through a Cys residue imbedded in a conserved motif, PRCGXPD.  Removal of the pro-domain enables access of a catalytic solvent mol. and substrate mols. to the active site cleft, which harbors a hydrophobic S1'-pocket as main determinant of specificity.  Together with the catalytic Zn2+ ion, this pocket has been targeted since the onset of drug development against MMPs.  However, the inability of 1st- and 2nd-generation inhibitors to distinguish between different MMPs has led to failures in clin. trials.  More recent approaches have produced highly specific inhibitors to tackle selected MMPs, thus anticipating the development of more successful drugs in the near future.  Further strategies should include the detailed structural characterization of the remaining 10 MMPs to assist in achieving higher drug selectivity.  Here, the authors discuss the general architecture of MMP catalytic domains and its implication in function, zymogenic activation, and drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ2E3a08DbpbVg90H21EOLACvtfcHk0lj8OV6_9vZZcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKit7g%253D&md5=2bc4aa7e4f23c51da4404bf725c1bf30</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2009.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2009.04.003%26sid%3Dliteratum%253Aachs%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DMarrero%26aufirst%3DA.%26aulast%3DGomis-R%25C3%25BCth%26aufirst%3DF.%2BX.%26atitle%3DMatrix%2520Metalloproteinases%253A%2520Fold%2520and%2520Function%2520of%2520Their%2520Catalytic%2520Domains%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2010%26volume%3D1803%26issue%3D1%26spage%3D20%26epage%3D28%26doi%3D10.1016%2Fj.bbamcr.2009.04.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aureli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gioia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerbara, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasciglione, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ascenzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coletta, M.</span></span> <span> </span><span class="NLM_article-title">Structural Bases for Substrate and Inhibitor Recognition by Matrix Metalloproteinases</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">2192</span>– <span class="NLM_lpage">2222</span>, <span class="refDoi"> DOI: 10.2174/092986708785747490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F092986708785747490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=18781944" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFCksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2192-2222&issue=22&author=L.+Aureliauthor=M.+Gioiaauthor=I.+Cerbaraauthor=S.+Monacoauthor=G.+Fasciglioneauthor=S.+Mariniauthor=P.+Ascenziauthor=A.+Topaiauthor=M.+Coletta&title=Structural+Bases+for+Substrate+and+Inhibitor+Recognition+by+Matrix+Metalloproteinases&doi=10.2174%2F092986708785747490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Structural bases for substrate and inhibitor recognition by matrix metalloproteinases</span></div><div class="casAuthors">Aureli, Loretta; Gioia, Magda; Cerbara, Ilaria; Monaco, Susanna; Fasciglione, Giovanni Francesco; Marini, Stefano; Ascenzi, Paolo; Topai, Alessandra; Coletta, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2192-2222</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of Zn-dependent metalloproteinases which are involved in the proteolytic processing of several components of the extracellular matrix.  As a consequence, MMPs are implicated in several physiol. and pathol. processes, such as skeletal growth and remodeling, wound healing, cancer, arthritis, and multiple sclerosis, raising very widespread interest toward this class of enzymes as potential therapeutic targets.  Here, structure-function relations are discussed to highlight the role of different MMP domains on substrate/inhibitor recognition and processing and to attempt the formulation of advanced guidelines, based on natural substrates, for the design of inhibitors more efficient in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-8qHgMffS-LVg90H21EOLACvtfcHk0lhqEBZqzGZQwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFCksbg%253D&md5=9e7ee25ffcf16877cca6463b6f5559c3</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.2174%2F092986708785747490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785747490%26sid%3Dliteratum%253Aachs%26aulast%3DAureli%26aufirst%3DL.%26aulast%3DGioia%26aufirst%3DM.%26aulast%3DCerbara%26aufirst%3DI.%26aulast%3DMonaco%26aufirst%3DS.%26aulast%3DFasciglione%26aufirst%3DG.%26aulast%3DMarini%26aufirst%3DS.%26aulast%3DAscenzi%26aufirst%3DP.%26aulast%3DTopai%26aufirst%3DA.%26aulast%3DColetta%26aufirst%3DM.%26atitle%3DStructural%2520Bases%2520for%2520Substrate%2520and%2520Inhibitor%2520Recognition%2520by%2520Matrix%2520Metalloproteinases%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26issue%3D22%26spage%3D2192%26epage%3D2222%26doi%3D10.2174%2F092986708785747490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schechter, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A.</span></span> <span> </span><span class="NLM_article-title">On the Size of the Active Site in Proteases. I. Papain</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1967</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(67)80055-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2FS0006-291X%2867%2980055-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=6035483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=157-162&issue=2&author=I.+Schechterauthor=A.+Berger&title=On+the+Size+of+the+Active+Site+in+Proteases.+I.+Papain&doi=10.1016%2FS0006-291X%2867%2980055-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">On the size of the active site in proteases.  I.  Papain</span></div><div class="casAuthors">Schechter, Israel; Berger, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-62</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The action of papain on 40 diastereoisomeric peptides of alanine, ranging in length from Ala2 to Ala6, was studied to investigate the size of the active site.  The variations observed in the rates of hydrolysis lead to the conclusion that papain has a large active site which extends over ∼25 A. and can be divided into 7 "subsites," each accommodating 1 amino acid residue of the peptide substrate.  The subsites are located on both sides of the catalytic site, 4 on the one side and 3 on the other.  It is postulated that a long "groove" analogous to that found by x-ray analysis in lysozyme is present.  The substrate is believed to fit into the groove, binding to several subsites of specific geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_kZeRVAOVyrVg90H21EOLACvtfcHk0lhqEBZqzGZQwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D&md5=a58ceccdbb5cc5c021af06912835f77c</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2867%2980055-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252867%252980055-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DOn%2520the%2520Size%2520of%2520the%2520Active%2520Site%2520in%2520Proteases.%2520I.%2520Papain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1967%26volume%3D27%26issue%3D2%26spage%3D157%26epage%3D162%26doi%3D10.1016%2FS0006-291X%2867%2980055-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span> <i>PyMOL Molecular
Graphics
System</i>, <span class="NLM_edition">version 2.3.2</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>, <span class="NLM_year">2020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+PyMOL+Molecular%0AGraphics%0ASystem%2C+version+2.3.2%3B+Schr%C3%B6dinger%2C+LLC%2C+2020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26jtitle%3DPyMOL%2520Molecular%250AGraphics%250ASystem%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabre, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Pascual-Teresa, B.</span></span> <span> </span><span class="NLM_article-title">Targeting Matrix Metalloproteinases: Exploring the Dynamics of the S1′ Pocket in the Design of Selective, Small Molecule Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">10205</span>– <span class="NLM_lpage">10219</span>, <span class="refDoi"> DOI: 10.1021/jm500505f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500505f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10205-10219&issue=24&author=B.+Fabreauthor=A.+Ramosauthor=B.+De+Pascual-Teresa&title=Targeting+Matrix+Metalloproteinases%3A+Exploring+the+Dynamics+of+the+S1%E2%80%B2+Pocket+in+the+Design+of+Selective%2C+Small+Molecule+Inhibitors&doi=10.1021%2Fjm500505f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Matrix Metalloproteinases: Exploring the Dynamics of the S1' Pocket in the Design of Selective, Small Molecule Inhibitors</span></div><div class="casAuthors">Fabre, Benjamin; Ramos, Ana; de Pascual-Teresa, Beatriz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10205-10219</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are important targets for pathol. conditions such as arthritis, chronic obstructive pulmonary disease, and cancer.  The failure of the first broad-spectrum MMP inhibitors in clin. trials has led researchers to address the selectivity as one of their main objectives.  The S1' pocket has been widely used to modulate the selectivity of these enzymes because it displays the highest variability in length and shape among MMPs.  In this review, we encourage medicinal chemists to also consider the dynamics of this pocket as an important parameter to achieve the desired selectivity.  To support this proposal, we collect examples from the literature where the flexibility of the S1' pocket was highlighted as a relevant and significant issue affecting selectivity.  We also review the exptl. studies on the dynamics of this pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVMrlJGwAibrVg90H21EOLACvtfcHk0liq6liO8DoLZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrnF&md5=7ad8fad793d1bff66bf6e5c7275834ca</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Fjm500505f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500505f%26sid%3Dliteratum%253Aachs%26aulast%3DFabre%26aufirst%3DB.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DDe%2BPascual-Teresa%26aufirst%3DB.%26atitle%3DTargeting%2520Matrix%2520Metalloproteinases%253A%2520Exploring%2520the%2520Dynamics%2520of%2520the%2520S1%25E2%2580%25B2%2520Pocket%2520in%2520the%2520Design%2520of%2520Selective%252C%2520Small%2520Molecule%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D24%26spage%3D10205%26epage%3D10219%26doi%3D10.1021%2Fjm500505f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, B.</span></span> <span> </span><span class="NLM_article-title">Recent Developments in the Design of Specific Matrix Metalloproteinase Inhibitors Aided by Structural and Computational Studies</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">322</span>, <span class="refDoi"> DOI: 10.2174/1381612053382115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F1381612053382115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15723627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVKnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=295-322&issue=3&author=B.+Rao&title=Recent+Developments+in+the+Design+of+Specific+Matrix+Metalloproteinase+Inhibitors+Aided+by+Structural+and+Computational+Studies&doi=10.2174%2F1381612053382115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in the design of specific matrix metalloproteinase inhibitors aided by structural and computational studies</span></div><div class="casAuthors">Rao, B. Govinda</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-322</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  It was 10 years since a 3-dimensional structure of the catalytic domain of a Matrix Metalloprotease (MMP) was revealed for the 1st time in 1994.  More than 80 structures of different MMPs in apo and inhibited forms, detd. by x-ray crystallog. and NMR methods, were published by the end of year 2003.  A large no. of very potent inhibitors were disclosed in published and patent literature.  Several MMP inhibitors entered clin. trials for the treatment of cancer and arthritis.  Most of the 1st generation inhibitors have hydroxamic acid as the Zinc-binding group and have limited specificity.  With the failure of these inhibitors in clin. trials, more efforts were directed to the design of specific inhibitors with different Zn-binding groups in recent years.  This review will summarize all the published structural information and focus on the inhibitors that were designed to take advantage of the nonprime side of the MMP active site using structural information and computational anal.  Representative structures from all MMPs are aligned to a target structure to provide a better understanding of the similarities and differences of the active site pockets.  This anal. supports the view that the differences in the nonprime side pockets provide better opportunities for designing inhibitors with higher specificity.  Published information on all the Zinc-binding groups of MMP inhibitors is reviewed for the 1st time.  Pros and cons of inhibitors with non-hydroxamate Zinc-binding groups in terms of specificity, toxicity, and pharmacokinetic properties are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4xnMcPhOoqrVg90H21EOLACvtfcHk0liq6liO8DoLZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVKnsrw%253D&md5=db7c6b330cdce553acaca12dd3a1d1f8</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.2174%2F1381612053382115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612053382115%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DB.%26atitle%3DRecent%2520Developments%2520in%2520the%2520Design%2520of%2520Specific%2520Matrix%2520Metalloproteinase%2520Inhibitors%2520Aided%2520by%2520Structural%2520and%2520Computational%2520Studies%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2005%26volume%3D11%26issue%3D3%26spage%3D295%26epage%3D322%26doi%3D10.2174%2F1381612053382115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nation, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagare, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Orazio, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pachicano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepehrband, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buennagel, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benzinger, T. L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fagan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chui, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toga, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">Blood-brain Barrier Breakdown Is an Early Biomarker of Human Cognitive Dysfunction</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">270</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1038/s41591-018-0297-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1038%2Fs41591-018-0297-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30643288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXlvFSguro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=270-276&issue=2&author=D.+A.+Nationauthor=M.+D.+Sweeneyauthor=A.+Montagneauthor=A.+P.+Sagareauthor=L.+M.+D%E2%80%99Orazioauthor=M.+Pachicanoauthor=F.+Sepehrbandauthor=A.+R.+Nelsonauthor=D.+P.+Buennagelauthor=M.+G.+Harringtonauthor=T.+L.+S.+Benzingerauthor=A.+M.+Faganauthor=J.+M.+Ringmanauthor=L.+S.+Schneiderauthor=J.+C.+Morrisauthor=H.+C.+Chuiauthor=M.+Lawauthor=A.+W.+Togaauthor=B.+V.+Zlokovic&title=Blood-brain+Barrier+Breakdown+Is+an+Early+Biomarker+of+Human+Cognitive+Dysfunction&doi=10.1038%2Fs41591-018-0297-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction</span></div><div class="casAuthors">Nation, Daniel A.; Sweeney, Melanie D.; Montagne, Axel; Sagare, Abhay P.; D'Orazio, Lina M.; Pachicano, Maricarmen; Sepehrband, Farshid; Nelson, Amy R.; Buennagel, David P.; Harrington, Michael G.; Benzinger, Tammie L. S.; Fagan, Anne M.; Ringman, John M.; Schneider, Lon S.; Morris, John C.; Chui, Helena C.; Law, Meng; Toga, Arthur W.; Zlokovic, Berislav V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">270-276</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Vascular contributions to cognitive impairment are increasingly recognized1-5 as shown by neuropathol.6,7, neuroimaging4,8-11, and cerebrospinal fluid biomarker4,12 studies.  Moreover, small vessel disease of the brain has been estd. to contribute to approx. 50% of all dementias worldwide, including those caused by Alzheimer's disease (AD)3,4,13.  Vascular changes in AD have been typically attributed to the vasoactive and/or vasculotoxic effects of amyloid-β (Aβ)3,11,14, and more recently tau15.  Animal studies suggest that Aβ and tau lead to blood vessel abnormalities and blood-brain barrier (BBB) breakdown14-16.  Although neurovascular dysfunction3,11 and BBB breakdown develop early in AD1,4,5,8-10,12,13, how they relate to changes in the AD classical biomarkers Aβ and tau, which also develop before dementia17, remains unknown.  To address this question, we studied brain capillary damage using a novel cerebrospinal fluid biomarker of BBB-assocd. capillary mural cell pericyte, sol. platelet-derived growth factor receptor-β8,18, and regional BBB permeability using dynamic contrast-enhanced magnetic resonance imaging8-10.  Our data show that individuals with early cognitive dysfunction develop brain capillary damage and BBB breakdown in the hippocampus irresp. of Alzheimer's Aβ and/or tau biomarker changes, suggesting that BBB breakdown is an early biomarker of human cognitive dysfunction independent of Aβ and tau.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvlm03Rnw7FrVg90H21EOLACvtfcHk0lhubUwg74xvOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXlvFSguro%253D&md5=cea06fe825ac40408c4e224601c92d10</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1038%2Fs41591-018-0297-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41591-018-0297-y%26sid%3Dliteratum%253Aachs%26aulast%3DNation%26aufirst%3DD.%2BA.%26aulast%3DSweeney%26aufirst%3DM.%2BD.%26aulast%3DMontagne%26aufirst%3DA.%26aulast%3DSagare%26aufirst%3DA.%2BP.%26aulast%3DD%25E2%2580%2599Orazio%26aufirst%3DL.%2BM.%26aulast%3DPachicano%26aufirst%3DM.%26aulast%3DSepehrband%26aufirst%3DF.%26aulast%3DNelson%26aufirst%3DA.%2BR.%26aulast%3DBuennagel%26aufirst%3DD.%2BP.%26aulast%3DHarrington%26aufirst%3DM.%2BG.%26aulast%3DBenzinger%26aufirst%3DT.%2BL.%2BS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DRingman%26aufirst%3DJ.%2BM.%26aulast%3DSchneider%26aufirst%3DL.%2BS.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DChui%26aufirst%3DH.%2BC.%26aulast%3DLaw%26aufirst%3DM.%26aulast%3DToga%26aufirst%3DA.%2BW.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DBlood-brain%2520Barrier%2520Breakdown%2520Is%2520an%2520Early%2520Biomarker%2520of%2520Human%2520Cognitive%2520Dysfunction%26jtitle%3DNat.%2520Med.%26date%3D2019%26volume%3D25%26issue%3D2%26spage%3D270%26epage%3D276%26doi%3D10.1038%2Fs41591-018-0297-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montagne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlokovic, B. V.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s Disease: A Matter of Blood-brain Barrier Dysfunction?</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>214</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3151</span>– <span class="NLM_lpage">3169</span>, <span class="refDoi"> DOI: 10.1084/jem.20171406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1084%2Fjem.20171406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29061693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlWmt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=2017&pages=3151-3169&issue=11&author=A.+Montagneauthor=Z.+Zhaoauthor=B.+V.+Zlokovic&title=Alzheimer%E2%80%99s+Disease%3A+A+Matter+of+Blood-brain+Barrier+Dysfunction%3F&doi=10.1084%2Fjem.20171406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: a matter of blood-brain barrier dysfunction?</span></div><div class="casAuthors">Montagne, Axel; Zhao, Zhen; Zlokovic, Berislav V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3151-3169</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">1540-9538</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The blood-brain barrier (BBB) keeps neurotoxic plasma-derived components, cells, and pathogens out of the brain.  An early BBB breakdown and/or dysfunction have been shown in Alzheimer's disease (AD) before dementia, neurodegeneration and/or brain atrophy occur.  However, the role of BBB breakdown in neurodegenerative disorders is still not fully understood.  Here, we examine BBB breakdown in animal models frequently used to study the pathophysiol. of AD, including transgenic mice expressing human amyloid-β precursor protein, presenilin 1, and tau mutations, and apolipoprotein E, the strongest genetic risk factor for AD.  We discuss the role of BBB breakdown and dysfunction in neurodegenerative process, pitfalls in BBB measurements, and how targeting the BBB can influence the course of neurol. disorder.  Finally, we comment on future approaches and models to better define, at the cellular and mol. level, the underlying mechanisms between BBB breakdown and neurodegeneration as a basis for developing new therapies for BBB repair to control neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq41vuMCIwSUbVg90H21EOLACvtfcHk0lhubUwg74xvOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWmt7zJ&md5=eb18daf55d05460948c3065c92861f0c</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1084%2Fjem.20171406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20171406%26sid%3Dliteratum%253Aachs%26aulast%3DMontagne%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DZlokovic%26aufirst%3DB.%2BV.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%253A%2520A%2520Matter%2520of%2520Blood-brain%2520Barrier%2520Dysfunction%253F%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2017%26volume%3D214%26issue%3D11%26spage%3D3151%26epage%3D3169%26doi%3D10.1084%2Fjem.20171406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rempe, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartz, A. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, B.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinases in the Brain and Blood-brain Barrier: Versatile Breakers and Makers</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1481</span>– <span class="NLM_lpage">1507</span>, <span class="refDoi"> DOI: 10.1177/0271678X16655551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1177%2F0271678X16655551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27323783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVyrsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=1481-1507&issue=9&author=R.+G.+Rempeauthor=A.+M.+S.+Hartzauthor=B.+Bauer&title=Matrix+Metalloproteinases+in+the+Brain+and+Blood-brain+Barrier%3A+Versatile+Breakers+and+Makers&doi=10.1177%2F0271678X16655551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers</span></div><div class="casAuthors">Rempe, Ralf G.; Hartz, Anika M. S.; Bauer, Bjoern</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1481-1507</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Matrix metalloproteinases are versatile endopeptidases with many different functions in the body in health and disease.  In the brain, matrix metalloproteinases are crit. for tissue formation, neuronal network remodeling, and blood-brain barrier integrity.  Many reviews have been published on matrix metalloproteinases before, most of which focus on the two best studied matrix metalloproteinases, the gelatinases MMP-2 and MMP-9, and their role in one or two diseases.  In this review, we provide a broad overview of the role various matrix metalloproteinases play in brain disorders.  We summarize and review current knowledge and understanding of matrix metalloproteinases in the brain and at the blood-brain barrier in neuroinflammation, multiple sclerosis, cerebral aneurysms, stroke, epilepsy, Alzheimer's disease, Parkinson's disease, and brain cancer.  We discuss the detrimental effects matrix metalloproteinases can have in these conditions, contributing to blood-brain barrier leakage, neuroinflammation, neurotoxicity, demyelination, tumor angiogenesis, and cancer metastasis.  We also discuss the beneficial role matrix metalloproteinases can play in neuroprotection and anti-inflammation.  Finally, we address matrix metalloproteinases as potential therapeutic targets.  Together, in this comprehensive review, we summarize current understanding and knowledge of matrix metalloproteinases in the brain and at the blood-brain barrier in brain disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoybuTHruCv67Vg90H21EOLACvtfcHk0li2v7uTUdtIkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVyrsbjP&md5=e1c7f23e71b3b8a06bdcd99ff652cbb5</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1177%2F0271678X16655551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0271678X16655551%26sid%3Dliteratum%253Aachs%26aulast%3DRempe%26aufirst%3DR.%2BG.%26aulast%3DHartz%26aufirst%3DA.%2BM.%2BS.%26aulast%3DBauer%26aufirst%3DB.%26atitle%3DMatrix%2520Metalloproteinases%2520in%2520the%2520Brain%2520and%2520Blood-brain%2520Barrier%253A%2520Versatile%2520Breakers%2520and%2520Makers%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2016%26volume%3D36%26issue%3D9%26spage%3D1481%26epage%3D1507%26doi%3D10.1177%2F0271678X16655551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span> <span> </span><span class="NLM_article-title">MMP-9 Inhibition: A Therapeutic Strategy in Ischemic Stroke</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">573</span>, <span class="refDoi"> DOI: 10.1007/s12035-013-8538-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs12035-013-8538-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24026771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCitrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=563-573&issue=1&author=M.+Chaturvediauthor=L.+Kaczmarek&title=MMP-9+Inhibition%3A+A+Therapeutic+Strategy+in+Ischemic+Stroke&doi=10.1007%2Fs12035-013-8538-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-9 Inhibition: a Therapeutic Strategy in Ischemic Stroke</span></div><div class="casAuthors">Chaturvedi, Mayank; Kaczmarek, Leszek</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">563-573</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Ischemic stroke is a leading cause of disability worldwide.  In cerebral ischemia there is an enhanced expression of matrix metallo-proteinase-9 (MMP-9), which has been assocd. with various complications including excitotoxicity, neuronal damage, apoptosis, blood-brain barrier (BBB) opening leading to cerebral edema, and hemorrhagic transformation.  Moreover, the tissue plasminogen activator (tPA), which is the only US-FDA approved treatment of ischemic stroke, has a brief 3 to 4 h time window and it has been proposed that detrimental effects of tPA beyond the 3 h since the onset of stroke are derived from its ability to activate MMP-9 that in turn contributes to the breakdown of BBB.  Therefore, the available literature suggests that MMP-9 inhibition can be of therapeutic importance in ischemic stroke.  Hence, combination therapies of MMP-9 inhibitor along with tPA can be beneficial in ischemic stroke.  In this review we will discuss the current status of various strategies which have shown neuroprotection and extension of thrombolytic window by directly or indirectly inhibiting MMP-9 activity.  In the introductory part of the review, we briefly provide an overview on ischemic stroke, commonly used models of ischemic stroke and a role of MMP-9 in ischemia.  In next part, the literature is organized as various approaches which have proven neuroprotective effects through direct or indirect decrease in MMP-9 activity, namely, using biotherapeutics, involving MMP-9 gene inhibition using viral vectors; using endogenous inhibitor of MMP-9, repurposing of old drugs such as minocycline, new chem. entities like DP-b99, and finally other approaches like therapeutic hypothermia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2kGS9IvaXvrVg90H21EOLACvtfcHk0li2v7uTUdtIkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCitrvP&md5=21828bf3861b708e60c7d90e367aff33</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1007%2Fs12035-013-8538-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-013-8538-z%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DM.%26aulast%3DKaczmarek%26aufirst%3DL.%26atitle%3DMMP-9%2520Inhibition%253A%2520A%2520Therapeutic%2520Strategy%2520in%2520Ischemic%2520Stroke%26jtitle%3DMol.%2520Neurobiol.%26date%3D2014%26volume%3D49%26issue%3D1%26spage%3D563%26epage%3D573%26doi%3D10.1007%2Fs12035-013-8538-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ahmady, Z. S.</span></span> <span> </span><span class="NLM_article-title">Selective Drug Delivery Approaches to Lesioned Brain through Blood Brain Barrier Disruption</span>. <i>Expert Opin. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1080/17425247.2018.1444601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1080%2F17425247.2018.1444601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29466890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXks1Gqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2018&pages=335-349&issue=4&author=Z.+S.+Al-Ahmady&title=Selective+Drug+Delivery+Approaches+to+Lesioned+Brain+through+Blood+Brain+Barrier+Disruption&doi=10.1080%2F17425247.2018.1444601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Selective drug delivery approaches to lesioned brain through blood brain barrier disruption</span></div><div class="casAuthors">Al-Ahmady, Zahraa S.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Delivery</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">335-349</span>CODEN:
                <span class="NLM_cas:coden">EODDAW</span>;
        ISSN:<span class="NLM_cas:issn">1742-5247</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: The development of therapeutics for central nervous system (CNS) disorders is still considered a challenging area in drug development due to insufficient translocation through the blood-brain barrier (BBB).  Under normal conditions, BBB restrict the penetration of more than 98% of blood-borne mols. including drugs to the CNS.  However, recent research findings have proven that the nature of the BBB is altered in several neurol. conditions.  This complexity encourages revisiting drug delivery strategies to the CNS as this can give a wide range of opportunities for CNS drug development.: This review focuses on nanotechnol.-based drug delivery platforms designed for selective recruitment into the lesioned brain by taking advantages of BBB disruption that is assocd. with certain neurol. conditions.: Current CNS therapeutic strategies do not fully address the pathophysiol. adaptation of BBB in their design.  The lack of selective delivery to the brain lesions has been the culprit behind the failure of many CNS therapeutics.  This highlighted the need for smart designs of advanced drug delivery systems that take advantage of BBB structural changes in CNS diseases.  Recently, promising examples have been reported in this area, however, more work is still required beyond the preclin. testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2cT7q9jWEZLVg90H21EOLACvtfcHk0li2v7uTUdtIkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXks1Gqtbc%253D&md5=ed6d813b6f146befb1e20bbb6744ea6b</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1080%2F17425247.2018.1444601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425247.2018.1444601%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Ahmady%26aufirst%3DZ.%2BS.%26atitle%3DSelective%2520Drug%2520Delivery%2520Approaches%2520to%2520Lesioned%2520Brain%2520through%2520Blood%2520Brain%2520Barrier%2520Disruption%26jtitle%3DExpert%2520Opin.%2520Drug%2520Delivery%26date%3D2018%26volume%3D15%26issue%3D4%26spage%3D335%26epage%3D349%26doi%3D10.1080%2F17425247.2018.1444601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sosa, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priestley, R. D.</span></span> <span> </span><span class="NLM_article-title">Nanomedicine as a Non-Invasive Strategy for Drug Delivery across the Blood Brain Barrier</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>515</i></span> (<span class="NLM_issue">1–2</span>),  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2016.10.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.ijpharm.2016.10.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27769885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslans7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=515&publication_year=2016&pages=331-342&issue=1%E2%80%932&author=V.+H.+Tamauthor=C.+Sosaauthor=R.+Liuauthor=N.+Yaoauthor=R.+D.+Priestley&title=Nanomedicine+as+a+Non-Invasive+Strategy+for+Drug+Delivery+across+the+Blood+Brain+Barrier&doi=10.1016%2Fj.ijpharm.2016.10.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier</span></div><div class="casAuthors">Tam, Vivienne H.; Sosa, Chris; Liu, Rui; Yao, Nan; Priestley, Rodney D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">515</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">331-342</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The blood brain barrier (BBB) is a major obstacle to drug delivery for diseases of the central nervous system (CNS).  This brief review highlights the current invasive and non-invasive technologies available to address this problem.  In particular, nanomedicine has shown much promise as a non-invasive strategy due to its drug loading capabilities, ease of targeting to the BBB, and small size.  The versatility of this technol. in terms of type of drug and imaging agent, carrier material, and targeting mechanism is highlighted in this review.  The recent inclusion of imaging agents in the nanocarriers has important consequences for the field of theranostics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbTTspDc8UJ7Vg90H21EOLACvtfcHk0liOsaJW51QfdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslans7jN&md5=8b94abd6a8c4015169fc0215baabe252</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2016.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2016.10.031%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DV.%2BH.%26aulast%3DSosa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPriestley%26aufirst%3DR.%2BD.%26atitle%3DNanomedicine%2520as%2520a%2520Non-Invasive%2520Strategy%2520for%2520Drug%2520Delivery%2520across%2520the%2520Blood%2520Brain%2520Barrier%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2016%26volume%3D515%26issue%3D1%25E2%2580%25932%26spage%3D331%26epage%3D342%26doi%3D10.1016%2Fj.ijpharm.2016.10.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizzo, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehra, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilken-Resman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boroumand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorne, R. G.</span></span> <span> </span><span class="NLM_article-title">Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3937</span>– <span class="NLM_lpage">3966</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00548</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00548" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVWit77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=3937-3966&issue=12&author=N.+N.+Kumarauthor=M.+E.+Pizzoauthor=G.+Nehraauthor=B.+Wilken-Resmanauthor=S.+Boroumandauthor=R.+G.+Thorne&title=Passive+Immunotherapies+for+Central+Nervous+System+Disorders%3A+Current+Delivery+Challenges+and+New+Approaches&doi=10.1021%2Facs.bioconjchem.8b00548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches</span></div><div class="casAuthors">Kumar, Niyanta N.; Pizzo, Michelle E.; Nehra, Geetika; Wilken-Resman, Brynna; Boroumand, Sam; Thorne, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3937-3966</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Passive immunotherapy, i.e., the administration of exogenous antibodies that recognize a specific target antigen, has gained significant momentum as a potential treatment strategy for several central nervous system (CNS) disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and brain cancer, among others.  Advances in antibody engineering to create therapeutic antibody fragments or antibody conjugates have introduced new strategies that may also be applied to treat CNS disorders.  However, drug delivery to the CNS for antibodies and other macromols. has thus far proven challenging, due in large part to the blood-brain barrier (BBB) and blood-cerebrospinal fluid barriers (BCSFBs) that greatly restrict transport of peripherally administered mols. from the systemic circulation into the CNS.  Here, we summarize the various passive immunotherapy approaches under study for the treatment of CNS disorders, with a primary focus on disease-specific and target site-specific challenges to drug delivery and new, cutting edge methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLRWkTz_J0DLVg90H21EOLACvtfcHk0lh9lfV0ol_7fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVWit77K&md5=02fd78cf1cb2cfcdcc29975194c88be1</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00548%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DN.%2BN.%26aulast%3DPizzo%26aufirst%3DM.%2BE.%26aulast%3DNehra%26aufirst%3DG.%26aulast%3DWilken-Resman%26aufirst%3DB.%26aulast%3DBoroumand%26aufirst%3DS.%26aulast%3DThorne%26aufirst%3DR.%2BG.%26atitle%3DPassive%2520Immunotherapies%2520for%2520Central%2520Nervous%2520System%2520Disorders%253A%2520Current%2520Delivery%2520Challenges%2520and%2520New%2520Approaches%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26issue%3D12%26spage%3D3937%26epage%3D3966%26doi%3D10.1021%2Facs.bioconjchem.8b00548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rafi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourseif, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omidi, Y.</span></span> <span> </span><span class="NLM_article-title">Blood-Brain Barrier Transport Machineries and Targeted Therapy of Brain Diseases</span>. <i>BioImpacts</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.15171/bi.2016.30</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.15171%2Fbi.2016.30" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28265539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVaqtbrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=225-248&issue=4&author=J.+Bararauthor=M.+A.+Rafiauthor=M.+M.+Pourseifauthor=Y.+Omidi&title=Blood-Brain+Barrier+Transport+Machineries+and+Targeted+Therapy+of+Brain+Diseases&doi=10.15171%2Fbi.2016.30"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Blood-brain barrier transport machineries and targeted therapy of brain diseases</span></div><div class="casAuthors">Barar, Jaleh; Rafi, Mohammad A.; Pourseif, Mohammad M.; Omidi, Yadollah</div><div class="citationInfo"><span class="NLM_cas:title">BioImpacts</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">225-248</span>CODEN:
                <span class="NLM_cas:coden">BIOICT</span>;
        ISSN:<span class="NLM_cas:issn">2228-5660</span>.
    
            (<span class="NLM_cas:orgname">Tabriz University of Medical Sciences</span>)
        </div><div class="casAbstract">Introduction: Desired clin. outcome of pharmacotherapy of brain diseases largely depends upon the safe drug delivery into the brain parenchyma.  However, due to the robust blockade function of the blood-brain barrier (BBB), drug transport into the brain is selectively controlled by the BBB formed by brain capillary endothelial cells and supported by astrocytes and pericytes.  Methods: In the current study, we have reviewed the most recent literature on the subject to provide an insight upon the role and impacts of BBB on brain drug delivery and targeting.  Results: All drugs, either small mols. or macromols., designated to treat brain diseases must adequately cross the BBB to provide their therapeutic properties on biol. targets within the central nervous system (CNS).  However, most of these pharmaceuticals do not sufficiently penetrate into CNS, failing to meet the intended therapeutic outcomes.  Most lipophilic drugs capable of penetrating BBB are prone to the efflux functionality of BBB.  In contrast, all hydrophilic drugs are facing severe infiltration blockage imposed by the tight cellular junctions of the BBB.  Hence, a no. of strategies have been devised to improve the efficiency of brain drug delivery and targeted therapy of CNS disorders using multimodal nanosystems (NSs).  Conclusions: In order to improve the therapeutic outcomes of CNS drug transfer and targeted delivery, the discriminatory permeability of BBB needs to be taken under control.  The carrier-mediated transport machineries of brain capillary endothelial cells (BCECs) can be exploited for the discovery, development and delivery of small mols. into the brain.  Further, the receptor-mediated transport systems can be recruited for the delivery of macromol. biologics and multimodal NSs into the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr7E4mzJJc37Vg90H21EOLACvtfcHk0lhTVe2VtVA5pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVaqtbrE&md5=1181e875fafa634642ef67f9c49498c8</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.15171%2Fbi.2016.30&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15171%252Fbi.2016.30%26sid%3Dliteratum%253Aachs%26aulast%3DBarar%26aufirst%3DJ.%26aulast%3DRafi%26aufirst%3DM.%2BA.%26aulast%3DPourseif%26aufirst%3DM.%2BM.%26aulast%3DOmidi%26aufirst%3DY.%26atitle%3DBlood-Brain%2520Barrier%2520Transport%2520Machineries%2520and%2520Targeted%2520Therapy%2520of%2520Brain%2520Diseases%26jtitle%3DBioImpacts%26date%3D2016%26volume%3D6%26issue%3D4%26spage%3D225%26epage%3D248%26doi%3D10.15171%2Fbi.2016.30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabathuler, R.</span></span> <span> </span><span class="NLM_article-title">Approaches to Transport Therapeutic Drugs across the Blood-brain Barrier to Treat Brain Diseases</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2009.07.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.nbd.2009.07.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19664710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2010&pages=48-57&issue=1&author=R.+Gabathuler&title=Approaches+to+Transport+Therapeutic+Drugs+across+the+Blood-brain+Barrier+to+Treat+Brain+Diseases&doi=10.1016%2Fj.nbd.2009.07.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases</span></div><div class="casAuthors">Gabathuler, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-57</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The central nervous system is protected by barriers which control the entry of compds. into the brain, thereby regulating brain homeostasis.  The blood-brain barrier, formed by the endothelial cells of the brain capillaries, restricts access to brain cells of blood-borne compds. and facilitates nutrients essential for normal metab. to reach brain cells.  This very tight regulation of the brain homeostasis results in the inability of some small and large therapeutic compds. to cross the blood-brain barrier (BBB).  Therefore, various strategies are being developed to enhance the amt. and concn. of therapeutic compds. in the brain.  In this review, we will address the different approaches used to increase the transport of therapeutics from blood into the brain parenchyma.  We will mainly conc. on the physiol. approach which takes advantage of specific receptors already expressed on the capillary endothelial cells forming the BBB and necessary for the survival of brain cells.  Among all the approaches used for increasing brain delivery of therapeutics, the most accepted method is the use of the physiol. approach which takes advantage of the transcytosis capacity of specific receptors expressed at the BBB.  The low d. lipoprotein receptor related protein (LRP) is the most adapted for such use with the engineered peptide compd. (EPiC) platform incorporating the Angiopep peptide in new therapeutics the most advanced with promising data in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXnM4hn2vGGrVg90H21EOLACvtfcHk0lhTVe2VtVA5pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGms7jE&md5=ede4d80cd5fabc1080289b5446072d07</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2009.07.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2009.07.028%26sid%3Dliteratum%253Aachs%26aulast%3DGabathuler%26aufirst%3DR.%26atitle%3DApproaches%2520to%2520Transport%2520Therapeutic%2520Drugs%2520across%2520the%2520Blood-brain%2520Barrier%2520to%2520Treat%2520Brain%2520Diseases%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2010%26volume%3D37%26issue%3D1%26spage%3D48%26epage%3D57%26doi%3D10.1016%2Fj.nbd.2009.07.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golub, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannobile, W. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorsa, T.</span></span> <span> </span><span class="NLM_article-title">Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms</span>. <i>Adv. Dent. Res.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1177/08959374980120010501</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1177%2F08959374980120010501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=9972117" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADyaK1M7jvVSltg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1998&pages=12-26&issue=1&author=L.+M.+Golubauthor=H.-M.+Leeauthor=M.+E.+Ryanauthor=W.+V.+Giannobileauthor=J.+Payneauthor=T.+Sorsa&title=Tetracyclines+Inhibit+Connective+Tissue+Breakdown+by+Multiple+Non-Antimicrobial+Mechanisms&doi=10.1177%2F08959374980120010501"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms</span></div><div class="casAuthors">Golub L M; Lee H M; Ryan M E; Giannobile W V; Payne J; Sorsa T</div><div class="citationInfo"><span class="NLM_cas:title">Advances in dental research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">12-26</span>
        ISSN:<span class="NLM_cas:issn">0895-9374</span>.
    </div><div class="casAbstract">A seminal experiment involving a germ-free rat model of connective tissue breakdown (followed soon thereafter by a series of in vitro studies) identified an unexpected non-antimicrobial property of tetracyclines (TCs).  This ability of TCs to inhibit matrix metalloproteinases (MMPs) such as collagenase was found to reflect multiple direct and indirect mechanisms of action, and to be therapeutically useful in a variety of dental (e.g., adult periodontitis) and medical (e.g., arthritis, osteoporosis, cancer) diseases.  The site on the TC molecule responsible for its MMP-inhibitory activity was identified which led to the development of a series of chemically modified non-antimicrobial analogs, called CMTs, which also have therapeutic potential but do not appear to induce antibiotic side-effects.  Longitudinal double-blind studies on humans with adult periodontitis have demonstrated that a sub-antimicrobial dose of doxycycline (previously reported to suppress collagenase activity in the periodontal pocket) is safe and effective and has recently been approved by the FDA as an adjunct to scaling and root planing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS67MxfhHdRnAHqQV89nF-2fW6udTcc2eafF-ZvmUA6L7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7jvVSltg%253D%253D&md5=d4a1a1d96883c4e662854f18c3ae12e4</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1177%2F08959374980120010501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F08959374980120010501%26sid%3Dliteratum%253Aachs%26aulast%3DGolub%26aufirst%3DL.%2BM.%26aulast%3DLee%26aufirst%3DH.-M.%26aulast%3DRyan%26aufirst%3DM.%2BE.%26aulast%3DGiannobile%26aufirst%3DW.%2BV.%26aulast%3DPayne%26aufirst%3DJ.%26aulast%3DSorsa%26aufirst%3DT.%26atitle%3DTetracyclines%2520Inhibit%2520Connective%2520Tissue%2520Breakdown%2520by%2520Multiple%2520Non-Antimicrobial%2520Mechanisms%26jtitle%3DAdv.%2520Dent.%2520Res.%26date%3D1998%26volume%3D12%26issue%3D1%26spage%3D12%26epage%3D26%26doi%3D10.1177%2F08959374980120010501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blum, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chtarto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenenbaum, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brotchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levivier, M.</span></span> <span> </span><span class="NLM_article-title">Clinical Potential of Minocycline for Neurodegenerative Disorders</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">359</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2004.07.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.nbd.2004.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15571972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVansbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=359-366&issue=3&author=D.+Blumauthor=A.+Chtartoauthor=L.+Tenenbaumauthor=J.+Brotchiauthor=M.+Levivier&title=Clinical+Potential+of+Minocycline+for+Neurodegenerative+Disorders&doi=10.1016%2Fj.nbd.2004.07.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical potential of minocycline for neurodegenerative disorders</span></div><div class="casAuthors">Blum, David; Chtarto, Abdelwahed; Tenenbaum, Liliane; Brotchi, Jacques; Levivier, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-366</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Minocycline, an antibiotic of the tetracycline family, has been shown to display neurorestorative or neuroprotective properties in various models of neurodegenerative diseases.  In particular, it has been shown to delay motor alterations, inflammation and apoptosis in models of Huntington's disease, amyotrophic lateral sclerosis and Parkinson's disease.  Despite controversies about its efficacy, the relative safety and tolerability of minocycline have led to the launching of various clin. trials.  The present review summarizes the available data supporting the clin. testing of minocycline for these neurodegenerative disorders.  In addn., the authors extend the authors' discussion to the potential applications of minocycline for combining this treatment with cellular and mol. therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRD0d9GE-PnrVg90H21EOLACvtfcHk0lhZCMbOXaueGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVansbvI&md5=0760d1b014e761b686709d01aa341b35</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2004.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2004.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DBlum%26aufirst%3DD.%26aulast%3DChtarto%26aufirst%3DA.%26aulast%3DTenenbaum%26aufirst%3DL.%26aulast%3DBrotchi%26aufirst%3DJ.%26aulast%3DLevivier%26aufirst%3DM.%26atitle%3DClinical%2520Potential%2520of%2520Minocycline%2520for%2520Neurodegenerative%2520Disorders%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2004%26volume%3D17%26issue%3D3%26spage%3D359%26epage%3D366%26doi%3D10.1016%2Fj.nbd.2004.07.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Teronen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heikkilä, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konttinen, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanemaaijer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teronen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorsa, T.</span></span> <span> </span><span class="NLM_article-title">MMP Inhibition and Downregulation by Bisphosphonates</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>878</i></span> (<span class="NLM_issue">358</span>),  <span class="NLM_fpage">453</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.1999.tb07702.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fj.1749-6632.1999.tb07702.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10415748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK1MXkslemsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=878&publication_year=1999&pages=453-465&issue=358&author=O.+Teronenauthor=P.+Heikkil%C3%A4author=Y.+T.+Konttinenauthor=M.+Laitinenauthor=T.+Saloauthor=R.+Hanemaaijerauthor=A.+Teronenauthor=P.+Maisiauthor=T.+Sorsa&title=MMP+Inhibition+and+Downregulation+by+Bisphosphonates&doi=10.1111%2Fj.1749-6632.1999.tb07702.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">MMP inhibition and downregulation by bisphosphonates</span></div><div class="casAuthors">Teronen, Olli; Heikkila, Pia; Konttinen, Yrjo T.; Laitinen, Minna; Salo, Tuula; Hanemaaijer, Roeland; Teronen, Anneli; Maisi, Paivi; Sorsa, Timo</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">878</span>
        (<span class="NLM_cas:issue">Inhibition of Matrix Metalloproteinases</span>),
    <span class="NLM_cas:pages">453-465</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">New York Academy of Sciences</span>)
        </div><div class="casAbstract">Bisphosphonates are a group of drugs capable of inhibiting bone resorption, and are thus used for the treatment of bone diseases, such as Paget's disease, osteoporosis, and for bone metastases of malignant tumors.  Their primary cellular target is considered to be the osteoclast.  The mol. mechanisms responsible for the downregulation of bone resorption by bisphosphonates have remain unclear.  We have discovered that various matrix metalloproteinases (MMPs) are inhibited in vitro by several bisphosphonates.  This novel finding may, in part, explain the efficacy of bisphosphonates in their current indications in humans.  In enzyme activity tests using purified and recombinant enzymes, we have obsd. the inhibition of MMP-1, -2, -3, -7, -8, -9, -12, -13, and -14 by clondronate, alendronate, pamidronate, zolendronate, nedrinate, and clodrinate.  The IC50s range from 50 to 150 μM.  We have also shown that clondronate can downregulate the expression of MT1-MMP protein and mRNA in several cell lines.  Addnl., several bisphosphonates decrease the degree of invasion of malignant melanoma (C8161) and fibrosarcoma (HT1080) cells through artificial basement membrane (Matrigel) in cell cultures at IC50s of 50-150 μM and below.  Having low toxicity and proven to be well tolerated after several years in human use, bisphosphonates have the potential to become one of the main MMP-inhibitors for MMP-related human soft and hard tissue-destructive diseases in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX5dePnWitWrVg90H21EOLACvtfcHk0lhZCMbOXaueGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXkslemsL0%253D&md5=fe3c87d4da0524727b9ddcbcdf86dc3e</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1999.tb07702.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1999.tb07702.x%26sid%3Dliteratum%253Aachs%26aulast%3DTeronen%26aufirst%3DO.%26aulast%3DHeikkil%25C3%25A4%26aufirst%3DP.%26aulast%3DKonttinen%26aufirst%3DY.%2BT.%26aulast%3DLaitinen%26aufirst%3DM.%26aulast%3DSalo%26aufirst%3DT.%26aulast%3DHanemaaijer%26aufirst%3DR.%26aulast%3DTeronen%26aufirst%3DA.%26aulast%3DMaisi%26aufirst%3DP.%26aulast%3DSorsa%26aufirst%3DT.%26atitle%3DMMP%2520Inhibition%2520and%2520Downregulation%2520by%2520Bisphosphonates%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1999%26volume%3D878%26issue%3D358%26spage%3D453%26epage%3D465%26doi%3D10.1111%2Fj.1749-6632.1999.tb07702.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Izidoro-Toledo, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belo, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanus-Santos, J. E.</span></span> <span> </span><span class="NLM_article-title">Effects of Statins on Matrix Metalloproteinases and Their Endogenous Inhibitors in Human Endothelial Cells</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>383</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">547</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1007/s00210-011-0623-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs00210-011-0623-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21448567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlvFWitr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2011&pages=547-554&issue=6&author=T.+C.+Izidoro-Toledoauthor=D.+A.+Guimaraesauthor=V.+A.+Beloauthor=R.+F.+Gerlachauthor=J.+E.+Tanus-Santos&title=Effects+of+Statins+on+Matrix+Metalloproteinases+and+Their+Endogenous+Inhibitors+in+Human+Endothelial+Cells&doi=10.1007%2Fs00210-011-0623-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells</span></div><div class="casAuthors">Izidoro-Toledo, Tatiane C.; Guimaraes, Danielle A.; Belo, Vanessa A.; Gerlach, Raquel F.; Tanus-Santos, Jose Eduardo</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">547-554</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Statins exert anti-inflammatory effects and downregulate matrix metalloproteinases (MMPs) expression, thus contributing to restore cardiovascular homeostasis in cardiovascular diseases.  We aimed at comparing the effects of different statins (simvastatin, atorvastatin, and pravastatin) on MMP-2, MMP-9, tissue inhibitors of metalloproteinases (TIMP)-1, TIMP-2, and MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios released by human umbilical vein endothelial cells (HUVEC) stimulated by phorbol myristate acetate (PMA).  HUVECs were incubated with statins (0.1-10 μM) for 12 h before stimulation with PMA 100 nM.  Monolayers were used to perform cell viability assays and the supernatants were collected to det. MMPs and TIMPs levels by gelatin zymog. and/or enzyme immunoassay.  While treatment with PMA increased MMP-9 and TIMP-1 levels (by 556% and 159%, resp.; both P < 0.05), it exerted no effects on MMP-2 and TIMP-2 levels.  Simvastatin and atorvastatin, but not pravastatin, attenuated PMA-induced increases in MMP-9 levels (P < 0.05).  Only atorvastatin decreased baseline MMP-2 levels significantly (P < 0.05).  We found no effects on TIMP-2 levels.  Simvastatin and atorvastatin, but not pravastatin, decreased MMP-9/TIMP-1 ratio significantly (both P < 0.05), whereas atorvastatin and pravastatin, but not simvastatin, decreased MMP-2/TIMP-2 ratio significantly (both P < 0.05).  Our data support the notion that statins with different physicochem. features exert variable effects on MMP/TIMP ratios (which reflect net MMP activity).  Our results suggest that more lipophilic statins (simvastatin and atorvastatin), but not the hydrophilic statin pravastatin, downregulate net MMP-9 activity.  However, atorvastatin and pravastatin may downregulate net MMP-2 activity.  The clin. implications of the present findings deserve further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeUewGHR2nArVg90H21EOLACvtfcHk0lhEFKm47dr_QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlvFWitr8%253D&md5=47c9ed06738531d3595250bd0ba66abd</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1007%2Fs00210-011-0623-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-011-0623-0%26sid%3Dliteratum%253Aachs%26aulast%3DIzidoro-Toledo%26aufirst%3DT.%2BC.%26aulast%3DGuimaraes%26aufirst%3DD.%2BA.%26aulast%3DBelo%26aufirst%3DV.%2BA.%26aulast%3DGerlach%26aufirst%3DR.%2BF.%26aulast%3DTanus-Santos%26aufirst%3DJ.%2BE.%26atitle%3DEffects%2520of%2520Statins%2520on%2520Matrix%2520Metalloproteinases%2520and%2520Their%2520Endogenous%2520Inhibitors%2520in%2520Human%2520Endothelial%2520Cells%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2011%26volume%3D383%26issue%3D6%26spage%3D547%26epage%3D554%26doi%3D10.1007%2Fs00210-011-0623-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piura, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinovich, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyomin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huleihel, M.</span></span> <span> </span><span class="NLM_article-title">Thalidomide Distinctly Affected TNF-A, IL-6 and MMP Secretion by an Ovarian Cancer Cell Line (SKOV-3) and Primary Ovarian Cancer Cells</span>. <i>Eur. Cytokine Netw.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">122</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1684/ecn.2013.0342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1684%2Fecn.2013.0342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24284039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVygsLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=122-129&issue=3&author=B.+Piuraauthor=L.+Medinaauthor=A.+Rabinovichauthor=V.+Dyominauthor=M.+Huleihel&title=Thalidomide+Distinctly+Affected+TNF-A%2C+IL-6+and+MMP+Secretion+by+an+Ovarian+Cancer+Cell+Line+%28SKOV-3%29+and+Primary+Ovarian+Cancer+Cells&doi=10.1684%2Fecn.2013.0342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Thalidomide distinctly affected TNF-α, IL-6 and MMP secretion by an ovarian cancer cell line (SKOV-3) and primary ovarian cancer cells</span></div><div class="casAuthors">Piura, Benjamin; Medina, Liat; Rabinovich, Alex; Dyomin, Victor; Huleihel, Mahmoud</div><div class="citationInfo"><span class="NLM_cas:title">European Cytokine Network</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">122-129</span>CODEN:
                <span class="NLM_cas:coden">ECYNEJ</span>;
        ISSN:<span class="NLM_cas:issn">1952-4005</span>.
    
            (<span class="NLM_cas:orgname">John Libbey Eurotext</span>)
        </div><div class="casAbstract">Background. Thalidomide inhibits TNF-α prodn. in lipopolysaccharide-stimulated monocytes.  The aim of this study was to evaluate the effect of thalidomide on TNF-α, IL-6 and MMP secretion in epithelial ovarian carcinoma cells.  Materials and methods. SKOV-3 cells and primary epithelial ovarian carcinoma cells were cultured in the presence of various concns. of thalidomide.  Cell proliferation was examd. by MTT proliferation assay.  TNF-α and IL-6 levels were detd. in the supernatants of the cell cultures by ELISA, and MMP activity was examd. by gelatin zymog.  Results. Thalidomide did not significantly affect the proliferation and growth of SKOV-3 cells.  However, it decreased significantly the capacity of SKOV-3 cells and primary epithelial ovarian carcinoma cells to secrete TNF-α.  Thalidomide also significantly decreased the capacity of SKOV-3 cells, but not primary epithelial ovarian carcinoma cells, to secrete MMP-9 and MMP-2.  However, thalidomide did not affect IL-6 secretion in SKOV-3 cells or primary epithelial ovarian carcinoma cells.  Conclusion. Our study suggests that thalidomide distinctly affected TNF-α, IL-6 and MMPs secretion by an ovarian carcinoma cell line (SKOV-3) and primary ovarian cancer cells.  This might suggest a different susceptibility of these two types of cells to thalidomide, and/or that the mechanisms of secretion of the factors examd. are differently regulated in these cells.  Our results may deepen our understanding the mechanism/s of action of thalidomide in ovarian carcinoma cells.  The results might have important implications in future therapeutic strategies that will incorporate thalidomide and other cytokine inhibitors in the treatment of epithelial ovarian carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroZ0pUkj08a7Vg90H21EOLACvtfcHk0lhEFKm47dr_QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVygsLrI&md5=5ef240f565728a9320a754ba3779847c</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1684%2Fecn.2013.0342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1684%252Fecn.2013.0342%26sid%3Dliteratum%253Aachs%26aulast%3DPiura%26aufirst%3DB.%26aulast%3DMedina%26aufirst%3DL.%26aulast%3DRabinovich%26aufirst%3DA.%26aulast%3DDyomin%26aufirst%3DV.%26aulast%3DHuleihel%26aufirst%3DM.%26atitle%3DThalidomide%2520Distinctly%2520Affected%2520TNF-A%252C%2520IL-6%2520and%2520MMP%2520Secretion%2520by%2520an%2520Ovarian%2520Cancer%2520Cell%2520Line%2520%2528SKOV-3%2529%2520and%2520Primary%2520Ovarian%2520Cancer%2520Cells%26jtitle%3DEur.%2520Cytokine%2520Netw.%26date%3D2013%26volume%3D24%26issue%3D3%26spage%3D122%26epage%3D129%26doi%3D10.1684%2Fecn.2013.0342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gearing, A. J. H.</span></span> <span> </span><span class="NLM_article-title">Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2735</span>– <span class="NLM_lpage">2776</span>, <span class="refDoi"> DOI: 10.1021/cr9804543</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr9804543" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADyaK1MXls1Kku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1999&pages=2735-2776&issue=9&author=M.+Whittakerauthor=C.+D.+Floydauthor=P.+Brownauthor=A.+J.+H.+Gearing&title=Design+and+Therapeutic+Application+of+Matrix+Metalloproteinase+Inhibitors&doi=10.1021%2Fcr9804543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors</span></div><div class="casAuthors">Whittaker, Mark; Floyd, Christopher D.; Brown, Peter; Gearing, Andrew J. H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2735-2776</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 389 refs.  MMP inhibitors may be an important new class of therapeutic agents for the treatment of diseases characterized by excessive extracellular matrix degrdn. and/or remodelling, such as cancer and chronic inflammatory diseases such as rheumatoid arthritis, atherosclerosis, and MS.  This review describes progress in the design of MMP inhibitors and outlines the results of early clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGACjaK8AEZbVg90H21EOLACvtfcHk0livaKDaogegSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXls1Kku7c%253D&md5=e226080188f791f5d1ce8c61b64ad33a</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Fcr9804543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr9804543%26sid%3Dliteratum%253Aachs%26aulast%3DWhittaker%26aufirst%3DM.%26aulast%3DFloyd%26aufirst%3DC.%2BD.%26aulast%3DBrown%26aufirst%3DP.%26aulast%3DGearing%26aufirst%3DA.%2BJ.%2BH.%26atitle%3DDesign%2520and%2520Therapeutic%2520Application%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DChem.%2520Rev.%26date%3D1999%26volume%3D99%26issue%3D9%26spage%3D2735%26epage%3D2776%26doi%3D10.1021%2Fcr9804543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coussens, L. M.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase Inhibitors and Cancer: Trials and Tribulations</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>295</i></span> (<span class="NLM_issue">5564</span>),  <span class="NLM_fpage">2387</span>– <span class="NLM_lpage">2392</span>, <span class="refDoi"> DOI: 10.1126/science.1067100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1126%2Fscience.1067100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11923519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD38XisFSmtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2002&pages=2387-2392&issue=5564&author=L.+M.+Coussens&title=Matrix+Metalloproteinase+Inhibitors+and+Cancer%3A+Trials+and+Tribulations&doi=10.1126%2Fscience.1067100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer therapy: matrix metalloproteinase inhibitors and cancer: trials and tribulations</span></div><div class="casAuthors">Coussens, Lisa M.; Fingleton, Barbara; Matrisian, Lynn M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">5564</span>),
    <span class="NLM_cas:pages">2387-2392</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  For at least 30 yr, matrix metalloproteinases (MMPs) have been heralded as promising targets for cancer therapy on the basis of their massive up-regulation in malignant tissues and their unique ability to degrade all components of the extracellular matrix.  Preclin. studies testing the efficacy of MMP suppression in tumor models were so compelling that synthetic metalloproteinase inhibitors (MPI) were rapidly developed and routed into human clin. trials.  The results of these trials have been disappointing.  Here we review the studies that brought MPI into clin. testing and discuss the design and outcome of the trials in light of new information about the cellular source, substrates, and mode of action of MMPs at different stages of tumor progression.  The important lessons learned from the MPI experience may be of great value for future studies of MPI and for cancer drug development in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquzqvwAiv5frVg90H21EOLACvtfcHk0livaKDaogegSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XisFSmtb0%253D&md5=be0d4cfc46c6c451a2374e3545cb4ec6</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1126%2Fscience.1067100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1067100%26sid%3Dliteratum%253Aachs%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26atitle%3DMatrix%2520Metalloproteinase%2520Inhibitors%2520and%2520Cancer%253A%2520Trials%2520and%2520Tribulations%26jtitle%3DScience%26date%3D2002%26volume%3D295%26issue%3D5564%26spage%3D2387%26epage%3D2392%26doi%3D10.1126%2Fscience.1067100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major Jourden, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">To Bind Zinc or Not to Bind Zinc: An Examination of Innovative Approaches to Improved Metalloproteinase Inhibition</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1803</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">72</span>– <span class="NLM_lpage">94</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2009.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbamcr.2009.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19712708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKitLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1803&publication_year=2010&pages=72-94&issue=1&author=J.+A.+Jacobsenauthor=J.+L.+Major+Jourdenauthor=M.+T.+Millerauthor=S.+M.+Cohen&title=To+Bind+Zinc+or+Not+to+Bind+Zinc%3A+An+Examination+of+Innovative+Approaches+to+Improved+Metalloproteinase+Inhibition&doi=10.1016%2Fj.bbamcr.2009.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition</span></div><div class="casAuthors">Jacobsen, Jennifer A.; Major Jourden, Jody L.; Miller, Melissa T.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1803</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-94</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This short review highlights some recent advances in matrix metalloproteinase inhibitor (MMPi) design and development.  Three distinct approaches to improved MMP inhibition are discussed: (1) the identification and investigation of novel zinc-binding groups (ZBGs), (2) the study of non-zinc-binding MMPi, and (3) mechanism-based MMPi that form covalent adducts with the protein.  Each of these strategies is discussed and their resp. advantages and remaining challenges are highlighted.  The studies discussed here bode well for the development of ever more selective, potent, and well-tolerated MMPi for treating several important disease pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbxHz-QbzTTrVg90H21EOLACvtfcHk0livaKDaogegSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKitLg%253D&md5=ad63d40149284ff3051de5bed442fbcd</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2009.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2009.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DJ.%2BA.%26aulast%3DMajor%2BJourden%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BT.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DTo%2520Bind%2520Zinc%2520or%2520Not%2520to%2520Bind%2520Zinc%253A%2520An%2520Examination%2520of%2520Innovative%2520Approaches%2520to%2520Improved%2520Metalloproteinase%2520Inhibition%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2010%26volume%3D1803%26issue%3D1%26spage%3D72%26epage%3D94%26doi%3D10.1016%2Fj.bbamcr.2009.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullagar, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1021/jm101266s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101266s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1WqtLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=591-602&issue=2&author=J.+A.+Jacobsenauthor=J.+L.+Fullagarauthor=M.+T.+Millerauthor=S.+M.+Cohen&title=Identifying+Chelators+for+Metalloprotein+Inhibitors+Using+a+Fragment-Based+Approach&doi=10.1021%2Fjm101266s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Identifying Chelators for Metalloprotein Inhibitors Using a Fragment-Based Approach</span></div><div class="casAuthors">Jacobsen, Jennifer A.; Fullagar, Jessica L.; Miller, Melissa T.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead design (FBLD) has been used to identify new metal-binding groups for metalloenzyme inhibitors.  When screened at 1 mM, a chelator fragment library (CFL-1.1) of 96 compds. produced hit rates ranging from 29% to 43% for five matrix metalloproteases (MMPs), 24% for anthrax lethal factor (LF), 49% for 5-lipoxygenase (5-LO), and 60% for tyrosinase (TY).  The ligand efficiencies (LE) of the fragment hits are excellent, in the range of 0.4-0.8 kcal/mol.  The MMP enzymes all generally elicit the same chelators as hits from CFL-1.1; however, the chelator fragments that inhibit structurally unrelated metalloenzymes (LF, 5-LO, TY) vary considerably.  To develop more advanced hits, one hit from CFL-1.1, 8-hydroxyquinoline, was elaborated at four different positions around the ring system to generate new fragments. 8-Hydroxyquinoline fragments substituted at either the 5- or 7-positions gave potent hits against MMP-2, with IC50 values in the low micromolar range.  The 8-hydroxyquinoline represents a promising new chelator scaffold for the development of MMP inhibitors that was discovered by use of a metalloprotein-focused chelator fragment library.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEhMn4K1QBJLVg90H21EOLACvtfcHk0ljajiD8QO5ZaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1WqtLvE&md5=1ef31ce8e5939f7d1c69aed8a409cd8d</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1021%2Fjm101266s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101266s%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DJ.%2BA.%26aulast%3DFullagar%26aufirst%3DJ.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BT.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DIdentifying%2520Chelators%2520for%2520Metalloprotein%2520Inhibitors%2520Using%2520a%2520Fragment-Based%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D2%26spage%3D591%26epage%3D602%26doi%3D10.1021%2Fjm101266s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero-Perez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarreal, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, S. M.</span></span> <span> </span><span class="NLM_article-title">Zinc-Binding Groups Modulate Selective Inhibition of MMPs</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">812</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700290</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fcmdc.200700290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=18181119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1emtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=812-820&issue=5&author=A.+Agrawalauthor=D.+Romero-Perezauthor=J.+A.+Jacobsenauthor=F.+J.+Villarrealauthor=S.+M.+Cohen&title=Zinc-Binding+Groups+Modulate+Selective+Inhibition+of+MMPs&doi=10.1002%2Fcmdc.200700290"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc-binding groups modulate selective inhibition of MMPs</span></div><div class="casAuthors">Agrawal, Arpita; Romero-Perez, Diego; Jacobsen, Jennifer A.; Villarreal, Francisco J.; Cohen, Seth M.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">812-820</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The need for selective matrix metalloproteinase (MMP) inhibition is of interest because of the range of pathologies mediated by different MMP isoforms.  The development of more selective MMP inhibitors (MMPi) may help to overcome some of the undesired side effects that have hindered the clin. success of these compds.  In an effort to devise new approaches to selective inhibitors, herein the authors describe several novel MMPi and show that their selectivity is dependent on the nature of the zinc-binding group (ZBG).  This is in contrast to most current MMPi, which obtain isoform selectivity solely from the peptidomimetic backbone portion of the compd.  In the present study, six different hydroxypyrone and hydroxypyridinone ZBGs were appended to a common biphenyl backbone and the inhibition efficiency of each inhibitor was detd. in vitro (IC50 values) against MMP-1, -2, -3, -7, -8, -9, -12, and -13.  The results show that the selectivity profile of each inhibitor is different as a result of the various ZBGs.  Computational modeling studies were used to explain some trends in the obsd. selectivity profiles.  To assess the importance of the ZBG in a biol. model, two of the semiselective, potent MMPi (and one control) were evaluated using an isolated perfused rat heart system.  Hearts were subjected to ischemia reperfusion injury, and recovery of contractile function was examd.  In this model, only one of the two MMPi showed significant and sustained heart recovery, demonstrating that the choice of ZBG can have a significant effect in a relevant pathophysiol. endpoint.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmDxoMI4DNj7Vg90H21EOLACvtfcHk0ljajiD8QO5ZaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1emtL8%253D&md5=6e0c84c04d315c9a7ee827e558849e0a</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700290%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DA.%26aulast%3DRomero-Perez%26aufirst%3DD.%26aulast%3DJacobsen%26aufirst%3DJ.%2BA.%26aulast%3DVillarreal%26aufirst%3DF.%2BJ.%26aulast%3DCohen%26aufirst%3DS.%2BM.%26atitle%3DZinc-Binding%2520Groups%2520Modulate%2520Selective%2520Inhibition%2520of%2520MMPs%26jtitle%3DChemMedChem%26date%3D2008%26volume%3D3%26issue%3D5%26spage%3D812%26epage%3D820%26doi%3D10.1002%2Fcmdc.200700290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skiles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonnella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, A.</span></span> <span> </span><span class="NLM_article-title">The Design, Structure, and Clinical Update of Small Molecular Weight Matrix Metalloproteinase Inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">2911</span>– <span class="NLM_lpage">2977</span>, <span class="refDoi"> DOI: 10.2174/0929867043364018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F0929867043364018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=15544483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVyntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=2911-2977&issue=22&author=J.+Skilesauthor=N.+Gonnellaauthor=A.+Jeng&title=The+Design%2C+Structure%2C+and+Clinical+Update+of+Small+Molecular+Weight+Matrix+Metalloproteinase+Inhibitors&doi=10.2174%2F0929867043364018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Skiles, Jerry W.; Gonnella, Nina C.; Jeng, Arco Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2911-2977</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of zinc-contg. enzymes involved in the degrdn. and remodeling of extracellular matrix proteins.  Under normal physiol. conditions, the activities of these enzymes are well-regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs).  Chronic stimulation of MMP activities due to an imbalance in the levels of MMPs and TIMPs was implicated in the pathogenesis of a variety of diseases such as cancer, osteoarthritis, and rheumatoid arthritis.  Thus, MMP inhibitors are expected to be useful for the treatment of these disorders.  Because of their importance in a variety of pathol. conditions, a no. of small mol. wt. MMP inhibitors have entered clin. trials in humans.  However, the results of these trials were extremely disappointing and have led many investigators to conclude that MMP inhibitors have no therapeutic benefit in human cancer.  To date, the 1st generation MMP inhibitors exhibited poor bioavailability while 2nd-generation compds. revealed that prolonged treatment caused musculoskeletal pain and inflammation or had a lack of efficacy.  This article describes the design of small mol. wt. MMP inhibitors, a brief description of available 3-dimensional MMP structures, a review of the proposed therapeutic utility of MMP inhibitors, and a clin. update of compds. that have entered clin. trials in humans.  The exptl. detd. structures used in the structure-based design of MMP inhibitors are thoroughly covered.  Major emphasis is on recently published and/or patented potent MMP inhibitors, from approx. Jan. 2000 to Apr. 2003, and their pharmacol. properties.  Protein inhibitors of these proteolytic enzymes, i.e. TIMPs, will not be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0LYPCikT-orVg90H21EOLACvtfcHk0ljajiD8QO5ZaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVyntbg%253D&md5=10e7288182d59fadf4691d1bf3795533</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.2174%2F0929867043364018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364018%26sid%3Dliteratum%253Aachs%26aulast%3DSkiles%26aufirst%3DJ.%26aulast%3DGonnella%26aufirst%3DN.%26aulast%3DJeng%26aufirst%3DA.%26atitle%3DThe%2520Design%252C%2520Structure%252C%2520and%2520Clinical%2520Update%2520of%2520Small%2520Molecular%2520Weight%2520Matrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26issue%3D22%26spage%3D2911%26epage%3D2977%26doi%3D10.2174%2F0929867043364018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Third Generation of Matrix Metalloprotease Inhibitors: Gain in Selectivity by Targeting the Depth of the S1’ Cavity</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1508</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2010.07.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.biochi.2010.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20696203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtl2isLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2010&pages=1501-1508&issue=11&author=L.+Develauthor=B.+Czarnyauthor=F.+Beauauthor=D.+Georgiadisauthor=E.+Sturaauthor=V.+Dive&title=Third+Generation+of+Matrix+Metalloprotease+Inhibitors%3A+Gain+in+Selectivity+by+Targeting+the+Depth+of+the+S1%E2%80%99+Cavity&doi=10.1016%2Fj.biochi.2010.07.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity</span></div><div class="casAuthors">Devel, Laurent; Czarny, Bertrand; Beau, Fabrice; Georgiadis, Dimitris; Stura, Enrico; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1501-1508</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Following the disappointment of clin. trials with early broad-spectrum synthetic inhibitors of matrix metalloproteases (MMPs), the field is now resurging with a new focus on the development of more selective inhibitors.  Compds. able to fully discriminate between different members of the MMP family are sorely needed for therapeutic applications.  Chem. efforts over the past years have led to very few selective inhibitors of MMPs.  The over-exploitation of the hydroxamate function, or other strong zinc-binding groups, might be responsible for this failure.  By resorting to weaker zinc-chelating groups, like phosphoryl or carboxylic groups, inhibitors with improved selectivity profiles have been developed.  However, the most encouraging results have been obtained with compds. that avoid targeting the zinc but gain their affinity from plunging deeper into the MMP S1' cavity.  Analyses of the crystal structures of MMP-13 and MMP-8 complexes with such compds. provide novel insights for the design of more selective inhibitors for other members of the MMP family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAZawXfNu_tLVg90H21EOLACvtfcHk0ljavnh34RENxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtl2isLrE&md5=e7c5a03fbf3ff95b904430458a1c804c</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2010.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2010.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DStura%26aufirst%3DE.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DThird%2520Generation%2520of%2520Matrix%2520Metalloprotease%2520Inhibitors%253A%2520Gain%2520in%2520Selectivity%2520by%2520Targeting%2520the%2520Depth%2520of%2520the%2520S1%25E2%2580%2599%2520Cavity%26jtitle%3DBiochimie%26date%3D2010%26volume%3D92%26issue%3D11%26spage%3D1501%26epage%3D1508%26doi%3D10.1016%2Fj.biochi.2010.07.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuccinardi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossello, A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2100</span>, <span class="refDoi"> DOI: 10.2174/138161207781039706</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F138161207781039706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17627541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Ogu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=2087-2100&issue=20&author=E.+Nutiauthor=T.+Tuccinardiauthor=A.+Rossello&title=Matrix+Metalloproteinase+Inhibitors%3A+New+Challenges+in+the+Era+of+Post+Broad-Spectrum+Inhibitors&doi=10.2174%2F138161207781039706"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors</span></div><div class="casAuthors">Nuti, Elisa; Tuccinardi, Tiziano; Rossello, Armando</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2087-2100</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  More than two decades have been spent to develop many families of synthetic matrix metalloproteinases inhibitors (MMPI) as therapeutical agents for serious pathologies.  Unfortunately, clin. trials conducted on broad-spectrum inhibitors have yielded disappointing results, esp. in the cancer pathol. area.  Despite these outcomes, some small synthetic MMPI are in advanced trials or launched in clin. ones for cancer, arthritis, periodontal diseases.  Today many groups are developing intensive efforts to find new classes of inhibitors characterized by improved potency and, above all, high selectivity against the specific MMP involved in each targeted pathol.  The new challenges include the development of new MMPI bearing more effective ZBGs and the development of new allosteric non-zinc binding inhibitors, devoid of ZBGs.  An anal. of more recent results in this field reported on journals and patents will be developed, to consider some of the more interesting new highly selective synthetic MMPI, their SARs, the new theor. approaches used for modeling and the results of their biol. evaluations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMCtqrLRJtEbVg90H21EOLACvtfcHk0ljavnh34RENxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Ogu7w%253D&md5=011104d90447c23592ff58e5c09cdf91</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.2174%2F138161207781039706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161207781039706%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DMatrix%2520Metalloproteinase%2520Inhibitors%253A%2520New%2520Challenges%2520in%2520the%2520Era%2520of%2520Post%2520Broad-Spectrum%2520Inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2007%26volume%3D13%26issue%3D20%26spage%3D2087%26epage%3D2100%26doi%3D10.2174%2F138161207781039706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dormán, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cseh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdú, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kónya, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kupai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovács, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferdinandy, P.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase Inhibitors</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">949</span>– <span class="NLM_lpage">964</span>, <span class="refDoi"> DOI: 10.2165/11318390-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2165%2F11318390-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20481653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlalsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=949-964&issue=8&author=G.+Dorm%C3%A1nauthor=S.+Csehauthor=I.+Hajd%C3%BAauthor=L.+Barnaauthor=D.+K%C3%B3nyaauthor=K.+Kupaiauthor=L.+Kov%C3%A1csauthor=P.+Ferdinandy&title=Matrix+Metalloproteinase+Inhibitors&doi=10.2165%2F11318390-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility</span></div><div class="casAuthors">Dorman, Gyorgy; Cseh, Sandor; Hajdu, Istvan; Barna, Laszlo; Konya, Denes; Kupai, Krisztina; Kovacs, Laszlo; Ferdinandy, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">949-964</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Adis Data Information BV</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) play an important role in tissue remodelling assocd. with various physiol. and pathol. processes, such as morphogenesis, angiogenesis, tissue repair, arthritis, chronic heart failure, chronic obstructive pulmonary disease, chronic inflammation and cancer metastasis.  As a result, MMPs are considered to be viable drug targets in the therapy of these diseases.  Despite the high therapeutic potential of MMP inhibitors (MMPIs), all clin. trials have failed to date, except for doxycycline for periodontal disease.  This can be attributed to (i) poor selectivity of the MMPIs, (ii) poor target validation for the targeted therapy and (iii) poorly defined predictive preclin. animal models for safety and efficacy.  Lessons from previous failures, such as recent discoveries of oxidative/nitrosative activation and phosphorylation of MMPs, as well as novel non-matrix related intra- and extracellular targets of MMP, give new hope for MMPI development for both chronic and acute diseases.  In this article we critically review the major structural determinants of the selectivity and the milestones of past design efforts of MMPIs where 2-/3-dimensional structure-based methods were intensively applied.  We also analyze the in vitro screening and preclin./clin. pharmacol. approaches, with particular emphasis on drawing conclusions on how to overcome efficacy and safety problems through better target validation and design of preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpr90df3aVC2rVg90H21EOLACvtfcHk0ljavnh34RENxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlalsb8%253D&md5=a3ef6e419599ae64a7165d1b3eca5e4a</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.2165%2F11318390-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11318390-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DDorm%25C3%25A1n%26aufirst%3DG.%26aulast%3DCseh%26aufirst%3DS.%26aulast%3DHajd%25C3%25BA%26aufirst%3DI.%26aulast%3DBarna%26aufirst%3DL.%26aulast%3DK%25C3%25B3nya%26aufirst%3DD.%26aulast%3DKupai%26aufirst%3DK.%26aulast%3DKov%25C3%25A1cs%26aufirst%3DL.%26aulast%3DFerdinandy%26aufirst%3DP.%26atitle%3DMatrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DDrugs%26date%3D2010%26volume%3D70%26issue%3D8%26spage%3D949%26epage%3D964%26doi%3D10.2165%2F11318390-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span> <span> </span><span class="NLM_article-title">Recent Advances in MMP Inhibitor Design</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">136</span>, <span class="refDoi"> DOI: 10.1007/s10555-006-7894-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1007%2Fs10555-006-7894-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16680577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=115-136&issue=1&author=J.+F.+Fisherauthor=S.+Mobashery&title=Recent+Advances+in+MMP+Inhibitor+Design&doi=10.1007%2Fs10555-006-7894-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in MMP inhibitor design</span></div><div class="casAuthors">Fisher, Jed F.; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-136</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The search for an MMP inhibitor with anticancer efficacy is a nearly three-decade endeavor.  This inhibitor is yet to be found.  The reasons for this failure include shortcomings in the chem. of these compds. (including broad MMP sub-type selectivity, metabolic lability, and toxicity) as well as the emerging, and arguably extraordinary, complexity of MMP cell (and cancer) biol.  Together these suggest that the successful anticancer inhibitor must possess MMP selectivity against the MMP subtype whose involvement is crit., yet highly temporally (with respect to metastatic progression) and mechanistically (with respect to matrix degrdn.) regulated.  This review summarizes the progression of chem. structure and mechanistic thinking toward these objectives, with emphasis on the disappointment, the perseverance, and the resilient optimism that such an inhibitor is there to be discovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqgy2dldRRXLVg90H21EOLACvtfcHk0li6FElKFstoqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktlaksrs%253D&md5=ceed8438ad533dac294e22102e5ba8bf</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1007%2Fs10555-006-7894-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-006-7894-9%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DJ.%2BF.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DRecent%2520Advances%2520in%2520MMP%2520Inhibitor%2520Design%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2006%26volume%3D25%26issue%3D1%26spage%3D115%26epage%3D136%26doi%3D10.1007%2Fs10555-006-7894-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span> <span> </span><span class="NLM_article-title">Progress in the Development of Matrix Metalloproteinase Inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">1388</span>– <span class="NLM_lpage">1395</span>, <span class="refDoi"> DOI: 10.2174/092986708784567680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2174%2F092986708784567680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=18537616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1388-1395&issue=14&author=G.+Tuauthor=W.+Xuauthor=H.+Huangauthor=S.+Li&title=Progress+in+the+Development+of+Matrix+Metalloproteinase+Inhibitors&doi=10.2174%2F092986708784567680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in the development of matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Tu, GuoGang; Xu, WenFang; Huang, HuiMing; Li, ShaoHua</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1388-1395</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteinases involved in the degrdn. and remodeling of extracellular matrix proteins that are assocd. with the tumorigenic process.  MMPs promote tumor invasion and metastasis, regulating host defense mechanisms and normal cell function.  Thus, MMP inhibitors (MMPIs) are expected to be useful for the treatment of diseases such as cancer, osteoarthritis, and rheumatoid arthritis.  A vast no. of MMPIs have been developed in recent years.  With the failure of these inhibitors in clin. trials, more efforts have been directed to the design of specific inhibitors with different Zn-binding groups.  This review summarizes the current status of MMPIs, the design of small mol. wt. MMPIs, a brief description of available three-dimensional MMP structures, a review of the proposed therapeutic utility of MMPIs, and a clin. update of compds. that have entered clin. trials in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofpnHvDcAn-rVg90H21EOLACvtfcHk0li6FElKFstoqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVyhs7w%253D&md5=2cf2aff42def16a2b76a363d1d498daa</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.2174%2F092986708784567680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708784567680%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DS.%26atitle%3DProgress%2520in%2520the%2520Development%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26issue%3D14%26spage%3D1388%26epage%3D1395%26doi%3D10.2174%2F092986708784567680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senn, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, R.</span></span> <span> </span><span class="NLM_article-title">Design and Structural Evolution of Matrix Metalloproteinase Inhibitors</span>. <i>Chem. - Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">34</span>),  <span class="NLM_fpage">7960</span>– <span class="NLM_lpage">7980</span>, <span class="refDoi"> DOI: 10.1002/chem.201805361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fchem.201805361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30720221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXos1WitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=7960-7980&issue=34&author=T.+Fischerauthor=N.+Sennauthor=R.+Riedl&title=Design+and+Structural+Evolution+of+Matrix+Metalloproteinase+Inhibitors&doi=10.1002%2Fchem.201805361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Structural Evolution of Matrix Metalloproteinase Inhibitors</span></div><div class="casAuthors">Fischer, Thomas; Senn, Nicole; Riedl, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7960-7980</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are involved in a multitude of severe diseases.  Despite MMPs being considered druggable targets, past drug-discovery programs have not delivered the anticipated clin. benefits.  This review examines the latest structural evolution of small-mol. inhibitors of MMPs, with a focus on the development of novel chem. entities with improved affinity and selectivity profiles.  X-ray crystallog. data of the protein targets and cocrystal structures with inhibitors proved to be key for the success achieved during this ambitious endeavor.  An evolutionary view on the structural diversity generated for this class of mols. is provided.  This encouraging development paves the way for the clin. utilization of this class of highly relevant therapeutic targets.  The structure-based design of superior MMP inhibitors highlights the power of this technique and displays strategies for the development of treatment options based on the modulation of challenging drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnxijtyd8uL7Vg90H21EOLACvtfcHk0li6FElKFstoqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXos1WitbY%253D&md5=366df24421036cc428d37c7c905271d1</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1002%2Fchem.201805361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201805361%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DT.%26aulast%3DSenn%26aufirst%3DN.%26aulast%3DRiedl%26aufirst%3DR.%26atitle%3DDesign%2520and%2520Structural%2520Evolution%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2019%26volume%3D25%26issue%3D34%26spage%3D7960%26epage%3D7980%26doi%3D10.1002%2Fchem.201805361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saravanan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span> <span> </span><span class="NLM_article-title">Sulphonamides: Deserving Class as MMP Inhibitors?</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.ejmech.2012.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23287054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVeiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=89-100&author=P.+Jainauthor=C.+Saravananauthor=S.+K.+Singh&title=Sulphonamides%3A+Deserving+Class+as+MMP+Inhibitors%3F&doi=10.1016%2Fj.ejmech.2012.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Sulphonamides: Deserving class as MMP inhibitors?</span></div><div class="casAuthors">Jain, Pranjali; Saravanan, Chinnadurai; Singh, Sushil Kumar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The importance of sulfonamide moiety in medicinal chem. cannot be ignored as it constitutes an important class of extensively used drugs.  Recently, sulfonamides have also been reported for their matrix metalloproteinase (MMP) inhibitory activity.  MMPs are calcium- and zinc-dependent endopeptidases, involved in both inter- and intra-cellular activity.  This review documents the emergence of sulfonamides as matrix metalloproteinase inhibitors (MMPIs) from the first generation to the recent third generation MMPIs, their mode of action - how sulfonamides act on MMPs as well as the structure activity relationship along with their therapeutic uses in chronic obstructive pulmonary disease (COPD), ulcer, asthma, arthritis and cancer.  From this review, readers can get answer for the question- is sulfonamides a potential class of MMPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1FEujtONsfbVg90H21EOLACvtfcHk0liB5HjiGZTTHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVeiu7o%253D&md5=10dc47ad65684dad2cd3622b82378d2b</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DP.%26aulast%3DSaravanan%26aufirst%3DC.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26atitle%3DSulphonamides%253A%2520Deserving%2520Class%2520as%2520MMP%2520Inhibitors%253F%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D60%26spage%3D89%26epage%3D100%26doi%3D10.1016%2Fj.ejmech.2012.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuffaro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosalia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepshi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carbotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camodeca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciccone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossello, A.</span></span> <span> </span><span class="NLM_article-title">Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1626</span>– <span class="NLM_lpage">1637</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600235</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fcmdc.201600235" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27356908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyhsbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1626-1637&author=E.+Nutiauthor=D.+Cuffaroauthor=F.+D%E2%80%99Andreaauthor=L.+Rosaliaauthor=L.+Tepshiauthor=M.+Fabbiauthor=G.+Carbottiauthor=S.+Ferriniauthor=S.+Santamariaauthor=C.+Camodecaauthor=L.+Cicconeauthor=E.+Orlandiniauthor=S.+Nencettiauthor=E.+A.+Sturaauthor=V.+Diveauthor=A.+Rossello&title=Sugar-Based+Arylsulfonamide+Carboxylates+as+Selective+and+Water-Soluble+Matrix+Metalloproteinase-12+Inhibitors&doi=10.1002%2Fcmdc.201600235"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors</span></div><div class="casAuthors">Nuti, Elisa; Cuffaro, Doretta; D'Andrea, Felicia; Rosalia, Lea; Tepshi, Livia; Fabbi, Marina; Carbotti, Grazia; Ferrini, Silvano; Santamaria, Salvatore; Camodeca, Caterina; Ciccone, Lidia; Orlandini, Elisabetta; Nencetti, Susanna; Stura, Enrico A.; Dive, Vincent; Rossello, Armando</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1626-1637</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-12 (MMP-12) can be considered an attractive target to study selective inhibitors useful in the development of new therapies for lung and cardiovascular diseases.  .In this study, a new series of arylsulfonamide carboxylates, with increased hydrophilicity resulting from conjugation with a β-N-acetyl-D-glucosamine moiety, were designed and synthesized as MMP-12 selective inhibitors.  Their inhibitory activity was evaluated on human MMPs by using the fluorimetric assay, and a crystallog. anal. was performed to characterize their binding mode.  Among these glycoconjugates, a nanomolar MMP-12 inhibitor with improved water soly., compd. I was identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiqGwhIwzturVg90H21EOLACvtfcHk0liB5HjiGZTTHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyhsbbK&md5=bc140624b010a1bca6bb7dfc7365eea3</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600235%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DCuffaro%26aufirst%3DD.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DF.%26aulast%3DRosalia%26aufirst%3DL.%26aulast%3DTepshi%26aufirst%3DL.%26aulast%3DFabbi%26aufirst%3DM.%26aulast%3DCarbotti%26aufirst%3DG.%26aulast%3DFerrini%26aufirst%3DS.%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3DCamodeca%26aufirst%3DC.%26aulast%3DCiccone%26aufirst%3DL.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DStura%26aufirst%3DE.%2BA.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DSugar-Based%2520Arylsulfonamide%2520Carboxylates%2520as%2520Selective%2520and%2520Water-Soluble%2520Matrix%2520Metalloproteinase-12%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D1626%26epage%3D1637%26doi%3D10.1002%2Fcmdc.201600235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuffaro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camodeca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piragine, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossello, A.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase-12 Inhibitors: Synthesis, Structure-Activity Relationships and Intestinal Absorption of Novel Sugar-Based Biphenylsulfonamide Carboxylates</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">5804</span>– <span class="NLM_lpage">5815</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.10.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bmc.2018.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=30429099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFKmt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=5804-5815&issue=22&author=D.+Cuffaroauthor=C.+Camodecaauthor=F.+D%E2%80%99Andreaauthor=E.+Piragineauthor=L.+Testaiauthor=V.+Calderoneauthor=E.+Orlandiniauthor=E.+Nutiauthor=A.+Rossello&title=Matrix+Metalloproteinase-12+Inhibitors%3A+Synthesis%2C+Structure-Activity+Relationships+and+Intestinal+Absorption+of+Novel+Sugar-Based+Biphenylsulfonamide+Carboxylates&doi=10.1016%2Fj.bmc.2018.10.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Matrix metalloproteinase-12 inhibitors: synthesis, structure-activity relationships and intestinal absorption of novel sugar-based biphenylsulfonamide carboxylates</span></div><div class="casAuthors">Cuffaro, Doretta; Camodeca, Caterina; D'Andrea, Felicia; Piragine, Eugenia; Testai, Lara; Calderone, Vincenzo; Orlandini, Elisabetta; Nuti, Elisa; Rossello, Armando</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5804-5815</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">MMP-12 is a validated target in pulmonary and cardiovascular diseases.  The principal obstacles to clin. development of MMP-12 inhibitors are an inadequate selectivity for the target enzyme and a poor water soly., with consequent poor oral bioavailability.  We recently reported a new class of sugar-based arylsulfonamide carboxylates with a nanomolar activity for MMP-12, a good selectivity and an improved water soly.  In this study, we designed and synthesized new derivs. to characterize the structure-activity relationship (SAR) within this class of glycoconjugate inhibitors.  All the new derivs. were tested on human recombinant MMP-12 and MMP-9 in order to evaluate their affinity and the selectivity for the target enzyme.  Among them, the four most promising compds. were selected to assess their intestinal permeability using an ex vivo everted gut sac model.  Given the high polarity and structural similarity to glucose, compd. 3 was demonstrated to cross the intestinal membrane by using the facilitative GLUT2 transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr39tPCiDpjGLVg90H21EOLACvtfcHk0liB5HjiGZTTHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFKmt7jN&md5=dde01819969c8d6baac4d21340abb598</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DCuffaro%26aufirst%3DD.%26aulast%3DCamodeca%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DF.%26aulast%3DPiragine%26aufirst%3DE.%26aulast%3DTestai%26aufirst%3DL.%26aulast%3DCalderone%26aufirst%3DV.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DMatrix%2520Metalloproteinase-12%2520Inhibitors%253A%2520Synthesis%252C%2520Structure-Activity%2520Relationships%2520and%2520Intestinal%2520Absorption%2520of%2520Novel%2520Sugar-Based%2520Biphenylsulfonamide%2520Carboxylates%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26issue%3D22%26spage%3D5804%26epage%3D5815%26doi%3D10.1016%2Fj.bmc.2018.10.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nuti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuffaro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camodeca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciccone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tepshi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nencetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossello, A.</span></span> <span> </span><span class="NLM_article-title">Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4421</span>– <span class="NLM_lpage">4435</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00096</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00096" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXptVWis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4421-4435&author=E.+Nutiauthor=D.+Cuffaroauthor=E.+Bernardiniauthor=C.+Camodecaauthor=L.+Panelliauthor=S.+Chavesauthor=L.+Cicconeauthor=L.+Tepshiauthor=L.+Veraauthor=E.+Orlandiniauthor=S.+Nencettiauthor=E.+A.+Sturaauthor=M.+A.+Santosauthor=V.+Diveauthor=A.+Rossello&title=Development+of+Thioaryl-Based+Matrix+Metalloproteinase-12+Inhibitors+with+Alternative+Zinc-Binding+Groups%3A+Synthesis%2C+Potentiometric%2C+NMR%2C+and+Crystallographic+Studies&doi=10.1021%2Facs.jmedchem.8b00096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies</span></div><div class="casAuthors">Nuti, Elisa; Cuffaro, Doretta; Bernardini, Elisa; Camodeca, Caterina; Panelli, Laura; Chaves, Silvia; Ciccone, Lidia; Tepshi, Livia; Vera, Laura; Orlandini, Elisabetta; Nencetti, Susanna; Stura, Enrico A.; Santos, M. Amelia; Dive, Vincent; Rossello, Armando</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4421-4435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-12 (MMP-12) selective inhibitors could play a role in the treatment of lung inflammatory and cardiovascular diseases.  In the present study, the previously reported 4-methoxybiphenylsulfonyl hydroxamate and carboxylate based inhibitors (I and II) were modified to enhance their selectivity for MMP-12.  In the newly synthesized thioaryl derivs., the nature of the zinc binding group (ZBG) and the sulfur oxidn. state were changed.  Biol. assays carried out in vitro on human MMPs with the resulting compds. led to identification of a sulfide, III, bearing an N-1-hydroxypiperidine-2,6-dione (HPD) group as new ZBG.  Compd. III is a promising hit compd. since it displayed a nanomolar affinity for MMP-12 with a marked selectivity over MMP-9, MMP-1, and MMP-14.  Soln. complexation studies with Zn2+ were performed to characterize the chelating abilities of the new compds. and confirmed the bidentate binding mode of HPD derivs.  X-ray crystallog. studies using MMP-12 and MMP-9 catalytic domains were carried out to rationalize the biol. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGompUvE-tYWNLVg90H21EOLACvtfcHk0ljUl9tOmnVuBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXptVWis7Y%253D&md5=2b8d3c42ee0eb148735605580ae9172d</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00096%26sid%3Dliteratum%253Aachs%26aulast%3DNuti%26aufirst%3DE.%26aulast%3DCuffaro%26aufirst%3DD.%26aulast%3DBernardini%26aufirst%3DE.%26aulast%3DCamodeca%26aufirst%3DC.%26aulast%3DPanelli%26aufirst%3DL.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DCiccone%26aufirst%3DL.%26aulast%3DTepshi%26aufirst%3DL.%26aulast%3DVera%26aufirst%3DL.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DNencetti%26aufirst%3DS.%26aulast%3DStura%26aufirst%3DE.%2BA.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DRossello%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520Thioaryl-Based%2520Matrix%2520Metalloproteinase-12%2520Inhibitors%2520with%2520Alternative%2520Zinc-Binding%2520Groups%253A%2520Synthesis%252C%2520Potentiometric%252C%2520NMR%252C%2520and%2520Crystallographic%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4421%26epage%3D4435%26doi%3D10.1021%2Facs.jmedchem.8b00096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardo, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotra, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span> <span> </span><span class="NLM_article-title">Potent and Selective Mechanism-Based Inhibition of Gelatinases</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>122</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">6799</span>– <span class="NLM_lpage">6800</span>, <span class="refDoi"> DOI: 10.1021/ja001461n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja001461n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktlOqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=6799-6800&issue=12&author=S.+Brownauthor=M.+M.+Bernardoauthor=Z.+Liauthor=L.+P.+Kotraauthor=Y.+Tanakaauthor=R.+Fridmanauthor=S.+Mobashery&title=Potent+and+Selective+Mechanism-Based+Inhibition+of+Gelatinases&doi=10.1021%2Fja001461n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and Selective Mechanism-Based Inhibition of Gelatinases</span></div><div class="casAuthors">Brown, Stephen; Bernardo, M. Margarida; Li, Zhi-Hong; Kotra, Lakshmi P.; Tanaka, Yasuhiro; Fridman, Rafael; Mobashery, Shahriar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">6799-6800</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Increased level of activity for human gelatinases, MMP-2 and MMP-9, has been implicated in the process of tumor metastasis and angiogenesis.  As a result, we have been interested in the selective inhibition of these two key MMPs.  For this purpose, we have resorted to the design of mechanism-based inhibitors (also known as "kcat inhibitors" or "suicide substrates").  This type of inhibitor has the potential to impart high selectivity in inhibition of closely related enzymes, such as MMPs.  Our strategy for mechanism-based inhibition of MMPs by compd. I is depicted in Scheme 1.  The strategy envisions that coordination of the thiirane with the active-site zinc ion would activate it for modification by a nucleophile in the enzyme active site.  The biphenyl moiety in compds. 1-6 would fit in the P1' subsite of gelatinases, which is a deep hydrophobic pocket.  Energy-minimized complexes of MMP-2 and MMP-9 with compd. I indicated that the biphenyl group would fit in the active site analogously to the same group in reversible inhibitors of MMP-2 and MMP-9.  This binding mode would bring the sulfur of the thiirane in I into the coordination sphere of the zinc ion.  The models indicated that the thiirane moiety in compds. 2 and 3, with longer carbon backbones, would not be able to coordinate with the zinc ion, but would fit in an extended conformation in the active site.  Compds. I-6 were evaluated with MMPs.  Whereas inhibitors 2-6 showed either no inhibition or relatively poor inhibition of the MMPs (Ki values of micromolar at best), the behavior of inhibitor I was different.  Inhibitor I showed a dual behavior.  It served as a mechanism-based inhibitor with a partition ratio of 79 + 10 (i.e., kcat/kinac) for MMP-2 and of 416 + 63 for MMP-9.  Furthermore, it also behaved as a slow-binding inhibitor, for which the rate consts. for the on-set of inhibition (kon) and recovery of activity from inhibition (koff) were evaluated.  It would appear that coordination of the thiirane with the zinc ion (as seen in the energy-minimized computational models) would set in motion a conformational change, which is presumed from the slow-binding kinetic behavior.  The kinetic data fit the model for slow-binding inhibition.  Covalent modification of the enzymes ensued this conformational change.  We incubated inhibitor I with MMP-2 to the point that less than 5% activity remained.  This inhibitor-enzyme complex was dialyzed over 3 days, which resulted in recovery of approx. 50% of the activity.  This observation is consistent with modification of the active site Glu-404, via the formation of an ester bond, which is a relatively labile covalent linkage.  We observe selectivity in inhibition of gelatinases by inhibitor I.  The Ki values are 13.9 ± 0.4 and 600 ± 200 nM for MMP-2 and MMP-9, resp.  In contrast, the corresponding Ki values for the other MMPs tested, including MMP-3, which does show the slow-binding mechanism-based inhibition profile, are in the micromolar range.  Interestingly, the values for kon, are 611- and 78-fold larger for MMP-2 and MMP-9, resp., than that for MMP-3.  Collectively, these kinetic parameters make inhibitor I a potent and selective inhibitor for both MMP-2 and MMP-9, more so for MMP-2.  We have detd. previously that two mols. of either TIMP-1 or TIMP-2 bind to activated MMP-2 and MMP-9.  One binding event is high affinity and would appear physiol. relevant, whereas the second binding event takes place with relatively lower affinity (micromolar).  Inhibition of MMP-2 and MMP-9 by TIMP-2 and TIMP-1, resp., also follows slow-binding kinetics.  The kinetic parameters for these interactions at the high affinity site are presented.  We find it noteworthy that the kinetic parameters for the slow-binding component of inhibition of MMP-2 and MMP-9 by inhibitor I (kon and koff) approach closely the same parameters for those of the TIMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_leOdGm4bBrVg90H21EOLACvtfcHk0ljUl9tOmnVuBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktlOqt7Y%253D&md5=15101fcf9ff6340558e63b181b62a6dd</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1021%2Fja001461n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja001461n%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DBernardo%26aufirst%3DM.%2BM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DKotra%26aufirst%3DL.%2BP.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26atitle%3DPotent%2520and%2520Selective%2520Mechanism-Based%2520Inhibition%2520of%2520Gelatinases%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26issue%3D12%26spage%3D6799%26epage%3D6800%26doi%3D10.1021%2Fja001461n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleifeld, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotra, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gervasi, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardo, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">X-Ray Absorption Studies of Human Matrix Metalloproteinase-2 (MMP-2) Bound to a Highly Selective Mechanism-Based Inhibitor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">17125</span>– <span class="NLM_lpage">17131</span>, <span class="refDoi"> DOI: 10.1074/jbc.M011604200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M011604200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=11278946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjvFGitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=17125-17131&issue=20&author=O.+Kleifeldauthor=L.+P.+Kotraauthor=D.+C.+Gervasiauthor=S.+Brownauthor=M.+M.+Bernardoauthor=R.+Fridmanauthor=S.+Mobasheryauthor=I.+Sagi&title=X-Ray+Absorption+Studies+of+Human+Matrix+Metalloproteinase-2+%28MMP-2%29+Bound+to+a+Highly+Selective+Mechanism-Based+Inhibitor&doi=10.1074%2Fjbc.M011604200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanism-based inhibitor. Comparison with the latent and active forms of the enzyme</span></div><div class="casAuthors">Kleifeld, Oded; Kotra, Lakshmi P.; Gervasi, David C.; Brown, Stephen; Bernardo, M. Margarida; Fridman, Rafael; Mobashery, Shahriar; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">17125-17131</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Malignant tumors express high levels of zinc-dependent endopeptidases called matrix metalloproteinases (MMPs), which are thought to facilitate tumor metastasis and angiogenesis by hydrolyzing components of the extracellular matrix.  Of these enzymes, gelatinases A (MMP-2) and B (MMP-9), have esp. been implicated in malignant processes, and thus, they have been a target for drugs designed to block their activity.  Therefore, understanding their mol. structure is key for a rational approach to inhibitor design.  Here, the authors have conducted x-ray absorption spectroscopy of the full-length human MMP-2 in its latent, active, and inhibited states and report the structural changes at the zinc ion site upon enzyme activation and inhibition.  The authors have also examd. the mol. structure of MMP-2 in complex with SB-3CT, a recently reported novel mechanism-based synthetic inhibitor that was designed to be highly selective in gelatinases.  It is shown that SB-3CT directly binds the catalytic zinc ion of MMP-2.  Interestingly, the novel mode of binding of the inhibitor to the catalytic zinc reconstructs the conformational environment around the active site metal ion back to that of the proenzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKUVKfewB1R7Vg90H21EOLACvtfcHk0lhSNyaGhWR9AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjvFGitrY%253D&md5=cb92e0e1e44d1c636a840140c115c4b6</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M011604200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M011604200%26sid%3Dliteratum%253Aachs%26aulast%3DKleifeld%26aufirst%3DO.%26aulast%3DKotra%26aufirst%3DL.%2BP.%26aulast%3DGervasi%26aufirst%3DD.%2BC.%26aulast%3DBrown%26aufirst%3DS.%26aulast%3DBernardo%26aufirst%3DM.%2BM.%26aulast%3DFridman%26aufirst%3DR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DX-Ray%2520Absorption%2520Studies%2520of%2520Human%2520Matrix%2520Metalloproteinase-2%2520%2528MMP-2%2529%2520Bound%2520to%2520a%2520Highly%2520Selective%2520Mechanism-Based%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D20%26spage%3D17125%26epage%3D17131%26doi%3D10.1074%2Fjbc.M011604200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gooyit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckow, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolter, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span> <span> </span><span class="NLM_article-title">Selective Gelatinase Inhibitor Neuroprotective Agents Cross the Blood-Brain Barrier</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">736</span>, <span class="refDoi"> DOI: 10.1021/cn300062w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300062w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWhsrfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=730-736&issue=10&author=M.+Gooyitauthor=M.+A.+Suckowauthor=V.+A.+Schroederauthor=W.+R.+Wolterauthor=S.+Mobasheryauthor=M.+Chang&title=Selective+Gelatinase+Inhibitor+Neuroprotective+Agents+Cross+the+Blood-Brain+Barrier&doi=10.1021%2Fcn300062w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Gelatinase Inhibitor Neuroprotective Agents Cross the Blood-Brain Barrier</span></div><div class="casAuthors">Gooyit, Major; Suckow, Mark A.; Schroeder, Valerie A.; Wolter, William R.; Mobashery, Shahriar; Chang, Mayland</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">730-736</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SB-3CT, a potent and selective inhibitor of matrix metalloproteinase-2 and -9, has shown efficacy in several animal models of neurol. diseases.  One of the greatest challenges in the development of therapeutics for neurol. diseases is the inability of drugs to cross the blood-brain barrier.  A sensitive bioanal. method based on ultraperformance liq. chromatog. with multiple-reaction monitoring detection was developed to measure levels of SB-3CT, its active metabolite, the α-Me analog, and its p-hydroxy metabolite in plasma and brain.  The compds. are rapidly absorbed and are readily distributed to the brain.  The pharmacokinetic properties of these gelatinase inhibitors and the efficacy shown by SB-3CT in animal models of stroke, subarachnoid hemorrhage, and spinal cord injury indicate that this class of compds. holds considerable promise in the treatment of diseases of the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmol4U6a2bIbVg90H21EOLACvtfcHk0lhSNyaGhWR9AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWhsrfE&md5=05f147cd30e827b2d81b155af8a6c418</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Fcn300062w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300062w%26sid%3Dliteratum%253Aachs%26aulast%3DGooyit%26aufirst%3DM.%26aulast%3DSuckow%26aufirst%3DM.%2BA.%26aulast%3DSchroeder%26aufirst%3DV.%2BA.%26aulast%3DWolter%26aufirst%3DW.%2BR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DSelective%2520Gelatinase%2520Inhibitor%2520Neuroprotective%2520Agents%2520Cross%2520the%2520Blood-Brain%2520Barrier%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26issue%3D10%26spage%3D730%26epage%3D736%26doi%3D10.1021%2Fcn300062w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ranasinghe, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheepens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sirimanne, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of MMP-9 Activity Following Hypoxic Ischemia in the Developing Brain Using a Highly Specific Inhibitor</span>. <i>Dev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">417</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1159/000343257</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1159%2F000343257" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23171520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2012&pages=417-427&issue=5&author=H.+S.+Ranasingheauthor=A.+Scheepensauthor=E.+Sirimanneauthor=M.+D.+Mitchellauthor=C.+E.+Williamsauthor=M.+Fraser&title=Inhibition+of+MMP-9+Activity+Following+Hypoxic+Ischemia+in+the+Developing+Brain+Using+a+Highly+Specific+Inhibitor&doi=10.1159%2F000343257"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of MMP-9 Activity following Hypoxic Ischemia in the Developing Brain Using a Highly Specific Inhibitor</span></div><div class="casAuthors">Ranasinghe, Himani S.; Scheepens, Arjan; Sirimanne, Ernest; Mitchell, Murray D.; Williams, Christopher E.; Fraser, Mhoyra</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Neuroscience (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">417-427</span>CODEN:
                <span class="NLM_cas:coden">DENED7</span>;
        ISSN:<span class="NLM_cas:issn">0378-5866</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Perinatal hypoxic ischemic (HI) brain injury is a leading cause of long-term neurol. handicap in newborn babies.  Recently, excessive activity of matrix metalloproteinases (MMPs), and in particular MMP-9, has been implicated in the etiol. of HI injuries to the immature brain.  Our previous study suggested that MMP-9 may be involved in the development of the delayed injury processes following HI injury to the developing brain.  Given this, we therefore propose that MMP-9 may be a useful target for rescue therapies in the injured developing brain.  To address this, we chose to use SB-3CT, a highly selective inhibitor that is known to target only MMP-2 and MMP-9, to attenuate the elevated MMP-9 activity seen following HI injury to the developing brain.  Twenty-one-day-old postnatal Wistar rats were subjected to unilateral carotid artery occlusion followed by exposure to hypoxia (8% oxygen for 1 h).  SB-3CT (50 mg/kg body wt. in 25% DMSO/75% polyethylene glycol) or an equal vol. of vehicle or saline diluent was then administered i.p. at 2, 5 and 14 h following the insult.  Gelatin zymog. revealed that pro-MMP-9 levels were significantly reduced at 6 h following hypoxic ischemia (p ≤ 0.05).  However, our results showed that despite significantly inhibiting brain pro-MMP-9 activity after hypoxic ischemia, SB-3CT failed to confer significant neuroprotection in postnatal day 21 rats 3 days after an HI insult.  Further investigations are warranted using a recently reported selective water-sol. version of SB-3CT or another MMP-9 selective inhibitor to resolve the role of MMP-9 in the etiol. of HI injury in the developing brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxpRv7eWe3D7Vg90H21EOLACvtfcHk0lhSNyaGhWR9AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyqs78%253D&md5=429fef8bd3080501a530b4d34cfce258</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1159%2F000343257&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000343257%26sid%3Dliteratum%253Aachs%26aulast%3DRanasinghe%26aufirst%3DH.%2BS.%26aulast%3DScheepens%26aufirst%3DA.%26aulast%3DSirimanne%26aufirst%3DE.%26aulast%3DMitchell%26aufirst%3DM.%2BD.%26aulast%3DWilliams%26aufirst%3DC.%2BE.%26aulast%3DFraser%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520MMP-9%2520Activity%2520Following%2520Hypoxic%2520Ischemia%2520in%2520the%2520Developing%2520Brain%2520Using%2520a%2520Highly%2520Specific%2520Inhibitor%26jtitle%3DDev.%2520Neurosci.%26date%3D2012%26volume%3D34%26issue%3D5%26spage%3D417%26epage%3D427%26doi%3D10.1159%2F000343257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gooyit, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahasenan, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenwalter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suckow, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolter, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mobashery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, M.</span></span> <span> </span><span class="NLM_article-title">O -Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors That Cross the Blood-Brain Barrier</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8139</span>– <span class="NLM_lpage">8150</span>, <span class="refDoi"> DOI: 10.1021/jm401217d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401217d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVeksbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=8139-8150&issue=20&author=M.+Gooyitauthor=W.+Songauthor=K.+V.+Mahasenanauthor=K.+Lichtenwalterauthor=M.+A.+Suckowauthor=V.+A.+Schroederauthor=W.+R.+Wolterauthor=S.+Mobasheryauthor=M.+Chang&title=O+-Phenyl+Carbamate+and+Phenyl+Urea+Thiiranes+as+Selective+Matrix+Metalloproteinase-2+Inhibitors+That+Cross+the+Blood-Brain+Barrier&doi=10.1021%2Fjm401217d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">O-Phenyl Carbamate and Phenyl Urea Thiiranes as Selective Matrix Metalloproteinase-2 Inhibitors that Cross the Blood-Brain Barrier</span></div><div class="casAuthors">Gooyit, Major; Song, Wei; Mahasenan, Kiran V.; Lichtenwalter, Katerina; Suckow, Mark A.; Schroeder, Valerie A.; Wolter, William R.; Mobashery, Shahriar; Chang, Mayland</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8139-8150</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Brain metastasis occurs in 20-40% of cancer patients.  Treatment is mostly palliative, and the inability of most drugs to penetrate the brain presents one of the greatest challenges in the development of therapeutics for brain metastasis.  Matrix metalloproteinase-2 (MMP-2) plays important roles in invasion and vascularization of the central nervous system and represents a potential target for treatment of brain metastasis.  Carbonate, O-Ph carbamate, urea, and N-Ph carbamate derivs. of SB-3CT, a selective and potent gelatinase inhibitor, were synthesized and evaluated.  The O-Ph carbamate and urea variants were selective and potent inhibitors of MMP-2.  Carbamate (I) was metabolized to a potent gelatinase inhibitor, which was present at therapeutic concns. in the brain.  In contrast, Ph urea (II) crossed the blood-brain barrier, however, higher doses would result in therapeutic brain concns.  Carbamate I and urea II show potential for intervention of MMP-2-dependent diseases such as brain metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxJd0iAL1uYrVg90H21EOLACvtfcHk0lieAXrzDdSroQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVeksbrF&md5=f84950242a75d2c2c947eeee5630fc64</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1021%2Fjm401217d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401217d%26sid%3Dliteratum%253Aachs%26aulast%3DGooyit%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DMahasenan%26aufirst%3DK.%2BV.%26aulast%3DLichtenwalter%26aufirst%3DK.%26aulast%3DSuckow%26aufirst%3DM.%2BA.%26aulast%3DSchroeder%26aufirst%3DV.%2BA.%26aulast%3DWolter%26aufirst%3DW.%2BR.%26aulast%3DMobashery%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DM.%26atitle%3DO%2520-Phenyl%2520Carbamate%2520and%2520Phenyl%2520Urea%2520Thiiranes%2520as%2520Selective%2520Matrix%2520Metalloproteinase-2%2520Inhibitors%2520That%2520Cross%2520the%2520Blood-Brain%2520Barrier%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D20%26spage%3D8139%26epage%3D8150%26doi%3D10.1021%2Fjm401217d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span> <span> </span><span class="NLM_article-title">MMP-9 Inhibitor SB-3CT Attenuates Behavioral Impairments and Hippocampal Loss after Traumatic Brain Injury in Rat</span>. <i>J. Neurotrauma</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">1225</span>– <span class="NLM_lpage">1234</span>, <span class="refDoi"> DOI: 10.1089/neu.2013.3230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1089%2Fneu.2013.3230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=24661104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC2crmslWitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=1225-1234&issue=13&author=F.+Jiaauthor=Y.+H.+Yinauthor=G.+Y.+Gaoauthor=Y.+Wangauthor=L.+Cenauthor=J.+Jiang&title=MMP-9+Inhibitor+SB-3CT+Attenuates+Behavioral+Impairments+and+Hippocampal+Loss+after+Traumatic+Brain+Injury+in+Rat&doi=10.1089%2Fneu.2013.3230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat</span></div><div class="casAuthors">Jia Feng; Yin Yu Hua; Gao Guo Yi; Wang Yu; Cen Lian; Jiang Ji-Yao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurotrauma</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1225-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The aim of this study was to evaluate the potential efficacy of SB-3CT, a matrix metallopeptidase 9 inhibitor, on behavioral and histological outcomes after traumatic brain injury (TBI) in rats.  Adult male Sprague-Dawley rats were randomly divided into three groups (n=15/group): TBI with SB-3CT treatment, TBI with saline, and sham injury.  The TBI model was induced by a fluid percussion TBI device.  SB-3CT (50 mg/kg in 10% dimethyl sulfoxide) was administered intraperitoneally at 30 min, 6 h, and 12 h after the TBI.  Motor function (beam-balance/beam-walk tests) and spatial learning/memory (Morris water maze) were assessed on post-operative Days 1-5 and 11-15, respectively.  Fluoro-Jade staining, immunofluorescence, and cresyl violet-staining were carried out for histopathological evaluation at 24 h, 72 h, and 15 days after TBI, respectively.  It was shown that TBI can result in significant behavioral deficit induced by acute neurodegeneration, increased expression of cleaved caspase-3, and long-term neuronal loss.  SB-3CT intervention via the current regime provides robust behavioral protection and hippocampal neurons preservation from the deleterious effects of TBI.  Hence, the efficacy of SB-3CT on TBI prognosis could be ascertained.  It is believed that the current study adds to the growing literature in identifying SB-3CT as a potential therapy for human brain injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRF6ppVsbFbvJcXNb62YGmbfW6udTcc2eYapRsu8hbVrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crmslWitg%253D%253D&md5=fc658ed558d1253792292a130e3dcca4</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1089%2Fneu.2013.3230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fneu.2013.3230%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DF.%26aulast%3DYin%26aufirst%3DY.%2BH.%26aulast%3DGao%26aufirst%3DG.%2BY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCen%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DJ.%26atitle%3DMMP-9%2520Inhibitor%2520SB-3CT%2520Attenuates%2520Behavioral%2520Impairments%2520and%2520Hippocampal%2520Loss%2520after%2520Traumatic%2520Brain%2520Injury%2520in%2520Rat%26jtitle%3DJ.%2520Neurotrauma%26date%3D2014%26volume%3D31%26issue%3D13%26spage%3D1225%26epage%3D1234%26doi%3D10.1089%2Fneu.2013.3230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogakos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makaritis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuniasse, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yiotakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">11152</span>– <span class="NLM_lpage">11160</span>, <span class="refDoi"> DOI: 10.1074/jbc.M600222200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M600222200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=16481329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFWjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=11152-11160&issue=16&author=L.+Develauthor=V.+Rogakosauthor=A.+Davidauthor=A.+Makaritisauthor=F.+Beauauthor=P.+Cuniasseauthor=A.+Yiotakisauthor=V.+Dive&title=Development+of+Selective+Inhibitors+and+Substrate+of+Matrix+Metalloproteinase-12&doi=10.1074%2Fjbc.M600222200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12</span></div><div class="casAuthors">Devel, Laurent; Rogakos, Vassilis; David, Arnaud; Makaritis, Anastasios; Beau, Fabrice; Cuniasse, Philippe; Yiotakis, Athanasios; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">11152-11160</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Four phosphinic peptide libraries with compds. having the general formula p-Br-Ph-(PO2-CH2)-Xaa'-Yaa'-Zaa'-NH2 have been prepd. and screened against 10 matrix metalloproteinases (MMPs).  We identified two phosphinic peptides with Ki values of 0.19 and 4.4 nM toward MMP-12 (macrophage elastase) that are more than 2-3 orders of magnitude less potent toward the other MMPs tested.  These highly selective MMP-12 inhibitors contain a Glu-Glu motif in their Yaa'-Zaa' positions.  Incorporation of this Glu-Glu motif into the sequence of a nonspecific fluorogenic peptide cleaved by MMPs provides a highly selective substrate for MMP-12.  A model of one of these inhibitors interacting with MMP-12 suggests that the selectivity obsd. might be due, in part, to the presence of two unique polar residues in MMP-12, Thr239 and Lys177.  These MMP-12-selective inhibitors may have important therapeutic applications to diseases in which MMP-12 has been suggested to play a key role, such as in emphysema, atherosclerosis, and aortic abdominal aneurysm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCB87ECATf7bVg90H21EOLACvtfcHk0lhpAV27UDVa4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFWjsLs%253D&md5=ef003d08431c8bccda87c29e1aa32b26</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M600222200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M600222200%26sid%3Dliteratum%253Aachs%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DRogakos%26aufirst%3DV.%26aulast%3DDavid%26aufirst%3DA.%26aulast%3DMakaritis%26aufirst%3DA.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DCuniasse%26aufirst%3DP.%26aulast%3DYiotakis%26aufirst%3DA.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DDevelopment%2520of%2520Selective%2520Inhibitors%2520and%2520Substrate%2520of%2520Matrix%2520Metalloproteinase-12%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D16%26spage%3D11152%26epage%3D11160%26doi%3D10.1074%2Fjbc.M600222200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassar-Lajeunesse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchinat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Molecular Determinants of a Selective Matrix Metalloprotease-12 Inhibitor: Insights from Crystallography and Thermodynamic Studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.1021/jm301574d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301574d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlelsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1149-1159&issue=3&author=B.+Czarnyauthor=E.+A.+Sturaauthor=L.+Develauthor=L.+Veraauthor=E.+Cassar-Lajeunesseauthor=F.+Beauauthor=V.+Calderoneauthor=M.+Fragaiauthor=C.+Luchinatauthor=V.+Dive&title=Molecular+Determinants+of+a+Selective+Matrix+Metalloprotease-12+Inhibitor%3A+Insights+from+Crystallography+and+Thermodynamic+Studies&doi=10.1021%2Fjm301574d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Determinants of a Selective Matrix Metalloprotease-12 Inhibitor: Insights from Crystallography and Thermodynamic Studies</span></div><div class="casAuthors">Czarny, Bertrand; Stura, Enrico A.; Devel, Laurent; Vera, Laura; Cassar-Lajeunesse, Evelyne; Beau, Fabrice; Calderone, Vito; Fragai, Marco; Luchinat, Claudio; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1149-1159</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The mol. determinants responsible for the potency of the RXP470.1 phosphinic peptide inhibitor toward matrix metalloprotease-12 (MMP-12) remain elusive.  To address this issue, structure-activity study, X-ray crystallog., and isothermal titrn. calorimetry (ITC) expts. were performed.  The crystal structure of MMP-12/inhibitor complex (1.15 Å) reveals that the inhibitor establishes multiple interactions with the MMP-12 active site, with its long P1' side chain filling most of the S1' deep cavity.  ITC expts. indicate that the binding of this inhibitor to MMP-12 is mostly entropy driven (ΔG° = -13.1 kcal/mol, ΔH° = -2.53 kcal/mol, and -TΔS° = -10.60 kcal/mol) and involves a proton uptake from the buffer.  Comparing phosphinic vs. hydroxamate inhibitors reveals that the chelation of the zinc ion is slightly different, leading the inhibitor backbone to adopt a position in which the hydrogen bonding with the MMP-12 active site is less favorable in phosphinic inhibitor while maintaining high affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonVg7l2QsQ_bVg90H21EOLACvtfcHk0lhHX6P2Zjuhxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlelsrc%253D&md5=481c06c2374ff4204e2793874a589ec3</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1021%2Fjm301574d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301574d%26sid%3Dliteratum%253Aachs%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DStura%26aufirst%3DE.%2BA.%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DVera%26aufirst%3DL.%26aulast%3DCassar-Lajeunesse%26aufirst%3DE.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DCalderone%26aufirst%3DV.%26aulast%3DFragai%26aufirst%3DM.%26aulast%3DLuchinat%26aufirst%3DC.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DMolecular%2520Determinants%2520of%2520a%2520Selective%2520Matrix%2520Metalloprotease-12%2520Inhibitor%253A%2520Insights%2520from%2520Crystallography%2520and%2520Thermodynamic%2520Studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D3%26spage%3D1149%26epage%3D1159%26doi%3D10.1021%2Fjm301574d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rouanet-Mehouas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassar-Lajeunesse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span> <span> </span><span class="NLM_article-title">Zinc-Metalloproteinase Inhibitors: Evaluation of the Complex Role Played by the Zinc-Binding Group on Potency and Selectivity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">414</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01420</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01420" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWmsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=403-414&issue=1&author=C.+Rouanet-Mehouasauthor=B.+Czarnyauthor=F.+Beauauthor=E.+Cassar-Lajeunesseauthor=E.+A.+Sturaauthor=V.+Diveauthor=L.+Devel&title=Zinc-Metalloproteinase+Inhibitors%3A+Evaluation+of+the+Complex+Role+Played+by+the+Zinc-Binding+Group+on+Potency+and+Selectivity&doi=10.1021%2Facs.jmedchem.6b01420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Zinc-metalloproteinase inhibitors: Evaluation of the complex role played by the zinc-binding group on potency and selectivity</span></div><div class="casAuthors">Rouanet-Mehouas, Cecile; Czarny, Bertrand; Beau, Fabrice; Cassar-Lajeunesse, Evelyne; Stura, Enrico A.; Dive, Vincent; Devel, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">403-414</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The most exploited strategy to develop potent Zn-metalloprotease inhibitors relies on a core Zn chelator and a peptidic or nonpeptidic scaffold that provides supplementary interactions for optimized potency and selectivity.  Applied to matrix metalloproteases (MMPs) with highly conserved catalytic domains, this strategy failed to identify inhibitors with the desired selectivity profiles.  To question the precise role of the Zn-binding group (ZBG), the authors carried out a study on MMP-12 inhibitors with a common peptidic core but different ZBGs.  The authors found that exchanging the ZBG modified inhibitor positioning and affected its dynamics and selectivity.  The binding properties of these compds. were compared through biochem., structural, and calorimetric studies, showing a complex interplay between cooperative interactions and dynamics dictated by the ZBG.  Improving selectivity will require expanding the ZBG repertoire within inhibitor libraries, since relying on a single ZBG significantly decreases the chance to identify effective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_v2xSUupLKLVg90H21EOLACvtfcHk0lhQ9P7smWeRfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWmsr7L&md5=d6ec22a45611ef6bb28e18cefb9f7264</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01420%26sid%3Dliteratum%253Aachs%26aulast%3DRouanet-Mehouas%26aufirst%3DC.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DCassar-Lajeunesse%26aufirst%3DE.%26aulast%3DStura%26aufirst%3DE.%2BA.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DDevel%26aufirst%3DL.%26atitle%3DZinc-Metalloproteinase%2520Inhibitors%253A%2520Evaluation%2520of%2520the%2520Complex%2520Role%2520Played%2520by%2520the%2520Zinc-Binding%2520Group%2520on%2520Potency%2520and%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D1%26spage%3D403%26epage%3D414%26doi%3D10.1021%2Facs.jmedchem.6b01420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lajeunesse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Insights from Selective Non-Phosphinic Inhibitors of MMP-12 Tailored to Fit with an S1′ Loop Canonical Conformation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">35900</span>– <span class="NLM_lpage">35909</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.139634</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M110.139634" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20817735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlyntb7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=35900-35909&issue=46&author=L.+Develauthor=S.+Garciaauthor=B.+Czarnyauthor=F.+Beauauthor=E.+Lajeunesseauthor=L.+Veraauthor=D.+Georgiadisauthor=E.+Sturaauthor=V.+Dive&title=Insights+from+Selective+Non-Phosphinic+Inhibitors+of+MMP-12+Tailored+to+Fit+with+an+S1%E2%80%B2+Loop+Canonical+Conformation&doi=10.1074%2Fjbc.M110.139634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Insights from Selective Non-phosphinic Inhibitors of MMP-12 Tailored to Fit with an S1' Loop Canonical Conformation</span></div><div class="casAuthors">Devel, Laurent; Garcia, Sandra; Czarny, Bertrand; Beau, Fabrice; Lajeunesse, Evelyne; Vera, Laura; Georgiadis, Dimitris; Stura, Enrico; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">35900-35909</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">After the disappointment of clin. trials with early broad spectrum synthetic inhibitors of matrix metalloproteinases (MMPs), the field is now resurging with a new focus on the development of selective inhibitors that fully discriminate between different members of the MMP family with several therapeutic applications in perspective.  Here, we report a novel class of highly selective MMP-12 inhibitors, without a phosphinic zinc-binding group, designed to plunge deeper into the S1' cavity of the enzyme.  The best inhibitor from this series, identified through a systematic chem. exploration, displays nanomolar potency toward MMP-12 and selectivity factors that range between 2 and 4 orders of magnitude toward a large set of MMPs.  Comparison of the high resoln. x-ray structures of MMP-12 in free state or bound to this new MMP-12 selective inhibitor reveals that this compd. fits deeply within the S1' specificity cavity, maximizing surface/vol. ratios, without perturbing the S1' loop conformation.  This is in contrast with highly selective MMP-13 inhibitors that were shown to select a particular S1' loop conformation.  The search for such compds. that fit precisely to preponderant S1' loop conformation of a particular MMP may prove to be an alternative effective strategy for developing selective inhibitors of MMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ8qFgfjdCB7Vg90H21EOLACvtfcHk0ljAVD_xmjPPMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlyntb7N&md5=ce4a49985e0a8906820e879c154bb91a</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.139634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.139634%26sid%3Dliteratum%253Aachs%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DGarcia%26aufirst%3DS.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DLajeunesse%26aufirst%3DE.%26aulast%3DVera%26aufirst%3DL.%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DStura%26aufirst%3DE.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DInsights%2520from%2520Selective%2520Non-Phosphinic%2520Inhibitors%2520of%2520MMP-12%2520Tailored%2520to%2520Fit%2520with%2520an%2520S1%25E2%2580%25B2%2520Loop%2520Canonical%2520Conformation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D46%26spage%3D35900%26epage%3D35909%26doi%3D10.1074%2Fjbc.M110.139634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassar-Lajeunesse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stura, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Simple Pseudo-Dipeptides with a P2′ Glutamate: A Novel Inhibitor Family of Matrix Metalloproteases and Other Metzincins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">32</span>),  <span class="NLM_fpage">26647</span>– <span class="NLM_lpage">26656</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.380782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M112.380782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=22689580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFaqsbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=26647-26656&issue=32&author=L.+Develauthor=F.+Beauauthor=M.+Amouraauthor=L.+Veraauthor=E.+Cassar-Lajeunesseauthor=S.+Garciaauthor=B.+Czarnyauthor=E.+A.+Sturaauthor=V.+Dive&title=Simple+Pseudo-Dipeptides+with+a+P2%E2%80%B2+Glutamate%3A+A+Novel+Inhibitor+Family+of+Matrix+Metalloproteases+and+Other+Metzincins&doi=10.1074%2Fjbc.M112.380782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Simple Pseudo-dipeptides with a P2' Glutamate</span></div><div class="casAuthors">Devel, Laurent; Beau, Fabrice; Amoura, Mehdi; Vera, Laura; Cassar-Lajeunesse, Evelyne; Garcia, Sandra; Czarny, Bertrand; Stura, Enrico A.; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">26647-26656</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A series of pseudo-peptides with general formula X-L-Glu-NH2 (with X corresponding to an acyl moiety with a long aryl-alkyl side chain) have been synthesized, evaluated as inhibitors of matrix metalloproteases (MMPs), and found to display remarkable nanomolar affinity.  The loss in potency assocd. with a substitution of the P2' L-glutamate by a L-glutamine corroborates the importance of a carboxylate at this position.  The binding mode of some of these inhibitors was characterized in soln. and by X-ray crystallog. in complex with various MMPs.  The X-ray crystal structures reveal an unusual binding mode with the glutamate side chain chelating the active site zinc ion.  Competition expts. between these inhibitors and acetohydroxamic acid, a small zinc-binding mol., are in accord with the crystallog. results.  One of these pseudo-dipeptides displays potency and selectivity toward MMP-12 similar to the best MMP-12 inhibitors reported to date.  This novel family of pseudo peptides opens new opportunities to develop potent and selective inhibitors for several metzincins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnrbDIuByI17Vg90H21EOLACvtfcHk0lil3QR5QRjUHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFaqsbjJ&md5=071a0d7c5dfafb512449997e929f6d9d</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.380782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.380782%26sid%3Dliteratum%253Aachs%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DAmoura%26aufirst%3DM.%26aulast%3DVera%26aufirst%3DL.%26aulast%3DCassar-Lajeunesse%26aufirst%3DE.%26aulast%3DGarcia%26aufirst%3DS.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DStura%26aufirst%3DE.%2BA.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DSimple%2520Pseudo-Dipeptides%2520with%2520a%2520P2%25E2%2580%25B2%2520Glutamate%253A%2520A%2520Novel%2520Inhibitor%2520Family%2520of%2520Matrix%2520Metalloproteases%2520and%2520Other%2520Metzincins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26issue%3D32%26spage%3D26647%26epage%3D26656%26doi%3D10.1074%2Fjbc.M112.380782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nury, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bregant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassar-Lajeunesse, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Detection of Endogenous Matrix Metalloprotease-12 Active Form with a Novel Broad Spectrum Activity-Based Probe</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">5636</span>– <span class="NLM_lpage">5644</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.419499</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M112.419499" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23271741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVGlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=5636-5644&issue=8&author=C.+Nuryauthor=S.+Bregantauthor=B.+Czarnyauthor=F.+Berthonauthor=E.+Cassar-Lajeunesseauthor=V.+Dive&title=Detection+of+Endogenous+Matrix+Metalloprotease-12+Active+Form+with+a+Novel+Broad+Spectrum+Activity-Based+Probe&doi=10.1074%2Fjbc.M112.419499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of Endogenous Matrix Metalloprotease-12 Active Form with a Novel Broad Spectrum Activity-based Probe</span></div><div class="casAuthors">Nury, Catherine; Bregant, Sarah; Czarny, Bertrand; Berthon, Fannely; Cassar-Lajeunesse, Evelyne; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5636-5644</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Matrix metalloproteases (MMPs) have attracted considerable attention as crit. mediators of pathol. tissue remodeling processes.  However it remains an unresolved challenge to detect their active forms in biol. samples.  To prove the efficacy of a recently developed MMP activity-based probe, we examd. the content in MMP active forms of bronchoalveolar lavage fluids (BALf) from male C57BL/6 mice exposed to ultrafine carbon black nanoparticles, a model of chronic obstructive pulmonary disease (COPD).  This probe was shown to label proteins, mostly expressed in BALf of mice exposed to nanoparticles.  Using competition assays with a selective MMP-12 inhibitor as well as MMP-12 knock-out mice, one of these proteins was identified as the active form of the catalytic domain of MMP-12.  This new probe can detect the active form of MMP-12 down to a threshold of 1 fmol.  Radioactive counting showed the concn. of the active form of MMP-12 to be around 1 fmol/μl in BALf from nanoparticle-treated mice.  A less sensitive probe would therefore not have detected MMP-12.  As the probe can detect other MMPs in the femtomolar range, it is a potentially powerful tool for monitoring the levels of MMP active forms in various diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9O4lT6P-B_rVg90H21EOLACvtfcHk0lil3QR5QRjUHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVGlsL4%253D&md5=8fe1b32d9845b045823f2766b9c3ee93</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.419499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.419499%26sid%3Dliteratum%253Aachs%26aulast%3DNury%26aufirst%3DC.%26aulast%3DBregant%26aufirst%3DS.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DBerthon%26aufirst%3DF.%26aulast%3DCassar-Lajeunesse%26aufirst%3DE.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DDetection%2520of%2520Endogenous%2520Matrix%2520Metalloprotease-12%2520Active%2520Form%2520with%2520a%2520Novel%2520Broad%2520Spectrum%2520Activity-Based%2520Probe%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D8%26spage%3D5636%26epage%3D5644%26doi%3D10.1074%2Fjbc.M112.419499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khomiak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konopka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rejmak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaczmarek, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarragó, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prades, R.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Selective and Blood-Brain Barrier-Permeable Hydroxamate-Based Gelatinase Inhibitors</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">103365</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.103365</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bioorg.2019.103365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31676116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2htbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2020&pages=103365&author=A.+Bertranauthor=D.+Khomiakauthor=A.+Konopkaauthor=E.+Rejmakauthor=E.+Bulskaauthor=J.+Secoauthor=L.+Kaczmarekauthor=T.+Tarrag%C3%B3author=R.+Prades&title=Design+and+Synthesis+of+Selective+and+Blood-Brain+Barrier-Permeable+Hydroxamate-Based+Gelatinase+Inhibitors&doi=10.1016%2Fj.bioorg.2019.103365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of selective and blood-brain barrier-permeable hydroxamate-based gelatinase inhibitors</span></div><div class="casAuthors">Bertran, Alexandra; Khomiak, Danylo; Konopka, Anna; Rejmak, Emilia; Bulska, Ewa; Seco, Jesus; Kaczmarek, Leszek; Tarrago, Teresa; Prades, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103365</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Matrix metalloproteinases (MMPs), a family of zinc-contg. endopeptidases involved in the degrdn. of the extracellular matrix, make a major contribution to the progression of a vast no. of diseases, such cancer or epilepsy.  Although several MMP inhibitors (MMPi) have been developed to date for the treatment of cancer, they have all failed in clin. trials due to lack of efficacy and, most importantly, the presence of severe side effects.  The latter can be explained by their lack of selectivity of these inhibitors.  In this regard, MMPs' family members have a high structural homol., which challenge the development of selective inhibitors for a specific MMP.  Here, we have used in silico calcns. and in vitro data to design MMPi that selectively target gelatinases (MMP-2 and MMP-9) and have the capacity to cross the blood-brain barrier.  Following this approach, we obtained compd. 40 that shows high proteolytic stability and low cytotoxicity.  This compd. may be of particular interest for the treatment of central nervous diseases such epilepsy or Alzheimer's disease, where gelatinase activity is increased.  Our data show the specificity of compd. 40 for recombinant MMP-9 and MMP-2 and endogenous MMP-9 from rat hippocampal cell cultures, and reveals its permeability across the blood-brain barrier in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRv1ljGyR_9bVg90H21EOLACvtfcHk0lgxqvWLvtmhow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2htbbI&md5=50252efc3de6b7340e227af13638997a</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.103365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.103365%26sid%3Dliteratum%253Aachs%26aulast%3DBertran%26aufirst%3DA.%26aulast%3DKhomiak%26aufirst%3DD.%26aulast%3DKonopka%26aufirst%3DA.%26aulast%3DRejmak%26aufirst%3DE.%26aulast%3DBulska%26aufirst%3DE.%26aulast%3DSeco%26aufirst%3DJ.%26aulast%3DKaczmarek%26aufirst%3DL.%26aulast%3DTarrag%25C3%25B3%26aufirst%3DT.%26aulast%3DPrades%26aufirst%3DR.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Selective%2520and%2520Blood-Brain%2520Barrier-Permeable%2520Hydroxamate-Based%2520Gelatinase%2520Inhibitors%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D94%26spage%3D103365%26doi%3D10.1016%2Fj.bioorg.2019.103365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sela-Passwell, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenblum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Bases for Allosteric Control of MMP Activities: Can It Pave the Path for Selective Inhibition?</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1803</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2009.04.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bbamcr.2009.04.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVKit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1803&publication_year=2010&pages=29-38&issue=1&author=N.+Sela-Passwellauthor=G.+Rosenblumauthor=T.+Shohamauthor=I.+Sagi&title=Structural+and+Functional+Bases+for+Allosteric+Control+of+MMP+Activities%3A+Can+It+Pave+the+Path+for+Selective+Inhibition%3F&doi=10.1016%2Fj.bbamcr.2009.04.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and functional bases for allosteric control of MMP activities: Can it pave the path for selective inhibition?</span></div><div class="casAuthors">Sela-Passwell, Netta; Rosenblum, Gabriel; Shoham, Tsipi; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1803</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-38</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The Zn-dependent matrix metalloproteinases (MMPs) belong to a large family of structurally homologous enzymes.  These enzymes are involved in a wide variety of biol. processes ranging from physiol. cell proliferation and differentiation to pathol. states assocd. with tumor metastasis, inflammation, tissue degeneration, and cell death.  Controlling the enzymic activity of specific individual MMPs by antagonist mols. is highly desirable, 1st, for studying their individual roles, and 2nd as potential therapeutic agents.  However, blocking the enzymic activity with synthetic small inhibitors appears to be an extremely difficult task.  Thus, this is an unmet need presumably due to the high structural homol. between MMP catalytic domains.  Recent reports have recognized a potential role for exosite or allosteric protein regions, distinct from the extended catalytic pocket, in mediating MMP activation and substrate hydrolysis.  This raises the possibility that MMP enzymic and nonenzymic activities may be modified via antagonist mols. targeted to such allosteric sites or to alternative enzyme domains.  Here, the authors discuss the structural and functional bases for potential allosteric control of MMPs and highlight potential alternative enzyme domains as targets for designing highly selective MMP inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBcsEfeLnJsbVg90H21EOLACvtfcHk0lgxqvWLvtmhow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVKit7Y%253D&md5=19792cf064947626de1ed92c7e3ddddb</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2009.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2009.04.010%26sid%3Dliteratum%253Aachs%26aulast%3DSela-Passwell%26aufirst%3DN.%26aulast%3DRosenblum%26aufirst%3DG.%26aulast%3DShoham%26aufirst%3DT.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DStructural%2520and%2520Functional%2520Bases%2520for%2520Allosteric%2520Control%2520of%2520MMP%2520Activities%253A%2520Can%2520It%2520Pave%2520the%2520Path%2520for%2520Selective%2520Inhibition%253F%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2010%26volume%3D1803%26issue%3D1%26spage%3D29%26epage%3D38%26doi%3D10.1016%2Fj.bbamcr.2009.04.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Udi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitternacht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arad-Yellin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderone, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melikian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toccafondi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berezovsky, I. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luchinat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span> <span> </span><span class="NLM_article-title">Unraveling Hidden Regulatory Sites in Structurally Homologous Metalloproteases</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>425</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">2330</span>– <span class="NLM_lpage">2346</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2013.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.jmb.2013.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=23583775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsleqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2013&pages=2330-2346&issue=13&author=Y.+Udiauthor=M.+Fragaiauthor=M.+Grossmanauthor=S.+Mitternachtauthor=R.+Arad-Yellinauthor=V.+Calderoneauthor=M.+Melikianauthor=M.+Toccafondiauthor=I.+N.+Berezovskyauthor=C.+Luchinatauthor=I.+Sagi&title=Unraveling+Hidden+Regulatory+Sites+in+Structurally+Homologous+Metalloproteases&doi=10.1016%2Fj.jmb.2013.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Unraveling hidden regulatory sites in structurally homologous metalloproteases</span></div><div class="casAuthors">Udi, Yael; Fragai, Marco; Grossman, Moran; Mitternacht, Simon; Arad-Yellin, Rina; Calderone, Vito; Melikian, Maxime; Toccafondi, Mirco; Berezovsky, Igor N.; Luchinat, Claudio; Sagi, Irit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2330-2346</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Monitoring enzymic activity in vivo of individual homologous enzymes such as the matrix metalloproteinases (MMPs) by antagonist mols. is highly desired for defining physiol. and pathophysiol. pathways.  However, the rational design of antagonists targeting enzyme catalytic moieties specific to one of the homologous enzymes often appears to be an extremely difficult task.  This is mainly due to the high structural homol. at the enzyme active sites shared by members of the protein family.  Accordingly, controlling enzymic activity via alternative allosteric sites has become an attractive proposition for drug design targeting individual homologous enzymes.  Yet, the challenge remains to identify such regulatory alternative sites that are often hidden and scattered over different locations on the protein's surface.  We have designed branched amphiphilic mols. exhibiting specific inhibitory activity towards individual members of the MMP family.  These amphiphilic isomers share the same chem. nature, providing versatile nonspecific binding reactivity that allows to probe hidden regulatory residues on a given protein surface.  Using the advantage provided by amphiphilic ligands, here we explore a new approach for detg. hidden regulatory sites.  This approach includes diverse exptl. anal., such as structural spectroscopic analyses, NMR, and protein crystallog. combined with computational prediction of effector binding sites.  We demonstrate how our approach works by analyzing members of the MMP family that possess a unique set of such sites.  Our work provides a proof of principle for using ligand effectors to unravel hidden regulatory sites specific to members of the structurally homologous MMP family.  This approach may be exploited for the design of novel mol. effectors and therapeutic agents affecting protein catalytic function via interactions with structure-specific regulatory sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg66HKNxyp5LVg90H21EOLACvtfcHk0liMZlHYW-kzbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsleqsbk%253D&md5=dfde6f555846dab0c8729ea3b64b6ac4</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2013.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2013.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DUdi%26aufirst%3DY.%26aulast%3DFragai%26aufirst%3DM.%26aulast%3DGrossman%26aufirst%3DM.%26aulast%3DMitternacht%26aufirst%3DS.%26aulast%3DArad-Yellin%26aufirst%3DR.%26aulast%3DCalderone%26aufirst%3DV.%26aulast%3DMelikian%26aufirst%3DM.%26aulast%3DToccafondi%26aufirst%3DM.%26aulast%3DBerezovsky%26aufirst%3DI.%2BN.%26aulast%3DLuchinat%26aufirst%3DC.%26aulast%3DSagi%26aufirst%3DI.%26atitle%3DUnraveling%2520Hidden%2520Regulatory%2520Sites%2520in%2520Structurally%2520Homologous%2520Metalloproteases%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D425%26issue%3D13%26spage%3D2330%26epage%3D2346%26doi%3D10.1016%2Fj.jmb.2013.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span> <span> </span><span class="NLM_article-title">New Strategies for Targeting Matrix Metalloproteinases</span>. <i>Matrix Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>44–46</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">246</span>, <span class="refDoi"> DOI: 10.1016/j.matbio.2015.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.matbio.2015.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=25595836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2gu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44%E2%80%9346&publication_year=2015&pages=239-246&author=G.+B.+Fields&title=New+Strategies+for+Targeting+Matrix+Metalloproteinases&doi=10.1016%2Fj.matbio.2015.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">New strategies for targeting matrix metalloproteinases</span></div><div class="casAuthors">Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Matrix Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">44-46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">239-246</span>CODEN:
                <span class="NLM_cas:coden">MTBOEC</span>;
        ISSN:<span class="NLM_cas:issn">0945-053X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The development of matrix metalloproteinase (MMP) inhibitors has often been frustrated by a lack of specificity and subsequent off-target effects.  More recently, inhibitor design has considered secondary binding sites (exosites) to improve specificity.  Small mols. and peptides have been developed that bind exosites in the catalytic (CAT) domain of MMP-13, the CAT or hemopexin-like (HPX) domain of MT1-MMP, and the collagen binding domain (CBD) of MMP-2 and MMP-9.  Antibody-based approaches have resulted in selective inhibitors for MMP-9 and MT1-MMP that target CAT domain exosites.  Triple-helical "mini-proteins" have taken advantage of collagen binding exosites, producing a family of novel probes.  A variety of non-traditional approaches that incorporate exosite binding into the design process has yielded inhibitors with desirable selectivities within the MMP family.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMGHejEGVH3rVg90H21EOLACvtfcHk0liMZlHYW-kzbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2gu74%253D&md5=ef3430aa5d044a91b3ab115f26667119</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.matbio.2015.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.matbio.2015.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DG.%2BB.%26atitle%3DNew%2520Strategies%2520for%2520Targeting%2520Matrix%2520Metalloproteinases%26jtitle%3DMatrix%2520Biol.%26date%3D2015%26volume%3D44%25E2%2580%259346%26spage%3D239%26epage%3D246%26doi%3D10.1016%2Fj.matbio.2015.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z. P.</span></span> <span> </span><span class="NLM_article-title">Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1168</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fcmdc.201700349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28722301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFynsbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1157-1168&issue=15&author=X.+W.+Xieauthor=R.+Z.+Wanauthor=Z.+P.+Liu&title=Recent+Research+Advances+in+Selective+Matrix+Metalloproteinase-13+Inhibitors+as+Anti-Osteoarthritis+Agents&doi=10.1002%2Fcmdc.201700349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents</span></div><div class="casAuthors">Xie, Xin-Wen; Wan, Ren-Zhong; Liu, Zhao-Peng</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1157-1168</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP-13) plays a key role in the degrdn. of type II collagen in cartilage and bone in osteoarthritis (OA).  The subtle differences between the S1' loop of MMP-13 and that of other MMPs offer a structural base for the design of selective MMP-13 inhibitors to mitigate the unperceived risk assocd. with inhibiting other MMP isoforms.  In this review, we summarize zinc-binding and non-zinc-binding selective MMP-13 inhibitors.  The zinc-binding MMP-13 inhibitors contain a small set of zinc-binding groups (ZBGs), including hydroxamic acid, pyrimidinetrione, reversed hydroxamic acid and hydantoin, carboxylic acid, 1,2,4,-triazole, and 1,2,4,-triazolone.  The non-zinc-binding MMP-13 inhibitors have different structural scaffolds, including di-Ph ethers, biaryls (aryltetrazoliums, arylfurans, pyrazole-indoles), pyrimidines, and aryl/cycloalkyl-fused pyrimidines.  This review provides a systematic overview of recent developments in MMP-13 inhibitors for the treatment of OA, with emphasis on their enzyme inhibitory potency, selectivity, and biol. activities, and highlights the various binding modes of typical inhibitors with MMP-13.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_kElEBU8rt7Vg90H21EOLACvtfcHk0lhSNtd9vKYM3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFynsbrI&md5=96433c8ec608829c497d471d7aceab13</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700349%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DX.%2BW.%26aulast%3DWan%26aufirst%3DR.%2BZ.%26aulast%3DLiu%26aufirst%3DZ.%2BP.%26atitle%3DRecent%2520Research%2520Advances%2520in%2520Selective%2520Matrix%2520Metalloproteinase-13%2520Inhibitors%2520as%2520Anti-Osteoarthritis%2520Agents%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26issue%3D15%26spage%3D1157%26epage%3D1168%26doi%3D10.1002%2Fcmdc.201700349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauer-Fields, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chase, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillargeon, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saldanha, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stawikowska, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span> <span> </span><span class="NLM_article-title">High Throughput Screening of Potentially Selective MMP-13 Exosite Inhibitors Utilizing a Triple-Helical FRET Substrate</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">990</span>– <span class="NLM_lpage">1005</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bmc.2008.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=18358729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlOhur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=990-1005&issue=3&author=J.+L.+Lauer-Fieldsauthor=D.+Minondauthor=P.+S.+Chaseauthor=P.+E.+Baillargeonauthor=S.+A.+Saldanhaauthor=R.+Stawikowskaauthor=P.+Hodderauthor=G.+B.+Fields&title=High+Throughput+Screening+of+Potentially+Selective+MMP-13+Exosite+Inhibitors+Utilizing+a+Triple-Helical+FRET+Substrate&doi=10.1016%2Fj.bmc.2008.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate</span></div><div class="casAuthors">Lauer-Fields, Janelle L.; Minond, Dmitriy; Chase, Peter S.; Baillargeon, Pierre E.; Saldanha, S. Adrian; Stawikowska, Roma; Hodder, Peter; Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">990-1005</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The major components of the cartilage extracellular matrix are type II collagen and aggrecan.  Matrix metalloproteinase 13 (MMP-13) has been implicated as the protease responsible for collagen degrdn. in cartilage during osteoarthritis (OA).  In the present study, a triple-helical FRET substrate has been utilized for high throughput screening (HTS) of MMP-13 with the MLSCN compd. library (n ∼ 65,000).  Thirty-four compds. from the HTS produced pharmacol. dose-response curves.  A secondary screen using RP-HPLC validated 25 compds. as MMP-13 inhibitors.  Twelve of these compds. were selected for counter-screening with 6 representative MMP family members.  Five compds. were found to be broad-spectrum MMP inhibitors, 3 inhibited MMP-13 and one other MMP, and 4 were selective for MMP-13.  One of the selective inhibitors was more active against MMP-13 triple-helical peptidase activity compared with single-stranded peptidase activity.  Since the THP FRET substrate has distinct conformational features that may interact with MMP secondary binding sites (exosites), novel non-active site-binding inhibitors may be identified via HTS protocols utilizing such assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc6QPfFleUqrVg90H21EOLACvtfcHk0lhSNtd9vKYM3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlOhur0%253D&md5=4fb566e532ff6271ba60771cc6453eb3</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DLauer-Fields%26aufirst%3DJ.%2BL.%26aulast%3DMinond%26aufirst%3DD.%26aulast%3DChase%26aufirst%3DP.%2BS.%26aulast%3DBaillargeon%26aufirst%3DP.%2BE.%26aulast%3DSaldanha%26aufirst%3DS.%2BA.%26aulast%3DStawikowska%26aufirst%3DR.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DFields%26aufirst%3DG.%2BB.%26atitle%3DHigh%2520Throughput%2520Screening%2520of%2520Potentially%2520Selective%2520MMP-13%2520Exosite%2520Inhibitors%2520Utilizing%2520a%2520Triple-Helical%2520FRET%2520Substrate%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D3%26spage%3D990%26epage%3D1005%26doi%3D10.1016%2Fj.bmc.2008.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darout, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Identification of Novel, Exosite-Binding Matrix Metalloproteinase-13 Inhibitor Scaffolds</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">7180</span>– <span class="NLM_lpage">7184</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bmcl.2011.09.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=22018790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=7180-7184&issue=23&author=J.+Rothauthor=D.+Minondauthor=E.+Daroutauthor=Q.+Liuauthor=J.+Lauerauthor=P.+Hodderauthor=G.+B.+Fieldsauthor=W.+R.+Roush&title=Identification+of+Novel%2C+Exosite-Binding+Matrix+Metalloproteinase-13+Inhibitor+Scaffolds&doi=10.1016%2Fj.bmcl.2011.09.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds</span></div><div class="casAuthors">Roth, Joshua; Minond, Dmitriy; Darout, Etzer; Liu, Qin; Lauer, Janelle; Hodder, Peter; Fields, Gregg B.; Roush, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7180-7184</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP-13) has been implicated as the protease responsible for collagen degrdn. in cartilage during osteoarthritis (OA).  Compds. that inhibit the metalloproteinase at the Zn binding site typically lack specificity among MMP family members.  Analogs of the low-micromolar lead MMP-13 inhibitor (I), discovered through high-throughput screening, were synthesized to investigate structure-activity relationships in this inhibitor series.  Systematic modifications of I led to the discovery of MMP-13 inhibitors II and III which are more selective than I against other MMPs.  Compd. II is also approx. fivefold more potent as an MMP-13 inhibitor than the original HTS-derived lead compd. I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopP_zkFk8mibVg90H21EOLACvtfcHk0liygZHthUL9pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVaqtr7E&md5=cfde0e006c073edab16683e478bab78a</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.077%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DMinond%26aufirst%3DD.%26aulast%3DDarout%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DLauer%26aufirst%3DJ.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DFields%26aufirst%3DG.%2BB.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DIdentification%2520of%2520Novel%252C%2520Exosite-Binding%2520Matrix%2520Metalloproteinase-13%2520Inhibitor%2520Scaffolds%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D23%26spage%3D7180%26epage%3D7184%26doi%3D10.1016%2Fj.bmcl.2011.09.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spicer, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodder, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minond, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">9598</span>– <span class="NLM_lpage">9611</span>, <span class="refDoi"> DOI: 10.1021/jm501284e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501284e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOgsrvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9598-9611&issue=22&author=T.+P.+Spicerauthor=J.+Jiangauthor=A.+B.+Taylorauthor=J.+Y.+Choiauthor=P.+J.+Hartauthor=W.+R.+Roushauthor=G.+B.+Fieldsauthor=P.+S.+Hodderauthor=D.+Minond&title=Characterization+of+Selective+Exosite-Binding+Inhibitors+of+Matrix+Metalloproteinase+13+That+Prevent+Articular+Cartilage+Degradation+in+Vitro&doi=10.1021%2Fjm501284e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro</span></div><div class="casAuthors">Spicer, Timothy P.; Jiang, Jianwen; Taylor, Alexander B.; Choi, Jun Yong; Hart, P. John; Roush, William R.; Fields, Gregg B.; Hodder, Peter S.; Minond, Dmitriy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9598-9611</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matrix metalloproteinase 13 (MMP-13) has been shown to be the main collagenase responsible for degrdn. of articular cartilage during osteoarthritis and therefore represents a target for drug development.  As a result of high-throughput screening and structure-activity relationship studies, the authors identified a novel, highly selective class of MMP-13 inhibitors.  Mechanistic characterization revealed a noncompetitive nature of these inhibitors with binding consts. in the low micromolar range.  Crystallog. analyses revealed two binding modes for compd. I in the MMP-13 S1' subsite and in an S1/S2* subsite.  Type II collagen- and cartilage-protective effects exhibited by the 3 compds. suggested that these compds. might be efficacious in future in vivo studies.  Finally, these compds. were also highly selective when tested against a panel of 30 proteases, which, in combination with a good CYP inhibition profile, suggested low off-target toxicity and drug-drug interactions in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCW6fx0sdNp7Vg90H21EOLACvtfcHk0liygZHthUL9pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOgsrvF&md5=11b482b88311bf59b842995dd23d2b6a</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1021%2Fjm501284e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501284e%26sid%3Dliteratum%253Aachs%26aulast%3DSpicer%26aufirst%3DT.%2BP.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DA.%2BB.%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DHart%26aufirst%3DP.%2BJ.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26aulast%3DFields%26aufirst%3DG.%2BB.%26aulast%3DHodder%26aufirst%3DP.%2BS.%26aulast%3DMinond%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520Selective%2520Exosite-Binding%2520Inhibitors%2520of%2520Matrix%2520Metalloproteinase%252013%2520That%2520Prevent%2520Articular%2520Cartilage%2520Degradation%2520in%2520Vitro%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D22%26spage%3D9598%26epage%3D9611%26doi%3D10.1021%2Fjm501284e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuerst, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapinska, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hart, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roush, W. R.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5816</span>– <span class="NLM_lpage">5825</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00514</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVGmt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5816-5825&issue=13&author=J.+Y.+Choiauthor=R.+Fuerstauthor=A.+M.+Knapinskaauthor=A.+B.+Taylorauthor=L.+Smithauthor=X.+Caoauthor=P.+J.+Hartauthor=G.+B.+Fieldsauthor=W.+R.+Roush&title=Structure-Based+Design+and+Synthesis+of+Potent+and+Selective+Matrix+Metalloproteinase+13+Inhibitors&doi=10.1021%2Facs.jmedchem.7b00514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors</span></div><div class="casAuthors">Choi, Jun Yong; Fuerst, Rita; Knapinska, Anna M.; Taylor, Alexander B.; Smith, Lyndsay; Cao, Xiaohang; Hart, P. John; Fields, Gregg B.; Roush, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5816-5825</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the use of comparative structural anal. and structure-guided mol. design to develop potent and selective inhibitors of matrix metalloproteinase 13 (MMP-13).  The authors applied a three-step process, starting with a comparative anal. of the x-ray crystallog. structure of compd. 5 (III) in complex with MMP-13 with published structures of known MMP-13 inhibitor complexes followed by mol. design and synthesis of potent but nonselective zinc-chelating MMP inhibitors.  After demonstrating that the pharmacophores of the chelating inhibitors were binding within the MMP-13 active site, the Zn2+ chelating unit was replaced with nonchelating polar residues that bridged over the Zn2+ binding site and reached into a solvent accessible area.  After two rounds of structural optimization, these design approaches led to small mol. MMP-13 inhibitors 10d (I)and (S)-17b (II), which bind within the substrate-binding site of MMP-13 and surround the catalytically active Zn2+ ion without chelating to the metal.  These compds. exhibit at least 500-fold selectivity vs. other MMPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Tr2dWc11W7Vg90H21EOLACvtfcHk0lj77OjPWcb7uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVGmt7fM&md5=9006603b13358fa670d43575c24b9ede</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00514%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BY.%26aulast%3DFuerst%26aufirst%3DR.%26aulast%3DKnapinska%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DA.%2BB.%26aulast%3DSmith%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DHart%26aufirst%3DP.%2BJ.%26aulast%3DFields%26aufirst%3DG.%2BB.%26aulast%3DRoush%26aufirst%3DW.%2BR.%26atitle%3DStructure-Based%2520Design%2520and%2520Synthesis%2520of%2520Potent%2520and%2520Selective%2520Matrix%2520Metalloproteinase%252013%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5816%26epage%3D5825%26doi%3D10.1021%2Facs.jmedchem.7b00514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mototani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanzaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terauchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kori, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel, Highly Potent, and Selective Quinazoline-2-Carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">8886</span>– <span class="NLM_lpage">8902</span>, <span class="refDoi"> DOI: 10.1021/jm500981k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500981k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8886-8902&issue=21&author=H.+Naraauthor=K.+Satoauthor=T.+Naitoauthor=H.+Mototaniauthor=H.+Okiauthor=Y.+Yamamotoauthor=H.+Kunoauthor=T.+Santouauthor=N.+Kanzakiauthor=J.+Terauchiauthor=O.+Uchikawaauthor=M.+Kori&title=Discovery+of+Novel%2C+Highly+Potent%2C+and+Selective+Quinazoline-2-Carboxamide-Based+Matrix+Metalloproteinase+%28MMP%29-13+Inhibitors+without+a+Zinc+Binding+Group+Using+a+Structure-Based+Design+Approach&doi=10.1021%2Fjm500981k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach</span></div><div class="casAuthors">Nara, Hiroshi; Sato, Kenjiro; Naito, Takako; Mototani, Hideyuki; Oki, Hideyuki; Yamamoto, Yoshio; Kuno, Haruhiko; Santou, Takashi; Kanzaki, Naoyuki; Terauchi, Jun; Uchikawa, Osamu; Kori, Masakuni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8886-8902</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP-13) has been implicated to play a key role in the pathol. of osteoarthritis.  On the basis of X-ray crystallog., we designed a series of potent MMP-13 selective inhibitors optimized to occupy the distinct deep S1' pocket including an adjacent branch.  Among them, carboxylic acid inhibitor 21k exhibited excellent potency and selectivity for MMP-13 over other MMPs.  An effort to convert compd. 21k to the mono sodium salt 38 was promising in all animal species studied.  Moreover, no overt toxicity was obsd. in a preliminary repeat dose oral toxicity study of compd. 21k in rats.  A single oral dose of compd. 38 significantly reduced degrdn. products (CTX-II) released from articular cartilage into the joint cavity in a rat MIA model in vivo.  In this article, we report the discovery of highly potent, selective, and orally bioavailable MMP-13 inhibitors as well as their detailed structure-activity data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGzMIFSbDatLVg90H21EOLACvtfcHk0lj77OjPWcb7uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrvP&md5=087e338412a2daeb1006a48e08d67bbd</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1021%2Fjm500981k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500981k%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DNaito%26aufirst%3DT.%26aulast%3DMototani%26aufirst%3DH.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuno%26aufirst%3DH.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Novel%252C%2520Highly%2520Potent%252C%2520and%2520Selective%2520Quinazoline-2-Carboxamide-Based%2520Matrix%2520Metalloproteinase%2520%2528MMP%2529-13%2520Inhibitors%2520without%2520a%2520Zinc%2520Binding%2520Group%2520Using%2520a%2520Structure-Based%2520Design%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D21%26spage%3D8886%26epage%3D8902%26doi%3D10.1021%2Fjm500981k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nara, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaieda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mototani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanzaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terauchi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kori, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-Yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">608</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2nurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=608-626&issue=2&author=H.+Naraauthor=A.+Kaiedaauthor=K.+Satoauthor=T.+Naitoauthor=H.+Mototaniauthor=H.+Okiauthor=Y.+Yamamotoauthor=H.+Kunoauthor=T.+Santouauthor=N.+Kanzakiauthor=J.+Terauchiauthor=O.+Uchikawaauthor=M.+Kori&title=Discovery+of+Novel%2C+Highly+Potent%2C+and+Selective+Matrix+Metalloproteinase+%28MMP%29-13+Inhibitors+with+a+1%2C2%2C4-Triazol-3-Yl+Moiety+as+a+Zinc+Binding+Group+Using+a+Structure-Based+Design+Approach&doi=10.1021%2Facs.jmedchem.6b01007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach</span></div><div class="casAuthors">Nara, Hiroshi; Kaieda, Akira; Sato, Kenjiro; Naito, Takako; Mototani, Hideyuki; Oki, Hideyuki; Yamamoto, Yoshio; Kuno, Haruhiko; Santou, Takashi; Kanzaki, Naoyuki; Terauchi, Jun; Uchikawa, Osamu; Kori, Masakuni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">608-626</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of a superposition study of x-ray crystal structures of complexes of quinazoline deriv. I and triazole deriv. II with matrix metalloproteinase (MMP)-13 catalytic domain, a novel series of fused pyrimidine compds. which possess a 1,2,4-triazol-3-yl group as a zinc binding group (ZBG) was designed.  Among the herein described and evaluated compds., 5-(3-fluorophenyl)-4-oxo-N-{3-[2-[1H-1,2,4-triazol-3-yloxy]ethoxy]benzyl}-3,4-dihydrothieno[2,3-d]-pyrimidine-2-carboxamide (31f) exhibited excellent potency for MMP-13 (IC50 = 0.036 nM) and selectivities (greater than 1500-fold) over other MMPs (MMP-1, 2, 3, 7, 8, 9, 10, and 14) and tumor necrosis factor-α converting enzyme (TACE).  Furthermore, the inhibitor was shown to protect bovine nasal cartilage explants against degrdn. induced by interleukin-1 and oncostatin M.  In this article, the authors report the discovery of extremely potent, highly selective, and orally bioavailable fused pyrimidine derivs. that possess a 1,2,4-triazol-3-yl group as a novel ZBG for selective MMP-13 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ8Gj9214XrLVg90H21EOLACvtfcHk0ljHvNyNz8tcHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2nurvE&md5=2965566ea0c85df0bc5f806ef5650627</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01007%26sid%3Dliteratum%253Aachs%26aulast%3DNara%26aufirst%3DH.%26aulast%3DKaieda%26aufirst%3DA.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DNaito%26aufirst%3DT.%26aulast%3DMototani%26aufirst%3DH.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DKuno%26aufirst%3DH.%26aulast%3DSantou%26aufirst%3DT.%26aulast%3DKanzaki%26aufirst%3DN.%26aulast%3DTerauchi%26aufirst%3DJ.%26aulast%3DUchikawa%26aufirst%3DO.%26aulast%3DKori%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520Novel%252C%2520Highly%2520Potent%252C%2520and%2520Selective%2520Matrix%2520Metalloproteinase%2520%2528MMP%2529-13%2520Inhibitors%2520with%2520a%25201%252C2%252C4-Triazol-3-Yl%2520Moiety%2520as%2520a%2520Zinc%2520Binding%2520Group%2520Using%2520a%2520Structure-Based%2520Design%2520Approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D2%26spage%3D608%26epage%3D626%26doi%3D10.1021%2Facs.jmedchem.6b01007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuscu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzo, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeLeon, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaber, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">4977</span>– <span class="NLM_lpage">4988</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-4552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1158%2F0008-5472.CAN-10-4552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21646471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFartrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=4977-4988&issue=14&author=A.+Dufourauthor=N.+S.+Sampsonauthor=J.+Liauthor=C.+Kuscuauthor=R.+C.+Rizzoauthor=J.+L.+DeLeonauthor=J.+Zhiauthor=N.+Jaberauthor=E.+Liuauthor=S.+Zuckerauthor=J.+Cao&title=Small-Molecule+Anticancer+Compounds+Selectively+Target+the+Hemopexin+Domain+of+Matrix+Metalloproteinase-9&doi=10.1158%2F0008-5472.CAN-10-4552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9</span></div><div class="casAuthors">Dufour, Antoine; Sampson, Nicole S.; Li, Jian; Kuscu, Cem; Rizzo, Robert C.; DeLeon, Jennifer L.; Zhi, Jizu; Jaber, Nadia; Liu, Eric; Zucker, Stanley; Cao, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4977-4988</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Lack of target specificity by existing matrix metalloproteinase (MMP) inhibitors has hindered antimetastatic cancer drug discovery.  Inhibitors that bind to noncatalytic sites of MMPs and disrupt protease signaling function have the potential to be more specific and selective.  In this work, compds. that target the hemopexin (PEX) domain of MMP-9 were identified using an in silico docking approach and evaluated using biochem. and biol. approaches.  Two of the selected compds. interfere with MMP-9-mediated cancer cell migration and proliferation in cells expressing exogenous or endogenous MMP-9.  Furthermore, these inhibitors do not modulate MMP-9 catalytic activity.  The lead compd., N-[4-(difluoromethoxy)phenyl]-2-[(4-oxo-6-propyl-1H-pyrimidin-2-yl)sulfanyl]-acetamide, specifically binds to the PEX domain of MMP-9, but not other MMPs.  This interaction between the compd. and the PEX domain results in the abrogation of MMP-9 homodimerization and leads to blockage of a downstream signaling pathway required for MMP-9-mediated cell migration.  In a tumor xenograft model, this pyrimidinone retarded MDA-MB-435 tumor growth and inhibited lung metastasis.  Thus, we have shown for the first time that a novel small-mol. interacts specifically with the PEX domain of MMP-9 and inhibits tumor growth and metastasis by reducing cell migration and proliferation.  Cancer Res; 71(14); 4977-88.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN0dKAuaguzbVg90H21EOLACvtfcHk0lgGL-0Sdkfr1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFartrc%253D&md5=fcb7ef8db5fd4f2dd93e340600c670a7</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-4552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-4552%26sid%3Dliteratum%253Aachs%26aulast%3DDufour%26aufirst%3DA.%26aulast%3DSampson%26aufirst%3DN.%2BS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DKuscu%26aufirst%3DC.%26aulast%3DRizzo%26aufirst%3DR.%2BC.%26aulast%3DDeLeon%26aufirst%3DJ.%2BL.%26aulast%3DZhi%26aufirst%3DJ.%26aulast%3DJaber%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DZucker%26aufirst%3DS.%26aulast%3DCao%26aufirst%3DJ.%26atitle%3DSmall-Molecule%2520Anticancer%2520Compounds%2520Selectively%2520Target%2520the%2520Hemopexin%2520Domain%2520of%2520Matrix%2520Metalloproteinase-9%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D14%26spage%3D4977%26epage%3D4988%26doi%3D10.1158%2F0008-5472.CAN-10-4552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Remacle, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golubkov, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiryaev, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbins, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chernov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheltsov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellecchia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strongin, A. Y.</span></span> <span> </span><span class="NLM_article-title">Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2339</span>– <span class="NLM_lpage">2349</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-4149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1158%2F0008-5472.CAN-11-4149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=22406620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1ymtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2339-2349&issue=9&author=A.+G.+Remacleauthor=V.+S.+Golubkovauthor=S.+A.+Shiryaevauthor=R.+Dahlauthor=J.+L.+Stebbinsauthor=A.+V.+Chernovauthor=A.+V.+Cheltsovauthor=M.+Pellecchiaauthor=A.+Y.+Strongin&title=Novel+MT1-MMP+Small-Molecule+Inhibitors+Based+on+Insights+into+Hemopexin+Domain+Function+in+Tumor+Growth&doi=10.1158%2F0008-5472.CAN-11-4149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth</span></div><div class="casAuthors">Remacle, Albert G.; Golubkov, Vladislav S.; Shiryaev, Sergey A.; Dahl, Russell; Stebbins, John L.; Chernov, Andrei V.; Cheltsov, Anton V.; Pellecchia, Maurizio; Strongin, Alex Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2339-2349</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Membrane type-1 matrix metalloproteinase (MT1-MMP) is a promising drug target in malignancy.  The structure of MT1-MMP includes the hemopexin domain (PEX) that is distinct from and addnl. to the catalytic domain.  Current MMP inhibitors target the conserved active site in the catalytic domain and, as a result, repress the proteolytic activity of multiple MMPs instead of MT1-MMP alone.  In our search for noncatalytic inhibitors of MT1-MMP, we compared the protumorigenic activity of wild-type MT1-MMP with an MT1-MMP mutant lacking PEX (ΔPEX).  In contrast to MT1-MMP, ΔPEX did not support tumor growth in vivo, and its expression resulted in small fibrotic tumors that contained increased levels of collagen.  Because these findings suggested an important role for PEX in tumor growth, we carried out an inhibitor screen to identify small mols. targeting the PEX domain of MT1-MMP.  Using the Developmental Therapeutics Program (National Cancer Institute/NIH), virtual ligand screening compd. library as a source and the X-ray crystal structure of PEX as a target, we identified and validated a novel PEX inhibitor.  Low dosage, intratumoral injections of PEX inhibitor repressed tumor growth and caused a fibrotic, ΔPEX-like tumor phenotype in vivo.  Together, our findings provide a preclin. proof of principle rationale for the development of novel and selective MT1-MMP inhibitors that specifically target the PEX domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokdpmWy18oyrVg90H21EOLACvtfcHk0lgGL-0Sdkfr1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1ymtL0%253D&md5=aac476734e061847f75ad5e0f5e89907</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-4149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-4149%26sid%3Dliteratum%253Aachs%26aulast%3DRemacle%26aufirst%3DA.%2BG.%26aulast%3DGolubkov%26aufirst%3DV.%2BS.%26aulast%3DShiryaev%26aufirst%3DS.%2BA.%26aulast%3DDahl%26aufirst%3DR.%26aulast%3DStebbins%26aufirst%3DJ.%2BL.%26aulast%3DChernov%26aufirst%3DA.%2BV.%26aulast%3DCheltsov%26aufirst%3DA.%2BV.%26aulast%3DPellecchia%26aufirst%3DM.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26atitle%3DNovel%2520MT1-MMP%2520Small-Molecule%2520Inhibitors%2520Based%2520on%2520Insights%2520into%2520Hemopexin%2520Domain%2520Function%2520in%2520Tumor%2520Growth%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26issue%3D9%26spage%3D2339%26epage%3D2349%26doi%3D10.1158%2F0008-5472.CAN-11-4149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scannevin, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haarlander, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurlino, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deckman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewandowski, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devine, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzordzorme, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tounge, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayoumy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalk-Hihi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, K. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Highly Selective Chemical Inhibitor of Matrix Metalloproteinase-9 (MMP-9) That Allosterically Inhibits Zymogen Activation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span> (<span class="NLM_issue">43</span>),  <span class="NLM_fpage">17963</span>– <span class="NLM_lpage">17974</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.806075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M117.806075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=28860188" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslehs7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=17963-17974&issue=43&author=R.+H.+Scannevinauthor=R.+Alexanderauthor=T.+M.+Haarlanderauthor=S.+L.+Burkeauthor=M.+Singerauthor=C.+Huoauthor=Y.+M.+Zhangauthor=D.+Maguireauthor=J.+Spurlinoauthor=I.+Deckmanauthor=K.+I.+Carrollauthor=F.+Lewandowskiauthor=E.+Devineauthor=K.+Dzordzormeauthor=B.+Toungeauthor=C.+Milliganauthor=S.+Bayoumyauthor=R.+Williamsauthor=C.+Schalk-Hihiauthor=K.+Leonardauthor=P.+Jacksonauthor=M.+Toddauthor=L.+C.+Kuoauthor=K.+J.+Rhodes&title=Discovery+of+a+Highly+Selective+Chemical+Inhibitor+of+Matrix+Metalloproteinase-9+%28MMP-9%29+That+Allosterically+Inhibits+Zymogen+Activation&doi=10.1074%2Fjbc.M117.806075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation</span></div><div class="casAuthors">Scannevin, Robert H.; Alexander, Richard; Haarlander, Tara Mezzasalma; Burke, Sharon L.; Singer, Monica; Huo, Cuifen; Zhang, Yue-Mei; Maguire, Diane; Spurlino, John; Deckman, Ingrid; Carroll, Karen I.; Lewandowski, Frank; Devine, Eric; Dzordzorme, Keli; Tounge, Brett; Milligan, Cindy; Bayoumy, Shariff; Williams, Robyn; Schalk-Hihi, Celine; Leonard, Kristi; Jackson, Paul; Todd, Matthew; Kuo, Lawrence C.; Rhodes, Kenneth J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">43</span>),
    <span class="NLM_cas:pages">17963-17974</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Aberrant activation of matrix metalloproteinases (MMPs) is a common feature of pathol. cascades obsd. in diverse disorders, such as cancer, fibrosis, immune dysregulation, and neurodegenerative diseases.  MMP-9, in particular, is highly dynamically regulated in several pathol. processes.  Development of MMP inhibitors has therefore been an attractive strategy for therapeutic intervention.  However, a long history of failed clin. trials has demonstrated that broad-spectrum MMP inhibitors have limited clin. utility, which has spurred the development of inhibitors selective for individual MMPs.  Attaining selectivity has been tech. challenging because of sequence and structural conservation across the various MMPs.  Here, through a biochem. and structural screening paradigm, the authors have identified JNJ0966, a highly selective compd. that inhibited activation of MMP-9 zymogen and subsequent generation of catalytically active enzyme.  JNJ0966 had no effect on MMP-1, MMP-2, MMP-3, MMP-9, or MMP-14 catalytic activity and did not inhibit activation of the highly related MMP-2 zymogen.  The mol. basis for this activity was characterized as an interaction of JNJ0966 with a structural pocket in proximity to the MMP-9 zymogen cleavage site near Arg 106, which is distinct from the catalytic domain.  JNJ0966 was efficacious in reducing disease severity in a mouse exptl. autoimmune encephalomyelitis model, demonstrating the viability of this therapeutic approach.  This discovery reveals an unprecedented pharmacol. approach to MMP inhibition, providing an opportunity to improve selectivity of future clin. drug candidates.  Targeting zymogen activation in this manner may also allow for pharmaceutical exploration of other enzymes previously viewed as intractable drug targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRTVPKDSQkOrVg90H21EOLACvtfcHk0lhuMWBRB5AEWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslehs7%252FP&md5=56f8b03dbe9b59d85224fb8464732734</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.806075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.806075%26sid%3Dliteratum%253Aachs%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DHaarlander%26aufirst%3DT.%2BM.%26aulast%3DBurke%26aufirst%3DS.%2BL.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DHuo%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%2BM.%26aulast%3DMaguire%26aufirst%3DD.%26aulast%3DSpurlino%26aufirst%3DJ.%26aulast%3DDeckman%26aufirst%3DI.%26aulast%3DCarroll%26aufirst%3DK.%2BI.%26aulast%3DLewandowski%26aufirst%3DF.%26aulast%3DDevine%26aufirst%3DE.%26aulast%3DDzordzorme%26aufirst%3DK.%26aulast%3DTounge%26aufirst%3DB.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DBayoumy%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DR.%26aulast%3DSchalk-Hihi%26aufirst%3DC.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%26aulast%3DTodd%26aufirst%3DM.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DRhodes%26aufirst%3DK.%2BJ.%26atitle%3DDiscovery%2520of%2520a%2520Highly%2520Selective%2520Chemical%2520Inhibitor%2520of%2520Matrix%2520Metalloproteinase-9%2520%2528MMP-9%2529%2520That%2520Allosterically%2520Inhibits%2520Zymogen%2520Activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26issue%3D43%26spage%3D17963%26epage%3D17974%26doi%3D10.1074%2Fjbc.M117.806075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alford, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seeliger, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ojima, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampson, N. S.</span></span> <span> </span><span class="NLM_article-title">Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">2788</span>– <span class="NLM_lpage">2803</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00758</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00758" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFCrtLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=2788-2803&issue=11&author=V.+M.+Alfordauthor=A.+Kamathauthor=X.+Renauthor=K.+Kumarauthor=Q.+Ganauthor=M.+Awwaauthor=M.+Tongauthor=M.+A.+Seeligerauthor=J.+Caoauthor=I.+Ojimaauthor=N.+S.+Sampson&title=Targeting+the+Hemopexin-like+Domain+of+Latent+Matrix+Metalloproteinase-9+%28proMMP-9%29+with+a+Small+Molecule+Inhibitor+Prevents+the+Formation+of+Focal+Adhesion+Junctions&doi=10.1021%2Facschembio.7b00758"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions</span></div><div class="casAuthors">Alford, Vincent M.; Kamath, Anushree; Ren, Xiaodong; Kumar, Kunal; Gan, Qianwen; Awwa, Monaf; Tong, Michael; Seeliger, Markus A.; Cao, Jian; Ojima, Iwao; Sampson, Nicole S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2788-2803</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A lack of target specificity has greatly hindered the success of inhibitor development against matrix metalloproteinases (MMPs) for the treatment of various cancers.  The MMP catalytic domains are highly conserved, whereas the hemopexin-like domain of MMPs are unique to each family member.  The hemopexin-like domain of MMP-9 enhances cancer cell migration through self-interaction and hetero-interactions with cell surface proteins including CD44 and α4β1 integrin.  These interactions activate EGFR-MAP kinase dependent signaling that leads to cell migration.  In this work, we generated a library of compds., based on hit mol., N-[4-(difluoromethoxy)phenyl]-2-[(4-oxo-6-propyl-1H-pyrimidin-2-yl)sulfanyl]-acetamide, that target the hemopexin-like domain of MMP-9.  We identify N-(4-fluorophenyl)-4-(4-oxo-3,4,5,6,7,8-hexahydroquinazolin-2-ylthio)butanamide, 3c, as a potent lead (Kd = 320 nM) that is specific for binding to proMMP-9 hemopexin-like domain.  We demonstrate that I disruption of MMP-9 homodimerization prevents assocn. of proMMP-9 with both α4β1 integrin and CD44 and results in dissocn. of EGFR.  This disruption results in decreased phosphorylation of Src and its downstream target proteins focal adhesion kinase (FAK) and paxillin (PAX), which are implicated in promoting tumor cell growth, migration, and invasion.  Using a chicken chorioallantoic membrane in vivo assay, we demonstrate that 500 nM I blocks cancer cell invasion of the basement membrane and reduces angiogenesis.  In conclusion, we present a mechanism of action for 3c whereby targeting the hemopexin domain results in decreased cancer cell migration through simultaneous disruption of α4β1 integrin and EGFR signaling pathways, thereby preventing signaling bypass.  Targeting through the hemopexin-like domain is a powerful approach to anti-metastatic drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPnLsccijPtrVg90H21EOLACvtfcHk0lhZSG1FsAvy2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFCrtLfM&md5=0ba3d1fbf04f7e998b26abaf926b05e0</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00758%26sid%3Dliteratum%253Aachs%26aulast%3DAlford%26aufirst%3DV.%2BM.%26aulast%3DKamath%26aufirst%3DA.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DGan%26aufirst%3DQ.%26aulast%3DAwwa%26aufirst%3DM.%26aulast%3DTong%26aufirst%3DM.%26aulast%3DSeeliger%26aufirst%3DM.%2BA.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DOjima%26aufirst%3DI.%26aulast%3DSampson%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520the%2520Hemopexin-like%2520Domain%2520of%2520Latent%2520Matrix%2520Metalloproteinase-9%2520%2528proMMP-9%2529%2520with%2520a%2520Small%2520Molecule%2520Inhibitor%2520Prevents%2520the%2520Formation%2520of%2520Focal%2520Adhesion%2520Junctions%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26issue%3D11%26spage%3D2788%26epage%3D2803%26doi%3D10.1021%2Facschembio.7b00758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sagi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talmi-Frank, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arkadash, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, V.</span></span> <span> </span><span class="NLM_article-title">Matrix Metalloproteinase Protein Inhibitors: Hightlighting a New Beginning for Metalloproteinases in Medicine</span>. <i>Met. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.2147/MNM.S65143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.2147%2FMNM.S65143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=31-47&author=I.+Sagiauthor=D.+Talmi-Frankauthor=V.+Arkadashauthor=N.+Papoauthor=V.+Mohan&title=Matrix+Metalloproteinase+Protein+Inhibitors%3A+Hightlighting+a+New+Beginning+for+Metalloproteinases+in+Medicine&doi=10.2147%2FMNM.S65143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.2147%2FMNM.S65143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FMNM.S65143%26sid%3Dliteratum%253Aachs%26aulast%3DSagi%26aufirst%3DI.%26aulast%3DTalmi-Frank%26aufirst%3DD.%26aulast%3DArkadash%26aufirst%3DV.%26aulast%3DPapo%26aufirst%3DN.%26aulast%3DMohan%26aufirst%3DV.%26atitle%3DMatrix%2520Metalloproteinase%2520Protein%2520Inhibitors%253A%2520Hightlighting%2520a%2520New%2520Beginning%2520for%2520Metalloproteinases%2520in%2520Medicine%26jtitle%3DMet.%2520Med.%26date%3D2016%26volume%3D3%26spage%3D31%26epage%3D47%26doi%3D10.2147%2FMNM.S65143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fields, G. B.</span></span> <span> </span><span class="NLM_article-title">The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma</span>. <i>Cells</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">984</span>, <span class="refDoi"> DOI: 10.3390/cells8090984</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3390%2Fcells8090984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=984&issue=9&author=G.+B.+Fields&title=The+Rebirth+of+Matrix+Metalloproteinase+Inhibitors%3A+Moving+Beyond+the+Dogma&doi=10.3390%2Fcells8090984"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">The rebirth of matrix metalloproteinase inhibitors: moving beyond the dogma</span></div><div class="casAuthors">Fields, Gregg B.</div><div class="citationInfo"><span class="NLM_cas:title">Cells</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">984</span>CODEN:
                <span class="NLM_cas:coden">CELLC6</span>;
        ISSN:<span class="NLM_cas:issn">2073-4409</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago.  Initial clin. trials were disappointing, resulting in a neg. view of MMPs as therapeutic targets.  As a better understanding of MMP biol. and inhibitor pharmacokinetic properties emerged, it became clear that initial MMP inhibitor clin. trials were held prematurely.  Further complicating matters were problematic conclusions drawn from animal model studies.  The most recent generation of MMP inhibitors have desirable selectivities and improved pharmacokinetics, resulting in improved toxicity profiles.  Application of selective MMP inhibitors led to the conclusion that MMP-2, MMP-9, MMP-13, and MT1-MMP are not involved in musculoskeletal syndrome, a common side effect obsd. with broad spectrum MMP inhibitors.  Specific activities within a single MMP can now be inhibited.  Better definition of the roles of MMPs in immunol. responses and inflammation will help inform clinic trials, and multiple studies indicate that modulating MMP activity can improve immunotherapy.  There is a U.S.  Food and Drug Administration (FDA)-approved MMP inhibitor for periodontal disease, and several MMP inhibitors are in clinic trials, targeting a variety of maladies including gastric cancer, diabetic foot ulcers, and multiple sclerosis.  It is clearly time to move on from the dogma of viewing MMP inhibition as intractable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY8YcT4Rj5RLVg90H21EOLACvtfcHk0lhZSG1FsAvy2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtVSltrY%253D&md5=4ff4b435717c123cd5043df32587c853</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.3390%2Fcells8090984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells8090984%26sid%3Dliteratum%253Aachs%26aulast%3DFields%26aufirst%3DG.%2BB.%26atitle%3DThe%2520Rebirth%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%253A%2520Moving%2520Beyond%2520the%2520Dogma%26jtitle%3DCells%26date%3D2019%26volume%3D8%26issue%3D9%26spage%3D984%26doi%3D10.3390%2Fcells8090984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yiu, C. K. Y.</span></span> <span> </span><span class="NLM_article-title">The Past, Present and Future Perspectives of Matrix Metalloproteinase Inhibitors</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>207</i></span>,  <span class="NLM_fpage">107465</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2019.107465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.pharmthera.2019.107465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31863819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVyrurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=207&publication_year=2020&pages=107465&author=K.+Liauthor=F.+R.+Tayauthor=C.+K.+Y.+Yiu&title=The+Past%2C+Present+and+Future+Perspectives+of+Matrix+Metalloproteinase+Inhibitors&doi=10.1016%2Fj.pharmthera.2019.107465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">The past, present and future perspectives of matrix metalloproteinase inhibitors</span></div><div class="casAuthors">Li, Kang; Tay, Franklin R.; Yiu, Cynthia Kar Yung</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">207</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107465</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Matrix metalloproteinases (MMPs) are a large family of enzymes that degrade the extracellular matrix (ECM).  Under pathol. conditions, overexpression of MMPs or insufficient control by tissue inhibitors of MMPs (TIMPs) results in the dysregulation of tissue remodeling and causes a variety of diseases such as encephalomyelitis, rheumatoid arthritis, Alzheimer's disease and tumors.  Therefore, the high affinity of MMPs for biomols. renders them attractive targets for inhibition when homeostasis breaks down in the ECM.  There are 4 generations of MMP inhibitors (MMPIs), ranging from small mols. or peptides to antibodies and protein-engineered inhibitors of metalloproteinase.  Although a plethora of MMPIs has been synthesized, most of them have failed in clin. trials or are still in the lab. stage of development.  The present review summarizes the development of MMPIs, their assocd. problems and discusses future directions for the development of the future generations of MMPIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruRCapSoUsk7Vg90H21EOLACvtfcHk0lix_z6fX325-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVyrurrO&md5=bbcac8e8bc77198311c39604ed653dc1</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2019.107465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2019.107465%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DK.%26aulast%3DTay%26aufirst%3DF.%2BR.%26aulast%3DYiu%26aufirst%3DC.%2BK.%2BY.%26atitle%3DThe%2520Past%252C%2520Present%2520and%2520Future%2520Perspectives%2520of%2520Matrix%2520Metalloproteinase%2520Inhibitors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2020%26volume%3D207%26spage%3D107465%26doi%3D10.1016%2Fj.pharmthera.2019.107465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, R.</span></span> <span> </span><span class="NLM_article-title">Monoclonal Antibodies against Metzincin Targets</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">52</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1111/bph.14186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1111%2Fbph.14186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=29488211" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvVems74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=52-66&issue=1&author=S.+Santamariaauthor=R.+de+Groot&title=Monoclonal+Antibodies+against+Metzincin+Targets&doi=10.1111%2Fbph.14186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Monoclonal antibodies against metzincin targets</span></div><div class="casAuthors">Santamaria, Salvatore; de Groot, Rens</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-66</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The metzincin clan of metalloproteinases includes the MMP, disintegrin and metalloproteinase (ADAM) and ADAM with thrombospondin motifs families, which cleave extracellular targets in a wide range of (patho)physiol. processes.  Antibodies constitute a powerful tool to modulate the activity of these enzymes for both therapeutic and research purposes.  In this review, we give an overview of monoclonal antibodies (mAbs) that have been tested in preclin. disease models, human trials and important studies of metzincin structure and function.  Initial attempts to develop therapeutic small mol. inhibitors against MMPs were hampered by structural similarities between metzincin active sites and, consequently, off-target effects.  Therefore, more recently, mAbs have been developed that do not bind to the active site but bind to surface-exposed loops that are poorly conserved in closely related family members.  Inhibition of protease activity by these mAbs occurs through a variety of mechanisms, including (i) barring access to the active site, (ii) disruption of exosite binding, and (iii) prevention of protease activation.  These different modes of inhibition are discussed in the context of the antibodies' potency, selectivity and, importantly, the effects in models of disease and clin. trials.  In addn., various innovative strategies that were used to generate anti-metzincin mAbs are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyGrQwnEmcRLVg90H21EOLACvtfcHk0lix_z6fX325-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvVems74%253D&md5=30fa232b6ff5f312b56af1bb68b7d23a</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1111%2Fbph.14186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14186%26sid%3Dliteratum%253Aachs%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3Dde%2BGroot%26aufirst%3DR.%26atitle%3DMonoclonal%2520Antibodies%2520against%2520Metzincin%2520Targets%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2019%26volume%3D176%26issue%3D1%26spage%3D52%26epage%3D66%26doi%3D10.1111%2Fbph.14186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nam, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remacle, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strongin, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span> <span> </span><span class="NLM_article-title">Active-Site MMP-Selective Antibody Inhibitors Discovered from Convex Paratope Synthetic Libraries</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">52</span>),  <span class="NLM_fpage">14970</span>– <span class="NLM_lpage">14975</span>, <span class="refDoi"> DOI: 10.1073/pnas.1609375114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1073%2Fpnas.1609375114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=27965386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyisrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=14970-14975&issue=52&author=D.+H.+Namauthor=C.+Rodriguezauthor=A.+G.+Remacleauthor=A.+Y.+Stronginauthor=X.+Ge&title=Active-Site+MMP-Selective+Antibody+Inhibitors+Discovered+from+Convex+Paratope+Synthetic+Libraries&doi=10.1073%2Fpnas.1609375114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries</span></div><div class="casAuthors">Nam, Dong Hyun; Rodriguez, Carlos; Remacle, Albert G.; Strongin, Alex Y.; Ge, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">14970-14975</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Proteases are frequent pharmacol. targets, and their inhibitors are valuable drugs in multiple pathologies.  The catalytic mechanism and the active-site fold, however, are largely conserved among the protease classes, making the development of the selective inhibitors exceedingly challenging.  In the authors' departure from the conventional strategies, the authors reviewed the structure of known camelid inhibitory antibodies, which block enzyme activities via their unusually long, convex-shaped paratopes.  The authors synthesized the human Fab antibody library (over 1.25×109 individual variants) that carried the extended 23-27-residue complementarity-detg. region (CDR)-H3 segments.  As a proof of principle, the authors used the catalytic domain of matrix metalloproteinase-14 (MMP-14), a promalignant protease and a drug target in cancer, as bait.  In the authors' screens, the authors identified 20 binders, of which 14 performed as potent and selective inhibitors of MMP-14 rather than as broad-specificity antagonists.  Specifically, Fab 3A2 bound to MMP-14 in the vicinity of the active pocket with a high 4.8 nM affinity and was similarly efficient (9.7 nM) in inhibiting the protease cleavage activity.  The authors suggest that the convex paratope antibody libraries described here could be readily generalized to facilitate the design of the antibody inhibitors to many addnl. enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr__N9kyl6nprVg90H21EOLACvtfcHk0lgA-9yCZeX0Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyisrvE&md5=3e86c573d3ca022cefcc8a32777b4cbe</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1609375114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1609375114%26sid%3Dliteratum%253Aachs%26aulast%3DNam%26aufirst%3DD.%2BH.%26aulast%3DRodriguez%26aufirst%3DC.%26aulast%3DRemacle%26aufirst%3DA.%2BG.%26aulast%3DStrongin%26aufirst%3DA.%2BY.%26aulast%3DGe%26aufirst%3DX.%26atitle%3DActive-Site%2520MMP-Selective%2520Antibody%2520Inhibitors%2520Discovered%2520from%2520Convex%2520Paratope%2520Synthetic%2520Libraries%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26issue%3D52%26spage%3D14970%26epage%3D14975%26doi%3D10.1073%2Fpnas.1609375114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustafa, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benitez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, R.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span> <span> </span><span class="NLM_article-title">Functional Selection of Protease Inhibitory Antibodies</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">16314</span>– <span class="NLM_lpage">16319</span>, <span class="refDoi"> DOI: 10.1073/pnas.1903330116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1073%2Fpnas.1903330116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31363054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFylsLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=16314-16319&issue=33&author=T.+Lopezauthor=Z.+Mustafaauthor=C.+Chenauthor=K.+B.+Leeauthor=A.+Ramirezauthor=C.+Benitezauthor=X.+Luoauthor=R.-R.+Jiauthor=X.+Ge&title=Functional+Selection+of+Protease+Inhibitory+Antibodies&doi=10.1073%2Fpnas.1903330116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Functional selection of protease inhibitory antibodies</span></div><div class="casAuthors">Lopez, Tyler; Mustafa, Zahid; Chen, Chuan; Lee, Ki Baek; Ramirez, Aaron; Benitez, Chris; Luo, Xin; Ji, Ru-Rong; Ge, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">16314-16319</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Crit. for diverse biol. processes, proteases represent one of the largest families of pharmaceutical targets.  To inhibit pathogenic proteases with desired selectivity, monoclonal antibodies (mAbs) hold great promise as research tools and therapeutic agents.  However, identification of mAbs with inhibitory functions is challenging because current antibody discovery methods rely on binding rather than inhibition.  This study developed a highly efficient selection method for protease inhibitory mAbs by coexpressing 3 recombinant proteins in the periplasmic space of Escherichia coli-an antibody clone, a protease of interest, and a β-lactamase modified by insertion of a protease cleavable peptide sequence.  During functional selection, inhibitory antibodies prevent the protease from cleaving the modified β-lactamase, thereby allowing the cell to survive in the presence of ampicillin.  Using this method to select from synthetic human antibody libraries, we isolated panels of mAbs inhibiting 5 targets of 4 main protease classes: matrix metalloproteinases (MMP-14, a predominant target in metastasis; MMP-9, in neuropathic pain), β-secretase 1 (BACE-1, an aspartic protease in Alzheimer's disease), cathepsin B (a cysteine protease in cancer), and Alp2 (a serine protease in aspergillosis).  Notably, 37 of 41 identified binders were inhibitory.  Isolated mAb inhibitors exhibited nanomolar potency, exclusive selectivity, excellent proteolytic stability, and desired biol. functions.  Particularly, anti-Alp2 Fab A4A1 had a binding affinity of 11 nM and inhibition potency of 14 nM, anti-BACE1 IgG B2B2 reduced amyloid beta (Aβ40) prodn. by 80% in cellular assays, and IgG L13 inhibited MMP-9 but not MMP-2/-12/-14 and significantly relieved neuropathic pain development in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoExtbIbbqGyrVg90H21EOLACvtfcHk0lgA-9yCZeX0Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFylsLrK&md5=b3adfa90935908131cf63be184c3125d</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1903330116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1903330116%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DT.%26aulast%3DMustafa%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DK.%2BB.%26aulast%3DRamirez%26aufirst%3DA.%26aulast%3DBenitez%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DJi%26aufirst%3DR.-R.%26aulast%3DGe%26aufirst%3DX.%26atitle%3DFunctional%2520Selection%2520of%2520Protease%2520Inhibitory%2520Antibodies%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2019%26volume%3D116%26issue%3D33%26spage%3D16314%26epage%3D16319%26doi%3D10.1073%2Fpnas.1903330116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogakos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yiotakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newby, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">A Selective Matrix Metalloproteinase-12 Inhibitor Retards Atherosclerotic Plaque Development in Apolipoprotein E-Knockout Mice</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">528</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.110.219147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1161%2FATVBAHA.110.219147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=21212406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitVOgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=528-535&issue=3&author=J.+L.+Johnsonauthor=L.+Develauthor=B.+Czarnyauthor=S.+J.+Georgeauthor=C.+L.+Jacksonauthor=V.+Rogakosauthor=F.+Beauauthor=A.+Yiotakisauthor=A.+C.+Newbyauthor=V.+Dive&title=A+Selective+Matrix+Metalloproteinase-12+Inhibitor+Retards+Atherosclerotic+Plaque+Development+in+Apolipoprotein+E-Knockout+Mice&doi=10.1161%2FATVBAHA.110.219147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice</span></div><div class="casAuthors">Johnson, Jason L.; Devel, Laurent; Czarny, Bertrand; George, Sarah J.; Jackson, Christopher L.; Rogakos, Vassilis; Beau, Fabrice; Yiotakis, Athanasios; Newby, Andrew C.; Dive, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">528-535</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">OBJECTIVE: Matrix metalloproteinase (MMP)-12 has been implicated in plaque progression and instability and is also amenable to selective inhibition.  In this study, we investigated the influence of a greater than 10-fold selective synthetic MMP-12 inhibitor on plaque progression in the apolipoprotein E knockout mouse model of atherosclerosis.  METHODS AND RESULTS: A phosphinic peptide (RXP470.1) that is a potent, selective murine MMP-12 inhibitor significantly reduced atherosclerotic plaque cross-sectional area by approx. 50% at 4 different vascular sites in male and female apolipoprotein E knockout mice fed a Western diet.  Furthermore, RXP470.1 treatment resulted in less complex plaques with increased smooth muscle cell:macrophage ratio, less macrophage apoptosis, increased cap thickness, smaller necrotic cores, and decreased incidence of calcification.  Addnl. in vitro and in vivo findings indicate that attenuated monocyte/macrophage invasion and reduced macrophage apoptosis probably underlie the beneficial effects obsd. on atherosclerotic plaque progression with MMP-12 inhibitor treatment.  CONCLUSION: Our data demonstrate that a selective MMP-12 inhibitor retards atherosclerosis development and results in a more fibrous plaque phenotype in mice.  Our study provides proof of principle to motivate translational work on MMP-12 inhibitor therapy in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo74SZTSfuG57Vg90H21EOLACvtfcHk0lgl77eLwFQ21w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitVOgtbk%253D&md5=9cd9e21179e9182bede144c02da7d858</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.110.219147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.110.219147%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DJ.%2BL.%26aulast%3DDevel%26aufirst%3DL.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DGeorge%26aufirst%3DS.%2BJ.%26aulast%3DJackson%26aufirst%3DC.%2BL.%26aulast%3DRogakos%26aufirst%3DV.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DYiotakis%26aufirst%3DA.%26aulast%3DNewby%26aufirst%3DA.%2BC.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DA%2520Selective%2520Matrix%2520Metalloproteinase-12%2520Inhibitor%2520Retards%2520Atherosclerotic%2520Plaque%2520Development%2520in%2520Apolipoprotein%2520E-Knockout%2520Mice%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2011%26volume%3D31%26issue%3D3%26spage%3D528%26epage%3D535%26doi%3D10.1161%2FATVBAHA.110.219147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nahra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, W.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, C.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baragi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyer, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.-K.</span></span> <span> </span><span class="NLM_article-title">Quinazolinones and Pyrido[3,4- D ]Pyrimidin-4-Ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">835</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1021/jm701274v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701274v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFehsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=835-841&issue=4&author=J.+J.+Liauthor=J.+Nahraauthor=A.+R.+Johnsonauthor=A.+Bunkerauthor=P.+O%E2%80%99Brienauthor=W.-S.+Yueauthor=D.+F.+Ortwineauthor=C.-F.+Manauthor=V.+Baragiauthor=K.+Kilgoreauthor=R.+D.+Dyerauthor=H.-K.+Han&title=Quinazolinones+and+Pyrido%5B3%2C4-+D+%5DPyrimidin-4-Ones+as+Orally+Active+and+Specific+Matrix+Metalloproteinase-13+Inhibitors+for+the+Treatment+of+Osteoarthritis&doi=10.1021%2Fjm701274v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Quinazolinones and Pyrido[3,4-d]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis</span></div><div class="casAuthors">Li, Jie Jack; Nahra, Joe; Johnson, Adam R.; Bunker, Amy; O'Brien, Patrick; Yue, Wen-Song; Ortwine, Daniel F.; Man, Chiu-Fai; Baragi, Vijay; Kilgore, Kenneth; Dyer, Richard D.; Han, Hyo-Kyung</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">835-841</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Quinazolinones 8 and pyrido[3,4-d]pyrimidin-4-ones 9 as orally active and specific matrix metalloproteinase-13 inhibitors were discovered for the treatment of osteoarthritis.  Starting from a high-through-put screening (HTS) hit thizolopyrimidin-dione (I), the authors obtained two chemotypes, using computer-aided drug design (CADD) and methodical structure-activity relationship (SAR) studies.  They occupy the unique S1'-specificity pocket and do not bind to the Zn2+ ion.  Some pyrido[3,4-d]pyrimidin-4-ones, such as (II), possess favorable absorption, distribution, metab., and elimination (ADME) and safety profiles.  The compd. II effectively prevents cartilage damage in rabbit animal models of osteoarthritis without inducing musculoskeletal side effects when given at extremely high doses to rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYnmhx10vW57Vg90H21EOLACvtfcHk0liy2DwDcuFmUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFehsr0%253D&md5=b24d7f6aad20e14333ecf13610b2794a</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1021%2Fjm701274v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701274v%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DNahra%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DBunker%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%26aulast%3DYue%26aufirst%3DW.-S.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DMan%26aufirst%3DC.-F.%26aulast%3DBaragi%26aufirst%3DV.%26aulast%3DKilgore%26aufirst%3DK.%26aulast%3DDyer%26aufirst%3DR.%2BD.%26aulast%3DHan%26aufirst%3DH.-K.%26atitle%3DQuinazolinones%2520and%2520Pyrido%255B3%252C4-%2520D%2520%255DPyrimidin-4-Ones%2520as%2520Orally%2520Active%2520and%2520Specific%2520Matrix%2520Metalloproteinase-13%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Osteoarthritis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D4%26spage%3D835%26epage%3D841%26doi%3D10.1021%2Fjm701274v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref217"><div class="reference"><strong class="refLabel"><a href="#ref217" class="rightTabRefNumLink">217</a></strong><div class="NLM_citation" id="rightTab-cit217"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Settle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemirovskiy, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidmar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruminski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnute, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunyer, T.</span></span> <span> </span><span class="NLM_article-title">Cartilage Degradation Biomarkers Predict Efficacy of a Novel, Highly Selective Matrix Metalloproteinase 13 Inhibitor in a Dog Model of Osteoarthritis: Confirmation by Multivariate Analysis That Modulation of Type Ii Collagen and Aggrecan Degradation Pepti</span>. <i>Arthritis Rheum.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3006</span>– <span class="NLM_lpage">3015</span>, <span class="refDoi"> DOI: 10.1002/art.27596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fart.27596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=20533541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref217/cit217&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=3006-3015&issue=10&author=S.+Settleauthor=L.+Vickeryauthor=O.+Nemirovskiyauthor=T.+Vidmarauthor=A.+Bendeleauthor=D.+Messingauthor=P.+Ruminskiauthor=M.+Schnuteauthor=T.+Sunyer&title=Cartilage+Degradation+Biomarkers+Predict+Efficacy+of+a+Novel%2C+Highly+Selective+Matrix+Metalloproteinase+13+Inhibitor+in+a+Dog+Model+of+Osteoarthritis%3A+Confirmation+by+Multivariate+Analysis+That+Modulation+of+Type+Ii+Collagen+and+Aggrecan+Degradation+Pepti&doi=10.1002%2Fart.27596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit217R"><div class="casContent"><span class="casTitleNuber">217</span><div class="casTitle"><span class="NLM_cas:atitle">Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis</span></div><div class="casAuthors">Settle, Steven; Vickery, Lillian; Nemirovskiy, Olga; Vidmar, Tom; Bendele, Alison; Messing, Dean; Ruminski, Peter; Schnute, Mark; Sunyer, Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3006-3015</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To demonstrate that the novel highly selective matrix metalloproteinase 13 (MMP-13) inhibitor PF152 reduces joint lesions in adult dogs with osteoarthritis (OA) and decreases biomarkers of cartilage degrdn.  Methods: The potency and selectivity of PF152 were evaluated in vitro using 16 MMPs, TACE, and ADAMTS-4 and ADAMTS-5, as well as ex vivo in human cartilage explants.  In vivo effects were evaluated at 3 concns. in mature beagles with partial medial meniscectomy.  Gross and histol. changes in the femorotibial joints were evaluated using various measures of cartilage degeneration.  Biomarkers of cartilage turnover were examd. in serum, urine, or synovial fluid.  Results were analyzed individually and in combination using multivariate anal.  Results: The potent and selective MMP-13 inhibitor PF152 decreased human cartilage degrdn. ex vivo in a dose-dependent manner.  PF152 treatment of dogs with OA reduced cartilage lesions and decreased biomarkers of type II collagen (type II collagen neoepitope) and aggrecan (peptides ending in ARGN or AGEG) degrdn.  The dose required for significant inhibition varied with the measure used, but multivariate anal. of 6 gross and histol. measures indicated that all doses differed significantly from vehicle but not from each other.  Combined anal. of cartilage degrdn. markers showed similar results.  Conclusion: This highly selective MMP-13 inhibitor exhibits chondroprotective effects in mature animals.  Biomarkers of cartilage degrdn., when evaluated in combination, parallel the joint structural changes induced by the MMP-13 inhibitor.  These data support the potential therapeutic value of selective MMP-13 inhibitors and the use of a set of appropriate biomarkers to predict efficacy in OA clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFetQBLK-edLVg90H21EOLACvtfcHk0liy2DwDcuFmUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSqtrvL&md5=83b761d6731b0287d78bbee6263f4df5</span></div><a href="/servlet/linkout?suffix=cit217&amp;dbid=16384&amp;doi=10.1002%2Fart.27596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27596%26sid%3Dliteratum%253Aachs%26aulast%3DSettle%26aufirst%3DS.%26aulast%3DVickery%26aufirst%3DL.%26aulast%3DNemirovskiy%26aufirst%3DO.%26aulast%3DVidmar%26aufirst%3DT.%26aulast%3DBendele%26aufirst%3DA.%26aulast%3DMessing%26aufirst%3DD.%26aulast%3DRuminski%26aufirst%3DP.%26aulast%3DSchnute%26aufirst%3DM.%26aulast%3DSunyer%26aufirst%3DT.%26atitle%3DCartilage%2520Degradation%2520Biomarkers%2520Predict%2520Efficacy%2520of%2520a%2520Novel%252C%2520Highly%2520Selective%2520Matrix%2520Metalloproteinase%252013%2520Inhibitor%2520in%2520a%2520Dog%2520Model%2520of%2520Osteoarthritis%253A%2520Confirmation%2520by%2520Multivariate%2520Analysis%2520That%2520Modulation%2520of%2520Type%2520Ii%2520Collagen%2520and%2520Aggrecan%2520Degradation%2520Pepti%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26issue%3D10%26spage%3D3006%26epage%3D3015%26doi%3D10.1002%2Fart.27596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref218"><div class="reference"><strong class="refLabel"><a href="#ref218" class="rightTabRefNumLink">218</a></strong><div class="NLM_citation" id="rightTab-cit218"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlovsky, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortwine, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Man, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornemeier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banotai, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baragi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roark, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Datta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyer, R. D.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span> (<span class="NLM_issue">38</span>),  <span class="NLM_fpage">27781</span>– <span class="NLM_lpage">27791</span>, <span class="refDoi"> DOI: 10.1074/jbc.M703286200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1074%2Fjbc.M703286200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=17623656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref218/cit218&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVeju7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=27781-27791&issue=38&author=A.+R.+Johnsonauthor=A.+G.+Pavlovskyauthor=D.+F.+Ortwineauthor=F.+Priorauthor=C.+F.+Manauthor=D.+A.+Bornemeierauthor=C.+A.+Banotaiauthor=W.+T.+Muellerauthor=P.+McConnellauthor=C.+Yanauthor=V.+Baragiauthor=C.+Leschauthor=W.+H.+Roarkauthor=M.+Wilsonauthor=K.+Dattaauthor=R.+Guzmanauthor=H.+K.+Hanauthor=R.+D.+Dyer&title=Discovery+and+Characterization+of+a+Novel+Inhibitor+of+Matrix+Metalloprotease-13+That+Reduces+Cartilage+Damage+in+Vivo+without+Joint+Fibroplasia+Side+Effects&doi=10.1074%2Fjbc.M703286200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit218R"><div class="casContent"><span class="casTitleNuber">218</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects</span></div><div class="casAuthors">Johnson, Adam R.; Pavlovsky, Alexander G.; Ortwine, Daniel F.; Prior, Faith; Man, Chiu-Fai; Bornemeier, Dirk A.; Banotai, Craig A.; Mueller, W. Thomas; McConnell, Patrick; Yan, Chunhong; Baragi, Vijay; Lesch, Charles; Roark, W. Howard; Wilson, Michael; Datta, Kaushik; Guzman, Roberto; Han, Hyo-Kyung; Dyer, Richard D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">27781-27791</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Matrix metalloproteinase-13 (MMP13) is a Zn2+-dependent protease that catalyzes the cleavage of type II collagen, the main structural protein in articular cartilage.  Excess MMP13 activity causes cartilage degrdn. in osteoarthritis, making this protease an attractive therapeutic target.  However, clin. tested MMP inhibitors have been assocd. with a painful, joint-stiffening musculoskeletal side effect that may be due to their lack of selectivity.  In our efforts to develop a disease-modifying osteoarthritis drug, we have discovered MMP13 inhibitors that differ greatly from previous MMP inhibitors; they do not bind to the catalytic zinc ion, they are noncompetitive with respect to substrate binding, and they show extreme selectivity for inhibiting MMP13.  By structure-based drug design, we generated an orally active MMP13 inhibitor that effectively reduces cartilage damage in vivo and does not induce joint fibroplasias in a rat model of musculoskeletal syndrome side effects.  Thus, highly selective inhibition of MMP13 in patients may overcome the major safety and efficacy challenges that have limited previously tested non-selective MMP inhibitors.  MMP13 inhibitors such as the ones described here will help further define the role of this protease in arthritis and other diseases and may soon lead to drugs that safely halt cartilage damage in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCiHwTVRtp7bVg90H21EOLACvtfcHk0lgpYOQQTbbsIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVeju7nP&md5=9cc5d9b2edff3847141f21c42f86faf8</span></div><a href="/servlet/linkout?suffix=cit218&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M703286200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M703286200%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DA.%2BR.%26aulast%3DPavlovsky%26aufirst%3DA.%2BG.%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DPrior%26aufirst%3DF.%26aulast%3DMan%26aufirst%3DC.%2BF.%26aulast%3DBornemeier%26aufirst%3DD.%2BA.%26aulast%3DBanotai%26aufirst%3DC.%2BA.%26aulast%3DMueller%26aufirst%3DW.%2BT.%26aulast%3DMcConnell%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DBaragi%26aufirst%3DV.%26aulast%3DLesch%26aufirst%3DC.%26aulast%3DRoark%26aufirst%3DW.%2BH.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DDatta%26aufirst%3DK.%26aulast%3DGuzman%26aufirst%3DR.%26aulast%3DHan%26aufirst%3DH.%2BK.%26aulast%3DDyer%26aufirst%3DR.%2BD.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520a%2520Novel%2520Inhibitor%2520of%2520Matrix%2520Metalloprotease-13%2520That%2520Reduces%2520Cartilage%2520Damage%2520in%2520Vivo%2520without%2520Joint%2520Fibroplasia%2520Side%2520Effects%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26issue%3D38%26spage%3D27781%26epage%3D27791%26doi%3D10.1074%2Fjbc.M703286200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref219"><div class="reference"><strong class="refLabel"><a href="#ref219" class="rightTabRefNumLink">219</a></strong><div class="NLM_citation" id="rightTab-cit219"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Botkjaer, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwok, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terp, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karatt-Vellatt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santamaria, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCafferty, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreasen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ditzel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, G.</span></span> <span> </span><span class="NLM_article-title">Development of a Specific Affinity-Matured Exosite Inhibitor to MT1-MMP That Efficiently Inhibits Tumor Cell Invasion in Vitro and Metastasis in Vivo</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">16773</span>– <span class="NLM_lpage">16792</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.7780</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.18632%2Foncotarget.7780" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26934448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref219/cit219&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A280%3ADC%252BC28jmsFWksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=16773-16792&issue=13&author=K.+A.+Botkjaerauthor=H.+F.+Kwokauthor=M.+G.+Terpauthor=A.+Karatt-Vellattauthor=S.+Santamariaauthor=J.+McCaffertyauthor=P.+A.+Andreasenauthor=Y.+Itohauthor=H.+J.+Ditzelauthor=G.+Murphy&title=Development+of+a+Specific+Affinity-Matured+Exosite+Inhibitor+to+MT1-MMP+That+Efficiently+Inhibits+Tumor+Cell+Invasion+in+Vitro+and+Metastasis+in+Vivo&doi=10.18632%2Foncotarget.7780"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit219R"><div class="casContent"><span class="casTitleNuber">219</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivo</span></div><div class="casAuthors">Botkjaer Kenneth A; Kwok Hang Fai; Murphy Gillian; Kwok Hang Fai; Terp Mikkel G; Ditzel Henrik J; Karatt-Vellatt Aneesh; McCafferty John; Santamaria Salvatore; Itoh Yoshifumi; Andreasen Peter A; Andreasen Peter A; Ditzel Henrik J</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">16773-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The membrane-associated matrix metalloproteinase-14, MT1-MMP, has been implicated in pericellular proteolysis with an important role in cellular invasion of collagenous tissues.  It is substantially upregulated in various cancers and rheumatoid arthritis, and has been considered as a potential therapeutic target.  Here, we report the identification of antibody fragments to MT1-MMP that potently and specifically inhibit its cell surface functions.  Lead antibody clones displayed inhibitory activity towards pro-MMP-2 activation, collagen-film degradation and gelatin-film degradation, and were shown to bind to the MT1-MMP catalytic domain outside the active site cleft, inhibiting binding to triple helical collagen.  Affinity maturation using CDR3 randomization created a second generation of antibody fragments with dissociation constants down to 0.11 nM, corresponding to an improved affinity of 332-fold with the ability to interfere with cell-surface MT1-MMP functions, displaying IC50 values down to 5 nM.  Importantly, the new inhibitors were able to inhibit collagen invasion by tumor-cells in vitro and in vivo primary tumor growth and metastasis of MDA-MB-231 cells in a mouse orthotopic xenograft model.  Herein is the first demonstration that an inhibitory antibody targeting sites outside the catalytic cleft of MT1-MMP can effectively abrogate its in vivo activity during tumorigenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTuEBmqbwQOv7HHuJhbyicZfW6udTcc2eaW4G0NIUK1GLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jmsFWksA%253D%253D&md5=60cb2ede64bdf8853ad4eca9c5599bca</span></div><a href="/servlet/linkout?suffix=cit219&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.7780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.7780%26sid%3Dliteratum%253Aachs%26aulast%3DBotkjaer%26aufirst%3DK.%2BA.%26aulast%3DKwok%26aufirst%3DH.%2BF.%26aulast%3DTerp%26aufirst%3DM.%2BG.%26aulast%3DKaratt-Vellatt%26aufirst%3DA.%26aulast%3DSantamaria%26aufirst%3DS.%26aulast%3DMcCafferty%26aufirst%3DJ.%26aulast%3DAndreasen%26aufirst%3DP.%2BA.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DDitzel%26aufirst%3DH.%2BJ.%26aulast%3DMurphy%26aufirst%3DG.%26atitle%3DDevelopment%2520of%2520a%2520Specific%2520Affinity-Matured%2520Exosite%2520Inhibitor%2520to%2520MT1-MMP%2520That%2520Efficiently%2520Inhibits%2520Tumor%2520Cell%2520Invasion%2520in%2520Vitro%2520and%2520Metastasis%2520in%2520Vivo%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26issue%3D13%26spage%3D16773%26epage%3D16792%26doi%3D10.18632%2Foncotarget.7780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref220"><div class="reference"><strong class="refLabel"><a href="#ref220" class="rightTabRefNumLink">220</a></strong><div class="NLM_citation" id="rightTab-cit220"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Devy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanamandra, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pieters, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frans, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhove, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gool, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rank, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pazmany, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoonbroodt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladner, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoet, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderikx, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">TenHoor, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabbani, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentino, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dransfield, D. T.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1517</span>– <span class="NLM_lpage">1526</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-3255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1158%2F0008-5472.CAN-08-3255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=19208838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref220/cit220&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhslynsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=1517-1526&issue=4&author=L.+Devyauthor=L.+Huangauthor=L.+Naaauthor=N.+Yanamandraauthor=H.+Pietersauthor=N.+Fransauthor=E.+Changauthor=Q.+Taoauthor=M.+Vanhoveauthor=A.+Lejeuneauthor=R.+van+Goolauthor=D.+J.+Sextonauthor=G.+Kuangauthor=D.+Rankauthor=S.+Hoganauthor=C.+Pazmanyauthor=Y.+L.+Maauthor=S.+Schoonbroodtauthor=A.+E.+Nixonauthor=R.+C.+Ladnerauthor=R.+Hoetauthor=P.+Henderikxauthor=C.+TenHoorauthor=S.+A.+Rabbaniauthor=M.+L.+Valentinoauthor=C.+R.+Woodauthor=D.+T.+Dransfield&title=Selective+Inhibition+of+Matrix+Metalloproteinase-14+Blocks+Tumor+Growth%2C+Invasion%2C+and+Angiogenesis&doi=10.1158%2F0008-5472.CAN-08-3255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit220R"><div class="casContent"><span class="casTitleNuber">220</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis</span></div><div class="casAuthors">Devy, Laetitia; Huang, Lili; Naa, Laurent; Yanamandra, Niranjan; Pieters, Henk; Frans, Nicolas; Chang, Edward; Tao, Qingfeng; Vanhove, Marc; Lejeune, Annabelle; van Gool, Reinoud; Sexton, Daniel J.; Kuang, Guannan; Rank, Douglas; Hogan, Shannon; Pazmany, Csaba; Ma, Yu Lu; Schoonbroodt, Sonia; Nixon, Andrew E.; Ladner, Robert C.; Hoet, Rene; Henderikx, Paula; TenHoor, Chris; Rabbani, Shafaat A.; Valentino, Maria Luisa; Wood, Clive R.; Dransfield, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1517-1526</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Inhibition of specific matrix metalloproteinases (MMP) is an attractive noncytotoxic approach to cancer therapy.  MMP-14, a membrane-bound zinc endopeptidase, has been proposed to play a central role in tumor growth, invasion, and neovascularization.  Besides cleaving matrix proteins, MMP-14 activates proMMP-2 leading to an amplification of pericellular proteolytic activity.  To examine the contribution of MMP-14 to tumor growth and angiogenesis, the authors used DX-2400, a highly selective fully human MMP-14 inhibitory antibody discovered using phage display technol.  DX-2400 blocked proMMP-2 processing on tumor and endothelial cells, inhibited angiogenesis, and slowed tumor progression and formation of metastatic lesions.  The combination of potency, selectivity, and robust in vivo activity shows the potential of a selective MMP-14 inhibitor for the treatment of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9CyBaO8dtwbVg90H21EOLACvtfcHk0lgg3UlXzZ9Eqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhslynsLg%253D&md5=e21aa828522a8711d432d171613c919a</span></div><a href="/servlet/linkout?suffix=cit220&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-3255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-3255%26sid%3Dliteratum%253Aachs%26aulast%3DDevy%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DNaa%26aufirst%3DL.%26aulast%3DYanamandra%26aufirst%3DN.%26aulast%3DPieters%26aufirst%3DH.%26aulast%3DFrans%26aufirst%3DN.%26aulast%3DChang%26aufirst%3DE.%26aulast%3DTao%26aufirst%3DQ.%26aulast%3DVanhove%26aufirst%3DM.%26aulast%3DLejeune%26aufirst%3DA.%26aulast%3Dvan%2BGool%26aufirst%3DR.%26aulast%3DSexton%26aufirst%3DD.%2BJ.%26aulast%3DKuang%26aufirst%3DG.%26aulast%3DRank%26aufirst%3DD.%26aulast%3DHogan%26aufirst%3DS.%26aulast%3DPazmany%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DY.%2BL.%26aulast%3DSchoonbroodt%26aufirst%3DS.%26aulast%3DNixon%26aufirst%3DA.%2BE.%26aulast%3DLadner%26aufirst%3DR.%2BC.%26aulast%3DHoet%26aufirst%3DR.%26aulast%3DHenderikx%26aufirst%3DP.%26aulast%3DTenHoor%26aufirst%3DC.%26aulast%3DRabbani%26aufirst%3DS.%2BA.%26aulast%3DValentino%26aufirst%3DM.%2BL.%26aulast%3DWood%26aufirst%3DC.%2BR.%26aulast%3DDransfield%26aufirst%3DD.%2BT.%26atitle%3DSelective%2520Inhibition%2520of%2520Matrix%2520Metalloproteinase-14%2520Blocks%2520Tumor%2520Growth%252C%2520Invasion%252C%2520and%2520Angiogenesis%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26issue%3D4%26spage%3D1517%26epage%3D1526%26doi%3D10.1158%2F0008-5472.CAN-08-3255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref221"><div class="reference"><strong class="refLabel"><a href="#ref221" class="rightTabRefNumLink">221</a></strong><div class="NLM_citation" id="rightTab-cit221"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ager, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkpatrick, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodack, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Askoxylakis, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snuderl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzikansky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finkelstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dransfield, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devy, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boucher, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span> <span> </span><span class="NLM_article-title">Blockade of MMP14 Activity in Murine Breast Carcinomas: Implications for Macrophages, Vessels, and Radiotherapy</span>. <i>JNCI J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>107</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1093/jnci/djv017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref221/cit221&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1093%2Fjnci%2Fdjv017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2015&pages=1-12&issue=4&author=E.+I.+Agerauthor=S.+V.+Kozinauthor=N.+D.+Kirkpatrickauthor=G.+Seanoauthor=D.+P.+Kodackauthor=V.+Askoxylakisauthor=Y.+Huangauthor=S.+Goelauthor=M.+Snuderlauthor=A.+Muzikanskyauthor=D.+M.+Finkelsteinauthor=D.+T.+Dransfieldauthor=L.+Devyauthor=Y.+Boucherauthor=D.+Fukumuraauthor=R.+K.+Jain&title=Blockade+of+MMP14+Activity+in+Murine+Breast+Carcinomas%3A+Implications+for+Macrophages%2C+Vessels%2C+and+Radiotherapy&doi=10.1093%2Fjnci%2Fdjv017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit221&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2Fdjv017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252Fdjv017%26sid%3Dliteratum%253Aachs%26aulast%3DAger%26aufirst%3DE.%2BI.%26aulast%3DKozin%26aufirst%3DS.%2BV.%26aulast%3DKirkpatrick%26aufirst%3DN.%2BD.%26aulast%3DSeano%26aufirst%3DG.%26aulast%3DKodack%26aufirst%3DD.%2BP.%26aulast%3DAskoxylakis%26aufirst%3DV.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DGoel%26aufirst%3DS.%26aulast%3DSnuderl%26aufirst%3DM.%26aulast%3DMuzikansky%26aufirst%3DA.%26aulast%3DFinkelstein%26aufirst%3DD.%2BM.%26aulast%3DDransfield%26aufirst%3DD.%2BT.%26aulast%3DDevy%26aufirst%3DL.%26aulast%3DBoucher%26aufirst%3DY.%26aulast%3DFukumura%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DBlockade%2520of%2520MMP14%2520Activity%2520in%2520Murine%2520Breast%2520Carcinomas%253A%2520Implications%2520for%2520Macrophages%252C%2520Vessels%252C%2520and%2520Radiotherapy%26jtitle%3DJNCI%2520J.%2520Natl.%2520Cancer%2520Inst.%26date%3D2015%26volume%3D107%26issue%3D4%26spage%3D1%26epage%3D12%26doi%3D10.1093%2Fjnci%2Fdjv017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref222"><div class="reference"><strong class="refLabel"><a href="#ref222" class="rightTabRefNumLink">222</a></strong><div class="NLM_citation" id="rightTab-cit222"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaneko, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dransfield, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandison, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itoh, Y.</span></span> <span> </span><span class="NLM_article-title">Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade</span>. <i>Arthritis Rheumatol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1002/art.39414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fart.39414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=26315469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref222/cit222&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslSgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=521-531&issue=2&author=K.+Kanekoauthor=R.+O.+Williamsauthor=D.+T.+Dransfieldauthor=A.+E.+Nixonauthor=A.+Sandisonauthor=Y.+Itoh&title=Selective+Inhibition+of+Membrane+Type+1+Matrix+Metalloproteinase+Abrogates+Progression+of+Experimental+Inflammatory+Arthritis%3A+Synergy+With+Tumor+Necrosis+Factor+Blockade&doi=10.1002%2Fart.39414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit222R"><div class="casContent"><span class="casTitleNuber">222</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade</span></div><div class="casAuthors">Kaneko, Kazuyo; Williams, Richard O.; Dransfield, Daniel T.; Nixon, Andrew E.; Sandison, Ann; Itoh, Yoshifumi</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">521-531</span>CODEN:
                <span class="NLM_cas:coden">ARRHBO</span>;
        ISSN:<span class="NLM_cas:issn">2326-5191</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : In rheumatoid arthritis (RA), destruction of articular cartilage by the inflamed synovium is considered to be driven by increased activities of proteolytic enzymes, including matrix metalloproteinases (MMPs).  The purpose of this study was to investigate the therapeutic potential of selective inhibition of membrane type 1 MMP (MT1-MMP) and its combination with tumor necrosis factor (TNF) blockage in mice with collagen-induced arthritis (CIA).  Methods : CIA was induced in DBA/1 mice by immunization with bovine type II collagen.  From the onset of clin. arthritis, mice were treated with MT1-MMP selective inhibitory antibody DX-2400 and/or TNFR-Fc fusion protein.  Disease progression was monitored daily, and serum, lymph nodes, and affected paws were collected at the end of the study for cytokine and histol. analyses.  For in vitro anal., bone marrow-derived macrophages were stimulated with lipopolysaccharide for 24 h in the presence of DX-2400 and/or TNFR-Fc to analyze cytokine prodn. and phenotype.  Results : DX-2400 treatment significantly reduced cartilage degrdn. and disease progression in mice with CIA.  Importantly, when combined with TNF blockade, DX-2400 acted synergistically, inducing long-term benefit.  DX-2400 also inhibited the up-regulation of interleukin-12 (IL-12)/IL-23 p40 via polarization toward an M2 phenotype in bone marrow-derived macrophages.  Increased prodn. of IL-17 induced by anti-TNF, which correlated with an incomplete response to anti-TNF, was abrogated by combined treatment with DX-2400 in CIA.  Conclusion : Targeting MT1-MMP provides a potential strategy for joint protection, and its combination with TNF blockade may be particularly beneficial in RA patients with an inadequate response to anti-TNF therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH7BAkTfRak7Vg90H21EOLACvtfcHk0liukHa6FHyH1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslSgsL0%253D&md5=60c7ae76bed70c0e2b3c2124b57dbd43</span></div><a href="/servlet/linkout?suffix=cit222&amp;dbid=16384&amp;doi=10.1002%2Fart.39414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.39414%26sid%3Dliteratum%253Aachs%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26aulast%3DDransfield%26aufirst%3DD.%2BT.%26aulast%3DNixon%26aufirst%3DA.%2BE.%26aulast%3DSandison%26aufirst%3DA.%26aulast%3DItoh%26aufirst%3DY.%26atitle%3DSelective%2520Inhibition%2520of%2520Membrane%2520Type%25201%2520Matrix%2520Metalloproteinase%2520Abrogates%2520Progression%2520of%2520Experimental%2520Inflammatory%2520Arthritis%253A%2520Synergy%2520With%2520Tumor%2520Necrosis%2520Factor%2520Blockade%26jtitle%3DArthritis%2520Rheumatol.%26date%3D2016%26volume%3D68%26issue%3D2%26spage%3D521%26epage%3D531%26doi%3D10.1002%2Fart.39414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref223"><div class="reference"><strong class="refLabel"><a href="#ref223" class="rightTabRefNumLink">223</a></strong><div class="NLM_citation" id="rightTab-cit223"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, R.</span></span> <span> </span><span class="NLM_article-title">Development of a Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-7/-13 Inhibitor</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1548</span>, <span class="refDoi"> DOI: 10.3390/molecules22091548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.3390%2Fmolecules22091548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref223/cit223&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaiur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1548&author=T.+Fischerauthor=R.+Riedl&title=Development+of+a+Non-Hydroxamate+Dual+Matrix+Metalloproteinase+%28MMP%29-7%2F-13+Inhibitor&doi=10.3390%2Fmolecules22091548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit223R"><div class="casContent"><span class="casTitleNuber">223</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a non-hydroxamate dual matrix metalloproteinase (MMP)-7/-13 inhibitor</span></div><div class="casAuthors">Fischer, Thomas; Riedl, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1548/1-1548/27</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Matrix metalloproteinase 7 (MMP-7) is a member of the MMP superfamily and is able to degrade extracellular matrix proteins such as casein, gelatin, fibronectin and proteoglycan.  MMP-7 is a validated target for the development of small mol. drugs against cancer.  MMP-13 is within the enzyme class the most efficient contributor to type II collagen degeneration and is a validated target in arthritis and cancer.  We have developed the dual MMP-7/-13 inhibitor ZHAWOC6941 with IC50-values of 2.2 μM (MMP-7) and 1.2 μM (MMP-13) that is selective over a broad range of MMP isoforms.  It spares MMP-1, -2, -3, -8, -9, -12 and -14, making it a valuable modulator for targeted polypharmacol. approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUe3LxiuAsWLVg90H21EOLACvtfcHk0liukHa6FHyH1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaiur%252FF&md5=f7f10191eada9a280279de822c0487d4</span></div><a href="/servlet/linkout?suffix=cit223&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22091548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22091548%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DT.%26aulast%3DRiedl%26aufirst%3DR.%26atitle%3DDevelopment%2520of%2520a%2520Non-Hydroxamate%2520Dual%2520Matrix%2520Metalloproteinase%2520%2528MMP%2529-7%252F-13%2520Inhibitor%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D1548%26doi%3D10.3390%2Fmolecules22091548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref224"><div class="reference"><strong class="refLabel"><a href="#ref224" class="rightTabRefNumLink">224</a></strong><div class="NLM_citation" id="rightTab-cit224"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gall, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hohl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frasson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wermelinger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mittl, P. R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sievers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, R.</span></span> <span> </span><span class="NLM_article-title">Drug Design Inspired by Nature: Crystallographic Detection of an Auto-Tailored Protease Inhibitor Template</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">4051</span>– <span class="NLM_lpage">4055</span>, <span class="refDoi"> DOI: 10.1002/anie.201812348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1002%2Fanie.201812348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref224/cit224&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVansL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2019&pages=4051-4055&issue=12&author=F.+M.+Gallauthor=D.+Hohlauthor=D.+Frassonauthor=T.+Wermelingerauthor=P.+R.+E.+Mittlauthor=M.+Sieversauthor=R.+Riedl&title=Drug+Design+Inspired+by+Nature%3A+Crystallographic+Detection+of+an+Auto-Tailored+Protease+Inhibitor+Template&doi=10.1002%2Fanie.201812348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit224R"><div class="casContent"><span class="casTitleNuber">224</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Design Inspired by Nature: Crystallographic Detection of an Auto-Tailored Protease Inhibitor Template</span></div><div class="casAuthors">Gall, Flavio M.; Hohl, Deborah; Frasson, David; Wermelinger, Tobias; Mittl, Peer R. E.; Sievers, Martin; Riedl, Rainer</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4051-4055</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">De novo drug discovery is still a challenge in the search for potent and selective modulators of therapeutically relevant target proteins.  Here, we disclose the unexpected discovery of a peptidic ligand 1 by X-ray crystallog., which was auto-tailored by the therapeutic target MMP-13 through partial self-degrdn. and subsequent structure-based optimization to a highly potent and selective β-sheet peptidomimetic inhibitor derived from the endogenous tissue inhibitors of metalloproteinases (TIMPs).  The incorporation of non-proteinogenic amino acids in combination with a cyclization strategy proved to be key for the de novo design of TIMP peptidomimetics.  The optimized cyclic peptide 4 (ZHAWOC7726) is membrane permeable with an IC50 of 21 nm for MMP-13 and an attractive selectivity profile with respect to a polypharmacol. approach including the anticancer targets MMP-2 (IC50: 170 nm) and MMP-9 (IC50: 140 nm).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfsjNPNOrK2LVg90H21EOLACvtfcHk0ljWHIkq8kV_TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVansL0%253D&md5=01c3b9232b54eee221917b570ecc5b3a</span></div><a href="/servlet/linkout?suffix=cit224&amp;dbid=16384&amp;doi=10.1002%2Fanie.201812348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201812348%26sid%3Dliteratum%253Aachs%26aulast%3DGall%26aufirst%3DF.%2BM.%26aulast%3DHohl%26aufirst%3DD.%26aulast%3DFrasson%26aufirst%3DD.%26aulast%3DWermelinger%26aufirst%3DT.%26aulast%3DMittl%26aufirst%3DP.%2BR.%2BE.%26aulast%3DSievers%26aufirst%3DM.%26aulast%3DRiedl%26aufirst%3DR.%26atitle%3DDrug%2520Design%2520Inspired%2520by%2520Nature%253A%2520Crystallographic%2520Detection%2520of%2520an%2520Auto-Tailored%2520Protease%2520Inhibitor%2520Template%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2019%26volume%3D58%26issue%3D12%26spage%3D4051%26epage%3D4055%26doi%3D10.1002%2Fanie.201812348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref225"><div class="reference"><strong class="refLabel"><a href="#ref225" class="rightTabRefNumLink">225</a></strong><div class="NLM_citation" id="rightTab-cit225"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El Ashry, E. S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awad, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teleb, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abu-Serie, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abd Al Moaty, M. N.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design and Optimization of Pyrimidine- and 1,2,4-triazolo[4,3-A]pyrimidine-Based Matrix Metalloproteinase-10/13 Inhibitors via Dimroth Rearrangement towards Targeted Polypharmacology</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">103616</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.1016%2Fj.bioorg.2020.103616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=32032847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref225/cit225&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisV2hu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2020&pages=103616&author=E.+S.+H.+El+Ashryauthor=L.+F.+Awadauthor=M.+Telebauthor=N.+A.+Ibrahimauthor=M.+M.+Abu-Serieauthor=M.+N.+Abd+Al+Moaty&title=Structure-Based+Design+and+Optimization+of+Pyrimidine-+and+1%2C2%2C4-triazolo%5B4%2C3-A%5Dpyrimidine-Based+Matrix+Metalloproteinase-10%2F13+Inhibitors+via+Dimroth+Rearrangement+towards+Targeted+Polypharmacology&doi=10.1016%2Fj.bioorg.2020.103616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit225R"><div class="casContent"><span class="casTitleNuber">225</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology</span></div><div class="casAuthors">El Ashry, El Sayed Helmy; Awad, Laila Fathy; Teleb, Mohamed; Ibrahim, Nihal Ahmed; Abu-Serie, Marwa M.; Abd Al Moaty, Mohamed Nabil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103616pp.</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study described the design, synthesis and optimization of novel MMP-10/13 inhibitors with enhanced MMP-10 potency and selectivity towards polypharmacol.  Firstly, a series of 6-Me pyrimidinone hydrazones I [Ar = 4-MeOC6H4, 4-ClC6H4, 4-BrC6H4, etc.] was synthesized via conventional and ultrasonic-assisted methods, then evaluated for MMP-10/13 inhibition.  The most active deriv., compd. I [Ar = 4-MeOC6H4] exhibited acceptable dual potency with 7-fold selectivity for MMP-10 (IC50 = 53 nM) over MMP-13.  Such hydrazones were then cyclized to the corresponding isomeric 1,2,4-triazolo[4,3-a]pyrimidines II and III and their MMP-10/13 inhibition assay revealed, in most cases, superior dual activities with general MMP-10 selectivity compared to the corresponding precursors I.  In addn., a clear structure activity relationship trend was deduced within the identified regioisomers, where compds. II [Ar = 4-ClC6H4, 4-BrC6H4] were far more active against MMP-10/13 than their regioisomers III [Ar = 4-ClC6H4, 4-BrC6H4].  Remarkably, compd. II [Ar = 4-BrC6H4] exhibited the highest MMP-10 inhibition (IC50 = 24 nM), whereas compd. II [Ar = 4-MeOC6H4] was the most potent MMP-13 inhibitor (IC50 = 294 nM).  Moreover, compd. II [Ar = 4-BrC6H4] exhibited 19-fold selectivity for MMP-10 over MMP-13, 10-fold over MMP-9 and 29-fold over MMP-7.  Docking studies were performed to provide reasonable explanation for structure-activity relationships and isoform selectivity.  Compds. II [Ar = 4-BrC6H4, 4-MeOC6H4] were then evaluated for their anticancer activities against three human cancers to assess their therapeutic potential at cellular level via MTT assay and both compds. exhibited superior anticancer activities compared to quercetin.  Their in silico ligand efficiency metrics, physicochem. properties and ADME parameters were drug-like.  Guided by such findings that pointed to compd. II [Ar = 4-BrC6H4] as the most promising compd. in this study, further structure optimization was carried out via photoirradn.-mediated Dimroth rearrangement of the inactive triazolopyrimidine compd. III [Ar = 4-BrC6H4] to its potent regioisomer compd. II [Ar = 4-BrC6H4].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqml1aUujQox7Vg90H21EOLACvtfcHk0ljWHIkq8kV_TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisV2hu7k%253D&md5=749009ed7909329c61c7b3766c3b5c76</span></div><a href="/servlet/linkout?suffix=cit225&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103616%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BAshry%26aufirst%3DE.%2BS.%2BH.%26aulast%3DAwad%26aufirst%3DL.%2BF.%26aulast%3DTeleb%26aufirst%3DM.%26aulast%3DIbrahim%26aufirst%3DN.%2BA.%26aulast%3DAbu-Serie%26aufirst%3DM.%2BM.%26aulast%3DAbd%2BAl%2BMoaty%26aufirst%3DM.%2BN.%26atitle%3DStructure-Based%2520Design%2520and%2520Optimization%2520of%2520Pyrimidine-%2520and%25201%252C2%252C4-triazolo%255B4%252C3-A%255Dpyrimidine-Based%2520Matrix%2520Metalloproteinase-10%252F13%2520Inhibitors%2520via%2520Dimroth%2520Rearrangement%2520towards%2520Targeted%2520Polypharmacology%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D96%26spage%3D103616%26doi%3D10.1016%2Fj.bioorg.2020.103616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref226"><div class="reference"><strong class="refLabel"><a href="#ref226" class="rightTabRefNumLink">226</a></strong><div class="NLM_citation" id="rightTab-cit226"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swetha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganeshpurkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S. K.</span></span> <span> </span><span class="NLM_article-title">Multifunctional Hybrid Sulfonamides as Novel Therapeutic Agents for Alzheimer’s Disease</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">3161</span>– <span class="NLM_lpage">3178</span>, <span class="refDoi"> DOI: 10.4155/fmc-2019-0106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=10.4155%2Ffmc-2019-0106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=31838895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref226/cit226&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlygurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=3161-3178&issue=24&author=R.+Swethaauthor=D.+Kumarauthor=S.+K.+Guptaauthor=A.+Ganeshpurkarauthor=R.+Singhauthor=G.+Guttiauthor=D.+Kumarauthor=S.+Janaauthor=S.+Krishnamurthyauthor=S.+K.+Singh&title=Multifunctional+Hybrid+Sulfonamides+as+Novel+Therapeutic+Agents+for+Alzheimer%E2%80%99s+Disease&doi=10.4155%2Ffmc-2019-0106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit226R"><div class="casContent"><span class="casTitleNuber">226</span><div class="casTitle"><span class="NLM_cas:atitle">Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer's disease</span></div><div class="casAuthors">Swetha, Rayala; Kumar, Devendra; Gupta, Sukesh K.; Ganeshpurkar, Ankit; Singh, Ravi; Gutti, Gopichand; Kumar, Dileep; Jana, Srabanti; Krishnamurthy, Sairam; Singh, Sushil K.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">3161-3178</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: A breakthrough in modern medicine, in terms of treatment of Alzheimer's disease, is yet to be seen, as the scene is currently plagued with numerous clin. trial failures.  Here, we are exploring multifunctional hybrid sulfonamides for their anti-Alzheimer activity due to the complex nature of the disease.  Results & methodol.: Compd. 41 showed significant inhibition of MMP-2 (IC50: 18.24 ± 1.62 nM), AChE (IC50: 4.28 ± 0.15μM) and BuChE (IC50: 1.32 ± 0.02μM).  It also exhibited a metal-chelating property, as validated by an in vitro metal-induced Aβ aggregation assay using confocal fluorescence imaging.  Whereas, MTT and DPPH assays revealed it to be nontoxic and neuroprotective with substantial antioxidant property.  Conclusion: The present study puts forth potent yet nontoxic lead mols., which foray into the field of multitargeted agents for the treatment of Alzheimer's disease.  Graphical abstr. :.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1hLG6EnH_2bVg90H21EOLACvtfcHk0lgHzkTXu_2K6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlygurnK&md5=39172cb2b65e602d591f323fccf422b7</span></div><a href="/servlet/linkout?suffix=cit226&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2019-0106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2019-0106%26sid%3Dliteratum%253Aachs%26aulast%3DSwetha%26aufirst%3DR.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DGaneshpurkar%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DGutti%26aufirst%3DG.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DJana%26aufirst%3DS.%26aulast%3DKrishnamurthy%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DS.%2BK.%26atitle%3DMultifunctional%2520Hybrid%2520Sulfonamides%2520as%2520Novel%2520Therapeutic%2520Agents%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2019%26volume%3D11%26issue%3D24%26spage%3D3161%26epage%3D3178%26doi%3D10.4155%2Ffmc-2019-0106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RM8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RM8','PDB','1RM8'); return false;">PDB: 1RM8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SLM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1SLM','PDB','1SLM'); return false;">PDB: 1SLM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CAQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1CAQ','PDB','1CAQ'); return false;">PDB: 1CAQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UEA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UEA','PDB','1UEA'); return false;">PDB: 1UEA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GQL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GQL','PDB','4GQL'); return false;">PDB: 4GQL</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TH9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TH9','PDB','5TH9'); return false;">PDB: 5TH9</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00352&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00352%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-19%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00352" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67990ca618013cb2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
